2021擭搙 杒棦戝妛堛妛晹丒戝妛昦堾尋媶嬈愌廤(HTML斉)
乮拲丗尨杮偱屼妋擣壓偝偄乯
夝朥妛 (彫愳扨埵)
[妛弍榑暥]
110001. [尨挊] An analysis of the demographic history of the risk allele R4810K in RNF213 of moyamoya disease. Koganebuchi K1, Sato K2, Fujii K2, Kumabe T2, Haneji K, Toma T, Ishida H, Joh K, Soejima H, Mano S, Ogawa M3, Oota H3: Ann Hum Genet 2021/9; 85 (5): 166-77. (彫嬥熀壚峕1, 嵅摗岞弐2, 摗堜惔岶2, 孏晹弐岹2, 彫愳尦擵3, 懢揷攷庽3: 1戝妛堾堛椕宯尋媶壢, 2擼奜, 3夝朥)
[妛夛丒尋媶夛摍]
712001. [妛夛 (崙嵺)] (僔儞億僕僂儉) An approach to understand the phenotypic diversity of human populations using local medaka populations as a model. Katsumura T1: The 2nd AsiaEvo Conference (2021/8/18), Web奐嵜. (彑懞孾巎1: 1夝朥)
722001. [妛夛 (慡崙)] (僔儞億僕僂儉) 僐儘僫壭偵偍偗傞夝朥妛嫵堢傊偺偲傝偔傒亅杒棦戝妛堛妛晹偵偍偗傞堦椺亅. 怴堜梇懢1, 彫愳尦擵1 (1夝朥): 戞127夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛 (2022/3/29), Web奐嵜.
723001. [妛夛 (慡崙)] (堦斒島墘) ApoE KO儊僟僇偺嶌惉偲偦偺峴摦夝愅. 栘懞暥徍1, 彑懞孾巎1, 懢揷攷庽1, 彫愳尦擵1, 抾撪廏柧 (1夝朥): 擔杮恑壔妛夛戞23夞搶嫗戝夛 (2021/8/19), Web奐嵜.
723002. [妛夛 (慡崙)] (堦斒島墘) 撽暥恖暢愇傪梡偄偨儅僀僋儘僶僀僆乕儉夝愅. 惣懞椱壚, 扟栰彶桬1, 彑懞孾巎1, 彫嬥熀壚峕2, 榓媣戝夘, 孎扟恀旻, 悪杮棾懢, 懢揷攷庽1, 堜僲忋堩楴 (1夝朥, 2戝妛堾堛椕宯尋媶壢): 擔杮恑壔妛夛戞23夞搶嫗戝夛 (2021/8/19), Web奐嵜.
723003. [妛夛 (慡崙)] (堦斒島墘) 惈宱尡偺側偄僆僗儊僟僇偼弶傔偰偺惈揑僷乕僩僫乕偵懳偟偰攝嬼幰慖岲惈傪帵偡. 戝栧彨姲, 埨釼丂尗, 彑懞孾巎1, 嶁杮峗棽, 抾撪廏柧 (1夝朥): 戞40夞擔杮摦暔峴摦妛夛戝夛 (2021/9/22), Web奐嵜.
723004. [妛夛 (慡崙)] (堦斒島墘) 怷偲愳偺偮側偑傝偑堐帩偡傞傾儅僑偺惗妶巎懡條惈: 栰奜憖嶌幚尡偲僎僲儉夝愅偺梈崌傊. 忋揷傞偄, 嬥娾丂柅, 徠堜丂宒, 戨杮丂妜, 晲搰峅旻, 彑懞孾巎1, 嫶岥峃擵, 嶳嶉丂梛, 嵅摗戱嵠 (1夝朥), 戞69夞擔杮惗懺妛夛戝夛, (2022/3/17), Web奐嵜.
723005. [妛夛 (慡崙)] (堦斒島墘) 夝朥幚廗帪偵偍偗傞偛堚懱偺儂儖儉傾儖僨僸僪擹搙曄壔偲旝惗暔 (嬠椶) 偺敪惗. 嶰塝惓柧1, 怴堜梇懢1, 彑懞孾巎1, 彫愳尦擵1 (1夝朥): 戞127夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛 (2022/3/27), Web奐嵜.
723006. [妛夛 (慡崙)] (堦斒島墘) ApoE KO儊僟僇偺峴摦夝愅偲儊僟僇偺怴婏惈捛媮偵娭楢偡傞僎僲儉椞堟偺扵嶕. 栘懞暥徍1, 懢揷攷庽1, 彫愳尦擵1, 抾撪廏柧, 彑懞孾巎1 (1夝朥): 戞127夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛 (2022/3/28), Web奐嵜.
723007. [妛夛 (慡崙)] (堦斒島墘) 僒働 (Oncorhynchus keta) 偵偍偗傞儊僗壔婄杄傪敽偆惛憙栐擕摢忬鵑朎慄庮偺堦椺. 惣隊弐擵1,2, 彫夑岤摽, 愮梩梞柧, 惔悈宐巕, 挿嶁崉巙, 惔悈桬堦, 彑懞孾巎2, 彫愳尦擵2 (1宍懺宯, 2夝朥): 戞127夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛 (2022/3/28), Web奐嵜.
732001. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 儊僟僇廤抍偱僸僩廤抍偺懡條惈偺恑壔傪扵傞. 彑懞孾巎 (夝朥): 戞11夞掕椺尋媶夛: 幮夛惈偺婲尨偲恑壔 (2021/10/2), Web奐嵜.
732002. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 儊僟僇抧堟廤抍偱尒傜傟傞怴婏惈捛媮偺堘偄偲偦傟偵娭楢偡傞堚揱巕偺扵嶕. 彑懞孾巎 (夝朥): 戞3夞B03斍尋媶夛 (2021/10/30), Web奐嵜.
夝朥妛 (嶃忋扨埵)
[妛弍榑暥]
110002. [尨挊] Attenuated 兝-adrenergic response in calcium/calmodulin-dependent protein kinase IV-knockout mice. Murakami M, Murakami AM, Matsuzaki Y, Sawamura D, Ohba T, Miyoshi I, Itagaki S, Sakagami H1: PLoS One 2021/4; 16 (4): e0249932. (嶃忋梞峴1: 1夝朥)
110003. [尨挊] GluA2 overexpression in oligodendrocyte progenitors promotes postinjury oligodendrocyte regeneration. Khawaja RR, Agarwal A, Fukaya M1, Jeong HK, Gross S, Gonzalez-Fernandez E, Soboloff J, Bergles DE, Kang SH: Cell Rep 2021/5; 35 (7): 109147. (怺扟徆峅1: 1夝朥)
110004. [尨挊] Telencephalon-specific Alkbh1 conditional knockout mice display hippocampal atrophy and impaired learning. Kawarada L, Fukaya M1, Saito R, Kassai H, Sakagami H1, Aiba A: FEBS Lett 2021/6; 595 (12): 1671-80. (怺扟徆峅1, 嶃忋梞峴1: 1夝朥)
110005. [尨挊] Phospholipase D and phosphatidylinositol-4-phosphate 5-kinase 1 are involved in the regulation of oligodendrocyte morphological differentiation. Kato Y, Ochiai A, Seki Y, Morimoto T, Oizumi H, Ohbuchi K, Mizoguchi K, Yamamoto M, Sakagami H1, Miyamoto Y, Yamauchi J: Exp Cell Res 2021/8; 405 (1): 112654. (嶃忋梞峴1: 1夝朥)
110006. [尨挊] Localization of phosphatidylinositol 4-phosphate 5-kinase (PIP5K) 兛 confined to the surface of lipid droplets and adjacent narrow cytoplasm in progesterone-producing cells of in situ ovaries of adult mice. Sirisin J, Kamnate A, Polsan Y, Somintara S, Chomphoo S, Sakagami H1, Kondo H, Hipkaeo W: Acta Histochem 2021/10; 123 (7): 151794. (嶃忋梞峴1: 1夝朥)
110007. [尨挊] Cytohesin-2 mediates group I metabotropic glutamate receptor-dependent mechanical allodynia through the activation of ADP ribosylation factor 6 in the spinal cord. Ito A1, Fukaya M2, Sugawara T2, Hara Y2, Okamoto H1, Yamauchi J, Sakagami H2: Neurobiol Dis 2021/11; 159: 105466. (埳摗桜巕1, 怺扟徆峅2, 悰尨寬擵2, 尨丂朏怢2, 壀杮峗巏1, 嶃忋梞峴2: 1杻悓, 2夝朥)
110008. [尨挊] Localization of PIP5K兞 selectively in proprioceptive peripheral fields and also in sensory ganglionic satellite cells as well as neuronal cell membranes and their central terminals. Chomphoo S, Sakagami H1, Kondo H, Hipkaeo W: J Anat 2021/11; 239 (5): 1196-206. (嶃忋梞峴1: 1夝朥)
110009. [尨挊] Oligomerization of Ca2+/calmodulin-dependent protein kinase kinase. Fukumoto Y, Harada Y, Ohtsuka S, Kanayama N, Magari M, Hatano N, Sakagami H1, Tokumitsu H: Biochem Biophys Res Commun 2022/1; 587: 160-5. (嶃忋梞峴1: 1夝朥)
[妛夛丒尋媶夛摍]
723008. [妛夛 (慡崙)] (堦斒島墘) The cytohesin-2-Arf6 signaling pathway mediates group I mGluR-dependent mechanical allodynia in the mouse spinal cord. 怺扟徆峅1, 壀杮峗巏2, 嶃忋梞峴1 (1夝朥, 2杻悓): 戞44夞擔杮恄宱壢妛戝夛丒戞1夞CJK崙嵺夛媍 (2021/7/31), 恄屗 (僴僀僽儕僢僪奐嵜).
惗棟妛 (愳忋扨埵)
惗棟妛 (崅嫶扨埵)
[妛弍榑暥]
110010. [尨挊] Regulation of Rhcg, an ammonia transporter, by aldosterone in the kidney. Eguchi K, Izumi Y, Yasuoka Y1, Nakagawa T, Ono M, Maruyama K, Matsuo N, Hiramatsu A, Inoue H, Nakayama Y, Nonoguchi H2, Lee HW, Weiner ID, Kakizoe Y, Kuwabara T, Mukoyama M: J Endocrinol 2021/5; 249 (2): 95-112. (埨壀桳婭巕1, 栰乆岥攷巎2: 1惗棟, 2杒棦戝妛儊僨傿僇儖僙儞僞乕)
110011. [尨挊] Effects of Angiotensin II on Erythropoietin Production in the Kidney and Liver. Yasuoka Y1, Izumi Y, Fukuyama T2, Inoue H, Oshima T3, Shimada Y2,4, Nagaba Y2,4, Mukoyama M, Sato Y5, Sands JM, Kawahara K, Nonoguchi H2: Molecules 2021/9; 26 (17): 5399. (埨壀桳婭巕1, 暉嶳丂棽2, 戝搱桭旤3, 搰揷朏棽2,4, 挿応丂懽2,4, 嵅摗梇堦5, 栰乆岥攷巎2: 1惗棟, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3惗暔暔棟宯, 4恡憻撪, 5堛椕塹惗妛晹)
110012. [尨挊] Mechanical actions of dendritic-spine enlargement on presynaptic exocytosis. Ucar H, Watanabe S, Noguchi J, Morimoto Y, Iino Y, Yagishita S, Takahashi N1, Kasai H: Nature 2021/12; 600 (7890): 686-9. (崅嫶椣巕1: 1惗棟)
110013. [尨挊] Effects of Roxadustat on Erythropoietin Production in the Rat Body. Yasuoka Y1, Izumi Y, Fukuyama T2, Omiya H, Pham TD, Inoue H, Oshima T3, Yamazaki T2, Uematsu T2, Kobayashi N2, Shimada Y2,4, Nagaba Y2,4, Yamashita T, Mukoyama M, Sato Y5, Wall SM, Sands JM, Takahashi N1, Kawahara K, Nonoguchi H2: Molecules 2022/2; 27 (3): 1119. (埨壀桳婭巕1, 暉嶳丂棽2, 戝搱桭旤3, 嶳嶈戝夑2, 怉徏悞擵2, 彫椦寷拤2, 搰揷朏棽4, 挿応丂懽4, 嵅摗梇堦5, 崅嫶椣巕1, 栰乆岥攷巎2: 1惗棟, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3惗暔暔棟宯, 4恡憻撪, 5堛椕塹惗妛晹)
110014. [尨挊] Three live-imaging techniques for comprehensively understanding the initial trigger for insulin-responsive intracellular GLUT4 trafficking. Hatakeyama, H1. Kobayashi, K. Kanzaki, M: iScience 2022/3; 25 (4): 104164. (敥嶳桾峃1: 1惗棟)
522001. [島嵗]亂嫵堢島墘亃3. 嵶朎婡擻偺壜帇壔. 崅嫶椣巕 (惗棟): 斿擜婍奜壢 2021/6; 34 (椪帪憹姧): 666-7.
540001. [偦偺懠 (尋媶曬崘廤)] 岝僾儘乕僽傪妶梡偟偨僀儞僗儞儕儞暘斿婡峔偺夝柧. 崅嫶椣巕 (惗棟): 傾僗僥儔僗昦懺戙幱尋媶夛乽暯惉29擭搙彆惉尋媶曬崘廤乿2021/5.
540002. [偦偺懠] 亀壢妛彠椼嬥丒尋媶彆惉偺憽掓傪庴偗偰亁撪暘斿尋媶偺怴偨側抧暯傪媮傔偰. 崅嫶椣巕 (惗棟): 撪摗婰擮壢妛怳嫽嵿抍帪曬 2021/9; 108: p.51.
[挊丂彂]
620001. [妛弍彂 (暘扴幏昅)]亂悈丒揹夝幙傪壢妛偡傞 (恡偲摟愅2021擭5寧憹戝崋)亃[惗棟妛揑婎慴] 憤榑丂嵶朎奜塼偺儂儊僆僗僞僔僗偵偍偗傞恡憻偺栶妱, p.641-7. 壨尨崕夒, 埨壀桳婭巕1 (1惗棟), 搶嫗堛妛幮, 搶嫗, 2021/5敪峴.
620002. [妛弍彂 (暘扴幏昅)]亂棤偯偗丒偮側偘丒棟夝偡傞!丂昦懺惗棟偐傜傂傕偲偔悈丒揹夝幙堎忢 (娕岇媄弍2021擭10寧憹姧崋)亃戞1復 夝朥惗棟憤偞傜偄丂2. 懱塼検偲僫僩儕僂儉, p.18-21. 埨壀桳婭巕 (惗棟), 曇: 晽娫堩榊, 儊僡僇儖僼儗儞僪幮, 搶嫗, 2021/10敪峴.
620003. [妛弍彂 (暘扴幏昅)]亂棤偯偗丒偮側偘丒棟夝偡傞!丂昦懺惗棟偐傜傂傕偲偔悈丒揹夝幙堎忢 (娕岇媄弍2021擭10寧憹姧崋)亃戞2復 悈丒揹夝幙堎忢偺昦懺惗棟丂1. 懱塼検挷愡偺儊僇僯僘儉, p.35-9. 埨壀桳婭巕 (惗棟), 曇: 晽娫堩榊, 儊僡僇儖僼儗儞僪幮, 搶嫗, 2021/10敪峴.
[妛夛丒尋媶夛摍]
722002. [妛夛 (慡崙)] (僔儞億僕僂儉) Imaging analysis of granule dynamics within insulin-secreting cells. 敥嶳桾峃1, 戝搱桭旤2, 崅嫶椣巕1 (1惗棟, 2惗暔暔棟宯): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20), Web奐嵜.
722003. [妛夛 (慡崙)] (僔儞億僕僂儉) Roles of MEK/ERK signaling in pancreatic b cells under insulin resistant status. 惗搰朏巕, 埦郪尦惏, 彫椦捈庽, 抶栰堜徦, 恴朘撪峗徯, 庣杮桽堦, 揧揷岝懢榊, 懌棫丂弤, 懞扟嫥巎, 悈忋峗嵠, 崅嫶椣巕1, 怉栘峗擇榊 (1惗棟): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20), Web奐嵜.
723009. [妛夛 (慡崙)] (堦斒島墘) Presynaptic terminals can sense spine enlargement and mechanical pressure to provide stronger synaptic transmission. Ucar H, Noguchi J, Watanabe S, Morimoto Y, Yagishita S, 崅嫶椣巕1, Kasai H (1惗棟): 戞44夞擔杮恄宱壢妛戝夛丒戞1夞CJK崙嵺夛媍 (2021/7/30), 恄屗 (僴僀僽儕僢僪奐嵜).
723010. [妛夛 (慡崙)] (堦斒島墘) FilGAP偼億僪僒僀僩偵偍偄偰嵶朎亅ECM娫偺愙拝傪惂屼偡傞. 鋙愳惓帯, 惸摗峃擇, 敥嶳桾峃1, 崅嫶椣巕1, 孖尨廏崉, 懢揷埨棽 (1惗棟): 戞44夞擔杮暘巕惗暔妛夛擭夛 (2021/12/1), 墶昹.
723011. [妛夛 (慡崙)] (堦斒島墘) Single-molecule analysis for cytoskeletal dependence of intracellular insulin granule behavior. 敥嶳桾峃1, 戝搱桭旤2, 彫栰怴堦榊, 崅嫶椣巕1 (1惗棟, 2惗暔暔棟宯): 戞99夞擔杮惗棟妛夛戝夛 (2022/3/16), 愬戜 (僴僀僽儕僢僪奐嵜).
733001. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 壢尋旓怽惪偵傑偮傢傞僄僩僙僩儔. 敥嶳桾峃 (惗棟): 杒棦戝妛堛妛晹壢尋旓妉摼僼僅乕儔儉 (2021/8/4), Web奐嵜.
733002. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僀儞僗儕儞暘斿梓棻偺嵶朎撪嫇摦偺壜帇壔寁應. 敥嶳桾峃1, 戝搱桭旤2, 崅嫶椣巕1 (1惗棟, 2惗暔暔棟宯): 戞251夞惗棟妛搶嫗択榖夛 (2021/10/16), Web奐嵜.
733003. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 杮堢惉僾儘僌儔儉偱摼偨偙偲偲彨棃揥朷. 敥嶳桾峃 (惗棟): 師悽戙尋媶幰僔儞億僕僂儉2021 (2021/10/27), Web奐嵜.
733004. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嵶朎撪堦暘巕寁應偵婎偯偔惗棟婡擻偺棟夝傪栚巜偟偰. 敥嶳桾峃 (惗棟): 師悽戙尋媶幰僔儞億僕僂儉2021 (2021/10/27), Web奐嵜.
惗壔妛 (嶄扨埵)
[妛弍榑暥]
110015. [尨挊] Highly accurate and precise quantification strategy using stable isotope dimethyl labeling coupled with GeLC-MS/MS. Konno R, Matsui T, Ito H, Kawashima, Y Itakura M1, Kodera Y: Biochem Biophys Res Commun 2021/4; 550: 37-42. (斅憅丂惤1: 1惗壔)
110016. [尨挊] LC-MS peak assignment based on unanimous selection by six machine learning algorithms. Ito H, Matsui T, Konno R, Itakura M1, Kodera Y: Sci Rep 2021/12; 11 (1): 23411. (斅憅丂惤1: 1惗壔)
110017. [尨挊] D1 Receptor Mediated Dopaminergic Neurotransmission Facilitates Remote Memory of Contextual Fear Conditioning. Saito N, Itakura M1, Sasaoka T: Front Behav Neurosci 2022/2; 16: 751053. (斅憅丂惤1: 1惗壔)
[妛夛丒尋媶夛摍]
723012. [妛夛 (慡崙)] (堦斒島墘) MYCN憹暆宆恄宱夎庮嵶朎偑帵偡僠儈僕儖巁崌惉峺慺慾奞嵻傊偺崅姶庴惈偲偦偺儊僇僯僘儉. 惔惉怣堦1, 嶄丂棽堦1, 栧徏寬帯 (1惗壔): 戞80夞擔杮娻妛夛妛弍憤夛 (2021/10/2), 墶昹 (僴僀僽儕僢僪奐嵜).
惗壔妛 (漭戙扨埵)
[妛夛丒尋媶夛摍]
723013. [妛夛 (慡崙)] (堦斒島墘) 働僞儈儞偺擼撪戙幱嶻暔偵傛傞峈偆偮嶌梡婡峔. 揤栰巎柅1, 壀揷戝彆1,2, 漭戙尋擇1,2 (1戝妛堾堛椕宯尋媶壢, 2惗壔): 戞94夞擔杮惗壔妛夛戝夛 (2021/11/3-5), Web奐嵜.
723014. [妛夛 (慡崙)] (堦斒島墘) 儕儞僋僗堚揱巕曄堎偵傛傞堚揱惈幘姵偺敪徢婡峔偺夝柧. 婱揷戝抭1, 娵旜抦旻1,2, 悰扟捗婱巕2, 漭戙尋擇1,2 (1戝妛堾堛椕宯尋媶壢, 2惗壔): 戞94夞擔杮惗壔妛夛戝夛 (2021/11/3-5), Web奐嵜.
723015. [妛夛 (慡崙)] (堦斒島墘) PSD-95寢崌暘巕儅僊儞偼嫽暠惈僔僫僾僗偵嬊嵼偡傞. 崅嫶弶揟庨1, 娵旜抦旻1,2, 悰扟捗婱巕2, 漭戙尋擇1,2 (1戝妛堾堛椕宯尋媶壢, 2惗壔): 戞94夞擔杮惗壔妛夛戝夛 (2021/11/3-5), Web奐嵜.
723016. [妛夛 (慡崙)] (堦斒島墘) 儅僂僗偺擼偵偍偗傞傾僼傽僨傿儞偺僗僾儔僀僔儞僌僶儕傾儞僩偺嬊嵼. 慜嶁岝婸1, 娵旜抦旻1,2, 悰扟捗婱巕2, 漭戙尋擇1,2 (1戝妛堾堛椕宯尋媶壢, 2惗壔): 戞94夞擔杮惗壔妛夛戝夛 (2021/11/3-5), Web奐嵜.
暘巕堚揱妛
[妛弍榑暥]
110018. [尨挊] Dynamic Spatiotemporal Expression Changes in Connexins of the Developing Primate's Cochlea. Hosoya M, Fujioka M1, Murayama AY, Ogawa K, Okano H, Ozawa H: Genes (Basel) 2021/7; 12 (7): 1082. (摗壀惓恖1: 1暘巕堚揱)
110019. [尨挊] Three cases of otitis media caused by Mycobacterium abscessus subsp. abscessus: Importance of medical treatment and efficacy of surgery. Nishiyama Y, Nishiyama T, Kanzaki S, Oishi N, Fujioka M1, Yamada H, Ebisuno C, Kaiho M, Uwamino Y, Fukano H, Hoshino Y, Hasegawa N, Ogawa K: J Infect Chemother 2021/8; 27 (8): 1251-7. (摗壀惓恖1: 1暘巕堚揱)
110020. [尨挊] Investigation of the hearing levels of siblings affected by a single GJB2 variant: Possibility of genetic modifiers. Hosoya M, Fujioka M1, Nara K, Morimoto N, Masuda S, Sugiuchi T, Katsunuma S, Takagi A, Morita N,?Ogawa K, Kaga K, Matsunaga T: Int J Pediatr Otorhinolaryngol 2021/10; 149: 110840. (摗壀惓恖1: 1暘巕堚揱)
110021. [尨挊] Neuronal development in the cochlea of a nonhuman primate model, the common marmoset. Hosoya M, Fujioka M1, Murayama AY, Ozawa H, Okano H, Ogawa K. Dev Neurobiol 2021/11; 81 (8): 905-38. (摗壀惓恖1: 1暘巕堚揱)
110022. [尨挊] Multicenter phase III trial of regenerative treatment for chronic tympanic membrane perforation. Kanemaru S, Kanai R, Omori K, Yamamoto N, Okano T, Kishimoto I, Ogawa K, Kanzaki S, Fujioka M1, Oishi N, Naito Y, Kakehata S, Nakamura H, Yamada S, Omae K, Kawamoto A, Fukushima M: Auris Nasus Larynx 2021/12; 48 (6): 1054-60. (摗壀惓恖1: 11暘巕堚揱)
110023. [尨挊] Analysis of conductive olfactory dysfunction using computational fluid dynamics. Asama Y, Furutani A, Fujioka M1, Ozawa H, Takei S, Shibata S, Ogawa K: PLoS One 2022/1; 17 (1): e0262579. (摗壀惓恖1: 1暘巕堚揱)
110024. [尨挊] Transcanal endoscopic ear surgery for management of ossicular malformation: clinical outcomes of 17 cases. Yoshida A, Hosoya M, Kanzaki S, Fujioka M1, Ozawa H: Acta Otolaryngol 2022/2; 142 (2): 154-60. (摗壀惓恖1: 1暘巕堚揱)
110025. [尨挊] Otic Organoids Containing Spiral Ganglion Neuron-like Cells Derived from Human-induced Pluripotent Stem Cells as a Model of Drug-induced Neuropathy. Kurihara S, Fujioka M1, Hirabayashi M, Yoshida T, Hosoya M, Nagase M, Kato F, Ogawa K, Okano H, Kojima H, Okano HJ:丂Stem Cells Transl Med 2022/3; 11 (3): 282-96. (摗壀惓恖1: 1暘巕堚揱)
120001. [尨挊] 奜帹摴娻徢椺22帹偺専摙. 楅栘惉彯, 戝愇捈庽, 彫郪岹擵, 恄嶈丂徎, 摗壀惓恖1, 惣嶳悞宱, 栰岥丂彑, 嵶扟丂惤, 娭悈恀棟巕, 嵵摗丂恀, 彫愳丂堣 (1暘巕堚揱): 擔杮帹旲堲岮壢妛夛夛曬 2021/3;124(3):197-204.
310001. [徢椺曬崘] Complete Removal of Stage II Congenital Cholesteatoma Destroying Temporomandibular Joints Using Transcanal Endoscopic Ear Surgery With a Mirror Technique: A Case Report. Ogawa S, Hosoya M, Fujioka M1, Ogawa K: J Int Adv Otol 2022/1; 18 (1): 88-91. (摗壀惓恖1: 1暘巕堚揱)
310002. [徢椺曬崘] A Case Report of a Middle Ear Mass Originated From Cartilage-like Tissue Treated With Transcanal Endoscopic Ear Surgery. Suda S, Kitamura M, Kawaida M, Fujioka M1, Ozawa H:丂Ear Nose Throat J 2021/12: 1455613211065510. (摗壀惓恖1: 1暘巕堚揱)
520001. [憤愢] iPS嵶朎憂栻偺幚嵺: Pendred徢岓孮偵懳偡傞僔儘儕儉僗彮検椕朄. 摗壀惓恖1, 嵶扟丂惤 (1暘巕堚揱): 擔杮帹旲堲岮壢摢栩晹奜壢妛夛夛曬2021/10; 124 (10): 1331-40.
522002. [島嵗]亂帹柭丒擄挳傊偺岠壥揑傾僾儘乕僠亃姶壒擄挳帯椕偺嬤枹棃. 摗壀惓恖1, 嶳栰绯媊惏, 嵶扟丂惤 (1暘巕堚揱): ENTONI 2021/5; 258: 63-8.
522003. [島嵗]亂僩儔儞僗儗乕僔儑僫儖埾堳夛婇夋丂僥乕儅: Pendred徢岓孮偺帯椕亃偁偨傜偟偄憂栻偺偐偨偪嶌傝: 幘姵摦暔儌僨儖傪梡偄側偄旕椪彴POC尋媶 (iPS嵶朎憂栻). 摗壀惓恖1, 惣嶳寢旤, 廐嶳戶屓 (1暘巕堚揱): Otology Japan 2021/12; 31 (4): 425-34.
522004. [島嵗]亂BIOLOGY TOPICS亃彫宆楈挿椶僐儌儞儅乕儌僙僢僩傪梡偄偨挳妎尋媶. 孖尨丂徛, 壀栰僕僃僀儉僗梞彯, 摗壀惓恖1 (1暘巕堚揱): BIO Clinica 2022/2;37 (2): 207-9.
[妛夛丒尋媶夛摍]
712002. [妛夛 (崙嵺)] (僔儞億僕僂儉) DRUG DISCOVERY AND DEVELOPMENT FOR THE HEARING LOSS USING PATIENT-DERIVED IPSCS: A PHASE I/IIA CLINICAL TRIAL FOR PENDRED SYNDROME/DFNB4. Fujioka M1: The 7th East Asian Symposium on Otology (EASO 2022) (2022/3/24-26), Tokyo Japan (僴僀僽儕僢僪奐嵜). (摗壀惓恖1: 1暘巕堚揱)
713001. [妛夛 (崙嵺)] (堦斒島墘) Beyond the borders: Current status and challenges of the hiPSC-based medicine for inner ear disorders. Fujioka M1: Korean Otologic Society Annual Meeting (2021/4/3), Web奐嵜. (摗壀惓恖1: 1暘巕堚揱)
713002. [妛夛 (崙嵺)] (堦斒島墘) DRUG DISCOVERY AND DEVELOPMENT FOR THE HEARING LOSS USING PATIENT-DERIVED IPSCS: A PHASE I/IIA CLINICAL TRIAL FOR PENDRED SYNDROME/DFNB4. Fujioka M1: ISSCR/JSRM 2021 Tokyo International Symposium (2021/10/27-29), 搶嫗 (僴僀僽儕僢僪奐嵜). (摗壀惓恖1: 1暘巕堚揱)
713003. [妛夛 (崙嵺)] (堦斒島墘) Induced marginal cells of inner ear from human iPS cells as the disease models for hearing loss. Saegusa C1, Ozawa H, Okano H, Fujioka M1: ISSCR/JSRM 2021 Tokyo International Symposium (2021/10/27-29), 搶嫗 (僴僀僽儕僢僪奐嵜). (嶰巬抭崄1, 摗壀惓恖1: 1暘巕堚揱)
722004. [妛夛 (慡崙)] (儈僯僔儞億僕僂儉) 姶妎忋旂偲撪儕儞僷鵑偺柶塽妛揑僋儘僗僩乕僋: T嵶朎埶懚惈姶妎忋旂摿堎揑帺屓柶塽惈擄挳僩儔儞僗僕僃僯僢僋儅僂僗偑帵偡偙偲. 摗壀惓恖1, 悈懌朚梇, 嶰巬抭崄1, 恄嶈丂徎 (1暘巕堚揱): 戞1夞擔杮帹旲堲岮壢柶塽傾儗儖僊乕姶愼徢妛夛憤夛丒妛弍島墘夛 (2021/6/30-7/2), 嬥戲.
722005. [妛夛 (慡崙)] (妛弍僙儈僫乕) 撪帇嬀壓帹壢庤弍偵偍偗傞揹摦幃崪庤弍婍夿 (挻壒攇崪嶍奐庤弍婡婍) 偺巊梡宱尡. 摗壀惓恖 (暘巕堚揱): 戞122夞擔杮帹旲堲岮壢妛夛憤夛丒妛弍島墘夛 (2021/5/12-15), 嫗搒 (僴僀僽儕僢僪奐嵜).
722006. [妛夛 (慡崙)] (僔儞億僕僂儉) 帹壢妛偵偍偗傞儀儞僠儍乕婇嬈偺摦岦: 擔杮弶偺帹壢娭楢儀儞僠儍乕婇嬈乽姅幃夛幮僆僩儕儞僋 (Otolink Inc.)乿. 彫愳丂堣, 怴揷惔堦, 摗壀惓恖1, 嵶扟丂惤, 徏嶈嵅塰巕 (1暘巕堚揱): 戞31夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2021/10/13-16), 搶嫗 (僴僀僽儕僢僪奐嵜).
722007. [妛夛 (慡崙)] (僔儞億僕僂儉)亂婎慴偲椪彴偺壦偗嫶亃iPS嵶朎憂栻偺幚嵺: Pendred徢岓孮偺昦懺夝愅偲僔儘儕儉僗彮検椕朄偺憂弌. 摗壀惓恖1 (1暘巕堚揱): 戞64夞擔杮峛忬態妛夛妛弍廤夛 (2021/11/18-20), 搶嫗 (僴僀僽儕僢僪奐嵜).
722008. [妛夛 (慡崙)] (僔儞億僕僂儉) 撪帹忈奞偵懳偡傞iPS嵶朎憂栻: Pendred徢岓孮偵懳偡傞僔儘儕儉僗椕朄偺戞I/II憡堛巘庡摫帯尡 (PENDLRA帋尡). 摗壀惓恖 (暘巕堚揱): 戞21夞擔杮嵞惗堛椕妛夛憤夛 (2022/3/17-19), Web奐嵜.
723017. [妛夛 (慡崙)] (堦斒島墘) 宑滀媊弇戝妛椪彴堚揱妛僙儞僞乕擄挳堚揱奜棃偺摦岦亅擄挳偵偍偗傞椪彴堚揱妛偺孾敪偲怴婯堛椕傊偺揥朷亅. 嶳栰绯媊惏, 摗壀惓恖1, 媑昹孿桽, 嵶扟丂惤, 彫愳丂堣, 徏塱払梇 (1暘巕堚揱): 戞122夞擔杮帹旲堲岮壢妛夛憤夛丒妛弍島墘夛 (2021/5/12-15), 嫗搒 (僴僀僽儕僢僪奐嵜).
723018. [妛夛 (慡崙)] (堦斒島墘) 僇僟僶乕傪梡偄偨帹壢庤弍嫵堢僙儈僫乕偵偮偄偰. 榓嵅栰峗堦榊, 戝愇捈庽, 摗壀惓恖1, 撿廋巌榊, 暯夑椙旻, 惣嶳悞宱, 峳栘峃抭, 彫愳丂堣 (1暘巕堚揱): 戞122夞擔杮帹旲堲岮壢妛夛憤夛丒妛弍島墘夛 (2021/5/12-15), 嫗搒 (僴僀僽儕僢僪奐嵜).
723019. [妛夛 (慡崙)] (堦斒島墘) 摉壢偵偍偗傞ZAOSONiC傪梡偄偨帹壢庤弍偺宱尡. 恵揷屽巎, 杒懞丂廩, 挿扟晹壞婓, 搒抸怢壚, 嵶扟丂惤, 戝愇捈庽, 彫愳丂堣, 摗壀惓恖1, 恄嶈丂徎 (1暘巕堚揱): 戞122夞擔杮帹旲堲岮壢妛夛憤夛丒妛弍島墘夛 (2021/5/12-15), 嫗搒 (僴僀僽儕僢僪奐嵜).
723020. [妛夛 (慡崙)] (堦斒島墘) 屻柪楬朄偵傛傞挳恄宱庮釃庤弍偵傛傝挳椡壏懚偟摼偨徢椺偺挳椡梊屻偺専摙. 嵶扟丂惤, 戝愇捈庽, 搒抸怢壚, 杒懞丂廩, 挿扟晹壞婓, 摗壀惓恖1, 恄嶈丂徎, 彫愳丂堣 (1暘巕堚揱): 戞122夞擔杮帹旲堲岮壢妛夛憤夛丒妛弍島墘夛 (2021/5/12-15), 嫗搒 (僴僀僽儕僢僪奐嵜).
723021. [妛夛 (慡崙)] (堦斒島墘) bFGF傪梡偄偨屰枌慂岴暵嵔弍偺帯椕惉愌偵娭偡傞専摙. 恄嶈丂徎, 摗壀惓恖1, 戝愇捈庽, 彫愳丂堣 (1暘巕堚揱): 戞122夞擔杮帹旲堲岮壢妛夛憤夛丒妛弍島墘夛 (2021/5/12-15), 嫗搒 (僴僀僽儕僢僪奐嵜).
723022. [妛夛 (慡崙)] (堦斒島墘) 傔傑偄傪悘敽偡傞枛徑惈婄柺恄宱杻醿傪掓偟懡敪惈峝壔徢偑媈傢傟偨1椺. 媑揷桳嵒, 搒抸怢壚, 恄嶈丂徎, 摗壀惓恖1, 戝愇捈庽, 彫愳丂堣 (1暘巕堚揱): 戞83夞帹旲堲岮壢椪彴妛夛憤夛丒妛弍島墘夛 (2021/6/26-27), 嶥杫 (僴僀僽儕僢僪奐嵜).
723023. [妛夛 (慡崙)] (堦斒島墘) 傾僷僞僀僩恖岺帹彫崪傪梡偄偨帹峝壔徢庤弍偺弍屻挿婜惉愌. 嶳栰绯媊惏, 摗壀惓恖1, 恄嶈丂徎, 戝愇捈庽, 搒抸怢壚, 彫愳丂堣 (1暘巕堚揱): 戞83夞帹旲堲岮壢椪彴妛夛憤夛丒妛弍島墘夛 (2021/6/26-27), 嶥杫 (僴僀僽儕僢僪奐嵜).
723024. [妛夛 (慡崙)] (堦斒島墘) 摉壢偵偍偗傞Bell杻醿, Hunt徢岓孮偵懳偡傞婄柺恄宱尭壸弍偺帯椕惉愌. 恵揷屽巎, 搒抸怢壚, 摗壀惓恖1, 恄嶈丂徎, 戝愇捈庽, 彫郪岹擵 (1暘巕堚揱): 戞31夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2021/10/13-16), 搶嫗 (僴僀僽儕僢僪奐嵜).
723025. [妛夛 (慡崙)] (堦斒島墘) 弍慜僗働乕儖傾僂僩偐傜挊柧偵弍屻挳椡夞暅傪擣傔偨挳恄宱庮釃庤弍椺. 嶅丂桰桟, 嵶扟丂惤, 戝愇捈庽, 惣嶳悞宱, 搒抸怢壚, 庒椦丂婤, 撿丂棽擇, 摗壀惓恖1, 恄嶈丂徎, 彫郪岹擵 (1暘巕堚揱): 戞31夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2021/10/13-16), 搶嫗 (僴僀僽儕僢僪奐嵜).
723026. [妛夛 (慡崙)] (堦斒島墘) 屒敪惈挳恄宱庮釃偺堚揱巕僾儘僼傽僀儖偵婎偯偄偨椪彴揑摿挜偵娭偡傞専摙. 庒椦丂婤, 榓嵅栰峗堦榊, 戝愇捈庽, 嵶扟丂惤, 搒抸怢壚, 杒懞丂廩, 挿扟晹壞婓, 撿丂棽擇, 惣嶳悞宱, 摗壀惓恖1, 彫郪岹擵 (1暘巕堚揱): 戞31夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2021/10/13-16), 搶嫗 (僴僀僽儕僢僪奐嵜).
723027. [妛夛 (慡崙)] (堦斒島墘) 僸僩懡擻惈姴嵶朎偐傜偺寣娗忦曈墢嵶朎暘壔桿摫宯偺専摙. 嶰巬抭崄1, 嵶扟丂惤, 摗壀惓恖1, 彫郪岹擵 (1暘巕堚揱): 戞31夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2021/10/13-16), 搶嫗 (僴僀僽儕僢僪奐嵜).
723028. [妛夛 (慡崙)] (堦斒島墘) 堦懁惈奜帹摴暵嵔徢椺偵懳偟擃崪揱摫曗挳婍憰梡偑嶨壒壓挳庢偵梌偊傞塭嬁. 惣嶳悞宱, 戝愇捈庽, 怴揷惔堦, 楅栘戝夘, 摗壀惓恖1, 嵶扟丂惤, 搒抸怢壚, 庒椦丂婤, 撿丂棽擇 (1暘巕堚揱): 戞66夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2021/10/20-22), 搶嫗.
723029. [妛夛 (慡崙)] (堦斒島墘) 弮壒挳椡専嵏偱偺3000Hz應掕偺堄媊. 撿丂棽擇, 戝愇捈庽, 杧丂柧旤, 湯揷偐偍傝, 摗壀惓恖1, 惣嶳悞宱, 嵶扟丂惤, 搒抸怢壚, 庒椦丂婤 (1暘巕堚揱): 戞66夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2021/10/20-22), 搶嫗.
723030. [妛夛 (慡崙)] (堦斒島墘) 僐儌儞儅乕儌僙僢僩偺擄挳儌僨儖偵偍偗傞擼Voxel Based Analysis偍傛傃峴摦夝愅. 暯椦尮婓, 孖尨丂徛, 栰晲岾巕, 椡晲惞寧, 摗壀惓恖1, 嶳杮丂桾, 彫搰攷屓 (1暘巕堚揱): 戞66夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2021/10/20-22), 搶嫗.
723031. [妛夛 (慡崙)] (堦斒島墘) 摉壢偵偍偗傞鍡揹恾専嵏偺岺晇. 杧丂柧旤, 嵶扟丂惤, 戝愇捈庽, 嶳栰绯媊惏, 摗壀惓恖1, 湯揷偐偍傝, 惣嶳悞宱, 搒抸怢壚, 庒椦丂婤, 撿丂棽擇 (1暘巕堚揱): 戞66夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2021/10/20-22), 搶嫗.
723032. [妛夛 (慡崙)] (堦斒島墘)堦夁惈偵FT3崅抣傪掓偟偨Pendred徢岓孮偺堦椺. 崅嫶棙撧, 孖尨丂孧, 彫椦嵅婭巕, 媨壓榓婫, 墶揷寬堦, 悪揷奊棦撨, 擔旲丂塴, 摗壀惓恖1, 埳摗丂桾 (1暘巕堚揱)丗戞94夞擔杮撪暘斿妛夛妛弍憤夛 ( 2021/4/22-24), Web奐嵜.
723033. [妛夛 (慡崙)] (堦斒島墘) 摉堾偺擄挳堚揱奜棃偵偍偗傞婎慴丒椪彴堦懱宆尋媶. 摗壀惓恖1, 嶳栰绯媊惏, 媑昹孿桽, 嵶扟丂惤, 嶰巬抭崄1, 彫郪岹擵, 彫嶈寬師榊, 徏塱払梇 (1暘巕堚揱): 擔杮恖椶堚揱妛夛戞66夞戝夛/戞28夞擔杮堚揱巕恌椕妛夛戝夛崌摨奐嵜 (2021/10/13-16), 墶昹 (僴僀僽儕僢僪奐嵜).
732003. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 杮婥偱乽椪彴傪曄偊傞僩儔儞僗儗乕僔儑儞乿傪栚巜偡恖偑怱妡偗傞傋偒婎慴尋媶偺億僀儞僩. 摗壀惓恖 (暘巕堚揱): 戞1夞帹僆儞儔僀儞尋媶夛 (2021/4/1), Web奐嵜.
733005. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 掅梡検僔儘儕儉僗椕朄偵偍偗傞桳奞帠徾: Pendred徢岓孮/DFNB4傪懳徾偵. 嶳栰绯媊惏, 摗壀惓恖1, 惣嶳寢旤 (1暘巕堚揱): 戞2夞僔儘儕儉僗怴嶌梡尋媶夛 (JASMIN尋媶夛) (2021/10/23), 搶嫗 (僴僀僽儕僢僪奐嵜).
733006. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Pendred徢岓孮/DFNB4偵懳偡傞丆僆乕僩僼傽僕乕懀恑傪嶌梡婡彉偲偟偨僔儘儕儉僗彮検椕朄偺扨巤愝擇廳栍専暲峴孮娫斾妑戞I/IIa憡堛巘庡摫帯尡 (PENDLRA帋尡). 摗壀惓恖1, 嵶扟丂惤, 嶳栰绯媊惏 (1暘巕堚揱): 戞2夞僔儘儕儉僗怴嶌梡尋媶夛 (JASMIN尋媶夛) (2021/10/23), 搶嫗 (僴僀僽儕僢僪奐嵜).
'20擭搙埲慜暘
[妛弍榑暥]
'20-110001. [尨挊] Deficiency of large tumor suppressor kinase 1 causes congenital hearing loss associated with cochlear abnormalities in mice. Nishiyama T, Fujioka M1, Saegusa C1, Oishi N, Harada T, Hosoya M, Saya H, Ogawa K: Biochem Biophys Res Commun 2021/1; 534: 921-6. (摗壀惓恖1, 嶰巬抭崄1: 1暘巕堚揱)
'20-110002. [尨挊] The common marmoset as suitable nonhuman alternative for the analysis of primate cochlear development. Hosoya M, Fujioka M1, Murayama AY, Okano H, Ogawa K: FEBS J 2021/1; 288 (1): 325-53. (摗壀惓恖1: 1暘巕堚揱乯
'20-110003. [尨挊] Hydroxyapatite Prostheses in Endoscopic Transcanal Stapes Surgery for Otosclerosis Cases. Hosoya M, Fujioka M1, Ogawa K: Ear Nose Throat J 2021/2: 145561321989143. (摗壀惓恖1: 1暘巕堚揱)
栻棟妛
[妛弍榑暥]
110026. [尨挊] Roles of Thromboxane Receptor Signaling in Enhancement of Lipopolysaccharide-Induced Lymphangiogenesis and Lymphatic Drainage Function in Diaphragm. Matsuda H1, Ito Y2, Hosono K2, Tsuru S1, Inoue T3, Nakamoto S4, Kurashige C1, Hirashima M, Narumiya S, Okamoto H1, Majima M2: Arterioscler Thromb Vasc Biol 2021/4; 41 (4): 1390-407. (徏揷峅旤1, 埳摗媊栫2, 嵶栰壛撧巕2, 捗棷悽棦1, 堜忋抭恗3, 拞杮廋巌4, 錟廳愮奊1, 壀杮峗巏1, 攏搱惓棽2: 1杻悓, 2栻棟, 3徚壔婍撪, 4堦斒丒彫帣丒娞抇鋁奜)
110027. [尨挊] Macrophages contribute to liver repair after monocrotaline-induced liver injury via SDF-1/CXCR4. Otaka F1, Ito Y2, Nakamoto S3, Nishizawa N3, Hyodo, T4, Hosono K2, Majima M2, Koizumi W1, Amano H2: Exp Ther Med 2021/7; 22 (1): 668. (戝崅巎惞1, 埳摗媊栫2, 拞杮廋巌3, 惣郪怢嫳3, 暫摗揙栫4, 嵶栰壛撧巕2, 攏搱惓棽2, 彫愹榓嶰榊1, 揤栰塸庽2: 1徚壔婍撪, 2栻棟, 3堦斒丒彫帣丒娞抇鋁奜, 4戝妛堾堛椕宯尋媶壢)
110028. [尨挊] Recovery of Liver Sinusoidal Endothelial Cells Following Monocrotaline-induced Liver Injury. Otaka F1, Ito Y2, Goto T3, Kojo K4, Tanabe M3, Hosono K2, Majima M2, Koizumi W1, Amano H2: In Vivo 2021/9-10; 35 (5): 2577-87. (戝崅巎惞1, 埳摗媊栫2, 屻摗戩栫3, 屆忛丂寷4, 揷绯旤撧3, 嵶栰壛撧巕2, 攏搱惓棽2, 彫愹榓嶰榊1, 揤栰塸庽2: 1徚壔婍撪, 2栻棟, 3戝妛堾堛椕宯尋媶壢, 4壓晹徚壔娗奜)
110029. [尨挊] Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization. Goto T1, Ito Y2, Satoh M3, Nakamoto S4, Nishizawa N4, Hosono K2, Naitoh T5, Eshima K3, Iwabuchi K3, Hiki N6, Amano H2: Front Immunol 2021/10; 12: 754106. (屻摗戩栫1, 埳摗媊栫2, 嵅摗丂夒3, 拞杮廋巌4, 惣郪怢嫳4, 嵶栰壛撧巕2, 撪摗丂崉5, 峕搰峩擇3, 娾熀榓栫3, 斾婇捈庽6, 揤栰塸庽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3柶塽, 4堦斒丒彫帣丒娞抇鋁奜, 5壓晹徚壔娗奜, 6忋晹徚壔娗奜)
110030. [尨挊] The role of thromboxane prostanoid receptor signaling in gastric ulcer healing. Yamane S1, Amano H2, Ito Y2, Betto T1, Matsui Y3, Koizumi W1, Narumiya S, Majima M2: .Int J Exp Pathol 2022/2; 103 (1): 4-12. (嶳崻憗婭巕1, 揤栰塸庽2, 埳摗媊栫2, 暿醕朁峀1, 徏堜孾晇3, 彫愹榓嶰榊1, 攏搱惓棽2: 1徚壔婍撪, 2栻棟, 3屇媧婍奜)
510001. [憤愢] VEGFR1-tyrosine kinase signaling in pulmonary fibrosis. Amano H1, Matsui Y2, Hatanaka K1, Hosono K1, Ito Y1: Inflamm Regen 2021/6; 41 (1): 16. (揤栰塸庽1, 徏堜孾晇2, 敤拞丂岞1, 嵶栰壛撧巕1, 埳摗媊栫1: 1栻棟, 2屇媧婍奜)
520002. [憤愢] 娞儅僋儘僼傽乕僕偺懡條惈. 埳摗媊栫 (栻棟): 杒棦堛妛 2021/12; 51 (2): 73-81.
[妛夛丒尋媶夛摍]
723034. [妛夛 (慡崙)] (堦斒島墘) 娞嫊寣嵞燇棳忈奞屻偺娞廋暅偵偍偗傞iNKT嵶朎偺栶妱. 屻摗戩栫1, 埳摗媊栫2, 嵅摗丂夒3, 拞杮廋巌4, 嵶栰壛撧巕2, 敤拞丂岞2, 攏搱惓棽2, 揤栰塸庽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3柶塽, 4堦斒丒彫帣丒娞抇鋁奜): 戞42夞擔杮墛徢膼秷銑w夛 (2021/7/7), Web奐嵜.
723035. [妛夛 (慡崙)] (堦斒島墘) 擏夎慻怐宍惉偵偍偗傞mPGES-1/PGE2 axis偺婡彉偺夝愅. 暫摢揙栫, 揤栰塸庽1, 埳摗媊栫1, 嵶栰壛撧巕1, 敤拞丂岞1, 峕搰峩擇2, 椦丂丂愹, 怉徏丂抭, 怰椙惷抝, 晲揷丂孾3, 攏搱惓棽1 (1栻棟, 2柶塽, 3宍惉丒旤奜): 戞42夞擔杮墛徢膼秷銑w夛 (2021/7/7), Web奐嵜.
723036. [妛夛 (慡崙)] (堦斒島墘) 2師惈儕儞僷晜庮偵偍偗傞撪場惈僩儘儞儃僉僒儞偺栶妱. 嵶栰壛撧巕1, 旤搰棙徍2, 埳摗媊栫1, 敤拞丂岞1, 媨抧丂娪2, 攏搱惓棽1, 惉媨丂廃, 揤栰塸庽1 (1栻棟, 2怱憻寣娗奜): 戞42夞擔杮墛徢膼秷銑w夛 (2021/7/7), Web奐嵜.
723037. [妛夛 (慡崙)] (堦斒島墘) 妶惈壔NKT嵶朎偼儅僋儘僼傽乕僕嬌惈曄姺傪壛懍偝偣偰娞廋暅傪懀恑偡傞 (Activated iNKT cells promote liver repair by acceleration of macrophage polarization). 埳摗媊栫1, 屻摗戩栫2, 嵅摗丂夒3, 嶳壓丂撝2, 挿揷恀桼巕4, 揷绯旤撧2, 敤拞丂岞1, 嵶栰壛撧巕1, 揤栰塸庽1 (1栻棟, 2戝妛堾堛椕宯尋媶壢, 3柶塽, 4媬柦): 戞95夞擔杮栻棟妛夛擭夛 (2022/3/8), 暉壀 (僴僀僽儕僢僪奐嵜).
723038. [妛夛 (慡崙)] (堦斒島墘) 擏夎慻怐宍惉傪懀恑偡傞mPGES-1/PGE2宱楬偺儊僇僯僘儉偲惂屼惈T嵶朎偲偺娭楢惈偺夝愅 (Analysis of microsomal Prostaglandin E syntase-1 (mPGEs-1)/PGE2 axis mechanism and relationship between regulatory T cells (Tregs) in promoting granulation formation). 暫摢揙栫, 揤栰塸庽1, 埳摗媊栫1, 嵶栰壛撧巕1, 敤拞丂岞1, 峕搰峩擇2, 椦丂丂愹, 怉徏丂抭, 怰椙惷抝, 晲揷丂孾3, 攏搱惓棽1 (1栻棟, 2柶塽, 3宍惉丒旤奜): 戞95夞擔杮栻棟妛夛擭夛 (2022/3/8), 暉壀 (僴僀僽儕僢僪奐嵜).
723039. [妛夛 (慡崙)] (堦斒島墘) mPGES-1/PGE2/EP4宱楬偼嫊寣夵慞傪懀恑偡傞 (The microsomal prostaglandin E synthase-1/PGE2 /EP4 axis induces blood flow recovery via recruitment of regulatory T cells). 揤栰塸庽1, 峕搰峩擇2, 埳摗媊栫1, 嵶栰壛撧巕1, 敤拞丂岞1, 惉媨丂廃, 怰椙惷梇, 攏搱惓棽1 (1栻棟, 2柶塽): 戞95夞擔杮栻棟妛夛擭夛 (2022/3/8), 暉壀 (僴僀僽儕僢僪奐嵜).
723040. [妛夛 (慡崙)] (堦斒島墘) 僩儘儞儃僉僒儞A2庴梕懱僔僌僫儖偼, 儕儞僷娗怴惗傪惂屼偟懕敪惈儕儞僷晜庮傪夵慞偡傞 (Thromboxane A 2 receptor signaling improves secondary lymphedema and promotes lymphangiogenesis). 嵶栰壛撧巕1, 旤搰棙徍2, 埳摗媊栫1, 敤拞丂岞1, 媨抧丂娪2, 攏搱惓棽1, 惉媨丂廃, 揤栰塸庽1 (1栻棟, 2怱憻寣娗奜): 戞95夞擔杮栻棟妛夛擭夛 (2022/3/9), 暉壀 (僴僀僽儕僢僪奐嵜).
733007. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擏夎慻怐宍惉偵偍偗傞mPGES-1/PGE2 axis偺栶妱偺専摙. 暫摢揙栫, 揤栰塸庽1, 埳摗媊栫1, 嵶栰壛撧巕1, 敤拞丂岞1, 峕搰峩擇2, 椦丂丂愹, 怉徏丂抭, 怰椙惷抝, 晲揷丂孾3, 攏搱惓棽1 (1栻棟, 2柶塽, 3宍惉丒旤奜): 戞144夞擔杮栻棟妛夛娭搶晹夛 (2021/6/5), Web奐嵜.
733008. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 惂屼惈T嵶朎偺mPGES-1/PGE2 axis偵傛傞擏夎慻怐宍惉偺栶妱. 暫摢揙栫, 揤栰塸庽1, 埳摗媊栫1, 嵶栰壛撧巕1, 敤拞丂岞1, 峕搰峩擇2, 椦丂丂愹, 怉徏丂抭, 怰椙惷抝, 晲揷丂孾3, 攏搱惓棽1 (1栻棟, 2柶塽, 3宍惉丒旤奜): 戞145夞擔杮栻棟妛夛娭搶晹夛 (2021/10/9), Web奐嵜.
733009. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 2師惈儕儞僷晜庮偵偍偗傞儕儞僷娗怴惗傪惂屼偡傞僩儘儞儃僉僒儞A2庴梕懱僔僌僫儖偺栶妱. 嵶栰壛撧巕1, 旤搰棙徍2, 埳摗媊栫1, 敤拞丂岞1, 媨抧丂娪2, 攏搱惓棽1, 惉媨丂廃, 揤栰塸庽1 (1栻棟, 2怱憻寣娗奜): 戞145夞擔杮栻棟妛夛娭搶晹夛 (2021/10/9), Web奐嵜.
733010. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Role of IFN-兞 produced by iNKT cells in liver repair after hepatic ischemiareperfusion injury in mice. 屻摗戩栫1, 埳摗媊栫2, 嵅摗丂夒3, 拞杮廋巌4, 嵶栰壛撧巕2, 敤拞丂岞2, 揤栰塸庽2, 攏搱惓棽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3柶塽, 4堦斒丒彫帣丒娞抇鋁奜): 戞145夞擔杮栻棟妛夛娭搶晹夛 (2021/10/9), Web奐嵜.
733011. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) RAMP1僔僌僫儖偺帀朾娞撪墛徢梷惂岠壥. 埳摗媊栫1, 嵶栰壛撧巕1, 屻摗戩栫2, 揷绮旤撧2, 嶳壓丂撝2, 挿揷恀桼巕3, 敤拞丂岞1, 攏搱惓棽1, 揤栰塸庽1 (1栻棟, 2戝妛堾堛椕宯尋媶壢, 3媬柦): 戞145夞擔杮栻棟妛夛娭搶晹夛 (2021/10/9), Web奐嵜.
旝惗暔妛
[妛弍榑暥]
110031. [尨挊] Efficacy and safety of 0.0584% hydrocortisone aceponate topical spray and systemic oclacitinib combination therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled trial. Takahashi J, Kanda S, IImanishi I1, Hisano T, Fukamachi T, Taguchi N, Momiyama S, Nishiyama S, Motegi T, Iyori K: Vet Dermatol 2021/4; 32 (2): 119-e25. (崱惣巗楴1: 1旝惗暔)
110032. [尨挊] Influence of hospital size on antimicrobial resistance and advantages of restricting antimicrobial use based on cumulative antibiograms in dogs with Staphylococcus pseudintermedius infections in Japan. Iyori K, Shishikura T, Shimoike K, Minoshima K, Imanishi I1, Toyoda Y: Vet Dermatol 2021/5; 32 (6): 668-e178. (崱惣巗楴1: 1旝惗暔)
110033. [尨挊] Anaphylaxis after rabies vaccination for dogs in Japan. Yoshida M, Mizukami K, Hisasue M, Imanishi I1, Kurata K, Ochiai M, Itoh M, Nasukawa T, Uchiyama J, Tsujimoto H, Sakaguchi M: J Vet Med Sci 2021/8; 83 (8): 1202-5. (崱惣巗楴1: 1旝惗暔)
110034. [尨挊] IgE reactivity to milk components in dogs with cutaneous adverse food reactions. Shimakura H, Nasukawa T, Uchiyama J, Sugimoto R, Imanishi I1, Oota S, Mizukami K, Fujimura M, Sakaguchi M: J Vet Med Sci 2021/10; 83 (10): 1509-12. (崱惣巗楴1: 1旝惗暔)
310003. [徢椺曬崘] Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome. Gotoh K, Sakaguchi Y1, Kato H, Osaki H, Jodai Y, Wakuda M, Take A1, Hayashi S1, Morita E, Sugie T, Ito Y, Ohmiya N: Anaerobe 2022/2; 73: 102502. (嶃岥媊旻1, 晲丂丂峎1, 椦丂弐帯1: 1旝惗暔)
510002. [憤愢] Epithelial-immune crosstalk with the skin microbiota in homeostasis and atopic dermatitis - a mini review. Kobayashi T, Imanishi I1: Vet Dermatol 2021/12; 32 (6): 533-e147. (崱惣巗楴1: 1旝惗暔)
520003. [憤愢] 2020擭屻敿偍傛傃2021擭偵彸擣偝傟偨Helicobacter懏偺怴嬠庬偺徯夘亅曬崘榑暥傛傝亅. 椦丂弐帯 (旝惗暔): Helicobacter Research 2022/1; 26 (1): 116-9.
521001. [夝愢] 椪彴堛偵抦偭偰傎偟偄昞嵼惈擽旂徢. 崱惣巗楴 (旝惗暔): 廱堛椪彴旂晢壢 2021/4; 27 (1): 44569.
522005. [島嵗] 怘偺埨慡丒埨怱壢妛亅怘昳惢憿尰応丒怘昳偵偐偐傢傞旝惗暔墭愼偲偦偺懳嶔亅[5] 怘昳惢憿尰応偵偍偗傞夎朎宍惉嵶嬠. 嶃岥媊旻 (旝惗暔): 擔杮杊嬠杊陘妛夛帍 2021/5; 49 (5): 223-8.
540003. [偦偺懠 (尋媶曬崘彂)]亂壢妛尋媶旓曗彆嬥丒庒庤尋媶乽僶僋僥儕僆僼傽乕僕梟嬠峺慺傪梡偄偨僨傿僼傿僔儖嬠嵶朎暻偺峔憿夝愅偲偦偺墳梡 (尋媶婜娫: 2020擭搙乣2021擭搙)乿亃尋媶戙昞幰: 晲丂丂峎1 (1旝惗暔):乽僶僋僥儕僆僼傽乕僕梟嬠峺慺傪梡偄偨僨傿僼傿僔儖嬠嵶朎暻偺峔憿夝愅偲偦偺墳梡乿2020擭搙幚巤忬嫷曬崘彂 2021/5; https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-20K16250/20K162502020hokoku/.
540004. [偦偺懠 (尋媶曬崘彂)]亂壢妛尋媶旓曗彆嬥丒婎斦尋媶 (C)乽僨傿僼傿僔儖嬠僶僋僥儕僆僼傽乕僕偺廻庡擣幆婡峔偺夝柧媦傃帯椕偲梊杊傊偺墳梡 (尋媶婜娫: 2019擭搙乣2021擭搙)乿亃尋媶戙昞幰: 嶃岥媊旻1, 尋媶暘扴幰: 壛摗偼傞, 戝媨捈栘, 撪嶳弤暯, 屻摗榓媊, 枀旜廩晀, 椦丂弐帯1 (1旝惗暔):乽僨傿僼傿僔儖嬠僶僋僥儕僆僼傽乕僕偺廻庡擣幆婡峔偺夝柧媦傃帯椕偲梊杊傊偺墳梡乿2020擭搙幚巤忬嫷曬崘彂 2021/5; https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-19K07560/19K075602020hokoku/.
540005. [偦偺懠 (尋媶曬崘彂)]亂壢妛尋媶旓曗彆嬥丒婎斦尋媶 (C)乽僼傽乕僕撪嵼壔偵傛傞僺儘儕嬠偺帩懕姶愼婡峔偺専徹 (尋媶婜娫: 2018擭搙乣2020擭搙)乿亃尋媶戙昞幰: 撪嶳弤暯, 尋媶暘扴幰: 徏嶈栁揥, 椦丂弐帯1, 嶃岥媊旻1, 嶰幒恗旤 (1旝惗暔)乽僼傽乕僕撪嵼壔偵傛傞僺儘儕嬠偺帩懕姶愼婡峔偺専徹乿2020擭搙幚愌曬崘彂 2021/5; https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-18K07127/18K071272020jisseki/.
540006. [偦偺懠 (尋媶曬崘彂)]亂壢妛尋媶旓曗彆嬥丒婎斦尋媶 (C)乽僼傽乕僕撪嵼壔偵傛傞僺儘儕嬠偺帩懕姶愼婡峔偺専徹 (尋媶婜娫: 2018擭搙乣2020擭搙)乿亃尋媶戙昞幰: 撪嶳弤暯, 尋媶暘扴幰: 徏嶈栁揥, 椦丂弐帯1, 嶃岥媊旻1, 嶰幒恗旤 (1旝惗暔):乽僼傽乕僕撪嵼壔偵傛傞僺儘儕嬠偺帩懕姶愼婡峔偺専徹乿2018擭搙乣2020擭搙尋媶惉壥曬崘彂 2021/5; https://kaken.nii.ac.jp/ja/file/KAKENHI-PROJECT-18K07127/18K07127seika.pdf.
540007. [偦偺懠 (尋媶曬崘彂)]亂岞塿嵿抍朄恖 崟廧堛妛尋媶怴嫽嵿抍丒2019擭搙 (戞27夞) 尋媶彆惉嬥乽僶僋僥儕僆僼傽乕僕偺旜晹媧拝暘巕傪棙梡偟偨僨傿僼傿僔儖嬠姅偺怴婯恦懍専弌朄偺奐敪 (尋媶婜娫: 2019擭10寧乣2020擭9寧)乿亃尋媶戙昞幰: 嶃岥媊旻1, 嫤椡尋媶幰: 壛摗偼傞, 枀旜廩晀, 屻摗榓媊, 撪嶳弤暯, 晲丂丂峎1, 嶃岥惌惔 (1旝惗暔):乽僶僋僥儕僆僼傽乕僕偺旜晹媧拝暘巕傪棙梡偟偨僨傿僼傿僔儖嬠姅偺怴婯恦懍専弌朄偺奐敪乿2019擭搙曬崘彂 2021/6.
540008. [偦偺懠 (尋媶曬崘廤)]亂傗偢傗怘偲寬峃尋媶強丒2019擭搙尋媶彆惉尋媶乽怘暔偑傕偨傜偡寬峃偲偺娭楢亅桳梡惈曻慄嬠偺挵撪偵偍偗傞栶妱亅(尋媶婜娫: 2019擭11寧乣2021擭11寧)乿亃尋媶戙昞幰: 晲丂丂峎1, 巜摫幰: 嶃岥媊旻1, 嫟摨尋媶幰: 壛摗偼傞, 椦丂弐帯1 (1旝惗暔):乽怘暔偑傕偨傜偡寬峃偲偺娭楢亅桳梡惈曻慄嬠偺挵撪偵偍偗傞栶妱亅乿2019擭搙尋媶惉壥曬崘彂 2022/1.
[妛夛丒尋媶夛摍]
722009. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) The panel of antibiotic-resistant strains of Helicobacter pylori. 椦丂弐帯1, Yokota K, Osaki T, Yokota S, Takeuchi H, Rimbara E (1旝惗暔): 戞27夞擔杮僿儕僐僶僋僞乕妛夛妛弍廤夛 (2021/9/25), Web奐嵜.
722010. [妛夛 (慡崙)] (僔儞億僕僂儉) C宆偲D宆儃僣儕僰僗撆慺傪巟攝偡傞僶僋僥儕僆僼傽乕僕偺梟尨壔婡峔偺夝愅. 嶃岥媊旻1, 晲丂丂峎1, 屻摗榓媊, 嶳杮桼栱巕, 岾揷抦巕, 岦杮夒堣, 彫嶈弐巌, 椦丂弐帯1, 椦丂揘栫, 彫孎湪擇 (1旝惗暔): 戞95夞擔杮嵶嬠妛夛憤夛 (2022/3/29), Web奐嵜.
723041. [妛夛 (慡崙)] (堦斒島墘) 擽醥怾偺帺慠敪徢摦暔儌僨儖 (僀僰昞嵼惈擽旂徢) 偵懳偡傞僼傽乕僕桼棃峺慺僄儞僪儔僀僔儞偺専摙. 崱惣巗楴1, 惣摗岞巌, 挬斾撧椙懢, 椦丂弐帯1, 捗媣堜棙峀, 撪嶳弤暯 (1旝惗暔): 95夞擔杮姶愼徢妛夛妛弍島墘夛乛戞69夞擔杮壔妛椕朄妛夛憤夛崌摨妛夛 (2021/5/7), 墶昹 (僴僀僽儕僢僪奐嵜).
723042. [妛夛 (慡崙)] (堦斒島墘) 崻栰嵷偐傜偺曻慄嬠偺暘棧偲偦偺挵撪娐嫬惗懚擻偺昡壙. 晲丂丂峎1, 嶃岥媊旻1, 堫嫶桟婲, 屻摗榓媊, 椦丂弐帯1, 壛摗偼傞, 戝媨捈栘 (1旝惗暔): 戞35夞擔杮曻慄嬠妛夛戝夛 (2021/9/18), Web奐嵜.
723043. [妛夛 (慡崙)] (堦斒島墘) 娕岇巘偑巊梡偡傞懍姡惈嶤幃庤巜徚撆栻傪擖傟傞実懷梡億乕僠偺嵶嬠墭愼偲娗棟忬嫷偺専摙. 埳摗摴巕, 擇媨丂埄, 愇堜榓巕, 恀揷杻旤, 搰揷柧宐, 戝栰揟巕, 嬥嶳撝岹, 椦丂弐帯1 (1旝惗暔): 戞36夞擔杮娐嫬姶愼妛夛憤夛丒妛弍廤夛 (2021/9/20), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723044. [妛夛 (慡崙)] (堦斒島墘) 偣傫栂傪敽偆嵞敪惈Clostridioides difficile姶愼徢偵懳偡傞暢曋旝惗暔堏怉椕朄乣嵞敪梊杊岠壥傪帵偟偨徢椺偺挵撪旝惗暔憄媦傃偦偺戙幱嶻暔偺夝愅乣. 嶃岥媊旻1, 屻摗榓媊, 晲丂丂峎1, 旜嶉敼恖, 忛戙峃婱, 榓媣揷岝婤, 椦丂弐帯1, 壛摗偼傞, 戝媨捈栘 (1旝惗暔): 擔杮栻妛夛戞142擭夛 (2022/3/25), Web奐嵜.
723045. [妛夛 (慡崙)] (堦斒島墘) 怘暔偍傛傃僸僩暢曋偐傜暘棧偟偨曻慄嬠偺恖岺徚壔塼偱偺惗巆惈. 晲丂丂峎1, 嶃岥媊旻1, 堫嫶桟婲, 屻摗榓媊, 椦丂弐帯1, 壛摗偼傞, 戝媨捈栘 (1旝惗暔): 戞95夞擔杮嵶嬠妛夛憤夛 (2022/3/29), Web奐嵜.
731001. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 僸僩偲僀僰偵偍偗傞傾儗儖僊乕偺嫇摦偺堘偄乣僽僪僂媴嬠偺夁忚憹怋乣. 崱惣巗楴 (旝惗暔): 戞20夞柶塽傾儗儖僊乕Terakoya曌嫮夛 (2021/6/25), Web奐嵜.
732004. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 嵞敪惈僋儘僗僩儕僕僂儉丒僨傿僼傿僔儖姶愼徢偵懳偡傞怴慛曋丒僶儞僋僪僫乕搥寢曋偵傛傞岲婥揑暢曋堏怉. 戝媨捈栘, 嶃岥媊旻1, 壛摗偼傞 (1旝惗暔): 擔杮徚壔婍昦妛夛搶奀巟晹戞135夞椺夛 (2021/12/11), 柤屆壆 (僴僀僽儕僢僪奐嵜).
婑惗拵妛丒擬懷堛妛
[妛弍榑暥]
110035. [尨挊] Venestatin from parasitic helminths interferes with receptor for advanced glycation end products (RAGE)-mediated immune responses to promote larval migration. Tsubokawa D1, Kikuchi T, Lee JM, Kusakabe T, Yamamoto Y, Maruyama H: PLoS Pathog 2021/6; 17 (6): e1009649. (捸愳戝屽1: 1婑惗拵丒擬懷堛妛)
110036. [尨挊] Mitochondria as a Potential Target for the Development of Prophylactic and Therapeutic Drugs against Schistosoma mansoni Infection. Talaam K, Inaoka DK, Hatta T1, Tsubokawa D1, Tsuji N1, Wada M, Saimoto H, Kita K, Hamano S: Antimicrob Agents Chemother 2021/9; 65 (10): e0041821. (敧揷妜巑1, 捸愳戝屽1, 捯丂彯棙1: 1婑惗拵丒擬懷堛妛)
510003. [憤愢] The antiviral immunity of ticks against transmitted viral pathogens. Talactac MR, Hernandez EP, Hatta T1, Yoshii K, Kusakisako K, Tsuji N1, TanakaT: Dev Comp Immunol 2021/6; 119: 104012. (敧揷妜巑1, 捯丂彯棙1: 1婑惗拵丒擬懷堛妛)
520004. [憤愢]亂嵟愭抂堛椕偺崱亃徚壔娗婑惗寰拵偑桳偡傞僇儖僔僂儉寢崌僞儞僷僋幙偺峈墛徢婡擻. 捸愳戝屽 (婑惗拵丒擬懷堛妛): Medical Science Digest 2022/3; 48 (3): 36-8.
[妛夛丒尋媶夛摍]
723046. [妛夛 (慡崙)] (堦斒島墘) 婑惗寰拵S100條暘巕偺廔枛摐壔嶻暔庴梕懱 (RAGE) 傪夘偡傞墛徢墳摎傊偺嶌梡. 捸愳戝屽1, 嵅摗丂夒2 (1婑惗拵丒擬懷堛妛, 2柶塽): 戞44夞擔杮暘巕惗暔妛夛擭夛 (2021/12/1), 墶昹.
昦棟妛 (懞塤扨埵)
[妛弍榑暥]
110037. [尨挊] Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer. Ichinoe M1, Mikami T, Yanagisawa N, Yoshida T1,2, Hana K, Endou H, Okayasu I1, Sengoku N, Ogata H, Saegusa M1, Shibuya K, Murakumo Y1: J Clin Pathol 2021/9; 74 (9): 589-95. (堦屗徆柧1, 媑揷丂岟1,2, 壀埨丂孧1, 嶰巬丂怣1, 懞塤朏庽1: 1昦棟, 2怴悽婭堛椕丒墶抐揑堛椕)
110038. [尨挊] CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer. Adachi K1, Sakurai Y2, Ichinoe M2, Tadehara M1, Tamaki A1, Kesen Y2, Kato T2, Mii S, Enomoto A, Takahashi M, Koizumi W3, Murakumo Y2: Virchows Arch 2022/4; 480 (4): 819-29. doi: 10.1007/s00428-021-03230-2. Epub 2021 Nov 11. (埨払丂夣1, 烴堜桋崅2, 堦屗徆柧2, 澍尨彨椙1, 嬍抲柧姲1, 焼愬桾棞崄2, 壛摗戶嵠2, 彫愹榓嶰榊3, 懞塤朏庽2: 1戝妛堾堛椕宯尋媶壢, 2昦棟, 3徚壔婍撪)
110039. [尨挊] Upregulation of REV7 correlates with progression of malignant melanoma. Hoshino A1, Nakayama C1, Jiang SX1, Sakurai Y1, Kato T1, Numata Y2, Umezawa A2, Ichinoe M1, Murakumo Y1: Pathol Int 2022/1; 72 (1): 14-24. (惎栰徍朏1, 拞嶳 抦壚1, 徲丂悽埉1, 烴堜桋崅1, 壛摗戶嵠1, 徖揷夑巕2, 攡戲撝巕2, 堦屗徆柧1, 懞塤朏庽1: 1昦棟, 2宍懺宯)
110040. [尨挊] Clinicopathological Significance of BRCAness in Resectable Pancreatic Ductal Adenocarcinoma and Its Association With Anticancer Drug Sensitivity in Pancreatic Cancer Cells. Tadehara M1, Kato T2, Adachi K1, Tamaki A1, Kesen Y2, Sakurai Y2, Ichinoe M2, Koizumi W3, Murakumo Y2: Pancreas 2022/2; 51 (2): 183-9. (澍尨彨椙1, 壛摗戶嵠2, 埨払丂夣1, 嬍抲柧姲1, 焼愬桾棞崄2, 烴堜桋崅2, 堦屗徆柧2, 彫愹榓嶰榊3, 懞塤朏庽2: 1戝妛堾堛椕宯尋媶壢, 2昦棟, 3徚壔婍撪)
[妛夛丒尋媶夛摍]
723047. [妛夛 (慡崙)] (堦斒島墘) 鋁懱晹偵敪惗偟偨Pancreatic hamartoma偺1椺. 焼愬桾棞崄1, 懞塤朏庽1, 堦屗徆柧1 (1昦棟): 戞110夞擔杮昦棟妛夛憤夛 (2021/4/22), 搶嫗 (僴僀僽儕僢僪奐嵜).
723048. [妛夛 (慡崙)] (堦斒島墘) 鋁憻娻偵偍偗傞CD109敪尰偺椪彴揑, 嵶朎惗暔妛揑堄媊偺夝愅. 埨払丂夣1, 烴堜桋崅2, 壛摗戶嵠2, 堦屗徆柧2, 懞塤朏庽2 (1戝妛堾堛椕宯尋媶壢, 2昦棟): 戞80夞擔杮娻妛夛妛弍憤夛 (2021/9/30), 墶昹 (僴僀僽儕僢僪奐嵜).
723049. [妛夛 (慡崙)] (堦斒島墘) 鋁娻偵偍偗傞BRCAness偺椪彴昦棟妛揑摿惈偍傛傃鋁娻嵶朎姅偵偍偗傞峈娻嵻姶庴惈. 澍尨彨椙1, 壛摗戶嵠2, 埨払丂夣1, 烴堜桋崅2, 堦屗徆柧2, 懞塤朏庽2 (1戝妛堾堛椕宯尋媶壢, 2昦棟): 戞80夞擔杮娻妛夛妛弍憤夛 (2021/9/30), 墶昹 (僴僀僽儕僢僪奐嵜).
'20擭搙埲慜暘
[妛弍榑暥]
'20-110004. [尨挊] Increased expression of REV7 in small cell lung carcinomas and its association with tumor cell survival and proliferation. Sanoyama I1, Sakurai Y1, Ichinoe M1, Hoshino A1, Kesen Y1, Kato T1, Numata Y2, Umezawa A2, Jiang SX1, Murakumo Y1: Pathol Int 2021/1; 71 (1): 15-23. (崃嶳丂摓1, 烴堜桋崅1, 堦屗徆柧1, 惎栰徍朏1, 焼愬桾棞崄1, 壛摗戶嵠1, 徖揷夑巕2, 攡戲撝巕2, 徲丂悽埉1, 懞塤朏庽1: 1昦棟, 2宍懺宯)
[妛夛丒尋媶夛摍]
'20-723001. [妛夛 (慡崙)] (堦斒島墘) 彫嵶朎攛娻偵偍偗傞REV7敪尰偺堄媊偺夝愅. 崃嶳丂摓1, 懞塤朏庽1, 堦屗徆柧1, 攡戲撝巕2 (1昦棟, 2宍懺宯): 戞109夞擔杮昦棟妛夛憤夛 (2020/7/1-31), Web奐嵜.
昦棟妛 (嶰巬扨埵)
[妛弍榑暥]
110041. [尨挊] Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of Ovarian High-Grade Serous Carcinoma. Matsumoto T1, Oda Y, Hasegawa Y, Hashimura M2, Oguri Y2, Inoue H1, Yokoi A3, Tochimoto M3, Nakagawa M, Jiang Z, Saegusa M1: Am J Pathol 2021/10; 191 (10): 1837-50. (徏杮弐塸1, 嫶懞旤婭2, 彫孖峃巕2, 堜忋媣巕1, 墶堜垽崄3, 撊杮徆岶3, 嶰巬丂怣1: 1昦棟, 2宍懺宯, 3戝妛堾堛椕宯尋媶壢)
110042. [尨挊] Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer. Jaiswal A, Murakami K, Elia A, Shibahara Y1, Done SJ, Wood SA, Donato NJ, Ohashi PS, Michael Reedijk M: Proc Natl Acad Sci U S A 2021/9; 118 (38): e2101592118. (幠尨桾婭巕1: 1昦棟)
110043. [尨挊] Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma. Goto M, Shibahara Y1, Baciu C, Allison F, Yeung JC, Darling GE, Liu M: Ann Surg Oncol 2021/9; 28 (9): 4943-51. (幠尨桾婭巕1: 1昦棟)
110044. [尨挊] Cytoplasmic EBP50 and elevated PARP1 are unfavorable prognostic factors in ovarian clear cell carcinoma. Matsumoto T1, Yoki A2, Konno R, Oguri Y3, Hashimura M3, Tochimoto M2, Nakagawa M, Jiang Z, Ishibashi Y, Ito T, Kodera Y, Saegusa M1: Carcinogenesis 2021/10; 42 (9): 1162-70. (徏杮弐塸1, 墶堜垽崄2, 彫孖峃巕3, 嫶懞旤婭3, 撊杮徆岶2, 嶰巬丂怣1: 1昦棟, 2戝妛堾堛椕宯尋媶壢, 3宍懺宯)
110045. [尨挊] Intestinal Stem Cell Marker ASCL2 is a Novel Prognostic Predictor in Esophageal Adenocarcinoma. Shibahara Y1, Espin-Garcia O, Conner J, Weiss J, Derouet M, Allen J, Allison F, Kalimuthu S, Yeung JC, Darling GE: Cureus 2022/1; 14 (1): e21021. (幠尨桾婭巕1: 1昦棟)
[妛夛丒尋媶夛摍]
722011. [妛夛 (慡崙)] (僔儞億僕僂儉) 師悽戙偺嵶朎専嵏巑偺嫵堢偲摥偒曽: 杒棦戝妛偵偍偗傞師悽戙偺嵶朎専嵏巑嫵堢. 惣懞桼崄棦1, 垻晹捈栫1, 嶳嶉峢巎2, 嶳壓榓栫3, 崅嫶攷擵1, 嶰巬丂怣4, 嵅摗擵弐5, 屆揷楁巕1 (1堛椕塹惗妛晹, 2戝妛堾堛椕宯尋媶壢, 3昦棟晹, 4昦棟, 5屇媧婍奜): 戞62夞擔杮椪彴嵶朎妛夛憤夛弔婜戝夛 (2021/6/5), 愮梩 (僴僀僽儕僢僪奐嵜).
723050. [妛夛 (慡崙)] (堦斒島墘) 棏憙娻偺怴婯梊屻場巕偺摨掕, 婡擻夝愅, 偦偟偰椪彴墳梡偵娭偡傞尋媶. 墶堜垽崄1, 徏杮弐塸2, 嫶懞旤婭3, 彫孖峃巕3, 搉曈丂崑, 挿扟愳壝懃, 嶰巬丂怣1 (1昦棟, 2堛椕塹惎妛晹, 3宍懺宯): 戞110夞擔杮昦棟妛夛憤夛 (2021/4/22), 墶昹 (僴僀僽儕僢僪奐嵜).
723051. [妛夛 (慡崙)] (堦斒島墘) 銹夎庮偵偍偗傞S100A4/儈僆僔儞9 axis偺婡擻夝愅. 愇捤寢婌1, 將帞丂墌2, 徏杮弐塸3, 嶰巬丂怣4 (1戝妛堾堛椕宯尋媶壢, 2擼奜, 3堛椕塹惗妛晹, 4昦棟): 戞110夞擔杮昦棟妛夛憤夛 (2021/4/22), 墶昹 (僴僀僽儕僢僪奐嵜).
723052. [妛夛 (慡崙)] (堦斒島墘) 棏憙柧嵶朎娻偵偍偄偰EBP50/PARP-1 axis偼峈娻嵻懴惈擻妉摼偵婑梌偡傞. 徏杮弐塸1, 墶堜垽崄2, 嵁栰丂椇, 彫帥媊抝, 嶰巬丂怣2 (1堛椕塹惗妛晹, 2昦棟): 戞110夞擔杮昦棟妛夛憤夛 (2021/4/23), 墶昹 (僴僀僽儕僢僪奐嵜).
723053. [妛夛 (慡崙)] (堦斒島墘) 巕媨撪枌娻偺EBP50/兝-僇僥僯儞/PTEN宯偵傛傞morule暘壔桿摫婡峔. 撿杻棦撧1, 墶堜垽崄2, 嫶懞旤婭3, 撊杮徆棽2, 拞愳錆桽2, 怣懢徍巕2, 嶰巬丂怣2 (1戝妛堾堛椕宯尋媶壢, 2昦棟, 3宍懺宯): 戞110夞擔杮昦棟妛夛憤夛 (2021/4/24), 墶昹 (僴僀僽儕僢僪奐嵜).
723054. [妛夛 (慡崙)] (堦斒島墘) 攛滸暯忋旂娻偺捈愙揾枙偲塼忬壔専懱嵶朎恌昗杮偱偺OG岲愼滸暯忋旂娻嵶朎悢偺嵎堎. 嶳鴵峢巎1, 徏旜桼婭巕2, 嶳壓榓栫3, 惣懞桼崄棦4, 垻晹捈栫4, 媑揷丂岟5, 嶰巬丂怣5, 嵅摗擵弐6, 屆揷楁巕4 (1戝妛堾堛椕宯尋媶壢, 2昦懺丒恌椕宯, 3昦棟晹, 4堛椕塹惗妛晹, 5昦棟, 6屇媧婍奜): 戞60夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2021/11/21), 暷巕.
塹惗妛
[妛弍榑暥]
110046. [尨挊] Influence of the position of the palatal bar on brain activity during speech. Kataoka K, Tamaki K, Ono Y, Hoshi K1, Ikuta R, Fujiwara M: Ann Jpn Prosthodont Soc 2021/4; 13 (2): 135-45. (惎丂壚朏1: 1塹惗)
110047. [尨挊] The progress of medication-related osteonecrosis of the jaw with conservative initial treatment: A 12-year retrospective study of 129 patients. Kaibuchi N, Hoshi K1, Yamazaki A, Miyamoto-Sangu N, Akagi Y, Okamoto T: Bone Rep 2021/4; 14: 101072. (惎丂壚朏1: 1塹惗)
110048. [尨挊] National Data Analysis and Systematic Review for Human Resources for Cervical Cancer Screening in Japan. Hamashima C, Sasaki S, Hosono S, Hoshi K1, Katayama T, Terasawa T: Asian Pac J Cancer Prev 2021/6; 22 (6): 1695-702. (惎丂壚朏1: 1塹惗)
110049. [尨挊] Modified Creatinine Index and Clinical Outcomes of Hemodialysis Patients: An Indicator of Sarcopenia? Yamamoto S, Matsuzawa R, Hoshi K1, Suzuki Y, Harada M, Watanabe T, Isobe Y, Imamura K, Osada S, Yoshida A, Kamiya K2, Matsunaga A2: J Ren Nutr 2021/7; 31 (4): 370-9. (惎丂壚朏1, 恄扟寬懢榊2, 徏塱撃旻2: 1塹惗, 2堛椕塹惗妛晹)
110050. [尨挊] Increased Prevalence of Atopic Dermatitis in Children Aged 0-3 Years Highly Exposed to Parabens. Arafune J, Tsujiguchi H, Hara A, Shimizu Y, Hori D, Nguyen TTT, Suzuki F, Hamagishi T, Yamada Y, Nakamura H, Yoshikawa T, Hayashi K, Shibata A, Fukutomi Y, Ohya Y, Yamamoto-Hanada K, Muto G1, Hirota R, Konoshita T, Kambayashi Y, Nakamura H: Int J Environ Res Public Health 2021/11; 18 (21):11657. (晲摗丂崉1: 1塹惗)
110051. [尨挊] Overview of Legal Measures for Managing Workplace COVID-19 Infection Risk in Several Asia-Pacific Countries. Derek M, Tsai FJ, Kim J, Tejamaya M, Putri V, Muto G1, Reginald A, Phanprasit W, Granadillos N, Bt Zainal Farid M, Capule CQ, Lin YW, Park J, Chen RY, Lee KH, Park J, Hashimoto H, Yoon C, Padungtod C, Park DU: Saf Health Work 2021/12; 12 (4): 530-5. (晲摗丂崉1: 1塹惗)
110052. [尨挊] A case control study of occupation and cardiovascular disease risk in Japanese men and women. Fukai K, Furuya Y, Nakazawa S, Kojimahara N, Hoshi K1, Toyota A, Tatemichi M: Sci Rep 2021/12; 11 (1): 23983. (惎丂壚朏1: 1塹惗)
110053. [尨挊] Depressive and anxiety symptoms among Japanese cancer survivors: Japan cancer survivorship research project. Endo M, Matsui K, Akaho R, Mitsui K, Yan Y, Imai Y, Ueda Y, Muto G1, Deshpande GA, Terao Y, Takeda S, Saito M, Hayashi K, Nishimura K, Tanigawa T: BMC Cancer 2022/2; 22 (1): 134. (晲摗丂崉1: 1塹惗)
110054. [尨挊] Occupational physical activity differentially affects the risk for developing later-onset Crohn's disease and ulcerative colitis among middle-aged and older populations. Furuya Y, Fukai K, Nakazawa S, Kojimahara N, Hoshi K1, Toyota A, Tatemichi M: Scand J Gastroenterol 2022/2; 57 (2): 206-13. (惎丂壚朏1: 1塹惗)
110055. [尨挊] Mortality risk in older Japanese people based on self-reported dyslipidemia treatment and socioeconomic status: The JAGES cohort study. Katsuyama Y, Kondo K, Kojima M, Kamiji K, Ide K, Iizuka G, Muto G1, Uehara T, Noda K, Ikusaka M: Prev Med Rep 2022/3; 27: 101779. (晲摗丂崉1: 1塹惗)
110056. [尨挊] 2-mercaptobenzothiazole generates 兞-H2AX via CYP2E1-dependent production of reactive oxygen species in urothelial cells. Qi Y1, Toyooka T, Horiguchi H2, Koda S, Wang RS: J Biochem Mol Toxicol 2022/6; 36 (6): e23043. doi: 10.1002/jbt.23043. Epub 2022 Mar 13. (Yonggang Qi1, 杧岥暫崉2: 1戝妛堾堛椕宯尋媶壢, 2塹惗)
120002. [尨挊] 尦惪亅壓惪峔憿 (惪晧丒嬈柋埾戸) 偵婲場偡傞戞3師嶻嬈偺楯摥埨慡塹惗偺壽戣偲夝寛傊岦偗偨揥朷亅IT偍傛傃堛椕嬈偵偍偗傞幚懺挷嵏. 晲摗丂崉1, 彫搱寬堦, 嶳嶈桭忎, 墦摗尮庽, 愇堜棟撧, 暉揷丂梞, 戝怷桼婭1, 墶嶳榓恗 (1塹惗): 嶻嬈堛妛僕儍乕僫儖 2021/5; 44 (3): 90-7.
220001. [弨尨挊] 寬恌屻庴椕峴摦梊應儌僨儖偺奐敪亅寬恌丒儗僙僾僩價僢僌僨乕僞偵AI 傪揔梡偡傞帋傒亅. 晲摗丂崉1, 曅壀椚巕, 戝栴傔偖傒, 屻摗丂壏, 暉揷丂梞, 墦摗尮庽, 墶嶳榓恗 (1塹惗): 嶻嬈堛妛僕儍乕僫儖 2021/7; 44 (4): 64-8.
522006. [島嵗]亂楢嵹: 怑堟偱怴宆僐儘僫僂僀儖僗偵岦偒崌偆匢亃怑堟幒撪嬻娫偺怴宆僐儘僫僂僀儖僗姶愼徢僋儔僗僞乕慾巭傪栚揑偲偟偨3枾掕検壔偲壜帇壔偺帋傒亅幒撪CO2擹搙傪悇掕偡傞姺婥僔儈儏儗乕僞乕偺峔抸偲幚徹亅. 陰摗岹擵, 晲摗丂崉1, 壴棦恀摴, 嫶杮惏抝 (1塹惗): 嶻嬈堛妛僕儍乕僫儖 2021/5; 44 (3): 35-41.
522007. [島嵗]亂摿廤: 偑傫姵幰偺廇楯宲懕乣With-cancer, Post-cancer乣亃嶻嬈堛偲偟偰偳偆娭傢傞偐: 庡帯堛偲偺楢実偵岦偗偨怑応偯偔傝. 晲摗丂崉 (塹惗): 寧姧曐抍楢 2021/6; 1347: 29-35.
522008. [島嵗]亂楢嵹: <寬峃> 戞1夞 偳偆恑傔傞?椉棫巟墖亃椉棫巟墖傪摥偔恖偺寬峃婋婡娗棟偲偟偰懆偊, 幚慔偡傞崙撪奜偺摦岦. 晲摗丂崉 (塹惗): 埨慡偲寬峃 2022/1; (1寧): 40-2.
522009. [島嵗]亂楢嵹: <寬峃> 戞2夞 偳偆恑傔傞?椉棫巟墖亃偑傫儕僥儔僔乕偲婇嬈妶摦偺帩懕壜擻惈傪崅傔傞. 晲摗丂崉 (塹惗): 埨慡偲寬峃 2022/2; (2寧): 35-7.
522010. [島嵗]亂楢嵹: <寬峃> 戞3夞 偳偆恑傔傞?椉棫巟墖亃椉棫巟墖傪巟偊傞偨傔偺幮撪奜偺儕僜乕僗妶梡. 晲摗丂崉 (塹惗): 埨慡偲寬峃 2022/3; (3寧): 46-8.
540009. [偦偺懠 (Plain language summary東栿)] 嬛墝帯椕偵偐偐傞旓梡傪尭妟偡傞夘擖偼, 嬛墝棪, 嬛墝偺帋傒, 帯椕偺棙梡傪憹壛偝偣傞偐? (Healthcare financing systems for increasing the use of tobacco dependence treatment). 東栿: 惎丂壚朏 (塹惗), 娔栿: 惔尨峃夘: Cochrane Database of Systematic Reviews 2017, Issue 9. Art. No.: CD004305. DOI: 10.1002/14651858.CD004305.pub5. 2021/6; https://www.cochrane.org/ja/CD004305/TOBACCO_jin-yan-zhi-liao-nikakarufei-yong-wojian-e-surujie-ru-hajin-yan-lu-jin-yan-noshi-mizhi-liao-noli[2021.06.27
540010. [偦偺懠 (Plain language summary東栿)] 惵擭婜偺嬛墝傪巟墖偡傞嬛墝僾儘僌儔儉偼偁傞偐? (Tobacco cessation interventions for young people [Fanshawe TR, Halliwell W, Lindson N, Aveyard P, Livingstone-Banks J, Hartmann-Boyce J]). 東栿: 惎丂壚朏 (塹惗), 娔栿: 惔尨峃夘, 2021/6/29.
540011. [偦偺懠 (Plain language summary東栿)] 嬛墝傪僒億乕僩偡傞栻: 儗價儏乕偺奣梫 (Pharmacological interventions for smoking cessation: an overview and network meta乚analysis). 東栿: 惎丂壚朏 (塹惗), 娔栿: 惔尨峃夘: Cochrane Database Syst Rev. 2013 May 31;(5):CD009329. DOI: 10.1002/14651858.CD009329.pub2. 2021/7; https://www.cochrane.org/ja/CD009329/TOBACCO_jin-yan-wosapotosuruyao-rebiyunogai-yao.
540012. [偦偺懠 (Plain language summary東栿)] 儅僗儊僨傿傾偵傛傞僉儍儞儁乕儞 (僥儗價, 儔僕僆, 怴暦, 娕斅, 彫嶜巕) 偼, 庒幰偑僞僶僐傪媧偄巒傔傞偺傪梷巭偱偒傞偐? (Mass media interventions for preventing smoking in young people). 東栿: 惎丂壚朏 (塹惗), 娔栿: 惔尨峃夘: Cochrane Database of Systematic Reviews 2017, Issue 6. Art. No.: CD001006.DOI: 10.1002/14651858.CD001006.pub3. 2021/7; https://www.cochrane.org/ja/CD001006/TOBACCO_masumedeianiyorukiyanpenterebirazioxin-wen-kan-ban-xiao-ce-zi-haruo-zhe-gatabakowoxi-ishi-merunowoyi.
540013. [偦偺懠 (Plain language summary東栿)] 媔墝幰偑, 僞僶僐傪媧偆杮悢傪尭傜偟偨傝, 堎側傞僞僶僐惢昳傪巊梡偡傞偙偲偱, 僞僶僐偺奞傪尭傜偡偙偲偑偱偒傞偐? (Interventions to reduce harm from continued tobacco use). 東栿: 惎丂壚朏 (塹惗), 娔栿: 惔尨峃夘: Cochrane Database of Systematic Reviews 2016, Issue 10. Art. No.: CD005231.DOI: 10.1002/14651858.CD005231.pub3. 2021/7; https://www.cochrane.org/ja/CD005231/TOBACCO_chi-yan-zhe-gatabakowoxi-uben-shu-wojian-rasitariyi-narutabakozhi-pin-woshi-yong.
540014. [偦偺懠 (尋媶曬崘彂)]亂椷榓3擭搙嶻嬈堛妛挷嵏尋媶彆惉亃怴宆僐儘僫僂僀儖僗摍偺惗暔妛揑敇業懳嶔偲偟偰偺, 崅儕僗僋怑堟 (堛椕丒堸怘丒嫽峴嬈) 偺嶌嬈娐嫬娗棟偵偍偗傞, 幒撪CO2擹搙傪婎慴偲偡傞巜昗偺採尵丒懨摉惈専徹側傜傃偵懳嶔幚慔偵偡傞儅僱僕儊儞僩僔僗僥儉偺峔抸. 晲摗丂崉 (塹惗): 椷榓3擭搙嶻嬈堛妛挷嵏尋媶彆惉尋媶曬崘彂 2022/3.
540015. [偦偺懠 (尋媶曬崘彂)]亂楯嵭幘昦椪彴尋媶帠嬈旓曗彆嬥亃帠柋強塹惗婎弨婯懃偵娭偡傞尋媶亅懨摉惈偲崙嵺婎弨偲偺挷榓亅. 晲摗丂崉1, 壴棦恀摴, 嫶杮惏抝, 陰摗岹擵, 拞懞桾擵, 墶嶳榓恗, 徏暯丂峗, 墦摗尮庽 (1塹惗):亂楯嵭幘昦椪彴尋媶帠嬈旓曗彆嬥亃椷榓3擭搙憤妵丒暘扴尋媶曬崘彂 2022/3.
540016. [偦偺懠 (尋媶曬崘彂)]亂楯嵭幘昦椪彴尋媶帠嬈旓曗彆嬥亃帠柋強塹惗婎弨婯懃偵娭偡傞尋媶亅懨摉惈偲崙嵺婎弨偲偺挷榓亅. 晲摗丂崉1, 壴棦恀摴, 嫶杮惏抝, 陰摗岹擵, 拞懞桾擵, 墶嶳榓恗, 徏暯丂峗, 墦摗尮庽 (1塹惗):亂楯嵭幘昦椪彴尋媶帠嬈旓曗彆嬥亃椷榓尦擭-3擭搙憤崌尋媶曬崘彂 2022/3.
[挊丂彂]
620004. [妛弍彂 (暘扴幏昅)]亂僾儔僀儅儕丒働傾偺棟榑偲幚慔亃戞12復 帯椕偲巇帠偺椉棫巟墖丂65. 姵幰偺帯椕偲巇帠偺椉棫巟墖 (憤榑丒慜曇)丂巇帠傗怑応傪峫椂偟偨帯椕偺採帵偼, 摥偔姵幰傊偺幮夛揑張曽獬偲側傞, p.130-1. 晲摗丂崉 (塹惗), 娔廋: 擔杮僾儔僀儅儕丒働傾楢崌妛夛, 曇: 壛摗岝庽, 婌悾庣恖, 挿椾桼堖巕, 暉堜宑懢榊, 嶰塝懢榊, 媨抧弮堦榊, 嶳杮丂桽, 堛帠怴曬幮, 搶嫗, 2021/10敪峴.
620005. [妛弍彂 (暘扴幏昅)]亂僾儔僀儅儕丒働傾偺棟榑偲幚慔亃戞12復 帯椕偲巇帠偺椉棫巟墖丂66. 姵幰偺帯椕偲巇帠偺椉棫巟墖 (憤榑丒屻曇)丂堛椕梡岅傪巇帠偺嶌嬈偺尵梩偵東栿偟偨庡帯堛堄尒彂偑尞. 僾儔僀儅儕丒働傾偺棟榑偲幚慔, p1.32-3. 晲摗丂崉 (塹惗), 娔廋: 擔杮僾儔僀儅儕丒働傾楢崌妛夛, 曇: 壛摗岝庽, 婌悾庣恖, 挿椾桼堖巕, 暉堜宑懢榊, 嶰塝懢榊, 媨抧弮堦榊, 嶳杮丂桽, 堛帠怴曬幮, 搶嫗, 2021/10敪峴.
620006. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓2022擭斉丂巹偼偙偆帯椕偟偰偄傞亃憤榑丂2 拞撆惈幘姵丂僇僪儈僂儉拞撆, p.1120-1. 杧岥暫崉 (塹惗), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2022/1敪峴.
620007. [妛弍彂 (暘扴幏昅)]亂崙柉偺塰梴敀彂 2021擭搙斉丂擔杮偺怘偲塰梴偑憂傞怴帪戙偺寬峃亃仭戞2晹 擔杮恖傪庢傝姫偔怘娐嫬丂戞1復 怘帠娐嫬偵偍偗傞椙岲側姺婥偲偼亅僄傾儘僝儖姶愼偺梊杊偲, 埨慡丒埨怱側夛怘偺幚尰偵岦偗偰亅, p.49-64. 晲摗丂崉 (塹惗), 娔廋: 拞懞挌師, 擔杮堛椕婇夋, 搶嫗, 2022/1敪峴.
[妛夛丒尋媶夛摍]
713004. [妛夛 (崙嵺)] (堦斒島墘) Current guidelines and strategies against COVID-19 clusters at workplaces in Japan - a model for evaluating 3Cs using indoor exhaled CO2 prediction system. Muto G1: The 12th IOHA International Scientific Conference (2021/9/11-15), Web奐嵜. (晲摗丂崉1: 1塹惗)
722012. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 擕偑傫姵幰傊偺乽幮夛揑張曽獬乿偺崙撪奜偺摦岦亅廇楯堄尒彂嶌惉巟墖僜僼僩偵傛傞, 堛巘嬈柋寉尭偲張曽僗僉儖偺昗弨壔亅. 晲摗丂崉 (塹惗): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722013. [妛夛 (慡崙)] (嫟嵜僙儈僫乕) 屇媧婍傾儗儖僊乕傗姶愼徢傪梊杊偡傞姺婥: 3枾昡壙僙儈僫乕. 晲摗丂崉1, 峅揷検擇 (1塹惗): 戞32夞擔杮塽妛夛妛弍憤夛 (2022/1/26-28), Web奐嵜.
722014. [妛夛 (慡崙)] (YIA僙僢僔儑儞) 摐擜昦姵幰偵偍偗傞恡憻偺敪徢梊杊傪栚揑偲偟偨惗妶廗姷夘擖旓梡懳岠壥暘愅. 楅栘桾懢1, 惎丂壚朏2, 敀娾丂寬, 暉揷丂宧 (1戝妛堾堛椕宯尋媶壢, 2塹惗): 戞12夞擔杮恡憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2022/3/26-27), 壀嶳 (僴僀僽儕僢僪奐嵜).
723055. [妛夛 (慡崙)] (堦斒島墘) 崅楊偺娭愡儕僂儅僠姵幰偺寬峃庻柦墑怢傪傔偞偟偨, 幮夛嶲壛偺幚懺偲, 擣抦婡擻掅壓/偆偮孹岦偲偺娭楢暘愅. 晲摗丂崉1, 崟戲旤抭巕, 彫搱弐媣, 塱扟桽巕, 彫搱夒戙 (1塹惗): 戞65夞擔杮儕僂儅僠妛夛憤夛丒妛弍廤夛 (2021/4/26-28), Web奐嵜.
723056. [妛夛 (慡崙)] (堦斒島墘) 屇婥CO2偲幒撪棻巕摦懺梊應偵傛傞3枾偺壜帇壔乚COVID-19僋儔僗僞乕儕僗僋昡壙. 晲摗丂崉1, 嫶杮惏抝, 榓揷峩帯, 墶嶳榓恗, 墦摗尮庽, 戝怷桼婭1, 杧岥暫崉1, 壴棦恀摴 (1塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/18-21), 徏杮 (僴僀僽儕僢僪奐嵜).
723057. [妛夛 (慡崙)] (堦斒島墘) 桳奞嬈柋傊偺廬帠婜娫偲偑傫滊姵偺娭楢亅慡崙楯嵭昦堾昦怑楌挷嵏僨乕僞儀乕僗傛傝亅. 怺堜峲懢, 屆壆桟巕, 拞郪徦巕, 彫搰尨揟巕, 惎丂壚朏1, 朙揷復岹, 棫摴徆岾 (1塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/18-21), 徏杮 (僴僀僽儕僢僪奐嵜), 戞94夞擔杮嶻嬈塹惗妛夛島墘廤 嶻嬈塹惗妛嶨帍 2021/4; 63 (椪帪憹姧崋): 335.
723058. [妛夛 (慡崙)] (堦斒島墘) 摐擜昦姵幰偵偍偗傞摐擜昦崌暪徢偺滊姵偲怑嬈楌偲偺娭楢亅慡崙楯嵭昦堾昦怑楌僨乕僞儀乕僗傛傝亅. 拞郪徦巕, 怺堜峲懢, 屆壆桟巕, 彫搰尨揟巕, 惎丂壚朏1, 棫摴徆岾, 朙揷復岹 (1塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/18-21), 徏杮 (僴僀僽儕僢僪奐嵜), 戞94夞擔杮嶻嬈塹惗妛夛島墘廤 嶻嬈塹惗妛嶨帍 2021/4; 63 (椪帪憹姧崋): 458.
723059. [妛夛 (慡崙)] (堦斒島墘) 捵釃惈戝挵墛偺怑嬈楌偵偍偗傞敪徢儕僗僋偺専摙亅慡崙楯嵭昦堾昦怑楌僨乕僞儀乕僗傛傝亅. 屆壆桟巕, 怺堜峲懢, 拞郪徦巕, 彫搰尨揟巕, 惎丂壚朏1, 朙揷復岹, 棫摴徆岾 (1塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/18-21), 徏杮 (僴僀僽儕僢僪奐嵜), 戞94夞擔杮嶻嬈塹惗妛夛島墘廤 嶻嬈塹惗妛嶨帍 2021/4; 63 (椪帪憹姧崋): 460.
723060. [妛夛 (慡崙)] (堦斒島墘) 嶻嬈塹惗媄弍晹夛尋廋夛: 僔儈儏儗乕僞乕傪梡偄偨幚椺. 嶳撪晲婭, 陰摗岹擵, 嶳栰桪巕, 晲摗丂崉1, 婱巙岶梞, 拞尨峗旻, 拞懞丂廋, 斞揷桾婱巕, 嫶杮惏抝 (1塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/18-21), 徏杮 (僴僀僽儕僢僪奐嵜).
723061. [妛夛 (慡崙)] (堦斒島墘) 戝妛昦堾椉棫巟墖奜棃偺奐愝乚偑傫丒擄昦丒弞娐婍偺懡怑庬楢実偵傛傞庢傝慻傒 (戞2曬). 戝怷桼婭1, 晲摗丂崉1, 憗嶁桼旤巕2, 嵍塃揷揘2, 杧岥暫崉1, 掔丂柧弮3 (1塹惗, 2僩乕僞儖僒億乕僩僙, 3岞廜塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/18-21), 徏杮 (僴僀僽儕僢僪奐嵜).
723062. [妛夛 (慡崙)] (堦斒島墘) COVID-19懳嶔偵妶梡壜擻側姺婥僔儈儏儗乕僞乕偺奐敪 (戞堦曬) 婎杮揑側峫偊曽. 婱巙岶梞, 拞尨峗旻, 拞懞丂廋, 嶳撪晲婭, 晲摗丂崉1, 斞揷桾婱巕, 陰摗岹擵, 嶳揷寷堦, 嶳栰桪巕, 嫶杮惏抝 (1塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/18-21), 徏杮 (僴僀僽儕僢僪奐嵜).
723063. [妛夛 (慡崙)] (堦斒島墘) COVID-19懳嶔偵妶梡壜擻側姺婥僔儈儏儗乕僞乕偺奐敪 (戞擇曬) 幚應抣偺斾妑. 陰摗岹擵, 嶳撪晲婭, 晲摗丂崉1, 婱巙岶梞, 拞尨峗旻, 拞懞丂廋, 斞揷桾婱巕, 嶳栰桪巕, 嫶杮惏抝 (1塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/18-21), 徏杮 (僴僀僽儕僢僪奐嵜).
723064. [妛夛 (慡崙)] (堦斒島墘) 怑堟偺COVID-19梊杊懳嶔僐儞僒儖僥乕僔儑儞-峴惌丒嶻嬈曐寬丒娐嫬塹惗偺怴偨側楢実. 愇嫶嶗巕, 晲摗丂崉1, 墶嶳榓恗, 墦摗尮庽, 愇堜棟撧, 戝栴傔偖傒, 戝怷桼婭1, 拞戲丂朙, 岦峕桭桟, 嫶杮惏抝, 榓揷峩帯 (1塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/18-21), 徏杮 (僴僀僽儕僢僪奐嵜).
723065. [妛夛 (慡崙)] (堦斒島墘) 朏崄懓傾儈儞椶MOCA偺曄堎懱嵶朎姅孮DT40傪梡偄偨DNA廋暅宱楬偺扵嶕. 彫椦嵐曚, 孷丂塱崉1, 朙壀払巑, 墹丂悙惗, 晲揷弐堦, 峛揷栁庽 (1戝妛堾堛椕宯尋媶壢): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/18-21), 徏杮 (僴僀僽儕僢僪奐嵜).
723066. [妛夛 (慡崙)] (堦斒島墘) CPX (怱攛塣摦晧壸帋尡) 巤峴帪偺摉堾偱偺姶愼梊杊懳嶔. 拞懞撧嶗, 惎丂尋堦, 嶳娸壞巕, 惉揷岤巕, 嶳揷旤抭帯, 崅嫶丂朙, 栄撪姲巕, 晲摗丂崉1, 嫶杮惏抝 (1塹惗): 戞27夞擔杮怱憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2021/6/19-20), 枊挘 (僴僀僽儕僢僪奐嵜).
723067. [妛夛 (慡崙)] (堦斒島墘) 僆儖僩僼僃僯儗儞僕傾儈儞偺嶰師尦旂晢拁愊惈偲in vitro堚揱撆惈偵娭偡傞尋媶. 孷丂塱崉1, 朙壀払巑, 攼栘桾楥庽, 墹丂悙惗, 峛揷栁庽, 杧岥暫崉2 (1戝妛堾堛椕宯尋媶壢, 2塹惗): 戞48夞擔杮撆惈妛夛妛弍擭夛 (2021/7/7-9), 恄屗 (僴僀僽儕僢僪奐嵜).
723068. [妛夛 (慡崙)] (堦斒島墘) 僆儖僩僼僃僯儗儞僕傾儈儞偺旂晢拁愊惈偲堚揱撆惈偵娭偡傞尋媶. 孷丂塱崉1, 朙壀払巑, 攼栘桾楥庽, 墹丂悙惗, 峛揷栁庽, 杧岥暫崉2 (1戝妛堾堛椕宯尋媶壢, 2塹惗): 擔杮娐嫬曄堎尨僎僲儉妛夛戞50夞婰擮戝夛 (2021/11/1-2), 墶恵夑 (僴僀僽儕僢僪奐嵜).
723069. [妛夛 (慡崙)] (堦斒島墘) 儊僞丒傾僫儕僔僗偵傛傞FIT僇僢僩僆僼抣偺専摙. 扅栰晀峗, 帥郪峎旻, 嵅乆栘惔庻, 曅嶳婱暥, 嵶栰妎戙, 惎丂壚朏1, 垻晹峗堦榊, 郷搰偪偝偲 (1塹惗): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4-7), 恄屗 (僴僀僽儕僢僪奐嵜), 擔杮徚壔婍偑傫専恌妛夛嶨帍 2021/10; 59 (Suppl 2): 665.
723070. [妛夛 (慡崙)] (堦斒島墘) 怴宆僐儘僫僂傿儖僗姶愼梊杊懳嶔僐儞僒儖僥乕僔儑儞楢実: 幒撪僋儔僗僞乕壔偺慾巭 晲摗丂崉1, 壴棦恀摴, 墶嶳榓恗, 墦摗尮庽, 崟戲旤抭巕, 戝怷桼婭1, 榓揷峩帯 (1塹惗): 戞80夞擔杮岞廜塹惗妛夛憤夛 (2021/12/21), 搶嫗 (僴僀僽儕僢僪奐嵜).
723071. [妛夛 (慡崙)] (堦斒島墘) 擄昦朄巤峴慜屻偺儀乕僠僃僢僩昦堛椕庴媼幰塽妛憸偺曄壔. 崟戲旤抭巕, 堫梩丂桾, 晲摗丂崉1, 墶嶳榓恗 (1塹惗): 戞80夞擔杮岞廜塹惗妛夛憤夛 (2021/12/21-23), 搶嫗 (僴僀僽儕僢僪奐嵜).
723072. [妛夛 (慡崙)] (堦斒島墘) 寬峃宱塩偼, 寬恌屻庴椕峴摦傪懀恑偡傞: 婡夿妛廗傪梡偄偨, 怑堟50枩恖峴摦梊應儌僨儖. 晲摗丂崉1, 曅嬎椚巕 (1塹惗): 戞32夞擔杮塽妛夛妛弍憤夛 (2022/1/26-28), Web奐嵜.
723073. [妛夛 (慡崙)] (堦斒島墘) 帺棫崅楊幰偵偍偗傞娭愡儕僂儅僠偺恌抐偲僼儗僀儖, 幮夛揑攚宨偵娭偡傞専摙: JAGES墶抐尋媶. 彫搱夒戙, 搉绯椙懢, 埨壀幚壚巕, 抾撪尋帪, 嵵摗丂柉, 帥晹寬嵠, 彫搱弐媣, 旜搰弐擵, 晲摗丂崉1, 戝娭嵐埶, 嬤摗崕懃 (1塹惗): 戞32夞擔杮塽妛夛妛弍憤夛 (2022/1/26-28), Web奐嵜.
723074. [妛夛 (慡崙)] (堦斒島墘) 擄昦朄巤峴慜屻偺揤醰釋堛椕庴媼幰塽妛憸偺曄壔. 崟戲旤抭巕, 揤扟夒峴, 嶳忋丂弤, 抮揷巙泑, 廐嶳恀巙, 晲摗丂崉1, 墶嶳榓恗 (1塹惗): 戞32夞擔杮塽妛夛妛弍憤夛 (2022/1/26-28), Web奐嵜.
723075. [妛夛 (慡崙)] (堦斒島墘) 掅擹搙墧敇業偵傛傞棧擕屻偺巈儔僢僩偺拲堄椡掅壓偲奀攏拞D,L-僙儕儞傊偺塭嬁 戝怷桼婭1, 忋孍桾擇, 娭崻惓宐, 悪扟慞怣, 徏愳妜媣, 彫椦搷巕2, 晲摗丂崉1, 墶嶳榓恗, 妏揷惓巎, 曅崻恀悷, 釼摗峃徍, 媨杮揘栫, 壛摗偔傒巕, 杮娫丂峗, 杧岥暫崉1 (1塹惗, 2梊杊堛妛宯): 戞92夞擔杮塹惗妛夛妛弍憤夛 (2022/3/21), Web奐嵜.
723076. [妛夛 (慡崙)] (堦斒島墘) 帺壠嶻暷愛庢偵傛傝僇僪儈僂儉宱岥敇業傪庴偗偨擾嬈廬帠幰偺11擭娫偺捛愓挷嵏 杧岥暫崉1, 彫孎墄巕, 戝怷桼婭1, 彫椦搷巕2, 戝栰抭巕 (1塹惗, 2梊杊堛妛宯): 戞92夞擔杮塹惗妛夛妛弍憤夛 (2022/3/21), Web奐嵜.
723077. [妛夛 (慡崙)] (堦斒島墘) 慡崙楯嵭昦堾昦怑楌僨乕僞儀乕僗偵偍偗傞怑嬈惈恎懱妶摦亅怱寣娗幘姵曇 (夛媍榐). 屆壆桟巕, 怺堜峲懢, 拞郪徦巕, 彫搰尨揟巕, 惎丂壚朏1, 朙揷復岹, 棫摴徆岾 (1塹惗): 戞92夞擔杮塹惗妛夛妛弍憤夛 (2022/3/21-23), Web奐嵜, 擔杮塹惗妛嶨帍 2022/3; 77 (Suppl): S212.
723078. [妛夛 (慡崙)] (堦斒島墘) 慡崙楯嵭昦堾昦怑楌僨乕僞儀乕僗偵偍偗傞怑嬈惈恎懱妶摦亅偑傫曇 (夛媍榐). 怺堜峲懢, 屆壆桟巕, 拞郪徦巕, 彫搰尨揟巕, 惎丂壚朏1, 朙揷復岹, 棫摴徆岾 (1塹惗): 戞92夞擔杮塹惗妛夛妛弍憤夛 (2022/3/21-23), Web奐嵜, 擔杮塹惗妛嶨帍 2022/3; 77 (Suppl): S 213.
732005. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 廐揷導偺僇僪儈僂儉墭愼抧堟偵偍偗傞暷嶌擾壠偺宱岥僇僪儈僂儉敇業偲偦偺寬峃塭嬁. 杧岥暫崉 (塹惗): 儊僞儖僶僀僆僒僀僄儞僗尋媶夛2021 (2021/10/27), 墶昹 (僴僀僽儕僢僪奐嵜).
733012. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 抧堟僋儕僯僢僋敪擬奜棃偱偺僪儔僀僽僗儖乕PCR恌椕偵偍偗傞妶梡. 晲摗丂崉 (塹惗): 戞1夞挳恌僨乕僞尋媶夛 (2021/4/9), Web奐嵜.
733013. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 朏崄懓傾儈儞椶偵傛傞DNA懝彎偵偮偄偰. 墹丂悙惗, 桍応桼奊, 孷丂塱崉1, 朙壀払巑 (1戝妛堾堛椕宯尋媶壢): 戞48夞嶻嬈拞撆丒惗暔妛揑儌僯僞儕儞僌尋媶夛 (2021/10/2), Web奐嵜.
733014. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 掅擹搙墧敇業偵傛傞棧擕屻偺巈儔僢僩偺拲堄椡掅壓傊偺塭嬁. 戝怷桼婭1, 忋孍桾擇, 悪扟慞怣, 徏愳妜媣, 彫椦搷巕2, 晲摗丂崉1, 墶嶳榓恗, 妏揷惓巎, 杧岥暫崉1 (1塹惗, 2梊杊堛妛宯): 儊僞儖僶僀僆僒僀僄儞僗尋媶夛2021 (2021/10/28), 墶昹 (僴僀僽儕僢僪奐嵜).
733015. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) UHC崙嵺揥奐偵岦偗偨, 寬峃宱塩偵傛傞崙柉奆曐尟惂搙偺桳岠妶梡婎斦峔抸偺昡壙夝愅: Beyond next health policy亅a prediction model for maximizing UHC utizliation through healthy companies movement against NCDs in Japan. 晲摗丂崉1, 墦摗尮庽 (1塹惗): 戞28夞僼傽僀僓乕僿儖僗儕僒乕僠僼僅乕儔儉 (2021/12/11-12), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110005. [尨挊] Relationship between personal-sampled air lead and blood lead in low-lead-exposure workers in Japan to apply multiple regression models determining permissible air lead concentration. Ono A, Horiguchi H1: J Occup Health 2021/1; 63 (1): e12264. (杧岥暫崉1: 1塹惗)
[妛夛丒尋媶夛摍]
'20-733001. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僔僗僥儅僥傿僢僋儗價儏乕/儊僞傾僫儕僔僗偺嶌傜傟曽. 惎丂壚朏 (塹惗): NPO朄恖擔杮堛妛恾彂娰嫤夛 (JMLA) 2020擭搙昦堾晹夛庡嵜尋廋夛 (2021/3/6), Web奐嵜, 俶PO朄恖擔杮堛妛恾彂娰嫤夛 2020擭搙昦堾晹夛庡嵜尋廋夛乽僈僀僪儔僀儞傪抦傠偆乿彺榐廤 2021/3; p.1.
岞廜塹惗妛
[妛弍榑暥]
110057. [尨挊] Development and validation of the Japanese version of the team job crafting scale for nurses. Iida M, Watanabe K1, Imamura K, Sakuraya A, Asaoka H, Sato N, Nozawa K, Kawakami N: Res Nurs Health 2021/4; 44 (2): 329-43. (搉曈榓峀1: 1岞廜塹惗)
110058. [尨挊] Effect of smartphone-based stress management programs on depression and anxiety of hospital nurses in Vietnam: a three-arm randomized controlled trial. Imamura K, Tran TTT, Nguyen HT, Sasaki N, Kuribayashi K, Sakuraya A, Nguyen AQ, Bui TM, Nguyen QT, Nguyen NT, Nguyen KT, Nguyen GTH, Tran XTN, Truong TQ, Zhang MW, Minas H, Sekiya Y, Watanabe K1, Tsutsumi A1, Kawakami N: Sci Rep 2021/5; 11 (1): 11353. (搉曈榓峀1, 掔丂柧弮1: 1岞廜塹惗)
110059. [尨挊] Adolescent Work Values and Drug Use in Adulthood: A Longitudinal Prospective Cohort Study. Takano A, Fukasawa M, Watanabe K1, Nishi S, Kawakami N: Subst Use Misuse 2021/6; 56 (10): 1483-92. (搉曈榓峀1: 1岞廜塹惗)
110060. [尨挊] Associations Between Personal Values and Work Engagement: A Cross-Sectional Study Using A Representative Community Sample. Sato N, Watanabe K1, Nishi D, Kawakami N: J Occup Environ Med 2021/6; 63 (6): e335-40. (搉曈榓峀1: 1岞廜塹惗)
110061. [尨挊] Associations between work-related stressors and QALY in a general working population in Japan: a cross-sectional study. Hidaka Y, Imamura K, Watanabe K1, Tsutsumi A1, Shimazu A, Inoue A, Hiro H, Odagiri Y, Asai Y, Yoshikawa T, Yoshikawa E, Kawakami N: Int Arch Occup Environ Health 2021/8; 94 (6): 1375-83. (搉曈榓峀1, 掔丂柧弮1: 1岞廜塹惗)
110062. [尨挊] Association Between Adaptation of Management Philosophy and Mission Statement, and Work Engagement Among Japanese Workers: A 1-year Prospective Cohort Study in a Japanese Company. Eguchi H1, Inoue A1, Kachi Y1, Tsutsumi A1: J Occup Environ Med 2021/9; 63 (9): e601-4. (峕岥丂彯1, 堜忋彶恇1, 壜抦桰巕1, 掔丂柧弮1: 1岞廜塹惗)
110063. [尨挊] Association between Urban Upbringing and Compulsive Internet Use in Japan: A Cross-Sectional, Multilevel Study with Retrospective Recall. Yasuma N, Nishi D, Watanabe K1, Ishikawa H, Tachimori H, Takeshima T, Umeda M, Kawakami N: Int J Environ Res Public Health 2021/9; 18 (18): 9890. (搉曈榓峀1: 1岞廜塹惗)
110064. [尨挊] Effectiveness of an Internet-Based Machine-Guided Stress Management Program Based on Cognitive Behavioral Therapy for Improving Depression Among Workers: Protocol for a Randomized Controlled Trial. Kawakami N, Imamura K, Watanabe K1, Sekiya Y, Sasaki N, Sato N, SMART-CBT Project Team: JMIR Res Protoc 2021/9; 10 (9): e30305. (搉曈榓峀1: 1岞廜塹惗)
110065. [尨挊] The Effect of Perceived Gratitude From Others on Work Engagement: A Cross-Sectional Study. Komase Y, Watanabe K1, Sasaki N, Kawakami N: J Occup Environ Med 2021/9; 63 (9): e592-5. (搉曈榓峀1: 1岞廜塹惗)
110066. [尨挊] Heterogeneity in cognitive disability after a major disaster: A natural experiment study. Shiba K, Daoud A, Hikichi H1, Yazawa A, Aida J, Kondo K, Kawachi I: Sci Adv 2021/10; 7 (40): eabj2610. (堷抧攷擵1: 1岞廜塹惗)
110067. [尨挊] Predictors associated with the mental health of Japanese male registered nurses: focusing on environments with many female registered nurses and female patients' refusal to accept nursing services from male registered nurses. Kudo Y, Toyoda T, Sugimoto N, Tsutsumi A1: J Rural Med 2021/10; 16 (4): 191-9. (掔丂柧弮1: 1岞廜塹惗)
110068. [尨挊] Organizational Justice and Cognitive Failures in Japanese Employees: A Cross-Sectional Study. Inoue A, Eguchi H, Kachi Y1, Tsutsumi A1: J Occup Environ Med 2021/10; 63 (10): 901-6. (壜抦桰巕1, 掔丂柧弮1: 1岞廜塹惗)
110069. [尨挊] WORK-LIFE BALANCE IN THE CURRENT JAPANESE CONTEXT. Tsutsumi A1: International Journal of Person Centered Medicine 2021/10; 9 (4): 57-64. (掔丂柧弮1: 1岞廜塹惗)
110070. [尨挊] Association of child's disability status with father's health outcomes in Japan. Dhungel B, Tsuguhiko K, Ochi M, Gilmour S, Kachi Y1, Takehara K: SSM Popul Health 2021/10; 16: 100951. (壜抦桰巕1: 1岞廜塹惗)
110071. [尨挊] Association between sitting time at work and the onset of major depressive episode: a 1-year prospective cohort study using the Bayesian regression. Watanabe K1, Kawakami N: BMC Public Health 2021/10; 21 (1): 1960. (搉曈榓峀1: 1岞廜塹惗)
110072. [尨挊] Reliability and validity of the Chinese version of the New Brief Job Stress Questionnaire (New BJSQ) among workers in China. Hidaka Y, Watanabe K1, Imamura K, Tatha O, Kawakami N: Ind Health 2022/10; 60 (5): 407-19. doi: 10.2486/indhealth.2021-0027. Epub 2021 Nov 1. (搉曈榓峀1: 1岞廜塹惗)
110073. [尨挊] Prevalence of and associated factors for psychological distress among single fathers in Japan. Dhungel B, Kato T, Kachi Y1, Ochi M, Gilmour S, Takehara K: J Epidemiol 2021/10. doi: 10.2188/jea.JE20210273. Online ahead of print. (壜抦桰巕1: 1岞廜塹惗)
110074. [尨挊] Reliability and Validity of the Japanese Version of the 12-Item Psychosocial Safety Climate Scale (PSC-12J). Inoue A, Eguchi H, Kachi Y1, McLinton SS, Dollard MF, Tsutsumi A1: Int J Environ Res Public Health 2021/12; 18 (24): 12954. (壜抦桰巕1, 掔丂柧弮1: 1岞廜塹惗)
110075. [尨挊] Determining whether periodic health checkups have any preventive effect on deterioration in health among middle-aged adults: A hazards model analysis in Japan. Oshio T, Tsutsumi A1, Inoue A: J Occup Health 2021/11; 63 (1): e12291. (掔丂柧弮1: 1岞廜塹惗)
110076. [尨挊] Factors related to parenting stress among fathers of preschool children in Japan. Kachi Y1, Ochi M, Kato T, Otsuka M, Takehara K: Pediatr Int 2022/1; 64 (1): e15132. (壜抦桰巕1: 1岞廜塹惗)
110077. [尨挊] Suggestions for new organizational-level item pools for the national Stress Check Program from management philosophy and mission statement: A qualitative study using unsupervised learning. Watanabe K1, Inoue A, Eguchi H, Iwata N, Odagiri Y, Tsutsumi A1: J Occup Health 2022/1; 64 (1): e12335. (搉曈榓峀1, 掔丂柧弮1: 1岞廜塹惗)
110078. [尨挊] The Effect of the Imacoco Care Psychoeducation Website on Improving Psychological Distress Among Workers During the COVID-19 Pandemic: Randomized Controlled Trial. Imamura K, Sasaki N, Sekiya Y, Watanabe K1, Sakuraya A, Matsuyama Y, Nishi D, Kawakami N: JMIR Form Res 2022/3; 6 (3): e33883. (搉曈榓峀1: 1岞廜塹惗)
110079. [尨挊] Association between working overtime and psychological stress reactions in elementary and junior high school teachers in Japan: a large-scale cross-sectional study. Furihata R, Kuwabara M, Oba K, Watanabe K1, Takano N, Nagamine N, Maruyama Y, Ito N, Watanabe I, Tsubono K, Ikeda C, Sakamoto J: Ind Health 2022/3; 60 (2): 133-45. (搉曈榓峀1: 1岞廜塹惗)
120003. [尨挊]亂摿暿榑暥亃儊儞僞儖僿儖僗懳嶔: 怑堟偲抧堟偺楢実偺僊儍僢僾傪杽傔傞偨傔偵. 淎愳嬻旤, 怷岥師榊, 愐旜戝夒, 栰懞梞巕, 栰懞嫳巕, 戝暯揘栫, 埳摗峅恖, 堜忋彶恇, 掔丂柧弮1 (1岞廜塹惗): 擔杮岞廜塹惗嶨帍 2021/5; 68 (5): 311-9.
120004. [尨挊] 変偑崙偺楯摥幰偺怴宆僐儘僫儚僋僠儞偵懳偡傞堄幆偲怴宆僐儘僫儚僋僠儞傪愙庬偡傞摦婡偯偗偲偺娭楢惈. 岺摗埨巎, 屻摗桼婭, 奰尨壛戙巕, 媑揷榓巬, 墊杮婌旻, 怷丂抭巕, 壨栰孾巕, 掔丂柧弮1 (1岞廜塹惗): 楯摥埨慡塹惗尋媶 2021/9; 14 (2): 129-39.
120005. [尨挊] 擔杮恖彈惈楯摥幰偺廇楯忋壽戣偲側傞惗暔怱棟幮夛揑側梫場, 惂搙棙梡忬嫷, 婜懸偡傞怑応偱偺尋媶僥乕儅偺僯乕僘: 姵幰丒巗柉嶲夋 (PPI: Patient and Public Involvement) 偺榞慻傒傪梡偄偨僀儞僞乕僱僢僩挷嵏偵傛傞墶抐尋媶. 嵅乆栘撨捗, 捗栰崄撧旤, 擔崅寢堖, 埨摗奊旤巕, 愺堜桾旤, 烴扟偁偡偐, 擔栰垷栱巕, 堜忋椾巕1, 崱懞岾懢榊, 搉曈榓峀1, 掔丂柧弮1, 愳忋寷恖 (1岞廜塹惗): 嶻嬈塹惗妛嶨帍 2021/11; 63 (6): 275-90.
120006. [尨挊] 傢偑崙偺楯摥幰偵偍偗傞怴宆僐儘僫僂僀儖僗姶愼徢偺専嵏傪庴偗傞摦婡偯偗偵娭楢偡傞場巕. 岺摗埨巎, 屻摗桼婭, 奰尨壛戙巕, 媑揷榓巬, 墊杮婌旻, 怷丂抭巕, 壨栰孾巕, 掔丂柧弮1 (1岞廜塹惗): 岤惗偺巜昗 2021/12; 68 (15): 1-8.
510004. [憤愢] Review on the influence of paternal involvement in childcare on mothers, children, and fathers. Kato T, Ochi M, Kachi Y1, Suto M, Otsuka M, Takehara K: Nihon Koshu Eisei Zasshi 2022/5; 69 (5): 321-37. doi: 10.11236/jph.21-040. Epub 2022 Mar 16. (壜抦桰巕1: 1岞廜塹惗)
520005. [憤愢] (弞娐婍昦梊杊憤愢僔儕乕僘28: 梫場曇13) 惛恄幘姵偲弞娐婍幘姵. 掔丂柧弮 (岞廜塹惗): 擔杮弞娐婍昦梊杊妛夛帍 2021/11; 56 (3): 212-25.
520006. [憤愢] 儕乕僟乕僔僢僾偺棟榑偲嶻嬈曐寬愱栧怑偺儕乕僟乕僔僢僾傊偺墳梡; 暥專儗價儏乕. 彫椦桼壚, 堜忋彶恇, 捗栰崄撧旤, 烴扟偁偡偐, 戝捤懽惓, 峕岥丂彯, 搉曈榓峀1 (1岞廜塹惗): 嶻嬈堛妛儗價儏乕 2021; 33 (3): 225-50.
521002. [夝愢]亂 崙撪奜偺嶻嬈堛妛偵娭偡傞暥專徯夘亃嵸検楯摥惂偵敽偆寬峃娭楢梫場. 掔丂柧弮 (岞廜塹惗): 嶻嬈堛妛僕儍乕僫儖 2022/3; 45 (2): 95-101.
522011. [島嵗]亂摿廤: 怑応偵偍偗傞恎懱妶摦丒塣摦丒嵗埵峴摦偲儊儞僞儖僿儖僗亃恎懱妶摦丒塣摦傪懀恑偡傞怑応娐嫬. 搉曈榓峀 (岞廜塹惗): 嶻嬈僗僩儗僗尋媶 2021/4; 28 (2): 249-53.
522012. [島嵗]亂摿廤: 惛恄壢偑嬤偔偵側偄抧堟偵偍偗傞憤崌堛偺偨傔偺惛恄壢恌椕亃堛巘丒堛椕幰偺儊儞僞儖僿儖僗. 掔丂柧弮 (岞廜塹惗): 寧姧抧堟堛妛 2021/5; 31 (5): 440-4.
522013. [島嵗]亂儊僀儞僥乕儅: 僗僩儗僗偲恄宱宯亃A. 僗僩儗僗憤榑丂僗僩儗僗偺奣擮偲暘椶. 掔丂柧弮 (岞廜塹惗): Clinical Neuroscience 2021/6; 39 (6): 688-92.
522014. [島嵗]亂摿廤: 僷儚乕僴儔僗儊儞僩傪側偔偡偨傔偵亃3. 僷儚乕僴儔僗儊儞僩偲儊儞僞儖僿儖僗. 掔丂柧弮 (岞廜塹惗): 楯摥挷嵏 2021/6; 608: 17-22.
522015. [島嵗]亂摿廤: 偦偺屻偺帺嶦懳嶔II亅椪彴偵惗偐偡帺嶦懳嶔偺揥奐亅亃堛妛嫵堢偵帺嶦梊杊傪庢傝擖傟傞. 掔丂柧弮 (岞廜塹惗): 惛恄壢帯椕妛 2021/9; 36 (9): 1041-5.
522016. [島嵗]亂BOOK Review亃婎慴偐傜妛傇妝偟偄塽妛丂戞4斉. 掔丂柧弮 (岞廜塹惗): 昦堾 2021/9; 80 (9): 819.
522017. [島嵗]亂摿廤: 堛巘偺摥偒曽夵妚亃堛巘偺摥偒曽夵妚丂岞廜塹惗偺棫応偐傜. 掔丂柧弮 (岞廜塹惗): 擔杮惛恄壢昦堾嫤夛嶨帍 2021/11; 40 (11): 65-71.
522018. [島嵗]亂摿廤: 戞28夞擔杮嶻嬈僗僩儗僗妛夛摿廤崋亃[僔儞億僕僂儉] 僗僩儗僗僠僃僢僋惂搙偺尰忬偲崱屻偺揥朷. 掔丂柧弮 (岞廜塹惗): 嶻嬈僗僩儗僗尋媶 2021/11; 28 (4): 413-6.
522019. [島嵗]亂僐儊儞僩: 嵟怴尋媶偱暘偐偭偨乽柦偺奿嵎乿巰偵嬤偯偔怑嬈亃懱偵埆偄巇帠亅乽夁楯巰儔僀儞乿偺4攞傪挻偊傞寧327帪娫偺巆嬈. 掔丂柧弮 (岞廜塹惗): 彈惈僙僽儞 2022/1; 60 (3): 56-7.
522020. [島嵗]亂摿廤: COVID-19傪挻偊偰-偙傟偐傜偺惛恄堛妛傪傔偖傞娐嫬亃嶻嬈惛恄曐寬偵偍偗傞怴偨側壽戣偲偟偰偺僥儗儚乕僋. 掔丂柧弮 (岞廜塹惗): 椪彴惛恄堛妛 2022/3; 51 (3): 281-5.
540017. [偦偺懠 (尋媶曬崘彂)]亂傾儗儖僊乕丒娭愡儕僂儅僠偵滊姵偟偨楯摥幰偲姵幰偺梴堢幰偵懳偡傞帯椕偲廇楯偺椉棫巟墖儅僯儏傾儖亃IV 怑応偱偺椉棫巟墖偺恑傔曽. 掔丂柧弮1,2, 忋尨棦掱2 (1岞廜塹惗, 2傾儗儖僊乕幘姵偺姵幰偍傛傃椕堢幰偺廇楯丒廇妛巟墖傪悇恑偡傞偨傔偺尋媶斍): 傾儗儖僊乕丒娭愡儕僂儅僠偵滊姵偟偨楯摥幰偲姵幰偺梴堢幰偵懳偡傞帯椕偲廇楯偺椉棫巟墖儅僯儏傾儖尋媶曬崘彂 2021/4; p.9-11.
540018. [偦偺懠 (尋媶曬崘彂)]亂傾儗儖僊乕丒娭愡儕僂儅僠偵滊姵偟偨楯摥幰偲姵幰偺梴堢幰偵懳偡傞帯椕偲廇楯偺椉棫巟墖儅僯儏傾儖亃VI 幮夛帒尮偺妶梡丒楯摥娭學朄椷偺抦幆. 掔丂柧弮1,2, 忋尨棦掱2 (1岞廜塹惗, 2傾儗儖僊乕幘姵偺姵幰偍傛傃椕堢幰偺廇楯丒廇妛巟墖傪悇恑偡傞偨傔偺尋媶斍): 傾儗儖僊乕丒娭愡儕僂儅僠偵滊姵偟偨楯摥幰偲姵幰偺梴堢幰偵懳偡傞帯椕偲廇楯偺椉棫巟墖儅僯儏傾儖尋媶曬崘彂 2021/4; p.17-20.
540019. [偦偺懠 (CURRENT REPORT)] 戞36夞擔杮僗僩儗僗妛夛妛弍憤夛 奐嵜曬崘 儔僀僼僐乕僗偺帇揰偐傜尒偨僗僩儗僗壢妛. 掔丂柧弮 (岞廜塹惗): 寬峃奐敪 2021/6; 25 (4): 75-7.
540020. [偦偺懠 (尋媶曬崘彂)]亂岤惗楯摥徣 楯嵭幘昦椪彴尋媶曗彆嬥帠嬈亃帠嬈応偵偍偄偰帯椕偲巇帠偺椉棫巟墖傪偡傞偨傔偺攝椂偲偦偺寛掕僾儘僙僗偵娭偡傞尋媶. 峕岥丂彯 (尋媶戙昞幰), 掔丂柧弮1, 嵅乆栘帯堦榊, 恵夑枩抭, 搉曈丂揘, 嶳栰壝媣, 惸摗丂憦, 屆壆攷峴, 怷揷揘栫, 妬栘斏擵, 杒嫃丂柧, 怷塱梇懢, 晲摗丂崉2, 堜忋彶恇 (1岞廜塹惗, 2塹惗):亂岤惗楯摥徣 楯嵭幘昦椪彴尋媶曗彆嬥帠嬈亃椷榓3擭搙憤妵丒暘扴尋媶曬崘彂 2022/3.
[挊丂彂]
620008. [妛弍彂 (暘扴幏昅)]亂嶻嬈曐寬儅僯儏傾儖 夵掶8斉亃10 寬峃娗棟, p.167-229. 愇堜媊泫, 愹丂攷擵, 娾嶈彯恖, 妬栘斏擵, 釼摗岝惓, 晲椦丂嫓, 扟岥弶旤, 掔丂柧弮1, 淎丂彯揟, 曐棙丂堦, 杧峕惓抦, 怷丂峎帰, 媑愳丂揙 (1岞廜塹惗), 憤曇廤: 怷丂峎帰, 撿嶳摪, 搶嫗, 2021/6敪峴.
620009. [妛弍彂 (暘扴幏昅)]亂怑応偺儊儞僞儖僿儖僗晄挷丂崲擄帠椺傊偺懳墳椡偑偖傫偖傫忋偑傞SOAP婰榐弍亃p,178-94. 搉曈榓峀 (岞廜塹惗): 曇: 愳忋寷恖, 擄攇崕峴, 彫椦桼壚, 惤怣彂朳, 搶嫗, 2021/6敪峴.
620010. [妛弍彂 (暘扴幏昅)]亂儊儞僞儖僿儖僗丒儅僱僕儊儞僩専掕帋尡岞幃僥僉僗僩丂I庬儅僗僞乕僐乕僗 (戞5斉)亃戞8復2愡 娗棟娔撀幰傊偺嫵堢尋廋, p.341-8. 掔丂柧弮 (岞廜塹惗), 曇: 戝嶃彜岺夛媍強, 拞墰宱嵪幮, 搶嫗, 2021/7敪峴.
620011. [妛弍彂 (暘扴幏昅)]亂幮夛丒娐嫬偲寬峃 岞廜塹惗妛 2022擭斉亃CHAPTER 9 惛恄幘姵, p.97-102. 掔丂柧弮 (岞廜塹惗), 曇廤戙昞: 桍愳丂梞, 曇挊: 旜搰弐擵, 堛帟栻弌斉, 搶嫗, 2022/1敪峴.
620012. [妛弍彂 (暘扴幏昅)]亂幮夛丒娐嫬偲寬峃 岞廜塹惗妛 2022擭斉亃CHAPTER 10 帺嶦, 晄椂偺帠屘, 媠懸, 朶椡, p.103-6. 掔丂柧弮 (岞廜塹惗), 曇廤戙昞: 桍愳丂梞, 曇挊: 旜搰弐擵, 堛帟栻弌斉, 搶嫗, 2022/1敪峴.
[妛夛丒尋媶夛摍]
711001. [妛夛 (崙嵺)] (摿暿島墘) Long working hours and the consequences: health problems and work-life balance. Tsutsumi A1: 2nd Conference of the Asia Pacific Academy for Psychosocial Factors at Work (2021/7/30), Web奐嵜. (掔丂柧弮1: 1岞廜塹惗)
712003. [妛夛 (崙嵺)] Association of long working hours and ischemic stroke among Japanese workers. Tsutsumi A1: 16th International Congress of Behavioral Medicine (ICBM) (2021/6/7-12), Glasgow, UK (Web奐嵜), International Journal of Behavioral Medicine 2021/6; 28 (SUPPL 1): S130. (掔丂柧弮1: 1岞廜塹惗)
712004. [妛夛 (崙嵺)] (SEMI-PLENARY) Preventing overwork related disorders "Karoshi". Tsutsumi A1: 33rd International Congress on Occupational Health (ICOH 2022) (2022/2/9), Web奐嵜. (掔丂柧弮1: 1岞廜塹惗)
713005. [妛夛 (崙嵺)] (堦斒島墘) Association of long working hours and ischemic stroke among Japanese workers. Tsutsumi A1: 16th International Congress of Behavioural Medicine (ICBM) (2021/6/7), Web奐嵜. (掔丂柧弮1: 1岞廜塹惗)
722015. [妛夛 (慡崙)] (僔儞億僕僂儉) 慡偰偺恖偵嶻嬈曐寬偺岝傪亅懡條側攚宨偵傛傝摥偒偵偔偝傪書偊傞楯摥幰偵亅. 掔丂柧弮 (岞廜塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/21), 挿栰 (僴僀僽儕僢僪奐嵜), 嶻嬈塹惗妛嶨帍 戞94夞擔杮嶻嬈塹惗妛夛島墘廤 2021; 63 (椪帪憂姧): 145.
722016. [妛夛 (慡崙)] (僔儞億僕僂儉) AI帪戙偺寬峃堛椕僨乕僞妶梡偲偦偺壽戣. 掔丂柧弮 (岞廜塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/19), 挿栰 (僴僀僽儕僢僪奐嵜), 嶻嬈塹惗妛嶨帍 戞94夞擔杮嶻嬈塹惗妛夛島墘廤 2021; 63 (椪帪憂姧): 183.
722017. [妛夛 (慡崙)] (僔儞億僕僂儉) International Symposium. 掔丂柧弮 (岞廜塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/20), 挿栰 (僴僀僽儕僢僪奐嵜), 嶻嬈塹惗妛嶨帍 戞94夞擔杮嶻嬈塹惗妛夛島墘廤 2021; 63 (椪帪憂姧): 305.
722018. [妛夛 (慡崙)] (僔儞億僕僂儉) 寬峃偺幮夛揑寛掕梫場偵懳偡傞傾僾儘乕僠. 掔丂柧弮 (岞廜塹惗): 戞62夞擔杮怱恎堛妛夛憤夛側傜傃偵妛弍島墘夛 (2021/7/10), 崄愳 (僴僀僽儕僢僪奐嵜), 怱恎堛妛 2021; 61 (5): 18.
722019. [妛夛 (慡崙)] (僔儞億僕僂儉) 僐儘僫壭偵偍偗傞楯摥幰偺恎懱妶摦偺曄壔偲儊儞僞儖僿儖僗. 搉曈榓峀 (岞廜塹惗): 擔杮怱棟妛夛戞85夞戝夛 (2021/9/1-8), Web奐嵜.
722020. [妛夛 (慡崙)] (帺桼廤夛) 擔崰埖偆幮撪僨乕僞偐傜尰応偵栶棫偮儕僒乕僠僋僄僗僠儑儞傪峫偊傛偆. 搉曈榓峀1, 嬥怷丂屽, 壜抦桰巕1, 怺堜峲懢 (1岞廜塹惗): 戞31夞擔杮嶻嬈塹惗妛夛慡崙嫤媍夛 (2021/12/3), 嶰廳 (僴僀僽儕僢僪奐嵜).
722021. [妛夛 (慡崙)] (僔儞億僕僂儉) 堛椕嬑柋娐嫬夵慞偵傛傞堛巘偺摥偒曽夵妚亅堛巘偲偟偰偳偺傛偆偵摥偒偨偄偐亅戝妛嬑柋摍偺楯摥娐嫬偺夵慞偵岦偗偰偺挷嵏曬崘. 掔丂柧弮 (岞廜塹惗): 戞159夞擔杮堛妛夛僔儞億僕僂儉 (2021/12/25), 搶嫗, 擔杮堛巘夛嶨帍 2022/3; 150 (12): 2225.
722022. [妛夛 (慡崙)] (僔儞億僕僂儉) 崅僗僩儗僗幰柺愙尋廋偺偨傔偺儅僯儏傾儖偲摦夋: 崅僗僩儗僗幰柺愙偺偁傞傋偒曽岦惈. 掔丂柧弮 (岞廜塹惗): 戞28夞擔杮嶻嬈惛恄曐寬妛夛 (2021/11/20-2022/1/10), Web奐嵜, 嶻嬈惛恄曐寬戞28夞擔杮嶻嬈惛恄曐寬妛夛彺榐廤 2021/11; 29 (憹姧崋): 80-1.
722023. [妛夛 (慡崙)] (僔儞億僕僂儉) 崅僗僩儗僗幰柺愙偺偁傞傋偒曽岦惈. 掔丂柧弮1, 廐嶳丂崉 (1岞廜塹惗): 戞28夞擔杮嶻嬈惛恄曐寬妛夛 (2021/11/20-2022/1/10), Web奐嵜, 嶻嬈惛恄曐寬妛夛嶨帍 2021; 30 (2): 167-70.
722024. [妛夛 (慡崙)] (僔儞億僕僂儉) 幐攕偐傜妛傇嶻嬈僗僩儗僗: 帺嶦懳嶔嫵堢偺揥奐. 掔丂柧弮 (岞廜塹惗): 戞29夞擔杮嶻嬈僗僩儗僗妛夛 (2022/3/25-26), 垽抦 (僴僀僽儕僢僪奐嵜).
722025. [妛夛 (慡崙)] (僔儞億僕僂儉) 億僗僩僐儘僫傪尒悩偊偨僙儖僼儅僱僕儊儞僩乽恎懱妶摦乿. 搉曈榓峀 (岞廜塹惗): 戞29夞擔杮嶻嬈僗僩儗僗妛夛 (2022/3/26), 垽抦 (僴僀僽儕僢僪奐嵜).
723079. [妛夛 (慡崙)] (堦斒岥墘) 楯摥幰偺庡娤揑僂僃儖價乕僀儞僌岦忋偺偨傔偺柍嶌堊壔斾妑帋尡偺儊僞暘愅. 烴扟偁偡偐, 崱懞岾懢榊, 掔丂柧弮1, 搰捗柧恖, 愳忋寷恖 (1岞廜塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/20), 挿栰 (僴僀僽儕僢僪奐嵜), 嶻嬈塹惗妛嶨帍 戞94夞擔杮嶻嬈塹惗妛夛島墘廤 2021; 63 (椪帪憂姧): 336.
723080. [妛夛 (慡崙)] (堦斒岥墘) 儅僞僯僥傿僴儔僗儊儞僩偲娭楢偡傞怑応娐嫬梫場: 怴宆僐儘僫僂僀儖僗棳峴壓偱偺専摙. 壜抦桰巕1, 峕岥丂彯, 堜忋彶恇, 摗尨晲抝, 攏応岾巕, 懢揷丂姲1, 掔丂柧弮1 (1岞廜塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/19), 挿栰 (僴僀僽儕僢僪奐嵜), 嶻嬈塹惗妛嶨帍 戞94夞擔杮嶻嬈塹惗妛夛島墘廤 2021; 63 (椪帪憂姧): 364.
723081. [妛夛 (慡崙)] (億僗僞乕) 扨恎偲僥儗儚乕僋幚巤偵敽偆惛恄揑寬峃偺埆壔偵懳偡傞僆儞儔僀儞岎棳嶲壛偺娚徴岠壥. 堜忋彶恇, 嵅乆栘撨捗, 崱懞岾懢榊, 崱堜揝暯, 峕岥丂彯, 彫椦桼壚, 崅嶳攷岝, 掔丂柧弮1 (1岞廜塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/24-6/25), 挿栰 (僴僀僽儕僢僪奐嵜), 嶻嬈塹惗妛嶨帍 戞94夞擔杮嶻嬈塹惗妛夛島墘廤 2021; 63 (椪帪憂姧): 480.
723082. [妛夛 (慡崙)] (堦斒岥墘) 帺帯懱怑応偵偍偗傞OSHMS掕拝偲埨慡塹惗巜昗傗妶摦傊偺塭嬁昡壙戞27曬. 搉曈桾峎, 峛揷栁庽 ,嵅乆栘婤, 徏梩巎巕, 埳摗徍岲, 尨丂朚晇, 掔丂柧弮1, 娵嶳惓帯, 嶳岥廏庽 (1岞廜塹惗): 戞94夞擔杮嶻嬈塹惗妛夛 (2021/5/24-6/25), 挿栰 (僴僀僽儕僢僪奐嵜), 嶻嬈塹惗妛嶨帍 戞94夞擔杮嶻嬈塹惗妛夛島墘廤 2021; 63 (椪帪憂姧): 559.
723083. [妛夛 (慡崙)] (億僗僞乕) 忋巌丒摨椈偺巟墖偲怱棟揑僨傿僗僩儗僗偺夵慞偲偺娭楢: 1擭娫偺廲抐尋媶. 堜忋椾巕1, 堷抧攷擵1, 壜抦桰巕1, 搉曈榓峀1, 峳堜桳旤1, 娾揷丂徃, 掔丂柧弮1 (1岞廜塹惗): 戞31夞擔杮嶻嬈塹惗妛夛慡崙嫤媍夛 (2021/12/3-2022/1/10), 嶰廳 (僴僀僽儕僢僪奐嵜), 戞31夞擔杮嶻嬈塹惗妛夛慡崙嫤媍夛島墘廤 2021; p.253.
723084. [妛夛 (慡崙)] (億僗僞乕) 彫婯柾帠嬈強偺怑応娐嫬夵慞偵娭偡傞僀儞僞價儏乕挷嵏寢壥偲暘愅. 拞搱抦宐, 怷岥師榊, 撪揷梲擵, 悈杮惓巙, 嵅栰桭旤, 彫搰寶堦, 媑愳墄巕, 媑愳丂揙, 掔丂柧弮1 (1岞廜塹惗): 戞31夞擔杮嶻嬈塹惗妛夛慡崙嫤媍夛 (2021/12/3-2022/1/10), 嶰廳 (僴僀僽儕僢僪奐嵜), 戞31夞擔杮嶻嬈塹惗妛夛慡崙嫤媍夛島墘廤 2021; p.272.
723085. [妛夛 (慡崙)] (堦斒岥墘) 晝恊偺堢帣昿搙偲梒帣偺挿帪娫偺僥儗價帇挳偲偺娭楢: 21悽婭弌惗帣廲抐挷嵏傛傝. 壜抦桰巕1, 壛摗彸旻, 墇抭恀撧旤, 塱媑恀巕, 抾尨寬擇 (1岞廜塹惗), 戞80夞擔杮岞廜塹惗妛夛憤夛 (2021/12/21-2022/3/14), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮岞廜塹惗妛夛憤夛彺榐廤 2021/11; 80: 236.
723086. [妛夛 (慡崙)] (堦斒岥墘) 枛巕偑枹廇妛帣偺巕偳傕傪帩偮晝恊偺惗妶帪娫. 戝捤旤栯巕, 抾尨寬擇, 壛摗彸旻, 墇抭恀撧旤, 壜抦桰巕1 (1岞廜塹惗), 戞80夞擔杮岞廜塹惗妛夛憤夛 (2021/12/21-2022/3/14), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮岞廜塹惗妛夛憤夛彺榐廤 2021/11; 80: 236.
723087. [妛夛 (慡崙)] (堦斒岥墘) 崅楊幰曐寬偦偺懠. 掔丂柧弮 (岞廜塹惗): 戞32夞擔杮塽妛夛妛弍憤夛 (2022/1/26-28), Web奐嵜, 戞32夞擔杮塽妛夛妛弍憤夛島墘廤 2022; p.26.
732006. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 搶擔杮戝恔嵭旐嵭抧偵偍偗傞儗僕儕僄儞僗偲僜乕僔儍儖丒僉儍僺僞儖. 堷抧攷擵 (岞廜塹惗): JAGES婡峔愝棫3廃擭婰擮僔儞億僕僂儉乽寬峃婋婡傊偺儗僕儕僄儞僗偲怴帪戙傊偺扙旂亅姶愼徢丒帺慠嵭奞傪椺偵亅乿(2021/5/14), Web奐嵜.
732007. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 堛巘偺摥偒曽夵妚 Workstyle reform for Japanese doctors. 掔丂柧弮 (岞廜塹惗): 擔杮杻悓壢妛夛2021擭搙巟晹妛弍廤夛杒奀摴丒搶杒巟晹戞11夞妛弍廤夛 (2021/9/4-10/4), Web奐嵜.
732008. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 怑応偺懡條側奜崙弌恎恖嵽偺僀儞僋儖乕僕儑儞偺曽朄乣懡暥壔娫惛恄堛妛夛偺帇揰偐傜. 掔丂柧弮 (岞廜塹惗): 戞62夞嶻嬈惛恄塹惗尋媶夛 (2022/2/12), Web奐嵜.
732009. [妛夛 (抧曽夛丒尋媶夛)] (婎挷島墘) 怑応偺懡條側奜崙弌恎恖嵽偺僀儞僋儖乕僕儑儞偺悇恑. 掔丂柧弮 (岞廜塹惗): 戞62夞嶻嬈惛恄塹惗尋媶夛 (2022/2/12), Web奐嵜.
733016. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 抧堟嶻嬈曐寬僙儞僞乕偺彫婯柾帠嬈応偺儊儞僞儖僿儖僗妶摦偺巟墖偺尰忬. 峕岥丂彯, 擔栰垷栱巕, 掔丂柧弮1 (1岞廜塹惗): 戞62夞嶻嬈惛恄塹惗尋媶夛 (2022/2/12), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110006. [尨挊] Role ambiguity as an amplifier of the association between job stressors and workers' psychological ill-being: Evidence from an occupational survey in Japan. Oshio T, Inoue A, Tsutsumi A1: J Occup Health 2021/1; 63 (1): e12310. (掔丂柧弮1: 1岞廜塹惗)
'20-110007. [尨挊] Internet-based acceptance and commitment therapy programme 'Happiness Mom' for well-being: a protocol for a randomised controlled trial. Sasaki N, Imamura K, Nishi D, Watanabe K1, Sekiya Y, Tsuno K, Kobayashi Y, Kawakami N: BMJ Open 2021/2; 11 (2): e042167. (搉曈榓峀1: 1岞廜塹惗)
'20-110008. [尨挊] Association between energy drink consumption and substance use in adolescence: A systematic review of prospective cohort studies. Yasuma N, Imamura K, Watanabe K1, Nishi D, Kawakami N, Takano A: Drug Alcohol Depend 2021/2; 219: 108470. (搉曈榓峀1: 1岞廜塹惗)
朄堛妛
[妛弍榑暥]
110080. [尨挊] Y chromosome analysis for common surnames in the Japanese male population. Ochiai E1, Osawa M, Satoh S, Tamura T, Nakatome M, Kaneko Y, Kakimoto Y, Minaguchi K: J Hum Genet 2021/7; 66 (7): 731-8. (棊崌宐棟巕1: 1朄堛)
110081. [尨挊] A survey of solitary death by heat stroke in Yokohama City. Kakiuchi Y, Nagao R, Ochiai E1, Kakimoto Y, Osawa M: Journal of Public Health 2021/10; 29: 1055-9. (棊崌宐棟巕1: 1朄堛)
310004. [徢椺曬崘] Rare primary peritoneal mucinous adenocarcinoma in a 69-year-old man. Satoh F1, Tsutsumi Y: Clin Case Rep 2021/9; 9 (9): e04820. (嵅摗暥巕1: 1朄堛)
[妛夛丒尋媶夛摍]
713006. [妛夛 (崙嵺)] (億僗僞乕) Relation between sudden death during bathing and age-related changes in the heart. Satoh F1, Irie W1, Sasaki C1, Ochiai E1, Inoue H2, Saito J2, Kondo M2, Nakamaru N3, Sakamoto M3, Nagato J3: 100. Jahrestagung der Deutschen Gesellschaft f焤 Rechtsmedizin (2021/9/15), Munich, Germany (Web), Abstracts 2021/7; p.364. (嵅摗暥巕1, 擖峕丂徛1, 嵅乆栘愮庻巕1, 棊崌宐棟巕1, 堜忋擔嵷巕2, 釼摗弨堦榊2, 嬤摗恀斂2, 拞娵彯旤3, 嶃杮搷巕3, 挿栧弮暯3: 1朄堛, 2戝妛堾堛椕宯尋媶壢, 3宍懺宯)
723088. [妛夛 (慡崙)] (億僗僞乕) DSMS僾儘僕僃僋僩偵偍偗傞栻暔暘愅偺昳幙娗棟偵岦偗偨僽儔僀儞僪僥僗僩幚巤曬崘 (2020擭). 嵅乆栘愮庻巕1, 嵅摗暥巕1 (1朄堛): 戞105師擔杮朄堛妛夛妛弍慡崙廤夛 (2021/10/4-31), Web奐嵜, 島墘梫巪廤 2021/5; p.41.
723089. [妛夛 (慡崙)] (億僗僞乕) RapidHIT ID僔僗僥儉傪梡偄偨Touch DNA夝愅. 棊崌宐棟巕1,2, 徏搰丂桾2, 奯杮桼晍2, 戝郪帒庽2 (1朄堛, 2搶奀戝妛堛妛晹婎斦恌椕妛宯朄堛妛): 戞105師擔杮朄堛妛夛妛弍慡崙廤夛 (2021/10/4-31), Web奐嵜, 島墘梫巪廤 2021/5; p.49.
723090. [妛夛 (慡崙)] (億僗僞乕) 岎捠巰朣帠屘偵偍偗傞堄恾揑側幵椉徴撍偺娭梌. 戝郪帒庽1, 戝榓揷岾墑1, 怴徖戱奀1, 奯杮桼晍1, 捸堜廐抝1, 棊崌宐棟巕1,2, 嵅摗暥巕2 (1搶奀戝妛堛妛晹婎斦恌椕妛宯朄堛妛, 2朄堛): 戞105師擔杮朄堛妛夛妛弍慡崙廤夛 (2021/10/4-31), Web奐嵜, 島墘梫巪廤 2021/5; p.52.
723091. [妛夛 (慡崙)] (億僗僞乕) 婥摴傊偺攣曅媧堷傪擣傔偨偑寣拞CO-Hb朞榓搙偺忋徃傪擣傔側偐偭偨1朥専椺. 擖峕丂徛1, 嵅乆栘愮庻巕1, 拞娵彯旤2, 嶃杮搷巕2, 挿栧弮暯2, 堜忋擔嵷巕3, 嵅摗暥巕1 (1朄堛, 2宍懺宯, 3戝妛堾堛椕宯尋媶壢): 戞105師擔杮朄堛妛夛妛弍慡崙廤夛 (2021/10/4-31), Web奐嵜, 島墘梫巪廤 2021/5; p.57.
723092. [妛夛 (慡崙)] (堦斒岥墘) 僎僲儉僨乕僞偺帩偮屄恖幆暿惈. 揷懞桭婭1,2, 棊崌宐棟巕2,3, 嶳嶈堦庽1, 戝郪帒庽2 (1恄撧愳導寈嶡壢妛憑嵏尋媶強, 2搶奀戝妛堛妛晹婎斦恌椕妛宯朄堛妛, 3朄堛): 擔杮朄壢妛媄弍妛夛戞27夞妛弍廤夛 (2021/11/11-12), Web奐嵜, 擔杮朄壢妛媄弍妛夛帍 2021/10; 26(Suppl): 31.
723093. [妛夛 (慡崙)] (堦斒岥墘) 儀僢僪偐傜揮棊屻偵媫曄偟, 攕寣徢偵傛傝巰朣偟偨怴惗帣朥専椺. 嵅摗暥巕1, 擖峕丂徛1, 嵅乆栘愮庻巕1, 棊崌宐棟巕1, 拞娵彯旤2, 嶃杮搷巕2, 挿栧弮暯2, 堜忋擔嵷巕3, 釼摗弨堦榊3 (1朄堛, 2宍懺宯, 3戝妛堾堛椕宯尋媶壢): 戞27夞擔杮SIDS丒擕梒帣撍慠巰梊杊妛夛 (2022/2/19-20), Web奐嵜, 僾儘僌儔儉丒彺榐廤 2021/2; p24.
723094. [妛夛 (慡崙)] (堦斒岥墘) 擕梒帣撍慠巰椺偱専弌偝傟偨PHOX2B堚揱巕偺旕億儕傾儔僯儞儕僺乕僩曄堎. 戝郪帒庽1, 忋揷丂撃1, 撪摗弔尠1, 棊崌宐棟巕2, 奯杮桼晍1, 嵅摗暥巕2 (1搶奀戝妛堛妛晹婎斦恌椕妛宯朄堛妛, 2朄堛): 戞27夞擔杮SIDS丒擕梒帣撍慠巰梊杊妛夛 (2022/2/19-20), Web奐嵜, 僾儘僌儔儉丒彺榐廤 2021/2; p.30.
733017. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 擖梺拞媫巰偵偍偗傞擼恄宱嵶朎偺嫊寣惈曄壔偵偮偄偰偺専摙. 堜忋擔嵷巕1, 嵅摗暥巕2, 擖峕丂徛2, 嵅乆栘愮庻巕2, 棊崌宐棟巕2, 拞娵彯旤3, 嶃杮搷巕3, 挿栧弮暯3, 釼摗弨堦榊1 (1戝妛堾堛椕宯尋媶壢, 2朄堛, 3宍懺宯): 戞90夞擔杮朄堛妛夛妛弍娭搶抧曽廤夛 (2021/10/9), Web奐嵜, 島墘梫巪廤 2021/10; p.22.
733018. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 朄堛専懱偺栻暔暘愅偺幚嵺偲拲堄揰偵偮偄偰乣杒棦戝妛偺尰忬乣. 嵅乆栘愮庻巕 (朄堛): 戞6夞擔杮堛梡儅僗僗儁僋僩儖妛夛搶晹夛 (2021/11/6), Web奐嵜, JSBMS Letters 2021/6; 46 (2): 27.
幚尡摦暔妛
[妛弍榑暥]
110082. [尨挊] A highly efficient method for extracting peptides from a single mouse hypothalamus. Nakagawa Y, Matsui T, Konno R, Kawashima Y, Sato T1, Itakura M2, Kodera Y: Biochem Biophys Res Commun 2021/4; 548: 155-60. (嵅摗弐嵠1, 斅憅丂惤2: 1幚摦, 2惗壔)
110083. [尨挊] Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model. Kato T, Manabe R, Igarashi H, Kametani F, Hirokawa S, Sekine Y, Fujita N, Saito S, Kawashima Y, Hatano Y, Ando S, Nozaki H, Sugai A, Uemura M, Fukunaga M, Sato T1, Koyama A, Saito R, Sugie A, Toyoshima Y, Kawata H, Murayama S, Matsumoto M, Kakita A, Hasegawa M, Ihara M, Kanazawa M, Nishizawa M, Tsuji S, Onodera O: J Clin Invest 2021/11; 131 (22): e140555. (嵅摗弐嵠1: 1幚摦)
[挊丂彂]
620013. [妛弍彂 (暘扴幏昅)]亂僸僩偺暘巕堚揱妛 戞5斉亃21復 儌僨儖惗暔偲幘姵偺儌僨儖壔, p.735-76 嵅摗弐嵠 (幚摦), 娔栿: 屗揷払巎, 堜忋丂憦, 徏杮捈捠, 儊僨傿僇儖丒僒僀僄儞僗丒僀儞僞乕僫僔儑僫儖, 搶嫗, 2021/10敪峴.
[妛夛丒尋媶夛摍]
733019. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) ALS尨場堚揱巕嶻暔TDP-43偺夝愅. 嵅摗弐嵠 (幚摦): 2021擭搙擼尋媶強嫟摨棙梡嫟摨尋媶 (嶚壀斍) (2022/2/9), Web奐嵜.
柶塽妛
[妛弍榑暥]
110084. [尨挊] Natural Killer Cell Group 7 Sequence in Cytotoxic Cells Optimizes Exocytosis of Lytic Granules Essential for the Perforin-Dependent, but Not Fas Ligand-Dependent, Cytolytic Pathway. Morikawa Y, Murakami M, Kondo H1, Nemoto N, Iwabuchi K2, Eshima K2: Immunohorizons 2021/4; 5 (4): 234-45. (嬤摗丂嬒1, 娾熀榓栫2, 峕搰峩擇2: 1戝妛堾堛椕宯尋媶壢, 2柶塽)
110085. [尨挊] Activation of Invariant Natural Killer T Cells by 兛-Galactosylceramide Attenuates the Development of Angiotensin II-Mediated Abdominal Aortic Aneurysm in Obese ob/ob Mice. Saito A, Ishimori N, Tokuhara S, Homma T, Nishikawa M, Iwabuchi K1, Tsutsui H: Front Cardiovasc Med 2021/5; 8: 659418. (娾熀榓栫1: 1柶塽)
110086. [尨挊] A new approach to analysis of intracellular proteins and subcellular localization using cellprofiler and imageJ in combination. Hattori A1, Ohta E2, Nagai M3, Iwabuchi K4, Okano E: Methods 2021/4; S1046-2023 (21) 00111-0. doi: 10.1016/j.ymeth.2021.04.019. Online ahead of print. (暈晹惛恖1, 懢揷墄楴2, 塱堜恀婱巕3, 娾熀榓栫4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3擼恄宱撪, 4柶塽)
110087. [尨挊] Natural Killer T Cells Are Involved in Atherosclerotic Plaque Instability in Apolipoprotein-E Knockout Mice. Ohmura Y, Ishimori N, Saito A, Yokota T, Horii S, Tokuhara S, Iwabuchi K4, Tsutsui H: Int J Mol Sci 2021/11; 22 (22): 12451. (娾熀榓栫4: 4柶塽)
110088. [尨挊] Development of an immunochromatographic test for the detection of Mycoplasma pneumoniae GroES antigen. Matsui H, Sugimura M, Inoue-Tsuda M, Iwabuchi K4, Hanaki H: J Microbiol Methods 2021/12; 191: 106359. (娾熀榓栫4: 4柶塽)
110089. [尨挊] Adipose invariant NKT cells interact with CD1d-expressing macrophages to regulate obesity-related inflammation. Satoh M1, Iizuka M2, Majima M3, Ohwa C, Hattori A, Van Kaer L, Iwabuchi K1: Immunology 2022/4; 165 (4): 414-27. doi: 10.1111/imm.13447. Epub 2022 Feb 28. (嵅摗丂夒1, 斞捤傒偝傪2, 攏搱惓棽3, 娾熀榓栫1: 1柶塽, 2梊杊堛妛宯, 3栻棟)
522021. [島嵗]亂奜崙帍梫棗亃幚尡揑帺屓柶塽惈傇偳偆枌栐枌墛偺嵞敪偵偍偗傞僀儞僶儕傾儞僩僫僠儏儔儖僉儔乕T嵶朎偺杊岇揑栶妱. 揷怟壞奀, 壛摗懢婌, 嵅摗丂夒1, 斞捤傒偝傪2, 扟岥丂崕, 杒巗怢媊, 娾熀榓栫1 (1柶塽, 2梊杊堛妛宯)丗擔杮娽壢妛夛帍 2021/5; 125 (5): 558.
522022. [島嵗]亂摿廤1乹Basic Science乺: 帺慠柶塽宆T嵶朎偺怴揥奐亃帺慠T嵶朎尋媶偺恑揥. 娾熀榓栫 (柶塽): 墛徢偲柶塽 2021/6; 29 (4): 283-7.
522023. [島嵗]亂摿廤: 儀乕僠僃僢僩昦亅婎慴偲椪彴偺嵟怴抦尒亅亃II. 婎慴尋媶丂5. 幚尡揑帺屓柶塽惈傇偳偆枌墛儌僨儖偺墛徢惂屼. 娾熀榓栫1, 揷怟壞奀, 壛摗懢婌, 嵒摐丂夒 (1柶塽): 擔杮椪喱 2021/6; 79 (6): 843-9.
[妛夛丒尋媶夛摍]
722026. [妛夛 (慡崙)] (僔儞億僕僂儉乯惗懱杊屼尋媶偺尰忬偲揥朷: 帺慠T嵶朎傪夘偟偨幘姵惂屼偺帋傒. 娾熀榓栫 (柶塽): 戞32夞擔杮惗懱杊屼妛夛妛弍憤夛 (2021/9/8), Web奐嵜.
723095. [妛夛 (慡崙)] (堦斒島墘)亂20儕儞僷愡俀丒憿寣婍丒銪憻亃幚尡揑帺屓柶塽惈傇偳偆枌墛嵞敪儌僨儖偺NKT嵶朎偵傛傞惂屼. 娾熀榓栫 (柶塽): 戞110夞擔杮昦棟妛夛憤夛 (2021/4/24), 搶嫗 (僴僀僽儕僢僪奐嵜).
723096. [妛夛 (慡崙)] (堦斒島墘) 帀朾慻怐NKT嵶朎偲儅僋儘僼傽乕僕偺憡屳嶌梡偵傛傞枬惈墛徢偺惂屼. 嵅摗丂夒1, 娾熀榓栫1 (1柶塽): 戞30夞Kyoto T Cell Conference (2021/10/8), Web奐嵜.
723097. [妛夛 (慡崙)] (堦斒島墘) 彎奞梓棻枌暘巕Nkg7偵傛傞梓棻曻弌惂屼媦傃嵶朎彎奞婡擻懀恑. 峕搰峩擇1, 怷愳桪庽, 嬤摗丂嬒2, 懞忋丂撿, 崅徏徆巕1, 崻杮揟巕, 娾熀榓栫1 (1柶塽, 2戝妛堾堛椕宯尋媶壢): 戞30夞Kyoto T Cell Conference (2021/10/9), Web奐嵜.
723098. [妛夛 (慡崙)] (堦斒島墘) U1 RNP can induce NETosis to isolated mouse neutrophils through NOX2 independent pathway. 抾撪宐旤巕1, 戝捗丂恀2, 抾撪峃梇3, 娾熀榓栫1 (1柶塽, 2桝寣丒嵶朎堏怉, 3恡憻撪): 戞50夞擔杮柶塽妛夛妛弍廤夛 (2021/12/10), 撧椙 (僴僀僽儕僢僪奐嵜).
723099. [妛夛 (慡崙)] (堦斒島墘) Eomesodermin in CD8+ CTLs induces the expression of Nkg7 which specifically promotes perforin/granzyme-pathway of cytolysis by optimizing exocytosis of lytic granules. 峕搰峩擇1, 娾熀榓栫1, 怷愳桪庽, 嬤摗丂嬒2, 崻杮揟巕 (1柶塽, 2戝妛堾堛椕宯尋媶壢): 戞50夞擔杮柶塽妛夛妛弍廤夛 (2021/12/10), 撧椙 (僴僀僽儕僢僪奐嵜).
723100. [妛夛 (慡崙)] (堦斒島墘) Analyses of cross-reactivity of T cells specific for murine tumor cell lines. 嬤摗丂嬒1, 峕搰峩擇2, 墫尒丂榓3, 娾熀榓栫2 (1戝妛堾堛椕宯尋媶壢, 2柶塽, 3屇媧婍奜): 戞50夞擔杮柶塽妛夛妛弍廤夛 (2021/12/10), 撧椙 (僴僀僽儕僢僪奐嵜).
723101. [妛夛 (慡崙)] (堦斒島墘) Adipose iNKT cell interacting with macrophage regulates obesity-associated inflammation. 嵅摗丂夒1, 娾熀榓栫1 (1柶塽): 戞50夞擔杮柶塽妛夛妛弍廤夛 (2021/12/10), 撧椙 (僴僀僽儕僢僪奐嵜).
723102. [妛夛 (慡崙)] (堦斒島墘) Recurrence of experimental autoimmune uveoretinitis (EAU) induced by administration of Staphylococcal Enterotoxin B was ameliorated by NKT-cell activation. 戝榓愮掃1, 嵅摗丂夒2, 娾熀榓栫2 (1戝妛堾堛椕宯尋媶壢, 2柶塽): 戞50夞擔杮柶塽妛夛妛弍廤夛 (2021/12/10), 撧椙 (僴僀僽儕僢僪奐嵜).
733020. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嫻態旂幙忋旂嵶朎偺婡擻偵偍偗傞NF-築-inducing kinase偺婑梌偵偮偄偰. 峕搰峩擇1, 嶰郪壚撧, 娾熀榓栫1 (1柶塽): 戞40夞擔杮嫻態尋媶夛 (2021/2/6), Web奐嵜.
抧堟帣摱惛恄壢堛椕妛
嵞惗堛椕宍惉奜壢妛
抧堟憤崌堛椕妛
墛徢惈挵幘姵嫵堢丒椪彴尋媶妛
徚壔婍撪壢妛
[妛弍榑暥]
110090. [尨挊] Randomized study of prevention of gastrointestinal toxicities by nutritional support using an amino acid-rich elemental diet during chemotherapy in patients with esophageal cancer (KDOG 1101). Katada C1, Fukazawa S2, Sugawara M3, Sakamoto Y, Takahashi K, Takahashi A4, Watanabe A1, Wada T1, Ishido K1, Furue Y1, Harada H5, Hosoda K5, Yamashita K5,6, Hiki N5, Sato T7, Ichikawa T8, Shichiri M9, Tanabe S1,10, Koizumi W1: Esophagus 2021/4; 18 (2): 296-305. (寴揷恊棙1, 怺戲嵅宐巕2, 悰尨廩峀3, 崅嫶垷婭巕4, 搉绯峎幆1, 榓揷戱栫1, 愇屗尓師1, 屆峕峃柧1, 尨揷岹婸5, 嵶揷丂宩5, 嶳壓宲巎5,6, 斾婇捈庽5, 嵅摗晲榊7, 巗愳懜暥8, 幍棦崃媊9, 揷绯丂憦1,10, 彫愹榓嶰榊1: 1徚壔婍撪, 2塰梴晹, 3栻嵻晹, 4娕岇晹, 5忋晹徚壔娗奜, 6怴悽婭堛椕丒墶抐揑堛椕, 7堛椕媄弍嫵堢, 8堛椕塹惗妛晹, 9撪暘斿戙幱撪, 10怴悽婭堛椕丒愭抂堛椕)
110091. [尨挊] Determinant Factors on Differences in Survival for Gastric Cancer Between the United States and Japan Using Nationwide Databases. Ito Y, Miyashiro I, Ishikawa T, Akazawa K, Fukui K, Katai H, Nunobe S, Oda I, Isobe Y, Tsujitani S, Ono H, Tanabe S1,2, Fukagawa T, Suzuki S, Kakeji Y, Sasako M, Bilchik A, Fujita M: J Epidemiol 2021/4; 31 (4): 241-8. (揷绯丂憦1,2: 1怴悽婭堛椕丒愭抂堛椕, 2徚壔婍撪)
110092. [尨挊] Clinicopathological Features of Autoimmune Hepatitis with IgG4-Positive Plasma Cell Infiltration. Arase Y, Matsumoto K, Anzai K, Tsuruya K, Sugiyama S, Yoshihara S, Hirose S, Uojima H1, Hidaka H1, Nakazawa T1, Deguchi R, Kojima S, Takashimizu S, Shiraishi K, Shirai T, Kagawa T: Dig Dis 2021/5; 39 (3): 225-33. (嫑搱惏婭1, 擔崅丂墰1, 拞郪婱廏1: 1徚壔婍撪)
110093. [尨挊] Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease. Wada N1, Uojima H1, Satoh T2, Okina S3, Iwasaki S1, Shao X4, Takiguchi H, Arase Y, Itokawa N, Atsukawa M, Miyazaki K5, Hidaka H1, Kako M, Kagawa T, Iwakiri K, Horie R2, Suzuki T3, Koizumi W1: Dig Dis 2021/5; 39 (3): 234-42. (榓揷彯媣1, 嫑搱惏婭1, 嵅摗棽巌2, 墺丂慶惤3, 娾嶈廏堦榊1, 徲丂郪悡4, 媨鴵峗擇5, 擔崅丂墰1, 杧峕椙堦2, 楅栘棽峗3, 彫愹榓嶰榊1: 1徚壔婍撪, 2堛椕塹惗妛晹, 3寣塼撪, 4戝妛堾堛椕宯尋媶壢, 5桝寣丒嵶朎堏怉)
110094. [尨挊] Usefulness of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in elderly patients: a single-center retrospective cohort study. Ishido K1, Tanabe S1,2, Katada C1, Kubota Y1, Furue Y1, Wada T1, Watanabe A1, Koizumi W1: Jpn J Clin Oncol 2021/5; 51 (6): 895-904. (愇屗尓師1, 揷绯丂憦1,2, 寴揷恊棙1, 媣曐揷梲1, 屆峕峃柧1, 榓揷戱栫1, 搉绯峎幆1, 彫愹榓嶰榊1: 1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕)
110095. [尨挊] Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma. Tsujie M, Iwai T1, Kubo S, Ura T, Hatano E, Sakai D, Takeda Y, Kaibori M, Kobayashi T, Katanuma A, Katayose Y, Fukase K: Jpn J Clin Oncol 2021/5; 51 (6): 911-7. (娾堜抦媣1: 1徚壔婍撪)
110096. [尨挊] Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic Response. Toyoda H, Hiraoka A, Uojima H1, Nozaki A, Shimada N, Takaguchi K, Abe H, Atsukawa M, Matsuura K, Ishikawa T, Mikami S, Watanabe T, Itobayashi E, Tsuji K, Arai T, Yasuda S, Chuma M, Senoh T, Tsutsui A, Okubo T, Ehira T, Kumada T, Tanaka J: Hepatol Commun 2021/5; 5 (7): 1290-9. (嫑搱惏婭1: 1徚壔婍撪)
110097. [尨挊] Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry. Suzuki S, Takahashi A, Ishikawa T, Akazawa K, Katai H, Isobe Y, Miyashiro I, Ono H, Tanabe S1,2, Fukagawa T, Muro K, Nunobe S, Kadowaki S, Suzuki H, Irino T, Usune S, Miyata H, Kakeji Y, Registration Committee of the Japanese Gastric Cancer Association: Gastric Cancer 2021/5; 24 (3): 545-66. (揷绯丂憦1,2: 1怴悽婭堛椕丒愭抂堛椕, 2徚壔婍撪)
110098. [尨挊] Confirming Whether Fine Needle Biopsy Device Shortens the Learning Curve of Endoscopic Ultrasound-Guided Tissue Acquisition Without Rapid Onsite Evaluation. Lin MY, Wu CL, Kida M1, Chang WL,Sheu BS: Clin Endosc 2021/5; 54 (3): 420-7. (栘揷岝峀1: 1徚壔婍撪)
110099. [尨挊] Clinicopathological Features of Autoimmune Hepatitis with IgG4-Positive Plasma Cell Infiltration. Arase Y, Matsumoto K, Anzai K, Tsuruya K, Sugiyama S, Yoshihara S, Hirose S, Uojima H1, Hidaka H1, Nakazawa T1, Deguchi R, Kojima S, Takashimizu S, Shiraishi K, Shirai T, Kagawa T: Dig Dis 2021/5; 39 (3): 225-33. (嫑搱惏婭1, 擔崅丂墰1, 拞郪婱廏1: 1徚壔婍撪)
110100. [尨挊] New image-processing technology for endoscopic ultrasound-guided fine-needle aspiration biopsy specimen evaluation in patients with pancreatic cancer. Okuwaki K1, Imaizumi H1, Kida M1, Masutani H1, Watanabe M1, Adachi K2, Tadehara M2, Tamaki A2, Iwai T1, Yamauchi H1, Hasegawa R1, Kaneko T1, Kurosu T1, Koizumi W1: DEN open 2021/6; 2 (1): e21. (墱榚嫽夘1, 崱愹丂峅1, 栘揷岝峀1, 彙扟姲埲1, 搉曈恀堣1, 埨払丂夣2, 澍尨彨椙2, 嬍抲柧姲2, 娾堜抦媣1, 嶳撪峗巎1, 挿扟愳椡栫1, 嬥巕丂嫓1, 崟恵婱峗1, 彫愹榓嶰榊1: 1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢)
110101. [尨挊] Transoral surgery for superficial head and neck cancer: National Multi-Center Survey in Japan. Katada C1, Muto M, Fujii S, Yokoyama T, Yano T, Watanabe A, Iizuka T, Yoshinaga S, Tateya I, Mitani H, Shimizu Y, Takahashi A, Kamijo T, Hanaoka N, Abe M, Shiotani A, Kano K2, Asada Y, Matsuhashi T, Umeno H, Okami K, Goda K, Hori S, Ono Y, Terai S, Nagami Y, Takemura K, Kawada K, Ando M, Shimeno N, Arai A, Sakamoto Y, Ichinoe M3, Nemoto T, Fujita M, Watanabe H, Shimoda T, Ochiai A, Kato T, Hayashi R: Cancer Med 2021/6; 10 (12): 3848-61. (寴揷恊棙1, 壛擺岶堦2 堦屗徆柧3: 1徚壔婍撪, 2帹旲堲岮丒摢栩晹奜, 3昦棟)
110102. [尨挊] Defining the endoscopic ultrasound features of chronic pancreatitis in Asians: a multicenter validation study. Koh CJ, Lakhtakia S, Kida M1, Lesmana CRA, Ang TL, Vu CKF, Aye TT, Park SH, Almadi MA, Chong CC, Tang RSY, Wu X, Hilmi I, Dhir V, Pausawasdi N, Basha J, Jin ZD, Yang AM, Teoh AYB, Seo DW, Wang HP, Ho KY: Endoscop. 2021/6; 53 (6): 595-602. (栘揷岝峀1: 1徚壔婍撪)
110103. [尨挊] Histopathological comparison of aspiration and biopsy needles in endoscopic ultrasound-guided tissue acquisition in patients with subepithelial lesions. Watanabe M1, Okuwaki K1, Kida M1, Tadehara M2, Adachi K2, Masutani H1, Tamaki A2, Imaizumi H1, Iwai T1, Yamauchi H1, Kaneko T1, Hasegawa R1, Kurosu T1, Koizumi W1: Diagn Cytopathol 2021/7; 49 (7): 856-63. (搉绮恀堣1, 墱榚嫽夘1, 栘揷岝峀1, 澍尨彨椙2, 埨払丂夣2, 彙扟姲埲1, 嬍抲柧姲2, 崱愹丂峅1, 娾堜抦媣1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 崟恵婱峗1, 彫愹榓嶰榊1: 1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢)
110104. [尨挊] Cholecystitis after Placement of Covered Self-Expandable Metallic Stents in Patients with Distal Malignant Biliary Obstructions. Watanabe M1, Okuwaki K1, Woo J2, Kida M1, Imaizumi H1, Iwai T1, Yamauchi H1, Kaneko T1, Hasegawa R1, Kurosu T1, Minato N1, Haradome H3, Koizumi W1: Clin Endosc 2021/7; 54 (4): 589-95. (搉绮恀堣1, 墱榚嫽夘1, 鈀丂丂弫2, 栘揷岝峀1, 崱愹丂峅1, 娾堜抦媣1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 崟恵婱峗1, 柀丂彯婱1, 尨棷峅庽3, 彫愹榓嶰榊1: 1徚壔婍撪, 2曻幩慄 (夋憸), 3怴悽婭堛椕丒愭抂堛椕)
110027. [尨挊] Macrophages contribute to liver repair after monocrotaline-induced liver injury via SDF-1/CXCR4. Otaka F1, Ito Y2, Nakamoto S3, Nishizawa N3, Hyodo T4, Hosono K2, Majima M2, Koizumi W1, Amano H2: Exp Ther Med 2021/7; 22 (1): 668. (戝崅巎惞1, 埳摗媊栫2, 拞杮廋巌3, 惣郪怢嫳3, 暫摢揙栫4, 嵶栰壛撧巕2, 攏搱惓棽2, 彫愹榓嶰榊1, 揤栰塸庽2: 1徚壔婍撪, 2栻棟, 3堦斒丒彫帣丒娞抇鋁奜, 4宍惉丒旤梕奜)
110105. [尨挊] Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice. Toyoda H, Leong J, Landis C, Atsukawa M, Watanabe T, Huang DQ, Liu J, Quek SXZ, Ishikawa T, Arai T, Yokohama K, Chuma M, Takaguchi K, Uojima H1, Senoo T, Dang H, Maeda M, Hoang J, Le RH, Yasuda S, Thin KN, Tran S, Chien N, Henry L, Asai A, Fukunishi S, Cheung R, Lim SG, Trinh HN, Nguyen MH: Hepatology 2021/8; 74 (2): 656-66. (嫑搱惏婭1: 1徚壔婍撪)
110106. [尨挊] The Diagnosis of Drug-induced Liver Injury: Current Diagnostic Ability and Future Challenges of the Digestive Disease Week-Japan 2004 Scale 15 Years after Its Proposal. Watanabe M1, Shibuya A2, Yokomori H3, Koizumi W1: Intern Med 2021/8; 60 (16): 2557-68. (搉绮恀彶1, 廰扟柧棽2, 墶怷峅徍3, 彫愹榓嶰榊1: 1徚壔婍撪, 2堛椕埨慡丒娗棟, 3杒棦戝妛儊僨傿僇儖僙儞僞乕)
110107. [尨挊] Diagnostic Ability of High-definition Imaging Using Ultraslim Endoscopes in Early Gastric Cancer. Sugita T, Suzuki S, Ichijima R, Ogura K, Kusano C1, Ikehara H, Gotoda T, Moriyama M: J Gastric Cancer 2021/9; 21 (3): 246-57. (憪栰丂墰1: 1徚壔婍撪)
110108. [尨挊] Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology. Kikuchi N, Uojima H1, Hidaka H1, Iwasaki S1, Wada N1, Kubota K1, Nakazawa T1, Shibuya A2, Fujikawa T, Kako M, Sato T3, Koizumi W1: Hepatol Res 2021/9; 51 (9): 968-78. (嫑搱惏婭1, 擔崅丂墰1, 娾嶈廏堦榊1, 榓揷彯媣1, 孍揷岾夘1, 拞郪婱廏1, 廰扟柧棽2, 嵅摗徠巕3, 彫愹榓嶰榊1: 1徚壔婍撪, 2堛椕埨慡丒娗棟, 3塰梴晹)
110028. [尨挊] Recovery of Liver Sinusoidal Endothelial Cells Following Monocrotaline-induced Liver Injury. Otaka F1, Ito Y2, Goto T1, Kojo K3, Tanabe M1, Hosono K2, Majima M2, Koizumi W1, Amano H2: In Vivo 2021/9-10; 35 (5): 2577-87. (戝崅巎惞1, 埳摗媊栫2, 屻摗戩栫1, 屆忛丂寷3, 揷绯旤撧1, 嵶栰壛撧巕2, 攏搱惓棽2, 彫愹榓嶰榊1, 揤栰塸庽2: 1徚壔婍撪, 2栻棟, 3壓晹徚壔娗奜)
110109. [尨挊] Safety and feasibility of laparoscopic and endoscopic cooperative surgery for duodenal neoplasm: a retrospective multicenter study. Nunobe S1, Ri M1, Yamazaki K1, Uraoka M1, Ohata K1, Kitazono I1, Terashima M1, Yamagata Y1, Tanabe S1,2,3, Abe N1, Tsuji T1, Niimi K1, Kawakubo H1, Tsukada T1, Kitashiro S1, Ishizuka N1, Hiki N1,4 (1Society for the Study of Laparoscopic Endoscopic Cooperative Surgery): Endoscopy 2021/10; 53 (10): 1065-8. (揷绯丂憦1,2,3, 斾婇捈庽1,4: 2怴悽婭堛椕丒愭抂堛椕, 3徚壔婍撪, 4忋晹徚壔娗奜)
110110. [尨挊] A prospective multicenter study of endoscopic ultrasound-guided fine needle biopsy using a 22-gauge Franseen needle for pancreatic solid lesions. Ishigaki K1, Nakai Y1, Sasahira N1, Sugimori K1, Kitamura K1, Iwai T1,2, Matsubara S1, Shimura K1, Itoi T1, Ryozawa S1, Ushio J1, Doi S1, Imazu H1, Maetani I1, Isayama H1 (1Acquire Study Group): J Gastroenterol Hepatol 2021/10; 36 (10): 2754-61. (娾堜抦媣1,2: 2徚壔婍撪)
110111. [尨挊] Direct oral anticoagulants increase bleeding risk after endoscopic sphincterotomy: a retrospective study. Masuda S, Koizumi K, Nishino T, Tazawa T, Kimura K, Tasaki J, Ichita C, Sasaki A, Kako M, Uojima H1, Sugitani A: BMC Gastroenterol 2021/10; 24; 21 (1): 401. (嫑搱惏婭1: 1徚壔婍撪)
110112. [尨挊] Efficacy and safety of oral sulfate solution for bowel preparation in Japanese patients undergoing colonoscopy: Noninferiority-based, randomized, controlled study. Saito Y, Oka S, Tamai N, Kudo T, Kuniyoshi N, Shirakura T, Omae Y, Hamahata Y, Arai T, Tanaka S, Uedo N, Shimizu S, Fukuzawa M, Uraoka T, Ichinose S, Ogata H, Kobayashi K1,2, Saito S, Tajiri H: Dig Endosc 2021/11; 33 (7): 1131-8. (彫椦惔揟1,2: 1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪)
110113. [尨挊] Identifying Bleeding Etiologies by Endoscopy Affected Outcomes in 10,342 Cases With Hematochezia: CODE BLUE-J Study. Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K1, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Fukuzawa M, Itoi T, Uemura N, Kawai T, Kaise M: Am J Gastroenterol 2021/11; 116 (11): 2222-34. (愳娸壛撧1: 1徚壔婍撪)
110114. [尨挊] Dietary intake of vegetables, fruit, and antioxidants and risk of ulcerative colitis: A case-control study in Japan. Miyake Y1, Tanaka K1, Nagata C1, Furukawa S1, Andoh A1, Yokoyama T1, Yoshimura N1, Mori K1, Ninomiya T1, Yamamoto Y1, Takeshita E1, Ikeda Y1, Saito M1, Ohashi K1, Imaeda H1, Kakimoto K1, Higuchi K1, Nunoi H1, Mizukami Y1, Suzuki S1, Hiraoka S1, Okada H1, Kawasaki K1, Higashiyama M1, Hokari R1, Miura H1, Miyake T1, Kumagi T1, Kato H1, Hato N1, Sayama K1, Hiasa Y1; 1Japan Ulcerative Colitis Study Group (Collaborators: Yokoyama K2, et al): Nutrition 2021/11-12; 91-92: 111378. (墶嶳丂孫2: 2徚壔婍撪)
110115. [尨挊] Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Matsumoto T1, Okuwaki K1, Imaizumi H1, Kida M1, Iwai T1, Yamauchi H1, Kaneko T1, Hasegawa R1, Masutani H1, Tadehara M2, Adachi K2, Watanabe M1, Kurosu T1, Tamaki A2, Kikuchi H1, Ohno T1, Koizumi W1: Dig Dis Sci 2021/12; 66 (12): 4475-84. (徏杮崅柧1, 墱榚嫽夘1, 崱愹丂峅1, 栘揷岝峀1, 娾堜抦媣1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 彙扟姲埲1, 澍尨彨椙2, 埨払丂夣2, 搉曈恀堣1, 崟恵婱峗1, 嬍抲柧姲2, 媏抧廏旻1, 戝栰丂棽1, 彫愹榓嶰榊1: 1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢)
110116. [尨挊] Factors for unsuccessful endoscopic hemostasis in patients with severe peptic ulcer bleeding. Kubota Y1, Yamauchi H1, Nakatani K2, Iwai T1, Ishido K1, Masuda T2, Maruhashi T2, Tanabe S1,3: Scand J Gastroenterol 2021/12; 56 (12): 1396-405. (媣曐揷梲1, 嶳撪峗巎1, 拞扟寬搇2, 娾堜抦媣1, 愇屗尓師1, 憹揷抭惉2, 娵嫶岶徍2, 揷绯丂憦1,3: 1徚壔婍撪, 2媬柦, 3怴悽婭堛椕丒愭抂堛椕)
110117. [尨挊] Predictive Significance of Promoter DNA Methylation of Cysteine Dioxygenase Type 1 (CDO1) in Metachronous Gastric Cancer. Kubota Y1, Tanabe S1,2, Azuma M1, Horio K3, Fujiyama Y4, Soeno T4, Furue Y1, Wada T1, Watanabe A1, Ishido K1, Katada C1, Yamashita K5, Koizumi W1, Kusano C1: J Gastric Cancer 2021/12; 21 (4): 379-91. (媣曐揷梲1, 揷绯丂憦1,2, 搶丂悙抭1, 杧旜榓庻宐3, 摗嶳朏庽4, 揧栰岶暥4, 屆峕峃柧1, 榓揷戱栫1, 搉绯峎幆1, 愇屗尓師1, 寴揷恊棙1, 嶳壓宲巎5, 彫愹榓嶰榊1, 憪栰丂墰1: 1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕, 3昦懺丒恌椕宯, 4戝妛堾堛椕宯尋媶壢, 5怴悽婭堛椕丒墶抐揑堛椕)
110118. [尨挊] A genome-wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites. Kawaratani H, Sawai H, Onishi M, Kogiso T, Shimada N, Uojima H1, Nakajima T, Matsumoto N, Ikejima K, Ishikawa T, Terai S, Motoyama H, Komori A, Hirashima N, Saito S, Eguchi Y, Nojima M, Kawai Y, Tateyama M, Yoshiji H, Tanaka Y: Liver Int 2021/12; 41 (12): 2944-53. (嫑搱惏婭1: 1徚壔婍撪)
110119. [尨挊] Comparative study between sorafenib and lenvatinib as the first-line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real-world setting. Fukushima T, Morimoto M, Ueno M, Kubota K1, Uojima H1, Hidaka H1, Chuma M, Numata K, Tsuruya K, Hirose S, Kagawa T, Hattori N, Watanabe T, Matsunaga K, Yamamoto K, Tanaka K, Maeda S: JGH Open 2021/12; 6 (1): 29-35. (孍揷岾夘1, 嫑搱惏婭1, 擔崅丂墰1: 1徚壔婍撪)
110120. [尨挊] Long term impact of vonoprazan-based Helicobacter pylori treatment on gut microbiota and its relation to post-treatment body weight changes. Suzuki S, Gotoda T, Takano C, Horii T, Sugita T, Ogura K, Ichijima R, Kusano C1, Ikehara H: Helicobacter 2021/12; 26 (6): e12851. (憪栰丂墰1: 1徚壔婍撪)
110121. [尨挊] The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113. Yamada I1, Morizane C1, Okusaka T1, Mizusawa J1, Kataoka T1, Ueno M1, Ikeda M1, Okano N1, Todaka A1, Shimizu S1, Mizuno N1, Sekimoto M1, Tobimatsu K1, Yamaguchi H1, Nishina T1, Shirakawa H1, Kojima Y1, Oono T1, Kawamoto Y1, Furukawa M1, Iwai T1,2, Sudo K1, Okamura K1, Yamashita T1, Kato N1, Shioji K1, Shimizu K1, Nakagohri T1, Kamata K1, Ishii H1, FuruseJ1 (1JCOG-HBPOG): Sci Rep 2022/1; 12 (1): 987. (娾堜抦媣1,2: 2徚壔婍撪)
110122. [尨挊] Current status of diagnostic and therapeutic colonoscopy in Japan: The Japan Endoscopic Database Project. Saito Y1, Kodashima S1, Matsuda T1, Matsuda K1, Fujishiro M1, Tanaka K1, Kobayashi K1,3, Katada C1,3, Horimatsu T1, Muto M1, Ohtsuka K1, Oda I1, Kato M1, Kida M1,3, Hoteya S1, Yamamoto H1, Ryozawa S1, Iwakiri R2, Kutsumi H2, Kato M2, Haruma K2, Fujimoto K2, Iishi H2, Ogata H2, Uemura N2, Kaminishi M2, Tajiri H2, Inoue H2 (1MSED-J (Minimal Standard Endoscopic Database) Creation Subcommittee, Japan Gastroenterological Endoscopy Society, 2JED (Japan Endoscopy Database) Project Committee, Japan Gastroenterological Endoscopy Society): Dig Endosc 2022/1; 34 (1): 144-52. (彫椦惔揟1,3, 寴揷恊棙1,3, 栘揷岝峀1,3: 3徚壔婍撪)
110123. [尨挊] Efficacy and factors affecting procedure results of short-type single-balloon enteroscopy-assisted ERCP for altered anatomy: a multicenter cohort in Japan. Tanisaka Y, Ryozawa S, Itoi T, Yamauchi H1, Katanuma A, Okabe Y, Irisawa A, Nakahara K, Iwasaki E, Ishii K, Kin T, Terabe H, Izawa N, Morita R, Minami K, Araki R, Fujita A, Ogawa T, Mizuide M, Kida M1: Gastrointest Endosc 2022/2; 95 (2): 310-8.e1. (嶳撪峗巎1, 栘揷岝峀1: 1徚壔婍撪)
110030. [尨挊] The role of thromboxane prostanoid receptor signaling in gastric ulcer healing. Yamane S1, Amano H2, Ito Y2, Betto T1, Matsui Y3, Koizumi W1, Narumiya S, Majima M2: Int J Exp Pathol 2022/2; 103 (1): 4-12. (嶳崻憗婭巕1, 揤栰塸庽2, 埳摗媊栫2, 暿醕朁峀1, 徏堜孾晇3, 彫愹榓嶰榊1, 攏搱惓棽2: 1徚壔婍撪, 2栻棟, 3屇媧婍奜)
110124. [尨挊] Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort study. Kishino T, Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K1, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Kaise M: United European Gastroenterol J 2022/2; 10 (1): 93-103. (愳娸壛撧1: 1徚壔婍撪)
110125. [尨挊] Multicenter prospective study of the efficacy of stereomicroscopic on-site evaluation in endoscopic ultrasound-guided tissue acquisition in patients with pancreatic cancer. Watanabe M1, Okuwaki K1, Kida M1, Imaizumi H1, Matsumoto T1, Iwai T1, Hasegawa R1, Masutani H1, Kurosu T11, Minato N1, Tamaki A2, Ishizaki J, Kusano C1: Pancreatology 2022/3; 22 (2): 311-6. (搉曈恀堣1, 墱榚嫽夘1, 栘揷岝峀1, 崱愹丂峅1, 徏杮崅柧1, 娾堜抦媣1, 挿扟愳椡栫1, 彙扟姲埲1, 崟恵婱峗1, 柀丂彯婱1, 嬍抲柧姲2, 憪栰丂墰1: 1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢)
110126. [尨挊] Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis. Atsukawa M1, Tsubota A1, Kondo C1, Toyoda H1, Nakamuta M1, Takaguchi K1, Watanabe T1, Hiraoka A1, Uojima H1,2, Ishikawa T1, Iwasa M1, Tada T1, Nozaki A1, Chuma M1, Fukunishi S1, Asano T1, Ogawa C1, Abe H1, Kato K1, Hotta N1, Shima T1, Matsuura K1, Mikami S1, Tachi Y1, Fujioka S1, Okubo H1, Shimada N1, Tani J1, Morishita A1, Hidaka I1, Moriya A1, Tsuji K1, Akahane T1, Okubo T1, Arai T1, Kitamura M1, Morita K1, Kawata K1, Tanaka Y1, Kumada T1, Iwakiri K1 (1KTK49 Liver Study Group): Hepatol Res 2022/3; 52 (3): 235-46. (嫑搱惏婭1,2: 2徚壔婍撪)
110127. [尨挊] Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis. Chuma M, Uojima H1, Hattori N, Arase Y, Fukushima T, Hirose S, Kobayashi S, Ueno M, Tezuka S, Iwasaki S1, Wada N1, Kubota K1, Tsuruya K, Shimma Y, Ikeda H, Ehira T, Tokoro C, Iwase S, Miura Y, Moriya S, Watanabe T, Hidaka H1, Morimoto M, Numata K, Kusano C1, Kagawa T, Maeda S: Hepatol Res 2022/3; 52 (3): 269-80. (嫑搱惏婭1, 娾嶈廏堦榊1, 榓揷彯媣1, 孍揷岾夘1, 擔崅丂墰1, 憪栰丂墰1: 1徚壔婍撪)
110038. [尨挊] CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer. Adachi K1, Sakurai Y2, Ichinoe M2, Tadehara M1, Tamaki A1, Kesen Y2, Kato T2, Mii S, Enomoto A, Takahashi M, Koizumi W3, Murakumo Y2: Virchows Arch 2022/3; 480 (4): 819-29. doi: 10.1007/s00428-021-03230-2. Epub 2021 Nov 11. (埨払丂夣1, 烴堜桋崅2, 堦屗徆柧2, 澍尨彨椙1, 嬍抲柧姲1, 焼愬桾棞崄2, 壛摗戶嵠2, 彫愹榓嶰榊3, 懞塤朏庽2: 1戝妛堾堛椕宯尋媶壢, 2昦棟, 3徚壔婍撪)
310005. [徢椺曬崘] The First Case of Metastatic Pancreatic Leiomyosarcoma Derived from the Urinary Bladder Diagnosed Using an Endoscopic Ultrasound-guided Fine-needle Biopsy. Ishizaki A1, Okuwaki K1, Kida M1, Imaizumi H1, Iwai T1, Yamauchi H1, Kaneko T1, Hasegawa R1, Masutani H1, Tadehara M2, Adachi K2, Watanabe M1, Kurosu T1, Tamaki A2, Koizumi W1: Intern Med 2021/5; 60 (9): 1377-81. (愇嶈偁傗撨1, 墱榚嫽夘1, 栘揷岝峀1, 崱愹丂峅1, 娾堜抦媣1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 彙扟姲埲1, 澍尨彨椙2, 埨払丂夣2, 搉曈恀堣1, 崟恵婱峗1, 嬍抲柧姲2, 彫愹榓嶰榊1: 1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢)
310006. [徢椺曬崘] Pancreatic Schwannoma Diagnosed by Endoscopic Ultrasound-guided Fine-needle Aspiration. Hanaoka T1, Okuwaki K1, Imaizumi H1, Imawari Y1, Iwai T1, Yamauchi H1, Hasegawa R1, Adachi K2, Tadehara M2, Kurosu T1, Watanabe M1, Tamaki A2, Kida M1, Koizumi W1: Intern Med 2021/5; 60 (9): 1389-95. (壴壀懢榊1, 墱榚嫽夘1, 崱愹丂峅1, 堜夢桟夘1, 娾堜抦媣1, 嶳撪峗巎1, 挿扟愳椡栫1, 埨払丂夣2, 澍尨彨椙2, 崟恵婱峗1, 搉曈恀堣1, 嬍抲柧姲2, 栘揷岝峀1, 彫愹榓嶰榊1: 1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢)
310007. [徢椺曬崘] A case of immune checkpoint inhibitor-associated myocarditis after initiation of atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinoma. Iwasaki S1, Hidaka H1, Uojima H1, Hashimura M2, Nabeta T2, Sanoyama I3, Wada N1, Kubota K1, Nakazawa T1, Shibuya A4, Koizumi W1: Clin J Gastroenterol 2021/8; 14 (4): 1233-9. (娾嶈廏堦榊1, 擔崅丂墰1, 嫑搱惏婭1, 嫶懞旤曐2, 撶揷丂寬2, 崃嶳丂摓3, 榓揷彯媣1, 孍揷岾夘1, 拞郪婱廏1, 廰扟柧棽4, 彫愹榓嶰榊1: 1徚壔婍撪, 2弞娐婍撪, 3昦棟, 4堛椕埨慡丒娗棟)
310008. [徢椺曬崘] Endoscopic submucosal dissection of cervical esophageal cancer with hypopharyngeal invasion using a curved laryngoscope. Furue Y1, Katada C1, Kano K2, Yoshida T3, Yamashita T2: VideoGIE 2021/9; 6(12): 533-5. (屆峕峃柧1, 寴揷恊棙1, 壛擺岶堦2, 媑揷丂岟3, 嶳壓丂戱2: 1徚壔婍撪, 2帹旲堲岮丒摢栩晹奜, 3怴悽婭堛椕丒墶抐揑堛椕)
310009. [徢椺曬崘] A case of pancreatic neuroendocrine carcinoma with a favorable clinical response to pembrolizumab. Kogami T1, Iwai T1, Kida M1, Okuwaki K1, Hasegawa R1, Kurosu T1, Watanabe M1, Matsushita M1, Imawari K1, Adachi K2, Tadehara M2, Tamaki A2, Imaizumi H1, Koizumi W1: Clin J Gastroenterol 2021/12; 14 (6): 1804-10. (崈忋懢榊1, 娾堜抦媣1, 栘揷岝峀1, 墱榚嫽夘1, 挿扟愳椡栫1, 崟恵婱峗1, 搉曈恀堣1, 徏壓徆桾1, 堜夢壚嵷1, 埨払丂夣2, 澍尨彨椙2, 嬍抲柧姲2, 崱愹丂峅1, 彫愹榓嶰榊1: 1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢)
310010. [徢椺曬崘] Cartilage-hair Hypoplasia Complicated with Liver Cirrhosis Due to Chronic Intrahepatic Cholestasis. Kogami T1, Uojima H1, Ebato T2, Bando Y2, Hoshino A3, Saegusa M3, Ohbu M, Iwasaki S1, Wada N1, Kubota K1, Tanaka Y1, Hidaka H1, Nakazawa T1, Shibuya A4, Koizumi W1: Intern Med 2021/11; 60 (21): 3427-33. (崈忋懢榊1, 嫑搱惏婭1, 峕攇屗岶曘2, 嶁搶桼婭2, 惎栰徍朏3, 嶰巬丂怣3, 娾嶈廏堦榊1, 榓揷彯媣1, 孍揷岾夘1, 揷拞尗柧1, 擔崅丂墰1, 拞郪婱廏1, 廰扟柧棽4, 彫愹榓嶰榊1: 1徚壔婍撪, 2彫帣, 3昦棟, 4堛椕埨慡丒娗棟)
320001. [徢椺曬崘] 弍慜恌抐偑壜擻偱偁偭偨僋儘乕儞昦崌暪憗婜彫挵娻偺1椺. 拞旜塺堦, 扖枻寬巙, 崟栘攷夘, 擇栘丂椆, 彫嬥堜堦棽, 悪揷丂徍, 椦丂岹峴, 墶嶳丂孫1 (1徚壔婍撪): 擔杮徚壔婍昦妛夛嶨帍 2021/7: 118 (7): 645-51.
510005. [憤愢] Is There an Increasing Incidence of Gastroesophageal Junctional Adenocarcinoma and Barrett Esophagus in Asia? A Review of Diagnostic Conundrums. Tan PO, Soh AYS, Kusano C1, Lee YY, Gotoda T: Digestion 2022/1; 103 (1): 37-44. (憪栰丂墰1: 1徚壔婍撪)
510006. [憤愢] The Ideal Helicobacter pylori Treatment for the Present and the Future. Suzuki S, Kusano C1, Horii T, Ichijima R, Ikehara H: Digestion 2022/1; 103 (1): 62-8. (憪栰丂墰1: 1徚壔婍撪)
522024. [島嵗]亂摿廤: 嬞媫撪帇嬀偺崱亃[奺榑] II. 彫挵戝挵偺嬞媫撪帇嬀丂戝挵弌寣. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 徚壔婍撪帇嬀 2021/4; 33 (4): 740-5.
522025. [島嵗]亂摿廤: 鋁幘姵偵懳偡傞撪帇嬀帯椕偺偡傋偰亃[奺榑] I. 鋁幘姵偵懳偡傞撪帇嬀恌抐丂鋁庮釃偵懳偡傞EUS-FNA偵偍偗傞岺晇偲栤戣揰, 崱屻偺揥朷. 墱榚嫽夘1, 栘揷岝峀1, 娾堜抦媣1, 挿扟愳椡栫1, 彙扟姲埲1, 埨払丂夣2, 澍尨彨椙2, 崟恵婱峗1, 搉曈恀堣1, 嬍抲柧姲2, 崱愹丂峅1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢): 徚壔婍撪帇嬀 2021/9; 33 (9): 1411-7.
522026. [島嵗]亂摿廤: 栧柆埑槾恑徢偵懳偡傞恌椕亃3-8. 栧柆埑槾恑徢偺偍傕側崌暪徢亅恌椕偺幚嵺丂(8) 栧柆寣愷徢. 擔崅丂墰1, 嫑搱惏婭1 (1徚壔婍撪), 椪喱徚壔婍撪壢 2021/10; 36 (12): 1546-53.
522027. [島嵗] 摿廤: 娞憻恌椕2021丂傾僥僝儕僘儅僽+儀僶僔僘儅僽搊応屻偺揥奐亃9) 傾僥僝儕僘儅僽偲儀僶僔僘儅僽帯椕摫擖慜偍傛傃帯椕拞偺栧柆埑槾恑徢偺儅僱僕儊儞僩亅怘摴堓惷柆釒傪拞怱偵亅. 擔崅丂墰1, 尨丂桬曘1, 嫑搱惏婭1 (1徚壔婍撪): 娞憻僋儕僯僇儖傾僢僾僨乕僩 2021/10; 7 (1): 63-6.
522028. [島嵗]亂戝挵撪帇嬀僗僉儖傾僢僾亅憓擖偐傜恌抐傑偱亃[奺榑] III 娫堘偄偺側偄Characterization (幙揑恌抐乣怺払搙恌抐) 傪栚巜偟偰丂 EUS傪嬌傔傞. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 徚壔婍撪帇嬀 2021/10; 33 (10): 1629-33.
522029. [島嵗]亂摿廤: 彫挵撪帇嬀偑攦偊偨幘姵儅僱乕僕儊儞僩亃[奺榑] B. 恌抐擻偑戝偒偔岦忋偟偨昦懺丂墛徢惈幘姵. 墶嶳丂孫1, 尨揷梞暯1, 埳摗棽巑2, 嬥郪丂弫1, 暿醕朁峀1, 愳娸壛撧1, 嵅揷旤榓1, 彫椦惔揟1,3, 憪栰丂墰1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕) 徚壔婍撪帇嬀 2021/12; 33 (12): 1874-86.
522030. [島嵗] 惷柆釒帯椕偲寣娗撪帯椕, 栧柆寣愷帯椕 擔崅丂墰1, 嫑搱惏婭1, 拞郪婱廏1 (1徚壔婍撪): 擔杮撪壢妛夛嶨帍 2021/1; 111 (1): 66-73.
522031. [島嵗]亂摿廤: 娞峝曄徢偺恌抐帯椕偺嵟怴抦尒亃惷柆釒帯椕偲寣娗撪帯椕, 栧柆寣愷帯椕. 擔崅丂墰1, 嫑搱惏婭1, 拞郪婱廏1 (1徚壔婍撪): 擔杮撪壢妛夛嶨帍 2022/1; 111 (1): 66-73.
522032. [島嵗]亂娻撪帇嬀恌抐偺嵟怴儉乕僽儊儞僩亅H. pylori堿惈堓娻偺偡傋偰亃[憤榑] H. pylori堿惈堓娻偲偼壗偐?亅崱傑偱偲偙傟偐傜. 憪栰丂墰1, 抮尨媣挬, 屻摗揷戩巙 (1徚壔婍撪): 徚壔婍撪帇嬀 2022/2; 34 (2): 142-50.
522033. [島嵗]亂偙傫側偲偒偳偆偡傞亃[奺榑] IV 戝挵丂[恌抐] SD junction偑墇偊傜傟側偄. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 徚壔婍撪帇嬀 2022/3; 34 (3): 406-7.
530001. [偦偺懠 (Clinical Practice Guidelines)] Evidence-based clinical practice guidelines for liver cirrhosis 2020. Yoshiji H1,2, Nagoshi S1,2, Akahane T1,2, Asaoka Y1,2, Ueno Y1,2, Ogawa K1,2, Kawaguchi T1,2, Kurosaki M1,2, Sakaida I1,2, Shimizu M1,2, Taniai M1,2, Terai S1,2, Nishikawa H1,2, Hiasa Y1,2, Hidaka H1,2,3, Miwa H1,2, Chayama K2, Enomoto N1,2, Shimosegawa T1,2, Takehara T2, Koike K1,2 (1Guidelines Committee for Creating and Evaluating the Evidence-Based Clinical Practice Guidelines for Liver Cirrhosis, The Japanese Society of Gastroenterology, 2The Japan Society of hepatology): Hepatol Res 2021/7; 51 (7): 725-49. (擔崅丂墰1,2,3: 3徚壔婍撪)
530002. [偦偺懠 (Clinical Practice Guidelines)] Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. Yoshiji H1,2, Nagoshi S1,2, Akahane T1,2, Asaoka Y1,2, Ueno Y1,2, Ogawa K1,2, Kawaguchi T1,2, Kurosaki M1,2, Sakaida I1,2, Shimizu M1,2, Taniai M1,2, Terai S1,2, Nishikawa H1,2, Hiasa Y1,2, Hidaka H1,2,3, Miwa H1,2, Chayama K2, Enomoto N1,2, Shimosegawa T1,2, Takehara T2, Koike 1,2 (1Guidelines Committee for Creating and Evaluating the Evidence-Based Clinical Practice Guidelines for Liver Cirrhosis, The Japanese Society of Gastroenterology, 2The Japan Society of hepatology): J Gastroenterol 2021/7; 56 (7): 593-619. (擔崅丂墰1,2,3: 3徚壔婍撪)
530003. [偦偺懠 (Comment)] Endoscopic Closure After Endoscopic Resection for Superficial Non-Ampullary Duodenal Tumors. Tanabe S1,2, Wada T2: Clin Endosc 2021/7; 54 (4): 453-4. 揷绯丂憦1,2, 榓揷戱栫2 (1怴悽婭堛椕丒愭抂堛椕, 2徚壔婍撪)
530004. [偦偺懠 (Editorial)] Can we find a precise timing for endoscopic intervention in gastrointestinal bleeding? Kusano C1: Dig Endosc 2022/2; 34 (4): 750-2. (憪栰丂墰1: 1徚壔婍撪)
[挊丂彂]
620014. [妛弍彂 (暘扴幏昅)]亂徚壔娗恌抐丒帯椕庤媄偺偡傋偰2021 (堓偲挵2021擭5寧崋憹姧崋)亃堲岮摢: 恌抐丂捠忢撪帇嬀 (宱岥), p.532-3. 屆峕峃柧1, 寴揷恊棙1 (1徚壔婍撪), 堛妛彂堾, 搶嫗, 2021/5敪峴.
620015. [妛弍彂 (暘扴幏昅)]亂徚壔娗恌抐丒帯椕庤媄偺偡傋偰2021 (堓偲挵2021擭5寧崋憹姧崋)亃堓: 帯椕丂ESD愨墢懱宯 (Itknife, ITknife2), p.630-1. 揷绯丂憦1,2, 榓揷戱栫2 (1怴悽婭堛椕丒愭抂堛椕, 2徚壔婍撪), 堛妛彂堾, 搶嫗, 2021/5敪峴.
620016. [妛弍彂 (暘扴幏昅)]亂徚壔娗恌抐丒帯椕庤媄偺偡傋偰2021 (堓偲挵2021擭5寧崋憹姧崋)亃堓: 帯椕丂從庈弍: GAVE偵懳偡傞APC從庈帯椕, p.652. 揷绯丂憦1,2, 愇屗尓師2 (1怴悽婭堛椕丒愭抂堛椕, 2徚壔婍撪), 堛妛彂堾, 搶嫗, 2021/5敪峴.
620017. [妛弍彂 (暘扴幏昅)]亂怘摴丒堓惷柆釒 夵掶戞4斉亃戞V晹 怘摴惷柆釒帯椕偺幚嵺丂II. 懸婜丒梊杊椺傊偺懳墳丂2. 奺庬帯椕朄丂a. 栻暔椕朄, p.178-81. 擔崅丂墰1, 嫑搱惏婭1 (1徚壔婍撪), 娔廋: 彫尨彑晀, 嬤怷暥晇, 曇: 擖郪撃巙, 墬曐榓旻, 拞懞恀堦, 擔杮儊僨傿僇儖僙儞僞乕, 搶嫗, 2021/6敪峴.
620018. [妛弍彂 (暘扴幏昅)]亂鋁憻徢岓孮 (戞3斉)亅偦偺懠偺鋁憻幘姵傪娷傔偰亅 (暿嶜擔杮椪喱 椞堟暿徢岓孮僔儕乕僘 No.16)亃VII. 鋁墛丂4. 鋁壖惈擷朎丒WON偺昦懺偲帯椕, p.294-303. 栘揷岝峀1, 搉曈恀堣1, 崟恵婱峗1, 忋尨堦斂1, 挿扟愳椡栫1, 嬥巕丂嫓1, 墱榚嫽夘1, 娾堜抦媣1, 崱愹丂峅1 (1徚壔婍撪), 擔杮椪喱幮, 搶嫗, 2021/6敪峴.
620019. [妛弍彂 (暘扴幏昅)]亂偙傟偩偗偼撉傫偱偍偒偨偄! 徚壔婍撪帇嬀堛偺偨傔偺廳梫榑暥200曆 <抇丒鋁曇>亃鋁庮釃丂23-Q023. 鋁娻偺墦妘揮堏偼梊杊壜擻偐?, p.24. 25-Q025. 墦妘揮堏傪桳偡傞鋁娻偵懳偟偰FOLFIRINOX椕朄偼gemcitabine椕朄傛傝桳岠偐?, p.26. 26-Q026. 揮堏惈鋁娻偵懳偟偰gemcitabine偵nab-paclitaxel傪暪梡偡傞偙偲偼桳岠偐?. 娾堜抦媣 (徚壔婍撪), 曇: 巺堜棽晇, 擖郪撃巙, 妰徖楴惗, 埨揷堦楴, 椙戲徍柫, 僔乕價乕傾乕儖, 搶嫗, 2021/7敪峴.
620020. [妛弍彂 (暘扴幏昅)]亂徚壔娗撪帇嬀帯椕亅婎杮偐傜崅擄搙傑偱 (徚壔婍撪帇嬀2021擭33姫憹姧崋)亃[奺榑] I. 徚壔娗弌寣偵懳偡傞撪帇嬀揑巭寣弍丂[旕惷柆釒惈弌寣] 弌寣惈堓廫擇巜挵捵釃, p.43-8. 揷绯丂憦1,2, 媣曐揷梲1, 揷绯旤撧1, 杒尨丂尵1, 屆峕峃柧1, 搉绯峎幆1, 榓揷戱栫1, 愇屗尓師1, 寴揷恊棙1, 彫愹榓嶰榊1 (1徚壔婍撪), 搶嫗堛妛幮, 搶嫗, 2021/10敪峴.
620021. [妛弍彂 (暘扴幏昅)]亂徚壔娗撪帇嬀帯椕亅婎杮偐傜崅擄搙傑偱 (徚壔婍撪帇嬀2021擭33姫憹姧崋)亃[奺榑] I. 徚壔娗弌寣偵懳偡傞撪帇嬀揑巭寣弍丂[旕惷柆釒惈弌寣] 弌寣惈堓廫擇巜挵捵釃偵懳偡傞OTSC覗@, p.53-6. 媣曐揷梲1. 嶳撪峗巎1, 拞扟尋搇2, 榓揷戱栫1, 揷绯丂憦1,3 (1徚壔婍撪, 2媬柦, 3怴悽婭堛椕丒愭抂堛椕), 搶嫗堛妛幮, 搶嫗, 2021/10敪峴.
620022. [妛弍彂 (暘扴幏昅)]亂徚壔娗撪帇嬀帯椕亅婎杮偐傜崅擄搙傑偱 (徚壔婍撪帇嬀2021擭33姫憹姧崋)亃[奺榑] I. 徚壔娗弌寣偵懳偡傞撪帇嬀揑巭寣弍丂[旕惷柆釒惈弌寣] 戝挵弌寣 (宔幒傪彍偔), p.78-83. 嵅揷旤榓1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕), 搶嫗堛妛幮, 搶嫗, 2021/10敪峴.
620023. [妛弍彂 (暘扴幏昅)]亂愱栧堛偺偨傔偺徚壔婍昦妛 戞3斉亃VI 娞憻丂偝傑偞傑側昦懺偲帯椕丂栧柆埑槾恑徢, p468-72. 擔崅丂墰1, 嫑搱惏婭1 (1徚壔婍撪), 娔廋: 壓悾愳揙, 搉曈丂庣, 曇: 栘壓朏堦, 嬥巕廃堦, 妦揷攷巎, 懞忋榓惉, 埨摗丂楴, 巺堜棽晇, 堛妛彂堾, 搶嫗, 2021/11敪峴.
[妛夛丒尋媶夛摍]
713007. [妛夛 (崙嵺)] (堦斒島墘) Bilateral metallic stent placement for malignant hilar biliary obstruction. Iwai T1: Japan-Korea joint web meeting (2021/9/29), Web奐嵜. (娾堜抦媣1: 1徚壔婍撪)
713008. [妛夛 (崙嵺)] (堦斒島墘) Management of early gastric cancer Kusano C1: ASEAN GASTRO 2021 (2021/11/4-6), BangKok, Thailand (僴僀僽儕僢僪奐嵜). (憪栰丂墰1: 1徚壔婍撪)
721001. [妛夛 (慡崙)] (摿暿島墘) 捵釃惈戝挵墛偵偍偗傞帯椕慖戰偺峀偑傝. 墶嶳丂孫 (徚壔婍撪): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/16), 搶嫗 (僴僀僽儕僢僪奐嵜).
721002. [妛夛 (慡崙)] (摿暿島墘) 娞峝曄崌暪徢帯椕偺儅僱乕僕儊儞僩. 嫑搱惏婭 (徚壔婍撪): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/16), 搶嫗 (僴僀僽儕僢僪奐嵜).
721003. [妛夛 (慡崙)] (摿暿島墘) 偙傟偐傜偺栧柆埑槾恑徢乣娞峝曄恌椕僈僀僪儔僀儞2020偐傜尒偊偰偔傞傕偺乣. 擔崅丂墰 (徚壔婍撪): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
721004. [妛夛 (慡崙)] (摿暿島墘) 栧柆寣愷徢偵懳偡傞帯椕偺億僀儞僩乣憗婜帯椕偺廳梫惈傕娷傔偰乣. 擔崅丂墰 (徚壔婍撪): 戞57夞擔杮娞憻妛夛憤夛 (2021/6/17), 杒奀摴 (僴僀僽儕僢僪奐嵜).
721005. [妛夛 (慡崙)] (摿暿島墘) C宆娞墛帯椕偺堄媊偲偟偰偺娞峝曄偵偍偗傞Point of No Return. 嫑搱惏婭 (徚壔婍撪): 戞28夞擔杮栧柆埑槾恑徢妛夛憤夛 (2021/9/16), Web奐嵜.
721006. [妛夛 (慡崙)] (摿暿島墘) 旕戙彏惈娞峝曄偺恌抐丒帯椕偺up to date. 擔崅丂墰 (徚壔婍撪): 戞28夞擔杮栧柆埑槾恑徢妛夛憤夛 (2021/9/17), Web奐嵜.
722027. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 抇摴嫹嶓徢椺偵懳偡傞怴婯僈僀僪儚僀儎乕桿摫幃僽儔僔傪梡偄偨抇廯僙儖僽儘僢僋朄. 澍尨彨椙1, 墱榚嫽夘2, 栘揷岝峀2 (1戝妛堾堛椕宯尋媶壢, 2徚壔婍撪): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/15), 搶嫗 (僴僀僽儕僢僪奐嵜).
722028. [妛夛 (慡崙)] (僔儞億僕僂儉) 崅楊敪徢捵釃惈戝挵墛偲旕崅楊敪徢椺偺擖堾椺偵偍偗傞帯椕慖戰偵偮偄偰. 埳摗棽巑1, 墶嶳丂孫2, 彫椦惔揟2,3 (1戝妛堾堛椕宯尋媶壢, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/16), 搶嫗 (僴僀僽儕僢僪奐嵜).
722029. [妛夛 (慡崙)] (婎挷島墘) 栧柆埑槾恑徢偺恌抐偲帯椕偺嵟慜慄, 崱屻偵巆偝傟偨壽戣傕娷傔. 擔崅丂墰 (徚壔婍撪): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/16), 搶嫗 (僴僀僽儕僢僪奐嵜).
722030. [妛夛 (慡崙)] (僔儞億僕僂儉) 怴僈僀僪儔僀儞偵偍偄偰, 娞惈擼徢帯椕偵昡壙偝傟偨儗儃僇儖僯僠儞偲儕僼傽僉僔儈儞偺巊梡偵娭偡傞峫嶡. 嫑搱惏婭1, 擔崅丂墰1 (1徚壔婍撪): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
722031. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 僋儘乕儞昦偵崌暪偟偨壓晹徚壔娗娻偺7椺. 揷绯旤撧1, 彫椦惔揟2,3, 媣曐揷 (嵅揷) 旤榓3 (1戝妛堾堛椕宯尋媶壢, 2怴悽婭堛椕丒墶抐揑堛椕, 3徚壔婍撪): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
722032. [妛夛 (慡崙)] (僔儞億僕僂儉) 摢栩晹昞嵼娻偵懳偡傞撪帇嬀恌抐亅AI撪帇嬀恌抐峔抸偺帋傒. 寴揷恊棙1, 屆峕峃柧1, 揷绯丂憦1,2, 壛擺岶堦3, 嵶栰峗巎3, 嶳壓丂戱3, 堦屗徆柧4, 媑揷丂岟4, 懞塤朏庽4, 嶰巬丂怣4 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕, 3帹旲堲岮丒摢栩晹, 4昦棟): 戞110夞擔杮昦棟妛夛憤夛 (2021/4/22), 搶嫗 (僴僀僽儕僢僪奐嵜).
722033. [妛夛 (慡崙)] (僔儞億僕僂儉) 戝挵T1娻偺怺払搙恌抐偵偍偗傞EUS偺桳梡惈偵偮偄偰偺専摙. 暿醕朁峀1, 彫椦惔揟1,2, 媣曐揷 (嵅揷) 旤榓1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞101夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2021/5/14), 峀搰 (僴僀僽儕僢僪奐嵜).
722034. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 弍屻抇娗嬻挵暙崌晹嫹嶓偵偍偗傞僶儖乕儞彫挵嬀壓ERCP崲擄椺偵懳偡傞摉堾偺岺晇. 崟恵婱峗1, 栘揷岝峀1, 娾堜抦媣1 (1徚壔婍撪): 戞101夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2021/5/15), 峀搰 (僴僀僽儕僢僪奐嵜).
722035. [妛夛 (慡崙)] (僔儞億僕僂儉) 帯椕揔墳徚壔娗惷柆釒偺梊應場巕偲偟偰偺傾儖僽儈儞丒價儕儖價儞丒寣彫斅抣 (ABP criteria) 偺桳梡惈. 嫑搱惏婭1, 擔崅丂墰1, 娾嶈廏堦榊1 (1徚壔婍撪): 戞57夞擔杮娞憻妛夛憤夛 (2021/6/17), 杒奀摴 (僴僀僽儕僢僪奐嵜).
722036. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 娞僒儖僐儁僯傾恌抐婎弨偺桳梡惈偵娭偡傞懡巤愝慜岦偒専摙. 嫑搱惏婭1, 擔崅丂墰1 (1徚壔婍撪): 戞57夞擔杮娞憻妛夛憤夛 (2021/6/17), 杒奀摴 (僴僀僽儕僢僪奐嵜).
722037. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 傾儖僐乕儖惈娞忈奞偵懳偡傞Harm reduction摫擖屻偺drinking risk level偺曄壔偲帯椕岠壥偵娭偡傞専摙. 嫑搱惏婭1, 擔崅丂墰1 (1徚壔婍撪): 戞57夞擔杮娞憻妛夛憤夛 (2021/6/17), 杒奀摴 (僴僀僽儕僢僪奐嵜).
722038. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) PNPLA3堚揱巕懡宆偑娞峝曄崌暪徢敪惗偵梌偊傞塭嬁. 嫑搱惏婭1, 擔崅丂墰1, 堜夢壚嵷1 (1徚壔婍撪): 戞57夞擔杮娞憻妛夛憤夛 (2021/6/18), 杒奀摴 (僴僀僽儕僢僪奐嵜).
722039. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 鋁Solid pseudopapillary neoplasm偺椪彴揑摿挜偲EUS強尒偺専摙. 搉曈恀堣1, 栘揷岝峀1, 娾堜抦媣1, 墱榚嫽夘1, 挿扟愳椡栫1, 埨払丂夣2, 澍尨彨椙2, 崟恵婱峗1, 嬍抲柧姲2, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢): 戞52夞擔杮鋁憻妛夛戝夛 (2021/9/23), 搶嫗 (僴僀僽儕僢僪奐嵜).
722040. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 摉堾偱偺屄暿壔堛椕傪尒悩偊偨鋁娻偵懳偡傞EUS-TA偵偍偗傞岺晇. 墱榚嫽夘1, 搉曈恀堣1, 栘揷岝峀1, 崱愹丂峅2, 娾堜抦媣1, 嶳撪峗巎1, 挿扟愳椡栫1, 徏杮崅柧1, 彙扟姲埲1, 埨払丂夣3, 澍尨彨椙3, 拞扟惇屷1, 崟恵婱峗1, 柀丂彯婱1, 嬍抲柧姲3, 愇嶈弮榊1, 壴壀懢榊1, 崃晹桪嶌1, 彫愹榓嶰榊1 (1徚壔婍撪, 2JCHO憡柾栰昦堾, 3戝妛堾堛椕宯尋媶壢): 戞52夞擔杮鋁憻妛夛戝夛 (2021/9/23), 搶嫗 (僴僀僽儕僢僪奐嵜).
722041. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 堓娻梊杊傪栚揑偲偟偨庒擭幰H. pylori姶愼専嵏, 彍嬠帠嬈偺妋棫傪栚巜偟偰. 憪栰丂墰1, 杧堜晀婌, 巗搰椚擇, 楅栘丂隳, 抮尨媣挬, 屻摗揷戩巙 (1徚壔婍撪): 戞27夞擔杮僿儕僐僶僋僞乕妛夛妛弍廤夛 (2021/9/25), Web奐嵜.
722042. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 椙惈抇娗嫹嶓偵懳偡傞嬥懏僗僥儞僩偺桳梡惈. 娾堜抦媣1, 栘揷岝峀1, 憪栰丂墰1 (1徚壔婍撪): 戞57夞擔杮抇摴妛夛妛弍廤夛 (2021/10/8), 搶嫗 (僴僀僽儕僢僪奐嵜).
722043. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 摉堾偵偍偗傞鋁廃埻塼懱挋棷偵懳偡傞撪帇嬀揑帯椕偺尰忬偲嬼敪徢. 崟恵婱峗1, 娾堜抦媣1, 栘揷岝峀1 (1徚壔婍撪): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
722044. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 娞惈擼徢偵懳偡傞BRTO帯椕屻, 栧柆宎曄壔偑梊屻偵梌偊傞塭嬁偵娭偡傞専摙. 娾嶈廏堦榊1, 嫑搱惏婭1, 孍揷岾夘1 (1徚壔婍撪): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
722045. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) DDW-J2004儚乕僋僔儑僢僾栻暔惈娞忈奞恌抐婎弨偵媮傔傜傟傞嬤擭偺栻暔惈娞忈奞傊偺懳墳. 搉绮恀彶1,2, 戝捤弐榓1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2徚壔婍撪): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
722046. [妛夛 (慡崙)] (僔儞億僕僂儉) 憗婜戝挵娻偵懳偡傞戝挵ESD偵偮偄偰: 崅楊幰孮偲旕崅楊幰孮偺斾妑. 愳娸壛撧1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2021/11/12), 峀搰 (僴僀僽儕僢僪奐嵜).
722047. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 僞僋儘儕儉僗偺抁婜帯椕惉愌偐傜峫偊傞捵釃惈戝挵墛擖堾椺偵偍偗傞帯椕岠壥敾掕偺僞僀儈儞僌. 嬥郪丂弫1, 墶嶳丂孫1, 暿醕朁峀1, 愳娸壛撧1, 媣曐揷 (嵅揷) 旤榓1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2021/11/12), 峀搰 (僴僀僽儕僢僪奐嵜).
722048. [妛夛 (慡崙)] (僾儗僫儕乕僙僢僔儑儞) 怴偟偄婯栺嶔掕偵岦偗偨庢傝慻傒: 撪帇嬀椞堟偵偍偗傞尰忬偲壽戣. 憪栰丂墰 (徚壔婍撪): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/2-4), 墶昹 (僴僀僽儕僢僪奐嵜).
723103. [妛夛 (慡崙)] (堦斒岥墘) Crohn昦偺彫挵昦曄恌抐偵偍偗傞MR enterography偺桳梡惈偵偮偄偰偺専摙. 嬥郪丂弫1, 墶嶳丂孫1, 暿醕朁峀1, 愳娸壛撧1, 尨棷峅庽2, 媣曐揷 (嵅揷) 旤榓1, 彫椦惔揟1,3, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕, 3怴悽婭堛椕丒墶抐揑堛椕): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/15), 搶嫗 (僴僀僽儕僢僪奐嵜).
723104. [妛夛 (慡崙)] (堦斒岥墘) 椙惈抇娗嫹嶓偵懳偡傞嬥懏僗僥儞僩偺桳梡惈. 娾堜抦媣1, 栘揷岝峀1, 墱榚嫽夘1, 挿扟愳椡栫1, 嬥巕丂嫓1, 搉曈恀堣1, 崟恵婱峗1, 埨払丂夣2, 澍尨彨椙2, 嶳撪峗巎1, 崱愹丂峅3, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3憡柾栰昦堾): 戞101夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2021/5/15), 峀搰 (僴僀僽儕僢僪奐嵜).
723105. [妛夛 (慡崙)] (庡戣墘戣) 娞惈擼徢偵懳偡傞BRTO帯椕屻, 栧柆埑槾恑徢偑梊屻偵梌偊傞塭嬁偵娭偡傞専摙. 嫑搱惏婭1, 擔崅丂墰1 (1徚壔婍撪): 戞28夞擔杮栧柆埑槾恑徢妛夛憤夛 (2021/9/16-17), Web奐嵜.
723106. [妛夛 (慡崙)] (庡戣墘戣) 撪帇嬀揑帯椕揔墳徚壔娗惷柆釒偺梊應場巕偲偟偰偺寣彫斅悢/銪憻宎斾偺桳梡惈. 嫑搱惏婭1, 擔崅丂墰1 (1徚壔婍撪): 戞28夞擔杮栧柆埑槾恑徢妛夛憤夛 (2021/9/16-17), Web奐嵜.
723107. [妛夛 (慡崙)] (堦斒岥墘) ALBI grade偲娞僒儖僐儁僯傾偑娞峝曄姵幰偺梊屻偵梌偊傞塭嬁. 嫑搱惏婭1, 擔崅丂墰1 (1徚壔婍撪): 戞28夞擔杮栧柆埑槾恑徢妛夛憤夛 (2021/9/16-17), Web奐嵜.
723108. [妛夛 (慡崙)] (堦斒岥墘) 宱旂宱娞惷柆釒嵡愷弍偑憈岟偟偨恖岺汨栧惷柆釒弌寣偺1椺. 徏壓徆桾1, 擔崅丂墰1, 摗堜丂奭2, 娾嶈廏堦榊1, 榓揷彯媣1, 孍揷岾夘1, 嫑搱惏婭1, 拞郪婱廏1, 廰扟柧棽3, 彫愹榓嶰榊1 (1徚壔婍撪, 2曻幩慄 (夋憸), 3堛椕埨慡丒娗棟): 戞28夞擔杮栧柆埑槾恑徢妛夛憤夛 (2021/9/16-17), Web奐嵜.
723109. [妛夛 (慡崙)] (億僗僞乕) 廳撃側崌暪徢傪敪徢偟偨擄帯惈媡棳惈怘摴墛偺1椺. 嵅栰払嵠1, 揷绯丂憦1,2, 怷扟岹岝3, 媣曐揷梲4, 屆峕峃柧1, 搉绮峎幆1, 榓揷戱栫1, 愇屗尓師1, 寴揷恊棙1 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕, 3忋晹徚壔娗奜, 4戝妛堾堛椕宯尋媶壢): 戞75夞擔杮怘摴妛夛妛弍廤夛 (2021/9/23), 搶嫗 (僴僀僽儕僢僪奐嵜).
723110. [妛夛 (慡崙)] (億僗僞乕) 埆惈抇摴嫹嶓偵懳偡傞BONASTENT; M-Intraductal偺桳岠惈偲埨慡惈偵娭偡傞専摙. 嵅栰払嵠1, 挿扟愳椡栫1, 嬍抲柧姲2, 搉曈恀堣1, 崟恵婱峗1, 澍尨彨椙2, 埨払丂夣2, 墱榚嫽夘1, 娾堜抦媣1, 崱愹丂峅3, 栘揷岝峀1, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3JCHO憡柾栰昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
723111. [妛夛 (慡崙)] (億僗僞乕) 帺屓柶塽惈鋁墛偺恌抐偵偍偗傞EUS-TA偺桳梡惈偺専徹. 壴壀懢榊1, 墱榚嫽夘1, 栘揷岝峀1, 娾堜抦媣1, 挿扟愳椡栫1, 埨払丂夣2, 澍尨彨椙2, 崟恵婱峗1, 搉曈恀堣1, 嬍抲柧姲2, 崱愹丂峅3, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3JCHO憡柾栰昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
723112. [妛夛 (慡崙)] (億僗僞乕) 拞婯柾昦堾偵偍偗傞鋁庮釃偵懳偡傞幚懱尠旝嬀壓恦懍専懱昡壙傪梡偄偨EUS-TA摫擖弶婜偺恌抐擻偺専徹. 愇嶈弮榊1,2, 崱愹丂峅2, 暯堜揘旻1,2, 嬥丂柧揘2, 嶰巬梲堦2, 堜夢桟夘1, 嬍抲柧姲3, 搉曈恀堣1, 彙扟姲埲1, 墱榚嫽夘1, 栘揷岝峀1, 彫愹榓嶰榊1 (1徚壔婍撪, 2JCHO憡柾栰昦堾, 3戝妛堾堛椕宯尋媶壢): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
723113. [妛夛 (慡崙)] (億僗僞乕) C宆娞墛偵懳偡傞捈愙嶌梡宆峈僂僀儖僗栻偱偺帯椕屻48廡偵偍偗傞峈GPIIb/IIIa峈懱嶻惗B嵶朎偺曄壔偵娭偡傞専摙. 榓揷彯媣1, 嫑搱惏婭1, 娾嶈廏堦榊1, 孍揷岾夘1, 擔崅丂墰1, 拞郪婱廏1, 廰扟柧棽2, 嵅摗棽巌3 (1徚壔婍撪, 2堛椕埨慡丒娗棟, 3堛椕塹惗妛晹): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
723114. [妛夛 (慡崙)] (億僗僞乕) 愗彍晄擻鋁娻偵偍偗傞僒儖僐儁僯傾偺椪彴揑堄媊偵娭偡傞専摙. 愇嶈偁傗撨1, 墱榚嫽夘1, 栘揷岝峀1, 娾堜抦媣1, 嶳撪峗巎1, 挿扟愳椡栫1, 埨払丂夣2, 澍尨彨椙2, 崟恵婱峗1, 搉曈恀堣1, 嬍抲柧姲2, 崱愹丂峅3, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3JCHO憡柾栰昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/5), 恄屗 (僴僀僽儕僢僪奐嵜).
723115. [妛夛 (慡崙)] (億僗僞乕) 墛徢惈挵幘姵 (IBD) 旕揟宆椺偐傜MEFV堚揱巕娭楢挵墛偺恌抐傪偊偨3椺. 尨揷梞暯1, 墶嶳丂孫1, 嬥郪丂弫1, 暿醕朁岹1, 愳娸壛撧1, 媣曐揷 (嵅揷) 旤榓1, 彫椦惔揟1,2, 彫愹榓嶰榊1, 崅嫶攷擵3 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕, 3堛椕塹惗妛晹): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/5), 恄屗 (僴僀僽儕僢僪奐嵜).
723116. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞撪帇嬀揑鋁娗僪儗僫乕僕偺僗僩儔僥僕乕偲偦偺惉愌偺専徹. 崃晹桪嶌1, 搉曈恀堣1, 墱榚嫽夘1, 栘揷岝峀1, 娾堜抦媣1, 挿扟愳椡栫1, 彙扟姲埲1, 埨払丂夣2, 澍尨彨椙2, 崟恵婱峗1, 嬍抲柧姲2, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/5), 恄屗 (僴僀僽儕僢僪奐嵜).
723117. [妛夛 (慡崙)] (億僗僞乕) 娞峝曄姵幰偺梊屻偵娭偡傞娞僒儖僐儁僯傾恌抐婎弨偺桳梡惈偵娭偡傞懡巤愝慜岦偒専摙. 墶憅峲堦1, 嫑搱惏婭1, 擔崅丂墰1 (1徚壔婍撪): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/5), 恄屗 (僴僀僽儕僢僪奐嵜).
723118. [妛夛 (慡崙)] (堦斒島墘) Helicobacter pylori懳偡傞儃僲僾儔僓儞2嵻椕朄偲3嵻椕朄屻偺挵撪嵶嬠憄偺曄壔偵娭偡傞挿婜娤嶡尋媶. 楅栘丂隳, 杧堜晀婌, 崅栰抭孿, 悪揷抦幚, 彫柛壛撧巕, 巗搰椚擇, 憪栰丂墰1, 抮尨媣挬, 屻摗揷戩巙 (1徚壔婍撪): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/5), 恄屗 (僴僀僽儕僢僪奐嵜).
723119. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞媫惈抇鵑墛偵懳偡傞撪帇嬀揑宱擕摢揑抇鵑僪儗僫乕僕偺帯椕惉愌. 徏壓徆桾1, 搉曈恀堣1, 墱榚嫽夘1, 娾堜抦媣1, 挿扟愳椡栫1, 彙扟姲埲1, 埨払丂夣2, 澍尨彨椙2, 崟恵婱峗1, 嬍抲柧姲2, 栘揷岝峀1, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/6), 恄屗 (僴僀僽儕僢僪奐嵜).
723120. [妛夛 (慡崙)] (堦斒岥墘) 捵釃惈戝挵墛偵偍偗傞惗暔妛揑惢嵻愭峴昳偐傜屻懕昳傊偺愗傝懼偊偵敽偆帯椕惉愌偲埨慡惈偵偮偄偰偺専摙. 尨揷梞暯1, 墶嶳丂孫1, 嬥郪丂弫1, 暿醕朁峀1, 愳娸壛撧1, 媣曐揷 (嵅揷) 旤榓1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2021/11/12), 峀搰 (僴僀僽儕僢僪奐嵜).
723121. [妛夛 (慡崙)] (億僗僞乕) 堎帪惈堓娻偵偍偗傞CDO1堚揱巕DNA儊僠儖壔偺梊應揑堄媊. 媣曐揷梲1, 揷绯丂憦2,3, 搶丂悙抭2, 愇嫶丂樞1, 屆峕峃柧2, 榓揷戱栫2, 搉曈峎幆2, 愇屗尓師2, 寴揷恊棙2, 嶳壓宲巎4,5, 憪栰丂墰2 (1戝妛堾堛椕宯尋媶壢, 2徚壔婍撪, 3怴悽婭堛椕丒愭抂堛椕, 4怴悽婭堛椕丒墶抐揑堛椕, 5忋晹徚壔娗奜): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/2-4), 墶昹 (僴僀僽儕僢僪奐嵜).
723122. [妛夛 (慡崙)] (億僗僞乕) 2夞偺ESD巤峴楌偑偁傝H. pylori彍嬠屻宱夁娤嶡拞偵恑峴堓娻傪擣傔偨1椺. 愇嫶丂樞1, 揷绯丂憦2,3, 媣曐揷梲1, 屆峕峃柧3, 搉绮峎幆3, 榓揷戱栫3, 愇屗尓師3, 寴揷恊棙3, 憪栰丂墰3, 榟旜恀棟垽4, 斾婇捈庽4 (1戝妛堾堛椕宯尋媶壢, 2怴悽婭堛椕丒愭抂堛椕, 3徚壔婍撪, 4忋晹徚壔娗奜): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/2-4), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮堓娻妛夛憤夛婰帠 2022/3; 94: 474.
731002. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 捵釃惈戝挵墛偺昦懺偲撪壢帯椕偺嵟怴忣曬亅抧堟楢実傪娷傔偰. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 憡柾尨IBD帯椕WEB僙儈僫乕 (2021/4/22), Web奐嵜 (憡柾尨).
731003. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 椣棟怰嵏埾堳夛埾堳挿島墘. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 擔杮戝挵汨栧昦妛夛戞30夞嫵堢僙儈僫乕 (2021/5/7-13), Web奐嵜.
731004. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 捵釃惈戝挵墛偺昦懺偲撪壢帯椕偺嵟怴忣曬. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 彫揷尨僄儕傾UC帯椕僙儈僫乕 (2021/10/7), Web奐嵜 (彫揷尨).
732010. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 鋁娻偵懳偡傞EUS-FNAB偵偍偗傞恌抐惉愌岦忋偺偨傔偺専懱張棟曽朄偺岺晇亅SIPS偐傜SOSE傊亅. 搉曈恀堣1, 墱榚嫽夘1, 娾堜抦媣1, 栘揷岝峀1, 彫愹榓嶰榊1 (1徚壔婍撪): 戞112夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/6/12-13), Web奐嵜.
732011. [妛夛 (抧曽夛丒尋媶夛)] (儚乕僋僔儑僢僾) 懠憻婍娻偺儕儞僷愡揮堏偵傛傞埆惈怘摴嫹嶓偵懳偡傞OTCS傪暪梡偟偨怘摴僗僥儞僩棷抲弍偺幚巤壜擻惈. 榓揷戱栫1, 寴揷恊棙1, 揷绯丂憦1,2 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕): 戞112夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/6/12-13), Web奐嵜.
732012. [妛夛 (抧曽夛丒尋媶夛)] (儚乕僋僔儑僢僾) 偮偐傒捈偟婡擻傪桳偡傞僋儕僢僾偑巭寣偵桳岠偱偁偭偨捈挵Dieulafoy捵釃偺1椺. 嬥郪丂弫1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞112夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/6/12-13), Web奐嵜.
732013. [妛夛 (抧曽夛丒尋媶夛)] (徢椺僙僢僔儑儞) 壔妛曻幩慄椕朄 (CRT) 屻嬊強堚巆嵞敪怘摴娻偵媬嵪撪帇嬀帯椕, 媬嵪庤弍傪巤峴偟偨1椺. 屆峕峃柧1, 寴揷恊棙1, 怴尨惓戝2, 揷绯丂憦1,3, 彫愹榓嶰榊1 (1徚壔婍撪, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒愭抂堛椕): 戞112夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/6/12-13), Web奐嵜.
732014. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 徚壔娗忋旂惈庮釃偵懳偡傞撪帇嬀帯椕偺岺晇偲僐僣: 弶妛幰偱傕巤峴壜擻側U椞堟偵偍偗傞堓ESD偺岺晇 彫柛壛撧巕, 抮尨媣挬, 楅栘丂隳, 憪栰丂墰1, 屻摗揷戩巙 (1徚壔婍撪): 戞112夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/6/13), Web奐嵜.
732015. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 摉堾偵偍偗傞堓娻偵懳偡傞Nivolumab偺巊梡宱尡. 屆峕峃柧 (徚壔婍撪): Step Up Web Seminar (2021/6/25), 搶嫗.
732016. [妛夛 (抧曽夛丒尋媶夛)] (價僨僆儚乕僋僔儑僢僾) 徚壔娗弌寣偵懳偡傞帯椕偺岺晇丂偮偐傒捈偟婡擻傪桳偡傞僋儕僢僾偑巭寣偵桳岠偱偁偭偨捈挵Dieulafoy捵釃偺1椺. 嬥郪丂弫1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮徚壔婍昦妛夛娭搶巟晹戞365夞椺夛 (2021/7/10), Web奐嵜.
732017. [妛夛 (抧曽夛丒尋媶夛)] (儚乕僋僔儑僢僾) 崅楊幰偵偍偗傞壔妛曻幩慄椕朄傑偨偼曻幩慄帯椕屻偺嬊強堚巆嵞敪怘摴娻偵懳偡傞岝慄椡妛揑椕朄偺慿媦揑専摙. 怺愳嵷墰旤1, 屆峕峃柧1, 榓揷戱栫1, 搉绯峎幆1, 愇屗尓師1, 寴揷恊棙1, 揷绯丂憦1,2, 憪栰丂墰1 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕): 戞53夞恄撧愳導徚壔婍昦堛妛夛憤夛 (2021/10/30), Web奐嵜.
732018. [妛夛 (抧曽夛丒尋媶夛)] (儚乕僋僔儑僢僾) 崅楊敪徢捵釃惈戝挵墛偺敪徢屻憗婜偺妶摦惈偲帯椕慖戰偵偮偄偰. 埳摗棽巑1, 墶嶳丂孫2, 彫椦惔揟2,3, 憪栰丂墰2 (1戝妛堾堛椕宯尋媶壢, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕): 戞53夞恄撧愳導徚壔婍昦堛妛夛憤夛 (2021/10/30), Web奐嵜.
732019. [妛夛 (抧曽夛丒尋媶夛)] (儚乕僋僔儑僢僾) 帯桙愗彍晄擻崅楊鋁娻姵幰偵懳偡傞gemcitabine + nab-paclitaxel椕朄偺擡梕惈偲桳岠惈偺専徹. 彫愳戝曘1, 挿扟愳椡栫1, 崟恵婱峗1, 嬍抲柧姲2, 搉曈恀堣1, 埨払丂夣2, 澍尨彨椙2, 墱榚嫽夘1, 娾堜抦媣1, 崱愹丂峅3, 栘揷岝峀1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3JCHO憡柾栰昦堾): 戞53夞恄撧愳導徚壔婍昦堛妛夛憤夛 (2021/10/30), Web奐嵜.
732020. [妛夛 (抧曽夛丒尋媶夛)] (儚乕僋僔儑僢僾) 栧柆寣愷徢偵懳偡傞峈嬅屌椕朄偺専摙乣儚乕僼傽儕儞偲僄僪僉僒僶儞偺斾妑乣. 尨丂桬曘1, 嫑搱惏婭1, 擔崅丂墰1, 娾嶈廏堦榊1, 榓揷彯媣1, 孍揷岾1, 揷绯丂憦1,2, 憪栰丂墰1 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕): 戞53夞恄撧愳導徚壔婍昦堛妛夛憤夛 (2021/10/30), Web奐嵜.
732021. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 僶僀僆儅乕僇乕傪梡偄偨屄暿壔恌椕偺幚嵺. 娾堜抦媣1, 捗懞廏峃2, 屆愳惓媊3 (1徚壔婍撪, 2斿擜婍, 3晈恖): HBOC Seminar-憻婍墶抐偵屄暿壔帯椕傪峫偊傞- (2021/11/18), Web奐嵜.
733021. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 宱旂宱娞惷柆釒嵡愷弍偑憈岟偟偨恖岺汨栧惷柆釒弌寣偺1椺. 徏壓徆桾1, 擔崅丂墰1, 嫑搱惏婭1, 孍揷岾夘1, 榓揷彯媣1, 娾嶈廏堦榊1 (1徚壔婍撪): 擔杮徚壔婍昦妛夛
娭搶巟晹戞364夞椺夛 (2021/4/24), Web奐嵜.
733022. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 媫懍偵敪堢偟偨偲峫偊傜傟傞捵釃惈戝挵墛娭楢戝挵娻偺1椺. 尨揷梞暯1, 彫椦惔揟1,2, 嬥郪丂弫1, 暿醕朁岹1, 愳娸壛撧1, 墶嶳丂孫1, 媣曐揷 (嵅揷) 旤榓1, 彫愹榓嶰榊1, 崅嫶攷擵3 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕, 3堛椕塹惗妛晹): 戞112夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/6/12-13), Web奐嵜.
733023. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 堓vanishing tumor傪掓偟偨堓傾僯僒僉僗徢偺堦椺. 彫愳戝曘1, 搉曈恀堣1, 嬍抲柧姲2, 崟恵婱峗1, 埨払丂夣2, 澍尨彨椙2, 挿扟愳椡栫1, 墱榚嫽夘1, 娾堜抦媣1, 栘揷岝峀1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢): 擔杮徚壔婍昦妛夛娭搶巟晹戞365夞椺夛 (2021/7/10), Web奐嵜.
733024. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 壔妛椕朄偱昦惃僐儞僩儘乕儖傪摼傜傟偨暊枌拞旂庮偺1椺. 堫梩婭巕1, 搉绯峎幆1, 屆峕峃柧1, 榓揷戱栫1, 愇屗尓師1, 寴揷恊棙1, 揷绯丂憦1,2 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕): 擔杮徚壔婍昦妛夛娭搶巟晹戞366夞椺夛 (2021/9/18), Web奐嵜.
733025. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 捈挵銼釕傪崌暪偟偨捵釃惈戝挵墛偺堦椺. 撪摗巎柧1, 墶嶳丂孫1, 嬥郪丂弫1, 愳娸壛撧1, 暿醕朁峀1, 媣曐揷 (嵅揷) 旤榓1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮徚壔婍昦妛夛娭搶巟晹戞366夞椺夛 (2021/9/18), Web奐嵜.
733026. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) EUS-FNAB偱恌抐偟摼偨AFP嶻惗抇鵑娻偺1椺. 暯堜揘旻1,2 (1徚壔婍撪, 2JCHO憡柾栰昦堾): 擔杮撪壢妛夛戞671夞娭搶抧曽夛 (2021/9/12), Web奐嵜.
733027. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 弍慜偵恌抐偟摼偨桳宻惈暻奜敪堢宆GIST偺1椺. 杒愳攷擵1, 斞揷弤婱1, 斾棷娫抭婭1, 惣嶳丂棾1 (1徚壔婍撪): 擔杮挻壒攇堛妛夛戞33夞娭搶峛怣墇抧曽夛妛弍廤夛 (2021/10/16), 挿栰 (僴僀僽儕僢僪奐嵜).
733028. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恌抐偑崲擄偱偁偭偨栍挵尨敪MALT儕儞僷庮偺1愗彍椺. 杒愳攷擵1, 斞揷弤婱1, 斾棷娫抭婭1, 惣嶳丂棾1 (1徚壔婍撪): 擔杮挻壒攇堛妛夛戞33夞娭搶峛怣墇抧曽夛妛弍廤夛 (2021/10/16), 挿栰 (僴僀僽儕僢僪奐嵜).
733029. [妛夛 (抧曽夛丒尋媶夛)] (JGES-Kanto Cup) 鋁摢廫擇巜挵愗彍弍屻偺嫇忋嬻挵偐傜偺惷柆釒弌寣偵懳偟偰峝壔椕朄偑憈岟偟偨1椺. 堜夢壚嵷1, 娾堜抦媣1, 栘揷岝峀1, 擔崅丂墰1, 憪栰丂墰1 (1徚壔婍撪): 戞113夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/12/4-5), Web奐嵜.
733030. [妛夛 (抧曽夛丒尋媶夛)] (JGES-Kanto Cup) A case of successful endoscopic injection sclerotherapy for hemorrhagic anastomotic varices after pancreatic duodenectomy. 堜夢壚嵷1, 娾堜抦媣1, 憪栰丂墰1 (1徚壔婍撪): 戞113夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/12/4-5), Web奐嵜.
733031. [妛夛 (抧曽夛丒尋媶夛)] (庡戣墘戣) 摉堾偵偍偗傞弍屻抇娗嬻挵暙崌晹嫹嶓偵懳偡傞撪帇嬀僪儗僫乕僕愴棯. 釼摗岞嵠1, 崟恵婱峗1, 娾堜抦媣1, 栘揷岝峀1, 憪栰丂墰1 (1徚壔婍撪): 戞113夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/12/4-5), Web奐嵜.
733032. [妛夛 (抧曽夛丒尋媶夛)] (庡戣墘戣) Crohn昦 (CD) 偵偍偗傞彫挵偺嫹嶓昦曄昡壙偵桳梡側儌僟儕僥傿偺扵嶕. 嬥郪丂弫1, 墶嶳丂孫1, 彫椦惔揟1,2, 憪栰丂墰1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞113夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/12/4-5), Web奐嵜.
733033. [妛夛 (抧曽夛丒尋媶夛)] (庡戣墘戣) 怘摴惷柆釒帯椕屻偵PPI挿婜搳梌偑昁梫側徢椺傪尒嬌傔傞乣帯椕慜屻偺24帪娫pH儌僯僞儕儞僌偵婎偯偔専摙乣. 擔崅丂墰1, 嫑搱惏婭1, 殸暘栁攷2, 憪栰丂墰1 (1徚壔婍撪, 2怴昐崌儢媢憤崌昦堾): 戞113夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/12/4-5), Web奐嵜.
733034. [妛夛 (抧曽夛丒尋媶夛)] (庡戣墘戣) 峈寣愷栻暈梡姵幰偵懳偡傞徚壔婍撪帇嬀恌椕僈僀僪儔僀儞夵掕慜屻偵偍偗傞堓ESD屻弌寣偺専摙. 堜夢桟夘1, 榓揷戱栫1, 揷绯丂憦1,2, 憪栰丂墰1 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕): 戞113夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/12/4-5), Web奐嵜.
733035. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 弌寣傪掓偟LECS偵偰愗彍偟偨嫄戝側夁宍惉億儕乕僾偺1椺. 悰郪丂廏1, 揷绯丂憦1,2, 屆峕峃柧1, 榓揷戱栫1, 搉绯峎幆1, 愇屗尓師1, 寴揷恊棙1, 憪栰丂墰1, 榟旜恀棟垽3, 斾婇捈庽3 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕, 3忋晹徚壔娗奜): 戞113夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/12/4-5), Web奐嵜.
733036. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 彫挵撪堎暔傪撪帇嬀揑偵彍嫀偟摼偨Crohn昦偺1椺. 嵅栰払嵠1, 彫椦惔揟1,2, 埳摗棽巑3, 嬥郪丂弫1, 暿醕朁峀1, 愳娸壛撧1, 墶嶳丂孫1, 媣曐揷 (嵅揷) 旤榓1, 憪栰丂墰1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕, 3戝妛堾堛椕宯尋媶壢): 戞113夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/12/4-5), Web奐嵜.
733037. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 堓擲枌壓庮釃偵懳偡傞幚懱尠旝嬀壓恦懍専懱昡壙傪梡偄偨EUS-TA偺恌抐擻偺専摙亅EUS-TA摫擖弶婜巤愝偵偍偗傞惉愌亅. 暯堜揘旻1,2 (1徚壔婍撪, 2JCHO憡柾栰昦堾): 戞113夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/12/4-5), Web奐嵜.
733038. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) Crohn昦偵崌暪偟偨捈挵娻偺堦椺. 彫愳戝曘1, 暿醕朁峀1, 埳摗棽巑2, 嬥郪丂弫1, 愳娸壛撧1, 墶嶳丂孫1, 媣曐揷 (嵅揷) 旤榓1, 彫椦惔揟1,3, 憪栰丂墰1, 撪摗丂崉4, 嶰巬丂怣5 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕, 4壓晹徚壔娗奜, 5昦棟): 擔杮徚壔婍昦妛夛娭搶巟晹戞367夞椺夛 (2021/12/11), Web奐嵜.
733039. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 挵娗儀乕僠僃僢僩昦帯椕拞偵敪徢偟偨攛媦傃娞銪擽釃傪敽偭偨僲僇儖僕傾攕寣徢偺堦椺. 恵摗棟嵅巕1, 暿醕朁峀1, 嬥郪丂弫1, 愳娸壛撧1, 墶嶳丂孫1, 媣曐揷 (嵅揷) 旤榓1, 憪栰丂墰1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕棟): 擔杮徚壔婍昦妛夛娭搶巟晹戞368夞椺夛 (2022/2/5), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110009. [尨挊] Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial. Naganuma M1, Yokoyama Y1, Motoya S1, Watanabe K1, Sawada K1, Hirai F1, Yamamoto T1, Hanai H1, Omori T1, Kanai T1, Hibi T1; 1CAPTAIN study Group (Collaborators: Yokoyama K2, et al): J Gastroenterol 2020/4; 55 (4): 390-400. (墶嶳丂孫2: 2徚壔婍撪)
'20-522001. [島嵗] 亂摿廤: 堲岮摢丒栩晹怘摴娻傪尒摝偡側亅廍偄忋偘偐傜帯椕傑偱亃[憤榑] 堲摢丒怘摴娻偺崅儕僗僋孮偺峣傝崬傒偲偦偺墳梡朄. 屆峕峃柧 (徚壔婍撪): 徚壔婍撪帇嬀 2020/12; 32 (12): 1790-7.
[挊丂彂]
'20-620001. [妛弍彂 (暘扴幏昅)]亂捵釃惈戝挵墛偺恌椕僈僀僪 戞4斉亃戞11復丂怘帠偍傛傃惗妶巜摫, p.98-103. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪), 曇: NPO朄恖擔杮墛徢惈挵幘姵嫤夛, 暥岝摪, 搶嫗, 2021/1敪峴.
戝妛堾堛椕宯尋媶壢丂徚壔婍撪壢妛
婑晬島嵗乽墛徢惈挵幘姵椪彴尋媶島嵗乿
[妛弍榑暥]
110128. [尨挊] Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysis. Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T1,2, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M: J Gastroenterol Hepatol 2021/4; 36 (4): 864-72. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110129. [尨挊] Determining the usefulness of Capsule Scoring of Ulcerative Colitis in predicting relapse of inactive ulcerative colitis. Matsubayashi M, Kobayashi T1,2, Okabayashi S, Nakano M2, Sagami S2, Ozaki R, Kiyohara H, Morikubo H, Asonuma K, Miyatani Y2, Maeda S, Hibi T1,2: J Gastroenterol Hepatol 2021/4; 36 (4): 943-50. (彫椦丂戱1,2, 拞栰丂夒2, 嵅忋怶懢榊2, 媨扟樞桟2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110130. [尨挊] Accuracy of Ultrasound for Evaluation of Colorectal Segments in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. Sagami S1, Kobayashi T1,2, Miyatani Y1, Okabayashi S, Yamazaki H, Takada T, Kinoshita K, Alocca M, Kunisaki R, Ramaswamy PK, Shiraki M, Hibi T1,2, Kataoka Y: Clin Gastroenterol Hepatol 2021/5; 19 (5): 908-21.e6. (嵅忋怶懢榊1, 彫椦丂戱1,2, 媨扟樞桟1, 擔斾婭暥1,2: 1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢)
110131. [尨挊] International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases D'Amico F, Rubin DT, Kotze PG, Magro F, Siegmund B,_Kobayashi T1,2, Olivera PA, Bossuyt P, Pouillon L, Louis E, Dom巒ech E, Ghosh S, Danese S, Peyrin-Biroulet L: United European Gastroenterol J 2021/5; 9 (4): 451-60. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110132. [尨挊] Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study. Shinzaki S, Matsuoka K, Tanaka H, Takeshima F, Kato S, Torisu T, Ohta Y, Watanabe K, Nakamura S, Yoshimura N, Kobayashi T1,2, Shiotani A, Fumihito Hirai F, Hiraoka S, Watanabe M, Matsuura M, Nishimoto S, Mizuno S, Iijima H, Takehara T, Naka T, Kanai T, Matsumoto T: J Gastroenterol 2021/6; 56 (6): 560-9. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110133. [尨挊] Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group Shen B, Kochhar GS, Navaneethan U, Cross RK, Farraye FA, Iacucci M, Schwartz DA, Gonzalez-Lama Y, Schairer J, Kiran RP, Kotze PG, Kobayashi T1,2, Bortlik M, Liu X, Levy AN, Gonzalez Su噐ez B, Tang SJ, Coelho-Prabhu N, Lukas M, Bruining DH, El-Hachem S, Charles RJ, Chen Y, Sood A, Mao R, Loras C, Dulai PS, Picoraro JA, Chiorean M, Lukas M, Shergill A, Silverberg MS, Sandborn WJ, Bernstein CN: Lancet Gastroenterol Hepatol 2021/6; 6 (6): 482-97. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110134. [尨挊] Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T1,2, Saruta M, Hirai F, Hata K, Hiraoka S, Esaki M, Sugimoto K, Fuji T, Watanabe K, Nakamura S, Inoue N, Itoh T, Naganuma M, Hisamatsu T, Watanabe M, Miwa H, Enomoto N, Shimosegawa T, Koike K: J Gastroenterol 2021/6; 56 (6): 489-526. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110135. [尨挊] Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial. Kobayashi T1,2, Motoya S, Nakamura S, Yamamoto T, Nagahori M, Tanaka S, Hisamatsu T, Hirai F, Nakase H, Watanabe K, Matsumoto T, Tanaka M, Abe T, Suzuki Y, Watanabe M, Hibi T1,2, on behalf of the HAYABUSA Study Group: Lancet Gastroenterol Hepatol 2021/6; 6 (6): 429-37. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110136. [尨挊] Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial. Feagan BG, Danese S, Loftus Jr EV , Vermeire S, Schreiber S, Ritter T, Fogel R , Mehta R, Nijhawan S, Kempi玭ski R, Filip R, Hospodarskyy I, Seidler U, Seibold F, Beales ILP, Kim HJ, McNally J, Yun C, Zhao S, Liu X, Hsueh CH, Tasset C, Besuyen R, Watanabe M, Sandborn WJ, Rogler G, Hibi T1,2, Peyrin-Biroulet L: Lancet 2021/6; 397 (10292): 2372-84. (擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110137. [尨挊] Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta-analysis. Yoshihara T, Shinzaki S, Amano T, Iijima H, Takehara T, Inoue N, Uchino M, Esaki M, Kobayashi T1,2, Saruta M, Sugimoto K, Nakamura S, Hata K, Hirai F, Hiraoka S, Fujii T, Matsuura M, Matsuoka K, Watanabe K, Nakase H, Watanabe M: J Gastroenterol Hepatol 2021/7; 36 (7): 1744-53. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110138. [尨挊] Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S-methyltransferase inhibition. Morikubo H, Kobayashi T1,2, Ozaki R, Okabayashi S, Kuronuma S, Takeuchi O, Shiba T, Kiyohara H, Matsubayashi M, Sagami S2, Nakano M2, Ikezaki O, Hisamatsu T, Tanaka Y, Hibi T1,2: J Gastroenterol Hepatol 2021/8; 36 (8): 2116-24. (彫椦丂戱1,2, 嵅忋怶懢榊2, 拞栰丂夒2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110139. [尨挊] Stopping Anti-TNF in CD Remitters: Cons. Kobayashi T1,2: Inflamm Intest Dis 2021/8; 7 (1): 59-63. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110140. [尨挊] Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis. Kobayashi T1,2, Ito H, Ashida T, Yokoyama T, Nagahori M, Inaba T, Shikamura M, Yamaguchi T, Hori T, Pinton P, Watanabe M, Hibi T1,2: Intest Res 2021/10; 19 (4): 448-60. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110141. [尨挊] Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation Toyonaga T, Kobayashi T1,2, Kuronuma S, Ueno A, Kiyohara H, Okabayashi S, Takeuchi O, Redfern CPF, Terai H, Ozaki R, Sagami S2, Nakano M2, Coulthard SA, Tanaka Y, Hibi T1,2: J Gastroenterol 2021/11; 56 (11): 999-1007. (彫椦丂戱1,2, 嵅忋怶懢榊2, 拞栰丂夒2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110142. [尨挊] International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Olivera P, Zuily S, Kotze PG, Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T1,2, Lacolley P, Louis E, Magro F, Ng SC, Papa A, Raine T, Teixeira FV, Rubin D, Danese S, and Peyrin-Biroulet L: Nat Rev Gastroenterol Hepatol 2021/12; 18 (12): 857-73. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110143. [尨挊] Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease. Suzuki K, Kakuta Y, Naito T, Takagawa T, Hanai H, Araki H , Sasaki Y, Sakuraba H, Sasaki M , Hisamatsu H, Motoya S, Matsumoto T, Onodera M, Ishiguro Y, Nakase H, Andoh A, Hiraoka S, Shinozaki M, Fujii T, Katsurada T, Kobayashi T1,2, Fujiya M, Otsuka T, Oshima N, Suzuki Y, Sato Y , Hokari R , Noguchi M, Ohta Y, Matsuura M, Kawai Y, Tokunaga K, Nagasaki M , Kudo H, Minegishi N, Okamoto D , Shimoyama Y , Moroi R , Kuroha M , Shiga H, Li D, McGovern DPB, Kinouchi Y, Masamune A, MENDEL study group: Inflamm Bowel Dis 2022/1; 28 (1): 21-31. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110144. [尨挊] Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial. Vermeire S, D'Haens G, Baert F, Danese S, Kobayashi T1,2, Loftus EV, Bhatia S, Agboton C, Rosario M, Chen C, Zhang W, Kisfalvi K, Sandborn WJ: J Crohns Colitis 2022/1; 16 (1): 27-38. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110145. [尨挊] Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis Asonuma K, Kobayashi T1,2, Nakano M2, Sagami S2, Kiyohara H, Matsubayashi M, Morikubo H, Miyatani Y2, Okabayashi S, Yamazaki H, Kuroki Y, Hibi T1,2: Inflamm Bowel Dis 2022/2; 28 (2): 200-7. (彫椦丂戱1,2, 拞栰丂夒2, 嵅忋怶懢榊2, 媨扟樞桟2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110146. [尨挊] Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials. Ben-Horin S, Novack L, Mao R, Guo J, Zhao Y, Sergienko R, Zhang J, Kobayashi T1,2, Hibi T1,2, Chowers Y, Peyrin-Biroulet L, Colombel JF, Kaplan GG, Chen MH: Gastroenterology 2022/2; 162 (2): 482-94. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110147. [尨挊] Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitis. Sagami S1, Kobayashi T1,2, Aihara K, Umeda M, Odajima K, Morikubo H, Asonuma K, Miyatani Y1, Fukuda T, Matsubayashi M, Kiyohara H, Nakano M1, Hibi T1,2: Aliment Pharmacol Ther 2022/5; 55 (10): 1320-9. doi: 10.1111/apt.16817. Epub 2022 Feb 25. (嵅忋怶懢榊1, 彫椦丂戱1,2, 媨扟樞桟1, 拞栰丂夒1, 擔斾婭暥1,2: 1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢)
110148. [尨挊] Lower effectiveness of intravenous steroid treatment for moderate-to-severe ulcerative colitis in hospitalised patients with older onset: a multicentre cohort study Okabayashi S, Yamazaki H, Tominaga K, Miura M, Sagami S1, Matsuoka K, Yamaguchi Y, Noake T, Ozeki K, Miyazaki R, Kamano T, Fukuda T, Yoshioka K, Ando K, Fukuzawa M, Andoh A, Yamamoto Y, Hibi T1,2, Kobayashi T1,2, IBD Terakoya Group: Aliment Pharmacol Ther 2022/6; 55 (12): 1569-80. doi: 10.1111/apt.16865. Epub 2022 Mar 11. (嵅忋怶懢榊1, 彫椦丂戱1,2, 擔斾婭暥1,2: 1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢)
110149. [尨挊] Lack of Increased Risk of Lymphoma with Thiopurine Therapy Regardless of Dose and Duration of Treatment in Japanese Patients with Inflammatory Bowel Diseases. Kobayashi T1,2, Udagawa E, Hibi T1,2: Digestion 2022; 103 (2): 169-73. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
510007. [憤愢] Perspectives on Subcutaneous Infliximab for Rheuatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era. Schreiber S, Ben-Horin S, Alten R, Westhovens R, Peyrin-Biroulet L, Danese S, Hibi T1,2, Takeuchi K, Magro F, An Y, Kim DH, Yoon S, Reinisch W: Adv Ther 2022/6; 39 (6): 2342-64. doi: 10.1007/s12325-021-01990-6. Epub 2022 Jan 6. (擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
520007. [憤愢]亂墛徢惈挵幘姵偵偍偗傞Treat to Target偺僄價僨儞僗亃墛徢惈挵幘姵 偺儌僯僞儕儞僌亅旕怤廝惈僶僀僆儅乕僇乕. 彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 擔杮徚壔婍昦妛夛嶨帍 2021/3; 118 (3): 229-34.
522034. [島嵗]亂摿廤: 墛徢惈挵幘姵偺暘巕昗揑帯椕傪憤妵偡傞亃2. 惗暔妛揑惢嵻丒掅暘巕壔崌暔偺嶌梡婡彉. 彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): INTESTINE 2021/9; 25 (3): 255-8.
522035. [島嵗]亂楢嵹7-1亃姲夝婜捵釃惈戝挵墛姵幰偵偍偗傞僀儞僼儕僉僔儅僽偺媥栻偵偮偄偰偺懡巤愝嫟摨旕栍専儔儞僟儉壔斾妑帋尡 (HAYABUSA). 彫椦丂戱1,2, 杮扟丂憦, 拞懞巙榊, 嶳杮棽峴, 挿杧惓榓, 揷拞怣帯, 媣徏棟堦, 暯堜堣恗, 拠悾桾巙, 搉曈寷帯, 徏杮庡擵, 揷拞惓懃, 垻晹婱峴, 楅栘峃晇, 搉曈丂庣, 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): INTESTINE 2021/12; 25 (4): 441-4.
522036. [島嵗]亂庡戣: 墛徢惈挵幘姵偺擲枌帯桙傪嵞峫偡傞亃Crohn昦偵偍偗傞慡憌惈墛徢昡壙偺堄媊乕MRE偺棫応偐傜. 嵅忋怶懢榊1, 楅栘晀巌, 彫椦丂戱1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 堓偲挵 2022/2; 57 (2): 191-200.
522037. [島嵗]亂Diagnosis亃捵釃惈戝挵墛偵偍偗傞曋拞僶僀僆儅乕僇乕應掕偺椪彴揑桳梡惈. 暉杮桽巕, 搚嫃梞夘, 嶳杮棽峴, 壓嶳婱姲, 媣徏棟堦, 烴掚彶恖, 徏壀崕慞, 摗堜弐岝, 杮椦杻堖巕, 抾拞寬恖, 戝捤榓楴, 搉曈丂庣, 彫椦丂戱1,2, 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 堛妛偲栻妛 2022/3; 79 (4): 575-84.
522038. [島嵗]亂摿廤: 墛徢惈挵幘姵update亅恌抐丒帯椕偺嵟怴抦尒亅亃V. 摿榑丂2. 帯椕栚昗偲偟偰偺慻怐妛揑帯桙. 彫椦丂戱1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 擔杮椪喱 2022/ 80 (3): 520-3.
[妛夛丒尋媶夛摍]
713009. [妛夛 (崙嵺)] (堦斒島墘) Usefulness of colestimide for postoperative refractory diarrhea in patients with Crohn's disease. Hojo A1: The 9th annual meeting of Asian Organization for Crohn's and Colitis (AOCC 2021) (2021/10/14-16), Guangzhou, Chaina. (杒瀶丂栦1: 1杒棦戝妛杒棦尋媶強昦堾)
713010. [妛夛 (崙嵺)] (堦斒島墘) Predicting risk factors of steroid dependence after initial steroid therapy in ulcerative colitis. Miyatani Y1: The 9th annual meeting of Asian Organization for Crohn's and Colitis (AOCC 2021) (2021/10/14-16), Guangzhou, Chaina. (媨扟樞桟1: 1杒棦戝妛杒棦尋媶強昦堾)
713011. [妛夛 (崙嵺)] (堦斒島墘) IL-1R-mediated mechanisms of IL-10 production by gut macrophages. Hibi T1,2: The 9th annual meeting of Asian Organization for Crohn's and Colitis (AOCC 2021) (2021/10/14-16), Guangzhou, Chaina. (擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
713012. [妛夛 (崙嵺)] (堦斒島墘) Recommendations on abdominal ultrasound in inflammatory bowel disease (20-min pre-recorded presentation video). Kobayashi T1,2: The 9th annual meeting of Asian Organization for Crohn's and Colitis (AOCC 2021) (2021/10/14-16), Guangzhou, Chaina. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
713013. [妛夛 (崙嵺)] (堦斒島墘) Challenge case III (20-min pre-recorded presentation video). Kobayashi T1,2: The 9th annual meeting of Asian Organization for Crohn's and Colitis (AOCC 2021) (2021/10/14-16), Guangzhou, Chaina. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
713014. [妛夛 (崙嵺)] (堦斒島墘) Corticosteroid-free remission of Ulcerative Colitis with filgotinib maintenance therapy:Post hoc analysis of the phase 2b/3 SELECTION study. Hibi T1,2: The 15th IGICS (International Gastrointestinal Consensus Symposium) (2022/2/12), Tokyo, Japan. (擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
721007. [妛夛 (慡崙)] (摿暿島墘)亂巌夛亃挵偐傜僸僩慡恎傪銌偔怴偟偄帪戙偺摓棃 New Era for clarifying whole fuman body through the view of intestine. 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞76夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2021/11/12-13), 峀搰 (僴僀僽儕僢僪奐嵜).
722049. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 僋儘乕儞昦彫挵昦曄偺儌僯僞儕儞僌偵曋拞僇儖僾儘僥僋僠儞偼昁恵偐?乣LRG, CRP偲偺斾妑乣. 垻慮徖朚墰1, 彫椦丂戱1,2, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/15-/17), 怴廻 (僴僀僽儕僢僪奐嵜).
722050. [妛夛 (慡崙)] (僔儞億僕僂儉) 妶摦婜捵釃惈戝挵墛偺姲夝摫擖梊屻梊應偵偍偗傞嵟揔側儌僯僞儕儞僌朄 (徢忬?僶僀僆儅乕僇乕?挵娗僄僐乕?). 嵅忋怶懢榊1, 彫椦丂戱1,2, 摗媑壚撨巕1, 捁憙旤嶇1, 彫揷搰堦峅1, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞39夞擔杮戝挵専嵏妛夛憤夛 (2021/10/1), 搶嫗 (僴僀僽儕僢僪奐嵜).
722051. [妛夛 (慡崙)] (僒僥儔僀僩僔儞億僕僂儉)亂嵗挿亃IBD恌椕偵偍偗傞Shared Decision Making. 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
722052. [妛夛 (慡崙)] (僒僥儔僀僩僔儞億僕僂儉) 墛徢惈挵幘姵偺擔忢恌椕偵偍偄偰挵娗僄僐乕傪摫擖偡傞堄媊乽幚椪彴偱挵娗僄僐乕傪偳偆妶梡偡傞偐乿. 彫椦丂戱1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/6), 恄屗 (僴僀僽儕僢僪奐嵜).
722053. [妛夛 (慡崙)] (僽儗僢僋僼傽乕僗僩僙儈僫乕) 亂嵗挿亃枬惈曋旈徢恌椕偺億僀儞僩亅傎偳傛偄攔曋偲姵幰偺徫婄亅. 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/6), 恄屗 (僴僀僽儕僢僪奐嵜).
722054. [妛夛 (慡崙)] (傾僼僞僰乕儞僙儈僫乕)亂巌夛亃傾僼僞僰乕儞僙儈僫乕2: 擲枌帯桙偐傜峫偊傞堐帩椕帯亅儌僯僞儕儞僌傪娷傔偰亅. 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722055. [妛夛 (慡崙)] (傾僼僞僰乕儞僙儈僫乕) 姲夝堐帩椕朄偲偟偰偺GMA 乣峏側傞姵幰偝傫傊偺峷專乣. 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722056. [妛夛 (慡崙)] (崌摨僔儞億僕僂儉) 捵釃惈戝挵墛姵幰偵偍偗傞儈儕僉僘儅僽偺峈TNF兛峈懱懴惈娭楢媦傃幘姵妶摦惈娭楢堚揱巕敪尰傊偺塭嬁. 彫椦丂戱1,2, Steere Boyd, Higgs Richard, Gottlieb Klaus, Sands Bruce E, 愇捤抭巕, Krishnan Venkatesh, 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722057. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 捵釃惈戝挵墛姵幰偵懳偡傞僀儞僼儕僉僔儅僽媥栻偵娭偡傞儔儞僟儉壔斾妑尋媶 (HAYABUSA帋尡). 彫椦丂戱1,2, 杮扟丂憦, 拞懞巙榊, 嶳杮棽峴, 挿杧惓榓, 揷拞怣帯, 媣徏棟堦, 暯堜堣恗, 拠悾桾巙, 搉曈寷帯, 徏杮庡擵, 楅栘峃晇, 搉曈丂庣, 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722058. [妛夛 (慡崙)] (崌摨僔儞億僕僂儉) 僋儘乕儞昦彫挵昦曄偵懳偡傞僶僀僆儅乕僇乕偺桳梡惈斾妑. 垻慮徖朚墰1, 彫椦丂戱1,2, 媨扟樞桟1, 怷媣曐戱1, 杒瀶丂栦1, 暉揷抦岹, 嵅忋怶懢榊1, 拞栰丂夒1, 擔斾婭暥1 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722059. [妛夛 (慡崙)] (傾僼僞僰乕儞僙儈僫乕) AYA悽戙偺IBD姵幰偵懳偡傞娭傢傝曽乣恌椕壢傪挻偊偰僠乕儉傾僾儘乕僠傪妛傇乣. 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722060. [妛夛 (慡崙)] (僾儗僫儕乕僙僢僔儑儞) 捵釃惈戝挵墛偺捈挵強尒傪斀塮偡傞宱夛堿挻壒攇僷儔儊乕僞偺専嶕. 杒瀶丂栦1, 彫椦丂戱1,2, 嵅忋怶懢榊1, 怷媣曐戱1, 摗媑壚撨巕1, 攡揷旤嶇1, 彫揷搰堦峅1, 媨扟樞桟1, 暉揷抦岹, 垻慮徖朚墰1, 拞栰丂夒1, 屲廫棐椙揟, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722061. [妛夛 (慡崙)] (崌摨僔儞億僕僂儉) 僋儘乕儞昦彫挵昦曄偵懳偡傞僶僀僆儅乕僇乕偺桳梡惈斾妑. 垻慮徖朚墰1, 彫椦丂戱1,2, 媨扟樞桟1, 怷媣曐戱1, 杒瀶丂栦1, 暉揷抦峀1, 嵅忋怶懢榊1, 拞栰丂夒1, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞59夞擔杮彫挵妛夛妛弍廤夛 (2021/11/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722062. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 墛徢惈挵幘姵偵偍偗傞僸儏儈儔偺埵抲晅偗傪偁傜偨傔偰峫偊傞. 彫椦丂戱1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞18夞擔杮徚壔娗妛夛憤夛妛弍廤夛 (2022/2/11-12), 搶嫗 (僴僀僽儕僢僪奐嵜).
723123. [妛夛 (慡崙)] (堦斒岥墘) 拞摍搙偐傜廳搙偺妶摦婜UC姵幰偵懳偡傞filgotinib偺桳岠惈偲埨慡惈 (姲夝摫擖椕朄): 戞2b/3憡SELECTION帋尡. 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/15-/17), 怴廻 (僴僀僽儕僢僪奐嵜).
723124. [妛夛 (慡崙)] (堦斒岥墘) 拞摍搙偐傜廳搙偺妶摦婜UC姵幰偵懳偡傞filgotinib偺桳岠惈偲埨慡惈 (姲夝堐帩椕朄): 戞2b/3憡SELECTION帋尡. 擔斾婭暥1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞107夞擔杮徚壔婍昦妛夛憤夛 (2021/4/15-/17), 怴廻 (僴僀僽儕僢僪奐嵜).
723125. [妛夛 (慡崙)] (堦斒島墘) 僋儘乕儞昦姵幰偺弍屻擄帯惈壓棢偵懳偡傞僐儗僗僠儈僪偺桳梡惈 (徚P-18). 杒瀶丂栦 (杒棦戝妛杒棦尋媶強昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
723126. [妛夛 (慡崙)] (堦斒島墘) 擄帯惈捵釃惈戝挵墛偵懳偡傞僂僗僥僉僰儅僽偺岠壥揑側徢椺慖戰偺専摙 (徚P-62). 嶳柤圄巕 (杒棦戝妛杒棦尋媶強昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
723127. [妛夛 (慡崙)] (僨僕僞儖億僗僞乕僙僢僔儑儞) 亂嵗挿亃戝挵 (捵釃惈戝挵墛) 僨僕僞儖億僗僞乕僙僢僔儑儞撪10. 彫椦丂戱1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4), 恄屗 (僴僀僽儕僢僪奐嵜).
723128. [妛夛 (慡崙)] (僨僕僞儖億僗僞乕僙僢僔儑儞) 僠僆僾儕儞惢嵻偺崅梡検搳梌壜斲梊應偵偍偗傞搳梌弶婜MCV/WBC斾偺桳梡惈. 暉揷抦峀 (杒棦戝妛杒棦尋媶強昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/5), 恄屗 (僴僀僽儕僢僪奐嵜).
723129. [妛夛 (慡崙)] (堦斒島墘) 挵娗僄僐乕偼姲夝婜捵釃惈戝挵墛偺嵞擱傪梊應偱偒傞偐? 揷搰朑柌 (杒棦戝妛杒棦尋媶強昦堾): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/5), 恄屗 (僴僀僽儕僢僪奐嵜).
723130. [妛夛 (慡崙)] (堦斒島墘) 捵釃惈戝挵墛偵偍偗傞姲夝摫擖1廡屻挵娗僄僐乕偺抁婜梊屻梊應擻. 嵅忋怶懢榊1, 彫椦丂戱1,2, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/6), 恄屗 (僴僀僽儕僢僪奐嵜).
723131. [妛夛 (慡崙)] (堦斒島墘) 撪帇嬀揑姲夝偺捵釃惈戝挵墛姵幰偵偍偗傞1擭埲撪偺僗僥儘僀僪搳梌楌偲嵞擱偺専摙 (僾儘僩僐儖). 暉揷抦峀1, 郪揷偮側婻, 郌扟彯婓, 暉惗桳壺, 媨扟樞桟1, 嶳嶈丂戝, 徏壀崕慞 (1杒棦戝妛杒棦尋媶強昦堾): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723132. [妛夛 (慡崙)] (堦斒岥墘) 拞摍徢乣廳徢妶摦婜UC姵幰偺姲夝摫擖椕朄偲偟偰偺filgotinib偺桳岠惈偲埨慡惈 (擔杮搊榐廤抍). 擔斾婭暥1,2, 杮扟丂憦, 媣徏棟堦, 暯堜堣恗, 搉曈寷帯, 徏壀崕慞, 墡揷夒擵, 彫椦丂戱1,2, Brain G Feagan, Chantal Tasset, Robin Besuyen, Chohee Yun, Gerald Crans, Jie Zhang, 嬤摗丂梲, 搉曈丂庣 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723133. [妛夛 (慡崙)] (堦斒島墘) 拞摍徢乣廳徢妶摦婜UC姵幰偺姲夝堐帩椕朄偲偟偰偺filgotinib偺桳岠惈偲埨慡惈 (擔杮搊榐廤抍). 擔斾婭暥1,2, 杮扟丂憦, 媣徏棟堦, 暯堜堣恗, 搉曈寷帯, 徏壀崕慞, 墡揷夒擵, 彫椦丂戱1,2, Brain G Feagan, Chantal Tasset, Robin Besuyen, Chohee Yun, Gerald Crans, Jie Zhang, 嬤摗丂梲, 搉曈丂庣 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723134. [妛夛 (慡崙)] (堦斒島墘) 捵釃惈戝挵墛偵懳偡傞僽僨僝僯僪拲挵僼僅乕儉偺抁婜桳岠惈偺梊應場巕偺専摙. 恏搰丂椛1, 彫椦丂戱1,2, 徏椦恀墰, 杒瀶丂栦1, 媨扟樞桟1, 嵅忋怶懢榊1, 拞栰丂夒1, 屲廫棐椙揟, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢, 3墛徢惈挵幘姵): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723135. [妛夛 (慡崙)] (堦斒島墘) 挵娗偺Shear wave elastography偼捵釃惈戝挵墛偺墛徢傪斀塮偡傞. 怷媣曐戱1, 彫椦丂戱1,2, 嵅忋怶懢榊1, 憡尨壚撨巕1, 攡揷旤嶇1, 彫揷搰堦峅1, 媨扟樞桟1, 杒瀶丂栦1, 暉揷抦岹, 垻慮徖朚墰1, 拞栰丂夒1, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢, 3墛徢惈挵幘姵): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
723136. [妛夛 (慡崙)] (堦斒島墘) 捵釃惈戝挵墛姵幰偵懳偡傞幘姵娗棟傾僾儕働乕僔儑儞偺桳梡惈側傜傃偵幚尰壜擻惈. 媨扟樞桟1, 彫椦丂戱1,2, 怷媣曐戱1, 暉揷抦峀1, 垻慮徖朚墰1, 嵅忋怶懢榊1, 拞栰丂夒1, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞12夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (2021/11/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
731005. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) IBD椪彴尋媶偺5W1H. 彫椦丂戱1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 擔杮徚壔婍昦妛夛娭搶巟晹戞368夞椺夛 (2022/2/5), Web奐嵜.
733040. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 堓擲枌壓偵摿堎側宍懺偺懡朳惈偺擽釃傪宍惉偟, 廫擇巜挵捵釃偺慂攋偑媈傢傟偨1椺. 媣尨復峅1, 惣懞丂尗1,2, 媨扟樞桟1, 擔斾婭暥1, 彫椦丂戱1,3, 昹栰堣旤1, 墍揷孾懢1, 抾懞桽夘1, 敆丂桾擵1, 棊崌戝庽1, 愇堜椙岾1,4, 嵅忋怶懢榊1, 恏搰丂椛1, 杒瀶丂栦1, 拞栰丂夒1 (1杒棦戝妛杒棦尋媶強昦堾, 2徚壔婍撪, 3戝妛堾堛椕宯尋媶壢, 4壓晹徚壔娗奜): 擔杮徚壔婍昦妛夛娭搶巟晹戞366夞椺夛 (2021/9/18), Web奐嵜.
733041. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 挵儕儞僷娗奼挘徢偵傛傞抈敀楻弌惈堓挵徢傪棃偟偨捵釃惈戝挵墛戝挵慡揈弍屻偺1椺. 楅栘丂戓1, 惣懞丂尗1,2, 媨扟樞桟1, 恏搰丂椛1, 杒瀶丂栦1, 嵅忋怶懢榊1, 垻慮徖朚墰1, 拞栰丂夒1, 彫椦丂戱1,3, 擔斾婭暥1,3 (1杒棦戝妛杒棦尋媶強昦堾, 2徚壔婍撪, 3戝妛堾堛椕宯尋媶壢): 擔杮徚壔婍昦妛夛娭搶巟晹戞368夞椺夛 (2022/2/5), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110010. [尨挊] Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial. Kita T, Ashizuka S, Ohmiya N, Yamamoto T, Kanai T, Motoya S, Hirai F, Nakase H, Moriyama T, Nakamura M, Suzuki Y, Kanmura S, Kobayashi T1,2, Ohi H, Nozaki R, Mitsuyama K. Yamamoto S, Inatsu H, Watanbe K, Hibi T1,2, Kitamura K: J Gastroenterol 2021/2; 56 (2): 147-57. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
'20-110011. [尨挊] The dietary practices and beliefs of people living with inactive ulcerative colitis. Crooks B, McLaughlin J, Matsuoka K, Kobayashi T1,2, Yamazaki H, Limdi JK: Eur J Gastroenterol Hepatol 2021/3; 33 (3): 372-9. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
弞娐婍撪壢妛
[妛弍榑暥]
110150. [尨挊] Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry. Iso K, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H1, Nakahara S, Kato T, Hayashi H, Iwasaki Y, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, Okumura Y, AF Ablation Frontier Registry investigators: Heart Vessels 2021/4; 36 (4): 549-60. (怺扟塸暯1: 1弞娐婍撪)
110151. [尨挊] Optimized lesion size index (o-LSI): A novel predictor for sufficient ablation of pulmonary vein isolation. Matsuura G1, Kishihara J2, Fukaya H2, Oikawa J2, Ishizue N2, Saito D1, Sato T2, Arakawa Y2, Kobayashi S2, Shirakawa Y2, Nishinarita R2, Horiguchi A2, Niwano S2, Ako J2: J Arrhythm 2021/4; 37 (3): 558-65. (徏塝丂尦1, 娸尨丂弤2, 怺扟塸暯2, 媦愳丂弤2, 愇枛惉嵠2, 嵵摗戝庽1, 嵅摗揘榊2, 峳愳梇婭2, 彫椦廃暯2, 敀愳桾婎2, 惣惉揷椇2, 杧岥丂垽2, 掚栰怲堦2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
110152. [尨挊] Efficacy and safety of esaxerenone in patients with hypertension and concomitant heart failure. Naruke T1, Maemura K1, Oki T1, Yazaki M1, Fujita T1, Ikeda Y1, Nabeta T1, Ishii S1, Minami Y1, Fukaya H1, Yuge M, Shimohama T1, Kawaguchi T, Ako J1: Hypertens Res 2021/5; 44 (5): 601-3. (惉栄丂悞1, 慜懞寬帯1 , 戝栘戩枻1, 栴嶈杻桼1, 摗揷揝暯1, 抮揷桽婤1, 撶揷丂寬1, 愇堜弐曘1, 撿丂彯尗1, 怺扟塸暯1, 壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪)
110153. [尨挊] Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial Infarction. Wada H, Ogita M, Suwa S, Nakao K, Ozaki Y, Kimura K, Ako J1, Noguchi T, Yasuda S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A , Mano T,Wake M, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M, J-MINUET investigators: Int Heart J 2021/5; 62 (3): 520-7. (垻屆弫嵠1: 1弞娐婍撪)
110154. [尨挊] Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment. Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG, ODYSSEY OUTCOMES Committees and Investigators (Collaborators: Ako J1): Diabetes Care 2021/5; 44 (5): 1219-27. (垻屆弫嵠1: 1弞娐婍撪)
110155. [尨挊] Rivaroxaban monotherapy versus combination therapy according to patient risk of stroke and bleeding in atrial fibrillation and stable coronary disease: AFIRE trial subanalysis. Akao M, Yasuda S, Kaikita K, Ako J1, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H: Am Heart J 2021/6; 236: 59-68. (垻屆弫嵠1: 1弞娐婍撪)
110156. [尨挊] Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis. Nabeta T1, Hara M, Naruke T1, Maemura K1, Oki T1, Yazaki M1, Fujita T1, Ikeda Y1, Ishii S1, Koitabashi T1, Ako J1: J Arrhythm 2021/6; 37 (4): 1093-100. (撶揷丂寬1, 惉栄丂悞1, 慜懞寬帯1, 戝栘戩枻1, 栴嶈杻桼1, 摗揷揝暯1, 抮揷桽婤1, 愇堜弐曘1, 彫斅嫶弐旤1, 垻屆弫嵠1: 1弞娐婍撪)
110157. [尨挊] Association between acute myocardial infarction-to-cardiac rupture time and in-hospital mortality risk: a retrospective analysis of multicenter registry data from the Cardiovascular Research Consortium-8 Universities (CIRC-8U). Yoneyama K, Ishibashi Y, Koeda Y, Itoh T, Morino Y, Shimohama T1, Ako J1, Ilari Y, Yoshioka K, Kunishima T, Inami S, Ishikawa T, Sugimura H, Kozuma K, Sugi K, Yoshino H, Akashi YJ: Heart Vessels 2021/6; 36 (6): 782-9. (壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪)
110158. [尨挊] Transcatheter Aortic Valve Replacement in Patients With a Small Annulus - From the Japanese Nationwide Registry (J-TVT). Meguro K1, Kumamaru H, Kohsaka S, Hashimoto T1, Kakizaki R1, Kitamura T2, Shimizu H, Ako J1: Circ J 2021/6; 85 (7): 967-76. (栚崟寬懢榊1, 嫶壓戱栱1, 奰嶈椙懢1, 杒懞丂棩2, 垻屆弫嵠1: 1弞娐婍撪, 2怱憻寣娗奜)
110159. [尨挊] Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. Lam CSP, Giczewska A, Sliwa K, Edelmann F, Refsgaard J, Bocchi E, Ezekowitz JA, Hernandez AF, O'Connor CM, Roessig L, Patel MJ, Pieske B, Anstrom KJ, Armstrong PW, VICTORIA Study Group (Collaborators: Ako J1): JAMA Cardiol. 2021/6; 6 (6): 706-12. (垻屆弫嵠1: 1弞娐婍撪)
110160. [尨挊] JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, Usui A, Okishige K, Kusano K, Kumagai K, Goya M, Kobayashi Y, Shimizu A, Shimizu W, Shoda M, Sumitomo N, Seo Y, Takahashi A, Tada H, Naito S, Nakazato Y, Nishimura T, Nitta T, Niwano S1, Hagiwara N, Murakawa Y, Yamane T, Aiba T, Inoue K, Iwasaki Y, Inden Y, Uno K, Ogano M, Kimura M, Sakamoto S, Sasaki S, Satomi K, Shiga T, Suzuki T, Sekiguchi Y, Soejima K, Takagi M, Chinushi M, Nishi N, Noda T, Hachiya H, Mitsuno M, Mitsuhashi T, Miyauchi Y, Miyazaki A, Morimoto T, Yamasaki H, Aizawa Y, Ohe T, Kimura T, Tanemoto K, Tsutsui H, Mitamura H, JCS/JHRS Joint Working Group: Circ J. 2021/6; 85 (7): 1104-244. (掚栰怲堦1: 1弞娐婍撪)
110161. [尨挊] JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, Usui A, Okishige K, Kusano K, Kumagai K, Goya M, Kobayashi Y, Shimizu A, Shimizu W, Shoda M, Sumitomo N, Seo Y, Takahashi A, Tada H, Naito S, Nakazato Y, Nishimura T, Nitta T, Niwano S1, Hagiwara N, Murakawa Y, Yamane T, Aiba T, Inoue K, Iwasaki Y, Inden Y, Uno K, Ogano M, Kimura M, Sakamoto S, Sasaki S, Satomi K, Shiga T, Suzuki T, Sekiguchi Y, Soejima K, Takagi M, Chinushi M, Nishi N, Noda T, Hachiya H, Mitsuno M, Mitsuhashi T, Miyauchi Y, Miyazaki A, Morimoto T, Yamasaki H, Aizawa Y, Ohe T, Kimura T, Tanemoto K, Tsutsui H, Mitamura H, JCS/JHRS Joint Working Group: J Arrhythm 2021/6; 37 (4): 709-870. (掚栰怲堦1: 1弞娐婍撪)
110162. [尨挊] Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis. Nabeta T1, Hara M, Naruke T1, Maemura K1, Oki T1, Yazaki M1, Fujita T1, Ikeda Y1, Ishii S1, Koitabashi T1, Ako J1: J Arrhythm 2021/6; 37 (4): 1093-100. (撶揷丂寬1, 惉栄丂悞1, 慜懞寬帯1, 戝栘戩枻1, 栴嶈杻桼1, 摗揷 揝暯1, 抮揷桽婤1, 愇堜弐曘1, 彫斅嫶弐旤1, 垻屆弫嵠1: 1弞娐婍撪)
110163. [尨挊] Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure. Maeda D, Kagiyama N, Jujo K, Saito K, Kamiya K1, Saito H, Ogasahara Y, Maekawa E2, Konishi M, Kitai T, Iwata K, Wada H, Hiki M, Dotare T, Sunayama T, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Yonezawa R, Oka K, Momomura S, Matsue Y: Sci Rep 2021/7; 11 (1): 11957. (恄扟寬懢榊1, 慜愳宐旤2: 1堛椕塹惗妛晹, 2弞娐婍撪)
110164. [尨挊] Glucose-dependent diuresis in relation to improvements in renal-tubular markers of sodium-glucose cotransporter-2 inhibitors in hospitalized heart failure patients with diabetes. Ikeda Y1, Ishii S1, Maemura K1, Oki T1, Yazaki M1, Fujita T1, Nabeta T1, Maekawa E1, Koitabashi T1, Ako J1: Heart Vessels 2021/7; 36 (7): 978-85. (抮揷桽婤1, 愇堜弐曘1, 慜懞寬帯1, 戝栘戩枻1, 栴嶈杻桼1, 摗揷揝暯1, 撶揷丂寬1, 慜愳宐旤1, 撶揷丂寬1, 彫斅嫶弐旤1, 垻屆弫嵠1: 1弞娐婍撪)
110165. [尨挊] Clinical outcomes according to dose reduction criteria of apixaban in Japanese elderly patients with atrial fibrillation: J-ELD AF Registry subanalysis. Akao M, Yamashita T, Suzuki S, Okumura K, J-ELD AF Investigators (Collaborators: Ako J1): Heart Vessels 2021/7; 36 (7): 1035-46. (垻屆弫嵠1: 1弞娐婍撪)
110166. [尨挊] Plasma Concentration and Pharmacodynamics of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Acute Heart Failure. Nabeta T1, Kida K, Ishida M1, Shiono T1, Suzuki N, Doi S, Tsukahara M, Ohta Y, Kimura T, Yamaguchi K, Takita A, Matsumoto N, Akashi Y, Ako J1, Inomata T1: Clin Pharmacokinet 2021/8; 60 (8): 1061-71. (撶揷丂寬1, 愇揷嶰榓1, 墫栰曽柧1, 垻屆弫嵠1, 挅枔岶尦1: 1弞娐婍撪)
110167. [尨挊] Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction. Konishi M, Kagiyama N, Kamiya K1, Saito H, Saito K, Ogasahara Y, Maekawa E2, Misumi T, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Makino A, Oka K, Momomura S, Matsue Y: Eur J Prev Cardiol 2021/8; 28 (9): 1022-9. (恄扟寬懢榊1, 慜愳宐旤2: 1堛椕塹惗妛晹, 2弞娐婍撪))
110168. [尨挊] Ischemic/bleeding event after short dual-antiplatelet therapy in patients with high bleeding risk: Sub-analysis of the MODEL U-SES study. Hioki H1, Kozuma K, Kinoshita Y, Nanasato M, Ito Y, Yamaguchi J, Shiode N, Hibi K, Tanabe K, Ako J1, Morino Y, Hirohata A, Sonoda S, Nakagawa Y, Okada H, Nakagami T, Takamisawa I, Ando K, Abe M, Ikari Y: J Cardiol 2021/8; 78 (2): 107-13. (垻屆弫嵠1: 1弞娐婍撪)
110169. [尨挊] Clinical significance of ischemia-like electrocardiographic finding during heart failure treatment on left ventricular recovery in patients with non-ischemic dilated cardiomyopathy. Maemura K1, Ikeda Y1, Oki T1, Yazaki M1, Fujita T1, Nabeta T1, Ishii S1, Maekawa E1, Naruke T1, Koitabashi T1, Inomata T1, Ako J1: J Cardiol 2021/8; 78 (2): 142-9. (慜懞寬帯1, 抮揷桽婤1, 戝栘戩枻1, 栴嶈杻桼1, 摗揷揝暯1, 撶揷丂寬1, 愇堜弐曘1, 慜愳宐旤1, 惉栄丂悞1, 彫斅嫶弐旤1, 挅枔岶尦1, 垻屆弫嵠1: 1弞娐婍撪)
110170. [尨挊] The optimal ablation setting for a local impedance guided catheter in an in vitro experimental model. Kawano D, Mori H, Kato R, Tsutsui K, Ikeda Y, Sumitomo N, Fukaya H1, Iwanaga S, Nakano S, Muramatsu T, Matsumoto K: J Cardiovasc Electrophysiol 2021/8; 32 (8): 2069-76. (怺扟塸暯1: 1弞娐婍撪)
110171. [尨挊] Characteristics of carotid atherosclerosis in patients with plaque erosion. Kato A1, Minami Y1, Asakura K2, Katamine M2, Katsura A1, Muramatsu Y1, Sato T1, Kakizaki R1, Hashimoto T1, Meguro K1, Shimohama T1, Ako J1: J Thromb Thrombolysis 2021/8; 52 (2): 620-7. (壛摗嵤旤1, 撿丂彯尗1, 挬憅惔巎2, 曅曯 惓岍2, 宩丂桳抭1, 懞徏桾夘1, 嵅摗弐堯1, 奰嶈椙懢1, 嫶杮戱栱1, 栚崟寬懢榊1, 壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
110172. [尨挊] Predictors of Rapid Plaque Progression: An Optical Coherence Tomography Study. Araki M, Yonetsu T, Kurihara O, Nakajima A, Lee H, Soeda T, Minami Y1, McNulty I, Uemura S, Kakuta T, Jang IK: JACC Cardiovasc Imaging 2021/8; 14 (8): 1628-38. (撿丂彯尗1: 1弞娐婍撪)
110173. [尨挊] Novel Predictor for New-Onset Atrial High-Rate Episode in Patients With a Dual-Chamber Pacemaker. Nishinarita R1, Niwano S1, Oikawa J1, Saito D2, Sato T1, Matsuura G2, Arakawa Y1, Kobayashi S1, Shirakawa Y1, Horiguchi A1, Nakamura H1, Ishizue N1, Kishihara J1, Fukaya H1, Ako J1: Circ Rep 2021/8; 3 (9): 497-503. (惣惉揷椇1, 掚栰怲堦1, 媦愳丂弤1, 嵵摗戝庽2, 嵅摗揘榊1, 徏塝丂尦2, 峳愳梇婭1, 彫椦廃暯1, 敀愳桾婎1, 杧岥丂垽1, 拞懞梞斖1, 愇枛惉嵠1, 娸尨丂弤1, 怺扟塸暯1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
110174. [尨挊] Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol. Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, L梡ez-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg PG, ODYSSEY Outcomes Committees and Investigators (Collaborators: Ako J1): J Am Coll Cardiol. 2021/8; 78 (5): 421-33. (垻屆弫嵠1: 1弞娐婍撪)
110175. [尨挊] Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy - Insights From the J-MINUET Study. Hashimoto Y, Ozaki Y, Kan S, Nakao K, Kimura K, Ako J1, Noguchi T, Suwa S, Fujimoto K, Dai K, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Wake M, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Yasuda S, Ismail TF, Muramatsu T, Izawa H, Takahashi H, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M, J-MINUET Investigators: Circ J 2021/9; 85 (10): 1710-8. (垻屆弫嵠1: 1弞娐婍撪)
110176. [尨挊] Gender Differences in the Circadian and Seasonal Variations in Patients with Takotsubo Syndrome: A Multicenter Registry at Eight University Hospitals in East Japan. Yoshizawa M, Itoh T, Morino Y, Taniai S, Ishibashi Y, Komatsu T, Taguchi I, Nishinari M1, Ako J1, Kyono H, Furukawa T, Murakami T, Ikari Y, Kato R, Matsumoto K, Sakuma M, Sugimura H, Akashi YJ, Yoshino H, CIRC-8U study group: Intern Med 2021/9; 60 (17): 2749-55. (惣惉恀嬚1, 垻屆弫嵠1: 1弞娐婍撪)
110177. [尨挊] Impact of Social Frailty in Hospitalized Elderly Patients With Heart Failure: A FRAGILE-HF Registry Subanalysis. Jujo K, Kagiyama N, Saito K, Kamiya K, Saito H, Ogasahara Y, Maekawa E1, Konishi M, Kitai T, Iwata K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Yonezawa R, Oka K, Makizako H, Momomura S, Matsue Y: J Am Heart Asso 2021/9; 10 (17): e019954. (慜愳宐旤1: 1弞娐婍撪)
110178. [尨挊] Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials. Nishi T, Okada k, Kitahara H, Kameda R1, Ikutomi M, Imura S, Hollak MB, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Ellis GS, Kereiakes DJ, Stone GW, Honda Y, Kimura T, ABSORB III and ABSORB Japan Investigators: J Cardiol 2021/9; 78 (3): 224-9. (婽揷丂椙1: 1弞娐婍撪)
110179. [尨挊] The impact of pre-hospital 12-lead electrocardiogram and first contact by cardiologist in patients with ST-elevation myocardial infarction in Kanagawa, Japan. Mori H, Maeda A, Akashi Y, Ako J1, Ikari Y, Ebina T, Tamura K, Namiki A, Fukui K, Michishita I, Kimura K, Suzuki H: J Cardiol 2021/9; 78 (3): 183-92. (垻屆弫嵠1: 1弞娐婍撪)
110180. [尨挊] Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2. Watanabe H, Morimoto T, Ogita M, Suwa S, Natsuaki M, Suematsu N, Koeda Y, Morino Y, Nikaido A, Hata Y, Doi M, Hibi K, Kimura K, Yoda S, Kaneko T, Nishida K, Kawai K, Yamaguchi K, Wakatsuki T, Tonoike N, Yamamoto M, Shimizu S, Shimohama T1, Ako J1, Kimura T, STOPDAPT-2 Investigators: Cardiovasc Interv Ther 2021/10; 36 (4): 403-15. (壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪)
110181. [尨挊] Clinical significance of prehospital 12-lead electrocardiography in patients with ST-segment elevation myocardial infarction presenting with syncope: from a multicenter observational registry (K-ACTIVE study). Sato N1, Minami Y1, Ako J1, Maeda A, Akashi Y, Ikari Y, Ebina T, Tamura K, Namiki A, Fukui K, Michishita I, Kimura K, Suzuki H: Heart Vessels 2021/10; 36 (10): 1466-73. (嵅摗怢梞1, 撿丂彯尗1, 垻屆弫嵠1: 1弞娐婍撪)
110182. [尨挊] Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy - Insights From the J-MINUET Study. Hashimoto Y, Ozaki Y, Kan S, Nakao K, Kimura K, Ako J1, Noguchi T, Suwa S, Fujimoto K, Dai K, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Wake M, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Yasuda S, Ismail TF, Muramatsu T, Izawa H, Takahashi H, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M, J-MINUET Investigators: Circ J 2021/9; 85 (10): 1710-8. (垻屆弫嵠1: 1弞娐婍撪)
110183. [尨挊] Clinical and procedure characteristics in patients treated with polytetrafluoroethylene-covered stents after coronary perforation: a CIRC-8U multicenter registry and literature review. Itoh T, Kimura T, Kudo A, Morino Y, Ikari Y, Yoshioka K, Nakano M, Natsumeda M, Sakuma M, Inami S, Ako J1, Nishinari M1, Shimohama T1, Komatsu T, Ishikawa T, Taguchi I, Sugimura H, Mitarai T, Akashi Y, Suzuki N, Sugi K, Matsumoto K, Kohshoh H, Yoshino H, CIRC-8U Study Group: Cardiovasc Interv Ther 2021/10; 36 (4): 418-28. (垻屆弫嵠1, 惣惉恀嬚1, 壓昹岶榊1: 1弞娐婍撪)
110184. [尨挊] Impact of hemodialysis on clinical and angiographic outcomes in in-stent restenotic lesions following optical coherence tomography-guided drug-coated balloon treatment. Aoki J, Nakazawa G, Ando K, Nakamura S, Tobaru T, Sakurada M, Okada H, Hibi K, Zen K, Ikuta A, Fujii K, Habara M, Ako J1, Asano T, Ozaki S, Fusazaki T, Kozuma K, ELEGANT investigators: Cardiovasc Interv Ther 2021/10; 36 (4): 429-35. (垻屆弫嵠1: 1弞娐婍撪)
110185. [尨挊] Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial. Yazaki Y, Nakamura M, Iijima R, Yasuda S, Kaikita K, Akao M, Ako J1, Matoba T, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K , Ogawa H, AFIRE Investigators: Circulation 2021/10; 144 (17): 1449-51. (垻屆弫嵠1: 1弞娐婍撪)
110186. [尨挊] Association between intestinal oedema and oral loop diuretic resistance in hospitalized patients with acute heart failure. Ikeda Y1, Ishii S1, Maemura K1, Oki T1, Yazaki M1, Fujita T1, Nabeta T1, Maekawa E1, Koitabashi T1, Ako J1: ESC Heart Fail 2021/10; 8 (5): 4067-76. (抮揷桽婤1, 愇堜弐曘1, 慜懞寬帯1, 戝栘戩枻1, 栴嶈杻桼1, 摗揷揝暯1, 撶揷丂寬1, 慜愳宐旤1, 彫斅嫶弐旤1, 垻屆弫嵠1: 1弞娐婍撪)
110187. [尨挊] Validation of the atherothrombotic risk score for secondary prevention in patients with acute myocardial infarction: the J-MINUET study. Hashimoto T1, Minami Y1, Ako J1, Nakao K, Ozaki Y, Kimura K, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M, J-MINUET Investigators: Heart Vessels 202/10; 36 (10): 1506-13. (嫶杮戱栱1, 撿丂彯尗1, 垻屆弫嵠1: 1弞娐婍撪)
110188. [尨挊] Age and Phenotype of Patients With Plaque Erosion. Araki M, Yonetsu T, Kurihara O, Nakajima A, Lee H, Soeda T, Minami Y1, Higuma T, Kimura S, Takano M, Yan BP, Adriaenssens T, Boeder NF, Nef HM, Kim CJ, McNulty I, Crea F, Kakuta T, Jang IK: J Am Heart Assoc 2021/10; 10 (19): e020691. (撿丂彯尗1: 1弞娐婍撪)
110189. [尨挊] Optimal interlesion distance in ablation index-guided pulmonary vein isolation for atrial fibrillation. Kobayashi S1, Fukaya H1, Oikawa J1, Saito D2, Sato T1, Matsuura G2, Arakawa Y1, Shirakawa Y1, Nishinarita R1, Horiguchi A1, Ishizue N1, Kishihara J1, Niwano S1, Ako J1: J Interv Card Electrophysiol 2021/10; 62 (1): 123-31. (彫椦廃暯1, 怺扟塸暯1, 媦愳丂弤1, 嵵摗戝庽2, 嵅摗揘榊1, 徏塝丂尦2, 峳愳梇婭1, 敀愳桾婎1, 惣惉揷椇1, 杧岥丂垽1, 愇枛惉嵠1, 娸尨丂弤1, 掚栰怲堦1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
110190. [尨挊] Impact of Diastolic Vessel Restriction on Quality of Life in Symptomatic Myocardial Bridging Patients Treated With Surgical Unroofing: Preoperative Assessments With Intravascular Ultrasound and Coronary Computed Tomography Angiography. Hashikata T1, Honda Y, Wang H, Pargaonkar VS, Nishi T, Brooke Hollak M, Rogers IS, Nieman K, Yock PG, Fitzgerald PJ, Schnittger I, Boyd JH, Tremmel JA: Circ Cardiovasc Interv 2021/10; 14 (10): e011062. (敘曽寬岹1: 1弞娐婍撪)
110191. [尨挊] Bleeding and Subsequent Cardiovascular Events and Death in Atrial Fibrillation With Stable Coronary Artery Disease: Insights From the AFIRE Trial. Kaikita K, Yasuda S, Akao M, Ako J1, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H: Circ Cardiovasc Interv 2021/11; 14 (11): e010476. (垻屆弫嵠1: 1弞娐婍撪)
110192. [尨挊] Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations. Tan JWC, Chew DP, Tsui KL, Tan D, Duplyakov D, Hammoudeh A, Zhang B, Li Y, Xu K, Ong PJ, Firman D, Gamra H, Almahmeed W, Dalal J, Tam LW, Steg G, Nguyen QN, Ako J1, Suwaidi JA, Chan M, Sobhy M, Shehab A, Buddhari W, Wang Z, Fong AYY, Karadag B, Kim BK, Baber U, Chin CT, Han YL: Eur Cardiol 2021/11; 16: e43. (垻屆弫嵠1: 1弞娐婍撪)
110193. [尨挊] Coronary plaque and clinical characteristics of South Asian (Indian) patients with acute coronary syndromes: An optical coherence tomography study. Nakajima A, Subban V, Russo M, Bryniarski KL, Kurihara O, Araki M, Minami Y1, Soeda T, Yonetsu T, Crea F, Takano M, Higuma T, Kakuta T, Adriaenssens T, Boeder NF, Nef HM, Raffel OC, McNulty I, Lee H, Nakamura S, Abdullakutty J, Mathew R, Sankardas MA, Jang IK: Int J Cardiol 2021/11; 343: 171-9. (撿丂彯尗1: 1弞娐婍撪)
110194. [尨挊] Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting: Insights From the AFIRE Trial. Matoba T, Yasuda S, Kaikita K, Akao M, Ako J1, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H, AFIRE Investigators: JACC Cardiovasc Interv 2021/11; 14 (21): 2330-40. (垻屆弫嵠1: 1弞娐婍撪)
110195. [尨挊] Antithrombotic Therapy for Atrial Fibrillation and Coronary Artery Disease in Patients With Prior Atherothrombotic Disease: A Post Hoc Analysis of the AFIRE Trial. Matsuzawa Y, Kimura K, Yasuda S, Kaikita K, Akao M, Ako J1, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Hirayama A, Matsui K, Ogawa H, AFIRE Investigators: J Am Heart Assoc 2021/11; 10 (21): e020907. (垻屆弫嵠1: 1弞娐婍撪)
110196. [尨挊] Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation. Fukaya H1, Ako J1, Yasuda S, Kaikita K, Akao M, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H: Heart 2021/11; 107 (21): 1731-8. (怺扟塸暯1, 垻屆弫嵠1: 1弞娐婍撪)
110197. [尨挊] Fibrillation cycle length predicts cardiovascular events in patients with long-standing persistent atrial fibrillation. Nakamura H1, Niwano S1, Fukaya H1, Kishihara J1, Satoh A1, Oikawa J1, Yoshizawa T1, Ishizue N1, Igarashi T1, Fujiishi T1, Nishinarita R1, Horiguchi A1, Ako J1: Heart Vessels 2022/6; 37 (6): 1027-33. doi: 10.1007/s00380-021-01993-x. Epub 2021 Nov 19. (拞懞梞斖1, 掚栰怲堦1, 怺扟塸暯1, 娸尨丂弤1, 嵅摗丂梲1, 媦愳丂弤1, 媑郪抭帯1, 愇枛惉嵠1, 屲廫棐寬1, 摗愇庫旤1, 惣惉揷椇1, 杧岥丂垽1, 垻屆弫嵠1: 1弞娐婍撪)
110198. [尨挊] Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial. Sotomi Y, Kozuma K, Kashiwabara K, Higuchi Y, Ando K, Morino Y, Ako J1, Tanabe K, Muramatsu T, Nakazawa G , Hikoso S, Sakata Y, OPTIMA-AF Investigators: BMJ Open 2021/12; 11 (12): e048354. (垻屆弫嵠1: 1弞娐婍撪)
110199. [尨挊] Impact of physical performance on exercise capacity in older patients with heart failure with reduced and preserved ejection fraction. Saka K, Konishi M, Kagiyama N, Kamiya K1, Saito H, Saito K, Ogasahara Y, Maekawa E2, Misumi T, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Makino A, Oka K, Kimura K, Tamura K, Momomura S, Matsue Y: Exp Gerontol 2021/12; 156: 111626. (恄扟寬懢榊1, 慜愳宐旤2: 1堛椕塹惗妛晹, 2弞娐婍撪)
110200. [尨挊] Moderate potassium lowering effect of exogenous atrial natriuretic peptide in patients with acute heart failure. Konishi M, Akiyama E, Shibata A, Kida K, Ishii S1, Ikari Y, Kimura K, Tamura K, Matsumoto S: J Cardiol 2021/12; 78 (6): 558-63. (愇堜弐曘1: 1弞娐婍撪)
110201. [尨挊] Characteristics and optimal ablation settings of a novel, contact-force sensing and local impedance-enabled catheter in an ex vivo perfused swine ventricle model. Tsutsui K, Kawano D, Mori H, Kato R, Ikeda Y, Sumitomo N, Fukaya H1, Iwanaga S, Nakano S, Muramatsu T, Matsumoto K: J Cardiovasc Electrophysiol 2021/12; 32 (12): 3187-94. (怺扟塸暯1: 1弞娐婍撪)
110202. [尨挊] Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J. Nakamura M, Ako J1, Arai H, Hirayama A, Nohara A, Murakami Y, Ozaki A, Harada-Shiba M: J Atheroscler Thromb 2021/12; 28 (12): 1307-22. (垻屆弫嵠1: 1弞娐婍撪)
110203. [尨挊] Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study. Kusunose K, Yoshida H, Tanaka A, Teragawa H, Akasaki Y, Fukumoto Y, Eguchi K, Kamiya H, Kario K, Yamada H, Sata M, Node K, PRIZE Study Investigators (Collaborators: Ako J1): Hypertens Res 2022/1; 45 (1):106-15. (垻屆弫嵠1: 1弞娐婍撪)
110204. [尨挊] Different Determinants of the Recurrence of Atrial Fibrillation and Adverse Clinical Events in the Mid-Term Period After Atrial Fibrillation Ablation. Watanabe R, Nagashima K, Wakamatsu Y, Otsuka N, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H1, Nakahara S, Kato T, Hayashi H, Iwasaki Y, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, Okumura Y, AF Ablation Frontier Registry Investigators: Circ J 2022/1; 86 (2): 233-42. (怺扟塸暯1: 1弞娐婍撪)
110205. [尨挊] Risk for Proteinuria in Newly Defined Hypertensive People Based on the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline. Suzuki Y, Kaneko H, Okada A, Itoh H, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Yamaguchi S, Yano Y, Kamiya K1, Matsunaga A1, Ako J2, Fukui A, Yokoo T, Nishiyama A, Node K, Yamauchi T, Nangaku M, Yasunaga H, Komuro I: Am J Cardiol 2022/4; 168: 83-9. doi: 10.1016/j.amjcard.2021.12.023. Epub 2022 Jan 19. (恄扟寬懢榊1, 徏塱撃旻1, 垻屆弫嵠2: 1堛椕塹惗妛晹, 2弞娐婍撪)
110206. [尨挊] Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease. Hashimoto T1, Minami Y1, Asakura K1, Katamine M2, Kato A1, Katsura A1, Sato T1, Muramatsu Y1, Kameda R1, Meguro K1, Shimohama T1, Ako J1: J Clin Lipidol 2022/1-2; 16 (1): 104-11. (嫶壓戱栱1, 撿丂彯尗1, 挬憅惔巎1, 曅曯惓岍2, 壛摗嵤旤1, 宩丂桳抭1, 嵅摗弐廩1, 懞徏桾夘1, 婽揷丂椙1, 栚崟寬懢榊1, 壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕尋媶壢)
110207. [尨挊] Impact of triglyceride levels on plaque characteristics in patients with coronary artery disease. Asakura K1, Minami Y1, Kinoshita D1, Katamine M2, Kato A1, Katsura A1, Sato T1, Muramatsu Y1, Hashimoto T1, Kameda R1, Meguro K1, Shimohama T1, Ako J1: Int J Cardiol 2022/2; 348: 134-9. (挬憅惔巎1, 撿丂彯尗1, 栘壓戝帒1, 曅曯惓岍2, 壛摗嵤旤1, 宩丂桳抭1, 嵅摗弐廩1, 懞徏桾夘1, 嫶壓戱栱1, 婽揷丂椙1, 栚崟寬懢榊1, 壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕尋媶壢)
110208. [尨挊] Layered Plaque Characteristics and Layer Burden in Acute Coronary Syndromes. Nakajima A, Araki M, Minami Y1, Soeda T, Yonetsu T, McNulty I, Lee H, Nakamura S, Jang IK: Am J Cardiol 2022/2; 164: 27-33. (撿丂彯尗1: 1弞娐婍撪)
110209. [尨挊] The impact of kidney function in patients on antithrombotic therapy: a post hoc subgroup analysis focusing on recurrent bleeding events from the AFIRE trial. Matsui K, Yasuda S, Kaikita K, Akao M, Ako J1, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Ogawa H: BMC Med 2022/2; 20 (1): 69. (垻屆弫嵠1: 1弞娐婍撪)
110210. [尨挊] Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry. Usuda K, Kato T, Tsuda T, Tada H, Niwa S, Usui S, Sakata K, Hayashi K, Furusho H, Kawashiri M, Takamura M, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H1, Nakahara S, Shimizu W, Iwasaki Y, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Nagashima K, Okumura Y, on behalf of the AF Ablation Frontier Registry: Heart Vessels 2022/2; 37 (2): 327-36. (怺扟塸暯1: 1弞娐婍撪)
110211. [尨挊] Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry. Mori H, Fukui K, Maeda A, Akashi Y, Ako J1, Ikari Y, Ebina T, Tamura K, Namiki A, Michishita I, Kimura K, Suzuki H: J Cardiol 2022/6; 79 (6): 768-75. doi: 10.1016/j.jjcc.2022.02.007. Epub 2022 Feb 23. (垻屆弫嵠1: 1弞娐婍撪)
110212. [尨挊] Impact of Glucose Tolerance and Its Change on Incident Proteinuria: Analysis of a Nationwide Population-Based Dataset. Suzuki Y, Kaneko H, Okada A, Itoh H, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Yamaguchi S, Kamiya K1, Matsunaga A1, Ako J2, Node K, Yamauchi T, Nangaku M, Yasunaga H, Komuro I: Am J Nephrol 2022/2; 53 (4): 307-15. (恄扟寬懢榊1, 徏塱撃旻1, 垻屆弫嵠2: 1堛椕塹惗妛晹, 2弞娐婍撪)
110213. [尨挊] Re-worsening left ventricular ejection fraction after response to cardiac resynchronization therapy. Oki T1, Ishii S1, Takigami Y1, Eda Y1, Maemura K1, Yazaki M1, Fujita T1, Ikeda Y1, Nabeta T1, Maekawa E1, Koitabashi T1, Ako J1: J Cardiol 2022/3; 79 (3): 358-64. (戝栘戩枻1, 愇堜弐曘1, 戨忋丂桰1, 峕揷桪巕1, 慜懞寬帯1, 栴嶈杻桼1, 摗揷揝暯1, 抮揷桽婤1, 撶揷丂寬1, 慜愳宐旤1, 彫斅嫶弐旤1, 垻屆弫嵠1: 1弞娐婍撪)
110214. [尨挊] Re-worsening left ventricular ejection fraction after response to cardiac resynchronization therapy. Oki T1, Ishii S1, Takigami Y2, Eda Y2, Maemura K1, Yazaki M1, Fujita T1, Ikeda Y1, Nabeta T1, Maekawa E1, Koitabashi T1, Ako J1: J Cardiol 2022/3; 79 (3): 358-64. (戝栘戩枻1, 愇堜弐曘1, 戨忋丂桰2, 峕揷桪巕2, 慜懞寬帯1, 栴嶈杻桼1, 摗揷 揝暯1, 抮揷桽婤1, 撶揷丂寬1, 慜愳宐旤1, 彫斅嫶弐旤1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
110215. [尨挊] Catheter contact angle influences local impedance drop during radiofrequency catheter ablation: Insight from a porcine experimental study with 2 different LI-sensing catheters. Matsuura G1, Fukaya H2, Ogawa E, Kawakami S, Mori H, Saito D1, Sato T2, Nakamura H2, Ishizue N2, Oikawa J2, Kishihara J2, Niwano S2, Ako J2: J Cardiovasc Electrophysiol 2022/3; 33 (3): 380-8. (徏塝丂尦1, 怺扟塸暯2, 嵵摗戝庽1, 嵅摗揘榊2, 拞懞梞斖2, 愇枛 惉嵠2, 媦愳丂弤2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
110216. [尨挊] Change in Cardiovascular Health Metrics and Risk for Proteinuria Development: Analysis of a Nationwide Population-Based Database. Suzuki Y, Kaneko H, Okada A, Itoh H, Morita K, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Yamaguchi S, Kamiya K1, Matsunaga A1, Ako J2, Fukui A, Nishiyama A, Yokoo T, Node K, Yamauchi T, Nangaku M, Yasunaga H, Komuro I: Am J Nephrol 2022; 53 (2-3): 240-8. doi: 10.1159/000522147. Epub 2022 Mar 8. (恄扟寬懢榊1, 徏塱撃旻1, 垻屆弫嵠2: 1堛椕塹惗妛晹, 2弞娐婍撪)
210001. [弨尨挊] Efficacy and safety of esaxerenone in patients with hypertension and concomitant heart failure. Naruke T1, Maemura K1, Oki T1, Yazaki M1, Fujita T1, Ikeda Y1, Nabeta T1, Ishii S1, Minami Y1, Fukaya H1, Yuge M, Shimohama T1, Kawaguchi T, Ako J1: Hypertens Res 2021/5; 44 (5): 601-3. doi: 10.1038/s41440-020-00606-w. Epub 2021 Jan 8. (惉栄丂悞1, 慜懞寬帯1, 戝栘戩枻1, 栴嶈杻桼1, 摗揷揝暯1, 抮揷桽婤1, 撶揷丂寬1, 愇堜弐曘1, 撿丂彯尗1, 怺扟塸暯1, 壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪)
310011. [徢椺曬崘] Unique feature of novel activation mapping to identify the successful ablation site of atrial tachycardia. Kishihara J1, Fukaya H1, Oikawa J1, Ako J1: Heart Rhythm 2021/4; 18 (4): 653-4. (娸尨丂弤1, 怺扟塸暯1, 媦愳丂弤1, 垻屆弫嵠1: 1弞娐婍撪)
310012. [徢椺曬崘] Successful Retrieval of Entrapped Guide Extension Catheter in the Right Coronary Artery with Heavy Calcifications. Imura S, Hashikata T1, Ando M, Hosaka F: Int Heart J 2021/5; 62 (3): 682-6. (敘曽寬岹1: 1弞娐婍撪)
310013. [徢椺曬崘] Multiple Vasculopathies and Heart Failure in Patient With ACTA-2 Mutation. Saito D1, Nabeta T2, Inoue N3, Ishizue N2, Ako J2: Circ J 2021/8; 85 (9): 1588. (嵵摗戝庽1, 撶揷丂寬2, 堜忋怣岾3, 愇枛惉嵠2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3怱憻寣娗奜)
310014. [徢椺曬崘] Atrial flutter with an epicardial and endocardial breakthrough in the cavotricuspid isthmus. Kobayashi S1, Fukaya H1, Saito D2, Sato T1, Matsuura G2, Arakawa Y1, Shirakawa Y1, Nishinarita R1, Horiguchi A1, Ishizue N1, Oikawa J1, Kishihara J1, Niwano S1, Ako J1: J Arrhythm 2021/12; 38 (1): 160-2. (彫椦廃暯1, 怺扟塸暯1, 嵵摗戝庽2, 嵅摗揘榊1, 徏塝丂尦2, 峳愳梇婭1, 敀愳桾婎1, 惣惉揷椇1, 杧岥丂垽1, 愇枛惉嵠1, 娸尨丂弤1, 掚栰怲堦1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
310015. [徢椺曬崘] Cardiac sarcoidosis accompanied by a tumor-like blush on coronary angiography. Asakura K1, Minami Y2, Nagata T1, Koitabashi T2, Ako J2: J Cardiol Cases 2022/2; 26 (1): 21-3. (挬憅惔巎1, 撿丂彯尗2, 塱揷婱巕1, 彫斅嫶弐旤2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
510008. [憤愢] Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes. Tan JWC, Sim D, Ako J1, Almahmeed W, Cooper ME, Dalal JJ, Deerochanawong C, Huang DWC, Johar S, Kaul U, Kim SG, Koh N, Kong APS, Krittayaphong R, Kwok B, Matawaran BJ, Nguyen QN, Ong LM, Park JJ, Peng Y, Quek DK, Suastika K, Sukor N, Teo BW, Teoh CK, Zhang J, Reyes EB, Su Goh Y: Eur Cardiol 2021/4; 16: e14. (垻屆弫嵠1: 1弞娐婍撪)
510009. [憤愢] Cardiovascular Disease Prevention in the COVID-19 Era. Yokoyama M, Kamide N, Tojo T1, Yamaoka-Tojo M2: Austin J Cardiovasc Dis Atherosclerosis 2021/4; 8 (1): 1042. (搶瀶戝婸1, 搶瀶旤撧巕2: 1弞娐婍撪, 2堛椕塹惗妛晹)
510010. [憤愢] 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome. Tan JWC, Chew DP, Brieger D, Eikelboom J, Montalescot G, Ako J1, Kim BK, Quek DK, Aitken SJ, Chow CK, Chour S, Tse HF, Kaul U, Firdaus I, Kubo T, Liew BW, Chong TT, Sin KY, Yeh HI, Buddhari W, Chunhamaneewat N, Hasan F, Fox KA , Nguyen QN, Lo ST: Eur Cardiol 2021/6; 16: e26. (垻屆弫嵠1: 1弞娐婍撪)
510011. [憤愢] Wearable cardioverter-defibrillators after myocardial infarction: a review of its clinical utility and unmet needs in current clinical practice. Hioki H, Kozuma K, Kobayashi Y, Ando K, Morino Y, Kishihara J1, Ako J1, Ikari Y: Cardiovasc Interv Ther 2021/7. doi: 10.1007/s12928-021-00788-1. Online ahead of print. (娸尨丂弤1, 垻屆弫嵠1: 1弞娐婍撪)
510012. [憤愢] Optical Coherence Tomography of Coronary Plaque Progression and Destabilization: JACC Focus Seminar Part 3/3. Adriaenssens T, Allard-Ratick MP, Thondapu V, Sugiyama T, Raffel OC, Barlis P, Poon EKW, Araki M, Nakajima A, Minami Y1, Takano M, Kurihara O, Fuster V, Kakuta T, Jang IK: J Am Coll Cardiol 2021/9; 78 (12): 1275-87. (撿丂彯尗1: 1弞娐婍撪)
510013. [憤愢] 2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations. Tan JWC, Chew DP, Tsui KL, Tan D, Duplyakov D, Hammoudeh A, Zhang B, Li Y, Xu K, Ong PJ, Firman D, Gamra H, Almahmeed W, Dalal J, Tam LW, Steg G, Nguyen QN, Ako J1, Suwaidi JA, Chan M, Sobhy M, Shehab A, Buddhari W, Wang Z, Fong AYY, Karadag B, Kim BK, Baber U, Chin CT, Han YL: Eur Cardiol 2021/11; 16: e43. (垻屆弫嵠1: 1弞娐婍撪)
510014. [憤愢] Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia. Koh N, Ference BA, Nicholls SJ, Navar AM, Chew DP, Kostner K, He B, Tse HF, Dalal J, Santoso A, Ako J1, Tada H, Park JJ, Ong ML, Lim E, Subramaniam T, Li YH, Phrommintikul A, Iyengar SS, Ray S, Park KW, Tan HC, Chunhamaneewat N, Yeo KK, Tan JWC: Eur Cardiol 2021/12; 16: e54. (垻屆弫嵠1: 1弞娐婍撪)
510015. [憤愢] CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022. Ozaki Y, Hara H, Onuma Y, Katagiri Y, Amano T, Kobayashi Y, Muramatsu T, Ishii H, Kozuma K, Tanaka N, Matsuo H, Uemura S, Kadota K, Hikichi Y, Tsujita K, Ako J1, Nakagawa Y, Morino Y, Hamanaka I, Shiode N, Shite J, Honye J, Matsubara T, Kawai K, Igarashi Y, Okamura A, Ogawa T, Shibata Y, Tsuji T, Yajima J, Iwabuchi K, Komatsu N, Sugano T, Yamaki M, Yamada S, Hirase H, Miyashita Y, Yoshimachi F, Kobayashi M, Aoki J, Oda H, Katahira Y, Ueda K, Nishino M, Nakao K, Michishita I, Ueno T, Inohara T, Kohsaka S, Ismail TF, Serruys PW, Nakamura M, Yokoi H, Ikari Y, Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Cardiovascular Interventional Therapeutics (CVIT): Cardiovasc Interv Ther 2022/1; 37 (1): 1-34. (垻屆弫嵠1: 1弞娐婍撪)
522039. [島嵗]亂摿廤: 曎枌徢 (SHD) 崅楊幮夛偱曄傢偭偰偒偨帯椕揔墳亃<僙儈僫乕乛幚抧堛壠偑幚慔偡傋偒恌椕偺僾儘僙僗>丂姶愼惈怱撪枌墛偺恌抐偲儕僗僋. 彫斅嫶弐旤 (弞娐婍撪): Medical Practice 2021/4; 38 (4): 541-6.
522040. [島嵗]亂摿廤: 怱晄慡廤拞島嵗丂懡條壔偡傞怱晄慡傪偳偆恌偰偳偆懳張偡傞偐亃幆傞丂7 S-ICD傗WCD傪摜傑偊偨怱晄慡椺偺撍慠巰懳嶔. 娸尨丂弤 (弞娐婍撪): Heart View 2021/5; 25 (6): 45-50.
522041. [島嵗]亂摿廤: 僄僉僗僷乕僩偵妛傇丂抦偭偰偍偒偨偄怱揹恾恌抐偺僐僣偲棊偲偟寠亃仭抦偭偰偍偒偨偄怱揹恾堎忢丂揹夝幙堎忢. 掚栰怲堦 (弞娐婍撪): 弞娐婍僕儍乕僫儖 2021/5; 69 (2): 306-11.
522042. [島嵗]亂摿廤: 晄惍柆栻暔帯椕傪峫偊傞亅僈僀僪儔僀儞夵掕傪摜傑偊偰亅亃帯偡丂11 [Expertise] 暪懚幘姵崌暪怱朳嵶摦姵幰偵偍偗傞峈嬅屌椕朄. 怺扟塸暯 (弞娐婍撪): Heart View 2021/6; 25 (7).
522043. [島嵗]亂摿廤: 儁乕僗儊乕僇奜棃傛傠偯憡択亃恌傞丂5 [Expertise] 拝梡宆帺摦彍嵶摦婍 (WCD) 姵幰偺奜棃僼僅儘乕偲拲堄揰. 掚栰怲堦1, 娸尨丂弤1, 晲揷復悢2 (1弞娐婍撪, 2ME僙): Heat View 2021/8; 25 (9): 823-8.
522044. [島嵗]亂摿廤: 崅楊幰偺栻暔椕朄亅崅楊幰偺埨慡側栻暔椕朄僈僀僪儔僀儞偺夵掶傪尒悩偊偰亃7.乽尭傜偡僄價僨儞僗乿偺憂弌亅峈寣愷栻傪椺偵亅. 垻屆弫嵠 (弞娐婍撪): Geriatric Medicine 2021/9; 59 (9): 891-4.
522045. [島嵗]亂摿廤: 怱僄僐乕儔儃昁実! 惉恖愭揤惈怱幘姵偺婎杮島嵗亃怱幒拞妘寚懝偺僼僅儘乕傾僢僾偺怱僄僐乕偺僐僣. 彫斅嫶弐旤 (弞娐婍撪): 怱僄僐乕 2021/10; 22 (10): 908-17.
522046. [島嵗] 榖戣: COVID-19偲慡恎惈墛徢斀墳惈旝彫寣娗撪旂徢 (SIRME). 搶瀶戝婸1, 搶瀶旤撧巕2 (1弞娐婍撪, 2堛椕塹惗妛晹): 屇媧婍撪壢 2021/10; 40 (4): 407-16.
522047. [島嵗]亂摿廤: 弞娐婍椞堟偺峈寣愷椕朄偺偝傜側傞恑壔亃嵗択夛: 弌寣儕僗僋傪堄幆偟偨峈寣愷椕朄偺帪戙傊. 垻屆弫嵠1, 拞愳媊媣, 埨揷丂憦, 怺扟塸暯1 (1弞娐婍撪): Cardiac Practice 2021/10; 32 (1): 61-7.
522048. [島嵗]亂摿廤: 怱僄僐乕儔儃昁実! 惉恖愭揤惈怱幘姵偺婎杮島嵗亃怱幒拞妘寚懝偺僼僅儘乕傾僢僾偺怱僄僐乕偺僐僣. 彫斅嫶弐旤 (弞娐婍撪): 怱僄僐乕 2021/10; 22 (10): 908-17.
522049. [島嵗] 摿廤: 庤弍乛張抲慜偺埨慡側峈嬅屌栻丒峈寣彫斅栻偺媥栻. 怺扟塸暯 (弞娐婍撪): 擔杮堛帠怴曬 2021/12; 5093: 18-29.
522050. [島嵗]亂摿廤: 慡恎惈幘姵傪怱僄僐乕偱恌傞丂偙傟偩偗偼抦偭偰偍偒偨偄怱僄僐乕強尒亃銹尨昦偺怱崌暪徢傪怱僄僐乕偱恌傞. 彫斅嫶弐旤 (弞娐婍撪): 怱僄僐乕 2022/1; 23 (1): 26-43.
522051. [島嵗]亂摿廤: 擔忢恌椕偱憳嬾偡傞塃怱幘姵亃塃怱婡擻亅怱嬝徢. 彫斅嫶弐旤 (弞娐婍撪): 怱僄僐乕 2022/2; 23 (3): 240-50.
522052. [島嵗]亂摿廤: 弞娐婍幘姵崌暪擠怭丂姵幰偺曄壔傪尒摝偝側偄, 擠怭偐傜嶻屻娗棟傑偱亃[恌傞]丂4. 擠怭拞偺弞娐婍専嵏. 彫斅嫶弐旤 (弞娐婍撪): Heart View 2022/3; 26 (3): 20-4.
530005. [偦偺懠 (Comment)] Response to letter to the editor entitled ""Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure"". Yazaki M1, Nabeta T1, Ako J1: Clin Cardiol 2021/4; 44 (4): 444-5. (栴嶈杻桼1, 撶揷丂寬1, 垻屆弫嵠1: 1弞娐婍撪)
530006. [偦偺懠 (Editorial)] Atrial High-Rate Episodes Are a Comprehensive Surrogate Marker for Thromboembolic and Bleeding Events. Fukaya H1: Circ J 2021/7; 85 (8): 1338-40. (怺扟塸暯1: 1弞娐婍撪)
530007. [偦偺懠 (Published Erratum)] CORRIGENDUM: JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, Usui A, Okishige K, Kusano K, Kumagai K, Goya M, Kobayashi Y, Shimizu A, Shimizu W, Shoda M, Sumitomo N, Seo Y, Takahashi A, Tada H, Naito S, Nakazato Y, Nishimura T, Nitta T, Niwano S1, Hagiwara N, Murakawa Y, Yamane T, Aiba T, Inoue K, Iwasaki Y, Inden Y, Uno K, Ogano M, Kimura M, Sakamoto S, Sasaki S, Satomi K, Shiga T, Suzuki T, Sekiguchi Y, Soejima K, Takagi M, Chinushi M, Nishi N, Noda T, Hachiya H, Mitsuno M, Mitsuhashi T, Miyauchi Y, Miyazaki A, Morimoto T, Yamasaki H, Aizawa Y, Ohe T, Kimura T, Tanemoto K, Tsutsui H, Mitamura H, JCS/JHRS Joint Working Group: Circ J 2021/9; 85 (9): 1692-700. (掚栰怲堦1: 1弞娐婍撪)
530008. [偦偺懠 (Guideline)] JCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease. Nakamura M, Yaku H, Ako J1, Arai H, Asai T, Chikamori T, Daida H, Doi K, Fukui T, Ito T, Kadota K, Kobayashi J, Komiya T, Kozuma K, Nakagawa Y, Nakao K, Niinami H, Ohno T, Ozaki Y, Sata M, Takanashi S, Takemura H, Ueno T, Yasuda S, Yokoyama H, Fujita T, Kasai T, Kohsaka S, Kubo T, Manabe S, Matsumoto N, Miyagawa S, Mizuno T, Motomura N, Numata S, Nakajima H, Oda H, Otake H, Otsuka F, Sasaki K, Shimada K, Shimokawa T, Shinke T, Suzuki T, Takahashi M, Tanaka N, Tsuneyoshi H, Tojo T1, Une D, Wakasa S, Yamaguchi K, Akasaka T, Hirayama A, Kimura K, Kimura T, Matsui Y, Miyazaki S, Okamura Y, Ono M, Shiomi H, Tanemoto K, Japanese Circulation Society Joint Working Group: Circ J 2022/2; 86 (3): 477-588. (垻屆弫嵠1, 搶瀶戝婸1: 1弞娐婍撪)
540021. [偦偺懠 (Editorial Commentl)] 妡嫶榑暥偵懳偡傞Editorial Comment. 娸尨丂弤 (弞娐婍撪): 怱憻 2021/4; 53 (4):379.
540022. [偦偺懠 (Editorial Commentl)] 戝搱榑暥偵懳偡傞Editorial Comment. 彫斅嫶弐旤 (弞娐婍撪): 怱憻 2021/4; 53 (4): 408-9.
540023. [偦偺懠 (Editorial Commentl)] 墶嶳榑暥偵懳偡傞Editorial Comment. 彫斅嫶弐旤 (弞娐婍撪): 怱憻 2021/12; 53 (12): 1340-1.
[挊丂彂]
620024. [妛弍彂 (暘扴幏昅)]亂傢偐傞! 偱偒傞! 恡憻儕僴價儕僥乕僔儑儞Q&A亃I. 恡憻儕僴價儕僥乕僔儑儞傪幚巤偡傞偨傔偺婎慴抦幆丂5. 塣摦偡傞偲寣燋pH偼巁惈壔偟傑偡偐?, p.26-7. 壨尨崕夒, 壓昹岶榊1 (1弞娐婍撪), 曇: 嶳鉷朚峅, 惎栰弮堦, 徏塱撃旻, 堛帟栻弌斉, 搶嫗, 2021/5敪峴.
620025. [妛弍彂 (暘扴幏昅)]亂摨庬丒摨岠栻偺巊偄暘偗丂幘姵亊婎杮栻偺僄價僨儞僗傪惍棟偡傞 (寧娫栻帠5寧椪帪憹姧崋)亃戞1復 弞娐婍宯偺婎杮栻偺巊偄暘偗丂2. 怱晄慡傊偺兝幷抐栻偼偳偆慖傇, p.24-31. 撶揷丂寬 (弞娐婍撪), 曇: 巙夑丂崉, 偠傎偆, 搶嫗, 2021/5敪峴.
620026. [妛弍彂 (暘扴幏昅)]亂崱偙偦妛傃捈偡! 惗棟妛丒夝朥妛丂偁偺偲偒妛傫偩抦幆偲椪彴宱尡傪偮側偄偱, 擺摼偟偰摦偔! (儗僕僨儞僩僲乕僩憹姧Vol.23 No.8)亃戞1復 弞娐婍宯丂3. 嫊寣惈怱幘姵, p.29-36. 嫶杮戱栱1, 垻屆弫嵠1 (1弞娐婍撪), 曇: 攱暯丂揘, 梤搚幮, 搶嫗, 2021/7敪峴.
620027. [妛弍彂 (暘扴幏昅)]亂怱晄慡恌椕僷乕僼僃僋僩丂僔僠儏僄乕僔儑儞暿偺峫偊曽丒摦偒曽傪恎偵偮偗偰怱晄慡僷儞僨儈僢僋偵棫偪岦偐偆 (儗僕僨儞僩僲乕僩憹姧Vol.23 No.11)亃戞1復 媬媫奜棃偱偺怱晄慡丂3. 媫惈怱晄慡偺僙僇儞僪僞僢僠偐傜ICU/CCU擖幒傑偱偵峫偊傞偙偲, 傗傞傋偒偙偲, p.39-48. 撶揷丂寬 (弞娐婍撪), 曇: 栘揷孿椇, 梤搚幮, 搶嫗, 2021/9敪峴.
620028. [妛弍彂 (暘扴幏昅)]亂怱僄僐乕 寁應/昤弌偺僐僣, 恎偵偮偗偨偄峫偊曽/恑傔曽 (Heart View 2021擭11寧憹姧崋)亃II 恎偵偮偗偨偄峫偊曽/恑傔曽丂3 昦婥傪幆傞, 昦婥傪恌傞丂i. 偨偙偮傏怱嬝徢 (偨偙偮傏徢岓孮)丂匑怱僒儖僐僀僪乕僔僗丒怱傾儈儘僀僪乕僔僗, p.164-9. 彫斅嫶弐旤 (弞娐婍撪), 儊僕僇儖價儏乕幮, 搶嫗, 2021/10敪峴.
620029. [妛弍彂 (暘扴幏昅)]亂怴 PCI丒僇僥乕僥儖幒偺僺儞僠偐傜偺扙弌朄丂払恖偑嫵偊傞119偺僥僋僯僢僋亃XII PCI屻椕朄傕偆傑偔傗傞!丂115 僗僥儞僩嵞嫹嶓椺偺奜壢揔墳偺僞僀儈儞僌偼?, p.489-93. 撿丂彯尗 (弞娐婍撪), 曇: 懞徏弐嵠, 撿峕摪, 搶嫗, 2021/12敪峴.
620030. [妛弍彂 (暘扴幏昅)]亂擔忢恌椕偵妶偐偡恌椕僈僀僪儔僀儞UP-TO-DATE 2022-2023亃III. 弞娐婍幘姵丂3 嫹怱徢, p.158-62. 曅曯惓岍1, 壓昹岶榊1, 垻屆弫嵠1 (1弞娐婍撪), 娔廋: 栧榚丂岶, 彫幒堦惉, 媨抧椙庽, 儊僨傿僇儖儗價儏乕幮, 戝嶃, 2022/2敪峴.
620031. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂1) 峈寣愷栻丂1 奣愢, p.10-7. 壓昹岶榊1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620032. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂1) 峈寣愷栻丂2 峈寣彫斅栻, p.18-23. 婽揷丂椙1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620033. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂1) 峈寣愷栻丂3 峈嬅屌栻, p.24-31. 怺扟塸暯1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620034. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂2) 峈嫹怱徢栻丂1 奣愢, p.32-35. 2 徤巁栻, Ca漢峈栻, 僯僐儔儞僕儖, p.36-43. 杒棦棞幯1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620035. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂3) 怱晄慡帯椕栻丂1 奣愢, p.44-50. 彫斅嫶弐旤1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620036. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂3) 怱晄慡帯椕栻丂2 ACE慾奞栻/ARB, MRA, ARNI, p.51-61. 撶揷丂寬1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620037. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂3) 怱晄慡帯椕栻丂3 兝幷抐栻, p.62-7. 斞揷桽堦榊1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620038. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂3) 怱晄慡帯椕栻丂4 僀僶僽儔僕儞, p.68-72. 摗揷揝暯1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620039. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂4) 嫮怱栻, 徃埑栻丂1 奣愢, p.88-91. 2 惷拲嫮怱栻, 撪暈嫮怱栻, p.92-7. 嵅摗怢梞1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620040. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂5) 峈晄惍柆栻丂1 奣愢, p.98-105. 掚栰怲堦1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620041. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂5) 峈晄惍柆栻丂2 I孮栻, 叀孮栻, p.106-11. 娸尨丂弤1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620042. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂5) 峈晄惍柆栻丂3 IV孮栻, 僕僊僞儕僗惢嵻, p.112-8. 愇枛惉嵠1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620043. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂6) 崀埑栻丂2 兝幷抐栻, Ca漢峈栻, ARB, ACE慾奞栻, p.131-6. 慜愳宐旤1 (1弞娐婍撪), 娔廋: 抮揷棽摽1, 曇: 垻屆弫嵠, 梤搚幮, 搶嫗, 2022/3敪峴.
620044. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂7) 攛崅寣埑徢帯椕栻丂1 奣愢, p.137-42. 2 僾儘僗僞僒僀僋儕儞惢嵻, p.143-6. 3 僄儞僪僙儕儞庴梕懱漢峈栻, p.147-9. 4丂PDE-5慾奞栻偲sGC巋寖栻, p.150-3. 愇堜弐曘1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620045. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃婎慴曇丂8) 帀幙堎忢徢帯椕栻丂1 奣愢, p.154-6. 2 僗僞僠儞, 僄僛僠儈僽, p.157-9. 3 PCSK9慾奞栻, p.160-2. 4 偦偺懠偺栻嵻, p.163-7. 撿丂彯尗1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620046. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂1 栭娫廇怮拞偺撍慠偺嫻捝, p.168-73. 栚崟寬懢榊1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620047. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂2 1僇寧慜偐傜偺楯嶌帪嫻晹埑敆姶偲栭娫偺椻娋傪敽偆慜嫻晹捝, p.174-7. 3 恑峴堓娻傪擣傔偨楯嶌惈嫹怱徢姵幰, p.178-9. 嫶杮戱栱1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620048. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂4 嵟嬤昿搙偑憹偊偰偒偨摦湩, p.180-4. 拞懞梞斖1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620049. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂5 擔拞婲棫帪偺撍慠偺屇媧崲擄, p.185-90. 栘壓戝帒1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620050. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂6 憗挬偺幐恄傪敽偆嫻捝, p.191-63. 宩丂桳抭1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620051. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂7 帩懕偡傞嫻捝偵堷偒懕偄偰弌尰偟偨撍慠偺屇媧崲擄, p.197-204. 彫斅嫶弐旤1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620052. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂8 1廡娫慜偐傜偺奝歶偲栭娫敪嶌惈屇媧崲擄, p.205-11. 抮揷桽婤1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620053. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂9 壓戁晜庮傪敽偆栭娫敪嶌惈屇媧崲擄, p.212-8. 斞揷桽堦榊1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620054. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂10 奼挘宆怱嬝徢偺婛墲偲壓戁晜庮傪敽偆楯嶌帪屇媧崲擄, p.219-24. 摗揷揝暯1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620055. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂11 2廡娫慜偐傜偺楯嶌帪屇媧崲擄, p.225-8. 栴嶈杻桼1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620056. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂12 姶朻屻偺屇媧嬯, p.229-32. 嵅摗怢梞1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620057. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂13 柧偗曽偺摦湩, p.233-8. 媦愳丂弤1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
620058. [妛弍彂 (暘扴幏昅)]亂弞娐婍栻僪儕儖亃幚慔曇丂14 彊乆偵憹埆偟偨懅愗傟, p.239-41. 愇堜弐曘1 (1弞娐婍撪), 娔廋: 抮揷棽摽, 曇: 垻屆弫嵠1, 梤搚幮, 搶嫗, 2022/3敪峴.
[妛夛丒尋媶夛摍]
712005. [妛夛 (崙嵺)] (僔儞億僕僂儉) Optimal Strategies for the Treatment of Severe Calcified Lesions Under OCT Guidance. Minami Y1: the 19th Gwangju International Interventional Cardiology Symposium (GICS 2021) (2021/6/11), Gwangju, Korea. (撿丂彯尗1: 1弞娐婍撪)
712006. [妛夛 (崙嵺)] (僔儞億僕僂儉) New Lipid Guidelines: what is new and important? Ako J1: APSC 2021 (2021/10/3), Web奐嵜. (垻屆弫嵠1: 1弞娐婍撪)
712007. [妛夛 (崙嵺)] (僔儞億僕僂儉) Role of Wearable Cardioverter Defibrillator (WCD) in Acute Phase Care of Patients at High SCD Risk. Niwano S1: 14th Asia Pacific Heart Rhythm Society Scientific Session (APHRS 2021) (2021/11/13), Suzhou, China & Online. (掚栰怲堦1: 1弞娐婍撪)
713015. [妛夛 (崙嵺)] (堦斒島墘) Higher triglyceride level is associated with higher frequency of plaque with macrophage accumulation in coronary plaques among patients with low low-density lipoprotein cholesterol level. Asakura K1, Minami Y2, Katamine M1, Kato A2, Katsura A2, Hashimoto T2, Kinoshita D2, Ako J2: American College Cardiology (ACC) 2021 Scientific Session (2021/5/15-17), Web奐嵜. (挬憅惔巎1, 撿丂彯尗2, 曅曯惓岍1, 壛摗嵤旤2, 宩丂桳抭2, 嫶杮戱栱2, 栘壓戝帒2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713016. [妛夛 (崙嵺)] (堦斒島墘) Anti-thrombotic Therapy Decision-making in a Stable Patient Six Months After Complex PCI. Ako J1: American College Cardiology (ACC) 2021 Scientific Session (2021/5/15-17), Web奐嵜. (垻屆弫嵠1: 1弞娐婍撪)
713017. [妛夛 (崙嵺)] (堦斒島墘) Higher Red Cell Distribution Width is Associated with the Presence of Calcification in Coronary Plaque. Kato A1, Minami Y2, Nagata T1, Asakura K1, Katamine M1, Katsura A2, Kinoshita D3, Hashimoto T2, Ako J2: American College Cardiology (ACC) 2021 Scientific Session (2021/5/15-17), Web奐嵜. (壛摗嵤旤1, 撿丂彯尗2, 塱揷婱巕1, 挬憅惔巎1, 曅曯惓岍1, 宩丂桳抭2, 栘壓戝帒3, 嫶杮戱栱2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3媬柦)
713018. [妛夛 (崙嵺)] (堦斒島墘) Plaque Phenotype and Clinical Characteristics of South Asian (Indian) Patients with Acute Coronary Syndromes: An Optical Coherence Tomography Study. Nakajima A, Subban V, Russo M, Bryniarski K, Kurihara O, Araki M, Minami Y1, Soeda T, Yonetsu T, Crea F, Takano M, Higuma T, Kakuta T, Adriaenssens T, Boeder N, Nef H, Raffel OC, McNulty I, Lee H, Nakamura S, Abdullakutty J, Mathew R, Sankardas AM, Jang IK: American College Cardiology (ACC) 2021 Scientific Session (2021/5/15-17), Web奐嵜. (撿丂彯尗1: 1弞娐婍撪)
713019. [妛夛 (崙嵺)] (堦斒島墘) Severe Coronary Calcification is Associated with Higher Incidence of Device-oriented Clinical Events after Percutaneous Coronary Intervention. Nagata T1, Minami Y2, Asakura K1, Katamine M1, Kinoshita D3, Ako J2: American College Cardiology (ACC) 2021 Scientific Session (2021/5/15-17), Web奐嵜. (塱揷婱巕1, 撿丂彯尗2, 挬憅惔巎1, 曅曯惓岍1, 栘壓戝帒3, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3媬柦)
713020. [妛夛 (崙嵺)] (堦斒島墘) Higher Lipoprotein a Level is Associated with Vulnerable Characteristics in Nonculprit Plaque in Patients with Plaque Erosion. Kato A1, Kinoshita D2, Nagata T1, Asakura K1, Katamine M1, Katsura A3, Hashimoto T3, Minami Y3, Ako J3: American College Cardiology (ACC) 2021 Scientific Session (2021/5/15-17), Web奐嵜. (壛摗嵤旤1, 栘壓戝帒2, 塱揷婱巕1, 挬憅惔巎1, 曅曯惓岍1, 宩丂桳抭3, 嫶杮戱栱3, 撿丂彯尗3, 垻屆弫嵠3: 1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪)
713021. [妛夛 (崙嵺)] (堦斒島墘) What does real world data show us? Ako J1: Atherosclerosis Imaging Symposium (2021/6/26), Web奐嵜. (垻屆弫嵠1: 1弞娐婍撪)
713022. [妛夛 (崙嵺)] (堦斒島墘) Association between lowering heart rate during IMPELLA support and favorable short-term outcome in patients with cardiogenic shock. Maemura K1, Ikeda Y2, Eda Y1, Oki T1, Yazaki M3, Fujita T3, Iida Y3, Koriyama K4, Nabeta T3, Ishii S3, Maekawa E3, Koitabashi T3, Ako J3: European society of cardiology (ESC) congress 2021 (2021/8/27-30), Web奐嵜. (慜懞寬帯1, 抮揷桽婤2, 峕揷桪巕1, 戝栘戩枻1, 栴嶈杻桼3, 摗揷揝暯3, 斞揷桽堦榊3, 孲嶳宐巕4, 撶揷丂寬3, 愇堜弐曘3, 慜愳宐旤3, 彫斅嫶弐旤3, 垻屆弫嵠3: 1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪, 4憤崌恌椕)
713023. [妛夛 (崙嵺)] (堦斒島墘) Prognostic impact of atrial fibrillation under oral anticoagulation therapy in patients with type B acute aortic dissection. Ishizue N1, Fukaya H1, Saito D2, Matsuura G2, Sato T2, Kobayashi S1, Shirakawa Y1, Arakawa Y1, Oikawa J1, Kishihara J1, Niwano S1, Ako J1: European society of cardiology (ESC) congress 2021 (2021/8/27-30), Web奐嵜. (愇枛惉嵠1, 怺扟塸暯1, 釼摗戝庽2, 徏塝丂尦2, 嵅摗揘榊2, 彫椦廃暯1, 敀愳桾婎1, 峳愳梇婭1, 媦愳丂弤1, 娸尨丂弤1, 掚栰怲堦1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
713024. [妛夛 (崙嵺)] (堦斒島墘) Catheter contact angle influences local impedance drop during radiofrequency catheter ablation: Insight from a porcine experimental studyCatheter contact angle influences local impedance drop during radiofrequency catheter ablation: Insight from a porcine experimental study. Matsuura G1, Fukaya H2, Ogawa E3, Kawakami S1, Saito D1, Sato T1, Arakawa Y2, Kobayashi S2, Shirakawa Y2, Ishizue N2, Oikawa J2, Kishihara J2, Niwano S2, Ako J2: European society of cardiology (ESC) congress 2021 (2021/8/27-30), Web奐嵜. (徏塝丂尦1, 怺扟塸暯2, 彫愳宐旤桰3, 愳忋憦懢1, 釼摗戝庽1, 嵅摗揘榊1, 峳愳梇婭2, 彫椦廃暯2, 敀愳桾婎2, 愇枛惉嵠2, 媦愳丂弤2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3堛椕塹惗妛晹)
713025. [妛夛 (崙嵺)] (億僗僞乕) Rivaroxaban inhibits the vascular endothelial glycocalyx shedding under oxidative stress. Kitasato L1, Tojo M2, Ako J1: The 19th International Symposium of Atherosclerosis (ISA2021) (2021/10/24-27), Kyoto, Japan (僴僀僽儕僢僪奐嵜). (杒棦棞幯1, 搶瀶旤撧巕2, 垻屆弫嵠1: 1弞娐婍撪, 2堛椕塹惗妛晹)
713026. [妛夛 (崙嵺)] (堦斒島墘) High Bleeding Risk is Associated with a Higher Prevalence of Severe Calcified Plaque in Patients Requiring Percutaneous Coronary Intervention. Nagata T1, Minami Y2, Muramatsu Y2, Nakata T2, Asakura K1, Katamine M1, Kinoshita D2, Ako J2: American Heart Association (AHA) 2021 Scientific Session (2021/11/13-15), Web奐嵜. (塱揷婱巕1, 撿丂彯尗2, 懞徏桾夘2, 拞揷彔嵠2, 挬憅惔巎1, 曅曯惓岍1, 栘壓戝帒2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713027. [妛夛 (崙嵺)] (堦斒島墘) Lower EPA/AA ratio is associated with a higher prevalence of vulnerable characteristics in non-culprit coronary plaques in statin-treated patients with coronary artery disease. Asakura K1, Minami Y2, Kinoshita D2, Nagata T1, Katamine M1, Katsura A1, Hashimoto T2, Kameda R2, Meguro K2, Shimohama T2, Ako J2: American Heart Association (AHA) 2021 Scientific Session (2021/11/13-15), Web奐嵜. (挬憅惔巎1, 撿丂彯尗2, 栘壓戝帒2, 塱揷婱巕1 曅曯惓岍1, 宩丂桳抭2, 嫶杮戱栱2, 婽揷丂椙2, 栚崟寬懢榊2, 壓昹岶榊2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713028. [妛夛 (崙嵺)] (堦斒島墘) Higher body mass index is associated with a higher prevalence of thin-cap fibroatheroma in younger patients with type 2 diabetes mellitus. Katamine M1, Minami Y2, Asakura K1, Kato A2, Katsura A2, Sato T2, Muramatu Y2, Hashimoto T2, Kameda R2, Meguro K2, Shimohama T2, Ako J2: American Heart Association (AHA) 2021 Scientific Session (2021/11/13-15), Web奐嵜. (曅曯惓岍1, 撿丂彯尗2, 挬憅惔巎1, 壛摗嵤旤2, 宩丂桳抭2, 嵅摗弐廩2, 懞徏桾夘2, 嫶杮戱栱2, 婽揷丂椙2, 栚崟寬懢榊2, 壓昹岶榊2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713029. [妛夛 (崙嵺)] (堦斒島墘) Impact of catheter contact angle on local impedance drop and lesion size using the INTELLANAV STABLEPOINT ablation catheter: Insight from a porcine experimental study. Matsuura G1, Fukaya H2, Ogawa E3, Kawakami S1, Mori H, Saito D1, Sato T1, Nakamura H2, Ishizue N2, Oikawa J2, Kishihara J2, Niwano S2, Ako J2: American Heart Association (AHA) 2021 Scientific Session (2021/11/13-15), Web奐嵜. (徏塝丂尦1, 怺扟塸暯2, 彫愳宐旤桰3, 愳忋憦懢1, 釼摗戝庽1, 嵅摗揘榊1, 拞懞梞斖2, 愇枛惉嵠2, 媦愳丂弤2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3堛椕塹惗妛晹)
713030. [妛夛 (崙嵺)] (堦斒島墘) Is an Induction Test Necessary While Catheter Ablation of Atrial Fibrillation? Sato T1, Oikawa J2, Fukaya H2, Mitani Y1, Murayama Y1, Saito D1, Matsuura G1, Ishizue N2, Kishihara J2, Niwano S2, Ako J2: American Heart Association (AHA) 2021 Scientific Session (2021/11/13-15), Web奐嵜. (嵅摗揘榊1, 媦愳丂弤2, 怺扟塸暯2, 嶰扟桪懢楴1, 懞嶳桭夘1, 釼摗戝庽1, 徏塝丂尦1, 愇枛惉嵠2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713031. [妛夛 (崙嵺)] (堦斒島墘) Sex Differences in Culprit Plaque Characteristics in Acute Coronary Syndromes. Araki M, Nakajima A, Yonetsu T, Soeda T, Kurihara O, Higuma T, Kimura S, Minami Y1, Ako J1, Adriaenssens T, Nef H, Lee H, McNulty I, Sugiyama T, Kakuta T, Jang IK: American Heart Association (AHA) 2021 Scientific Session (2021/11/13-15), Web奐嵜. (撿丂彯尗1, 垻屆弫嵠1: 1弞娐婍撪)
713032. [妛夛 (崙嵺)] (堦斒島墘) High sensitivity C-reactive protein is associated with vulnerable characteristics in non-culprit plaques in patients with ST-segment elevation myocardial infarction. Katamine M1, Minami Y2, Asakura K1, Katsura A2, Hashimoto T2, Ako J2: ESC Asia 2021with APSC & AFC (2021/12/2-4), Web奐嵜. (曅曯惓岍1, 撿丂彯尗2, 挬憅惔巎1, 宩丂桳抭2, 嫶杮戱栱2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713033. [妛夛 (崙嵺)] (堦斒島墘) Management of diabetes mellitus in patients with cardiovascular disease. Ako J1: ESC Asia 2021with APSC & AFC (2021/12/2-4), Web奐嵜. (垻屆弫嵠1: 1弞娐婍撪)
713034. [妛夛 (崙嵺)] (堦斒島墘) The burden of diabetes mellitus in Asia. Ako J1: ESC Asia 2021with APSC & AFC (2021/12/2-4), Web奐嵜. (垻屆弫嵠1: 1弞娐婍撪)
721008. [妛夛 (慡崙)] (摿暿島墘) The Clinical Outcomes of DP-EES vs. BP-SES in a Real-world Cohort Study. 撿丂彯尗 (弞娐婍撪): Complex Cardiovasculr Therapeutics (CCT) 2021 Annual Meeting (2021/10/29), Web奐嵜.
722063. [妛夛 (慡崙)] (嫵堢埾堳夛婇夋) 怱僄僐乕恾偱尒嬌傔傞傋偒媫惈怱晄慡偺尨場幘姵. 彫斅嫶弐旤1, 戨忋丂桰2, 峕揷桪巕2, 慜懞寬帯2, 戝栘戩枻2, 摗揷揝暯1, 栴嶈杻桼1, 撶揷丂寬1, 抮揷桽婤3, 愇堜弐曘1, 孲嶳宐巕4, 慜愳宐旤1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦, 4憤崌恌椕): 擔杮怱僄僐乕恾妛夛戞32夞妛弍廤夛 (2021/4/23-25), Web奐嵜.
722064. [妛夛 (慡崙)] (嫵堢僙僢僔儑儞) 徢椺偐傜妛傇!怱僒儖僐僀僪乕僔僗偺懡條惈傪幆傞. 彫斅嫶弐旤1, 戨忋丂桰2, 峕揷桪巕2, 慜懞寬帯2, 戝栘戩枻2, 摗揷揝暯1, 栴嶈杻桼1, 撶揷丂寬1, 抮揷桽婤3, 愇堜弐曘1, 孲嶳宐巕4, 慜愳宐旤1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦, 4憤崌恌椕): 擔杮怱僄僐乕恾妛夛戞32夞妛弍廤夛 (2021/4/23-25), Web奐嵜.
722065. [妛夛 (慡崙)] (嫵堢僙僢僔儑儞) 嵍幒暻旍岤: 偙偺怱憻偼惛嵏偑昁梫? 孲嶳宐巕1, 彫斅嫶弐旤2, 摗揷揝暯2, 撶揷丂寬2, 抮揷桽婤3, 愇堜弐曘2, 慜愳宐旤2, 垻屆弫嵠2 (1憤崌恌椕, 2弞娐婍撪, 3媬柦): 擔杮怱僄僐乕恾妛夛戞32夞妛弍廤夛 (2021/4/23-25), Web奐嵜.
722066. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 姤摦柆幘姵偺栻暔椕朄. 垻屆弫嵠 (弞娐婍撪): 戞6夞擔杮怱寣娗嫤夛妛弍廤夛 (2021/4/25), Web奐嵜.
722067. [妛夛 (慡崙)] (Pro/Con) ECMO傪摫擖偡傞傕媬柦偱偒側偐偭偨攛崅寣埑崌暪擠晈偺堦椺. 摗揷揝暯 (弞娐婍撪): 戞6夞擔杮攛崅寣埑丒攛弞娐妛夛妛弍廤夛 (2021/5/6-8), 搶嫗 (僴僀僽儕僢僪奐嵜).
722068. [妛夛 (慡崙)] (僕儑僀儞僩僙僢僔儑儞) 僨傿儀乕僩偐傜怱晄慡塰梴偺壽戣傪峫偊傞. 慜愳宐旤 (弞娐婍撪): 戞27夞擔杮怱憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2021/6/19-20), 愮梩 (僴僀僽儕僢僪奐嵜).
722069. [妛夛 (慡崙)] (僔儞億僕僂儉) Role of Wearable Cardioverter Defibrillator (WCD) in Patients with Reduced EF and Heart Failure. 掚栰怲堦 (弞娐婍撪): 戞67夞擔杮晄惍柆怱揹妛夛妛弍戝夛 (2021/7/2), Web奐嵜.
722070. [妛夛 (慡崙)] (僔儞億僕僂儉) Smart PCI偺採埬乣OCT偐傜撉傒夝偔ACS梫場偺摿掕偲梊屻娗棟乣. 撿丂彯尗 (弞娐婍撪): Tokyo Percutaneous cardiovascular Intervention Conference (TOPIC) 2021 (2021/7/9-10), Web奐嵜.
722071. [妛夛 (慡崙)] (嫵堢島墘) 怱傾儈儘僀僪乕僔僗偺椪彴: 夋憸偐傜偄偐偵媈偆偐. 彫斅嫶弐旤 (弞娐婍撪): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
722072. [妛夛 (慡崙)] (僔儞億僕僂儉) Antithrombotic therapy after LMT bifurcation PCI. When should we stop DAPT? 垻屆弫嵠 (弞娐婍撪): Tokyo Percutaneous cardiovascular Intervention Conference (TOPIC) 2021 (2021/7/9-10), Web奐嵜.
722073. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 枬惈姤摦柆徢岓孮亅崱屻偺揥奐亅. 垻屆弫嵠 (弞娐婍撪): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
722074. [妛夛 (慡崙)] (椪彴丒偐偐傝偮偗堛僙僢僔儑儞) 嵟嬤僼僅儘乕偟偰偄側偐偭偨弞娐婍偺榖: 姤摦柆幘姵偺帯椕亅僈僀僪儔僀儞偺億僀儞僩亅. 垻屆弫嵠 (弞娐婍撪): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
722075. [妛夛 (慡崙)] (僗億儞僒乕僪僙儈僫乕) 乽尭傜偡僄價僨儞僗乿偺幚慔亅AFIRE峏側傞愗傝岥亅. 垻屆弫嵠 (弞娐婍撪): 僇僥乕僥儖傾僽儗乕僔儑儞娭楢廐婫戝夛2021 (2021/9/23-25), Web奐嵜.
722076. [妛夛 (慡崙)] (僔儞億僕僂儉) Protective roles of rivaroxaban on H202-induced oxidative stress injury in vascular endothelial glycocalyx through the PI3K/IQGAP1 pathway. 杒棦棞嵐1, 搶瀶旤撧巕2, 垻屆弫嵠1 (1弞娐婍撪, 2堛椕塹惗妛晹): CVMW2021怱寣娗戙幱廡娫 (戞38夞崙嵺怱憻尋媶妛夛擔杮晹夛憤夛) (2021/12/10-11), Web奐嵜.
722077. [妛夛 (慡崙)] (桪廏墘戣徿岓曗僙僢僔儑儞) 姤摦柆憿塭偱抁棈寣棳傪敽偆庮釒忬擹愼憸傪擣傔偨怱僒儖僐僀僪乕僔僗偺堦椺. 挬憅惔巎1, 撿丂彯尗2, 塱揷婱巕1, 婽揷丂椙2, 彫斅嫶弐旤2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞35夞擔杮姤幘姵妛夛妛弍廤夛 (2021/12/17-18), Web奐嵜.
723137. [妛夛 (慡崙)] (堦斒島墘) 怱嬝徢乣overview乣. 彫斅嫶弐旤1, 戨忋丂桰2, 峕揷桪巕2, 慜懞寬帯2, 戝栘戩枻2, 摗揷揝暯1, 栴嶈杻桼1, 撶揷丂寬1, 抮揷桽婤3, 愇堜弐曘1, 孲嶳宐巕4, 慜愳宐旤1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦, 4憤崌恌椕): 擔杮怱僄僐乕恾妛夛戞32夞妛弍廤夛 (2021/4/23-25), Web奐嵜.
723138. [妛夛 (慡崙)] (堦斒島墘) Pulmonary artery pulsatility index偲MitraClip屻偺嶰愲曎媡棳徢偍傛傃梊屻偲偺娭學. 摗揷揝暯1, 彫斅嫶弐旤1, 嫶懞旤曐1, 戨忋丂桰2, 孲嶳宐巕3, 慜愳宐旤1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3憤崌恌椕): 擔杮怱僄僐乕恾妛夛戞32夞妛弍廤夛 (2021/4/23-25), Web奐嵜.
723139. [妛夛 (慡崙)] (堦斒島墘) 寬恌傪宊婡偵恌抐偝傟偨怱憻庮釃椺偵偍偗傞怱僄僐乕恾偺栶妱偲帯椕愴棯. 塱揷婱巕1, 抮揷桽婤2, 峕揷桪巕1, 摗揷揝暯3, 孲嶳宐巕4, 慜愳宐旤3, 彫斅嫶弐旤3, 垻屆弫嵠3 (1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪, 4憤崌恌椕): 擔杮怱僄僐乕恾妛夛戞32夞妛弍廤夛 (2021/4/23-25), Web奐嵜.
723140. [妛夛 (慡崙)] (堦斒島墘) 攛寣娗奼挘栻偵傛偭偰怱撪廋暅弍偑壜擻偲側偭偨怱幒拞妘寚懝徢崌暪塃幒僯峯徢偺堦椺. 摗揷揝暯1, 戝栘丂戩, 抮揷桽婤2, 愇枛惉嵠1, 彫斅嫶弐旤1, 垻屆弫嵠1 (1弞娐婍撪, 2媬柦): 戞6夞擔杮攛崅寣埑丒攛弞娐妛夛妛弍廤夛 (2021/5/6-8), 搶嫗.
723141. [妛夛 (慡崙)] (堦斒島墘) 弞娐婍堛偺帇揰偐傜偙傟偐傜偺摐擜昦帯椕傪峫嶡偡傞. 垻屆弫嵠 (弞娐婍撪): Slender Club Japan Live Demonstration & Annual Meeting 2021 in TOKYO (2021/5/28-30), Web奐嵜.
723142. [妛夛 (慡崙)] (堦斒島墘) FRAGILE-HF research group: 崅楊怱晄慡姵幰偵偍偗傞埆塼幙偺桳昦棪偲梊屻傊偺塭嬁亅FRAGILE HF儗僕僗僩儕乕偐傜. 慜愳宐旤 (弞娐婍撪): 戞27夞擔杮怱憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2021/6/19-20), 愮梩 (僴僀僽儕僢僪奐嵜).
723143. [妛夛 (慡崙)] (堦斒岥墘) Time from diagnosis and atrial size are associated with the recurrence of atrial fibrillation after catheter ablation. 媦愳丂弤1, 怺扟塸暯1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 峳愳梇婭1, 彫椦廃暯1, 敀愳桾婎1, 杧岥丂垽1, 惣惉揷椇1, 愇枛惉嵠1, 娸尨丂弤1, 嵅摗丂梲1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞67夞擔杮晄惍柆怱揹妛夛妛弍戝夛 (2021/7/1-4), Web奐嵜.
723144. [妛夛 (慡崙)] (億僗僞乕) Right Ventricular Apex Pacing Increases the Left Ventricular Flow Energy Loss. 峳愳梇婭1, 怺扟塸暯1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 彫椦廃暯1, 敀愳桾婎1, 杧岥丂垽1, 惣惉揷椇1, 愇枛惉嵠1, 媦愳丂弤1, 娸尨丂弤1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞67夞擔杮晄惍柆怱揹妛夛妛弍戝夛 (2021/7/1-4), Web奐嵜.
723145. [妛夛 (慡崙)] (堦斒岥墘) Comorbidity with asymptomatic sinus bradycardia is an additional risk of permanent pacemaker implantation after catheter ablation for the patients with tachycardia-bradycardia syndrome. 惣惉揷椇1, 掚栰怲堦1, 媦愳丂弤1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 峳愳梇婭1, 彫椦廃暯1, 敀愳桾婎1, 杧岥丂垽1, 拞懞梞斖1, 愇枛惉嵠1, 娸尨丂弤1, 怺扟塸暯1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞67夞擔杮晄惍柆怱揹妛夛妛弍戝夛 (2021/7/1-4), Web奐嵜.
723146. [妛夛 (慡崙)] (堦斒島墘) 曪妵揑奜棃怱憻儕僴價儕僥乕僔儑儞偵傛傝廔枛摐壔嶻暔偍傛傃塣摦婡擻, 塣摦懴梕擻偑夵慞偟偨掅怱婡擻偺怱晄慡徢椺. 暯堜抭栫, 摗媑榓攷1, 廳揷丂嬇, 徏杮戩栫, 媏抮弫巕, 愇揷峅婤1, 愇揷嶰榓1, 懞壀崄怐, 搶瀶戝婸1 (1弞娐婍撪): 戞5夞擔杮弞娐婍棟妛椕朄妛夛妛弍戝夛 (2021/8/28), Web奐嵜.
723147. [妛夛 (慡崙)] (堦斒島墘) 僐儘僫壭偵偍偗傞怱憻僇僥乕僥儖幒偱偺曻幩慄旐偽偔娗棟偵偮偄偰偺専摙. 摗媑榓攷1, 愇揷峅婤1, 愇揷嶰榓1, 垻屆弫嵠1, 搶瀶戝婸1 (1弞娐婍撪): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17), 捁庢 (僴僀僽儕僢僪奐嵜).
723148. [妛夛 (慡崙)] (堦斒岥墘) IMPELLA 5.0偍傛傃廤妛揑怱晄慡帯椕偵傛傝惷拲嫮怱栻埶懚偐傜扙媝偱偒偨帩懕惈怱朳嵶摦崌暪奼挘宆怱嬝徢偺堦椺. 慜懞寬帯1, 抮揷桽婤2, 峕揷桪巕1, 戝栘戩枻1, 栴嶈杻桼3, 摗揷揝暯3, 斞揷桽堦榊3, 撶揷丂寬3, 愇堜弐曘3, 孲嶳宐巕4, 慜愳宐旤3, 彫斅嫶弐旤3, 垻屆弫嵠3 (1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪, 4憤崌恌椕): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
723149. [妛夛 (慡崙)] (堦斒岥墘) 悢擭娫尨場晄柧偱偁偭偨嵗埵偵偰掅巁慺寣徢傪掓偡傞Platypnea-orthodeoxiasyndrome偺1椺. 媑郪抭帯1, 掚栰怲堦1, 愇嶈桽栱, 搚堜徦巕, 峳愳梇婭1, 奰嶈椙懢1, 揷媨惵帬, 悪杮撃旻, 姳応懽惉, 堜娭帯榓, 媦愳丂弤1, 怺扟塸暯1, 崱栘棽懢, 垻屆弫嵠1 (1弞娐婍撪): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
723150. [妛夛 (慡崙)] (堦斒岥墘) 惷拲嫮怱栻埶懚忬懺偺枬惈怱晄慡傊偺CRT偺桳岠惈. 戝栘戩枻1, 抮揷桽婤2, 峕揷桪巕1, 慜懞寬帯1, 栴嶈杻桼3, 摗揷揝暯3, 斞揷桽堦榊3, 撶揷丂寬3, 愇堜弐曘3, 孲嶳宐巕4, 慜愳宐旤3, 彫斅嫶弐旤3, 垻屆弫嵠3 (1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪, 4憤崌恌椕): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
723151. [妛夛 (慡崙)] (堦斒岥墘) 暋悢偺曗彆弞娐僨僶僀僗偵傛傞寣娗傾僋僙僗惂尷壓偵怱幒昿攺傾僽儗乕僔儑儞傪巤峴偟, 掅怱攺弌傪棧扙偟摼偨嫊寣惈怱嬝徢偺堦椺. 徏塝丂尦1, 怺扟塸暯2, 摗揷揝暯2, 斞憅憗塮巕2, 釼摗戝庽1, 嵅摗揘榊1, 愇枛惉嵠2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
723152. [妛夛 (慡崙)] (堦斒岥墘) 怱朳嵶摦偺僇僥乕僥儖傾僽儗乕僔儑儞帪偺晄惍柆桿敪帋尡偺昁梫惈偵偮偄偰. 嵅摗揘榊1, 媦愳丂弤2, 怺扟塸暯2, 嶰扟桪懢楴1, 懞嶳桭夘1, 釼摗戝庽1, 徏塝丂尦1, 拞懞梞斖2, 愇枛惉嵠2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
723153. [妛夛 (慡崙)] (堦斒岥墘) 拝梡宆帺摦彍嵶摦婍 (WCD) 偺堾奜嶌摦偵傛傝媬柦偟摼偨摿敪惈怱幒嵶摦偺堦椺. 釼摗戝庽1, 娸尨丂弤2, 怺扟塸暯2, 嵅摗揘榊1, 徏塝丂尦1, 峳愳梇婭2, 敀愳桾婎2, 彫椦廃暯2, 愇枛惉嵠2, 媦愳丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
723154. [妛夛 (慡崙)] (堦斒岥墘) 怱晄慡傪敪徢偟恌抐偑偮偄偨廂弅擻偑曐偨傟偨惉恖嵍幒怱嬝鉱枾壔忈奞偺堦椺. 懞嶳桭夘1, 崱栘棽懢, 媑郪抭帯2, 奰嶈椙懢2, 嶰扟桪懢楴1, 釼摗戝庽1, 嵅摗揘榊1, 徏塝丂尦1, 拞懞梞斖2, 愇枛惉嵠2, 娸尨丂弤2, 怺扟塸暯2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
723155. [妛夛 (慡崙)] (堦斒島墘) 懱奜幃枌宆恖岺攛傪摫擖偡傞傕媬柦偟摼傜傟側偐偭偨攛崅寣埑徢崌暪擠晈偺堦椺. 摗揷揝暯1, 抮揷桽婤2, 撶揷丂寬1, 嫶杮戱栱1, 愇堜弐曘1, 孲嶳宐巕3, 慜愳宐旤1, 栚崟寬懢榊1, 彫斅嫶弐旤1, 垻屆弫嵠1 (1弞娐婍撪, 2媬柦, 3憤崌恌椕): 戞69夞擔杮怱憻昦妛夛妛弍廤夛 (2021/9/17-19), 捁庢 (僴僀僽儕僢僪奐嵜).
723156. [妛夛 (慡崙)] (堦斒島墘) 慜幒娫惷柆嬤朤傪婲尮偲偡傞怱幒婜奜廂弅偵懳偟偰Bipolar ablation偑桳岠偱偁偭偨堦椺. 愇枛惉嵠1, 怺扟塸暯1, 嶰扟桪懢楴2, 懞嶳桭夘2, 釼摗戝庽2, 徏塝丂尦2, 嵅摗揘榊2, 拞懞梞斖1, 娸尨丂弤1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 僇僥乕僥儖傾僽儗乕僔儑儞娭楢廐婫戝夛2021 (2021/9/23-25), Web奐嵜.
723157. [妛夛 (慡崙)] (堦斒島墘) 怱幒拞妘婲尮偺怱幒昿攺偵懳偟偰Bipolar ablation偑桳岠偱偁偭偨堦椺. 拞懞梞斖1, 怺扟塸暯1, 彫椦廃暯1, 峳愳梇婭1, 嵅摗揘榊2, 徏塝丂尦2, 愇枛惉嵠1, 媦愳丂弤1, 娸尨丂弤1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 僇僥乕僥儖傾僽儗乕僔儑儞娭楢廐婫戝夛2021 (2021/9/23-25), Web奐嵜.
723158. [妛夛 (慡崙)] (堦斒島墘) 怱撪廋暅弍枹巤峴偺惉恖婜扨怱幒徢偵崌暪偟偨暋悢偺栻嵻掞峈惈怱朳昿攺偵懳偟偰, 僇僥乕僥儖傾僽儗乕僔儑儞傪峴偭偨堦椺. 徏塝丂尦1, 怺扟塸暯2, 摗揷揝暯2, 釼摗戝庽1, 嵅摗揘榊1, 峳愳梇婭2, 敀愳桾婎2, 彫椦廃暯2, 拞懞梞斖2, 愇枛惉嵠2, 媦愳丂弤2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 僇僥乕僥儖傾僽儗乕僔儑儞娭楢廐婫戝夛2021 (2021/9/23-25), Web奐嵜.
723159. [妛夛 (慡崙)] (堦斒島墘) 怱朳嵶摦偺捛壛傾僽儗乕僔儑儞偱CARTO Finder覀蓚鎮閐river傊偺夘擖偑桳梡偱偁偭偨偲峫偊傜傟偨堦椺. 嵅摗揘榊1, 愇枛惉嵠2, 怺扟塸暯2, 嶰扟桪懢楴1, 懞嶳桭夘1, 釼摗戝庽1, 徏塝丂尦1, 拞懞梞斖2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 僇僥乕僥儖傾僽儗乕僔儑儞娭楢廐婫戝夛2021 (2021/9/23-25), Web奐嵜.
723160. [妛夛 (慡崙)] (堦斒島墘) 怱撪枌懁偺傒偺堦曽岦惈僽儘僢僋傪擣傔偨嶰愲曎椫壓戝惷柆嫭晹埶懚宆怱朳慹摦偺堦椺. 釼摗戝庽1, 怺扟塸暯2, 嵅摗揘榊1, 徏塝丂尦1, 峳愳梇婭2, 敀愳桾婎2, 彫椦廃暯2, 愇枛惉嵠2, 媦愳丂弤2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 僇僥乕僥儖傾僽儗乕僔儑儞娭楢廐婫戝夛2021 (2021/9/23-25), Web奐嵜.
723161. [妛夛 (慡崙)] (堦斒島墘) 塃幒慜擕摢嬝婎晹傪婲尮偲偡傞怱幒婜奜廂弅偵懳偟偰怱嬝從庈弍偑桳岠偱偁偭偨堦椺. 懞嶳桭夘1, 愇枛惉嵠2, 怺扟塸暯2, 嶰扟桪懢楴1, 釼摗戝庽1, 嵅摗揘榊1, 徏塝丂尦1, 拞懞梞斖2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 僇僥乕僥儖傾僽儗乕僔儑儞娭楢廐婫戝夛2021 (2021/9/23-25), Web奐嵜.
723162. [妛夛 (慡崙)] (堦斒島墘) 乽尭傜偡僄價僨儞僗乿偺幚慔亅AFIRE峏側傞愗傝岥亅. 垻屆弫嵠 (弞娐婍撪): ADATARA Live Demonstration 2021 (2021/9/30-10/1), Web奐嵜.
723163. [妛夛 (慡崙)] (堦斒島墘) Multicenter retrospective registry of cardiac sarcoidosis in Japan: a preliminary report from ILLUMINATE-CS. 撶揷丂寬1, Naruse Y, Taniguchi T, Kitani T, Yoshida K, Tanaka H, Okumura T, Baba Y, Kida K, Tamaki H, Sato K, Kitano D, Matsumoto S, Toma Y, Watanabe N, Miyazaki K, Saito H, Sato H, Kikuchi A, Ishihara S, Fukunaga M, Okabe T, Oyama K, Hidaka T, Yamaguchi T, Abe M, Ito M, Kato S, Ise T, Tamura Y, Ishida M, Matsue Y (1弞娐婍撪): 戞25夞擔杮怱晄慡妛夛妛弍廤夛 (2021/10/1-3), Web奐嵜.
723164. [妛夛 (慡崙)] (堦斒島墘) Relationship between ischemia-like electrocardiographic finding and myocardial scar in patients with non-ischemic cardiomyopathy. 慜懞寬帯1, 抮揷桽婤2, 峕揷桪巕1, 戝栘戩枻1, 栴嶈杻桼3, 摗揷揝暯3, 斞揷桽堦榊3, 孲嶳宐巕4, 撶揷丂寬3, 愇堜弐曘3, 慜愳宐旤3, 彫斅嫶弐旤3, 垻屆弫嵠3 (1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪, 4憤崌恌椕): 戞25夞擔杮怱晄慡妛夛妛弍廤夛 (2021/10/1-3), Web奐嵜.
723165. [妛夛 (慡崙)] (堦斒島墘) 怱僒儖僐僀僪乕僔僗. 撶揷丂寬 (弞娐婍撪): 戞25夞擔杮怱晄慡妛夛妛弍廤夛 (2021/10/1-3), Web奐嵜.
723166. [妛夛 (慡崙)] (堦斒島墘) Native T1 mapping and recovery of left ventricular ejection fraction in patients with newly diagnosed dilated cardiomyopathy. 栴嶈杻桼1, 撶揷丂寬1, 峕揷桪巕2, 慜懞寬帯2, 戝栘戩枻2, 摗揷揝暯1, 斞揷桽堦榊1, 孲嶳宐巕3, 抮揷桽婤4, 愇堜弐曘1, 慜愳宐旤1, 彫斅嫶弐旤1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3憤崌恌椕, 4媬柦): 戞25夞擔杮怱晄慡妛夛妛弍廤夛 (2021/10/1-3), Web奐嵜.
723167. [妛夛 (慡崙)] (堦斒島墘) 柍徢岓惈嶰愲曎媡棳偵敽偆塃朳奼戝偲愽嵼揑塭嬁偵偮偄偰偺専摙. 孲嶳宐巕1, 彫斅嫶弐旤2, 峕揷桪巕3, 慜懞寬擇3, 戝栘戩枻3, 栴嶈杻桼2, 摗揷揝暯2, 斞揷桟堦榊2, 抮揷桽婤4, 撶揷丂寬2, 愇堜弐曘2, 慜愳宐旤2, 垻屆弫嵠2 (1憤崌恌椕, 2弞娐婍撪, 3戝妛堾堛椕宯尋媶壢, 4媬柦): 戞25夞擔杮怱晄慡妛夛妛弍廤夛 (2021/10/1-3), Web奐嵜.
723168. [妛夛 (慡崙)] (堦斒島墘) Reappearing left ventricular mechanical dyssynchrony after MitraClip implantation: a case report. 戝栘戩枻1, 愇堜弐曘2, 戨忋丂桰1, 峕揷桪巕1, 栴嶈杻桼2, 慜懞寬擇1, 摗揷揝暯2, 抮揷桽婤3, 撶揷丂寬2, 慜愳宐旤2, 彫斅嫶弐旤2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3媬柦): 戞25夞擔杮怱晄慡妛夛妛弍廤夛 (2021/10/1-3), Web奐嵜.
723169. [妛夛 (慡崙)] (堦斒島墘) A Case of Fulminant Myocarditis Introduced 兝-blocker in Acute Phase with Veno-Arterial Extracorporeal Membrane Oxygenation and ImpellaTM CP. 峕揷桪巕1, 抮揷桽婤2, 慜懞寬擇1, 戝栘戩枻1, 栴嶈杻桼3, 摗揷揝暯3, 斞揷桟堦榊3, 孲嶳宐巕4, 撶揷丂寬3, 愇堜弐曘3, 慜愳宐旤3, 彫斅嫶弐旤3, 垻屆弫嵠3 (1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪, 4憤崌恌椕): 戞25夞擔杮怱晄慡妛夛妛弍廤夛 (2021/10/1-3), Web奐嵜.
723170. [妛夛 (慡崙)] (堦斒島墘) 僴乕僩僠乕儉偱deep discussion傪偟偨徢椺. 栚崟寬懢榊 (弞娐婍撪): Structure Club Japan Live Demonstration 2021 (2021/11/5-6), 搶嫗 (僴僀僽儕僢僪奐嵜).
723171. [妛夛 (慡崙)] (堦斒島墘) 弌寣僴僀儕僗僋姵幰偺峈寣愷椕朄傪嵞峫偡傞. 垻屆弫嵠 (弞娐婍撪): Complex Peripheral Angioplasty Conference (CPAC) 2021 (2021/11/26-27), Web奐嵜.
723172. [妛夛 (慡崙)] (堦斒島墘) The Big Change: 怱憻恌椕偺僌儘乕僽儗儃儕儏乕僔儑儞 垻屆弫嵠 (弞娐婍撪): 戞86夞擔杮弞娐婍妛夛妛弍廤夛 (JCS2022) (2022/3/11), Web奐嵜.
723173. [妛夛 (慡崙)] (堦斒島墘) Continuous positive alveolar pressure therapy is associated with a lower prevalence of coronary macrophage in patients with sleep apnea syndrome. 摗媑榓攷1, 愇揷峅婤1, 愇揷嶰榓1, 暯堜抭栫, 徏杮戩栫, 媏抮弫巕, 垻屆弫嵠1, 搶瀶戝婸1 (1弞娐婍撪): 戞86夞擔杮弞娐婍妛夛妛弍廤夛 (JCS2022) (2022/3/11), Web奐嵜.
723174. [妛夛 (慡崙)] (堦斒島墘) 惷拲嫮怱栻偐傜挿婜娫棧扙崲擄偱偁偭偨廳徢怱晄慡徢椺偵懳偡傞怱儕僴偺宱尡. 徏杮戩栫, 暯堜抭栫, 媏抮弫巕, 廳揷丂嬇, 摗媑榓攷1, 愇揷嶰榓1, 愇揷峅婤1, 搶瀶戝婸1 (1弞娐婍撪): 戞86夞擔杮弞娐婍妛夛妛弍廤夛 (JCS2022) (2022/3/11), Web奐嵜.
723175. [妛夛 (慡崙)] (堦斒島墘) 怱寣娗幘姵偺巆梋儕僗僋偵偍偗傞墛徢偺廳梫惈乣僐儗僗僩儘乕儖寢徎偺娭楢乣. 垻屆弫嵠 (弞娐婍撪): 戞86夞擔杮弞娐婍妛夛妛弍廤夛 (JCS2022) (2022/3/12), Web奐嵜.
723176. [妛夛 (慡崙)] (堦斒島墘) 怱憻儕僴價儕僥乕僔儑儞僙儞僞乕奐愝偵帄傞奜棃怱憻儕僴價儕僥乕僔儑儞堏峴棪偺曄壔. 媏抮弫巕, 摗媑榓攷1, 徏杮戩栫, 暯堜抭栫, 愇揷嶰榓1, 愇揷峅婤1, 搶瀶戝婸1 (1弞娐婍撪): 戞86夞擔杮弞娐婍妛夛妛弍廤夛 (JCS2022) (2022/3/12), Web奐嵜.暘
723177. [妛夛 (慡崙)] (堦斒島墘) 曪妵揑奜棃怱憻儕僴價儕僥乕僔儑儞偼嵟廔摐壔嶻暔傪夵慞偡傞. 暯堜抭栫, 徏杮戩栫, 摗媑榓攷1, 媏抮弫巕, 愇揷峅婤1, 愇揷嶰榓1, 廳揷丂嬇, 搶瀶戝婸1 (1弞娐婍撪): 戞86夞擔杮弞娐婍妛夛妛弍廤夛 (JCS2022) (2022/3/12), Web奐嵜.
723178. [妛夛 (慡崙)] (堦斒島墘) 怱晄慡帯椕偺曄慗乣崅僇儕僂儉寣徢偺榖戣傕娷傔偰乣. 垻屆弫嵠 (弞娐婍撪): 戞86夞擔杮弞娐婍妛夛妛弍廤夛 (JCS2022) (2022/3/13), Web奐嵜.
732022. [妛夛 (抧曽夛丒尋媶夛)] (夛挿婇夋) 怱晄慡帯椕偵偍偗傞僀儞僞乕儀儞僔儑儞堛偺怴偨側傞棫偪埵抲. 栚崟寬懢榊 (弞娐婍撪): 戞57夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛娭搶峛怣墇抧曽夛 (2021/5/8), 搶嫗 (僴僀僽儕僢僪奐嵜).
732023. [妛夛 (抧曽夛丒尋媶夛)] (夛挿婇夋) COVID-19偲怱寣娗幘姵. 垻屆弫嵠 (弞娐婍撪): 戞57夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛娭搶峛怣墇抧曽夛 (2021/5/8), 搶嫗 (僴僀僽儕僢僪奐嵜).
732024. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) ACS偵偍偗傞帀幙娗棟偺Tisp & Tricks. 撿丂彯尗 (弞娐婍撪): 戞57夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛娭搶峛怣墇抧曽夛 (2021/5/8), 搶嫗 (僴僀僽儕僢僪奐嵜).
732025. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 怱朳嵶摦偺峈寣愷帯椕-崅楊幮夛偵媮傔傜傟偰偄傞DOAC偺偁傝曽-. 掚栰怲堦 (弞娐婍撪): CadiOvascular MeICine in Sagamihara The 4th Night (2021/5/21), 憡柾尨.
732026. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) ACS偵偍偗傞帀幙娗棟偺Tisp & Tricks. 撿丂彯尗 (弞娐婍撪): 戞52夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛杒奀摴抧曽夛 (2021/5/22), Web奐嵜.
732027. [妛夛 (抧曽夛丒尋媶夛)] (僗億儞僒乕僪僙儈僫乕) 嵟怴僈僀僪儔僀儞偵婎偯偔GDMT偺廳梫惈偲+兛偺堛椕夘擖. 垻屆弫嵠 (弞娐婍撪): 戞261夞擔杮弞娐婍妛夛娭搶峛怣墇抧曽夛 (2021/9/12), Web奐嵜.
732028. [妛夛 (抧曽夛丒尋媶夛)] (摿暿僙儈僫乕) 弌寣僴僀儕僗僋姵幰偺峈寣愷椕朄傪嵞峫偡傞. 垻屆弫嵠 (弞娐婍撪): 戞37夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛嬤婨抧曽夛 (2021/10/9), Web奐嵜.
732029. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 尰戙偵偍偗傞晄惍柆栻暔帯椕偺埵抲偯偗-傾儈僆僟儘儞偲兝幷抐栻偲偦傟偐傜?-. 掚栰怲堦 (弞娐婍撪): 戞10夞怴妰晄惍柆帯椕僇儞僼傽儔儞僗 (2021/10/16), 怴妰.
732030. [妛夛 (抧曽夛丒尋媶夛)] (夛挿婇夋) 怱晄慡帯椕偵偍偗傞栻暔椕朄偲device帯椕. 垻屆弫嵠 (弞娐婍撪): 戞58夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛娭搶峛怣墇抧曽夛 (2021/10/16), 搶嫗 (僴僀僽儕僢僪奐嵜).
732031. [妛夛 (抧曽夛丒尋媶夛)] (傾僼僞僰乕儞僙儈僫乕) 堦曕愭偺SMART PCI偺僗僗儊. 撿丂彯尗 (弞娐婍撪): 戞58夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛娭搶峛怣墇抧曽夛 (2021/10/16), 搶嫗 (僴僀僽儕僢僪奐嵜).
732032. [妛夛 (抧曽夛丒尋媶夛)] (Award僙僢僔儑儞) 怱尨惈僔儑僢僋姵幰偵偍偗傞Impella曗彆壓偺怱攺悢悇堏偲椪彴揮婡偺娭學. 慜懞寬帯1, 抮揷桽婤2, 峕揷桪巕1, 戝栘戩枻1, 栴嶈杻桼3, 摗揷揝暯3, 斞揷桽堦榊3, 撶揷丂寬3, 愇堜弐曘3, 孲嶳宐巕4, 慜愳宐旤3, 彫斅嫶弐旤3, 垻屆弫嵠3 (1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪, 4憤崌恌椕): 戞261夞擔杮弞娐婍妛夛娭搶峛怣墇抧曽夛 (2021/9/6-12), Web奐嵜.
732033. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 怱朳拞妘寚懝乣弍屻偵恌傞傋偒億僀儞僩偲偼. 彫斅嫶弐旤 (弞娐婍撪): 擔杮挻壒攇堛妛夛戞33夞娭搶峛怣墇抧曽夛妛弍廤夛 (2021/10/16-17), 挿栰 (僴僀僽儕僢僪奐嵜).
732034. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 怱朳嵶摦偺峈寣愷帯椕亅怴僈僀僪儔僀儞偲崅楊幮夛偵媮傔傜傟傞DOAC慖戰亅. 掚栰怲堦 (弞娐婍撪): 挰揷巗怱幘姵僾儔僀儅儕働傾僼僅乕儔儉 (2021/12/20), 挰揷.
733042. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 奼挘宆怱嬝徢姵幰偵偍偗傞Native T1 mapping偲嵍幒嬱弌棪夵慞偺娭楢. 栴嶉杻桼1, 撶揷丂寬1, 慜懞寬帯2, 戝栘戩枻2, 摗揷揝暯1, 抮揷桽婤3, 愇堜弐曘1, 慜愳宐旤1, 彫斅嫶弐旤1, 挅枖岶尦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦): 戞7夞擔杮怱嬝徢尋媶夛 (2021/4/17), Web奐嵜.
733043. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 棏墌岴奐懚偵傛傞Platypnea orthodeoxia syndrome偵宱旂揑棏墌岴暵嵔弍傪峴偄夵慞傪擣傔偨1椺. 斞憅憗塮巕1, 栚崟寬懢榊1, 嫶杮戱栱1, 慜愳宐旤1, 垻屆弫嵠1 (1弞娐婍撪): 戞57夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛娭搶峛怣墇抧曽夛 (2021/5/8), 搶嫗 (僴僀僽儕僢僪奐嵜).
733044. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 曗彆弞娐梡億儞僾僇僥乕僥儖傪梡偄媬柦偟偨塃姤摦柆傪愑擟寣娗偲偡傞媫惈姤徢岓孮偺2椺. 斞憅憗塮巕1, 抮揷桽婤2, 栘壓戝帒1, 嫶杮戱栱1, 嵅摗怢梞2, 垻屆弫嵠1 (1弞娐婍撪, 2媬柦): 戞260夞擔杮弞娐婍妛夛娭搶峛怣墇抧曽夛 (2021/6/19), Web奐嵜.
733045. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恌抐偵嬯椂偟偨ATTRv偲AL傾儈儘僀僪乕僔僗偺崌暪椺. 峕揷桪巕1, 愇堜弐曘2, 壛摗廋柧, 戝栘戩枻1, 慜懞寬帯1, 栴嶈杻桼2, 摗揷揝暯2, 抮揷桽婤3, 撶揷丂寬2, 孲嶳宐巕4, 彫斅嫶弐旤2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3媬柦, 4憤崌恌椕): 戞42夞怱嬝惗専尋媶夛妛弍廤夛 (2021/6/21), 戝嶃 (僴僀僽儕僢僪奐嵜).
733046. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Hippo effector Yap1傪夘偟偨Amotl1偺怱嬝嵶朎憹怋傊偺栶妱. 杒棦棞幯 (弞娐婍撪): 戞21夞娭搶怱丒寣娗僼僅乕儔儉 (2021/7/10), 搶嫗 (Web奐嵜).
733047. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 慜棫態娻姵幰偵懳偡傞儂儖儌儞椕朄偑姶愼惈怱撪枌墛偺敪徢偺儕僗僋傪崅傔偨偲峫偊傜傟偨堦椺. 楅栘丂戓, 摗媑榓攷1, 愇揷嶰榓1, 愇揷峅婤1, 垻屆弫嵠1, 搶瀶戝婸1 (1弞娐婍撪): 戞261夞擔杮弞娐婍妛夛娭搶峛怣墇抧曽夛 (2021/9/6), Web奐嵜.
733048. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怱寣娗僀儀儞僩梊杊偺僷儔僟僀儉僔僼僩乣摐擜昦帯椕栻偺怴偨側揥奐乣. 垻屆弫嵠 (弞娐婍撪): 戞31夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛 (CVIT) 嬨廈丒壂撽抧曽夛 (2021/10/2), 杒嬨廈.
733049. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 媫惈A宆戝摦柆夝棧偵敽偆媫惈壓暻怱嬝峓嵡偵塃姤摦柆僗僥儞僩帯椕偟嵍姤摦柆傊偺夝棧偺攇媦傕敾柧偟奜壢嵞寶弍傪峴偭偨堦徢椺. 惣惉揷椇1, 峳旜寷巌榊, 妢尨丂戩, 悪嶈寬堦, 嶳壓婱戝, 悽戲暥壒, 娫悾戩尠 (1弞娐婍撪): 戞58夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛娭搶峛怣墇抧曽夛 (2021/10/15-16), 搶嫗 (僴僀僽儕僢僪奐嵜).
733050. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 娕岇巘庡摫宆偺曪妵揑怱憻儕僴價儕僥乕僔儑儞摫擖偵傛傝嵞擖堾婜娫傪墑挿偱偒偨廳徢怱晄慡偺堦椺. 媏抮弫巕, 摗媑榓攷1, 徏杮戩栫, 暯堜抭栫, 愇揷嶰榓1, 愇揷峅婤1, 搶瀶戝婸1 (1弞娐婍撪): 擔杮怱憻儕僴價儕僥乕僔儑儞妛夛戞6夞娭搶峛怣墇巟晹抧曽夛 (2021/10/16), Web奐嵜.
733051. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 帯椕慜屻偺怱僄僐乕乣庤弍偲僇僥乗僥儖帯椕偵敽偆怱僄僐乕傪峫偊傞乣愭揤惈怱幘姵亅怱朳拞妘寚懝亅. 彫斅嫶弐旤 (弞娐婍撪): 怣擹挰怱僄僐乕僇儞僼傽儗儞僗web島廗夛 (2021/11/13), Web奐嵜.
733052. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 敪徢偵怱嬝壦嫶偑娭梌偟偰偄偨偲峫偊傜傟偨媫惈怱嬝峓嵡偺堦椺. 斞憅憗塮巕1, 抮揷桽婤2, 嫶杮戱栱1, 婽揷丂椙1, 嵅摗怢梞2, 垻屆弫嵠1 (1弞娐婍撪, 2媬柦): 戞262夞擔杮弞娐婍妛夛娭搶峛怣墇抧曽夛 (2021/12/4), Web奐嵜.
733053. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘)亂Student Award Finalist亃傾儞僕僆僥儞僔儞庴梕懱僱僾儕儔僀僔儞慾奞栻摫擖帪偵掅怱攺弌検徢岓孮偲側傝怱晄慡僶僀僆儅乕僇乕偺夝庍偵擄廰偟偨奼挘宆怱嬝徢偺堦椺. 媨忛桟婯, 摗媑榓攷1, 楅栘丂戓, 愇揷嶰榓1, 愇揷峅婤1, 垻屆弫嵠1, 搶瀶戝婸1 (1弞娐婍撪): 戞262夞擔杮弞娐婍妛夛娭搶峛怣墇抧曽夛 (2021/12/4), Web奐嵜.
733054. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嫊寣惈怱幘姵姵幰偺峈寣愷椕朄偺恑曕. 垻屆弫嵠 (弞娐婍撪): 戞46夞擔杮怱憻昦妛夛嫵堢僙儈僫乕傾僪僶儞僗僐乕僗 (2022/2/27), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110012. [尨挊] Worries and concerns among healthcare workers during the coronavirus 2019 pandemic: A web-based cross-sectional survey. Sahashi Y, Endo H, Sugimoto T, Nabeta T1, Nishizaki K, Kikuchi A, Matsumoto S, Sato H, Goto T, Hasegawa K, Matsue Y: J Public Health Res 2020/11; 9 (4): 1936. (撶揷丂寬1: 1弞娐婍撪)
'20-110013. [尨挊] Optical Coherence Tomography Predictors for a Favorable Vascular Response to Statin Therapy. Nakajima A, Minami Y1, Araki M, Kurihara O, Soeda T, Yonetsu T, Wang Z, McNulty I, Lee H, Nakamura S, Jang IK: J Am Heart Assoc 2021/1; 10 (1): e018205. (撿丂彯尗1: 1弞娐婍撪)
'20-110014. [尨挊] Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease. Katamine M1, Minami Y2, Hashimoto T2, Ako J2: Pract Lab Med 2021/1; 24: e00202. (曅曯惓岍1, 撿丂彯尗2, 嫶杮戱栱2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
'20-110015. [尨挊] Predictors for Rapid Progression of Coronary Calcification: An Optical Coherence Tomography Study. Nakajima A, Araki M, Kurihara O, Minami Y1, Soeda T, Yonetsu T, Higuma T, Kakuta T, McNulty I, Lee H, Malhotra R, Nakamura S, Jang IK: J Am Heart Assoc 2021/2; 10 (3): e019235. (撿丂彯尗1: 1弞娐婍撪)
'20-522002. [島嵗]亂戞39夞搶嫗CCU尋媶夛僔儞億僕僂儉亃S-4. CCU/ICU偵偍偗傞怱憻撍慠巰儕僗僋昡壙偲梊杊朄亅WCD偵傛傞撍慠巰梊杊偺峫偊曽傪娷傔偰亅. 掚栰怲堦 (弞娐婍撪): ICU偲CCU 2020; 44 (暿嶜): S99-S103.
'20-522003. [島嵗]亂摿廤: COVID-19亃[悽奅偺堛妛帍偐傜] 19 嵍幒廂弅擻掅壓偺怱晄慡姵幰丂SGLT2慾奞栻偱怱寣娗巰儕僗僋14%掅壓亅Lancet. 怺扟塸暯 (弞娐婍撪): MMJ 2021/2; 2丒3寧崋: 42-6.
21-540001. [偦偺懠 (Editorial Commentl)] 拞搰榑暥偵懳偡傞Editorial Comment. 撶揷 寬 (弞娐婍撪): 怱憻 2021/3; 53 (3): 265.
[妛夛丒尋媶夛摍]
'20-722001. [妛夛 (慡崙)] (僔儞億僕僂儉) Confronting the Diversity of Cardiac Sarcoidosis. 彫斅嫶弐旤 (弞娐婍撪): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26-28), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723002. [妛夛 (慡崙)] (億僗僞乕) 愗彍晄壜擻側怱憻庮釃偵娭楢偟偨栻嵻掞峈惈怱幒昿攺偵懳偟偰, 宱惷柆怉崬傒宆彍嵶摦婍棷抲弍傪巤峴偟偨堦椺. 徏塝丂尦1, 娸尨丂弤2, 抮揷桽婤3, 塱揷婱巕1, 釼摗戝庽1, 嵅摗揘榊1, 峳愳梇婭2, 敀愳桾婎2, 彫椦廃暯2, 愇枛惉嵠2, 媦愳丂弤2, 怺扟塸暯2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3媬柦): 戞13夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2021/2/5-7), 戝嶃 (僴僀僽儕僢僪奐嵜).
'20-723003. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞宱僇僥乕僥儖揑戝摦柆曎抲姺弍屻峆媣揑儁乕僗儊乕僇怉崬傒弍偺惉愌. 嵅摗揘榊1, 娸尨丂弤2, 栚崟寬懢榊2, 釼摗戝庽1, 徏塝丂尦1, 峳愳梇婭2, 彫椦廃暯2, 敀愳桾婎2, 愇枛惉嵠2, 媦愳丂弤2, 怺扟塸暯2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪柦): 戞13夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2021/2/5-7), 戝嶃 (僴僀僽儕僢僪奐嵜).
'20-723004. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞怉偊崬傒宆儖乕僾儗僐乕僟乕 (ILR) 偺桳梡惈偺専摙. 釼摗戝庽1, 娸尨丂弤2, 怺扟塸暯2, 晲揷復悢3, 嵅摗揘榊1, 徏塝丂尦1, 峳愳梇婭2, 敀愳桾婎2, 彫椦廃暯2, 愇枛惉嵠2, 媦愳丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3ME晹): 戞13夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2021/2/5-7), 戝嶃 (僴僀僽儕僢僪奐嵜).
'20-723005. [妛夛 (慡崙)] (億僗僞乕) SelectSecure䝼蓚鎮閴E幒崅埵拞妘儁乕僔儞僌偑嵍幒撪寣棳偵媦傏偡塭嬁偺専摙. 峳愳梇婭1, 怺扟塸暯1, 娸尨丂弤1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 彫椦廃暯1, 敀愳桾婎1, 愇枛惉嵠1, 媦愳丂弤1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞13夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2021/2/5-7), 戝嶃 (僴僀僽儕僢僪奐嵜).
'20-723006. [妛夛 (慡崙)] (堦斒島墘) 惉恖愭揤惈怱幘姵case僇儞僼傽: 惉恖愭揤惈怱幘姵case3 (PDA). 彫斅嫶弐旤 (弞娐婍撪): 戞23夞僄僐乕僂傿儞僞乕僙儈僫乕 (2021/2/14), Web奐嵜.
'20-723007. [妛夛 (慡崙)] (堦斒島墘) Reduction of Intraventricular Flow Energy Loss per Stroke Work is Associated with Ventricular Recovery after Cardiac Resynchronization Therapy. 慜懞寬帯1, 抮揷桽婤2, 奰嶈椙懢3, 戝栘戩枻1, 栴嶈杻桼3, 摗揷揝暯3, 撶揷丂寬3, 愇堜弐曘3, 慜愳宐旤3, 彫斅嫶弐旤3, 垻屆弫嵠3 (1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26-28), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723008. [妛夛 (慡崙)] (堦斒島墘) Comparison Study Between Hypokinetic Non-Dilated Cardiomyopathy and Dilated Cardiomyopathy on Cardiac Outcomes. 峕揷桪巕1, 撶揷丂寬2, 戨忋丂桰1, 慜懞寬帯1, 戝栘戩枻1, 栴嶈杻桼2, 摗揷揝暯2, 抮揷桽婤3, 愇堜弐曘2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3媬柦): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26-28), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723009. [妛夛 (慡崙)] (堦斒島墘) Multicenter Pharmacokinetic and Pharmacodynamic Study of Oral Factor Xa Inhibitor Edoxaban in Non-valvular Atrial Fibrillation Patients with Acute Heart Failure. 撶揷丂寬1, Kida K, 愇揷嶰榓1, Shiono T, Suzuki N, Doi S, Tsukahara M, Akashi Y, 垻屆弫嵠1 (1弞娐婍撪): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26-28), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723010. [妛夛 (慡崙)] (堦斒島墘) Clinical Effects of Re-worsening Left Ventricular Function after Response to Cardiac Resynchronization Therapy. 戝栘戩枻1, 愇堜弐曘2, 慜懞寬帯1, 栴嶈杻桼2, 摗揷揝暯2, 抮揷桽婤3, 撶揷丂寬2, 孲嶳宐巕4, 慜愳宐旤2, 彫斅嫶弐旤2, 挅枖岶尦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3媬柦, 4憤崌恌椕): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26-28), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723011. [妛夛 (慡崙)] (堦斒島墘) Concomitance with vascular disease is associated with stroke and bleeding complication in patients with atrial fibrillation after catheter ablation. 怺扟塸暯1, 媦愳丂弤1, Otsuka T, Suzuki S, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Hirata A, Murakami M, Takami M, Kimura M, Nakahara S, Kato T, Iwasaki Y, Shimizu W, Harada T, Nakajima E, Okumura K, Koyama J, Yamane T, Tokuda M, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Hagiwara N, Ejima K, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y, Okumura Y (1弞娐婍撪): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26-28), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723012. [妛夛 (慡崙)] (堦斒島墘) Novel predict or of new-onset heart failure in patients with pacemaker. 敀愳桾婎1, 媦愳丂弤1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 峳愳梇婭1, 彫椦廃暯1, 愇枛惉嵠1, 娸尨丂弤1, 怺扟塸暯1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26-28), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723013. [妛夛 (慡崙)] (堦斒島墘) Different effects of catheter ablation on the exercise tolerance, leg strength, and quality of life: Paroxysmal vs. Persistent atrial fibrillation. 徏塝丂尦1, 怺扟塸暯2, 媦愳丂弤2, 釼摗戝庽1, 嵅摗揘榊1, 峳愳梇婭2, 彫椦廃暯2, 敀愳桾婎2, 愇枛惉嵠2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26-28), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723014. [妛夛 (慡崙)] (堦斒島墘) Esaxerenone Suppresses Electrical Remodeling in the Isoproterenol Induced Myocardial Injury Model. 嵅摗揘榊1, 掚栰怲堦2, 掚栰桾宐, 媦愳丂弤2, 釼摗戝庽1, 徏塝丂尦1, 峳愳梇婭2, 彫椦廃暯2, 敀愳桾婎2, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 娸尨丂弤2, 怺扟塸暯2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26-28), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723015. [妛夛 (慡崙)] (堦斒島墘) Atrial Late Potentials are Associated with Recurrence of Atrial Fibrillation after Catheter Ablation. 釼摗戝庽1, 怺扟塸暯2, 媦愳丂弤2, 嵅摗揘榊1, 徏塝丂尦1, 峳愳梇婭2, 彫椦廃暯2, 敀愳桾婎2, 愇枛惉嵠2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26-28), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-732001. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 崅楊幮夛偵偍偗傞怱朳嵶摦偺僩乕僞儖働傾亅晄惍柆栻暔帯椕僈僀僪儔僀儞夵掶傪摜傑偊偰亅. 掚栰怲堦 (弞娐婍撪): 怱朳嵶摦帯椕 Up to Date in 慜嫶 (2020/12/19), 慜嫶
'20-732002. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 崅楊幮夛偵偍偗傞怱朳嵶摦偺僩乕僞儖働傾亅晄惍柆栻暔帯椕僈僀僪儔僀儞夵掶傪摜傑偊偰亅. 掚栰怲堦 (弞娐婍撪): 僄儕僉儏乕僗恄撧愳 Web僔儞億僕僂儉乣崅楊幰偺峈寣愷椕朄傪峫偊傞乣 (2021/1/19), 憡柾尨.
'20-732003. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 崅楊幮夛偵偍偗傞怱朳嵶摦偺僩乕僞儖働傾亅晄惍柆栻暔帯椕僈僀僪儔僀儞夵掶傪摜傑偊偰亅. 掚栰怲堦 (弞娐婍撪): 戞15夞偝偑傒撪壢僙儈僫乕 (2021/2/26), 憡柾尨.
'20-733002. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 塃幒怱愲晹儁乕僔儞僌偲塃幒崅埵拞妘儁乕僔儞僌偑嵍幒撪寣棳偵媦傏偡塭嬁偺専摙. 峳愳梇婭1, 怺扟塸暯1, 娸尨丂弤1, 愇枛惉嵠1, 奰嶈椙懢1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 彫椦廃暯1, 敀愳桾婎1, 媦愳丂弤1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞1夞擔杮晄惍柆怱揹妛夛娭搶峛怣墇巟晹抧曽夛 (2021/1/30), Web奐嵜.
'20-733003. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 塃拞攛惷柆偲塃朳偺揹婥揑寢崌偵傛傝攛惷柆妘棧偵擄廰偟偨敪嶌惈怱朳嵶摦偺堦椺. 敀愳桾婎1, 怺扟塸暯1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 峳愳梇婭1, 彫椦廃暯1, 惣惉揷椇1, 杧岥丂垽1, 愇枛惉嵠1, 媦愳丂弤1, 娸尨丂弤1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞1夞擔杮晄惍柆怱揹妛夛娭搶峛怣墇巟晹抧曽夛 (2021/1/30), Web奐嵜.
'20-733004. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 愭揤惈怱幘姵弍屻怱朳慹摦偵偍偄偰AdvisorTMHD grid偱摼傜傟偨揹埵偑嫵孭揑偩偭偨堦椺. 彫椦廃暯1, 娸尨丂弤1, 怺扟塸暯1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 峳愳梇婭1, 敀愳桾婎1, 愇枛惉嵠1, 媦愳丂弤1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞1夞擔杮晄惍柆怱揹妛夛娭搶峛怣墇巟晹抧曽夛 (2021/1/30), Web奐嵜.
'20-733005. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僄儞僩儗僀儞儊儞僩儁乕僔儞僌偵偰怱撪枌-奜枌懁娫偺breakthrough傪徹柧偟摼偨perimitral AT偺1椺. 惣惉揷椇1, 媦愳丂弤1, 怺扟塸暯1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 峳愳梇婭1, 彫椦廃暯1, 敀愳桾婎1, 杧岥丂垽1, 拞懞梞斖1, 愇枛惉嵠1, 娸尨丂弤1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞1夞擔杮晄惍柆怱揹妛夛娭搶峛怣墇巟晹抧曽夛 (2021/1/30), Web奐嵜.
'20-733006. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 攛寣娗奼挘栻偵傛偭偰怱撪廋暅弍偑壜擻偲側偭偨怱幒拞妘寚懝徢崌暪塃幒擇峯徢偺堦椺. 彫栘慮隳1, 摗揷揝暯2, 塱揷婱巕1, 晊堜戝擇榊2, 慜愳宐旤2, 彫斅嫶弐旤2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞259夞擔杮弞娐婍妛夛娭搶峛怣墇抧曽夛 (2021/2/13-15), Web奐嵜.
'20-733007. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怱枌墛偵傛傞峉懇惈忈奞偺弌尰傪宊婡偵廳徢壔偟偨憁朮曎偍傛傃嶰愲曎媡棳徢偺1椺. 彫栘慮隳1, 摗揷揝暯2, 塱揷婱巕1, 晊堜戝擇榊2, 慜愳宐旤2, 彫斅嫶弐旤2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞259夞擔杮弞娐婍妛夛娭搶峛怣墇抧曽夛 (2021/2/13-15), Web奐嵜.
'20-733008. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怱晄慡 乣HFpEF/HFrEF 偽偐傝偑怱晄慡偠傖側偄乣 愭揤惈怱幘姵偺怱晄慡. 彫斅嫶弐旤 (弞娐婍撪): 怣擹挰怱僄僐乕僇儞僼傽儗儞僗web島墘夛 (2021/3/6), Web奐嵜.
擼恄宱撪壢妛
[妛弍榑暥]
110217. [尨挊] Asymptomatic acute ischemic lesions in intracerebral hemorrhage: Its frequency, MRI features, and risk factors. Kitamura E1, Iizuka T1, Mamorita N2, Nagai T1, Usui R1, Yanagida A, Nakamura M1, Ishima D1, Kaneko J1, Akutsu T1, Kanazawa N3, Nishiyama K1: J Neurol Sci 2021/7; 426: 117472. (杒懞塸擇1, 斞捤崅峗1, 庣揷寷悞2, 塱堜弐峴1, 塐堜丂椛1, 拞懞姴徍1, 堜搰戝曘1, 嬥巕弤懢榊1, 垻媣捗擇晇1, 嬥郪捈旤3, 惣嶳榓棙1: 1擼恄宱撪, 2堛椕塹惗妛晹, 3昦懺丒恌椕宯)
110218. [尨挊] The influence of right-left error in the placement of the Cc electrode in tibial nerve somatosensory evoked potentials (SEPs). Takahashi K1, Oishi C, Hamada Y, Nishiyama K1, Sonoo M: Clin Neurophysiol Pract 2021/7; 6: 215-8. (崅嫶榓嵐1, 惣嶳榓棙1: 1擼恄宱撪)
110219. [尨挊] Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies. Guasp M, Landa J, Martinez-Hernandez E, Sabater L, Iizuka T1, Simabukuro M, Nakamura M, Kinoshita M, Kurihara M, Kaida K, Bruna J, Kapetanovic S, S噉chez P, Ruiz-Garc抋 R, Naranjo L, Planagum� J, Munoz-Lopetegi A, Bataller L, Saiz A, Dalmau J, Graus F: Neurol Neuroimmunol Neuroinflamm 2021/7; 8 (5): e1053. (斞捤崅峗1: 1擼恄宱撪)
110220. [尨挊] Status epilepticus suspected autoimmune: Neuronal surface antibodies and main clinical features. Suga H, Yanagida A, Kanazawa N1, Ohara H, Kitagawa T, Hayashi M, Onozawa Y, Nagata N, Kaneko J1, Kitamura E1, Nishiyama K1, Iizuka T1: Epilepsia 2021/11; 62 (11): 2719-31. (嬥郪捈旤1, 嬥巕弤懢榊1, 杒懞塸擇1, 惣嶳榓棙1, 斞捤崅峗1: 1擼恄宱撪)
110221. [尨挊] Cholesterol crystal embolism-related cerebral infarction: Magnetic resonance imaging and clinical characteristics. Kondo Y1, Kanzaki M1, Ishima D1, Usui R1, Kimura A1, Usui K1, Amoh Y2, Takeuchi Y3, Kumabe T4, Ako J5, Miyaji K6, Nishiyama K1, Akutsu T1: eNeurologicalSci 2021/12; 25: 100388. (嬤摗桾巕1, 恄嶈恀幚1, 堜搰戝曘1,塐堜丂椛1, 栘懞暥彨1, 塒堜峩懢榊1, 揤塇峃擵2, 抾撪峃梇3, 孏晹弐岹4, 垻屆弫嵠5, 媨抧丂娪6, 惣嶳榓棙1, 垻媣捗擇晇1: 1擼恄宱撪, 2旂晢, 3恡憻撪, 4擼奜, 5弞娐婡撪, 6怱憻寣娗奜)
110222. [尨挊] Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis. Aizawa H, Kato H, Oba K, Kawahara T, Okubo Y, Saito T, Naito M, Urushitani M, Tamaoka A, Nakamagoe K, Ishii K, Kanda T, Masahisa Katsuno M , Atsuta N, Maeda Y, Nagai M1, Nishiyama K1, Ishiura H, Toda T, Kawata A, Abe K, Yabe I, Takahashi-Iwata I, Sasaki H, Warita H, Aoki M, Sobue G, Mizusawa H, Matsuyama Y, Haga T, Shin Kwak S: J Neurol 2022/2; 269 (2): 885-96. (塱堜恀婱巕1, 惣嶳榓棙1: 1擼恄宱撪)
310016. [徢椺曬崘] Gerstmann's Syndrome in a Patient Double-positive for Antibodies against the N-methyl-D-aspartate Receptor and NH2-terminal of 兛-enolase. Sugiyama A, Suzuki M, Suichi T, Uchida T, Iizuka T1, Tanaka K, Yoneda M, Kuwabara S: Intern Med 2021/5; 60 (9): 1463-8. (斞捤崅峗1: 1擼恄宱撪)
310017. [徢椺曬崘] Case Report: Dexmedetomidine for Intractable Clusters of Myoclonic Jerks and Paroxysmal Sympathetic Hyperactivity in Progressive Encephalomyelitis With Rigidity and Myoclonus. Fujino Y, Shiga K, Hori M, Tamura A, Iizuka T1: Front Neurol 2021/7; 12: 703050. (斞捤崅峗1: 1擼恄宱撪)
310018. [徢椺曬崘] Paraneoplastic Polymyositis Due to Renal Cell Carcinoma in a Patient with Autosomal Dominant Polycystic Kidney Disease. Noda-Narita S, Kanzaki M1, Uesaka Y, Suwabe T, Kinowaki K, Marui Y, Hoshino J, Sawa N, Ubara Y: Intern Med 2021/11; 60 (22): 3577-80. (恄嶈恀幚1: 1擼恄宱撪)
310019. [徢椺曬崘] Severe dysautonomia in glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus (PERM): A case report. Mizutani Y, Adachi S, Nakano S, Hayashi K, Higashi A, Kikuchi K, Maeda T, Murate K, Shima S, Iizuka T1, Ueda A, Ito M, Watanabe H: Auton Neurosci 2022/1; 237: 102910. (斞捤崅峗1: 1擼恄宱撪)
522053. [島嵗]亂摿廤: 堦曕恑傫偩娗棟丒梊杊丒帯椕傪幚慔! 擼懖拞偺栻偺巊偄曽亃挻媫惈婜擼懖拞偺慡恎娗棟. 彫扟徍攷, 惣嶳榓棙1 (1擼恄宱撪): 寧姧栻帠 2021/12; 63 (16): 34-9.
522054. [島嵗]亂摿廤: 摢捝恌椕update亃III. 摢捝偺恌抐偲帯椕丂1. 斀暅惈曅摢捝. 杒懞塸擇 (擼恄宱撪): 擔杮椪喱 2022/2; 80 (2): 249-55.
[挊丂彂]
620059. [妛弍彂 (暘扴幏昅)]亂嵟怴僈僀僪儔僀儞偵婎偯偔 恄宱幘姵 恌椕巜恓 2021-'22亃10. 嬝幘姵丂儈僩僐儞僪儕傾昦, p,386-94. 斞捤崅峗 (擼恄宱撪), 曇: 楅栘懃岹, 憤崌堛妛幮, 搶嫗, 2021/5敪峴.
620060. [妛弍彂 (暘扴幏昅)]亂Annual Review 恄宱 2021亃III. Clinical Topics丂7. 扙悜丒柶塽惈幘姵丂1 帺屓柶塽夘嵼惈擼墛偺僗儁僋僩儔儉, p.271-82. 斞捤崅峗1, 嬥郪捈旤2 (1擼恄宱撪, 2昦懺丒恌椕宯), 曇: 楅栘懃岹, 峳栘怣晇, 塅愳媊堦, 孠尨丂憦, 墫愳朏徍, 拞奜堛妛幮, 搶嫗, 2021/5敪峴.
620061. [妛弍彂 (暘扴幏昅)]亂拞悤恄宱偺帺屓柶塽惈丒墛徢惈幘姵僴儞僪僽僢僋 (Brain and Nerve 2021擭憹戝崋)亃仭戞2復 幘姵奺榑丂峈NMDA庴梕懱擼墛, p,595-604. 斞捤崅峗1, 嬥郪捈旤2, 桍揷撝巕3 (1擼恄宱撪, 2昦懺丒恌椕宯, 3宍懺宯), 堛妛彂堾, 搶嫗, 2021/5敪峴.
620062. [妛弍彂 (暘扴幏昅)]亂摢捝偺恌椕僈僀僪儔僀儞2021亃II 曅摢捝丂3. 梊杊椕朄丂CQ II-3-4 暋悢偺梊杊椕朄傪偳偺傛偆偵巊偄暘偗傞偐, p.207. CQ II-3-13 曅摢捝偦偺懠偺梊杊椕朄偼桳岠偐, p.235. V 偦偺懠偺堦師惈摢捝丂曅摢捝, 嬞挘宆摢捝, 孮敪摢捝埲奜偺1師惈摢捝偵偼偳偺傛偆側傕偺偑偁傞偐, p.326. 杒懞塸擇 (擼恄宱撪), 娔廋: 擔杮恄宱妛夛, 擔杮摢捝妛夛, 擔杮恄宱帯椕妛夛, 曇:乽摢捝偺恌椕僈僀僪儔僀儞乿嶌惉埾堳夛, 堛妛彂堾, 搶嫗, 2021/10敪峴.
620063. [妛弍彂 (暘扴幏昅)]亂嵟怴椪彴擼懖拞妛 (戞2斉) 壓亅嵟怴偺恌抐偲帯椕亅 (擔杮椪喱80姫憹姧崋2)亃XV. 擼峓嵡憤榑丂4. 媫惈婜帯椕丂(4) 擼曐岇椕朄, p.55-9. 垻媣捗擇晇 (擼恄宱撪), 擔杮椪喱幮, 搶嫗, 2022/2敪峴.
620064. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓2022擭斉丂巹偼偙偆帯椕偟偰偄傞亃15 恄宱丒嬝幘姵丂柍徢岓惈擼寣娗忈奞 (枹攋楐擼摦柆釒傪彍偔), p,949-51. 惣嶳榓棙 (擼恄宱撪), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2022/1敪峴.
620065. [妛弍彂 (暘扴幏昅)]亂敪揥偡傞擼懖拞恌椕偺嵟慜慄 (堛妛偺偁備傒3寧戞1搚梛摿廤)亃姫摢尵, p.969. 惣嶳榓棙 (擼恄宱撪), 堛帟栻弌斉, 搶嫗, 2022/3敪峴.
[妛夛丒尋媶夛摍]
722078. [妛夛 (慡崙)] (僔儞億僕僂儉) 擼墛丒悜枌墛崕暈偵岦偗偨恌椕傾儖僑儕僘儉偺峔抸: 乽恄宱姶愼徢偲帺屓柶塽惈擼墛偺僋儘僗僩乕僋乿偵偍偗傞乽帺屓柶塽惈擼墛偵偍偗傞恌抐傾儖僑儕僘儉偲椪彴僗儁僋僩儔儉偺奼偑傝乿. 斞捤崅峗 (擼恄宱撪): 戞62夞擔杮恄宱妛夛妛弍戝夛 (2021/5/21), 嫗搒 (僴僀僽儕僢僪奐嵜).
722079. [妛夛 (慡崙)] (僔儞億僕僂儉) 椪彴堛晹夛愝抲弨旛埾堳夛偐傜偺妶摦曬崘. 惣嶳榓棙 (擼恄宱撪): 戞62夞擔杮恄宱妛夛妛弍戝夛 (2021/5/22), 嫗搒 (僴僀僽儕僢僪奐嵜).
722080. [妛夛 (慡崙)] (儅儔僜儞儗僋僠儍乕) 帺屓柶塽惈擼墛偍傛傃偦偺椶墢幘姵偵偍偗傞媫惈徢岓惈敪嶌 徢岓偲昦懺). 斞捤崅峗 (擼恄宱撪): 戞54夞擔杮偰傫偐傫妛夛妛弍廤夛 (2021/9/25), 柤屆壆 (僴僀僽儕僢僪奐嵜).
722081. [妛夛 (慡崙)] (僔儞億僕僂儉) 峈NMDA庴梕懱擼墛偲帺棩恄宱忈奞. 斞捤崅峗 (擼恄宱撪): 戞74夞擔杮帺棩恄宱妛夛憤夛 (2021/10/24), Web奐嵜.
722082. [妛夛 (慡崙)] (僔儞億僕僂儉) 墛徢惈擼幘姵恌椕偵偍偗傞擼恄宱撪壢堛偺妶桇 (帺屓柶塽惈擼墛傗尨場晄柧偺偰傫偐傫廳愊忬懺傪娷傓). 斞捤崅峗 (擼恄宱撪): 戞39夞擔杮恄宱帯椕妛夛妛弍廤夛 (2021/10/29), 嶰廳 (僴僀僽儕僢僪奐嵜).
722083. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 曅摢捝慜挍偲摢捝敪嶌帪偺擼寣棳曄壔: 2憡惈恄宱寣娗曄壔. 斞捤崅峗 (擼恄宱撪): 戞49夞擔杮摢捝妛夛憤夛 (2021/11/19), 惷壀.
722084. [妛夛 (慡崙)] (僔儞億僕僂儉) 婥徾曄壔偼旂幙奼墑惈梷惂偵塭嬁傪媦傏偡偐. 杒懞塸擇 (擼恄宱撪): 擔杮摢捝妛夛 (2021/11/20), 惷壀.
723179. [妛夛 (慡崙)] (堦斒島墘) Combined technique傪梡偄偨婡夿揑寣愷夞廂椕朄偱媧堷僇僥乕僥儖偺寣愷埑拝偼昁恵偐? 塐堜丂椛1, 堜搰戝曘1, 栘懞暥彨1, 塒堜峩懢榊1, 恵夑桾庽1, 塱堜弐峴1, 孖揷塴棦巕1, 嬥巕弤懢榊1, 杒懞塸擇1, 恄嶈恀幚1, 恗栘丂弤2, 嶳杮戝曘2, 垻媣捗擇晇1, 惣嶳榓棙1 (1擼恄宱撪, 2擼奜): 戞62夞擔杮恄宱妛夛妛弍戝夛 (2021/5/19), 嫗搒 (僴僀僽儕僢僪奐嵜).
723180. [妛夛 (慡崙)] (堦斒島墘) 僐儗僗僥儘乕儖嵡愷徢偵偍偗傞栩摦柆嫹嶓偵偮偄偰偺専摙. 垻媣捗擇晇1, 嬤摗桾巕2, 塒堜峩懢榊1, 栘懞暥彨1, 塐堜丂椛1, 堜搰戝曘1, 恄嶈恀幚1, 斞捤崅峗1, 惣嶳榓棙1 (1擼恄宱撪, 2戝妛堾堛椕宯尋媶壢): 戞62夞擔杮恄宱妛夛妛弍戝夛 (2021/5/19), 嫗搒 (僴僀僽儕僢僪奐嵜).
723181. [妛夛 (慡崙)] (堦斒島墘) 戝擼婎掙妀幘姵偵偍偗傞嫽暠梷惂僶儔儞僗偺専摙. 晊妦彯旻1, 郷揷丂夒, 戙揷桰堦榊, 屗揷払巎, 惣嶳榓棙1, 挿扟愳堦巕 (1擼恄宱撪): 戞62夞擔杮恄宱妛夛妛弍戝夛 (2021/5/21), 嫗搒 (僴僀僽儕僢僪奐嵜).
723182. [妛夛 (慡崙)] (堦斒島墘) Clinico-immunological investigations in suspected autoimmune encephalitis or its related disorders. 斞捤崅峗1, 桍揷撝巕, 嬥郪捈旤2, 娾悾椚巕1, 挿揷撧弿旤3, 恵夑桾庽1, 嬥巕弤懢榊1, 杒懞塸擇1, 惣嶳榓棙1 (1擼恄宱撪, 2昦懺丒恌椕宯, 3戝妛堾堛椕宯尋媶壢): 戞62夞擔杮恄宱妛夛妛弍戝夛 (2021/5/21), 嫗搒 (僴僀僽儕僢僪奐嵜).
723183. [妛夛 (慡崙)] (堦斒島墘) Clinical and immunological investigations in autoimmune encephalitis and its related disorders. 斞捤崅峗1, 桍揷撝巕, 嬥郪捈旤2, 娾悾椚巕1, 挿揷撧弿旤3, 恵夑桾庽1, 嬥巕弤懢榊1, 杒懞塸擇1, 惣嶳榓棙1 (1擼恄宱撪, 2昦懺丒恌椕宯, 3戝妛堾堛椕宯尋媶壢): 戞62夞擔杮恄宱妛夛妛弍戝夛 (2021/5/21), 嫗搒 (僴僀僽儕僢僪奐嵜).
723184. [妛夛 (慡崙)] (堦斒島墘) Immunostaining pattern of neuronal surface antibodies with in-house IHC and commercial IHC. 桍揷撝巕, 斞捤崅峗1, 嬥郪捈旤2, 杒懞塸擇1, 恵夑桾庽1, 嬥巕弤懢榊1, 惣嶳榓棙1 (1擼恄宱撪, 2昦懺丒恌椕宯): 戞62夞擔杮恄宱妛夛妛弍戝夛 (2021/5/21), 嫗搒 (僴僀僽儕僢僪奐嵜).
723185. [妛夛 (慡崙)] (堦斒島墘) Effect of blue light on cortical spreading depression. 杒懞塸擇1, 嬥郪捈旤2, 斞捤崅峗1, 惣嶳榓棙1 (1擼恄宱撪, 2昦懺丒恌椕宯): 戞62夞擔杮恄宱妛夛妛弍戝夛 (2021/5/21), 嫗搒 (僴僀僽儕僢僪奐嵜).
723186. [妛夛 (慡崙)] (堦斒島墘) 帇恄宱愐悜墛偺嵞敪帪偵峈GluN1峈懱偑悜塼偐傜専弌偝傟偨39嵨彈惈. 嬥巕弤懢榊1, 嬥郪捈旤2, 斞捤崅峗1, 挿揷撧弿旤3, 恵夑桾庽1, 桍揷撝巕, 惣嶳榓棙1 (1擼恄宱撪, 2昦懺丒恌椕宯, 3戝妛堾堛椕宯尋媶壢): 戞33夞擔杮恄宱柶塽妛夛妛弍廤夛 (2021/10/21), Web奐嵜.
723187. [妛夛 (慡崙)] (堦斒島墘) 儔僢僩擼柶塽慻怐壔妛忋偺摿挜揑愼怓僷僞乕儞偵婎偯偄偨恄宱昞柺峈尨偺梊應: 梊旛揑尋媶. 挿揷撧弿旤1, 斞捤崅峗2, 嬥郪捈旤3, 桍揷撝巕, 恵夑桾庽2, 嬥巕弤懢榊2, 杒懞塸擇2, 惣嶳榓棙2 (1戝妛堾堛椕宯尋媶壢, 2擼恄宱撪, 3昦懺丒恌椕宯): 戞33夞擔杮恄宱柶塽妛夛妛弍廤夛 (2021/10/22), Web奐嵜.
723188. [妛夛 (慡崙)] (堦斒島墘) 敀怓岝偑cortical spreading depression偵梌偊傞塭嬁. 杒懞塸擇1, 嬥郪捈旤2, 斞捤崅峗1, 惣嶳榓棙1 (1擼恄宱撪, 2昦懺丒恌椕宯): 擔杮摢捝妛夛 (2021/11/21), 惷壀.
723189. [妛夛 (慡崙)] (堦斒島墘) 夁塣摦敪嶌偺擄帯晹暘偰傫偐傫偺弍慜昡壙偵偍偗傞峝枌奜揹嬌偺摿暿側桳梡惈偺専摙. 塱堜弐峴 (擼恄宱撪): 戞51夞擔杮椪彴恄宱惗棟妛夛妛弍戝夛 (2021/12/18), 愬戜 (僴僀僽儕僢僪奐嵜).
723190. [妛夛 (慡崙)] (堦斒島墘) 寉徢偐傜拞摍徢偺擼掙摦柆暵嵡徢偼曅杻醿傪掓偡傞. 垻媣捗擇晇1, 惣嶳榓棙1, 栘懞暥彨1, 塐堜丂椛1, 堜搰戝曘1, 嬥巕弤懢榊1, 嶳杮戝曘2, 栘嫋戱攏1, 挿搰丂惤1, 恵夑桾庽1, 拞懞姴徍1, 斞捤崅峗1, 杒懞塸擇1, 恄嶈恀幚1 (1擼恄宱撪, 2擼奜): STROKE 2022 (2022/3/17), 戝嶁 (僴僀僽儕僢僪奐嵜).
733055. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 斀暅惈偺柍嬠惈悜枌墛偲滸搷墛傪宊婡偵壠懓惈抧拞奀擬偲恌抐偟偨46嵨抝惈 拞懞姴徍1, 塱堜弐峴1, 埨払抭旤1, 栘嫋戱攏1, 嬥巕弤懢榊1, 恄嶉恀幚1, 峕攇屗岶曘2, 惣嶳榓棙1 (1擼恄宱撪, 2彫帣): 戞237夞擔杮恄宱妛夛娭搶丒峛怣墇抧曽夛 (2021/6/5), Web奐嵜.
733056. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 敪嶌帪摢旂擼攇奐巒慜偵DC揹埵傪擣傔偨慹戝昦曄偺擄帯嵍懁摢梩偰傫偐傫偺堦椺. 塱堜弐峴 (擼恄宱撪): 戞17夞擔杮偰傫偐傫妛夛嬤婨抧曽夛 (2021/7/18), 恄屗 (僴僀僽儕僢僪奐嵜).
733057. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 帇恄宱愐悜墛偺嵞敪偲摨帪偵峈NMDA庴梕懱擼墛傪敪徢偟偨39嵨彈惈椺. 弿曽寬椇1, 嬥巕弤懢榊1, 嬥郪捈旤2, 斞捤崅峗1, 暯嶳寬師1, 摽揷丂隳1, 埨払抭旤1, 垻媣捗擇晇1, 惣嶳榓棙1 (1擼恄宱撪, 2昦懺丒恌椕宯): 戞238夞擔杮恄宱妛夛娭搶丒峛怣墇抧曽夛 (2021/9/4), 搶嫗.
733058. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 廳徢嬝柍椡徢帯椕拞偵敪徢偟偨愐悜峝枌奜帀朾庮偺堦椺. 埨払抭旤1, 塐堜丂椛1, 嬥巕弤懢榊1, 垻媣捗擇晇1, 斞捤崅峗1, 惣嶳榓棙1 (1擼恄宱撪): 戞239夞擔杮恄宱妛夛娭搶丒峛怣墇抧曽夛 (2021/12/4), Web奐嵜.
733059. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 醶惈懳杻醿偱敪徢偟CSF1R堚揱巕偺怴婯曄堎傪擣傔偨恄宱幉嶕僗僼僃儘僀僪宍惉傪敽偆堚揱惈傃傑傫惈敀幙擼徢 (HDLS) 偺50嵨抝惈椺. 彫扟徍攷1, 塱堜恀婱巕1, 娾悾椚巕1, 暯嶳寬師1, 戝徖嵐怐, 愇塝峗擵, 捯丂徣師, 崅丂婭怣, 戨嶳壝媣, 惣嶳榓棙1 (1擼恄宱撪): 戞240夞擔杮恄宱妛夛娭搶丒峛怣墇抧曽夛 (2022/3/5), 搶嫗.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110016. [尨挊] Clinically based score predicting cryptogenic NORSE at the early stage of status epilepticus. Yanagida A, Kanazawa N1, Kaneko J2, Kaneko A2, Iwase R2, Suga H, Nonoda Y3, Onozawa Y4, Kitamura E2, Nishiyama K2, Iizuka T2: Neurol Neuroimmunol Neuroinflamm 2020/7; 7 (5): e849. (嬥郪捈旤1, 嬥巕弤懢榊2, 嬥巕丂岤2, 娾悾椚巕2, 栰乆揷朙3, 彫栰郪桾栫4, 杒懞塸擇2, 惣嶳榓棙2, 斞捤崅峗2: 1昦懺丒恌椕宯, 2擼恄宱撪, 3彫帣, 4椪専晹)
寣塼撪壢妛
[妛弍榑暥]
110223. [尨挊] Real-world assessment of myelodysplastic syndrome: Japanese claims data analysis . Tsutsue S, Suzuki T1, Kim H, Crawford B : Future Oncol 2022/1; 18 (1): 93-104. (楅栘棽峗1: 1寣塼撪)
521003. [夝愢] 僄儕僗儘億僄僠儞晄墳惈MDS偵懳偡傞儗僫儕僪儈僪丒僄儕僗儘億僄僠儞暪梡椕朄偺椪彴岠壥. 楅栘棽峗: 寣塼撪壢2021/9; 83 (3): 416-20.
522055. [島嵗]亂戝偒偔恑曕偟偨憿寣婍庮釃偺恌抐偲帯椕亃崪悜堎宍惉徢岓孮. 墶嶳恀婌1, 楅栘棽峗1 (1寣塼撪): 恌抐偲帯椕 2021/6; 109 (6): 761-5.
[挊丂彂]
620066. [妛弍彂 (暘扴幏昅)]亂怴椪彴庮釃妛 偑傫栻暔椕朄愱栧堛偺偨傔偵 夵掶戞6斉亃崪悜堎宍惉徢岓孮 (MDS), p. 598-602. 楅栘棽峗 (寣塼撪), 撿峕摪, 搶嫗, 2021/5敪峴.
620067. [妛弍彂 (暘扴幏昅)]亂愱栧堛偺偨傔偺寣塼昦妛亃VI 帯椕憤榑丂3 巟帩椕朄丂1) 僒僀僩僇僀儞椕朄, p,370-5. 墺丂慶惤 (寣塼撪), 曇: 楅栘棽峗, 抾拞崕搇, 抮揧棽擵, 堛妛彂堾, 搶嫗, 2022/3敪峴.
[妛夛丒尋媶夛摍]
713035. [妛夛 (崙嵺)] (堦斒島墘) Emerging strategies for myelodysplastic syndromes. Suzuki T1: The 12th JSH International Symposium 2021 in Kamakura (2021/5/14-15), Kamakura, Japan. (楅栘棽峗1: 1寣塼撪)
721009. [妛夛 (慡崙)] (摿暿島墘) 崪悜晄慡徢偺娪暿偲帯椕. 楅栘棽峗 (寣塼撪): 戞22夞擔杮専嵏寣塼妛夛妛弍廤夛 (2021/9/12), 恄撧愳 (僴僀僽儕僢僪奐嵜).
723191. [妛夛 (慡崙)] (堦斒島墘) CD45堿惈傾僌儗僢僔僽NK嵶朎敀寣昦偺堦椺. 摴壓梇夘1, 墺丂慶惤1, 姍揷峗柅1, 揷帥斖峴1, 杧暷桟堦1, 墶嶳恀婌1, 塇嶳宒埲2, 媨鴵峗擇3, 楅栘棽峗1 (1寣塼撪, 2戝妛堾堛椕宯尋媶壢, 3桝寣丒嵶朎堏怉): 戞83夞擔杮寣塼妛夛妛弍廤夛 (2021/9/23-25), Web奐嵜.
723192. [妛夛 (慡崙)] (堦斒島墘) 憿寣婍幘姵偵偍偗傞崪悜娐忬揝夎媴傪娷傓堎宍惉偵娭偡傞扨巤愝徢椺廤愊尋媶. 塇嶳宒埲1, 姍揷峗柅2, 垻晹桳崄3, 烴堜宑嶰3, 懞忋敧廳巕4, 庪栰桳嶌5, 楅栘棽峗2 (1戝妛堾堛椕宯尋媶壢, 2寣塼撪, 3椪専晹, 4宍懺宯, 5椪専妛): 戞83夞擔杮寣塼妛夛妛弍廤夛 (2021/9/23-25), Web奐嵜.
732035. [妛夛 (抧曽夛丒尋媶夛)] (抧堟堛椕僔儞億僕僂儉) 寣塼朘栤恌椕偵偍偗傞僞乕儈僫儖働傾偲嵼戭桝寣偺壜擻惈. 墺丂慶惤 (寣塼撪): 戞15夞擔杮寣塼妛夛娭搶峛怣墇抧曽夛 (2021/7/10), 敔崻 (僴僀僽儕僢僪奐嵜).
732036. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉)亂寣塼撪壢恌椕偺堛椕楢実亃寣塼朘栤恌椕偺恌偐偨: 嵼戭桝寣偵偮偄偰. 墺丂慶惤 (寣塼撪): 戞15夞擔杮寣塼妛夛娭搶峛怣墇抧曽夛 (2021/7/10), 敔崻 (僴僀僽儕僢僪奐嵜).
733060. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 枬惈崪悜惈敀寣昦姵幰偵偍偗傞僠儘僔儞僉僫乕僛慾奞栻偺挿婜巊梡偵娭楢偟偨悇掕巺媴懱鄅夁棪偺曄壔. 彫惣岹柧1, 姍揷峗柅1, 杮嫶抦旤1, 摴壓梇夘1, 杧暷桟堦1, 揷帥斖峴1, 墺丂慶惤1, 楅栘棽峗1 (1寣塼撪): 戞15夞擔杮寣塼妛夛娭搶峛怣墇抧曽夛 (2021/7/10), 敔崻.
733061. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) PNH崌暪擠怭偱掗墹愗奐偵偰暘曍偟嶻壢揑崌暪徢傪棃偟偨堦椺. 峕敤峎堦1, 墺丂慶惤1, 姍揷峗柅1, 揷帥斖峴1, 杧暷桟堦1, 摴壓梇夘1, 墶嶳恀婌1, 媨鴵峗擇2, 楅栘棽峗1 (1寣塼撪, 2桝寣丒嵶朎堏怉): 戞16夞擔杮寣塼妛夛娭搶峛怣墇抧曽夛 (2022/3/19), 搶嫗.
屇媧婍撪壢妛
[妛弍榑暥]
110224. [尨挊] Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320). Otani S1, Sasaki J2, Nakahara Y1, Fukui T1, Igawa S1, Naoki K1, Bessho A, Hosokawa S, Fukamatsu N, Nakamura Y, Kasai T, Sugiyama T, Tokito T, Seki N, Hamada A, Okamoto H, Masuda N: Invest New Drugs 2021/4; 39 (2): 530-6. (戝扟嶇巕1, 嵅乆栘帯堦榊2, 拞尨慞楴1, 暉堜朁栫1, 堜愳丂憦1, 桺栘崕旻1: 1屇媧婍撪, 2怴悽婭堛椕丒墶抐揑堛椕)
110225. [尨挊] Examination of endobronchial ultrasound-guided transbronchial needle aspiration using a puncture needle with a side trap. Miyazaki K, Hirasawa Y, Aga M, Aiko N, Hamakawa Y, Taniguchi Y, Misumi Y, Agemi Y, Shimokawa T, Hayashi H, Naoki K1, Okamoto H: Sci Rep 2021/5; 11 (1): 9789. (桺栘崕旻1: 1屇媧婍撪)
110226. [尨挊] Trends of concerns from diagnosis in patients with advanced lung cancer and their family caregivers: A 2-year longitudinal study. Sato T1, Fujisawa D, Arai D, Nakachi I, Takeuchi M, Nukaga S, Kobayashi K, Ikemura S, Terai H, Yasuda H, Kawada I, Sato Y, Satomi R, Takahashi S, Haraguchi-Hashiguchi M, Nakamura M, Oyamada Y, Terashima T, Sayama K, Saito F, Sakamaki F, Inoue T, Naoki K1, Fukunaga K, Soejima K: Palliat Med 2021/5; 35 (5): 943-51. (嵅摗丂悞1, 桺栘崕旻1: 1屇媧婍撪)
110227. [尨挊] Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy. Kusuhara S1, Igawa S1, Ichinoe M2, Nagashio R3, Kuchitsu Y3, Hiyoshi Y1, Shiomi K4, Murakumo Y2, Saegusa M2, Satoh Y4, Sato Y3, Naoki K1: Thorac Cancer 2021/5; 12 (10): 1570-8. (擁尨惌堦榊1, 堜愳丂憦1, 堦屗徆柧2, 挿墫丂椇3, 媭捗桳婭3, 擔媑峃峅1, 墫尒丂榓4, 懞塤朏庽2, 嶰巬丂怣2, 嵅摗擵弐4, 嵅摗梇堦3, 桺栘崕旻1: 1屇媧婍撪, 2昦棟, 3堛椕塹惗妛晹, 4屇媧婍奜)
110228. [尨挊] Platinum-doublet chemotherapy as second-line treatment for relapsed patients with small-cell lung cancer: A systematic review and meta-analysis. Horiuchi K, Sato T1, Kuno T, Takagi H, Hirsch FR, Powell CA, Fukunaga K: Lung Cancer 2021/6; 156: 59-67. (嵅摗丂悞1: 1屇媧婍撪)
110229. [尨挊] Implementation of clinical sequencing for molecular profiling in patients with advanced cancer. Fukui T1, Sakai K, Sasaki J2, Ishihara-Kakegawa M1, Igawa S1, Mitsufuji H3, Takeda M, Takahama T, Nakagawa K, Nishio K, Naoki K1: Cancer Biomark 2021/6; 31 (2): 119-26. (暉堜朁栫1, 嵅乆栘帯堦榊2, 妡愳枹婓巕1, 堜愳丂憦1, 嶰摗丂媣3, 桺栘崕旻1: 1屇媧婍撪, 2怴悽婭堛椕丒墶抐揑堛椕, 3娕岇妛晹)
110230. [尨挊] Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer. Ishioka K, Yasuda H, Hamamoto J, Terai H, Emoto K, Kim TJ, Hirose S, Kamatani T, Mimaki S, Arai D, Ohgino K, Tani T, Masuzawa K, Manabe T, Shinozaki T, Mitsuishi A, Ebisudani T, Fukushima T, Ozaki M, Ikemura S, Kawada I, Naoki K1, Nakamura M, Ohtsuka T, Asamura H, Tsuchihara K, Hayashi Y, Hegab AE, Kobayashi S, Kohno T, Watanabe H, Ornitz DM, Betsuyaku T, Soejima K, Fukunaga K: Cancer Res 2021/7; 81 (14): 3916-29. (桺栘崕旻1: 1屇媧婍撪)
110231. [尨挊] Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer. Fukuda K, Otani S1, Takeuchi S, Arai S, Nanjo S, Tanimoto A, Nishiyama A, Naoki K1, Yano S: Cancer Sci 2021/9; 112 (9): 3784-95. (戝扟嶇巕1, 桺栘崕旻1: 1屇媧婍撪)
110232. [尨挊] A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer. Igawa S1, Kasajima M1, Ono T1, Ozawa T1, Kakegawa M1, Kusuhara S1, Sato T1, Nakahara Y1, Fukui T1, Yokoba M2, Kubota M2, Mitsufuji H3, Sasaki J4, Naoki K1: Cancer Manag Res 2021/11; 13: 8695-705. (堜愳丂憦1, 妢搰恀巙1, 彫栰懽暯1, 彫郪婱桾1, 妡愳枹婓巕1, 擁尨惌堦榊1, 嵅摗丂悞1, 拞尨慞楴1, 暉堜朁栫1, 墶応惓揟2, 媣曐揷彑2, 嶰摗丂媣3, 嵅乆栘帯堦榊4, 桺栘崕旻1: 1屇媧婍撪, 2堛椕塹惗妛晹, 3娕岇妛晹, 4怴悽婭堛椕丒墶抐揑堛椕)
110233. [尨挊] Longitudinal Assessment of Prognostic Understanding in Patients with Advanced Lung Cancer and Its Association with Their Psychological Distress. Arai D, Sato T1, Nakachi I, Fujisawa D, Takeuchi M, Sato Y, Kawada I, Yasuda H, Ikemura S, Terai S, Nukaga S, Inoue T, Nakamura M, Oyamada Y, Terashima T, Sayama K, Saito F, Sakamaki F, Naoki K1, Fukunaga K, Soejima K: Oncologist 2021/12; 26 (12): e2265-e2273. (嵅摗丂悞1, 桺栘崕旻1: 1屇媧婍撪)
110234. [尨挊] Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy. Sinha A, Zou Y, Patel AS, Yoo S, Jiang F, Sato T1, Kong R, Watanabe H, Zhu J, Massion PP, Borczuk AC, Powell CA: Cancers (Basel) 2022/1; 14 (3): 708. (嵅摗丂悞1: 1屇媧婍撪)
110235. [尨挊] Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease. Igawa S1, Yokoba M2, Takakura A, Hosotani S1, Nakahara Y1, Sato T1, Mitsufuji H3, Sasaki J4, Naoki K1: Invest New Drugs 2022/2; 40 (1): 182-9. (堜愳丂憦1, 墶応惓揟2, 嵶扟恀巌1, 拞尨慞楴1, 嵅摗丂悞1, 嶰摗丂媣3, 嵅乆栘帯堦榊4, 桺栘崕旻1: 1屇媧婍撪, 2堛椕塹惗妛晹, 3娕岇妛晹, 4怴悽婭堛椕丒墶抐揑堛椕)
310020. [徢椺曬崘] A case of lung adenocarcinoma with a novel CD74-ROS1 fusion variant identified by comprehensive genomic profiling that responded to crizotinib and entrectinib. Haraguchi-Hashiguchi M, Sato T1, Watanabe R, Kagyo J, Matsuzaki T, Domoto H, Kato T, Nakahara Y1, Yokose T, Hiroshima Y, Shiomi T: Thorac Cancer 2021/9; 12 (18): 2504-7. (嵅摗丂悞1, 拞尨慞楴1: 1屇媧婍撪)
310021. [徢椺曬崘] Standard therapy-resistant small cell lung cancer showing dynamic transition of neuroendocrine fate during the cancer trajectory: A case report. Ito F, Sato T1, Emoto K, Kaizuka N1, Yagi K, Watanabe R, Haraguchi-Hashiguchi M, Ninomiya H, Ikematsu Y, Tanaka K, Domoto H, Shiomi T: Mol Clin Oncol 2021/12; 15 (6): 261. (嵅摗丂悞1, 奓捤媂庽1: 1屇媧婍撪)
310022. [徢椺曬崘] Successful Tepotinib Challenge After Capmatinib-Induced Interstitial Lung Disease in a Patient With Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation: Case Report. Haraguchi-Hashiguchi M, Sato T1, Yamamoto H1, Watanabe R, Kagyo J, Domoto H, Shiomi T: JTO Clin Res Rep 2021/12; 3 (2): 100271. (嵅摗丂悞1, 嶳杮峗婱1: 1屇媧婍撪)
[挊丂彂]
620068. [妛弍彂 (暘扴幏昅)]亂偑傫柶塽儁僨傿傾丂庮釃柶塽妛丒偑傫柶塽椕朄偺慡偰傪傑傞偛偲棟夝!亃椪彴曇,丂1復 偑傫柶塽椕朄丂柶塽僠僃僢僋億僀儞僩慾奞嵻匑 (峈PD-1峈懱), p.24-6. 桺栘崕旻 (屇媧婍撪), 曇: 媑懞丂惔, 梤搚幮, 搶嫗, 2022/2敪峴.
[妛夛丒尋媶夛摍]
713036. [妛夛 (崙嵺)] (堦斒島墘) Platinum-Doublets as Second-Line Treatment for Relapsed Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Sato T1, Horiuchi K, Kuno T, Takagi H, Fred R Hirsch, Charles A Powell, Fukunaga K: IASLC 2021 World Conference on Lung Cancer (2021/9/13), Web奐嵜. (嵅摗丂悞1: 1屇媧婍撪)
713037. [妛夛 (崙嵺)] (堦斒島墘) Clinical impact of post-progression survival on overall survival in NSCLC patients with pre-existing interstitial lung disease. Igawa S1, Yokoba M2, Takakura A, Hosotani S1, Nakahara Y1, Sato T1, Mitsufuji H3, Kubota M2, Sasaki J1,4, Naoki K1: The 25th congress of the Asian Pacific Society of Respirology (2021/11/20), Kyoto, Japan. (堜愳丂憦1, 墶応惓揟2, 嵶扟恀巌1, 拞尨慞楴1, 嵅摗丂悞1, 嶰摗丂媣3, 媣曐揷彑2, 嵅乆栘帯堦榊1,4, 桺栘崕旻1: 1屇媧婍撪, 2堛椕塹惗妛晹, 3娕岇妛晹, 4怴悽婭堛椕丒墶抐揑堛椕)
713038. [妛夛 (崙嵺)] (堦斒島墘) Utility of thoracoscopy under local anesthesia in the diagnosis of tuberculous pleurisy and drug susceptibility testing for tuberculosis. Manaka H1, Sato T1, Ozawa T1, Akazawa Y1, Nakano M1, Oguri A1, Sone H1, Hosotani S1, Ono T1, Harada S2, Kusuhara S1, Kasajima M1, Kakegawa M1, Nakahara Y1, Igawa S1, Yokoba M3, Sasaki J1,4, Kubota M3, Mitsufuji H5, Naoki K1: The 25th Congress of the Asian Pacific Society of Respirology (APSR 2021) (2021/11/20-21), Kyoto, Japan (僴僀僽儕僢僪奐嵜). (娫拞攷栫1, 嵅摗丂悞1, 彫郪婱桾1, 愒郪桰婓1, 拞栰恀惗恖1, 彫孖柧恖1, 慮崻塸擵1, 嵶扟恀巌1, 彫栰懽暯1, 尨揷恀栫2, 擁尨惌堦榊1, 妢搰恀巙1, 妡愳枹婓巕1, 拞尨慞楴1, 堜愳丂憦1, 墶応惓揟3, 嵅乆栘帯堦榊1,4, 媣曐揷彑3, 嶰摗丂媣5, 桺栘崕旻1: 1屇媧婍撪, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹, 4怴悽婭堛椕丒墶抐揑堛椕, 5娕岇妛晹)
713039. [妛夛 (崙嵺)] (堦斒島墘) Evaluation of atezolizumab monotherapy for chemotherapy-refractory patients with non-small cell lung cancer in clinical practice. Kasajima M1, Igawa S1, Katagiri M2, Kubota M2, Sasaki J1,3, Mitsuhuji H4, Yokoba M2, Sato T1, Nakahara Y1, Kakegawa M1, Kusuhara S1, Harada S5, Ozawa T1, Ono T1, Kurata T1, Naoki K1: The 25th Congress of the Asian Pacific Society of Respirology (APSR 2021) (2021/11/20-21), Kyoto, Japan (僴僀僽儕僢僪奐嵜). (妢搰恀巙1, 堜愳丂憦1, 曅嬎恀恖2, 媣曐揷彑2, 嵅乆栘帯堦榊1,3, 嶰摗丂媣4, 墶応惓揟2, 嵅摗丂悞1, 拞尨慞楴1, 妡愳枹婓巕1, 擁尨惌堦榊1, 尨揷恀栫5, 彫郪婱桾1, 彫栰懽暯1, 憅揷戱搇1, 桺栘崕旻1: 1屇媧婍撪, 2堛椕塹惗妛晹, 3怴悽婭堛椕丒墶抐揑堛椕, 4娕岇妛晹, 5戝妛堾堛椕宯尋媶壢)
721010. [妛夛 (慡崙)] (摿暿島墘) 旕彫嵶朎攛偑傫偺暘巕昗揑帯椕偲柶塽椕朄. 桺栘崕旻 (屇媧婍撪): 戞22夞擔杮娻帯椕妛夛傾僢僾僨乕僩嫵堢僐乕僗 (2021/6/19), Web奐嵜.
722085. [妛夛 (慡崙)] (僔儞億僕僂儉) With Corona慜屻偱偺摉堾婥娗巟嬀専嵏偺曄壔. 暉堜朁栫1, 嶳揷孫棞1, 彫孖柧恖1, 婽揷杻嵤幚1, 敧忋桳棦1, 慮崻塸擵1, 悪揷宨桟, 彫栰懽暯1, 彫郪婱桾1, 擁尨惌堦榊1, 妡愳枹婓巕1, 妢搰恀巙1, 堜愳丂憦1, 墶応惓揟2, 嶰摗丂媣3, 媣曐揷彑2, 桺栘崕旻1 (1屇媧婍撪, 2堛椕塹惗妛晹, 3娕岇妛晹): 戞44夞擔杮屇媧婍撪帇嬀妛夛妛弍廤夛 (2021/6/24), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723193. [妛夛 (慡崙)] (堦斒島墘) EGFR堚揱巕曄堎梲惈旕彫嵶朎攛娻姵幰傊偺傾僼傽僠僯僽帯椕偵偮偄偰偺専摙. 敧忋桳棟1, 堜愳丂憦1, 彫栰懽暯1, 妡愳枹婓巕1, 妢搰恀巙1, 暉堜朁栫1, 嶰摗丂媣2, 媣曐揷彑3, 嵅乆栘帯堦榊1,4, 桺栘崕旻1 (1屇媧婍撪, 2娕岇妛晹, 3堛椕塹惗妛晹, 4怴悽婭堛椕丒墶抐揑堛椕): 戞61夞擔杮屇媧婍妛夛妛弍島墘夛 (2021/4/23), 搶嫗 (僴僀僽儕僢僪奐嵜).
723194. [妛夛 (慡崙)] (堦斒島墘) 娫幙惈攛墛偑愭峴偟偨峈Signal recognition particle (SRP) 峈懱梲惈夡巰惈嬝墛偺堦椺. 擁杮棾栫, 壀怷丂宒, 憹郪孾懢, 挬憅悞摽, 恗壢丂捈, 拞敨惓懢榊, 愇堜丂惤, 桺栘崕旻1, 暉塱嫽堧 (1屇媧婍撪): 戞61夞擔杮屇媧婍妛夛妛弍島墘夛 (2021/4/23), 搶嫗 (僴僀僽儕僢僪奐嵜).
723195. [妛夛 (慡崙)] (堦斒島墘) 攛娻偵偍偗傞僼僐僔儖壔偺惂屼婡峔媦傃婡擻夝愅. 憹郪孾懢, 埨揷峗擵, 悪塝桰婤, 徏揷岤巙, 峕杮丂宩, 帥堜廏庽, 昹杮弮巕, 壛愳巙捗巕, 峳堜戝曘, 嵅摗丂悞1, 嶁杮嫓塅, 枛徏丂惤, 暃搰尋憿, 暉塱嫽堧 (1屇媧婍撪): 戞61夞擔杮屇媧婍妛夛妛弍島墘夛 (2021/4/23), 搶嫗 (僴僀僽儕僢僪奐嵜).
723196. [妛夛 (慡崙)] (堦斒島墘) 嵞敪彫嵶朎攛娻偵懳偡傞擇師帯椕偵偍偗傞僾儔僠僫暪梡壔妛椕朄偺桳岠惈偺専摙: 儊僞夝愅偲僔僗僥儅僥傿僢僋丒儗價儏乕. 杧撪峃暯, 嵅摗丂悞1, 岺栰弐庽, 崅栘庻恖, 壀揷恀旻, 釼摗嵤壞, 暉搰婱戝, 幝嶈懢榊, 層扟弐庽, 岝愇昷巎, 悪尨丂夣, 抾尨朁岹, 抮懞扖擵夘, 帥堜廏庽, 埨揷峗擵, 愳揷堦榊, Charles A Powell, 暉塱嫽堧, 暃搰尋憿 (1屇媧婍撪): 戞61夞擔杮屇媧婍妛夛妛弍島墘夛 (2021/4/23), 搶嫗 (僴僀僽儕僢僪奐嵜).
723197. [妛夛 (慡崙)] (堦斒島墘) 摉堾偱偺ROS1梈崌堚揱巕梲惈攛娻偺宱尡. 壀揷恀旻, 抮懞扖擵夘, 嵅摗丂悞1, 拞愳尨尗椇, 嫶岥悈梩, 釼摗嵤壞, 暉搰婱戝, 幝嶈懢榊, 杧撪峃暯, 悪尨丂夣, 岝愇昷巎, 層扟弐庽, 抾尨朁岹, 帥堜廏庽, 埨揷峗擵, 愳揷堦榊, 暃搰尋憿, 暉塱嫽堧 (1屇媧婍撪): 戞61夞擔杮屇媧婍妛夛妛弍島墘夛 (2021/4/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
723198. [妛夛 (慡崙)] (堦斒島墘) 恌抐偍傛傃姶庴惈専嵏栚揑偵嬊強杻悓壓嫻峯嬀専嵏傪峴偭偨寢妀惈嫻枌墛偺椪彴揑専摙. 彫孖柧恖1, 彫郪婱桾1, 嶰摗丂媣2, 嶳揷孫棞1, 婽揷杻嵤旤1, 敧忋桳棦1, 擁尨惌堦榊1, 尨揷恀栫3, 暉堜朁栫1, 堜愳丂憦1, 墶応惓揟4, 曅嬎恀恖4, 桺栘崕旻1 (1屇媧婍撪, 2娕岇妛晹, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): 戞61夞擔杮屇媧婍妛夛妛弍島墘夛 (2021/4/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
723199. [妛夛 (慡崙)] (堦斒島墘) 恑峴鋁娻偺醬捝偵懳偟偰巤愝娫楢実偵傛傝暊峯恄宱憄僽儘僢僋傪峴偭偰醬捝僐儞僩儘乕儖傪摼偨堦椺. 堥栰塱埶, 愳嶈桼壺, 嵅摗丂悞1, 崅嫶傒側傒, 彫郪桳婸, 奜墍栱惗, 晜揷惞巕, 椦丂杸栯 (1屇媧婍撪): 戞26夞擔杮娚榓堛椕妛夛妛弍戝夛 (2021/6/18), 墶昹.
723200. [妛夛 (慡崙)] (堦斒島墘) 恑峴攛偑傫姵幰媦傃壠懓偑書偊傞栤戣偵懳偡傞僗僋儕乕僯儞僌偲娚榓働傾偺庢傝慻傒. 晜揷惞巕, 嵅摗丂悞1, 憗愳捈巕, 奓捤媂庽1, 埳摗峅婭1, 壛峴弤巕, 墫尒揘栫, 嫶岥悈梩, 崅嫶傒側傒, 愳嶈桼壺, 彫郪桳婸, 堥栰塱埶 (1屇媧婍撪): 戞26夞擔杮娚榓堛椕妛夛妛弍戝夛 (2021/6/18), 墶昹.
723201. [妛夛 (慡崙)] (堦斒島墘) 婥娗巟嬀専嵏偱CPPA媦傃ABPA偺恌抐偵帄偭偨堦椺. 慮崻塸擵1, 嶰摗丂媣2, 彫栰懽暯1, 拞栰恀惗恖1, 愒郪桰婓1, 彫孖柧恖1, 嶳揷孫棞1, 婽揷杻嵤幚1, 悪揷宨桟, 彫郪婱桾1, 尨揷恀栫3, 擁尨惌堦榊1, 妡愳枹婓巕1, 妢搰恀巙1, 暉堜朁栫1, 堜愳丂憦1, 媣曐揷彑4, 桺栘崕旻1 (1屇媧婍撪, 2娕岇妛晹, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): 戞44夞擔杮屇媧婍撪帇嬀妛夛妛弍廤夛 (2021/6/24-7/30) 柤屆壆 (僴僀僽儕僢僪奐嵜).
723202. [妛夛 (慡崙)] (堦斒島墘) 憗婜攛態娻姵幰偵偍偗傞NAP1L1敪尰偺梊屻梊應儅乕僇乕偲偟偰偺桳梡惈偵偮偄偰. 挿墫丂椇1, 媭捗桳婭1, 堜愳丂憦2, 擁尨惌堦榊2, 桺栘崕旻2, 嵅摗擵弐3, 堦屗徆柧4, 懞塤朏庽4, 嶰巬丂怣4, 嵅摗梇堦1 (1堛椕塹惗妛晹, 2屇媧婍撪, 3屇媧婍奜, 4昦棟): 戞72夞擔杮揹婥塲摦妛夛憤夛 (2021/7/15), Web奐嵜.
723203. [妛夛 (慡崙)] (堦斒島墘) 旕彫嵶朎攛偑傫偵偍偗傞弍屻曗彆壔妛椕朄岠壥梊應儅乕僇乕偲偟偰偺TRAP1偺桳梡惈偵偮偄偰. 媭捗桳婭1, 堜愳丂憦2, 擁尨惌堦榊2, 桺栘崕旻2, 搚壆峠弿1, 嵅摗擵弐3, 堦屗徆柧4, 懞塤朏庽4, 嶰巬丂怣4, 嵅摗梇堦1, 挿墫丂椇1 (1堛椕塹惗妛晹, 2屇媧婍撪, 3屇媧婍奜, 4昦棟)戞72夞擔杮揹婥塲摦妛夛憤夛 (2021/7/16), Web奐嵜.
723204. [妛夛 (慡崙)] (堦斒島墘) 攛態娻偺彫嵶朎娻揮壔偵FGF9偑娭梌偡傞. 昹杮弮巕, 埨揷峗擵, 愇壀岹懢, 帥堜廏庽, 峕杮丂宩, 嶰杚岾戙, 峳堜戝曘, 憹郪孾懢, 愳揷堦榊, 桺栘崕旻1, 搚尨堦嵠, 彫椦丂恑, 壨栰棽巙, 暃搰尋憿 (1屇媧婍撪): 戞80夞擔杮娻妛夛妛弍憤夛 (2021/10/1), 墶昹 (僴僀僽儕僢僪奐嵜).
723205. [妛夛 (慡崙)] (堦斒島墘) 娫幙惈攛墛崌暪恑峴旕彫嵶朎攛娻姵幰偵懳偡傞2師壔妛椕朄偵偮偄偰偺専摙. 嵶扟恀巌1, 堜愳丂憦1, 崅憅丂峎, 嶳揷孫棞1, 婽揷杻嵤旤1, 慮崻塸擵1, 彫栰懽暯1, 彫郪婱桾1, 尨揷恀栫2, 擁尨惌堦榊1, 妢搰恀巙1, 妡愳枹婓巕1, 拞尨慞楴1, 嵅摗丂悞1, 嶰摗丂媣3, 墶応惓揟4, 媣曐揷彑4, 曅嬎恀恖, 嵅乆栘帯堦榊1,5, 桺栘崕旻1 (1屇媧婍撪, 2戝妛堾堛椕宯尋媶壢, 3娕岇妛晹, 4堛椕塹惗妛晹, 5怴悽婭堛椕丒墶抐揑堛椕): 戞62夞擔杮攛娻妛夛妛弍廤夛 (2021/11/26), 墶昹.
723206. [妛夛 (慡崙)] (堦斒島墘) EchoTip ProCore (Ecotip) 偍傛傃modified slow-pull朄 (MSP) 傪梡偄偨EBUS-TBNA偺専摙: 嵟廔曬崘. 媨嶈榓恖, 幠丂丂埢, 垻壨徆帯, 郷愳樞夘, 扟岥桭棟, 嶰妏桽惗, 忋尒梩巕, 壓愳峆惗, 桺栘崕旻1, 壀杮峗柧 (1屇媧婍撪): 戞62夞擔杮攛娻妛夛妛弍廤夛 (2021/11/28), 墶昹.
723207. [妛夛 (慡崙)] (堦斒島墘) MET exon 14 skipping梲惈攛態娻偵懳偟偰僇僾儅僠僯僽偱娫幙惈攛墛傪惗偠, 夵慞屻僥億僠僯僽傪搳梌偟偨堦椺. 嶳杮峗婱1, 嫶岥悈梩, 嵅摗丂悞1, 郷绮寬懡, 崃绯塸柧1, 埳摗峅婭1, 壛峴弤巕, 墫尒揘栫 (1屇媧婍撪): 戞62夞擔杮攛娻妛夛妛弍廤夛 (2021/11/27), 墶昹.
723208. [妛夛 (慡崙)] (堦斒島墘) FGF9偵傛傞攛態娻偺彫嵶朎娻壔偵娭偡傞専摙. 愇壀岹懢, 埨揷峗擵, 昹杮弮巕, 帥堜廏庽, 峳堜戝曘, 愵栰孿巕, 扟丂揘晇, 憹郪孾懢, 恀撶堐巙, 幝嶈懢榊, 岝愇昷巎, 層扟弐庽, 暉搰婱戝, 抮懞扖擵夘, 愳揷堦榊, 桺栘崕旻1, 戝捤丂悞, 熐懞彯惗, 暃搰尋憿, 暉塱嫽堧 (1媧婍撪): 戞62夞擔杮攛娻妛夛妛弍廤夛 (2021/11/28), 墶昹.
723209. [妛夛 (慡崙)] (堦斒島墘) A rP2 study comparing Nivo with CBDCA-PEM for EGFRm NSCLC acquired TKI-resistance not due to T790M (WJOG8515L). 拞懞丂撝, 椦丂廏晀, 忋懞崉戝, 岝壀栁庽, 埳摗寬懢榊, 撪揷弮擇, 揷懞梞曘, 娾杮峃抝, 壂丂徆塸, 杒墍丂憦, 挿扟愳婌堦, 媣曐徍恗, 桺栘崕旻1, 抮揷丂宒, 搉绮宨柧, 愮梩峃宧, 嶁堜榓巕, 惣旜榓恖, 嶳杮怣擵, 拞愳榓旻 (1屇媧婍撪): 戞19夞擔杮椪彴庮釃妛夛妛弍廤夛 (2022/2/17), 嫗搒 (僴僀僽儕僢僪奐嵜).
723210. [妛夛 (慡崙)] (堦斒島墘) Longitudinal evaluation of prognostic understanding and its associated factors in patients with advanced lung cancer. 峳堜戝曘, 嵅摗丂悞1, 拠抧堦榊, 摗郪戝曘, 抾撪杻棦, 嵅摗懽寷, 愳揷堦榊, 埨揷峗擵, 抮懞扖擵夘, 帥堜廏庽, 堜忋丂戩, 拞懞庣抝, 彫嶳揷媑岶, 帥搱丂婤, 嵅嶳岹堦, 釼摗巎晲, 嶁姫暥梇, 桺栘崕旻1, 暉塱嫽堧, 暃搰尋憿 (1屇媧婍撪): 戞19夞擔杮椪彴庮釃妛夛妛弍廤夛 (2022/2/19), 嫗搒 (僴僀僽儕僢僪奐嵜).
723211. [妛夛 (慡崙)] (堦斒島墘) Change in plasma level of damage-associated molecular patterns due to chemoradiotherapy in locally advanced NSCLC. 拞尨慞楴1, 嵵摗弔梞, 峠業丂戱, 昘幒廏抦, 桺栘崕旻1, 嶚揷揘楴 (1屇媧婍撪): 戞19夞擔杮椪彴庮釃妛夛妛弍廤夛 (2022/2/17-19), 嫗搒 (僴僀僽儕僢僪奐嵜).
733062. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 儁儞僽儘儕僘儅僽偵傛傞戝挵墛偵懳偟偰僀儞僼儕僉僔儅僽偺搳梌偑桳岠偱偁偭偨1椺. 嶳揷孫棞1, 彫栰懽暯1, 憅揷戱搇1, 拞栰恀惗恖1, 愒郪桰婓1, 婽揷杻嵤幚1, 娫拞攷栫1, 慮崻塸擵1, 嵶扟恀巌1, 彫郪婱桾1, 擁尨惌堦榊1, 妢搰恀巙1, 妡愳枹婓巕1, 拞尨慞楴1, 嵅摗丂悞1, 堜愳丂憦1, 堜愳丂憦1, 嶰摗丂媣2, 嵅乆栘帯堦榊1,3, 媣曐揷彑4, 桺栘崕旻1 (1屇媧婍撪, 2娕岇妛晹, 3怴悽婭堛椕丒墶抐揑堛椕, 4堛椕塹惗妛晹): 戞190夞擔杮攛娻妛夛娭搶巟晹妛弍廤夛 (2021/7/3), Web奐嵜.
733063. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Trousseau徢岓孮傪敽偆ALK梲惈攛滸暯忋旂娻偵傾儗僋僠僯僽偑挿婜偵憈岠偟偨1椺. 憅揷戱搇1, 拞尨慞楴1, 拞栰恀惗恖1, 愒郪桰婓1, 婽揷杻嵤幚1, 嶳揷孫棞1, 彫孖柧恖1, 崃绮塸柧1, 敧忋桳棦1, 嶳杮峗婱1, 埳摗峅婭1, 娫拞攷栫1, 奓捤愰庽1, 慮崻塸擵1, 嵶扟恀巌1, 彫栰懽暯1, 彫郪婱桾1, 尨揷恀栫2, 擁尨惌堦榊1, 妢搰恀巙1, 妡愳枹婓巕1, 嵅摗丂悞1, 堜愳丂憦1, 墶応惓揟3, 嶰摗丂媣4, 嵅乆栘峗堦榊1,5, 媣曐揷彑3, 曅嬎恀恖3, 嶰巬丂怣6, 桺栘崕旻1 (1屇媧婍撪, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹, 4娕岇妛晹, 5怴悽婭堛椕丒墶抐揑堛椕, 6昦棟): 戞190夞擔杮攛娻妛夛娭搶巟晹妛弍廤夛 (2021/7/3), Web奐嵜.
733064. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 彫嵶朎攛娻傊偺揮壔傪擣傔, 嵞惗専傪孞傝曉偟帯椕愴棯傪棫偰傞帠偱挿婜惗懚傪摼偨EGFR梲惈攛態娻偺堦椺. 愒郪桰婓1, 拞尨慞楴1, 拞栰恀惗恖1, 憅揷戱搇1, 婽揷杻嵤幚1, 嶳揷孫棞1, 彫孖柧恖1, 崃绮塸柧1, 敧忋桳棦1, 嶳杮峗婱1, 埳摗峅婭1, 娫拞攷栫1, 奓捤愰庽1, 慮崻塸擵1, 嵶扟恀巌1, 彫栰懽暯1, 彫郪婱桾1, 尨揷恀栫2, 擁尨惌堦榊1, 妢搰恀巙1, 妡愳枹婓巕1, 嵅摗丂悞1, 堜愳丂憦1, 墶応惓揟3, 嶰摗丂媣4, 嵅乆栘帯堦榊1,5, 媣曐揷彑3, 曅嬎恀恖3, 桺栘崕旻1, 嶰巬丂怣6 (1屇媧婍撪, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹, 4娕岇妛晹, 5怴悽婭堛椕丒墶抐揑堛椕, 6昦棟): 戞247夞擔杮屇媧婍妛夛娭搶抧曽夛 (2021/11/6), 廐梩尨 (僴僀僽儕僢僪奐嵜).
撪暘斿戙幱撪壢妛
[妛弍榑暥]
110236. [尨挊] The effectiveness of growth hormone replacement on energy expenditure and body composition in patients with adult growth hormone deficiency. Momozono A1, Hayashi A1, Takano K1, Shichiri M1: Endocr J 2021/4; 68 (4): 469-75. (搷墍丂柧1, 椦丂揘斖1, 崅栰岾楬1, 幍棦崃媊1: 1撪暘斿戙幱撪)
110237. [尨挊] Circulating prorenin: its molecular forms and plasma concentrations. Fujimoto K1, Kawamura S1, Bando S2, Kamata Y1, Kodera Y, Shichiri M1: Hypertension Research 2021/6; 44 (6): 674-84. (摗杮榓幚1, 愳懞嵐桭婓1, 嶁搶丂宒2, 姍揷桾擇1, 幍棦崃媊1: 1撪暘斿戙幱撪, 2戝妛堾堛椕宯尋媶壢)
110238. [尨挊] Effects of luseogliflozin on the secretion of islet hormones and incretins in patients with type 2 diabetes. Bando S1, Ichikawa R2, Taguchi T2, Fujimoto K2, Motomiya T, Taguchi M, Takano K2, Shichiri M2, Miyatsuka T2: Endocr J 2022/6; 69 (6): 681-7. (嶁搶丂宒1, 巗愳棆巘2, 揷岥丂朁2, 摗杮榓幚2, 崅栰岾楬2, 幍棦崃媊2, 媨捤丂寬2: 1戝妛堾堛椕宯尋媶壢, 2撪暘斿戙幱撪)
110239. [尨挊] Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia. Hayashi A1, Shimizu N1, Suzuki A1, Matoba K1, Momozono A1, Masaki T1, Ogawa A1, Moriguchi I, Takano K1, Kobayashi N, Shichiri M1: Diabetes Care 2021/7; 44 (7): 1647-56. (椦丂揘斖1, 惔悈弴栫1, 楅栘濄柤1, 揑応寬懢1, 搷墍丂柧1, 惓栘巏恖1, 彫愳尠巎1, 崅栰岾楬1, 幍棦崃媊1: 1撪暘斿戙幱撪)
110240. [尨挊] GIP_HUMAN[22-51] is a new proatherogenic peptide identified by native plasma peptidomics. Masaki T1, Kodera Y, Terasaki M, Fujimoto K1, Hirano T, Shichiri M1: Sci Rep 2021/7; 11 (1): 14470. (惓栘巏恖1, 摗杮榓幚1, 幍棦崃媊1: 1撪暘斿戙幱撪)
110241. [尨挊] Pill Counting in the Determination of Factors Affecting Medication Adherence in Patients with Type 2 Diabetes: A Retrospective Observational Study. Shiomi M, Kurobuchi M, Tanaka Y, Takada T1, Otori K: Diabetes Ther 2021/7; 12 (7): 1993-2005. (崅揷揘廏1: 1撪暘斿戙幱撪)
110242. [尨挊] Increased glycated albumin levels in patients with acromegaly related to glucose fluctuation caused by growth hormone excess but not albumin metabolism. Taguchi T1, Suzuki A1, Takano K1: Endocr J 2022/3; 69 (3): 225-33. (揷岥丂朁1, 楅栘濄柤1, 崅栰岾楬1: 1撪暘斿戙幱撪)
310023. [徢椺曬崘] Improved AcroQoL scores in acromegaly after sagittal split ramus osteotomy with Le Fort I osteotomy. Taguchi T1, Kimizuka S2, Takano K1: Endocrinol Diabetes Metab Case Rep 2021/4; 2021: 21-0001. (揷岥丂朁1, 孨捤岾巕2, 崅栰岾楬1: 1撪暘斿戙幱撪, 2宍惉丒旤奜)
310024. [徢椺曬崘] A case of adrenocortical adenoma harboring venous thrombus mimicking adrenal malignancy. Suzuki A1, Kamata Y1, Taguchi T1, Takano K1, Yamazaki Y, Sasano H, Shichiri M1: Endocr J 2021/7; 68 (7): 857-63. (楅栘濄柤1, 姍揷桾擇1, 揷岥丂朁1, 崅栰岾楬1, 幍棦崃媊1: 1撪暘斿戙幱撪)
522056. [島嵗]亂悽奅偺堛妛帍偐傜亃2宆摐擜昦姵幰傊偺廡1夞僀儞僗儕儞惢嵻寣摐崀壓嶌梡偲埨慡惈偼1擔1夞偲摨摍. 椦丂揘斖 (撪暘斿戙幱撪): The Mainichi Medical Journal 2021; 17 (2): 50.
[挊丂彂]
620069. [妛弍彂 (暘扴幏昅)]亂昦婥偲偔偡傝2021 婎慴偲幚慔 Expert's Guide (栻嬊2021擭憹姧Vol.72 No.4)亃7 戙幱撪暘斿宯偺昦婥偲偔偡傝丂A 戙幱宯幘姵丂摐擜昦 (崌暪徢傪娷傓), p.902-17. 椦丂揘斖1, 幍棦崃媊1 (1撪暘斿戙幱撪), 撿嶳摪, 搶嫗, 2021/4敪峴.
620070. [妛弍彂 (暘扴幏昅)]亂擠晈偺摐戙幱堎忢 恌椕丒娗棟儅僯儏傾儖 戞3斉亃II 擠怭拞偺娗棟丂11. 寣摐帺屓應掕 (SMBG) 偲偼壗偱偡偐?, p.94-7. 12. 寣摐帺屓應掕 (SMBG) 偺偲偒, 婥傪晅偗傞偙偲偼?, p.98-100. 巗愳棆巘 (撪暘斿戙幱撪), 曇: 擔杮摐擜昦丒擠怭妛夛, 儊僕僇儖價儏乕幮, 搶嫗, 2021/12敪峴.
620071. [妛弍彂 (暘扴幏昅)]亂偍栻棫偪BOOK2022丂夝朥惗棟丒昦懺惗棟偐傜栻妛娗棟傊 (栻嬊2022擭憹姧Vol. 73 No.4)亃仭戙幱宯, 撪暘斿幘姵丂30. 摐擜昦 (1宆摐擜昦, 2宆摐擜昦, 擠怭摐擜昦, 崌暪徢), p.547-61. 椦丂揘斖 (撪暘斿戙幱撪), 撿嶳摪, 搶嫗, 2022/3敪峴.
[妛夛丒尋媶夛摍]
723212. [妛夛 (慡崙)] (堦斒島墘) 摉堾偱恌抐丒帯椕偟偨峛忬態僋儕乕僛偺椪彴揑摿挜. 惎嶳埢巕1, 姍揷桾擇1, 惔悈弴栫1, 楅栘峍柤1, 摗搱丂椸1, 揷岥丂朁1, 楅栘梲旻1, 惓栘巏恖1, 崅栰岾楬1 (1撪暘斿戙幱撪): 戞94夞擔杮撪暘斿妛夛妛弍憤夛 (2021/4/22), Web奐嵜.
723213. [妛夛 (慡崙)] (堦斒島墘) 僸僩寣燋儁僾僠僪儈僋僗偵傛傞僗僾儔僶僔儞桼棃怴婯惗棟妶惈儁僾僠僪偺摨掕. 揷岥丂朁1, 幍棦崃媊1 (1撪暘斿戙幱撪): 戞94夞擔杮撪暘斿妛夛妛弍憤夛 (2021/4/22-24), Web奐嵜, 擔杮撪暘斿妛夛嶨帍, 2021/4; 97 (1): 229.
723214. [妛夛 (慡崙)] (堦斒島墘) Basal-Bolus帯椕拞2宆摐擜昦寣塼摟愅姵幰偵偍偗傞摟愅娭楢掅寣摐儕僗僋偺専摙. 椦丂揘斖1, 惔悈弴栫1, 揑応寬懢1, 怷岥偄傇偒, 崅栰岾楬1, 彫椦捈擵, 幍棦崃媊1 (1撪暘斿戙幱撪): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20-22), Web奐嵜, 摐擜昦 2021/4; 64 (Suppl): S-241.
723215. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞僐儘僫壭偱偺摐擜昦嬞媫擖堾姵幰偺専摙. 摗搱丂椸1, 椦丂揘斖1, 捯丂丂榑1, 堦搰桼壛巕1, 懞揷廐曚, 楅栘梲旻1, 徏塝棦峕2, 姍揷桾擇1, 崅栰岾楬1, 幍棦崃媊1 (1撪暘斿戙幱撪, 2憤崌恌椕): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20-22), Web奐嵜, 摐擜昦 2021/4; 64 (Suppl): S-258.
723216. [妛夛 (慡崙)] (堦斒島墘) Sensor Augmented Pump (SAP) 椕朄拞偺1宆摐擜昦姵幰偵偍偗傞怴宆僐儘僫僂僀儖僗姶愼徢 (COVID-19) 棳峴偺塭嬁. 楅栘峍柤1, 椦丂揘斖1, 栘懞崄棦1, 彫嶃枮棦奊2, 彆愳抦巕1, 敀愳棟塱1, 巗愳棆巘1, 崅栰岾楬1, 幍棦崃媊1 (1撪暘斿戙幱撪, 2憤崌恌椕): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20-22), Web奐嵜, 摐擜昦 2021/4; 64 (Suppl): S-285.
723217. [妛夛 (慡崙)] (堦斒島墘) 寣塼摟愅姵幰偺TIR偼HbA1c, 僌儕僐傾儖僽儈儞偲憡娭偡傞偺偐. 惔悈弴栫1, 椦丂揘斖1, 淎悾惓弐1, 彫揷丂宒1, 搚婒戩栫2, 彫愳尠巎1, 怷岥偄傇偒, 彫椦捈擵, 崅栰岾楬1, 幍棦崃媊1 (1撪暘斿戙幱撪, 2憤崌恌椕): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20-22), Web奐嵜, 摐擜昦 2021/4; 64 (Suppl): S-320.
723218. [妛夛 (慡崙)] (堦斒島墘) 寣塼摟愅姵幰偵偍偗傞CGM偲FGM偱傒偨TIR偺嵎偺専摙. 揑応寬懢1, 椦丂揘斖1, 惓栘巏恖1, 愳懞嵐桭婓1, 嶁搶丂宒2, 怷岥偄傇偒, 彫椦捈擵, 崅栰岾楬1, 幍棦崃媊1 (1撪暘斿戙幱撪, 2戝妛堾堛椕宯尋媶壢): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20-22), Web奐嵜, 摐擜昦 2021/4; 64 (Suppl): S-321.
723219. [妛夛 (慡崙)] (堦斒島墘) 摐擜昦惈恡徢嫵幒庴島幰偵偍偗傞寣塼摟愅摫擖偵帄傞徢椺偺摿挜. 楅栘梲旻1, 椦丂揘斖2, 庣壆払旤3 (1撪暘斿戙幱撪, 2椪専妛, 3寬峃娗棟僙): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20-22), Web奐嵜.
723220. [妛夛 (慡崙)] (堦斒島墘) CGM偵傛傞2宆摐擜昦寣塼摟愅姵幰偺寣摐摦懺偺夝柧: 摟愅娭楢掅寣摐偺昿搙偲偦偺椪彴揑摿挜偲偼? 椦丂揘斖1, 惔悈弴栫1, 楅栘峍柤1, 揑応寬懢1, 搷墍丂柧1, 惓栘巏恖1, 彫愳尠巎1, 怷岥偄傇偒, 崅栰岾楬1, 彫椦捈擵, 幍棦崃媊1 (1撪暘斿戙幱撪): 戞36夞擔杮摐擜昦崌暪徢妛夛丒戞27夞擔杮摐擜昦娽妛夛憤夛 (2021/10/8-9), 帬夑 (僴僀僽儕僢僪奐嵜), 摐擜昦崌暪徢 2021/9; 35 (Suppl): 232.
723221. [妛夛 (慡崙)] (堦斒島墘) 摉堾偱恌抐丒帯椕偟偨峛忬態僋儕乕僛偺椪彴揑摿挜. 惎嶳埢巕1, 姍揷桾擇1, 惔悈弴栫1, 楅栘峍柤1, 摗搱丂椸1, 揷岥丂朁1, 楅栘梲旻1, 惓栘巏恖1, 巗愳棆巘1, 崅栰岾楬1 (1撪暘斿戙幱撪): 戞64夞擔杮峛忬態妛夛妛弍廤夛 (2021/11/18-20), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮撪暘斿妛夛嶨帍 2021; 97 (5): 1132.
723222. [妛夛 (慡崙)] (堦斒島墘) RIA朄偲CLEIA朄偵偍偗傞寣燋傾儖僪僗僥儘儞擹搙偺憡娭惈偺専摙. 彫揷丂宒1, 揷岥丂朁1, 惎嶳埢巕1, 楅栘梲旻1, 惓栘巏恖1, 巗愳棆巘1, 姍揷桾擇1, 崅栰岾楬1 (1撪暘斿戙幱撪): 戞31夞椪彴撪暘斿戙幱Update (2021/11/26-27), 戝嶃 (僴僀僽儕僢僪奐嵜), 擔杮撪暘斿妛夛嶨帍 2021; 97 (2): 537.
723223. [妛夛 (慡崙)] (堦斒島墘) 曅懁暃恡揈弌傪峴偭偨ACTH旕埶懚惈戝寢愡惈暃恡旂幙夁宍惉偺1椺. 戝敥峃岹1, 崅揷揘廏1, 栘懞崄棦1, 堦搰桼壛巕1, 捯丂丂桜1, 摗揷揘晇2 (1撪暘斿戙幱撪, 2斿擜婍): 戞31夞椪彴撪暘斿戙幱Update (2021/11/26-27), 戝嶃 (僴僀僽儕僢僪奐嵜).
723224. [妛夛 (慡崙)] (堦斒島墘) 愭抂嫲晐徢偺偨傔SMBG傪梡偄偨寣摐娗棟偑偱偒偢帺戭擜摐應掕偱娗棟偟偨GDM偺堦椺. 埳搶偟偍傝1, 巗愳棆巘1, 惵栘丂掦1, 彫揷丂宒1, 崅栰岾楬1, 媨捤丂寬1 (1撪暘斿戙幱撪): 戞37夞擔杮摐擜昦丒擠怭妛夛擭師妛弍廤夛 (2021/11/27-28), 戝嶃 (僴僀僽儕僢僪奐嵜), 摐擜昦偲擠怭 2021; 21 (3): 92.
723225. [妛夛 (慡崙)] (堦斒島墘) isCGM (娫焄僗僉儍儞幃帩懕寣摐應掕) 偲怘帠娗棟傾僾儕傪梡偄偨擠怭摐擜昦娗棟. 椦丂揘斖 (撪暘斿戙幱撪): 戞37夞擔杮摐擜昦丒擠怭妛夛擭師妛弍廤夛 (2021/11/27-28), 戝嶃 (僴僀僽儕僢僪奐嵜), 摐擜昦偲擠怭 2021; 21 (3): 95.
723226. [妛夛 (慡崙)] (堦斒島墘) isCGM (娫焄僗僉儍儞幃帩懕寣摐應掕) 偲怘帠娗棟傾僾儕偵傛傞擠怭摐擜昦偺屄暿壔塰梴巜摫. 椦丂揘斖1, 嶳郪桰巕2, 恖尒杻旤巕2, 惔悈弴栫1, 摗搱丂椸1, 楅栘峍柤1, 揑応寬懢1, 楅栘梲旻1, 庣壆払旤3, 媨捤丂寬1 (1撪暘斿戙幱撪, 2塰梴晹, 3寬峃娗棟僙): 戞24夞丒戞25夞擔杮昦懺塰梴妛夛擭師妛弍廤夛 (2022/1/28-30), 嫗搒 (僴僀僽儕僢僪奐嵜), 擔杮昦懺塰梴妛夛帍 2022; 24/25 (Suppl): S-32.
723227. [妛夛 (慡崙)] (堦斒島墘) 摐擜昦惈恡徢偺寣塼摟愅摫擖抶墑偵懳偡傞懡怑庬僠乕儉堛椕偑傛傝岠壥傪敪婗偡傞偨傔偺怑庬偺慻傒崌傢偣. 楅栘梲旻1, 椦丂揘斖1, 恖尒杻旤巕2, 媨捤丂寬1, 庣壆払旤3 (1撪暘斿戙幱撪, 2塰梴晹, 3寬峃娗棟僙): 戞24夞丒戞25夞擔杮昦懺塰梴妛夛擭師妛弍廤夛 (2022/1/28-30), 嫗搒 (僴僀僽儕僢僪奐嵜), 擔杮昦懺塰梴妛夛帍 2022; 24/25 (Suppl): S-36.
723228. [妛夛 (慡崙)] (堦斒島墘) 2宆摐擜昦姵幰偵偍偗傞惗懱揹婥僀儞僺乕僟儞僗朄偵傛傞懱慻惉偺専摙. 墫尒傔偖傒, 惣嶳郰旤, 怷丂恀婓, 崅揷揘廏1, 旜捁彑栫 (1撪暘斿戙幱撪): 擔杮栻妛夛戞142擭夛 (2022/3/25), Web奐嵜.
733065. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 壓妠慜撍傪桳偡傞愭抂嫄戝徢姵幰偵懳偟偰, 忋壓妠崪崪愗傝弍傪峴偄AcroQoL僗僐傾偑夵慞偟偨堦椺. 攱尨丂榡1, 揷岥丂朁1, 惎嶳埢巕1, 楅栘梲旻1, 惓栘巏恖1, 巗愳棆巘1, 姍揷桾擇1, 孨捤岾巕2, 崅栰岾楬1 (1撪暘斿戙幱撪, 2宍惉丒旤奜): 戞22夞擔杮撪暘斿妛夛娭搶峛怣墇巟晹妛弍廤夛 (2021/9/24-25), Web奐嵜, 擔杮撪暘斿妛夛嶨帍, 2021; 97 (4): 779.
733066. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 2宆摐擜昦摟愅姵幰偵偍偄偰time in range偼壗傪帵偡偺偐? 椦丂揘斖1, 惔悈弴栫1, 楅栘峍柤1, 摗搱丂椸1, 揑応寬懢1, 怷岥偄傇偒, 彫椦捈擵, 崅栰岾楬1 (1撪暘斿戙幱撪): 戞20夞擔杮愭恑摐擜昦帯椕尋媶夛丒戞18夞1宆摐擜昦尋媶夛 (2021/11/6-7), 挿嶈 (僴僀僽儕僢僪奐嵜), 戞20夞擔杮愭恑摐擜昦帯椕尋媶夛丒戞18夞1宆摐擜昦尋媶夛僾儘僌儔儉丒彺榐廤 2021; p.58.
733067. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 2宆摐擜昦摟愅姵幰偵偍偗傞Time In Range偺堄媊. 椦丂揘斖1, 惔悈弴栫1, 楅栘峍柤1, 摗搱丂椸1, 揑応寬懢1, 怷岥偄傇偒, 崅栰岾楬1, 彫椦捈擵, 庪栰桳嶌2, 媨捤丂寬1 (1撪暘斿戙幱撪, 2椪専妛): 戞32夞擔杮摐擜昦惈恡徢尋媶夛 (2021/12/4-5), Web奐嵜, 戞32夞擔杮摐擜昦惈恡徢尋媶夛僾儘僌儔儉丒彺榐廤 2021; p.42.
733068. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 傾儀儖儅僽偵傛傝桿敪偝傟偨寑徢1宆摐擜昦偺1椺. 彫揷丂宒1, 惔悈弴栫1, 堦搰桼壛巕1, 栘懞崄棦1, 壓鑝廏憦1, 淎悾惓弐1, 崅栰岾楬1, 媨捤丂寬1 (1撪暘斿戙幱撪): 戞59夞擔杮摐擜昦妛夛娭搶峛怣墇抧曽夛 (2022/1/22), Web奐嵜.
733069. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 儕僽儗Link傪梡偄偰僀儞僗儕儞摫擖媦傃寣摐娗棟傪峴偭偨擠怭拞偺柧傜偐側摐擜昦偺1椺. 攱尨丂榡1, 揑応寬懢1, 惵栘丂掦1, 椦丂揘斖1, 崅栰岾楬1, 媨捤丂寬1 (1撪暘斿戙幱撪): 戞59夞擔杮摐擜昦妛夛娭搶峛怣墇抧曽夛 (2022/1/22), Web奐嵜.
733070. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 栻嵻惈傕媈傢傟傞摐擜昦惈働僩傾僔僪乕僔僗偺堦椺. 捯丂丂桜1, 堦搰桼壛巕1, 栘懞崄棦1, 戝敥峃峀1, 崅揷揘廏1 (1撪暘斿戙幱撪): 戞59夞擔杮摐擜昦妛夛娭搶峛怣墇抧曽夛 (2022/1/22), Web奐嵜.p
恡憻撪壢妛
[妛弍榑暥]
110243. [尨挊] Oral/oesophageal candidiasis is a risk factor for severe infection after kidney transplantation. Abe T1, Futamura K, Goto N, Ohara K, Ogasa T, Tomosugi T, Okada M, Hiramitsu T, Narumi S, Watarai Y: Nephrology (Carlton) 2022/1; 27 (1): 97-103. (垻晹揘栫1: 1恡憻撪)
110244. [尨挊] Endothelial ganglioside GM3 regulates angiogenesis in solid tumors. Suzuki M, Nagane M, Kato K, Yamauchi A, Shimizu T, Yamashita H, Aihara N, Kamiie J, Nagako Kawashima N1, Naito S1, Yamashita T: Biochem Biophys Res Commun 2021/9; 569: 10-6. (愳搰塱巕1, 撪摗惓媑1: 1恡憻撪)
110245. [尨挊] The relationship between podocytopathy and periglomerular fibrosis. Kamata F1, Naito S2, Kawashima N2, Takeuchi Y2: Kitasato Med J 2022/3; 52 (2): 1-11. (姍揷晣旤1, 撪摗惓媑2, 愳搰塱巕2, 抾撪峃梇2: 1戝妛堾堛椕宯尋媶壢, 2恡憻撪)
310025. [徢椺曬崘] Long-term clinical course of immunotactoid glomerulopathy complicated with diffuse large B-cell lymphoma. Takahashi H1, Sano T1, Kawamura S1, Sano K1, Miyasaka R1, Yamazaki T1, Sakakibara M1, Abe T1, Hashimoto K1, Nagaoka M1, Kamata M1, Naito S1, Aoyama T1, Moriya R2, Takeuchi Y1: CEN Case Rep 2022/5; 11 (2): 184-90. doi: 10.1007/s13730-021-00648-0. Epub 2021 Sep 26. (崅嫶丂梱1, 嵅栰丂棽1, 愳懞嵐桼旤1, 嵅栰宨巕1, 媨嶁棾攏1, 嶳嶈戱栫1, 嶅尨杻桭巕1, 垻晹揘栫1, 嫶杮宐巕1, 塱壀枹棃1, 姍揷恀棟巕1, 撪摗惓媑1, 惵嶳搶屲1, 庣扟棙壚2, 抾撪峃梇1: 1恡憻撪, 2堛妛嫵堢)
522057. 乽島嵗]亂嵟愭抂堛椕偺崱亃億僪僒僀僩嵶朎枌暘巕偵拝栚偟偨帯椕栻憂弌傊岦偗偰 . 撪摗惓媑1, 愳搰塱巕1 (1恡憻撪): Medical Science Digest 2022/2; 48 (2): 94-5.
540024. [偦偺懠 (尋媶曬崘彂)] 摐帀幙GM3偺僱僼儕儞丒儕儞巁壔惂屼婡峔傪棙梡偟偨憙忬巺媴懱峝壔徢偺帯椕朄偺妋棫. 愳搰塱巕1, 撪摗惓媑1, 崅栰桬懢2, 拠嶳尗堦3 (1恡憻撪, 2杒奀摴戝妛揹巕壢妛尋媶強, 3嶻嬈媄弍憤崌尋媶強): 壢妛尋媶旓彆惉帠嬈僨乕僞儀乕僗 (擔杮妛弍怳嫽夛) 2022/3.
[妛夛丒尋媶夛摍]
722086. [妛夛 (慡崙)] (僔儞億僕僂儉) 杒棦戝妛昦堾偵偍偗傞專恡懸婡姵幰偺尰忬偲栤戣揰乣堏怉撪壢堛偺帇揰偐傜乣. 垻晹揘栫1, 愇堜戝曘2, 媑揷堦惉2,3, 抾撪峃梇1 (1恡憻撪, 2斿擜婍, 3怴悽婭堛椕丒愭抂堛椕): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮摟愅堛妛夛嶨帍 2021/5; 54 (Suppl 1): 234.
723229. [妛夛 (慡崙)] (堦斒島墘) COVID-19傪敪徢偟偨摐擜昦崌暪崅楊堐帩摟愅姵幰偺1椺. 撪摗惓媑1, 愳懞嵐桼旤1, 榓揷払旻2, 嶳嶈戱栫1, 媨嶁棾攏1, 嵅栰宨巕1, 嶅尨杻桭巕1, 崅嫶丂椛1, 塱壀枹棃1, 惵嶳搶屲1, 嵅栰丂棽1, 崅嶳梲巕3, 抾撪峃梇1 (1恡憻撪, 2銹尨昦丒姶愼撪, 3怴悽婭堛椕丒墶抐揑堛椕): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/3), 墶昹 (僴僀僽儕僢僪奐嵜).
723230. [妛夛 (慡崙)] (堦斒島墘) 恡堏怉屻岥峯/怘摴僇儞僕僟徢偼廳徢姶愼徢偺梊應場巕偱偁傞. 垻晹揘栫1, 戝尨婓戙旤, 擇懞寬懢, 彫妢戝婲, 桭悪弐塸, 壀揷丂妛, 暯岝崅媣, 屻摗寷旻, 柭奀弐帯, 搉堜帄旻 (1恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/3), 墶昹 (僴僀僽儕僢僪奐嵜).
723231. [妛夛 (慡崙)] (堦斒島墘) 崅峈懱壙ANCA娭楢寣娗墛 (AAV) 偵懳偟慖戰揑寣燋岎姺 (Selective PE) 傪巤峴偟偨堦椺. 搰揷朏棽1,2, 挿応丂懽1,2, 峕尨偐偍傝1,2, 抾撪峃梇2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮摟愅堛妛夛嶨帍 2021/5; 54 (Suppl 1): 486.
723232. [妛夛 (慡崙)] (堦斒島墘) MPO-ANCA偲峈GBM峈懱摨帪梲惈RPGN偵懳偟慖戰揑寣燋岎姺傪峴偆傕堐帩摟愅偲側偭偨堦椺. 峕尨偐偍傝1,2, 搰揷朏棽1,2, 挿応丂懽1,2, 峕尨怣擵夘1, 栰乆岥攷巎1, 抾撪峃梇2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮摟愅堛妛夛嶨帍 2021/5; 54 (Suppl 1): 520.
723233. [妛夛 (慡崙)] (堦斒島墘) Alb抲姺検憹検偱憈岟偟偨慖戰揑寣燋岎姺偺1椺. 峕尨怣擵夘1, 怴堜幚墑1, 崅嫶攷媣1, 峕尨偐偍傝1,2, 搰揷朏棽1,2, 挿応丂懽1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮摟愅堛妛夛嶨帍 2021/5; 54 (Suppl 1): 487.
723234. [妛夛 (慡崙)] (堦斒島墘) 僟僀僆乕僪傪梡偄偨壓巿偺僣儗偵懳偡傞梊杊朄: 3徢椺偺曬崘. 崅嫶攷媣1, 怴堜幚墑1, 峕尨怣擵夘1, 峕尨偐偍傝1,2, 搰揷朏棽1,2, 挿応丂懽1,2, 墫嶈媣栫1 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮摟愅堛妛夛嶨帍 2021/5; 54 (Suppl 1): 440.
723235. [妛夛 (慡崙)] (堦斒島墘) 擜撆徢惈嫻枌墛偲恌抐偟僗僥儘僀僪帯椕傪峴偭偨4徢椺. 嶅尨杻桭巕1, 崅嫶丂椛1, 愳懞嵐桼旤1, 嵅栰宨巕1, 媨嶁棾攏1, 嶳嶈戱栫1, 嫶杮宐巕1, 塱壀枹棃1, 撪摗惓媑1, 惵嶳搶屲1, 嵅栰丂棽1, 抾撪峃梇1 (1恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4-6), 墶昹 (僴僀僽儕僢僪奐嵜).
723236. [妛夛 (慡崙)] (堦斒島墘) 寣塼摟愅姵幰偵崌暪偟偨Tumoral Calcinosis偵懳偟偰暃峛忬態揈弌弍偑憈岠偟偨堦椺. 愳懞嵐桼旤1, 崅嫶丂椛1, 嵅栰宨巕1, 媨嶁棾攏1, 嶳嶈戱栫1, 嶅尨杻桭巕1, 嫶杮宐巕1, 塱壀枹棃1, 撪摗惓媑1, 惵嶳搶屲1, 嵅栰丂棽1, 抾撪峃梇1 (1恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4-6), 墶昹 (僴僀僽儕僢僪奐嵜).
723237. [妛夛 (慡崙)] (堦斒島墘) 椉懁偵擜撆徢惈嫻枌墛傪敪徢偟, 僗僥儘僀僪帯椕傪峴偭偨寣塼摟愅姵幰偺1椺. 師揷撧墰1, 崅嫶丂椛1, 愳懞嵐桼旤1, 嵅栰宨巕1, 媨嶁棾攏1, 嶳嶈戱栫1, 嶅尨杻桭巕1, 嫶杮宐巕1, 塱壀枹棃1, 撪摗惓媑1, 惵嶳搶屲1, 嵅栰丂棽1, 抾撪峃梇1 (1恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4-6), 墶昹 (僴僀僽儕僢僪奐嵜).
723238. [妛夛 (慡崙)] (堦斒島墘) 摟愅摫擖婜偵尠嵼壔偟偨堓愗彍屻媧廂晄椙徢岓孮偺堦椺. 嵅栰宨巕1, 嵅栰丂棽1, 愳懞嵐桼旤1, 嶅尨杻桭巕1, 媨嶁棾攏1, 嶳嶈戱栫1, 嫶杮宐巕1, 塱壀枹棃1, 崅嫶丂椛1, 撪摗惓媑1, 惵嶳搶屲1, 抾撪峃梇1 (1恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4-6), 墶昹 (僴僀僽儕僢僪奐嵜).
723239. [妛夛 (慡崙)] (堦斒島墘) 僸僩恡惗専専懱傪梡偄偨摐帀幙GM3敪尰偺専摙. 撪摗惓媑1, 愳搰塱巕1, 愇奯捈巕, 抾撪峃梇1 (1恡憻撪): 戞64夞擔杮恡憻妛夛妛弍憤夛 (2021/6/18-20), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮恡憻妛夛帍 2022/6; 63 (4): 446.
723240. [妛夛 (慡崙)] (億僗僞乕) 堏怉恡婥庮惈恡岜恡墛傪敪徢偟偨偑堏怉恡婡擻壏懚偱偒偨1椺. 垻晹揘栫1, 抾撪峃梇1, 杒搰榓庽2, 愇堜戝曘2, 媑揷堦惉2,3, 戝尨婓戙旤, 擇懞寬懢, 彫妢戝婲, 桭悪弐塸, 壀揷丂妛, 暯岝崅媣, 屻摗寷旻, 柭奀弐帯, 搉堜帄旻 (1恡憻撪, 2斿擜婍, 3怴悽婭堛椕丒愭抂堛椕): 戞57夞擔杮堏怉妛夛憤夛 (2021/9/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
733071. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僒儖僐僀僪乕僔僗偵敽偆媫惈擜嵶娗娫幙惈恡墛偵傛傝媫惈恡晄慡傪掓偟, 僗僥儘僀僪帯椕偑憈岠偟偨堦椺. 峕尨偐偍傝1,2, 搰揷朏棽1,2, 挿応丂懽1,2, 搰揷丂敚1, 栰乆岥攷巎1, 抾撪峃梇2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2恡憻撪): 戞51夞擔杮恡憻妛夛搶晹妛弍戝夛 (2021/9/25), Web奐嵜, 擔杮恡憻妛夛帍 2021/9; 63 (6E): 728.
733072. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恡幚幙怹弫偺恌抐偑帯椕曽恓傪寛掕偟偨愡惈曈墢懷B嵶朎儕儞僷庮偺堦椺. 媨嶁棾攏1, 崅嫶丂椛1, 烴椦丂弐1, 徏揷桭崄棟1, 嶳嶈戱栫1, 嶅尨杻桭巕1, 垻晹揘栫1, 塱壀枹棃1, 姍揷恀棟巕1, 嵅栰丂棽1, 撪摗惓媑1, 惵嶳搶屲1, 抾撪峃梇1 (1恡憻撪): 戞51夞擔杮恡憻妛夛搶晹妛弍戝夛 (2021/9/25-26), Web奐嵜.
733073. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 儖乕僾僗恡墛V宆偑愭峴偟峈GBM恡墛傪崌暪偟偨1椺. 嶳嶈戱栫1, 崅嫶丂椛1, 烴椦丂弐1, 媨嶁棾攏1, 嶅尨杻桭巕1, 垻晹揘栫1, 塱壀枹棃1, 姍揷恀棟巕1, 嵅栰丂棽1, 撪摗惓媑1, 惵嶳搶屲1, 抾撪峃梇1 (1恡憻撪): 戞51夞擔杮恡憻妛夛搶晹妛弍戝夛 (2021/9/25-26), Web奐嵜.
733074. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僸僩僷儖儃僂僀儖僗B19姶愼娭楢C3恡徢偑媈傢傟偨1椺. 嶅尨杻桭巕1, 崅嫶丂椛1, 烴椦丂弐1, 媨嶁棾攏1, 嶳嶈戱栫1, 垻晹揘栫1, 塱壀枹棃1, 姍揷恀棟巕1, 嵅栰丂棽1, 撪摗惓媑1, 惵嶳搶屲1, 抾撪峃梇1 (1恡憻撪): 戞51夞擔杮恡憻妛夛搶晹妛弍戝夛 (2021/9/25-26), Web奐嵜.
733075. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉堾偵偍偗傞惉恖敪徢IgA寣娗墛偺椪彴宱夁偵偮偄偰. 嫶杮宐巕1, 嵅栰丂棽1, 愳懞嵐桼旤1, 嶅尨杻桭巕1, 媨嶁棾攏1, 嶳嶈戱栫1, 崅嫶丂椛1, 塱壀枹棃1, 撪摗惓媑1, 惵嶳搶屲1, 抾撪峃梇1 (1恡憻撪): 戞51夞擔杮恡憻妛夛搶晹妛弍戝夛 (2021/9/25-26), Web奐嵜.
733076. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怴婯枬惈恡憻昦儌僨儖摦暔偺夝愅. 嶳岥榓壴, 愳搰塱巕1, 嶳壓丂嫥, 撪摗惓媑1 (1恡憻撪): 2021擭搙杻晍戝妛廱堛妛晹廱堛妛壢懖嬈尋媶敪昞夛 (2021/11), 憡柾尨.
733077. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 廤妛揑帯椕偵傛傝媬柦偟摼偨Aeromonas hydrophila偵傛傞夡巰惈嬝枌墛偺1椺. 峕尨偐偍傝1,2, 搰揷朏棽1,2, 戝娭椇夘3, 攏応崄巕1,3, 挿応丂懽1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2恡憻撪, 3宍惉丒旤奜): 擔杮撪壢妛夛戞676夞娭搶抧曽夛 (2022/3/19), 搶嫗 (僴僀僽儕僢僪奐嵜).
'20擭搙埲慜暘
[妛弍榑暥]
'20-320001. [徢椺曬崘] 恡堏怉屻柶塽梷惂栻宲懕拞偵傕峉傢傜偢de novo捵釃惈戝挵墛傪敪徢偟偨1椺. 垻晹揘栫1, 抾撪宐旤巕2, 杒搰榓庽3, 愇堜戝曘3, 媑揷堦惉3,4, 嵅揷旤榓5, 嶳嶈戱栫1, 抾撪峃梇1 (1恡憻撪, 2柶塽, 3斿擜婍, 4怴悽婭堛椕丒愭抂堛椕, 5徚壔婍撪): 擔杮椪彴恡堏怉妛夛嶨帍 2020/12; 8 (2): 270-2.
[妛夛丒尋媶夛摍]
'20-733009. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僱僼儘乕僛徢岓孮偱敪徢偟僷儖儃僂僀儖僗B19 IgM梲惈傪敽偭偨娗撪憹怋惈恡墛偺堦椺. 嶅尨杻桭巕1, 崅嫶丂椛1, 愳懞嵐桼旤1, 嵅栰宨巕1, 嶳嶈戱栫1, 媨嶁棾攏1, 塱壀枹棃1, 撪摗惓媑1, 惵嶳搶屲1, 嵅栰丂棽1, 抾撪峃梇1, 忛丂尓曘, 嶳岥丂桾 (1恡憻撪): 戞75夞恄撧愳恡墛尋媶夛 (2021/2/20), 墶昹, 恡墛徢椺尋媶 2021; 38: 17-31.
銹尨昦丒姶愼撪壢妛
[妛弍榑暥]
110246. [尨挊] Analysis of the Time-To-Onset and Factors Affecting Clinical Outcomes of Immune Reconstitution Inflammatory Syndrome in People Living with HIV Using Data from the Japanese Spontaneous Reporting Database. Tanaka H, Wada T1, Ohyama K, Ishii T: J Pharm Pharm Sci 2021; 24: 153-60. (榓揷払旻1: 1銹尨昦磹鯎�)
[妛夛丒尋媶夛摍]
723241. [妛夛 (慡崙)] (堦斒島墘) 摉堾銹尨昦椞堟偵偍偗傞僒僀僩儊僈儘僂僀儖僗姶愼偺尰忬. 惎嶳棽峴1, 挿扟愳桋峗2, 懞徏丂彔2, 搶栰弐梞1, 嶳壀朚岹1, 崅嶳梲巕3 (1銹尨昦磹鯎�, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4-6), 墶昹 (僴僀僽儕僢僪奐嵜).
擕態丒峛忬態奜壢妛
[妛弍榑暥]
110247. [尨挊] Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study. Ishikawa T, Sakamaki K, Narui K, Nishimura H, Sangai T1, Tamaki K, Hasegawa Y, Watanabe K, Suganuma N, Michishita S, Sugae S, Aihara T, Tsugawa K, Kaise H, Taira N, Mukai H, for Comprehensive Support Project for Oncological Research of Breast Cancer: Breast 2021/4; 56: 70-7. (嶰奒婱巎1: 1擕態丒峛忬態奜)
110248. [尨挊] Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19). Aogi K, Watanabe K, Kitada M, Sangai T1, Ohtani S, Aruga T, Kawaguchi H, Fujisawa T, Maeda S, Morimoto T, Sato N, Takao S, Morita S, Masuda N, Toi M, Ohno S: Int J Clin Oncol 2021/7; 26 (7): 1229-36. (嶰奒婱巎1: 1擕態丒峛忬態奜)
110249. [尨挊] Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer. Ichinoe M, Mikami T, Yanagisawa N, Yoshida T, Hana K, Endou H, Okayasu I, Sengoku N1, Ogata H, Saegusa M2, Shibuya K, Murakumo Y2: J Clin Pathol 2021/9; 74 (9): 589-95. (愬愇婭旻1, 嶰巬丂怣2, 懞塤朏庽2: 1擕態丒峛忬態奜, 2昦棟)
110250. [尨挊] Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens. Dai MS, Feng YH, Chen SW, Masuda N, Yau T, Chen ST, Lu YS, Yap YS, Ang PCS, Chu SC, Kwong A, Lee KS, Ow S, Kim SB, Lin J, Chung HC, Ngan R, Kok VC, Rau KM, Sangai T1, Ng TY, Tseng LM, Bryce R, Bebchuk J, Chen MC, Hou MF: Breast Cancer Res Treat 2021/10; 189 (3): 665-76. (嶰奒婱巎1: 1擕態丒峛忬態奜)
522058. [島嵗]亂摿廤I: 崪悜桼棃梷惂嵶朎亃偑傫帯椕昗揑偲偟偰偺崪悜桼棃柶塽梷惂嵶朎 (MDSC). 壛摗丂峅 (擕態丒峛忬態奜): 椪彴柶塽丒傾儗儖僊乕壢 2021/7; 75 (6): 636-43.
[妛夛丒尋媶夛摍]
722087. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 庤弍壜擻側luminal擕娻偵懳偟偰偼庤弍傪愭峴偡傋偒偱偁傞. 嶰奒婱巎1, 帥揷偐偍傝 (1擕態丒峛忬態奜): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722088. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 僩儕僾儖僱僈僥傿僽擕娻偵偍偗傞ZEB1堚揱巕偺敪尰. 媏抮恀棟巕1, 戝栘宑巕2, 摗栰巎怐2, 墶揷岝墰1, 惣媨梞巎1, 壛摗丂峅1, 愬愇婭旻1, 嶰奒婱巎1 (1擕態丒峛忬態奜, 2戝妛堾堛椕宯尋媶壢):戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722089. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 媧堷幃惗専慻怐偵偍偗傞儕儞僷娗怤廝偺SN揮堏梊應場巕偲偟偰偺壜擻惈. 揷拞梪巕, 錟暲丂彑, 摗栰巎怐1, 惣媨梞巎2, 拞媨婭巕, 壀杮丂棨3, 撪摗壜撧巕3, 彫栰揷搊, 抾壓棙晇, 彫嶁桖尗, 嶰奒婱巎2 (1戝妛堾堛椕宯尋媶壢, 2擕態丒峛忬態奜, 3忋晹徚壔娗奜): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722090. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 摉堾偵偍偗傞擕娻弍屻忋巿儕儞僷晜庮敪徢姵幰偺攚宨場巕偺専 摙. 撪摗壜撧巕1, 摗栰巎怐2, 揷拞梪巕, 拞媨婭巕, 惣媨梞巎3, 彫嶁桖尗, 抾壓棙晇, 錟暲丂彑, 嶰奒婱巎3 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3擕態丒峛忬態奜): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722091. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 堚揱揑僴僀儕僗僋幰傪懳徾偲偟偨僒乕儀僀儔儞僗奜棃亅尰嫷偲揥朷亅. 拞捗愳抭巕, 摗杮峗巌, 弢丂恀堦, 嶰奒婱巎1, 嶁揷帯恖, 崅揷丂岇, 嶅尨弤懢, 嬔尒嫳巕, 帥拞椇懢榊, 嶳杮姲恖, 塅捗栰宐旤, 娭崻悙崄, 挿搱丂寬, 徏壓堦擵, 巗愳抭旻 (1擕態丒峛忬態奜): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722092. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 摉堾偵偍偗傞擭楊憌暿MMG専恌偺惉愌. 壀杮棽塸, 垻晹丂朙, 埳搶柧旤, 撪嶳拤惗, 墱杮拤擵, 崟娾旤奊, 忋搰抦巕, 殸桭榓慞, 愬愇婭旻1 (1擕態丒峛忬態奜): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722093. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 傾儀儅僔僋儕僽偑憈岠偟偨嵞敪抝惈擕娻偺1椺. 愬愇婭旻1, 撪摗壜撧巕2, 摗栰巎怐3, 揷拞梪巕, 媏抮恀棟巕1, 惣媨梞巎1, 嶰奒婱巎1 (1擕態丒峛忬態奜, 2忋晹徚壔娗奜, 3戝妛堾堛椕宯尋媶壢): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722094. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 擕娻偵旂晢嬝墛傪崌暪偟偨1椺. 惣媨梞巎1, 惵栘壴撧, 戝栘宑巕2, 媏抧恀棟巕1, 彫嶁桖尗, 愬愇婭旻1, 嶰奒婱巎1 (1擕態丒峛忬態奜, 2戝妛堾堛椕宯尋媶壢): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722095. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 摉堾偱宱尡偟偨抝惈擕娻5椺偺曬崘. 壀杮丂棨1, 揷拞梪巕, 撪摗壜撧巕1, 赓丂婭巕, 憼暲丂彑, 彫嶁桖尗, 嶰奒婱巎2 (1忋晹徚壔娗奜, 2擕態丒峛忬態奜): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722096. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 弍慜恌抐偱FA偲恌抐偟弍屻昦棟偱擕娻偲恌抐偝傟偨庒擭惈 (17嵥) 擕娻偺1椺. 椦丂嫗巕1, 榤扟旤撧1, 塇淎寬恗, 彫浉宑懢2, 愬愇婭旻1, 將帞丂墌3, 嶰奒婱巎1 (1擕態丒峛忬態奜, 2壓晹徚壔娗奜, 3擼奜) :戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722097. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 摉堾偵偍偗傞BRACAnalysis偺専摙. 榤扟旤撧1, 彫浉宑懢2, 塇淎寬恗, 椦丂嫗巕1 (1擕態丒峛忬態奜, 2壓晹徚壔娗奜): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722098. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 擕態態條鵑朎娻偺2椺. 斞捤旤崄, 杧揷埢巕, 釼摗惗楴, 媏抮恀棟巕1, 愬愇婭旻1 (1擕態丒峛忬態奜): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722099. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) COVID-19攛墛姰帯屻偵擕娻庤弍傪巤峴偟偨1椺. 惵栘壴撧, 媏抮恀棟巕1, 愬愇婭旻1, 墶揷岝墰1, 惣媨梞巎1, 壛摗丂峅1, 嶰奒婱巎1 (1擕態丒峛忬態奜): 戞29夞擔杮擕娻妛夛妛弍憤夛 (2021/7/1-3), 墶昹 (僴僀僽儕僢僪奐嵜).
722100. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 巓枀偱摨帪婜偵敪徢偟擠泂惈壏懚帯椕傪慖戰偟偨AYA悽戙HBOC偺1壠宯. 拞捗愳抭巕, 塅栰捗宐旤, 娭崻悙崄, 嶳杮姲恖, 嵅摗柧擔崄, 媑栰桳婓巕, 摗杮峗巌, 尟丂桋巕, 恄捗嶰壚, 嶰奒婱巎1, 徏壓堦擵, 惣懞丂婎, 塇揷丂柧, 巗愳抭旻 (1擕態丒峛忬態奜): 擔杮恖椶堚揱妛夛戞66夞戝夛/戞28夞擔杮堚揱巕恌椕妛夛戝夛 (2021/10/13-16), 墶昹 (僴僀僽儕僢僪奐嵜).
722101. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) HBOC恌椕偵偍偗傞堾撪楢実偲抧堟堛椕楢実偺峔抸. 峳栘彯旤1, 愳揷浠壚1, 榤扟旤撧1,2, 彫嶁桖尗, 憼暲丂彑, 峳栘惓梇1, 怴堜丂搘3, 嶰奒婱巎1,2, 愬愇婭旻2, 屆愳惓媊1,3, 娾悾弔巕3, 捗懞廏峃1,4, 揷敤寬堦4, 墱榚嫽夘5, 娾堜抦媣5, 栘揷岝峀5, 崅揷巎抝1,6 (1昦堾堚揱恌椕晹, 2擕態丒峛忬態奜, 3晈恖, 4斿擜婍, 5徚壔婍撪, 6戝妛堾堛椕宯尋媶壢): 擔杮恖椶堚揱妛夛戞66夞戝夛/戞28夞擔杮堚揱巕恌椕妛夛戝夛 (2021/10/13-16), 墶昹 (僴僀僽儕僢僪奐嵜).
723242. [妛夛 (慡崙)] (堦斒島墘) 僩儕僾儖僱僈僥傿僽擕娻偵偍偗傞ZEB1 堚揱巕偺堄媊. 媏抮恀棟巕1, 戝栘宑巕2, 摗栰巎怐2, 墶揷岝墰1, 惣媨梞巎1, 壛摗丂峅1, 愬愇婭旻1, 嶳壓宲巎3,4, 嶰奒婱巎1 (1擕態丒峛忬態奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕, 4忋晹徚壔娗奜): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723243. [妛夛 (慡崙)] (堦斒島墘) 媧堷幃惗専慻怐偵偍偗傞儕儞僷娗怤廝偺SN揮堏梊應場巕偲偟偰偺壜擻惈. 揷拞梪巕, 錟暲丂彑, 彫嶁桖尗, 摗栰巎怐1, 拞媨婭巕, 撪摗壜撧巕2, 彫栰揷搊, 抾壓棙晇, 惣媨梞巎3, 嶰奒婱巎3 (1戝妛堾堛椕宯尋媶壢, 2忋晹徚壔娗奜, 3擕態丒峛忬態奜): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723244. [妛夛 (慡崙)] (堦斒島墘) 夋憸恌抐偱栩摦柆怤廝傪媈偆徢椺偵偍偗傞neoadjuvant setting偱偺Lenvatinib巊梡宱尡. 壛摗丂峅1, 墶揷岝墰1, 媏抮恀棟巕1, 愬愇婭旻1, 嶰奒婱巎1 (1擕態丒峛忬態奜): 戞33夞擔杮撪暘斿奜壢妛夛憤夛 (2021/6/3-4), 寉堜戲.
723245. [妛夛 (慡崙)] (堦斒島墘) 峛忬態擕摢娻栩摦柆怹弫偵傛傞栩摦柆摯徢岓孮傪偒偨偟偨徢椺偵偍偗傞Lenvatinib巊梡宱尡. 壛摗丂峅1, 墶揷岝墰1, 媏抮恀棟巕1, 愬愇婭旻1, 嶰奒婱巎1 (1擕態丒峛忬態奜): 戞33夞擔杮撪暘斿奜壢妛夛憤夛 (2021/6/3-4), 寉堜戲.
723246. [妛夛 (慡崙)] (億僗僞乕) PRL嶻惗壓悅懱態庮傪崌暪偟偨Hyperparathyroidism-jaw tumor (HPT-JT) 徢岓孮偺1椺. 搰捗丂彨, 愳揷浠壚, 峳栘彯旤, 埨杮棿攏1, 榤扟旤撧2, 捗懞廏峃3, 彫嶁桖尗, 崅揷巎抝4 (1椪専晹, 2擕態丒峛忬態奜, 3斿擜婍, 4戝妛堾堛椕宯尋媶壢): 擔杮恖椶堚揱妛夛戞66夞/戝夛戞28夞擔杮堚揱巕恌椕妛夛戝夛崌摨奐嵜 (2021/10/14), 墶昹 (僴僀僽儕僢僪奐嵜).
732037. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 峛忬態旝彫擕摢娻偺愊嬌揑宱夁娤嶡偺奣梫偲棷堄揰. 壛摗丂峅 (擕態丒峛忬態奜): 戞8夞岤栘椪彴奜壢堛夛 (2021/7), 岤栘 (僴僀僽儕僢僪奐嵜).
732038. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 峛忬態旝彫擕摢娻偺愊嬌揑宱夁娤嶡偲棷堄偡傋偒億僀儞僩. 壛摗丂峅 (擕態丒峛忬態奜): 戞11夞惣恄撧愳撪暘斿丒戙幱幘姵尋媶夛 (2021), 憡柾尨 (僴僀僽儕僢僪奐嵜).
732039. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) (TKI) 桳奞帠徾儅僱僕儊儞僩偵偍偄偰戝愗側偙偲. 壛摗丂峅 (擕態丒峛忬態奜): Thyroid Cancer Meet The Expert in Kanagawa (2022/3), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110017. [尨挊] Is total endoscopic parathyroidectomy an acceptable treatment for patients with primary hyperparathyroidism due to a presumed solitary adenoma?亅comparison of minimally invasive total endoscopic parathyroidectomy and open minimally invasive parathyroidectomy. Saito Y, Ikeda Y, Katoh H1, Nakao A, Takami H: Gland Surg 2021/1; 10 (1): 83-9. (壛摗丂峅1: 1擕態丒峛忬態奜)
'20-310001. [徢椺曬崘] Neoadjuvant use of lenvatinib in locally advanced papillary thyroid carcinoma involving critical vessels. Katoh H1, Kajita S2, Yokota M3, Sengoku N1, Sangai T1: Int J Endocrine Oncol 2021/3; 7 (3): IJE33. doi.org/10.2217/ije-2020-0014. (壛摗丂峅1, 妬揷嶇旤擳2, 墶揷岝墰3, 愬愇婭旻1, 嶰奒婱巎1: 1擕態丒峛忬態奜, 2昦棟, 3戝妛堾堛椕宯尋媶壢)
[妛夛丒尋媶夛摍]
'20-723016. [妛夛 (慡崙)] (堦斒島墘) 峛忬態擕摢娻偵偍偗傞儕儞僷媴-扨媴斾 (LMR) 偺堄媊. 壛摗丂峅1, 惣媨梞巎1, 媏抮恀棟巕1, 愬愇婭旻1, 嶳壓宲巎2,3, 嶰奒婱巎1 (1擕態丒峛忬態奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞53夞擔杮撪暘斿奜壢妛夛妛弍戝夛 (2020/11/26), 怴廻.
堦斒丒彫帣丒娞抇鋁奜壢妛
[妛弍榑暥]
110251. [尨挊] Multicenter Propensity Score-Based Study of Laparoscopic Repeat Liver Resection for Hepatocellular Carcinoma: A Subgroup Analysis of Cases with Tumors Far from Major Vessels. Miyama A, Morise Z, Aldrighetti L, Belli G, Ratti F, Cheung TT, Lo CM, Tanaka S, Kubo S, Okamura Y, Uesaka K, Monden K, Sadamori H, Hashida K, Kawamoto K, Gotohda N, Chen K, Kanazawa A, Takeda Y, Ohmura Y, Ueno M, Ogura T, Suh KS, Kato Y, Sugioka A, Belli A, Nitta H, Yasunaga M, Cherqui D, Halim NA, Laurent A, Kaneko H, Otsuka Y, Kim KH, Cho HD, Lin CCW, Ome Y, Seyama Y, Troisi RI, Berardi G, Rotellar F, Wilson GC, Geller DA, Soubrane O, Yoh T, Kaizu T1, Kumamoto Y1, Han HS, Ekmekcigil E, Dagher I, Fuks D, Gayet B, Buell JF, Ciria R, Briceno J, O'Rourke N, Lewin J, Edwin B, Shinoda M, Abe Y, Hilal MA, Alzoubi M, Tanabe M, Wakabayashi G: Cancers (Basel) 2021/6; 13 (13): 3187. (奀捗婱巎1, 孏尦梇夘1: 1堦斒丒彫帣丒娞抇鋁奜)
110252. [尨挊] Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study. Nagakawa Y, Jang JY, Kawai M, Kim SC, Inoue Y, Yabushita Y, Heo JS, Honda M, Sugiura T, Kagawa S, Hayasaki A, Kwon W, Uemura K, Han HS, Sugimoto M, Ando Y, Nakamura M, Wada K, Kumamoto Y1, Osakae H, Tsuchida A, Yoon YS, Park JS, Yamaue H, Endo I: Ann Surg 2021/12. doi: 10.1097/SLA.0000000000005330. Online ahead of print. (孏尦梇夘1: 1堦斒丒彫帣丒娞抇鋁奜)
120007. [尨挊] 敪徢偐傜15擭埲忋宱夁偟偰傕捠堾偑昁梫側抁挵徢岓孮偺挿婜梊屻偺専摙. 弌壠嫓堦1, 揷拞丂寜1,2, 搉晹桋榊1, 彫愳徦巕1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 彫帣奜壢 2022/3; 54 (3): 241-6.
320002. [徢椺曬崘] 柶塽愼怓偱僌儖僇僑儞晹暘梲惈傪帵偟偨僌儖僇僑僲乕儅偺1椺. 嫜丂桾椇1, 惣郪怢嫳2, 揷搰丂峅2, 摗旜弐堯2, 壀杮岝婩巕2, 媣曐擟巎2, 憹郪恀幚巕3, 奀捗婱巎2, 懞塤朏庽4, 孏尦梇夘2 (1戝妛堾堛椕宯尋媶壢, 2堦斒丒彫帣丒娞抇鋁奜, 3旂晢, 4昦棟): 擔杮奜壢宯楢崌妛夛帍 2021/12; 46 (6): 709-16.
522059. [島嵗]亂摿廤: 忋晹徚壔娗庤弍偵偍偗傞僩儔僽儖僔儏乕僥傿儞僌亅崲擄徢椺丒嬼敪徢傊偺懳嶔亃娞嵍梩庼摦扙揮帪偺墶妘枌捈壓壓戝摦柆棳擖晹偵偍偗傞娞惷柆懝彎偵懳偡傞懳張 孏尦梇夘1, 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 斾婇捈庽2 (1堦斒丒彫帣丒娞抇鋁奜, 2忋晹徚壔娗奜): 庤弍 2021/6; 75 (7): 1205-9.
522060. [島嵗]亂摿廤: 惉恖堏峴巟墖偺擇柺惈亃[奺榑] 惉挿偵崌傢偣偨帺棫丒帺棩巟墖丂愱栧椞堟偺帺棫巟墖丂彫帣奜壢幘姵. 旜壴榓巕, 揷晬桾巕, 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 彫帣撪壢 2021/8; 53 (8): 1265-70.
522061. [島嵗]亂摿廤: 彫帣奜壢幘姵偺壠懓撪敪惗亃鋁抇娗崌棳堎忢徢. 揷拞丂寜1,2, 弌壠嫓堦2, 搉晹桋榊2 彫愳徦巕2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 彫帣奜壢 2021/12; 53 (12): 1291-5.
540025. [偦偺懠]亂埾堳夛曬崘亃乽擔杮彫帣奜壢妛夛擣掕巤愝/嫵堢娭楢巤愝偵偍偗傞僩儔儞僕僔儑儞幚懺挷嵏乿曬崘. 擔杮彫帣奜壢妛夛僩儔儞僕僔儑儞専摙埾堳夛 (揷拞丂寜1,2: 1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 擔杮彫帣奜壢妛夛嶨帍 2021/6; 57 (4): 773-81.
[挊丂彂]
620072. [妛弍彂 (暘扴幏昅)]亂昗弨彫帣奜壢妛丂戞8斉亃戞20復 暊暻丒鋊偍傛傃憀宎晹丂鋊懷僿儖僯傾, 暊暻攋楐, 鋊僿儖僯傾, 鋊挵娗堚巆, 棏墿挵娗堚巆, 擜枌娗堚巆,愭揤惈暊暻嬝宍惉晄慡 (prune belly 徢岓孮), p.272-9. 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜), 娔廋: 忋栰丂帬, 曇: 恗旜惓婰, 墱嶳岹恇, 揷怟払榊, 堛妛彂堾, 搶嫗, 2022/3敪峴.
[妛夛丒尋媶夛摍]
722102. [妛夛 (慡崙)] (僔儞億僕僂儉) 暊峯嬀壓宯摑揑娞愗彍偵偍偗傞埨慡惈傪峫椂偟偨庤弍庤媄. 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 壀杮岝婩巕, 摗嶳朏庽2, 嫜丂桾椇2, 嶰塝孾氭3, 嵅摗晲榊3, 嵶揷丂宩4, 愬愇婭旻5, 壛摗丂峅5, 揷拞丂寜1,6, 嶳壓宲巎4,7, 嶰奒婱巎5, 斾婇捈庽4, 撪摗丂崉3, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4忋晹徚壔娗奜, 5擕態丒峛忬態奜, 6怴悽婭堛椕丒愭抂堛椕, 7怴悽婭堛椕丒墶抐揑堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
722103. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 擔杮彫帣奜壢妛夛擣掕巤愝/嫵堢娭楢巤愝偵偍偗傞僩儔儞僕僔儑儞幚懺挷嵏. 揷晬桾巕, 戝嫶怢夘, 揷堜拞婱媣, 屆愳懽嶰, 嵵摗丂晲, 壛帯丂寶, 悰徖棟峕, 朷寧嬁巕, 旜壴榓巕, 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 戞58夞擔杮彫帣奜壢妛夛妛弍廤夛 (2021/4/29), 墶昹 (僴僀僽儕僢僪奐嵜).
722104. [妛夛 (慡崙)] (僔儞億僕僂儉) Coping with hemorrhage in laparoscopic pancreatic resection. 揷搰丂峅1, 奀捗婱巎1, 惣郪怢嫳1, 壀杮岝婩巕, 嫜丂桾椇2, 摗嶳朏庽2, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢): 戞33夞擔杮娞抇鋁奜壢妛夛妛弍廤夛 (2021/6/3), Web奐嵜.
722105. [妛夛 (慡崙)] (僔儞億僕僂儉) Standardization and safety of laparoscopic right posterior sectionectomy. 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 壀杮岝婩巕, 摗嶳朏庽2, 嫜丂桾椇2, 斾婇捈庽3, 撪摗丂崉4, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3忋晹徚壔娗奜, 4壓晹徚壔娗奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/9), 嫗搒 (僴僀僽儕僢僪奐嵜).
722106. [妛夛 (慡崙)] (僔儞億僕僂儉) 嫄戝鋊懷僿儖僯傾偺曐懚壛椕拞偵梊憐奜偺宱夁傪扝偭偨傕偺偺旂晢偱旐暍偟摼偨堦椺. 弌壠嫓堦1, 揷拞丂寜1,2, 搉晹桋榊1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞37夞擔杮彫帣奜壢妛夛廐婫僔儞億僕僂儉 (2021/10/30), 搶嫗 (僴僀僽儕僢僪奐嵜).
722107. [妛夛 (慡崙)] (僔儞億僕僂儉) 愗彍壜擻鋁娻偵懳偡傞弍慜僎儉僔僞價儞墫巁墫+S-1 (GS) 暪梡椕朄偺椪彴揑堄媊. 惣郪怢嫳1, 孏尦梇夘1, 揷搰丂峅1, 屲廫棐堦惏1, 媣曐擟巎1, 奀捗婱巎1, 怴尨惓戝2, 嵶揷丂宩2, 嶰塝孾氭3, 嵅摗晲榊3, 壛摗丂峅4, 嶰奒婱巎4, 撪摗丂崉3, 斾婇捈庽2 (1堦斒丒彫帣丒娞抇鋁奜, 2忋晹徚壔娗奜, 3壓晹徚壔娗奜, 4擕態丒峛忬態奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/19), 搶嫗 (僴僀僽儕僢僪奐嵜).
723247. [妛夛 (慡崙)] (堦斒島墘) 鋁娻偵懳偡傞暊峯嬀壓旜懁鋁愗彍弍偺庤弍庤媄偲抁婜惉愌. 惣郪怢嫳1, 揷搰丂峅1, 嫜丂桾椇2, 壀杮岝婩巕, 媣曐擟巎1, 嶰塝孾氭3, 壛摗丂峅4, 奀捗婱巎1, 愬愇婭旻4, 嵶揷丂宩5, 斾婇捈庽5, 嵅摗晲榊3, 嶰奒婱巎4, 撪摗丂崉3, 揷拞丂寜1,6, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4擕態丒峛忬態奜, 5忋晹徚壔娗奜, 6怴悽婭堛椕丒愭抂堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723248. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓鋁摢廫擇巜挵愗彍弍偺惉愌偲岺晇. 揷搰丂峅1, 奀捗婱巎1, 惣郪怢嫳1, 壀杮岝婩巕, 嫜丂桾椇2, 摗嶳朏庽2, 媣曐擟巎1, 嶰塝孾氭3, 壛摗丂峅4, 愬愇婭旻4, 嵶揷丂宩5, 嵅摗晲榊3, 嶳壓宲巎5,6, 揷拞丂寜1,7, 斾婇捈庽5, 撪摗丂崉3, 嶰奒婱巎4, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4擕態丒峛忬態奜, 5忋晹徚壔娗奜, 6怴悽婭堛椕丒墶抐揑堛椕, 7怴悽婭堛椕丒愭抂堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723249. [妛夛 (慡崙)] (堦斒島墘) 攋楐娞嵶朎娻偵懳偡傞暊峯嬀壓娞愗彍. 壀杮岝婩巕, 奀捗婱巎1, 揷搰丂峅1,惣郪怢嫳1, 媣曐擟巎1, 摗嶳朏庽2, 嫜丂桾椇2, 嶰塝孾氭3, 嵅摗晲榊3, 嵶揷丂宩4, 愬愇婭旻5, 壛摗丂峅5, 揷拞丂寜1,6, 嶳壓宲巎4,7, 嶰奒婱巎5, 斾婇捈庽4, 撪摗丂崉3, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4忋晹徚壔娗奜, 5擕態丒峛忬態奜, 6怴悽婭堛椕丒愭抂堛椕, 7怴悽婭堛椕丒墶抐揑堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723250. [妛夛 (慡崙)] (堦斒島墘) IPMN崙嵺恌椕僈僀僪儔僀儞偵偍偗傞EUS寢愡宎偲昦棟妛揑堎宆搙偺専摙. 摗嶳朏庽1, 惣郪怢嫳2, 壀杮岝婩巕, 嫜丂桾椇1, 拞杮廋巌2, 媣曐擟巎2, 揷搰丂峅2, 奀捗婱巎2, 孏尦梇夘2 (1戝妛堾堛椕宯尋媶壢, 2堦斒丒彫帣丒娞抇鋁奜): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/10), Web奐嵜.
723251. [妛夛 (慡崙)] (堦斒島墘) 戝妛昦堾偵偍偗傞16嵨埲忋偺庤弍徢椺偺専摙. 搉晹桋榊1, 揷拞丂寜1,2, 弌壠嫓堦1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞58夞擔杮彫帣奜壢妛夛妛弍廤夛 (2021/4/28-30), 墶昹 (僴僀僽儕僢僪奐嵜).
723252. [妛夛 (慡崙)] (堦斒島墘) The laparoscopic lens cleaning device reduces surgeon's stress in hepatobiliary-pancreatic laparoscopic surgery. 惣郪怢嫳1, 奀捗婱巎1, 揷搰丂峅1, 壀杮岝婩巕, 嫜丂桾椇2, 摗嶳朏庽2, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢): 戞33夞擔杮娞抇鋁奜壢妛夛妛弍廤夛 (2021/6/2), Web奐嵜.
723253. [妛夛 (慡崙)] (堦斒島墘) Intrahepatic Glissonian approach for S7 segmentectomy -Parenchymal transection- rst with direct dorsal approach under IOUS guidance. 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 壀杮岝婩巕, 摗嶳朏庽2, 嫜丂桾椇2, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢): 戞33夞擔杮娞抇鋁奜壢妛夛妛弍廤夛 (2021/6/2), Web奐嵜.
723254. [妛夛 (慡崙)] (堦斒島墘) 怴惗帣婜偵庤弍楌偺偁傞梒帣婜偵敪徢偟偨挵娗婥庮徢偺2椺. 搉晹桋榊1, 揷拞丂寜1,2, 弌壠嫓堦1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞34夞擔杮彫帣媬媫堛妛夛妛弍廤夛 (2021/6/18-20), 撧椙 (僴僀僽儕僢僪奐嵜).
723255. [妛夛 (慡崙)] (堦斒島墘) 掆棷惛憙庤弍帪偵擣傔偨梀棧懱偺2椺. 搉晹桋榊1, 揷拞丂寜1,2, 弌壠嫓堦1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞30夞擔杮彫帣斿擜婍壢妛夛憤夛丒妛弍廤夛 (2021/7/2), 戝嶃 (僴僀僽儕僢僪奐嵜).
723256. [妛夛 (慡崙)] (堦斒岥墘) 僗僩乕儅傪曐桳偡傞彫帣傗娫寚摫擜傪昁梫偲偡傞彫帣偺廇墍丒廇妛偺偨傔偺曌嫮夛帒椏偺嶌惉. 曐姞怢戙, 墱揷桾旤, 垻晹丂孫, 姍揷捈巕, 崅尒郪帬, 搶娫枹棃, 徏栰戝曘, 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂抐揑堛椕, 2堦斒丒彫帣丒娞抇鋁): 戞30夞擔杮憂彎丒僆僗僩儈乕丒幐嬛娗棟妛夛妛弍廤夛 (2021/7/3-5), Web奐嵜.
723257. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞PNEN偺帯椕惉愌. 嫜丂桾椇1, 惣郪怢嫳2, 揷搰丂峅2, 壀杮岝婩巕, 媣曐擟巎2, 奀捗婱巎2, 嶰奒婱巎3, 撪摗丂崉4, 斾婇捈庽5, 孏尦梇夘2 (1戝妛堾堛椕宯尋媶壢, 2堦斒丒彫帣丒娞抇鋁奜, 3擕態丒峛忬態奜, 4壓晹徚壔娗奜, 5忋晹徚壔娗奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/7), 嫗搒 (僴僀僽儕僢僪奐嵜).
723258. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓鋁愗彍弍偵偍偗傞弍拞嬼敪徢傊偺懳張朄. 揷搰丂峅1, 奀捗婱巎1, 惣郪怢嫳1, 壀杮岝婩巕, 嫜丂桾椇2, 摗嶳朏庽2, 媣曐擟巎1, 斾婇捈庽3, 撪摗丂崉4, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3忋晹徚壔娗奜, 4壓晹徚壔娗奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/8), 嫗搒 (僴僀僽儕僢僪奐嵜).
723259. [妛夛 (慡崙)] (堦斒島墘) 鋁塼楻傪嵟彫尷偵梷偊傞奰揷幃鋁嬻挵暙崌偲彫梩娫鋁愗棧偺採埬. 惣郪怢嫳1, 孏尦梇夘1, 壀杮岝婩巕, 嫜丂桾椇2, 摗嶳朏庽2, 揷搰丂峅1, 媣曐擟巎1, 奀捗婱巎1, 撪摗丂崉3, 斾婇捈庽4 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4忋晹徚壔娗奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/9), 嫗搒 (僴僀僽儕僢僪奐嵜).
723260. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞徚壔娗捠夁忈奞偺側偄戀曋惈暊枌墛偺専摙. 弌壠嫓堦1, 揷拞丂寜1,2 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/11), 媨嶈 (僴僀僽儕僢僪奐嵜).
723261. [妛夛 (慡崙)] (堦斒島墘) 撪帇嬀壓嵦庢専懱偵偍偗傞CDO1堚揱巕DNA儊僠儖壔偺椪彴揑堄媊. 惣郪怢嫳1, 摗嶳朏庽2, 嫜丂桾椇2, 屲廫棐堦惏1, 揷搰丂峅1, 媣曐擟巎1, 奀捗婱巎1, 墱榚嫽夘3, 娾堜抦媣3, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3徚壔婍撪): 戞52夞擔杮鋁憻妛夛戝夛 (2021/9/22), 搶嫗 (僴僀僽儕僢僪奐嵜).
723262. [妛夛 (慡崙)] (堦斒島墘) 抇摴娻偵懳偡傞暊峯嬀壓鋁摢廫擇巜挵愗彍偺摫擖. 揷搰丂峅1, 奀捗婱巎1, 惣郪怢嫳1, 屲廫棐堦惏1, 媣曐擟巎1, 墱榚嫽夘2, 娾堜抦媣2, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2徚壔婍撪): 戞57夞擔杮抇摴妛夛妛弍廤夛 (2021/10/7), 搶嫗 (僴僀僽儕僢僪奐嵜).
723263. [妛夛 (慡崙)] (堦斒島墘) 鋁娻偵懳偡傞暊峯嬀壓鋁懱旜晹愗彍弍偺弍栰揥奐偺岺晇. 揷搰丂峅1, 奀捗婱巎1, 惣郪怢嫳1, 壀杮岝婩巕, 嫜丂桾椇2, 屲廫棐堦惏1, 媣曐擟巎1, 嶳壓宲巎3,4, 嵅摗晲榊5, 揷拞丂寜1,6, 斾婇捈庽4, 撪摗丂崉5, 嶰奒婱巎7, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕, 4忋晹徚壔娗奜, 5壓晹徚壔娗奜, 6怴悽婭堛椕丒愭抂堛椕, 7擕態丒峛忬態奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723264. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓鋁摢廫擇巜挵愗彍弍偺岺晇. 揷搰丂峅1, 奀捗婱巎1, 惣郪怢嫳1, 壀杮岝婩巕, 嫜丂桾椇2, 屲廫棐堦惏1, 媣曐擟巎1, 嵅摗晲榊3, 揷拞丂寜1,4, 斾婇捈庽5, 撪摗丂崉3, 嶰奒婱巎6, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4怴悽婭堛椕丒愭抂堛椕, 5忋晹徚壔娗奜, 6擕態丒峛忬態奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723265. [妛夛 (慡崙)] (堦斒島墘) 銪憻偺壏懚偑壜擻偱偁偭偨摿敪惈偺怴惗帣銪憻懝彎偺堦椺. 壓宍彨墰1, 揷拞丂寜2,3, 弌壠嫓堦3, 搉晹桋榊3 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒愭抂堛椕, 3堦斒丒彫帣丒娞抇鋁奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723267. [妛夛 (慡崙)] (堦斒島墘) Oncologic emergency傪掓偟偨擕巁傾僔僪乕僔僗崌暪怴惗帣暃恡尨敪恄宱夎庮偺堦椺. 弌壠嫓堦1, 揷拞丂寜1,2, 搉晹桋榊1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞63夞擔杮彫帣寣塼丒偑傫妛夛妛弍廤夛 (2021/11/25), Web奐嵜.
723268. [妛夛 (慡崙)] (堦斒島墘) 旕忢偵婬側嫄戝暊暻庮釃偺堦椺. 搉晹桋榊1, 揷拞丂寜1,2, 弌壠嫓堦1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞63夞擔杮彫帣寣塼丒偑傫妛夛妛弍廤夛 (2021/11/25), Web奐嵜.
723269. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓娞愗彍偵偍偗傞弌寣丒抇廯楻懳嶔. 孏尦梇夘1, 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 屲廫棐堦惏1, 壀杮岝婩巕, 嫜丂桾椇2, 撪摗丂崉3, 斾婇捈庽4, 嵶揷丂宩4, 嵅摗晲榊3, 嶳棞崅峀3, 嶰塝孾氭3, 怴尨惓戝4, 嶰奒婱巎5 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4忋晹徚壔娗奜, 5擕態丒峛忬態奜): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/2), 恄屗.
723270. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓抇娗嬻挵暙崌偺掕宆壔偲抁婜惉愌. 揷搰丂峅1, 奀捗婱巎1, 惣郪怢嫳1, 壀杮岝婩巕, 嫜丂桾椇2, 屲廫棐堦惏1, 媣曐擟巎1, 嶳棞崅峀3, 嵶揷丂宩4, 嶳壓宲巎4,5, 嵅摗晲榊3, 揷拞丂寜1,6, 斾婇捈庽4, 撪摗丂崉3, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4忋晹徚壔娗奜, 5怴悽婭堛椕丒墶抐揑堛椕, 6怴悽婭堛椕丒愭抂堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/2), 恄屗.
723271. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓宯摑揑娞愗彍偺岺晇偍傛傃偦偺庤弍惉愌. 奀捗婱巎1, 屲廫棐堦惏1, 惣郪怢嫳1, 揷搰丂峅1, 媣曐擟巎1, 怴尨惓戝2, 嶰塝孾氭3, 嶳棞崅峀3, 壛摗丂峅4, 嵶揷丂宩2, 嵅摗晲榊3, 斾婇捈庽2, 撪摗丂崉3, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2忋晹徚壔娗奜, 3壓晹徚壔娗奜, 4擕態丒峛忬態奜): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/3), 恄屗.
723272. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓塃梩宯宯摑揑娞愗彍偺掕宆壔偵敽偆帯椕惉愌偺曄慗. 屲廫棐堦惏1, 奀捗婱巎1, 惣郪怢嫳1, 揷搰丂峅1, 媣曐擟巎1, 弌壠嫓堦1, 怴尨惓戝2, 嶳棞崅峀3, 嵶揷丂宩2, 嵅摗晲榊3, 揷拞丂寜1,4, 斾婇捈庽2, 撪摗丂崉3, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2忋晹徚壔娗奜, 3壓晹徚壔娗奜, 4怴悽婭堛椕丒愭抂堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/4), 恄屗.
732040. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 鋁娻偵懳偡傞暊峯嬀壓旜懁鋁愗彍偺儕儞僷愡妔惔偵偍偗傞夝朥妛揑儔儞僪儅乕僋. 惣郪怢嫳1, 揷搰丂峅1, 屲廫棐堦惏1, 媣曐擟巎1, 奀捗婱巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞15夞娞憻撪帇嬀奜壢尋媶夛丒戞13夞鋁憻撪帇嬀奜壢尋媶夛 (2021/11/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
732041. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 暊峯嬀壓鋁愗彍偱偺弍栰揥奐偺岺晇. 揷搰丂峅1, 奀捗婱巎1, 惣郪怢嫳1, 壀杮岝婩巕, 嫜丂桾椇2, 屲廫棐堦惏1, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢): 戞15夞娞憻撪帇嬀奜壢尋媶夛丒戞13夞鋁憻撪帇嬀奜壢尋媶夛 (2021/11/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
732042. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 暊峯嬀壓旜懁鋁愗彍偵偍偗傞reduced port surgery (needlescopic surgery) 偺帯椕惉愌. 惣郪怢嫳1, 揷搰丂峅1, 奀捗婱巎1, 屲廫棐堦惏1, 媣曐擟巎1, 嵶揷丂宩2, 嵅摗晲榊3, 撪摗丂崉3, 斾婇捈庽2, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2忋晹徚壔娗奜, 3壓晹徚壔娗奜): 9th Reduced Port Surgery Forum in Okinawa (2022/2/16), Web奐嵜.
733078. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 戀帣婜偵鋊懷鵑朎傪巜揈偝傟擜枌娗釕偲恌抐偝傟偨2椺. 搉晹桋榊1, 揷拞丂寜1,2, 弌壠嫓堦1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞7夞擔杮彫帣傊偦尋媶夛 (2021/4/9), Web奐嵜.
733079. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 敪徢偐傜15擭埲忋宱夁偟偰傕捠堾偑昁梫側抁挵徢岓孮徢椺偺挿婜梊屻偺専摙. 弌壠嫓堦1, 揷拞丂寜1,2, 搉晹桋榊1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞118夞搶嫗彫帣奜壢尋媶夛 (2021/6/1), 搶嫗 (僴僀僽儕僢僪奐嵜).
733080. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恖岺汨栧嵞憿愝傪昁梫偲偟偨廫擇巜挵暵嵔徢崌暪崅埵嵔汨偺1椺. 搉晹桋榊1, 揷拞丂寜1,2, 弌壠嫓堦1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞55夞擔杮彫帣奜壢妛夛娭搶峛怣墇抧曽夛 (2021/10/2), Web奐嵜.
733081. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 銪壏懚偑壜擻偱偁偭偨摿敪惈偺怴惗帣銪憻懝彎偺1椺. 壓宍彨墰1, 揷拞丂寜2,3, 弌壠嫓堦3, 搉晹桋榊3 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒愭抂堛椕, 3堦斒丒彫帣丒娞抇鋁奜): 戞55夞擔杮彫帣奜壢妛夛娭搶峛怣墇抧曽夛 (2021/10/2), Web奐嵜.
733082. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 栍挵宔幒偵懳偟偰暊峯嬀壓宔幒愗彍弍傪巤峴偟偨1椺. 搉晹桋榊1, 揷拞丂寜1,2, 弌壠嫓堦1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞40夞擔杮彫帣撪帇嬀奜壢丒庤弍庤媄尋媶夛 (2021/10/28), 搶嫗 (僴僀僽儕僢僪奐嵜).
733083. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 庡梫柆娗傛傝嫍棧偑偁傞嵞敪娞嵶朎娻偵懳偡傞暊峯嬀壓娞嵞愗彍: 崙嵺懡巤愝嫟摨屻傠岦偒尋媶僒僽僌儖乕僾夝愅. 庣悾慞堦, Aldrighetti Luca, Belli Giulio, 揷绯丂柅, 庒椦丂崉, ILLS-Tokyo Collaborator group (孏尦梇夘1, 懠) (1堦斒丒彫帣丒娞抇鋁奜): 戞15夞娞憻撪帇嬀奜壢尋媶夛丒戞13夞鋁憻撪帇嬀奜壢尋媶夛 (2021/11/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
733084. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 暊峯嬀壓娞愗彍偵偍偗傞弌寣丒抇廯楻懳嶔偍傛傃戝挵摨帪愗彍娭楢崌暪徢懳嶔. 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 屲廫棐堦惏1, 媣曐擟巎1, 嶳棞崅峀2, 嵶揷丂宩3, 嵅摗晲榊2, 斾婇捈庽3, 撪摗丂崉2, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2壓晹徚壔娗奜, 3忋晹徚壔娗奜): 戞15夞娞憻撪帇嬀奜壢尋媶夛丒戞13夞鋁憻撪帇嬀奜壢尋媶夛 (2021/11/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
733085. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 暊峯嬀壓宯摑揑娞愗彍偺掕宆壔偺岺晇偍傛傃帯椕惉愌偺曄慗. 屲廫棐堦惏1, 奀捗婱巎1, 壀杮岝婩巕, 嫜丂桾椇2, 惣郪怢嫳1, 揷搰丂峅1, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢): 戞15夞娞憻撪帇嬀奜壢尋媶夛丒戞13夞鋁憻撪帇嬀奜壢尋媶夛 (2021/11/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
733086. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉壢偵偍偗傞憀宎晹愗奐朄偵傛傞彫帣憀宎僿儖僯傾庤弍. 揷拞丂寜1,2, 弌壠嫓堦2, 搉晹桋榊2, 彫愳徦巕2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 戞12夞恄撧愳僿儖僯傾尋媶夛 (2021/12/4), Web奐嵜.
'20擭搙埲慜暘
[妛夛丒尋媶夛摍]
'20-722002. [妛夛 (慡崙)] (僔儞億僕僂儉) Technique and outcomes of laparoscopic distal pancreatectomy for pancreatic cancer. 惣郪怢嫳1, 揷搰丂峅1, 媣曐擟巎1, 奀捗婱巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/12), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723017. [妛夛 (慡崙)] (堦斒島墘) Difficulty assessment of HBP surgery Validation of an Index-based IWATE Criteria for Laparoscopic Liver Resection: A Multicenter Analysis by the Endoscopic Liver Surgery Study Group in Japan. Shogo T, Kawaguchi Y, Kubo S, Kanazawa A, Takeda Y, Hirokawa F, Nitta H, Nakajima T, 奀捗婱巎1, Kaibori M, Kojima T, Otsuka Y, Fuks David, Hasegawa K, Kokudo N, Kaneko H, Gayet Brice, Wakabayashi G (1堦斒丒彫帣丒娞抇鋁奜): 戞32夞擔杮娞抇鋁奜壢妛夛妛弍廤夛 (2021/2/24), Web奐嵜.
'20-723018. [妛夛 (慡崙)] (堦斒島墘) 僗僩乕儅傪曐桳偡傞彫帣偺廇墍丒廇妛偵偍偗傞壽戣偺柧妋壔亅堛椕幰偺宱尡偵婎偯偔幚懺挷嵏亅. 曐姞怢戙, 垻晹丂孫, 墱揷桾旤, 姍揷捈巕, 崅尒郪帬, 搶娫枹棃, 徏栰戝曘, 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 戞38夞擔杮僗僩乕儅丒攔煏儕僴價儕僥乕僔儑儞妛夛憤夛 (JSSCR) (2021/2/26-27), 暉壀 (僴僀僽儕僢僪奐嵜).
'20-723019. [妛夛 (慡崙)] (堦斒島墘) 娫寚摫擜傪昁梫偲偡傞彫帣偺廇墍丒廇妛偵偍偗傞壽戣偺柧妋壔亅堛椕幰偺宱尡偵婎偯偔幚懺挷嵏亅. 姍揷捈巕, 曐姞怢戙, 垻晹丂孫, 墱揷桾旤, 崅尒郪帬, 搶娫枹棃, 徏栰戝曘, 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 戞38夞擔杮僗僩乕儅丒攔煏儕僴價儕僥乕僔儑儞妛夛憤夛 (JSSCR) (2021/2/26-27), 暉壀 (僴僀僽儕僢僪奐嵜).
'20-723020. [妛夛 (慡崙)] (堦斒島墘) The advantages of laparoscopic approach in anatomical liver resection; a single center experience. 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/11), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723021. [妛夛 (慡崙)] (堦斒島墘) Impact of upper abdominal surgical history on short-term outcomes in laparoscopic liver resection. 孏尦梇夘1, 奀捗婱巎1, 揷搰丂峅1, 媣曐擟巎1, 惣郪怢嫳1, 壀杮岝婩巕1, 摗嶳朏庽2, 嫜丂桾椇2 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/11), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723022. [妛夛 (慡崙)] (堦斒島墘) Pancreatic transection procedure for laparoscopic distal pancreatectomy. 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 奀捗婱巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/11), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-733010. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 彫帣崅擄搙撪帇嬀庤弍偺媄弍廗摼偺偨傔偵乣怴惗帣怘摴暵嵔徢儌僨儖偺奐敪偲僩儗乕僯儞僌岠壥偺専徹乣. 弌壠嫓堦1, 撪揷峀晇, 愇娵揘栫, 搉晹桋榊1, 揷拞丂寜1,2 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞23夞KSOA (2021/2/27), Web奐嵜.
忋晹徚壔娗奜壢妛
[妛弍榑暥]
110253. [尨挊] Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer. Harada H1, Soeno T2, Nishizawa N3, Washio M1, Sakuraya M1, Ushiku H1, Niihara M1, Hosoda K1, Kumamoto Y3, Naitoh T4, Sangai T5, Hiki N1, Yamashita K1,6: Cancer Sci 2021/4; 112 (4): 1644-54. (尨揷岹婸1, 揧栰岶暥2, 惣郪怢嫳3, 榟旜恀棟垽1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 孏尦梇夘3, 撪摗丂崉4, 嶰奒婱巎5, 斾婇捈庽1, 嶳壓宲巎1,6: 1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3堦斒丒彫帣丒娞抇鋁奜, 4壓晹徚壔娗奜, 5擕態丒峛忬態奜, 6怴悽婭堛椕丒墶抐揑堛椕)
110254. [尨挊] Intraoperative conversion from laparoscopic gastrectomy to an open procedure: a decade of experience in a Japanese high-volume center. Kumagai K, Hiki N1, Nunobe S, Jiang X, Makuuchi R. Ida S, Ohashi M Yamaguchi T, Sano T: Surg Endosc 2021/4; 35 (4): 1834-42. (斾婇捈庽1: 1忋晹徚壔娗奜)
110255. [尨挊] Comparison of effects of six main gastrectomy procedures on patients' quality of life assessed by Postgastrectomy Syndrome Assessment Scale-45. Nakada K, Kawashima Y, Kinami S, Fukushima R, Yabusaki H, Seshimo A, Hiki N1, Koeda K, Kano M, Uenosono Y, Oshio A, Kodera Y: Gastrointest Surg. 2021/5; 13 (5): 461_75. (斾婇捈庽1: 1忋晹徚壔娗奜)
110256. [尨挊] Preoperative chemotherapy could modify recurrence patterns through postoperative complications in patients with gastric cancer. Hosoda K1, Ushiku H1, Katada C2, Ishido K2, Niihara M1, Sakuraya M1, Araki I1, Washio M1, Harada H1, Yamashita K1,3, Hiki N1: Langenbecks Arch Surg 2021/6; 406 (4): 1045-55. (嵶揷丂宩1, 媿媣廏庽1, 寴揷恊棙2, 愇屗尓師2, 怴尨惓戝1, 烴扟旤婱巕1, 峳栘堦暯懢1, 榟旜恀棟垽1, 尨揷岹婸1, 嶳壓宲巎1,3, 斾婇捈庽1: 1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕)
110257. [尨挊] Esophageal cancer patients' survival after complete response to definitive chemoradiotherapy: a retrospective analysis. Mori K, Sugawara K, Aikou S, Yamashita H, Yamashita K1,2, Ogura M, Chin K, Watanabe M , Matsubara H, Toh Y, Kakeji Y, Seto Y: Esophagus 2021/7; 18 (3): 629-37. (嶳壓宲巎1,2: 1怴悽婭堛椕丒墶抐揑堛椕, 2忋晹徚壔娗奜)
110258. [尨挊] Features of the complications for intracorporeal Billroth-I and Roux-en-Y reconstruction after laparoscopic distal gastrectomy for gastric cancer. Shoji Y, Kumagai K, Ida S, Ohashi M, Hiki N1, Sano T, Nunobe S: Langenbecks Arch Surg 2021/8; 406 (5): 1425-32. (斾婇捈庽1: 1忋晹徚壔娗奜)
110259. [尨挊] Therapeutic value of splenectomy to dissect splenic hilar lymph nodes for type 4 gastric cancer involving the greater curvature, compared with other types. Kano Y, Ohashi M, Ida S, Kumagai K, Makuuchi R, Sano T, Hiki N1, Nunobe S: Gastric Cancer 2020/9; 23 (5): 927-36. (斾婇捈庽1: 1忋晹徚壔娗奜)
110260. [尨挊] Comparison of Postoperative Quality of Life among Three Different Reconstruction Methods After Proximal Gastrectomy: Insights From the PGSAS Study. Yabusaki H, Kodera Y, Fukushima N, Hiki N1, Kinami S, Yoshida M, Aoyagi K, Ota S, Hata H, Noro H, Oshio A, Nakada K: World J Surg 2020/10; 44 (10): 3433-40. (斾婇捈庽1: 1忋晹徚壔娗奜)
110261. [尨挊] Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists. Kano Y, Ohashi M, Hiki N1, Takahari D, Chin K, Yamaguchi K, Ida, S, Kumagai K, Sano T, Nunobe S: Surg Today 2020/10; 50 (10): 1197-205. (斾婇捈庽1: 1忋晹徚壔娗奜)
110262. [尨挊] Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer. Takahashi R, Nunobe S, Osumi H, Takahari D, Yamamoto N, Ida S, Kumagai K, Ohashi M, Sano T, Hiki N1: Surg Today 2020/10; 50 (10): 1240-8. (斾婇捈庽1: 1忋晹徚壔娗奜)
110029. [尨挊] Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization. Goto T1, Ito Y2, Satoh M3, Nakamoto S4, Nishizawa N4, Hosono K2, Naitoh T5, Eshima K3, Iwabuchi K3, Hiki N6, Amano H2: Front Immunol 2021/10; 12: 754106. (屻摗戩栫1, 埳摗媊栫2, 嵅摗丂夒3, 拞杮廋巌4, 惣郪怢嫳4, 嵶栰壛撧巕2, 撪摗丂崉5, 峕搰峩擇3, 娾熀榓栫3, 斾婇捈庽6, 揤栰塸庽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3柶塽, 4堦斒丒彫帣丒娞抇鋁奜, 5壓晹徚壔娗奜, 6忋晹徚壔娗奜)
110263. [尨挊] Haploinsufficiency by minute MutL homolog 1 promoter DNA methylation may represent unique phenotypes of microsatellite instability-gastric carcinogenesis. Harada H1, Nie Y2, Araki I, Soeno T2, Chuman M1, Washio M1, Sakuraya M1, Ushiku H1, Niihara M1, Hosoda K1, Kumamoto Y3, Naitoh T4, Sangai T5, Hiki N1, Yamashita K1,6: PLoS One 2021/12; 16 (12): e0260303. (尨揷岹婸1, 嫜丂桾椇2, 揧栰岶暥2, 拞攏婎攷1, 榟旜恀棟垽1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 孏尦梇夘3, 撪摗丂崉4, 嶰奒婱巎5, 斾婇捈庽1, 嶳壓宲巎1,6: 1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3堦斒丒彫帣丒娞抇鋁奜, 4壓晹徚壔娗奜, 5擕態丒峛忬態奜, 6怴悽婭堛椕丒墶抐揑堛椕)
110264. [尨挊] Improved anastomotic technique for esophagojejunal anastomosis using circular stapler. Niihara M1, Hiki N1, Hosoda K1, Sakuraya M1, Washio M1, Chuman M1, Yamashita K1,2: Langenbecks Arch Surg 2022/2; 407 (1): 353-6. (怴尨惓戝1, 斾婇捈庽1, 嵶揷丂宩1, 烴扟旤婱巕1, 榟旜恀棟垽1, 拞攏婎攷1, 嶳壓宲巎1,2: 1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕)
110265. [尨挊] Indocyanine green fluorescence imaging for evaluating blood flow in the reconstructed conduit after esophageal cancer surgery. Koyanagi K, Ozawa S, Ninomiya Y, Yatabe K, Higuchi T1, Yamamoto M, Kanamori K, Tajima K: Surg Today 2022/3; 52 (3): 369-76. (旙岥丂奿1: 1忋晹徚壔娗奜)
110266. [尨挊] Preliminary Clinical Surgical Experience with Temporary Simultaneous Use of an Endoscope during Exoscopic Neurosurgery: An Observational Study. Murai Y, Shirokane K, Sato S, Higuchi T1, Kubota A, Ozeki T, Matano F, Sasakai K, Yamaguchi F, Morita A: J Clin Med 2022/3; 11 (7): 1753. (旙岥丂奿1: 1忋晹徚壔娗奜)
120008. [尨挊] 愗彍晄擻恑峴堓娻偵懳偡傞conversion庤弍徢椺偺梊屻場巕偺摨掕. 尨揷岹婸1, 嶳壓宲巎1,2, 揷绯丂憦3,4, 愇屗尓師4, 榓揷戱栫4, 榟旜恀棟垽2, 烴扟旤婱巕2, 媿媣廏庽2, 怴尨惓戝2, 嵶揷丂宩2, 斾婇捈庽2 (1怴悽婭堛椕丒墶抐揑堛椕, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒愭抂堛椕, 4徚壔婍撪): 擔杮徚壔婍奜壢妛夛嶨帍 2022/3; 55 (3): 147-55.
310026. [徢椺曬崘] Laparoscopic and endoscopic cooperative surgery for advanced gastric cancer as palliative surgery in elderly patients: a case report. Washio M1, Hiki N1, Hosoda K1, Niihara M1, Chuman M1, Sakuraya M1, Wada T2, Harada H1, Sato T3, Tanaka K4,5, Naitoh T6, Kumamoto Y5, Sangai T7, Tanabe S2,4, Yamashita K1,8: Surg Case Rep 2021/11; 7 (1): 241. (榟旜恀棟垽1, 斾婇捈庽1, 嵶揷丂宩1, 怴尨惓戝1, 拞攏婎攷1, 烴扟旤婱巕1, 榓揷戱栫2, 尨揷岹婸1, 嵅摗晲榊3, 揷拞丂寜4,5, 撪摗丂崉6, 孏尦梇夘5, 嶰奒婱巎7, 揷绯丂憦2,4, 嶳壓宲巎1,8: 1忋晹徚壔娗奜, 2徚壔婍撪, 3堛椕媄弍嫵堢, 4怴悽婭堛椕丒愭抂堛椕, 5堦斒丒彫帣丒娞抇鋁奜, 6壓晹徚壔娗奜, 7擕態丒峛忬態奜, 8怴悽婭堛椕丒墶抐揑堛椕)
510016. [憤愢] Robot-assisted minimally invasive esophagectomy for esophageal cancer: Meticulous surgery minimizing postoperative complications. Hosoda K1, Niihara M1, Harada H1, Yamashita K1,2, Hiki N1: Ann Gastroenterol Surg 2020/8; 4 (6): 608-17. (嵶揷丂宩1, 怴尨惓戝1, 尨揷岹婸1, 嶳壓宲巎1,2, 斾婇捈庽1: 1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕)
510017. [憤愢] Postoperative pancreatic fistula after gastrectomy for gastric cancer. Washio M1, Yamashita K1,2, Niihara M1, Hosoda K1, Hiki N1: Ann Gastroenterol Surg 2020/9; 4 (6): 618-27. (榟旜恀棟垽1, 嶳壓宲巎1,2, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1: 1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕)
522062. [島嵗]亂摿廤: 偼偠傔偰僫乕僗傊憽傞傜偔傜偔昦搹働傾僈僀僪!丂徚壔婍夝朥丒幘姵丒帯椕偺偐傫傌偒儅僢僾亃2 堓偺夝朥丒幘姵丒帯椕丒働傾. 烴扟旤婱巕 (忋晹徚壔娗奜): 徚壔婍僫乕僔儞僌 2021/4; 26 (4): 16-26.
522063. [島嵗)]亂徚壔婍娻; 恌抐偲帯椕偺偡傋偰亃III 椪彴徢忬偐傜偺娻恌抐僾儘僙僗丂3. 怘巚晄怳丒傞偄憠. 怴尨惓戝1, 斾婇捈庽1 (1忋晹徚壔娗奜): 徚壔婍奜壢 2021/5; 44 (6): 1031-3.
522064. [島嵗]亂摿廤: 帯椕偺幙傪崅傔傞! 忋庤側塰梴惢嵻偺慖傃曽丒巊偄曽; 徢椺偐傜峫偊傞塰梴惢嵻偺巊偄曽亃堓偑傫 (廃弍婜, 弍屻傪娷傓). 烴扟旤婱巕1, 斾婇捈庽1 (1忋晹徚壔娗奜): 栻帠 2021/6; 63 (8): 1575-8.
522065. [島嵗]亂摿廤: 暊峯嬀丒撪帇嬀崌摨庤弍 (LECS) 偺尰忬偲揥朷亃I. 憤榑丂1) LECS: 奐敪偺楌巎. 榟旜恀棟垽1, 斾婇捈庽1, 拞攏婎攷1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1 (1忋晹徚壔娗奜): 庤弍 2021/10; 75 (11): 1625-9.
522066. [島嵗]亂摿廤: 偑傫埆塼幙偺帯椕亅僌儗儕儞條嶌梡栻傾僫儌儗儕儞墫巁墫偺搊応亅亃1. 偑傫僒億乕僥傿僽働傾偲偑傫埆塼幙偺帯椕丂6) 偑傫埆塼幙偺塰梴椕朄. 怴尨惓戝1, 斾婇捈庽1 (1忋晹徚壔娗奜): Progress in Medicine 2021/11; 41 (11): 1087-90.
522067. [島嵗]亂徚壔娗撪帇嬀帯椕亅婎杮偐傜崅擄搙傑偱亃III. 擲枌壓憌丒嬝憌丒慡憌愗彍, 嬝憌愗奐丂Classical LECS偐傜偺崅擄搙LECS傊偺恑壔. 榟旜恀棟垽1, 斾婇捈庽1, 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 榓揷戱栫2, 尨揷岹婸1, 嶳壓宲巎1,3, 揷绮丂憦2,4 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕, 4怴悽婭堛椕丒愭抂堛椕): 徚壔婍撪帇嬀 2021/11; 33 (憹姧崋): 248-52.
522068. [島嵗]亂摿廤: 側偐側偐妛傋側偄 椙惈忋晹徚壔娗幘姵偺掅怤廝庤弍亃5. 堓庮釃偵懳偡傞LECS. 榟旜恀棟垽1, 斾婇捈庽1, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榓揷戱栫2, 拞攏婎攷1, 嶳壓宲巎1,3, 憪栰丂墰2, 揷绮丂憦2,4 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕, 4怴悽婭堛椕丒愭抂堛椕) 徚壔婍奜壢 2022/1; 45 (1): 53-60.
522069. [島嵗]亂奜壢堛偑抦偭偰偍偔傋偒 乻嵟怴斉乼 塰梴椕朄亃仭奺榑丂堓奜壢偵偍偗傞塰梴椕朄. 怴尨惓戝1, 烴扟旤婱巕1, 斾婇捈庽1 (1忋晹徚壔娗奜): 椪彴奜壢 2022/1; 77 (1): 57-60.
522070. [島嵗]亂摿廤: 忋晹徚壔娗椞堟嵞寶庤媄亅嵟嬤偺僩僺僢僋亃ICG寣棳昡壙傪梡偄偨堓娗嶌惢丒嵞寶. 彫桍榓晇, 澤栰嬇恖, 扟揷晹寬懢榊, 旙岥丂奿1, 嬥怷峗暯, 揷搰峃暯 (1晹徚壔娗奜): 庤弍 2022/2; 76 (2): 125-30.
522071. [島嵗]亂椪彴堓娻妛亅婎慴丒椪彴偺嵟怴摦岦亅 亃堓V. 娻偺帯椕丂4. 堓娻帯椕忋偺塰梴娗棟丂(2) 弍屻憗婜宱挵塰梴. 烴扟旤婱巕1, 斾婇捈庽1 (1忋晹徚壔娗奜): 擔杮椪喱 2022/3; 80 (憹姧崋3): 355-7.
[挊丂彂]
620073. [妛弍彂 (暘扴幏昅)]亂擔杮椪彴塰梴戙幱塰梴妛夛 JSPEN僥僉僗僩僽僢僋亃忋晹徚壔娗偑傫弍屻崌暪徢偵懳偡傞塰梴娗棟, p.453-6. 怴尨惓戝1, 斾婇捈庽1 (1忋晹徚壔娗奜), 曇: 擔杮椪彴塰梴戙幱妛夛, 撿峕摪, 搶嫗, 2021/4敪峴.
620074. [妛弍彂 (暘扴幏昅)]亂怴椪彴庮釃妛 夵掕戞6斉) 偑傫栻暔椕朄愱栧堛偺偨傔偵亃III 椪彴庮釃妛偺幚慔丂49 暃嶌梡懳嶔偲巟帩椕朄丂6. 塰梴僒億乕僩, p.698-702. 怴尨惓戝1, 斾婇捈庽1 (1忋晹徚壔娗奜), 曇: 擔杮椪彴庮釃妛夛, 撿峕摪, 搶嫗, 2021/5敪峴.
620075. [妛弍彂 (暘扴幏昅)]亂撪帇嬀奜壢徚壔婍嵞寶弍偺偡傋偰丂庤弍椡偑昁偢岦忋偡傞亃僄僱儖僊乕僨僶僀僗偺庬椶偲巊梡朄, p.8-13. 尨揷岹婸1, 斾婇捈庽1 (1忋晹徚壔娗奜), 曇: 垻晹揥師, 忋栰惓婭, 峕尨堦彯, 抾惌埳抦楴, 拞懞宑弔, 妛尋儊僨傿僇儖廏弫幮, 搶嫗, 2021/9敪峴.
620076. [妛弍彂 (暘扴幏昅)]亂暘巕庮釃儅乕僇乕帯椕僈僀僪儔僀儞 戞2斉亃憤愢4丂RAS/BRAF, p,19-27. 揷拞弐摴1, 嶳壓宲巎1,2 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕), 曇: 擔杮暘巕庮釃儅乕僇乕尋媶夛, 嬥尨弌斉, 搶嫗, 2021/9敪峴.
620077. [妛弍彂 (暘扴幏昅)]亂暘巕庮釃儅乕僇乕帯椕僈僀僪儔僀儞 戞2斉亃奺榑7丂戝挵娻, p.85-98. 墶堜孿屽1, 嶳壓宲巎1,2, 撪摗丂崉3 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3壓晹徚壔娗奜), 曇: 擔杮暘巕庮釃儅乕僇乕尋媶夛, 嬥尨弌斉, 搶嫗, 2021/9敪峴.
620078. [妛弍彂 (暘扴幏昅)]亂暊峯嬀壓堓愗彍弍岞幃僥僉僗僩亃戞II復 暊峯嬀壓堓慡揈 , p.112-9. 斾婇捈庽 (忋晹徚壔娗奜), 娔廋: 曇: 彫搱堦岾, 擔杮撪帇嬀奜壢妛夛嫵堢埾堳夛, 撿峕摪, 搶嫗, 2022/3敪峴.
620079. [妛弍彂 (暘扴幏昅)]亂徚壔婍撪帇嬀奜壢庤弍丂崌暪徢夞旔偺ABC亅崌暪徢傪壢妛偡傞亅亃暊峯嬀丒撪帇嬀崌摨庤弍 (laparoscopy andendoscopy cooperative surgery: LECS) 弍屻弌寣傗堓撪梕攔弌抶墑夞旔庤媄偺ABC, p.76-86. 榟旜恀棟垽1, 斾婇捈庽1 (1晹徚壔娗奜), 曇: 敀愇寷抝, 忋揷婱埿, 儊僕僇儖價儏乕幮, 搶嫗, 2022/3敪峴.
[妛夛丒尋媶夛摍]
722108. [妛夛 (慡崙)] (僔儞億僕僂儉) 怘摴堓愙崌晹娻偵懳偡傞儕儞僷愡妔惔岠壥偲帄揔弍幃偺専摙. 尨揷岹婸1, 揧栰岶暥2, 榟旜恀棟垽1, 媿媣廏庽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/9), Web奐嵜.
722109. [妛夛 (慡崙)] (僔儞億僕僂儉) 忋晹徚壔娗弍屻偺儕僴價儕僥乕僔儑儞堛妛偺曽岦惈偲壽戣. 怴尨惓戝1, 嵶揷丂宩1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞58夞擔杮儕僴價儕僥乕僔儑儞堛妛夛妛弍廤夛 (2021/6/10-13), 嫗搒 (僴僀僽儕僢僪奐嵜).
722110. [妛夛 (慡崙)] (僔儞億僕僂儉) 儘儃僢僩巟墖嫻峯嬀壓怘摴愗彍弍偺埵抲偯偗. 怴尨惓戝1, 嵶揷丂宩1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞46夞擔杮奜壢宯楢崌妛夛妛弍廤夛 (2021/6/19), Web奐嵜.
722111. [妛夛 (慡崙)] (嫵堢島墘) 偑傫帯椕偵偍偗傞塰梴偺栶妱. 斾婇捈庽 (忋晹徚壔娗奜): 戞8夞擔杮嵼戭塰梴娗棟妛夛妛弍廤夛 (2021/9/18-10/4), Web奐嵜.
722112. [妛夛 (慡崙)] (僔儞億僕僂儉) 怘摴堓愙崌晹娻偵懳偡傞暊峯嬀壓壓晹怘摴暚栧懁堓愗彍, 嫻峯嬀壓娤壒奐偒朄嵞寶. 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 尨揷岹婸1, 烴扟旤婱巕1, 榟旜恀棟垽1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮怘摴妛夛妛弍廤夛 (2021/9/23), 搶嫗 (僴僀僽儕僢僪奐嵜).
722113. [妛夛 (慡崙)] (僔儞億僕僂儉) 愗彍壜擻嬊強恑峴怘摴堓愙崌晹娻偵懳偡傞弍慜DOS壔妛椕朄偺抁婜挿婜惉愌. 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 拞攏婎攷1, 嵅摗晲榊2, 揷拞丂寜3,4, 撪摗 崉2, 孏尦梇夘4, 嶰奒婱巎5, 斾婇捈庽1 (1忋晹徚壔娗奜, 2壓晹徚壔娗奜, 3怴悽婭堛椕丒愭抂堛椕, 4堦斒丒彫帣丒娞抇鋁奜, 5擕態丒峛忬態奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
722114. [妛夛 (慡崙)] (僔儞億僕僂儉) Emerging novel concept of haplo-insufcient MSI positive gastric cancer. 嶳壓宲巎1,2, 尨揷岹婸2, 拞攏婎攷2, 烴扟旤婱巕2, 榟旜恀棟垽2, 怴尨惓戝2, 嵶揷丂宩2, 斾婇捈庽2 (1怴悽婭堛椕丒墶抐揑堛椕, 2忋晹徚壔娗奜): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/3), 墶昹 (僴僀僽儕僢僪奐嵜).
722115. [妛夛 (慡崙)] (僔儞億僕僂儉) Neoadjuvant Chemotherapy with DOS for Siewert Type 2 Esophagogastric Junction Cancer. 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 拞攏婎攷1, 寴揷恊棙2, 愇屗尓師2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/4), 墶昹 (僴僀僽儕僢僪奐嵜).
723273. [妛夛 (慡崙)] (堦斒島墘) 働儌僙儗僋僔儑儞帯椕愴棯偵偍偗傞恑峴怘摴娻奜壢揑愗彍屻偺嵞敪偺専摙. 怴尨惓戝1, 嶳壓宲巎1,2, 嵶揷丂宩1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/9), Web奐嵜.
723274. [妛夛 (慡崙)] (堦斒島墘) 堓娻偺CT偵傛傞椞堟暿怺払搙恌昡壙偵偮偄偰偺専摙. 墱栰峎懢1, 尨揷岹婸1, 榟旜恀棟垽1, 媿媣廏庽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/9), Web奐嵜.
723275. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞旕暵嵡惈挵娫枌嫊寣 (NOMI) 庤弍椺偺専摙. 壓宍彨墰1, 媿媣廏庽1, 尨揷岹婸1, 榟旜恀棟垽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/9), Web奐嵜.
723276. [妛夛 (慡崙)] (堦斒島墘) 怘摴娻偵偍偗傞帯椕慜C-reactive protein抣偺専摙. 屻摗戩栫1, 嶳壓宲巎2,3, 斾婇捈庽3, 嵶揷丂宩3, 怴尨惓戝3, 榟旜恀棟垽3, 媿媣廏庽3, 烴扟旤婱巕3, 尨揷岹婸3 (1戝妛堾堛椕宯尋媶壢, 2怴悽婭堛椕丒墶抐揑堛椕, 3忋晹徚壔娗奜): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723277. [妛夛 (慡崙)] (堦斒島墘) Stage I堓娻弍屻偵偍偗傞懠昦巰梊應場巕偺摨掕. 烴扟旤婱巕1, 嶳壓宲巎1,2, 揧栰岶暥3, 尨揷岹婸1, 榟旜恀棟垽1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1, 嵅摗晲榊4, 揷搰丂峅5, 奀捗婱巎5, 壛摗丂峅6, 愬愇婭旻6, 揷拞丂寜5,7, 撪摗丂崉4, 孏尦梇夘5, 嶰奒婱巎6 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3戝妛堾堛椕宯尋媶壢, 4壓晹徚壔娗奜, 5堦斒丒彫帣丒娞抇鋁奜, 6擕態丒峛忬態奜, 7怴悽婭堛椕丒愭抂堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723278. [妛夛 (慡崙)] (堦斒島墘) 彈惈奜壢堛偵懳偟偰, 堛嬊堳偼偳偆峫偊偰偄傞偐?亅彈惈奜壢堛儕乕僟乕抋惗偺偨傔偺峫嶡亅. 榟旜恀棟垽1, 斾婇捈庽1, 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 尨揷岹婸1, 嵅摗晲榊2, 揷搰丂峅3, 奀捗婱巎3, 壛摗丂峅4, 愬愇婭旻4, 揷拞丂寜3,5, 撪摗丂崉2, 孏尦梇夘3, 嶰奒婱巎4, 嶳壓宲巎1,6 (1忋晹徚壔娗奜, 2壓晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4擕態丒峛忬態奜, 5怴悽婭堛椕丒愭抂堛椕, 6怴悽婭堛椕丒墶抐揑堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723279. [妛夛 (慡崙)] (堦斒島墘) 僌儗儕儞偺堓撪暘晍偲堓垷慡揈弍偺庤媄偺岺晇. 媿媣廏庽1, 屻摗戩栫2, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 揧栰岶暥2, 撪摗丂崉3, 孏尦梇夘4, 嶰奒婱巎5, 嶳壓宲巎1,6, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4堦斒丒彫帣丒娞抇鋁奜, 5擕態丒峛忬態奜, 6怴悽婭堛椕丒墶抐揑堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723280. [妛夛 (慡崙)] (堦斒島墘) 弍慜壔妛椕朄偼堓娻弍屻崌暪徢偺嵞敪偵懳偡傞埆塭嬁傪廋慤偡傞偐? 嵶揷丂宩1, 媿媣廏庽1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 撪摗丂崉2, 孏尦梇夘3, 嶰奒婱巎4, 嶳壓宲巎1,5, 斾婇捈庽1 (1忋晹徚壔娗奜, 2壓晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4擕態丒峛忬態奜, 5怴悽婭堛椕丒墶抐揑堛椕): 戞46夞擔杮奜壢宯楢崌妛夛妛弍廤夛 (2021/6/18), Web奐嵜.
723281. [妛夛 (慡崙)] (堦斒島墘) 崅楊幰堓娻姵幰偵懳偡傞optional LECS. 榟旜恀棟垽1, 斾婇捈庽1, 尨揷岹婸1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 撪摗丂崉2, 孏尦梇夘3, 嶳壓宲巎1,4 (1忋晹徚壔娗奜, 2壓晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/7), 嫗搒 (僴僀僽儕僢僪奐嵜).
723282. [妛夛 (慡崙)] (堦斒島墘) 怘摴滸暯忋旂娻偺3q OncCassette偺堄媊. 揧栰岶暥1, 尨揷岹婸2, 烴扟旤婱巕2, 媿媣廏庽2, 榟旜恀棟垽2, 怴尨惓戝2, 嵶揷丂宩2, 斾婇捈庽2, 嶳壓宲巎2,3 (1戝妛堾堛椕宯尋媶壢, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/7), 嫗搒 (僴僀僽儕僢僪奐嵜).
723283. [妛夛 (慡崙)] (堦斒島墘) 暊悈愻忩嵶朎恌媈梲惈堓娻偵偮偄偰偺梊屻場巕偺専摙. 崟揷丂桰1, 尨揷岹婸1, 媿媣廏庽1, 揧栰岶暥2, 榟旜恀棟垽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/7), 嫗搒 (僴僀僽儕僢僪奐嵜).
723284. [妛夛 (慡崙)] (堦斒島墘) Siewert type II偺怘摴堓愙崌晹態娻偵懳偡傞庤弍慜壔妛椕朄. 媿媣廏庽1, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 揧栰岶暥2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/8), 嫗搒 (僴僀僽儕僢僪奐嵜).
723285. [妛夛 (慡崙)] (堦斒島墘) 儘儃僢僩巟墖堓愗彍弍偺廬棃宆暊峯嬀壓堓愗彍弍偵懳偡傞棙揰 偲栤戣揰. 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 撪摗丂崉2, 孏尦梇夘3, 嶳壓宲巎1,4, 斾婇捈庽1 (1忋晹徚壔娗奜, 2壓晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/8), 嫗搒 (僴僀僽儕僢僪奐嵜).
723286. [妛夛 (慡崙)] (堦斒島墘) LECS偵偍偗傞嫄戝堓暻寚懝晹偺幬幉暵嵔庤媄. 墱栰峎懢1, 榟旜恀棟垽1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓 宲巎1,2, 斾婇捈庽1, 孏尦梇夘3, 撪摗丂崉4 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3堦斒丒彫帣丒娞抇鋁奜, 4壓晹徚壔娗奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/8), 嫗搒 (僴僀僽儕僢僪奐嵜).
723287. [妛夛 (慡崙)] (堦斒島墘) cStage IV堓娻偵懳偡傞conversion庤弍徢椺偺梊屻場巕偺専摙. 尨揷岹婸1, 揧栰岶暥2, 榟旜恀棟垽1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/8), 嫗搒 (僴僀僽儕僢僪奐嵜).
723288. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞儘儃僢僩巟墖嫻峯嬀壓怘摴愗彍弍偺尰忬偲壽戣. 怴尨惓戝1, 嵶揷丂宩1, 媿媣廏庽1, 尨揷岹婸1, 烴扟旤婱巕1, 榟旜恀棟垽1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/9), 嫗搒 (僴僀僽儕僢僪奐嵜).
723289. [妛夛 (慡崙)] (堦斒島墘) Stage I堓娻弍屻偵偍偗傞懠昦巰梊應場巕偺摨掕乣僒儖僐儁僯傾偲懠昦巰偺娭楢偵偮偄偰乣. 烴扟旤婱巕1, 嶳壓宲巎1,2, 揧栰岶暥3, 尨揷岹婸1, 榟旜恀棟垽1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3戝妛堾堛椕宯尋媶壢): 戞36夞擔杮椪彴塰梴戙幱妛夛妛弍廤夛 (2021/7/21-22), 暫屔 (僴僀僽儕僢僪奐嵜).
723290. [妛夛 (慡崙)] (堦斒島墘) 堓愗彍屻僟儞僺儞僌徢忬偺夵慞偵帩懕寣摐儌僯僞儕儞僌偑桳梡偱偁偭偨堦椺. 怴尨惓戝1, 烴扟旤婱巕1, 嵶揷丂宩1, 媿媣廏庽1, 榟旜恀棟垽1, 尨揷岹婸1, 揧栰岶暥2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞36夞擔杮椪彴塰梴戙幱妛夛妛弍廤夛 (2021/7/21-22), 暫屔 (僴僀僽儕僢僪奐嵜).
723291. [妛夛 (慡崙)] (堦斒島墘) 儘儃僢僩巟墖嫻嬀壓怘摴愗彍偲廬棃偺嫻峯嬀壓怘摴愗彍偲偺抁婜惉愌偵娭偡傞専摙. 怴尨惓戝1, 嵶揷丂宩1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮怘摴妛夛妛弍廤夛 (2021/9/23-24), 搶嫗 (僴僀僽儕僢僪奐嵜).
723292. [妛夛 (慡崙)] (堦斒島墘) 怘摴滸暯忋旂娻3q OncCassette偺廳梫惈. 揧栰岶暥1, 尨揷岹婸2, 烴扟旤婱巕2, 媿媣廏庽2, 榟旜恀棟垽2, 怴尨惓戝2, 嵶揷丂宩2, 斾婇捈庽2, 嶳壓宲巎2,3 (1戝妛堾堛椕宯尋媶壢, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮怘摴妛夛妛弍廤夛 (2021/9/23-24), 搶嫗 (僴僀僽儕僢僪奐嵜).
723293. [妛夛 (慡崙)] (堦斒島墘) A Clinical Trial Plan; 堓愗彍弍屻偺憗婜塣摦椕朄傪暪梡偟偨傾儈僲巁丒摐丒帀朾擕嵻宱惷柆搳梌偺桳岠惈偺専摙. 烴扟旤婱巕1, 斾婇捈庽1, 拞攏婎攷1, 榟旜恀棟垽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮奜壢戙幱塰梴妛夛戞58夞妛弍廤夛 (2021/10/8), 暫屔 (僴僀僽儕僢僪奐嵜).
723294. [妛夛 (慡崙)] (堦斒島墘) 愗彍晄擻堓娻偵懳偡傞SOX椕朄屻偺Conversion surgery傊偺堏峴棪偺専摙. 拞攏婎攷1, 榟旜恀棟垽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 奀捗婱巎2, 嵅摗晲榊3, 孏尦梇夘2, 撪摗丂崉3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2堦斒丒彫帣丒娞抇鋁奜, 3壓晹徚壔娗奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723295. [妛夛 (慡崙)] (堦斒島墘) 怘摴巆堓暙崌偵偍偗傞媡棳徢忬偐傜傒偨怘摴巆堓暙崌. 怴尨惓戝1, 尨揷岹婸1, 嵶揷丂宩1, 烴扟旤婱巕1, 榟旜恀棟垽1, 拞攏婎攷1, 斾婇捈庽1 (1忋晹徚壔娗奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723296. [妛夛 (慡崙)] (堦斒島墘) 崅楊幰堓娻姵幰偵懳偡傞optional LECS. 榟旜恀棟垽1, 斾婇捈庽1, 拞攏婎攷1, 烴扟旤婱巕1, 榓揷戱栫2, 怴尨惓戝1, 嵶揷丂宩1, 揷绯丂憦2,3 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒愭抂堛椕): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/19), 搶嫗 (僴僀僽儕僢僪奐嵜).
723297. [妛夛 (慡崙)] (堦斒島墘) 儘儃僢僩巟墖嫻峯嬀壓怘摴愗彍弍偺帯椕惉愌. 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 拞攏婎攷1, 嵅摗晲榊2, 揷拞丂寜3,4, 撪摗丂崉2, 孏尦梇夘4, 嶰奒婱巎5, 斾婇捈庽1 (1忋晹徚壔娗奜, 2壓晹徚壔娗奜, 3怴悽婭堛椕丒愭抂堛椕, 4堦斒丒彫帣丒娞抇鋁奜, 5擕態丒峛忬態奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/19), 搶嫗 (僴僀僽儕僢僪奐嵜).
723298. [妛夛 (慡崙)] (堦斒島墘) 怘摴娻弍屻偺娗棟塰梴巑偵傛傞愛庢僄僱儖僊乕検偺挳庢偲懱廳曄壔偺専摙. 怴尨惓戝1, 媏抮撧曚巕2, 嵶揷丂宩1, 烴扟旤婱巕1, 榟旜恀棟垽1, 拞攏婎攷1, 斾婇捈庽1 (1忋晹徚壔娗奜, 2塰梴晹): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/19), 搶嫗 (僴僀僽儕僢僪奐嵜).
723299. [妛夛 (慡崙)] (堦斒島墘) 崅楊幰恑峴堓娻姵幰偵懳偡傞娚榓LECS. 娫拞宧夘1, 榟旜恀棟垽1, 墱栰峎懢1, 拞攏婎攷1, 榓揷戱栫2, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 揷绯丂憦2,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒愭抂堛椕): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/19), 搶嫗 (僴僀僽儕僢僪奐嵜).
723300. [妛夛 (慡崙)] (堦斒島墘) 埨慡惈偐傜傒偨恑峴堓娻偵懳偡傞暊峯嬀壓桯栧懁堓愗彍弍偺揔墳婎弨. 拞攏婎攷1, 榟旜恀棟垽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 奀捗婱巎2, 嵅摗晲榊3, 孏尦梇夘2, 撪摗丂崉3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2堦斒丒彫帣丒娞抇鋁奜, 3壓晹徚壔娗奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723301. [妛夛 (慡崙)] (堦斒島墘) A Clinical Trial Plan堓愗彍弍屻偺憗婜塣摦椕朄傪暪梡偟偨傾儈僲巁丒摐丒帀朾擕嵻宱惷柆搳梌偺桳岠惈偺専摙. 烴扟旤婱巕1, 斾婇捈庽1, 拞攏婎攷1, 榟旜恀棟垽1, 怴尨惓戝1, 嵶揷丂宩1 (1忋晹徚壔娗奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723302. [妛夛 (慡崙)] (堦斒島墘) 弍慜GNRI偼崅楊堓娻姵幰偺弍屻崌暪徢敪徢偺梊應場巕偲側傝摼傞偐? 烴扟旤婱巕1, 斾婇捈庽1, 拞攏婎攷1, 榟旜恀棟垽1, 怴尨惓戝1, 嵶揷丂宩1 (1忋晹徚壔娗奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18-20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723303. [妛夛 (慡崙)] (堦斒島墘) 嫄戝堓帀朾娭楢庮釃偵懳偟桯栧懁堓愗彍傪巤峴偟偨堦椺. 抮懞嫗擵夘1, 榟旜恀棟垽1, 墱栰峎懢1, 拞攏婎攷1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1 (1忋晹徚壔娗奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18-20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723304. [妛夛 (慡崙)] (堦斒島墘) 堓嬊強愗彍 (LECS) 屻偵婡擻傪扗傢側偄堓暻暵嵔朄偺岺晇. 烴扟旤婱巕1, 斾婇捈庽1, 拞攏婎攷1, 榟旜恀棟垽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/2), 暫屔 (僴僀僽儕僢僪奐嵜).
723305. [妛夛 (慡崙)] (堦斒島墘) 廫擇巜挵廳愊徢傪棃偟偨Brunner態夁宍惉偵懳偟暊峯嬀曗彆壓偵愗彍偟摼偨1椺. 壛摗抭擵1, 屲廫棐堦惏2, 奀捗婱巎2, 惣郪怢嫳2, 揷搰丂峅2, 弌壠嫓堦2, 怴尨惓戝1, 嶳棞崅峀3, 嵶揷丂宩1, 嶳壓宲巎1,4, 嵅摗晲榊3, 揷拞丂寜2,5, 斾婇捈庽1, 撪摗丂崉3, 孏尦梇夘2 (1忋晹徚壔娗奜, 2堦斒丒彫帣丒娞抇鋁奜, 3壓晹徚壔娗奜, 4怴悽婭堛椕丒墶抐揑堛椕, 5怴悽婭堛椕丒愭抂堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/3), 暫屔 (僴僀僽儕僢僪奐嵜).
723306. [妛夛 (慡崙)] (堦斒島墘) 怘摴娻偵懳偡傞儘儃僢僩巟墖嫻峯嬀壓怘摴愗彍弍偺抁婜惉愌. 嵶揷丂宩1, 怴尨惓戝1, 拞攏婎攷1, 榟旜恀棟垽1, 烴扟旤婱巕1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/3), 暫屔 (僴僀僽儕僢僪奐嵜).
723307. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓堓慡揈屻Over lap嵞寶庤媄偺億僀儞僩. 榟旜恀棟垽1, 斾婇捈庽1, 墱栰峎懢1, 拞攏婎攷1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嵅摗晲榊2, 奀捗婱巎3, 撪摗丂崉2, 孏尦梇夘3, 嶳壓宲巎1,4 (1忋晹徚壔娗奜, 2壓晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4怴悽婭堛椕丒墶抐揑堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/3), 暫屔 (僴僀僽儕僢僪奐嵜).
723308. [妛夛 (慡崙)] (堦斒島墘) 恑峴堓娻偵懳偡傞暊峯嬀壓桯栧懁堓愗彍弍偵偍偗傞#6儕儞僷愡偺帯椕揑妔惔庤媄. 拞攏婎攷1, 榟旜恀棟垽1, 烴扟旤婱巕1, 怴尨惓戝1, 奀捗婱巎2, 嵶揷丂宩1, 嵅摗晲榊3, 嶳壓宲巎1,4, 撪摗丂崉3, 孏尦梇夘2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2堦斒丒彫帣丒娞抇鋁奜, 3壓晹徚壔娗奜, 4怴悽婭堛椕丒墶抐揑堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/3), 暫屔 (僴僀僽儕僢僪奐嵜).
723309. [妛夛 (慡崙)] (堦斒島墘) 恑峴堓娻偵懳偡傞暊峯嬀壓桯栧懁堓愗彍弍偺埨慡惈偲崻帯惈偵娭偡傞RCT (JLSSG0901): 庡夝愅寢壥曬崘. 塹摗丂崉, 烴杮怣堦, 捯丂晀崕, 棝丂憡梇, 媑揷榓峅, 旍揷孿夘, 斾婇捈庽1, 殸嶈庡惻, 摽塱惓懃, 戝捸丂戝, 崅嬥柧揟, 嶰郪堦惉, 栘壓宧峅, 挿丂惏旻, 搚婒桽堦榊, 晍晹憂栫, 戝嶳揘巌, 敀愇寷抝, 杒栰惓崉 (1忋晹徚壔娗奜): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/2), 墶昹 (僴僀僽儕僢僪奐嵜).
723310. [妛夛 (慡崙)] (堦斒島墘) 怴偟偄堓娻庢埖偄婯栺: 怴偟偄婯栺嶔掕偵岦偗偨庢傝慻傒丂恑峴堓娻偵懳偡傞暊峯嬀壓桯栧懁堓愗彍弍偺埨慡惈偲崻帯惈偵娭偡傞RCT (JLSSG0901) 庡夝愅寢壥曬崘. 塹摗丂崉, 烴杮怣堦, 捯丂晀崕, 棝丂憡梇, 媑揷榓峅, 旍揷孿夘, 斾婇捈庽1, 殸嶈庡惻, 摽塱惓懃, 戝捸丂戝, 崅嬥柧揟, 嶰郪堦惉, 栘壓宧峅, 挿丂惏旻, 搚婒桽堦榊, 晍晹憂栫, 戝嶳揘巌, 敀愇寷抝, 杒栰惓崉 (1忋晹徚壔娗奜): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/2), 墶昹, 擔杮堓娻妛夛憤夛婰帠 2022/3; 94: 149.
723311. [妛夛 (慡崙)] (堦斒島墘) Which reconstruction should be optimal after gastrectomy for the upper gastric body cancer? 斾婇捈庽 (忋晹徚壔娗奜): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/3), 墶昹 (僴僀僽儕僢僪奐嵜).
723312. [妛夛 (慡崙)] (堦斒島墘) LECS with esophageal reconstruction for tumors around the EGJ. 榟旜恀棟垽1, 斾婇捈庽1, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榓揷戱栫2, 拞攏婎攷1, 憪栰丂墰2, 揷绯丂憦2,3, 嶳壓宲巎1,4 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒愭抂堛椕, 4怴悽婭堛椕丒墶抐揑堛椕): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/3), 墶昹 (僴僀僽儕僢僪奐嵜).
723313. [妛夛 (慡崙)] (堦斒島墘) 堓娻偵偍偗傞弍慜怺払搙偺晹埵暿恌抐. 墱栰峎懢1, 斾婇捈庽1, 拞攏婎攷1, 烴扟旤婱巕1, 榟旜恀棟垽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/3), 墶昹 (僴僀僽儕僢僪奐嵜).
723314. [妛夛 (慡崙)] (堦斒島墘) Laparoscopic distal gastrectomy for advanced gastric cancer-technique of N0.6 lymph node dissection-. 烴扟旤婱巕1, 斾婇捈庽1, 嵶揷丂宩1, 怴尨惓戝1, 榟旜恀棟垽1, 拞攏婎攷1, 嶳壓宲巎1,2 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/4), 墶昹 (僴僀僽儕僢僪奐嵜).
723315. [妛夛 (慡崙)] (堦斒島墘) 堓娻弍屻忈奞偺昡壙朄偲帯椕傊偺妶梡: 堓愗彍屻偺僟儞僺儞僌傪梷惂偡傞屄暿壔塰梴椕朄偺夘擖. 拞攏婎攷1, 媿媣廏庽1, 墱栰峎懢1, 榟旜恀棟垽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/4), 墶昹 (僴僀僽儕僢僪奐嵜).
723316. [妛夛 (慡崙)] (堦斒島墘) 堓娻栻暔椕朄巤峴帪偵偍偗傞塰梴曗彆椕朄偺桳梡惈. 惵嶳丂揙, 媑愳婱屓, 堜揷丂抭, 挿丂惏旻, 嶁姫尠懢榊, 埳摗桭堦, 摗扟榓惓, 戧岥怢峗, 愳搰媑擵, 惣愳榓岹, 晍晹憂栫, 斾婇捈庽1 (1忋晹徚壔娗奜): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/4), 墶昹 (僴僀僽儕僢僪奐嵜).
723317. [妛夛 (慡崙)] (堦斒島墘) 娚榓栚揑偱傾僫儌儗儕儞傪搳梌偟偨堓娻弍屻崪揮堏嵞敪偺1椺. 揷拞姲恖1, 烴扟旤婱巕1, 墱栰峎懢1, 拞攏婎攷1, 榟旜恀棟垽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/2-4), 墶昹 (僴僀僽儕僢僪奐嵜).
723318. [妛夛 (慡崙)] (堦斒島墘) 娻/惛憙峈尨KK-LC-1偼堓慻怐偺慜娻巜昗偲偟偰桳梡偱偁傞. 揧栰岶暥1, 暉嶳丂棽, 擇搉怣峕, 巗棃壝怢, 戝捤弐榓2, 愮栰怲堦榊3, 摗旜弐堯4, 娵嶳惓桾3, 拞懞榓摽4, 嬤摗峃巎5, 崅嫶掯恖4, 抮塱丂惤5, 彫椦寷拤, 嶳嶈丂摍6, 惣丂敧巏, 斾婇捈庽7 (1戝妛堾堛椕宯尋媶壢, 2徚壔婍撪, 3壓晹徚壔娗奜, 4堦斒丒彫帣丒娞抇鋁奜, 5擕態丒峛忬態奜, 6昦棟, 7忋晹徚壔娗奜): 戞94夞擔杮堓娻妛夛憤夛 (2022/3/2-4), 墶昹 (僴僀僽儕僢僪奐嵜).
731006. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 堓偑傫偵懳偡傞娚榓LECS偺Key note lecture: 堓偑傫偵懳偡傞LECS偺尰忬亅LECS尋媶夛傾儞働乕僩挷嵏偺傑偲傔亅. 榟旜恀棟垽1, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榓揷戱栫2, 拞攏婎攷1, 憪栰丂墰2, 嶳壓宲巎1,3, 揷绯丂憦2,4, 斾婇捈庽1 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕, 4怴悽婭堛椕丒愭抂堛椕): 戞23夞暊峯嬀撪帇嬀崌摨尋媶夛 (2022/3/4), Web奐嵜.
732043. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 椷榓偵偼偽偨偔LECS偺偙傟偐傜. 斾婇捈庽 (忋晹徚壔娗奜): 擔杮徚壔婍昦妛夛杒棨巟晹戞44夞嫵堢島墘夛 (2021/6/6), 晉嶳, 擔杮徚壔婍昦妛夛杒棨巟晹椺夛僾儘僌儔儉丒彺榐廤 2021/6; 131: 4.
732044. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 鈛鈨晹愗彍偵拝栚偟偨堓愗彍朄暿懱廳丒崪奿嬝検尭彮棪偺専摙. 烴扟旤婱巕1, 斾婇捈庽1, 拞攏婎攷1, 榟旜恀棟垽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞43夞擔杮塰梴傾僙僗儊儞僩尋媶夛 (2021/6/26), Web奐嵜.
732045. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 偑傫帯椕偵娭偡傞塰梴忈奞丒憻婍忈奞懳墳亂掅塰梴亃. 斾婇捈庽 (忋晹徚壔娗奜): 2022擭戞1夞NST愱栧椕朄巑峏怴昁恵僙儈僫乕 (2022/3/6), 嫗搒.
732046. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 廃弍婜娗棟 (憤榑). 斾婇捈庽 (忋晹徚壔娗奜): 2022擭戞1夞NST愱栧椕朄巑峏怴昁恵僙儈僫乕 (2022/3/6), 嫗搒.
733087. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) LECS偵偍偗傞嫄戝堓暻寚懝晹偺幬幉暵嵔庤媄. 墱栰峎懢1, 榟旜恀棟垽1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2, 斾婇捈庽1, 孏尦梇夘3, 撪摗丂崉4 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3堦斒丒彫帣丒娞抇鋁奜, 4壓晹徚壔娗奜): 戞75夞庤弍庤媄尋媶夛 (2021/5/14-15), 惷壀 (僴僀僽儕僢僪奐嵜).
733088. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉堾偵偍偗傞儘儃僢僩巟墖嫻峯嬀壓怘摴愗彍弍偺尰忬. 怴尨惓戝1, 嵶揷丂宩1, 媿媣廏庽1, 尨揷岹婸1, 烴扟旤婱巕1, 榟旜恀棟垽1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞75夞庤弍庤媄尋媶夛 (2021/5/14-15), 惷壀 (僴僀僽儕僢僪奐嵜).
733089. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉壢偵偍偗傞忋晹堓娻, 崅楊幰堓娻傊偺帯椕愴棯乣戙懼帯椕偲偟偰偺LECS傪娷傔偰. 榟旜恀棟垽1, 斾婇捈庽1, 尨揷岹婸1, 榓揷戱栫2, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 揷绯丂憦2,4 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕, 4怴悽婭堛椕丒愭抂堛椕): 戞43夞擔杮娻嬊強椕朄尋媶夛 (2021/5/21), Web奐嵜.
733090. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 弍慜崪奿嬝検尭彮偼懠昦巰梊應場巕偲側傝摼傞偐?乣 Stage I 堓娻偺専摙乣. 烴扟旤婱巕1, 嶳壓宲巎1,2, 揧栰岶暥3, 尨揷岹婸1, 榟旜恀棟垽1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3戝妛堾堛椕宯尋媶壢): 戞43夞擔杮娻嬊強椕朄尋媶夛 (2021/5/21), Web奐嵜.
733091. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僴僀儕僗僋暪懚幘姵傪帩偮堓娻偵懳偟LECS傪巤峴偟偨堦椺. 抮懞嫗擵夘1, 榟旜恀棟垽1, 墱栰峎懢1, 拞攏婎攷1, 榓揷戱栫2, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 揷绯丂憦2,4, 斾婇捈庽1 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕, 4怴悽婭堛椕丒愭抂堛椕): 戞860夞奜壢廤択夛 (2021/6/26), Web奐嵜.
733092. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 峯嬀壓偵廋暅偟偨Petersen僿儖僯傾浧撢偺1椺. 廐塱惤巙榊, 揷拞姲恖1, 墱栰峎懢1, 拞攏婎攷1, 榟旜恀棟垽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞861夞奜壢廤択夛 (2021/9/11), Web奐嵜.
733093. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 崅楊幰堓娻姵幰偵懳偡傞optional LECS. 榟旜恀棟垽1, 斾婇捈庽1, 拞攏婎攷1, 榓揷戱栫2, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 揷绯丂憦2,4 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕, 4怴悽婭堛椕丒愭抂堛椕): 戞53夞恄撧愳導徚壔婍昦堛妛夛憤夛 (2021/10/30), Web奐嵜.
733094. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 崅楊幰偺10 cm埲忋偺堓娻堓偑傫偵懳偡傞LECS偺堦椺. 榟旜恀棟垽1, 斾婇捈庽1, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榓揷戱栫2, 拞攏婎攷1, 憪栰丂墰2, 揷绯丂憦2,3, 嶳壓宲巎1,4 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒愭抂堛椕, 4怴悽婭堛椕丒墶抐揑堛椕): 戞14夞愭恑撪帇嬀帯椕尋媶夛 (J-CASE) (2021/11/6), Web奐嵜.
733095. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 帇妎傾僫儘僌僗働乕儖傪梡偄偨桯栧懁堓愗彍屻偺僟儞僺儞僌徢岓孮偵娭偡傞専摙. 拞攏婎攷1, 榟旜恀棟垽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞51夞堓奜壢丒弍屻忈奞尋媶夛 (2021/11/11), Web奐嵜.
733096. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怘摴嵞寶傪娷傓暚栧捈壓偺LECS偺寚懝岴朌崌偺僐僣. 榟旜恀棟垽1, 斾婇捈庽1, 榓揷戱栫2, 怴尨惓戝1, 揷绯丂憦2,3 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒愭抂堛椕): 戞113夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/12/4), Web奐嵜.
733097. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 巆堓態庮ESD屻慂岴偵傛傞抇廯惈屻暊枌墛偵懳偟偰奜壢帯椕偵偰媬柦偟摼偨堦椺. 彫郪寢壴1, 拞攏婎攷1, 崟揷丂桰1, 榟旜恀棟垽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞862夞奜壢廤択夛 (2021/12/8), Web奐嵜.
733098. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擠怭16廡偱敪惗偟偨暃銪擯揮偵懳偟暊峯嬀偱愗彍偟摼偨堦椺. 壓宍彨墰1, 惣郪怢嫳2, 娫拞宧夘1, 抮懞嫗擵夘1, 墱栰峎懢1, 昹栰堣旤, 拞愳錆桽3, 僂僢僪僴儉僗楁巕4, 嶰奒婱巎5, 撪摗丂崉6, 斾婇捈庽1, 孏尦梇夘2 (1忋晹徚壔娗奜, 2堦斒丒彫帣丒娞抇鋁奜, 3戝妛堾堛椕宯尋媶壢, 4曻幩慄 (夋憸), 5擕態丒峛忬態奜, 6壓晹徚壔娗奜): 戞863夞奜壢廤択夛 (2022/3/12), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110018. [尨挊] Size-dependent differences in the proximal remnant stomach: how much does a small remnant stomach after subtotal gastrectomy work? Yasufuku I, Ohashi M, Eto K, Ida S, Kumagai K, Nunobe S, Sano T, Hiki N1: Surg Endosc 2020/12; 34 (12): 5540-9. (斾婇捈庽1: 1忋晹徚壔娗奜)
[妛夛丒尋媶夛摍]
'20-723023. [妛夛 (慡崙)] (堦斒島墘) 價僢僋僨乕僞偐傜摼偨撪帇嬀奜壢偺僄價僨儞僗: NCD偵傛傞Real World僨乕僞偑堓娻偵偍偗傞庤弍庤媄傪曄偊傞壜擻惈. 斾婇捈庽1, 媑揷榓峅, 杮懡捠岶, 塹摗丂崉, 堜揷丂抭, 孏娵丂戱, 彫帥懽峅, 妡抧媑峅, 崱栰峅擵, 媨揷桾復, 悾屗懽擵, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/13), 墶昹 (僴僀僽儕僢僪奐嵜).
壓晹徚壔娗奜壢妛
[妛弍榑暥]
110267. [尨挊] Current status of laparoscopic bariatric/metabolic surgery in Japan: The sixth nationwide survey by the Japan Consortium of Obesity and Metabolic Surgery. Ohta M, Kasama K, Sasaki A, Naitoh T1, Seki Y, Inamine S, Oshiro T, Doki Y, Seto Y, Hayashi H, Uyama I, Takiguchi S, Kojima K, Mori T, Inomata M, Kitagawa Y, Kitano S, Japan Consortium of Obesity and Metabolic Surgery (JCOMS): Asian J Endosc Surg 2021/4; 14 (2): 170-7. (撪摗丂崉1: 1壓晹徚壔娗奜)
110268. [尨挊] Prediction of Long-Term Diabetes Remission After Metabolic Surgery in Obese East Asian Patients: a Comparison Between ABCD and IMS Scores. Ohta M, Seki Y, Ohyama T, Bai R, Kim SH, Oshiro T, Jiang T, Sasaki A, Naitoh T1, Yamaguchi T, Inamine S, Miyazaki Y, Ahn SM, Heo Y, Liang H, Choi SH, Yang W, Yao Q, Inoue K, Yamamoto H, Lee HJ, Park YS, Ha TK, Ryu SW, Wang C, Park S, Kasama K: Obes Surg 2021/4; 31 (4): 1485-95. (撪摗丂崉1: 1壓晹徚壔娗奜)
110269. [尨挊] Staging laparoscopy is mandatory for the treatment of pancreatic cancer to avoid missing radiologically negative metastases. Takadate T, Morikawa T, Ishida M, Aoki S, Hata T, Iseki M, Miura T, Ariake K, Maeda S, Kawaguchi K, Masuda K, Ohtsuka H, Mizuma M, Hayashi H, Nakagawa K, Motoi F, Kamei T, Naitoh T1, Unno M: Surg Today 2021/5; 51 (5): 686-94. (撪摗丂崉1: 1壓晹徚壔娗奜)
110270. [尨挊] Usefulness of laparoscopic surgery and preoperative examinations for chronic recurrent small bowel obstruction. Yahagi M1, Ishii Y1,2, Ochiai H1, Sako H1, Maeda H1, Takemura Y1, Oka T1, Soutome K1, Kamiya N1,3, Watanabe M1: Surg Today 2021/5; 51 (5): 807-13. (栴嶌夒巎1, 愇堜椙岾1,2, 棊崌戝庽1, 敆丂桾擵1, 慜揷擔嵷巕1, 抾懞桾夘1, 壀丂懽廈1, 屲寧彈宐堦1, 恄扟婭婸1,3, 搉绮徆旻1: 1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3屇媧婍奜)
110271. [尨挊] The role of bilio-pancreatic limb in nonalcoholic steatohepatitis improvement after duodenal-jejunal bypass in rats. Ichikawa H, Imoto H, Tanaka N, Fujishima F, Tsuchiya T, Watanabe K, Aoki T, Kohyama A, Morikawa T, Ohnuma S, Naitoh T1, Kamei T, Unno M: Surgery 2021/10; 170 (4): 1006-13. (撪摗丂崉1: 1壓晹徚壔娗奜)
110029. [尨挊] Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization. Goto T1, Ito Y2, Satoh M3, Nakamoto S4, Nishizawa N4, Hosono K2, Naitoh T5, Eshima K3, Iwabuchi K3, Hiki N6, Amano H2: Front Immunol 2021/10; 12: 754106. (屻摗戩栫1, 埳摗媊栫2, 嵅摗丂夒3, 拞杮廋巌4, 惣郪怢嫳4, 嵶栰壛撧巕2, 撪摗丂崉5, 峕搰峩擇3, 娾熀榓栫3, 斾婇捈庽6, 揤栰塸庽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3柶塽, 4堦斒丒彫帣丒娞抇鋁奜, 5壓晹徚壔娗奜, 6忋晹徚壔娗奜)
110272. [尨挊] Comprehensive Analysis of microRNA Profiles in Organoids Derived from Human Colorectal Adenoma and Cancer. Nagai H, Kuroha M, Handa T, Karasawa H, Ohnuma S, Naito T, Moroi R, Kanazawa Y, Shiga H, Hamada S, Kakuta Y, Naitoh T1, Kinouchi Y, Shimosegawa T, Masamune A: Digestion 2021/11; 102 (6): 860-9. (撪摗丂崉1: 1壓晹徚壔娗奜)
110273. [尨挊] A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo. Kokubo S, Ohnuma S, Murakami M, Kikuchi H, Funayama S, Suzuki H, Kajiwara T, Yamamura A, Karasawa H, Sugisawa N, Ohsawa K, Kano K, Aoki J, Doi T, Naitoh T1, Ambudkar SV, Unno M: Int J Mol Sci 2021/11; 22 (22): 12502. (撪摗丂崉1: 1壓晹徚壔娗奜)
320003. [徢椺曬崘] 庒擭彈惈偺慄堐態庮撪偵擣傔傜傟偨旕怹弫惈擕娗娻偺1椺. 慜揷擔嵷巕1, 慜揷堦榊1,2, 桍郪婱巕1, 屲寧彈宐堦1, 愺徖巎庽1, 栴撪尨媣1, 抮揷丂惓1, 愇堜椙岾1,3 (1杒棦戝妛杒棦尋媶強昦堾, 2昦棟, 3壓晹徚壔娗奜): 擕娻偺椪彴 2021/7; 36 (3): 249-57.
520008. [憤愢] 嬊強恑峴捈挵娻偵懳偡傞壔妛曻幩慄椕朄偺尰忬. 嵅摗晲榊1,2 (1堛椕媄弍嫵堢, 2壓晹徚壔娗奜): 杒棦堛妛 2021/6; 51 (1): 1-5.
522072. [島嵗]亂摿廤: 暊峯嬀壓庤弍偺婎杮亃1. 暊峯嬀壓庤弍偺摿挜. 撪摗丂崉1, 嵅摗晲榊1,2, 嶳棞崅峀1, 嶰塝孾氭1, 屆忛丂寷1, 揷拞弐摴1, 墶堜孿屽1, 嵶揷丂宩1, 嶳壓宲巎3,4, 孏尦梇夘5, 斾婇捈庽4 (1壓晹徚壔娗奜, 2堛椕媄弍嫵堢, 3怴悽婭堛椕丒墶抐揑堛椕, 4忋晹徚壔娗奜, 5堦斒丒彫帣丒娞抇鋁奜): 徚壔婍奜壢 2021/4; 44 (4): 385-90.
522073. [島嵗]亂楢嵹: 巹偺帯椕亃挵暵嵡 (僀儗僂僗). 棊崌戝庽1, 愇堜椙岾1,2, 搉绮徆旻1 (1杒棦尋媶強昦堾, 2壓晹徚壔娗奜): 擔杮堛帠怴曬 2021/4; 5061: 37-8.
522074. [島嵗]亂摿廤: 捈挵偑傫偺庤弍傪傔偖傞娕岇乣怘傋傞丒攔煏偡傞丒摦偔乿傪僒億乕僩偡傞乣亃僨乕僞偱傒傞捈挵偑傫偺摿挜. 嵅摗晲榊1,2, 嶳棞崅峀2, 撪摗丂崉2 (1堛椕媄弍嫵堢, 2壓晹徚壔娗奜): 偑傫娕岇 2021/9-10; 26 (7): 575-7.
522075. [島嵗]亂摿廤: 僗僐僺僗僩傪嬌傔傞亃仭奺榑丂暊峯嬀壓俽忬寢挵愗彍偱偺僗僐僺僗僩偺僥僋僯僢僋偲僐僣. 揷拞弐摴1, 墶堜孿屽1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1,2, 撪摗丂崉1 (1壓晹徚壔娗奜, 2堛椕媄弍嫵堢): 椪彴奜壢 2021/10; 76 (10): 1240-5.
530009. [偦偺懠 (joint consensus statement)] Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity. Sasaki A, Yokote K, Naitoh T1, Fujikura J, Hayashi K, Hirota Y, Inagaki N, Ishigaki Y, Kasama K, Kikkawa E, Koyama H, Masuzaki H, Miyatsuka T, Nozaki T, Ogawa W, Ohta M, Okazumi S, Shimabukuro M, Shimomura I, Nishizawa H, Saiki A, Seki Y, Shojima N, Tsujino M, Ugi S, Watada H, Yamauchi T, Yamaguchi T, Ueki K, Kadowaki T, Tatsuno I; Joint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, Joint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, the Japan Society for the Study of Obesity: Diabetol Int 2021/11; 13 (1): 1-30. (撪摗丂崉1: 1壓晹徚壔娗奜)
540026. [偦偺懠 (埾堳夛曬崘)] 擔杮恖偺旍枮2宆摐擜昦姵幰偵懳偡傞尭検丒戙幱夵慞庤弍偵娭偡傞僐儞僙儞僒僗僗僥乕僩儊儞僩 嵅乆栘復1, 撪摗丂崉1,2, 墶庤岾懢榊1, 堫奯挩栫1, 塿嶈桾復1, 柸揷桾岶1, 彫愳丂徛1, 壓懞埳堦榊1, 嶳撪晀惓1, 愇奯丂懽1, 妢娫榓揟1, 栰嶈崉峅1, 搰戃廩惗1, 摗憅弮擇1, 媨捤丂寬1,3, 彲搱怢峗1, 惣郪丂嬒1, 淎揷桬巑1, 塊栘丂抭1, 懢揷惓擵1, 壀廧怲堦1, 媑愳奊棞1, 彫嶳塸懃1, 釼栘岤恖1, 娭丂梞夘1, 捯栰尦徦1, 椦丂壥椦1, 嶳岥丂悞1, 棿栰堦榊1, 怉栘峗擇榊1, 栧榚丂岶1 (1擔杮恖偺旍枮2宆摐擜昦姵幰偵懳偡傞尭検丒戙幱夵慞庤弍偺揔墳婎弨偵娭偡傞3妛夛崌摨埾堳夛, 擔杮旍枮徢帯椕妛夛, 擔杮摐擜昦妛夛, 擔杮旍枮妛夛, 2壓晹徚壔娗奜, 3撪暘斿戙幱撪): 摐擜昦 2022/3; 65 (3): 109-77.
[挊丂彂]
620080. [妛弍彂 (暘扴幏昅)]亂寛掕斉!恾夝偱傕傟側偔傒偊傞丒傢偐傞丂傑傞偛偲徚壔婍僪儗乕儞丒僠儏乕僽娗棟 (徚壔婍僫乕僔儞僌2021擭弔婫憹姧)亃仭6復僪儗乕儞丒僠儏乕僽偵傑偮傢傞働傾偺Q&A丂3 偦偺傎偐偺働傾, p.233-8. 墶堜孿屽1, 撪摗丂崉1 (1壓晹徚壔娗奜), 娔廋: 屟揷 寬堦, 儊僨傿僇弌斉 戝嶃, 2021/4敪峴.
620081. [妛弍彂 (暘扴幏昅)]亂愱栧堛昁実 怴奜壢庤弍彂 怴偟偄庤弍庤媄偺僄僢僙儞僗 (椪彴嶨帍奜壢2021擭4寧憹姧崋)亃III. 彫挵丂3. 桙拝惈挵暵嵡偵懳偡傞暊峯嬀壓庤弍偺庤弍庤媄, p.477-81. 嶰塝孾氭1, 揷拞弐摴1, 墶堜孿屽1, 屆忛丂寷1, 嶳棞崅峀1, 奀捗婱巎1, 嵶揷丂宩, 嵅摗晲榊1,2, 嶳壓宲巎3,4, 孏尦梇夘5, 斾婇捈庽4, 撪摗丂崉1 (1壓晹徚壔娗奜, 2堛椕媄弍嫵堢, 3怴悽婭堛椕丒墶抐揑堛椕, 4忋晹徚壔娗奜, 5堦斒丒彫帣丒娞抇鋁奜), 撿峕摪, 2021/4敪峴.
620082. [妛弍彂 (暘扴幏昅)]亂愱栧堛偺偨傔偺徚壔婍昦妛 戞3斉亃III 彫挵丒戝挵丂奺榑丂徚壔娗娫幙庮釃 (GIST), p.286-8. 揷拞弐摴1, 撪摗丂崉1 (1壓晹徚壔娗奜), 娔廋: 壓悾愳揙, 搉曈丂庣, 曇: 栘壓朏堦, 嬥巕廃堦, 妦揷攷巎, 懞忋榓惉, 埨摗丂楴, 巺堜棽晇, 堛妛彂堾, 搶嫗, 2021/11敪峴.
[妛夛丒尋媶夛摍]
713040. [妛夛 (崙嵺)] (堦斒島墘) Contribution of neoadjuvant chemoradiotherapy with S-1/ Irinotecan to minimally invasive treatment for advanced rectal cancer. Kojo K1, Naitoh T1, Sato T1, Yamanashi T1, Miura H1, Yokoi K1, Tanaka T1: 2021 Scientific Session of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) (2021/8/31-9/3), Las Vegas, USA. (屆忛丂寷1, 撪摗丂崉1, 嵅摗晲榊1, 嶳棞崅峀1, 嶰塝孾氭1, 墶堜孿屽1, 揷拞弐摴1: 1壓晹徚壔娗奜)
722116. [妛夛 (慡崙)] (僔儞億僕僂儉) 徚壔娗僶僀僷僗弍偺摐擜昦夵慞岠壥偺敪尰婡彉. 撪摗丂崉1, 揷拞捈庽, 堜杮攷暥, 拞攏婎攷2, 嵶揷丂宩2, 奀栰椣柧, 嵅摗晲榊1, 嶳壓宲巎2,3, 孏尦梇夘4, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕, 4堦斒丒彫帣丒娞抇鋁奜): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/3), 暫屔 (僴僀僽儕僢僪奐嵜).
722117. [妛夛 (慡崙)] (僔儞億僕僂儉) 庒庤堛巘偵傛傞捈挵娻儘儃僢僩巟墖壓庤弍偺嫵堢偵偮偄偰偺専摙. 揷拞弐摴1, 嶳棞崅峀1, 嶰塝孾氭1, 搉晹峎巕2, 屻摗戩栫2, 墶堜孿屽1, 屆忛丂寷1, 嵅摗晲榊1, 嵶揷丂宩3, 奀捗婱巎4, 嶳壓宲巎3,5, 孏尦梇夘4, 斾婇捈庽3, 撪摗丂崉1 (1壓晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3忋晹徚壔娗奜, 4堦斒丒彫帣丒娞抇鋁奜, 5怴悽婭堛椕丒墶抐揑堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/3), 暫屔 (僴僀僽儕僢僪奐嵜).
722118. [妛夛 (慡崙)] (僔儞億僕僂儉) 婎慴丒椪彴尋媶偐傜傒偨徚壔娗僶僀僷僗弍摫擖偺昁梫惈. 撪摗丂崉1, 揷拞捈庽, 堜杮攷暥, 拞攏婎攷2, 嵶揷丂宩2, 奀栰椣柧, 嵅摗晲榊1, 嶳壓宲巎2,3, 孏尦梇夘4, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕, 4堦斒丒彫帣丒娞抇鋁奜): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/3), 暫屔 (僴僀僽儕僢僪奐嵜).
722119. [妛夛 (慡崙)] (僔儞億僕僂儉) 懡怑庬楢実偵傛傞僠乕儉堛椕偲偟偰偺弍屻娗棟亅戅堾傑偱偺弴挷側憗婜夞暅偺偨傔偵亅尭検丒戙幱夵慞庤弍偵偍偗傞懡怑庬楢実偺庢傝慻傒. 撪摗丂崉1, 拞攏婎攷2, 巗愳棆巘3, 媨捤丂寬3, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3撪暘斿戙幱撪): 戞43夞擔杮庤弍堛妛夛憤夛 (2022/1/29), 戝嶃 (僴僀僽儕僢僪奐嵜).
722120. [妛夛 (慡崙)] (僔儞億僕僂儉) 摉壢偵偍偗傞戝挵娻偵懳偡傞reduced port surgery. 愇堜椙岾1,2, 棊崌戝庽1, 敆丂桾擵1, 抾懞梇夘1, 昹栰堣旤1, 墍揷孾懢1, 慜揷擔嵷巕1, 屲寧彈宐堦1, 恄扟婭婸1,3, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜壢, 3屇媧婍奜): 9th Reduced Port Surgery Forum in Okinawa (2022/2/16-3/31), Web奐嵜, 9th Reduced Port Surgery Forum in Okinawa 僾儘僌儔儉丒彺榐廤 2022/2; p.44.
722121. [妛夛 (慡崙)] (僔儞億僕僂儉) 3妛夛崌摨僗僥乕僩儊儞僩姧峴屻偺尭検丒戙幱夵慞庤弍偺尰忬偲揥朷. 撪摗丂崉1, 拞攏婎攷2, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜): 戞42夞擔杮旍枮妛夛丒戞39夞擔杮旍枮徢帯椕妛夛妛弍廤夛 (2022/3/27), 墶昹 (僴僀僽儕僢僪奐嵜).
723319. [妛夛 (慡崙)] (堦斒島墘) 懡巤愝嫟摨娤嶡尋媶偺桳梡惈乣戝婯柾庤弍尋媶帠柋嬊12擭偺宱尡偐傜乣. 旍揷岒栴, 壀懞椇曘, 惣嶉戝曘, 廧堜撝旻, 嬥忛梞夘, 嶁堜媊帯, 搉绮徆旻1, 撪摗丂崉2 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜壢): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8), Web奐嵜.
723320. [妛夛 (慡崙)] (堦斒島墘) 廫擇巜挵嬻挵僶僀僷僗弍偺旕傾儖僐乕儖惈帀朾娞墛夵慞岠壥偵偍偗傞抇鋁楬偺栶妱. 巗愳塸岶, 揷拞捈庽, 堜杮攷暥, 恄嶳撃巎, 惵栘丂崑, 搉曈榓岹, 戝徖丂擡, 摗搰巎婌, 撪摗丂崉1, 愇揷岶愰, 婽堜丂彯, 奀栰椣柧 (1壓晹徚壔娗奜): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8), Web奐嵜.
723321. [妛夛 (慡崙)] (堦斒島墘) 弍屻桙拝惈挵暵嵡偵懳偡傞暊峯嬀壓庤弍偺尰忬: 傢傟傢傟偺岺晇偲帯椕惉愌. 棊崌戝庽1, 愇堜椙岾1,2, 敆丂桾擵1, 抾懞桾夘1, 慜揷擔嵷巕1, 屲寧彈宑堦1, 恄扟婭婸1,3, 壀丂懽廈1, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜壢, 3屇媧婍奜): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723322. [妛夛 (慡崙)] (堦斒島墘) 弍慜 CT 傪梡偄偨崪奿嬝慻惉昡壙偼Stage III戝挵娻偺挿婜梊屻傪梊應偡傞. 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1, 嵶揷丂宩2, 揷搰丂峅3, 奀捗婱巎3, 壛摗丂峅4, 愬愇婭旻4, 斾婇捈庽2, 孏尦梇夘3, 嶰奒婱巎4, 揷拞丂寜3,5, 嶳壓宲巎2,6, 撪摗丂崉1 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4擕態丒峛忬態奜, 5怴悽婭堛椕丒愭抂堛椕, 6怴悽婭堛椕丒墶抐揑堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723323. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞戝挵恄宱撪暘斿娻偺帯椕惉愌. 揷拞弐摴1, 嵅摗晲榊1, 峛斻揷晲巙2, 屻摗戩栫2, 墶堜孿屽1, 屆忛丂寷1, 嶰塝孾氭1, 嵶揷丂宩3, 奀捗婱巎4, 壛摗丂峅5, 愬愇婭旻5, 嶳壓宲巎3,6, 孏尦梇夘4, 嶰奒婱巎5, 揷拞丂寜4,7, 斾婇捈庽3, 撪摗丂崉1 (1壓晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3忋晹徚壔娗奜, 4堦斒丒彫帣丒娞抇鋁奜, 5擕態丒峛忬態奜, 6怴悽婭堛椕丒墶抐揑堛椕, 7怴悽婭堛椕丒愭抂堛椕): 戞121夞擔杮奜壢妛夛掕婜妛弍廤夛 (2021/4/8-10), Web奐嵜.
723324. [妛夛 (慡崙)] (堦斒島墘) 峛忬態慡揈弍傪巤峴偟偨嫶杮昦媫惈憹埆偺1椺. 屲寧彈宐堦1, 慜揷擔嵷巕1, 桍郪婱巕1, 壀丂懽廈1, 抾懞桾夘1, 敆丂桾擵1, 棊崌戝庽1, 戝嶌徆媊1, 恄扟婭婸1,2, 愇堜椙岾1,3, 慜揷堦榊1,4, 抮揷丂惓1, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2屇媧婍奜, 3壓晹徚壔娗奜, 4昦棟): 戞33夞擔杮撪暘斿奜壢妛夛憤夛 (2021/6/3-4), 寉堜戲 (僴僀僽儕僢僪奐嵜), 擔杮撪暘斿奜壢妛夛嶨帍 2021/5; 38 (Suppl 1): S109.
723325. [妛夛 (慡崙)] (堦斒島墘) 寢挵娻偵偍偗傞CD44僶儕傾儞僩掕検宯偺妋棫偲椪彴昦棟妛揑堄媊偵偮偄偰偺専摙. 峛斻揷晲巙1, 屻摗戩栫1, 揷拞弐摴2, 墶堜孿屽2, 屆忛丂寷2, 嶰塝孾氭2, 嶳棞崅峀2, 嵅摗晲榊2, 嶳壓宲巎3,4, 撪摗丂崉2 (1戝妛堾堛椕宯尋媶壢, 2壓晹徚壔娗奜, 3忋晹徚壔娗奜, 4怴悽婭堛椕丒墶抐揑堛椕): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/7), 嫗搒 (僴僀僽儕僢僪奐嵜).
723326. [妛夛 (慡崙)] (堦斒島墘) 恑峴墶峴寢挵娻偵懳偡傞帄揔愡妔惔斖埻偺専摙. 嶰塝孾氭1, 嵅摗晲榊1, 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嶳棞崅峀1, 嶳壓宲巎2,3, 孏尦梇夘4, 斾婇捈庽3, 撪摗丂崉1 (1壓晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3忋晹徚壔娗奜, 4堦斒丒彫帣丒娞抇鋁奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/7), 嫗搒 (僴僀僽儕僢僪奐嵜).
723327. [妛夛 (慡崙)] (堦斒島墘) 弍慜CT傪梡偄偨崪奿嬝掕検偺Stage III戝挵娻偵偍偗傞椪彴揑堄媊偺抝彈嵎偵偮偄偰偺専摙. 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1, 嶳壓宲巎2,3, 斾婇捈庽3, 孏尦梇夘4, 撪摗丂崉1 (1壓晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3忋晹徚壔娗奜, 4堦斒丒彫帣丒娞抇鋁奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/7), 嫗搒 (僴僀僽儕僢僪奐嵜).
723034. [妛夛 (慡崙)] (堦斒島墘) 娞嫊寣嵞燇棳忈奞屻偺娞廋暅偵偍偗傞iNKT嵶朎偺栶妱. 屻摗戩栫1, 埳摗媊栫2, 嵅摗丂夒3, 拞杮廋巌4, 嵶栰壛撧巕2, 敤拞丂岞2, 攏搱惓棽2, 揤栰塸庽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3柶塽, 4堦斒丒彫帣丒娞抇鋁奜): 戞42夞擔杮墛徢膼秷銑w夛 (2021/7/7), Web奐嵜.
723328. [妛夛 (慡崙)] (堦斒島墘) 僆儞僐僷僱儖専嵏偵婎偯偔僎僲儉堛椕偵傛偭偰姰慡憈岟偑摼傜傟偨恑峴嵞敪汨栧娗娻偺1椺. 揷拞弐摴1, 峛斻揷晲巙2, 屻摗戩栫2, 墶堜孿屽1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1, 斾婇捈庽3, 撪摗丂崉1 (1壓晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3忋晹徚壔娗奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/8), 嫗搒 (僴僀僽儕僢僪奐嵜).
723329. [妛夛 (慡崙)] (堦斒島墘) 尷嬊偡傞娞撪抇娗奼挘偱敪尒偝傟偨S忬寢挵娻弍屻娞揮堏偺1椺. 嶁杮桭尒巕, 墶揷榓巕1, 婙庤榓旻, 嬥郪廏婭, 嬥揷屽榊, 杧揷埢巕, 嵵摗惗楴, 奀捗婱巎2, 孏尦梇夘2 (1壓晹徚壔娗奜, 2堦斒丒彫帣丒娞抇鋁奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/8), 嫗搒 (僴僀僽儕僢僪奐嵜).
723330. [妛夛 (慡崙)] (堦斒島墘) 嬀帇壓庤弍帪戙偵偍偗傞摉堾偺媫惈拵悅墛偵懳偡傞嬞媫庤弍偲懸婡庤弍偺惉愌偺専摙. 抾懞桾夘1, 愇堜椙岾1,2, 壀丂懽廈1, 慜揷擔嵷巕1, 敆丂桾擵1, 棊崌戝庽1, 屲寧彈宐堦1, 恄扟婭婸1,3, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3屇媧婍奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/7-9), 嫗搒 (僴僀僽儕僢僪奐嵜), 擔杮徚壔婍奜壢妛夛憤夛76夞僾儘僌儔儉 2021/7; p.P293-6.
723331. [妛夛 (慡崙)] (堦斒島墘) 堓愗彍屻偺崪奿嬝検偺曄壔偲梊屻傊偺塭嬁. 敆丂桾擵1, 壀丂懽廈1, 抾懞桾夘1, 慜揷擔嵷巕1, 棊崌戝庽1, 屲寧彈宐堦1, 恄扟婭婸1,2, 愇堜椙岾1,3, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2屇媧婍奜, 3壓晹徚壔娗奜): 戞76夞擔杮徚壔婍奜壢妛夛憤夛 (2021/7/7-9), 嫗搒 (僴僀僽儕僢僪奐嵜), 擔杮徚壔婍奜壢妛夛憤夛76夞僾儘僌儔儉 2021/7; p.P022-1.
723332. [妛夛 (慡崙)] (堦斒島墘) 僆儞僐僷僱儖専嵏偵婎偯偔偑傫僎僲儉堛椕偱姰慡憈岟傪摼偨恑峴嵞敪汨栧娗娻偺1椺. 揷拞弐摴1, 峛斻揷晲巙1, 屻摗戩栫2, 墶堜孿屽1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1, 撪摗丂崉1, 嵅乆栘帯堦榊3 (1壓晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞59夞擔杮娻帯椕妛夛妛弍廤夛 (2021/10/21-23), 墶昹 (僴僀僽儕僢僪奐嵜).
723333. [妛夛 (慡崙)] (堦斒島墘) 峛忬態幘姵弍屻, 斀夞恄宱晄慡杻醿偺専摙. 屲寧彈宐堦1, 慜揷擔嵷巕1, 桍郪婱巕1, 墍揷孾懢1, 抾懞桾夘1, 昹栰堣旤1, 敆丂桾擵1, 棊崌戝庽1, 恄扟婭婸1,2, 愇堜椙岾1,3, 搉绮徆旻1, 抮揷丂惓1 (1杒棦戝妛杒棦尋媶強昦堾, 2屇媧婍奜, 3壓晹徚壔娗奜): 戞54夞擔杮撪暘斿奜壢妛夛妛弍戝夛 (2021/10/28-29), Web奐嵜, 擔杮撪暘斿奜壢妛夛嶨帍 2021/10; 38 (Suppl 2): S255.
723334. [妛夛 (慡崙)] (堦斒島墘) 堓愗彍弍偵偍偗傞撪憻帀朾偺塭嬁. 敆丂桾擵1, 壀丂懽廈1, 抾懞桾夘1, 慜揷擔嵷巕1, 棊崌戝庽1, 屲寧彈宐堦1, 恄扟婭婸1,2, 愇堜椙岾1,3, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2屇媧婍奜, 3壓晹徚壔娗奜): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (戞19夞擔杮徚壔婍奜壢妛夛戝夛) (2021/11/4-7), 恄屗 (僴僀僽儕僢僪奐嵜).
723335. [妛夛 (慡崙)] (堦斒島墘) S忬寢挵娻弍屻偵帳釕揮堏傪棃偟偨1椺. 娵嶳惓桾1, 撪摗惓婯, 愮栰怲堦榊1, 枼塝岹擵1, 摗旜弐廩2, 揧栰岶暥3, 拞攏婎攷4, 拞懞榓摽2, 嬤摗峃巎5, 崅嫶掯恖2, 撪摗丂崉1 (1壓晹徚壔娗奜, 2堦斒丒彫帣丒娞抇鋁奜, 3戝妛堾堛椕宯尋媶壢, 4忋晹徚壔娗奜, 5擕態丒峛忬態奜): 戞76夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2021/11/13), 峀搰 (僴僀僽儕僢僪奐嵜).
723336. [妛夛 (慡崙)] (堦斒島墘) 捈挵娻偵懳偡傞儘儃僢僩庤弍偲暊峯嬀壓庤弍偺斾妑専摙. 嶰塝孾氭1, 嶳棞崅峀1, 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嵅摗晲榊1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞76夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2021/11/12-13), 峀搰 (僴僀僽儕僢僪奐嵜).
723337. [妛夛 (慡崙)] (堦斒島墘) 恑峴嵞敪汨栧娗娻偵懳偟偰僆儞僐僷僱儖専嵏偵婎偯偄偨偑傫僎僲儉堛椕偑憈岟偟偨1椺. 揷拞弐摴1, 搉晹峎巕2, 屻摗戩栫2, 墶堜孿屽1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1, 撪摗丂崉1 (1壓晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢): 戞76夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2021/11/12-13), 峀搰 (僴僀僽儕僢僪奐嵜).
723338. [妛夛 (慡崙)] (堦斒島墘) 弍慜CT傪梡偄偨崪奿嬝掕検偲墛徢儅乕僇乕偺Stage III戝挵娻偵偍偗傞椪彴揑堄媊偵偮偄偰偺専摙. 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞76夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2021/11/12-13), 峀搰 (僴僀僽儕僢僪奐嵜).
723339. [妛夛 (慡崙)] (堦斒島墘) Stage III戝挵娻偵偍偗傞弍慜弍屻CT傪梡偄偨崪奿嬝慻惉昡壙偲墛徢儅乕僇乕偺憡娭. 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵶揷丂宩2, 奀捗婱巎3, 嵅摗晲榊1, 孏尦梇夘3, 斾婇捈庽2, 撪摗丂崉1 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18-20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723340. [妛夛 (慡崙)] (堦斒島墘) 奜壢揑帯椕夘擖傪偟偨戝挵NET (neuroendocrine tumor) 15椺偵偮偄偰偺専摙. 屻摗戩栫1, 揷拞弐摴2, 墶堜孿屽2, 屆忛丂寷2, 嶰塝孾氭2, 嶳棞崅峀2, 嵶揷丂宩3, 奀捗婱巎4, 嵅摗晲榊2, 孏尦梇夘4, 斾婇捈庽3, 撪摗丂崉2 (1戝妛堾堛椕宯尋媶壢, 2壓晹徚壔娗奜, 3忋晹徚壔娗奜, 4堦斒丒彫帣丒娞抇鋁奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18-20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723341. [妛夛 (慡崙)] (堦斒島墘) 態娻傪敽偆捈挵恄宱撪暘斿娻偵懳偟偰宱汨栧揑撪帇嬀壓掅怤廝庤弍傪巤峴偟偨1椺. 墍揷孾懢1, 棊崌戝庽1, 愇堜椙岾1,2, 屲寧彈宐堦1, 恄扟婭婸1,3, 敆丂桾擵1, 昹栰堣旤1, 抾懞桾夘1, 搉绯徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜壢, 3屇媧婍奜): 戞83夞擔杮椪彴奜壢妛夛憤夛 (2021/11/18-20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723342. [妛夛 (慡崙)] (堦斒島墘) 墶峴寢挵娻偵懳偡傞暊峯嬀壓庤弍偺帯椕惉愌. 嶰塝孾氭1, 揷拞弐摴1, 墶堜孿屽1, 屆忛丂寷1, 嶳棞崅峀1, 搉晹峎巕2, 屻摗戩栫2, 嵅摗晲榊1, 嵶揷丂宩3, 奀捗婱巎4, 嶳壓宲巎3,5, 孏尦梇夘4, 斾婇捈庽3, 撪摗丂崉1 (1壓晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3忋晹徚壔娗奜, 4堦斒丒彫帣丒娞抇鋁奜, 5怴悽婭堛椕丒墶抐揑堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/3), 暫屔 (僴僀僽儕僢僪奐嵜).
723343. [妛夛 (慡崙)] (堦斒島墘) 弍慜CT傪梡偄偨崪奿嬝掕検偺戝挵娻偵偍偗傞椪彴揑堄媊偲墛徢儅乕僇乕偺憡娭. 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵶揷丂宩2, 奀捗婱巎3, 嶳壓宲巎2,4, 嵅摗晲榊1, 斾婇捈庽2, 孏尦梇夘3, 撪摗丂崉1 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4怴悽婭堛椕丒墶抐揑堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/3), 暫屔 (僴僀僽儕僢僪奐嵜).
723344. [妛夛 (慡崙)] (堦斒島墘) 恑峴捈挵娻偵懳偡傞壔妛曻幩慄帯椕屻偺嬀帇壓懁曽儕儞僷愡妔惔偺帯椕惉愌. 屆忛丂寷1, 嵅摗晲榊1, 嶳棞崅峀1, 嶰塝孾氭1, 墶堜孿屽1, 揷拞弐摴1, 嵶揷丂宩2, 奀捗婱巎3, 嶳壓宲巎2,4, 斾婇捈庽2, 孏尦梇夘3, 撪摗丂崉1 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4怴悽婭堛椕丒墶抐揑堛椕): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/4), 暫屔 (僴僀僽儕僢僪奐嵜).
723345. [妛夛 (慡崙)] (堦斒島墘) 弍屻桙拝惈挵暵嵡偵懳偡傞暊峯嬀壓庤弍偵偍偗傞僼傽乕僗僩億乕僩憓擖偺岺晇. 棊崌戝庽1, 愇堜椙岾1,2, 敆丂桾擵1, 昹栰堣旤1, 抾懞梇夘1, 墍揷孾懢1, 恄扟婭婸1,3, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3屇媧婍奜): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/2-4), 恄屗 (僴僀僽儕僢僪奐嵜), 擔杮撪帇嬀奜壢妛夛嶨帍 2021/12; 26 (7): MO169-1.
723346. [妛夛 (慡崙)] (堦斒島墘) 暋悢夞偺暊晹庤弍楌偑偁傞桙拝惈挵暵嵡偵懳偟偰暊峯嬀壓庤弍傪巤峴偟偨1椺. 墍揷孾懢1, 棊崌戝庽1, 愇堜椙岾1,2, 恄扟婭婸1,3, 敆丂桾擵1, 昹栰堣旤1, 抾懞梇夘1, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3屇媧婍奜): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/2-4), 恄屗 (僴僀僽儕僢僪奐嵜), 擔杮撪帇嬀奜壢妛夛嶨帍 2021/12; 26 (7): MO198-2.
723347. [妛夛 (慡崙)] (堦斒島墘) 椙惈廲妘庮釃揈弌弍偵偍偗傞埨慡側庤弍庤媄偺専摙. 恄扟婭婸1,2, 墍揷孾懢1, 抾懞桾夘1, 昹栰堣旤1, 敆丂桾擵1, 棊崌戝庽1, 愇堜椙岾1,3 (1杒棦戝妛杒棦尋媶強昦堾, 2屇媧婍奜, 3壓晹徚壔娗奜): 戞34夞擔杮撪帇嬀奜壢妛夛憤夛 (2021/12/2-4), 恄屗 (僴僀僽儕僢僪奐嵜), 擔杮撪帇嬀奜壢妛夛嶨帍 2021/12; 26 (7): MO059-4.
723348. [妛夛 (慡崙)] (堦斒島墘) QOL岦忋傪栚巜偟偨IBD僙儞僞乕撪壢堛偲戝挵奜壢堛偲偺僐儔儃儗乕僔儑儞. 棊崌戝庽1, 愇堜椙岾1,2, 彫椦丂戱1,3 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3戝妛堾堛椕宯尋媶壢): 戞18夞擔杮徚壔娗妛夛憤夛妛弍廤夛 (GI Week 2022) (2022/2/11-12), 搶嫗 (僴僀僽儕僢僪奐嵜).
733099. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 弍慜恌抐壜擻偱偁偭偨夞挵NET偵懳偟撪帇嬀揑帯椕偍傛傃暊峯嬀壓崻帯愗彍傪巤峴偟偨1椺. 塱壀錆棙撧1, 棊崌戝庽1, 愇堜椙岾1,2, 惣懞丂尗1,3, 敆丂桾擵1, 抾懞桾夘1, 恄扟婭婸1,4, 戝嶌徆媊1, 拞栰丂夒1, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3徚壔婍撪, 4屇媧婍奜): 戞112夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2021/6/12-13), Web奐嵜, Progress of Digestive Endoscopy 2021/6; 99 (suppl): S128.
733100. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 捈挵娻偵懳偡傞儘儃僢僩庤弍偲暊峯嬀壓庤弍偺斾妑専摙. 嶰塝孾氭1, 嶳棞崅峀1, 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嵅摗晲榊1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞95夞戝挵娻尋媶夛 (2021/7/2), 埉愳 (僴僀僽儕僢僪奐嵜).
733101. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉堾偵偍偗傞崅楊幰偺戝挵娻曗彆壔妛椕朄巤峴幚懺偵偮偄偰偺専摙. 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞95夞戝挵娻尋媶夛 (2021/7/2), 埉愳 (僴僀僽儕僢僪奐嵜).
733102. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 堓擲枌壓偵摿堎側宍懺偺懡朳惈擽釃傪宍惉偟, 廫擇巜挵捵釃偺慂攋偑媈傢傟偨1椺. 媣尨復峅1, 嵅忋怶懢榊1, 昹栰堣旤1, 恏搰丂椛1, 杒瀶丂栦1, 媨扟樞桟1, 擔斾婭暥1,2, 墍揷孾懢1, 抾懞桾夘1, 敆丂桾擵1, 棊崌戝庽1, 愇堜椙岾1,3, 惣懞丂尗1,4, 彫椦丂戱1,2, 拞栰丂夒1 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4徚壔婍撪): 擔杮徚壔婍昦妛夛娭搶巟晹戞366夞椺夛 (2021/9/18), Web奐嵜, 擔杮徚壔婍昦妛夛娭搶巟晹椺夛僾儘僌儔儉丒彺榐廤366夞 2021/9; 彺榐廤366夞: 45.
733010. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Role of IFN-兞 produced by iNKT cells in liver repair after hepatic ischemiareperfusion injury in mice. 屻摗戩栫1, 埳摗媊栫2, 嵅摗丂夒3, 拞杮廋巌4, 嵶栰壛撧巕2, 敤拞丂岞2, 揤栰塸庽2, 攏搱惓棽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3柶塽, 4堦斒丒彫帣丒娞抇鋁奜): 戞145夞擔杮栻棟妛夛娭搶晹夛 (2021/10/9), Web奐嵜.
733103. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Stage II戝挵娻偺嵞敪儕僗僋場巕偺専摙. 搉晹峎巕1, 屆忛丂寷2, 屻摗戩栫1, 揷拞弐摴2, 墶堜孿屽2, 嶰塝孾氭2, 嶳棞崅峀2, 嵅摗晲榊2, 撪摗丂崉2 (1戝妛堾堛椕宯尋媶壢, 2壓晹徚壔娗奜): 戞96夞戝挵娻尋媶夛 (2022/1/21), 搶嫗 (僴僀僽儕僢僪奐嵜).
733104. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 朤僗僩乕儅僿儖僯傾偲僗僩乕儅扙傪崌暪偟, 挵娗夡巰傪棃偟偨1椺. 帪擟悞憦1, 嵅摗晲榊2, 揷拞弐摴2, 墶堜孿屽2, 屆忛丂寷2, 嶰塝孾氭2, 嶳棞崅峀2, 嶳壓宲巎3,4, 孏尦梇夘5, 斾婇捈庽4, 撪摗丂崉2 (1擕態丒峛忬態奜, 2壓晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕, 4忋晹徚壔娗奜, 5堦斒丒彫帣丒娞抇鋁奜) 戞863夞奜壢廤択夛 (2022/3/12), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110019. [尨挊] Background characteristics and diabetes remission after laparoscopic sleeve gastrectomy in Japanese patients with type 2 diabetes stratified by BMI: subgroup analysis of J-SMART. Saiki A, Yamaguchi T, Sasaki A, Naitoh T1, Matsubara H, Yokote K, Okazumi S, Ugi S, Yamamoto H, Ohta M, Ishigaki Y, Kasama K, Seki Y, Tsujino M, Shirai K, Miyazaki Y, Masaki T, Nagayama D, Tatsuno I: Diabetol Int 2021/1; 12 (3): 303-12. (撪摗丂崉1: 1壓晹徚壔娗奜)
'20-310002. [徢椺曬崘] Efficacy of laparoscopic sleeve gastrectomy for patient with morbid obesity and type 1 diabetes mellitus: a case report. Ichikawa H, Imoto H, Tanaka N, Musha H, Sawada S, Naitoh T1, Kamei T, Unno M: Surg Case Rep 2021/1; 7 (1): 7. (撪摗丂崉1: 1壓晹徚壔娗奜)
[妛夛丒尋媶夛摍]
'20-722003. [妛夛 (慡崙)] (僔儞億僕僂儉) Metabolic surgery偺戙幱夵慞岠壥偵偍偗傞抇廯巁偺堄媊: 廫擇巜挵丒嬻挵僶僀僷僗儌僨儖偐傜偺専徹. 揷拞捈庽, 堜杮攷暥, 媨抧抭梞, 搚壆隉桾, 埳惃堦楴, 忋栰抦隉, 巗愳塸岶, 搉曈榓岹, 惵栘丂崑, 恄嶳撃巎, 撪摗丂崉1, 戝徖丂擡, 婽堜丂彯, 奀栰椣柧 (1壓晹徚壔娗奜): 戞41夞擔杮旍枮妛夛丒戞38夞擔杮旍枮徢帯椕妛夛妛弍廤夛 (2021/3/21), Web奐嵜.
'20-723024. [妛夛 (慡崙)] (堦斒島墘) 挊柧側抇鵑燋枌壓晜庮憸傪掓偟偨慂岴惈抇鵑墛偺堦椺. 抾懞桾夘1, 敆丂桾擵1, 棊崌戝庽1, 恄扟婭婸1,2, 愇堜椙岾1,3, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2屇媧婍奜, 3壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10-13), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮撪帇嬀奜壢妛夛嶨帍 2021/3; 25 (7): DP82-7.
'20-723025. [妛夛 (慡崙)] (堦斒島墘) Postoperative outcomes of minimally-invasive surgery for congenital choledochoal dilatation. Morikawa T, Takadate T, Ishida M, Ohtsuka H, Miura T, Iseki M, Kawaguchi K, Masuda K, Mizuma M, Hayashi H, Nakagawa K, Kamei T, 撪摗丂崉1, Unno M (1壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/13), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-723026. [妛夛 (慡崙)] (堦斒島墘) 廫擇巜挵嬻挵僶僀僷僗弍偺旕傾儖僐乕儖惈帀朾娞墛夵慞岠壥偵偍偗傞Bilio-Pancreatic Limb 偺廳梫惈 巗愳塸岶, 揷拞捈庽, 堜杮攷暥, 恄嶳撃巎, 惵栘丂崑, 搉曈榓岹, 戝徖丂擡, 撪摗丂崉1, 婽堜丂彯, 奀栰椣柧 (1壓晹徚壔娗奜): 戞41夞擔杮旍枮妛夛丒戞38夞擔杮旍枮徢帯椕妛夛妛弍廤夛 (2021/3/21), Web奐嵜.
怱憻寣娗奜壢妛
[妛弍榑暥]
110274. [尨挊] Neutrophil-to-lymphocyte ratio is prognostic factor of prolonged pleural effusion after pediatric cardiac surgery. Yakuwa K1, Miyaji K1, Kitamura T1, Miyamoto T1, Ono M, Kaneko Y: JRSM Cardiovasc Dis 2021/4; 10: 20480040211009438. (敧孡堦婱1, 媨抧丂娪1, 杒懞丂棩1, 媨杮棽巌1: 1怱憻寣娗奜)
110275. [尨挊] Regional oxygen saturation change rate for detection of leg ischemia in minimally invasive cardiac surgery. Shikata F1, Nakamura Y, Okuzono Y, Uchigasaki Y, Yamauchi N: Perfusion 2021/5; 36 (4): 382-7. (幁揷暥徍1: 1怱憻寣娗奜)
110276. [尨挊] Low skeletal muscle density combined with muscle dysfunction predicts adverse events after adult cardiovascular surgery. Yamashita M1, Kamiya K2, Matsunaga A2, Kitamura T3, Hamazaki N4 Nozaki K4, Ichikawa T4, Maekawa E5, Meguro K5, Yamaoka-Tojo M2, Ako J5, Miyaji K3: Nutr Metab Cardiovasc Dis 2021/6; 31 (6): 1782-90. (嶳壓恀巌1, 恄扟寬懢榊2, 徏塱撃旻2, 杒懞丂棩3, 郷嶈怢柧4, 栰嶈峃暯4, 巗愳婱暥4, 慜愳宐旤5, 栚崟寬懢榊5, 搶瀶旤撧巕2, 垻屆弫嵠5, 媨抧丂娪3: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3怱憻寣娗奜, 4儕僴價儕晹, 5弞娐婍撪)
110277. [尨挊] Outcomes after Rivaroxaban Treatment of Extensive Deep Vein Thrombosis. Fujioka S1, Kitamura T1, Shikata F1, Mishima T1, Onishi Y1, Araki H1, Goto H1, Sasahara A1, Fukuzumi M1, Torii S1,2, Miyaji K1: Ann Vasc Surg 2022/9; 85: 246-52. (摗壀弐堦榊1, 杒懞丂棩1, 幁揷暥徍1, 旤搰棙徍1, 戝惣媊旻1, 峳婰弔撧1, 屻摗攷巙1, 嶚尨憦朙1, 暉嬿惓恇1, 捁堜怶嶰1,2, 媨抧丂娪1: 1怱憻寣娗奜, 2抧堟堛椕妛嫵堢)
110278. [尨挊] Near-infrared spectroscopy device selection affects intervention management for cerebral desaturation during cardiopulmonary bypass surgery. Kobayashi K1, Kitamura T1, Kohira S2, Inoue N1, Fukunishi T1, Miyaji K1: Gen Thorac Cardiovasc Surg 2022/1; 70 (1): 11-5. (彫椦寬夘1, 杒懞丂棩1, 彫暯丂憦2, 堜忋怣岾1, 暉惣戶恀1, 媨抧丂娪1: 1怱憻寣娗奜, 2堛椕塹惗妛晹)
110279. [尨挊] Unique Angiogenesis From Cardiac Arterioles During Pericardial Adhesion Formation. Namiguchi K, Sakaue T, Okazaki M, Kanno K, Komoda Y, Shikata F1, Kurata M, Ota N, Kubota Y, Kurobe H, Nishimura T, Masumoto J, Higashiyama S, Izutani H: Front Cardiovasc Med 2022/2; 8: 761591. (幁揷暥徍1: 1怱憻寣娗奜)
310027. [徢椺曬崘] Coarctation of the aorta with total anomalous pulmonary venous connection: a case report Hayashi H1, Sughimoto K, Oka N1, Tsuchida Y1, Miyaji K1: AME Case Rep 2021/4; 5: 11. (椦丂廏寷1, 壀丂摽旻1, 搚揷桬懢1, 媨抧丂娪1: 1怱憻寣娗奜)
310028. [徢椺曬崘] Aortic Valvuloplasty for Cusp Perforation Caused by Kawasaki Disease. Yamada Y, Shikata F1, Yamamoto R, Numata R, Yasukochi S, Takeuchi T: Indian J Pediatr 2021/4; 88 (4): 405. (幁揷暥徍1: 1怱憻寣娗奜)
310029. [徢椺曬崘] Emergency pericardial drainage without aortic repair for type A intramural haematoma complicated by cardiac tamponade. Kitamura T1, Miyaji K1: Interact Cardiovasc Thorac Surg 2021/5; 32 (6): 953-5. (杒懞丂棩1, 媨抧丂娪1: 1怱憻寣娗奜)
310030. [徢椺曬崘] A case of mitral valve repair complicated by acquired factor V deficiency. Nakashima K1, Hari Y1, Takagi H, Okazaki T, Kitamura T1, Miyaji K1: Gen Thorac Cardiovasc Surg 2021/5; 69 (5): 874-6. (拞搰岝婱1, 攇棦梲夘1, 杒懞丂棩1, 媨抧丂娪1: 1怱憻寣娗奜)
310031. [徢椺曬崘] AA case of mitral valve repair complicated by acquired factor V deficiency. Nakashima K, Hari Y, Takagi H, Okazaki T, Kitamura T1, Miyaji K1: Gen Thorac Cardiovasc Surg 2021/5; 69 (5): 874-6. (杒懞丂棩1, 媨抧丂娪1: 1怱憻寣娗奜)
310032. [徢椺曬崘] Treatment of Complete Displacement of the Bilateral Legs into an Aortic Aneurysm Using an Iliac Branch Device. Murai Y1, Tamura Y1, Tanaka Y1, Nakashima K1, Miyaji K1: J Endovasc Ther 2022/2; 29 (1): 143-9. (懞堜桟懢1, 揷懞岾曚1, 揷拞桟婱1, 拞搰岝婱1, 媨抧丂娪1: 1怱憻寣娗奜)
[妛夛丒尋媶夛摍]
713041. [妛夛 (崙嵺)] (堦斒島墘) Optimal High Flow Regional Cerebral Perfusion in Aortic Arch Reconstruction from the Perspective of Postoperative Renal Function. Shikata F1, Miyaji K1, Kohira S2, Goto H1, Torii S3, Kitamura T1, Mishima T1, Fukuzumi M1, Fujioka S1, Sasahara A1, Araki H1, Hataoka T1: The 58th Annual Meeting of Society of Thoracic Surgeons (STS) (2022/1/29-30), Web奐嵜. (幁揷暥徍1, 媨抧丂娪1, 屆暯丂憦2, 屻摗攷巙1, 捁堜怶嶰3, 杒懞丂棩1, 旤搰棙徍1, 暉嬿惓恇1, 摗壀弐堦榊1, 嶚尨憦朙1, 峳婰弔撧1, 敤壀丂搘1: 1怱憻寣娗奜, 2堛椕塹惗妛晹, 3抧堟堛椕嫵堢)
713042. [妛夛 (崙嵺)] (堦斒島墘) Samurai Cannulation (Direct True Lumen Cannulation) for Acute Stanford Type A Aortic Dissection:Experience with Initial 127 Patients. Sasahara A1, Kitamura T1, Hataoka T1, Goto H1, Araki H1, Fujioka S1, Fukuzumi M1, Shikata F1, Mishima T1, Torii S2, Miyaji K1: The 58th Annual Meeting of Society of Thoracic Surgeons (STS) (2022/1/29-30), Web奐嵜. (嶚尨憦朙1, 杒懞丂棩1, 敤壀丂搘1, 屻摗攷巙1, 峳婰弔撧1, 摗壀弐堦榊1, 暉嬿惓恇1, 幁揷暥徍1, 旤搰棙徍1, 捁堜怶嶰2, 媨抧丂娪1: 1怱憻寣娗奜, 2抧堟堛椕嫵堢)
723349. [妛夛 (慡崙)] (堦斒島墘) DOAC嫮壔椕朄偺埨慡惈偲岠壥偺専摙. 摗壀弐堦榊1, 旤搰棙徍1, 峳婰弔撧1, 杒懞丂棩1, 捁堜怶嶰2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞49夞擔杮寣娗奜壢妛夛妛弍憤夛 (2021/5/19-21), Web奐嵜, 擔杮寣娗奜壢妛夛嶨帍 2021/5; 30 (Suppl): PR14-1.
723350. [妛夛 (慡崙)] (堦斒島墘) EVAR弍屻, 椉懁媟偺戝摦柆釒撪堩扙偵懳偟偰native偺Terminal Aorta傪宱桼偟偰Pull through wire傪宍惉偟, IBE傪棷抲偟偨堦椺. 懞堜桟懢1, 揷懞岾曚1, 揷拞桟婱1, 拞搰岝婱1, 媨抧丂娪1 (1怱憻寣娗奜): 戞49夞擔杮寣娗奜壢妛夛妛弍憤夛 (2021/5/19-21), Web奐嵜, 擔杮寣娗奜壢妛夛嶨帍 2021/5; 30 (Suppl): O38-3.
723351. [妛夛 (慡崙)] (堦斒島墘) 擖堾壛椕傪梫偡傞戝寣娗幘姵姵幰偵偍偗傞媫惈婜帯椕幚巤慜屻偱偺暊晹崪奿嬝枾搙偺曄壔. 嶳壓恀巌, 恄扟寬懢榊1, 杒懞丂棩2, 郷嶈怢柧3, 栰嶈峃暯3, 慜愳宐旤4, 搶瀶旤撧巕1, 徏塱撃旻1, 垻屆弫嵠4, 媨抧丂娪2 (1堛椕塹惗妛晹, 2怱憻寣娗奜, 3儕僴價儕晹, 4弞娐婍撪): 戞57夞擔杮弞娐婍昦梊杊妛夛妛弍廤夛 (2021/5/28-6/15), Web奐嵜, 擔杮弞娐婍昦梊杊妛夛帍 2021/5; 56 (2): 176.
723352. [妛夛 (慡崙)] (堦斒島墘) 姶愼惈怱撪枌墛偵懳偡傞憁朮曎宍惉弍亅曎愲攳旂偲帺屓怱枌嵞寶偺僥僋僯僢僋亅. 杒懞丂棩1, 捁堜怶嶰2, 旤搰棙徍1, 摗壀弐堦榊1, 嶚尨憦朙1, 屻摗攷巙1, 峳婰弔撧1, 拞懞桪旘1, 愇摪攷宧1, 敤壀丂搘1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞74夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2021/10/31-11/3), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛嶨帍 2021/10; 69 (suppl): 315.
723353. [妛夛 (慡崙)] (堦斒島墘) 帺屓怱枌僷僢僠傪梡偄偨憁朮曎宍惉弍偺弍屻惉愌亅恖岺曎椫僒僀僓乕傪梡偄偨僥乕儔儕儞僌僥僋僯僢僋亅. 杒懞丂棩1, 捁堜怶嶰2, 旤搰棙徍1, 摗壀弐堦榊1, 嶚尨憦朙1, 屻摗攷巙1, 峳婰弔撧1, 拞懞桪旘1, 愇摪攷宧1, 敤壀丂搘1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞74夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2021/10/31-11/3), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛嶨帍 2021/10; 69 (suppl): 415.
723354. [妛夛 (慡崙)] (堦斒島墘) 媫惈戝摦柆夝棧A宆偵懳偡傞Frozen Elephant Trunk傪梡偄偨慡媩晹抲姺弍屻偺戝摦柆儕儌僨儕儞僌偺専摙. 摗壀弐堦榊1, 揷懞壚旤1, 峳婰弔撧1, 敧孡堦婱, 壀懞丂払1, 旤搰棙徍1, 杒懞丂棩1, 捁堜怶嶰2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞74夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2021/10/31-11/3), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛嶨帍 2021/10; 69 (suppl): 1092.
723355. [妛夛 (慡崙)] (堦斒島墘) 枬惈戝摦柆夝棧偵懳偡傞奜壢揑帯椕愴棯. 敤壀丂搘1, 摗壀弐堦榊1, 愇摪攷宧1, 拞懞桪旘1, 峳婰弔撧1, 屻摗攷巙1, 嶚尨憦朙1, 旤搰棙徍1, 杒懞丂棩1, 捁堜怶嶰2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞74夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2021/10/31-11/3), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛嶨帍 2021/10; 69 (suppl): 1122.
723356. [妛夛 (慡崙)] (堦斒島墘) 60嵨枹枮姵幰偵偍偗傞戝摦柆曎偺恖岺曎慖戰. 拞懞桪旘1, 杒懞丂棩1, 捁堜怶嶰2, 旤搰棙徍1, 摗壀弐堦榊1, 嶚尨憦朙1, 峳婰弔撧1, 屻摗攷巙1, 愇摪攷宧1, 敤壀丂搘1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞74夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2021/10/31-11/3), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛嶨帍 2021/10; 69 (suppl): 1164.
723357. [妛夛 (慡崙)] (堦斒島墘) 彫帣曗彆弞娐偵偍偗傞枌宆恖岺攛偐傜偺悈暘憆幐偵娭偡傞婎慴揑尋媶. 屆暯丂憦1, 奀榁崻抭戙1, 媨抧丂娪2, 捁堜怶嶰3, 杒懞丂棩2, 摗壀弐堦榊2, 嶚尨憦朙2, 屻摗攷巙2, 峳婰弔撧2, 拞懞桪旘2, 敤壀丂搘2 (1堛椕塹惗妛晹, 2怱憻寣娗奜, 3抧堟堛椕嫵堢): 戞74夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2021/10/31-11/3), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛嶨帍 2021/10; 69 (suppl): 1239.
723358. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞戝摦柆弅嶓/棧抐暋崌偵懳偡傞戝摦柆嵞寶弍偺拞婜墦妘惉愌. 屻摗攷巙1, 媨抧丂娪1, 幁揷暥徍1, 捁堜怶嶰2, 杒懞丂棩1, 摗壀弐堦榊1, 嶚尨憦朙1, 峳婰弔撧1, 拞懞桪旘1, 敤壀丂搘1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞74夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2021/10/31-11/3), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛嶨帍 2021/10; 69 (suppl): 1263.
723359. [妛夛 (慡崙)] (堦斒島墘) 嵍怱婡擻昡壙偵傛傞僼傽儘乕巐挜徢弍屻攛摦柆曎抲姺弍偺帄揔帪婜偺専摙. 屻摗攷巙1, 媨抧丂娪1, 幁揷暥徍1, 捁堜怶嶰2, 杒懞丂棩1, 摗壀弐堦榊1, 嶚尨憦朙1, 峳婰弔撧1, 拞懞桪旘1, 敤壀丂搘1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞74夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2021/10/31-11/3), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛嶨帍 2021/10; 69 (suppl): 1282.
723360. [妛夛 (慡崙)] (堦斒島墘) 惵擭婜偵偍偗傞僼傽儘乕巐挜徢弍屻攛摦柆惗懱曎抲姺弍偺拞婜墦妘惉愌. 幁揷暥徍1, 媨抧丂娪1, 屻摗攷巙1, 敤壀丂搘1, 捁堜怶嶰2, 杒懞丂棩1, 暉嬿惓恇1, 摗壀弐堦榊1, 嶚尨憦朙1, 峳婰弔撧1, 彫斅嫶弐旤3, 孲嶳宐巕4, 摗揷揝暯3 (1怱憻寣娗奜, 2抧堟堛椕嫵堢, 3弞娐婍撪, 4憤崌恌椕): 戞23夞擔杮惉恖愭揤惈怱幘姵妛夛憤夛丒妛弍廤夛 (2022/1/7-9), 暉壀.
723361. [妛夛 (慡崙)] (堦斒島墘) Routine Fenestrated Fontan庤弍偺墦妘惉愌. 幁揷暥徍1, 媨抧丂娪1, 敤壀丂搘1, 捁堜怶嶰2, 杒懞丂棩1, 旤搰棙徍1, 暉嬿惓恇1, 摗壀弐堦榊1, 嶚尨憦朙1, 屻摗攷巙1, 峳婰弔撧1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞52夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2022/3/3-5), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2022/3; 52: 163.
723362. [妛夛 (慡崙)] (堦斒島墘) 怱奜宆TAPVC偵懳偡傞憤攛惷柆姴乗嵍朳捈愙暙崌朄偺拞婜墦妘惉愌. 媨抧丂娪1, 幁揷暥徍1, 敤壀丂搘1, 捁堜怶嶰2, 杒懞丂棩1, 旤搰棙徍1, 摗壀弐堦榊1, 嶚尨憦朙1, 峳婰弔撧1, 屻摗攷巙1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞52夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2022/3/3-5), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2022/3; 52: 167.
723363. [妛夛 (慡崙)] (堦斒島墘) 崅棳検擼娨棳壓偱峴偭偨戝摦柆媩廋暅偺弍屻恡婡擻偺娤揰偐傜摫弌偝傟偨帄揔娨棳検. 幁揷暥徍1, 媨抧丂娪1, 屆暯丂憦2, 敤壀丂搘1, 捁堜怶嶰3, 杒懞丂棩1, 旤搰棙徍1, 暉嬿惓恇1, 摗壀弐堦榊1, 嶚尨憦朙1, 屻摗攷巙1, 峳婰弔撧1 (1怱憻寣娗奜, 2堛椕塹惗妛晹, 3抧堟堛椕嫵堢): 戞52夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2022/3/3-5), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2022/3; 52: 171.
723364. [妛夛 (慡崙)] (堦斒島墘) 惉恖奐怱弍廃弍婜NO媧擖椕朄偺岠壥亅傾僀僲僼儘乕85椺偺宱尡偐傜亅. 嶚尨憦朙1, 杒懞丂棩1, 敤壀丂搘1, 屻摗攷巙1, 峳婰弔撧1, 摗壀弐堦榊1, 暉嬿惓恇1, 幁揷暥徍1, 旤搰棙徍1, 捁堜怶嶰2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞52夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2022/3/3-5), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2022/3; 52: 207.
723365. [妛夛 (慡崙)] (堦斒島墘) 忋峴宎�50 mm, 捝傒�3/10, 忋峴ULP (-) 偺A宆IMH, 忋峴婾峯暵嵡夝棧偺弶婜曐懚椕朄. 杒懞丂棩1, 捁堜怶嶰2, 旤搰棙徍1, 幁揷暥徍1, 暉嬿惓恇1, 摗壀弐堦榊1, 嶚尨憦朙1, 峳婰弔撧1, 屻摗攷巙1, 敤壀丂搘1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞52夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2022/3/3-5), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2022/3; 52: 216.
723366. [妛夛 (慡崙)] (堦斒島墘) 宱旂傾僾儘乕僠偱偺僗僥儞僩僌儔僼僩撪憓弍偵偍偗傞崌暪徢梊杊偺岺晇. 摗壀弐堦榊1, 旤搰棙徍1, 敤壀丂搘1, 峳婰弔撧1, 屻摗攷巙1, 嶚尨憦朙1, 幁揷暥柧1, 暉嬿惓恇1, 杒懞丂棩1, 捁堜怶嶰2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞52夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2022/3/3-5), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2022/3; 52: 335.
723367. [妛夛 (慡崙)] (堦斒島墘) 媫惈戝摦柆夝棧偵偍偗傞僒儉儔僀僇僯儏儗乕僔儑儞-127椺偺宱尡. 嶚尨憦朙1, 杒懞丂棩1, 敤壀丂搘1, 屻摗攷巙1, 峳婰弔撧1, 摗壀弐堦榊1, 暉嬿惓恇1, 幁揷暥徍1, 旤搰棙徍1, 捁堜怶嶰2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞52夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2022/3/3-5), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2022/3; 52: 412.
723368. [妛夛 (慡崙)] (堦斒島墘) Norwood庤弍丒DKS暙崌屻偺怴戝摦柆曎椫宎偺奼戝偲媡棳偺専摙. 敤壀丂搘1, 幁揷暥徍1, 捁堜怶嶰2, 杒懞丂棩1, 旤搰棙徍1, 暉嬿惓恇1, 摗壀弐堦榊1, 嶚尨憦朙1, 峳婰弔撧1, 屻摗攷巙1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞52夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2022/3/3-5), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2022/3; 52: 421.
733105. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 攕寣徢惛嵏拞偵敪尒偝傟偨戝摦柆曎忋嫹嶓傪敽偆Williams徢岓孮姵帣偺戝摦柆夝棧偵懳偡傞庤弍宱尡. 徏塱宑楑1, 壀懞丂払1, 捁堜怶嶰2, 杒懞丂棩1, 旤搰棙徍1, 摗壀弐堦榊1, 敧孡堦婱, 峳婰弔撧1, 揷懞壚旤1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞186夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/6/5), Web奐嵜, 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2021/5; 186: 21.
733106. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 悢擭偺宱夁偱媫懍偵憹戝偟偨嫄戝嵍朳擲塼庮偺1椺. 敤壀丂搘1, 峳婰弔撧1, 杒懞丂棩1, 捁堜怶嶰2, 旤搰棙徍1, 摗壀弐堦榊1, 嶚尨憦朙1, 屻摗攷巙1, 拞懞桪旘1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞186夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/6/5), Web奐嵜, 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2021/5; 186: 30.
733107. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 奜彎惈嶰愲曎暵嵔晄慡徢偵懳偟偰嫻峯嬀壓嶰愲曎宍惉弍傪巤峴偟偨1椺. 敤壀丂搘1, 嶚尨憦朙1, 杒懞丂棩1, 捁堜怶嶰2, 旤搰棙徍1, 暉嬿惓恇1, 幁揷暥徍1, 摗壀弐堦榊1, 峳婰弔撧1, 屻摗攷巙1, 拞懞桪旘1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞187夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/11/6), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2021/11; 187: 10.
733108. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 惷柆娨棳堎忢傪敽偆懡銪徢, 姰慡宆朳幒拞妘寚懝, 塃幒掅宍惉偵懳偟偰, 擇怱幒廋暅傪峴偭偨堦椺. 屻摗攷巙1, 幁揷暥徍1, 捁堜怶嶰2, 杒懞丂棩1, 旤搰棙徍1, 摗壀弐堦榊1, 嶚尨憦朙1, 峳婰弔撧1, 拞懞桪旘1, 敤壀丂搘1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞187夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/11/6), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2021/11; 187: 13.
733109. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 媫惈怱嬝峓嵡屻偺怱幒拞妘慂岴偵懳偟偰嵍幒愗奐傾僾儘乕僠偱廋暅傪峴偭偨1椺. 朙揷恀庻1, 幠揷丂島1, 揷懞壚旤1, 彫尨朚媊, 嫜丂惓婎, 媨抧丂娪1 (1怱憻寣娗奜): 戞187夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/11/6), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2021/11; 187: 17.
733110. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擕帣婜VSD偵懳偡傞攛摦柆峣漀弍屻47擭偵VSD暵嵔, 攛摦柆宍惉, 塃幒棳弌楬宍惉傪巤峴偟偨徢椺. 屻摗攷巙1, 幁揷暥徍1, 戝惣媊旻1, 峳婰弔撧1, 嶚尨憦朙1, 摗壀弐堦榊1, 暉嬿惓恇1, 旤搰棙徍1, 杒懞丂棩1, 捁堜怶嶰2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞188夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2022/3/19), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2022/3; 188: 35.
733111. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 戝摦柆曎抲姺屻1擭偱曎嵗偺摦梙傪擣傔偨儀乕僠僃僢僩徢椺. 嵅摗弐榊, 杒懞丂棩1, 捁堜怶嶰2, 旤搰棙徍1, 幁揷暥徍1, 暉嬿惓恇1, 摗壀弐堦榊1, 嶚尨憦朙1, 峳婰弔撧1, 屻摗攷巙1, 戝惣媊旻1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞188夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽 (2022/3/19), 搶嫗 (僴僀僽儕僢僪奐嵜).
屇媧婍奜壢妛
[妛弍榑暥]
110280. [尨挊] Comparison of local therapy in patients with lung oligo-recurrence of non-small-cell lung cancer. Sonoda D1, Matsuura Y, Kondo Y1, Ichinose J, Nakao M, Ninomiya H, Nishio M, Okumura S, Satoh Y1, Mun M: J Surg Oncol 2021/5; 123 (8): 1828-35. (墍揷丂戝1, 嬤摗懽恖1, 嵅摗擵弐1: 1屇媧婍奜)
110281. [尨挊] Clinicopathologic Significance of False-Positive Lymph Node Status on FDG-PET in Lung Cancer. Endo H, Yamamoto R, Ichikawa A, Shiozawa S, Nishizawa N, Satoh Y1, Oriuchi N: Clin Lung Cancer 2021/5; 22 (3): 218-24. (嵅摗擵弐1: 1屇媧婍奜)
110282. [尨挊] Validation of the Japanese National Clinical Database Risk calculator for lung cancer surgery focused on postoperative morbidity. Kondo Y, Matsuura Y, Kawaguchi Y, Ichinose J, Nakao M, Okumura S, Satoh Y1, Mun M: Gen Thorac Cardiovasc Surg 2021/8; 69 (8): 1222-9. (嵅摗擵弐1: 1屇媧婍奜)
110283. [尨挊] Factors associated with lymph node metastasis upstage after resection for patients with micropapillary lung adenocarcinoma. Matsushima K1, Sonoda D1, Mitsui A1, Tamagawa S1, Hayashi S1, Naito M1, Matsui Y1, Shiomi K1, Satoh Y1: Thorac Cancer 2022/1; 13 (1): 48-53. (徏搰孿屷1, 墍揷丂戝1, 嶰堜丂垽1, 嬍愳丂払1, 椦丂徦巕1, 撪摗夒恗1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1: 1屇媧婍奜)
110284. [尨挊] A Reasonable Definition of Oligo-Recurrence in Non-Small-Cell Lung Cancer. Sonoda D1, Matsuura Y, Kondo Y1, Ichinose J, Nakao M, Ninomiya H, Nishio M, Okumura S, Satoh Y1, Mun M: Clin Lung Cancer 2022/1; 23 (1): 82-90. (墍揷丂戝1, 嬤摗懽恖1, 嵅摗擵弐1: 1屇媧婍奜)
110285. [尨挊] Characterization of morphological alterations in micropapillary adenocarcinoma of the lung using an established cell line. Sonoda D1, Kamizaki K, Matsuo Y1, Aruga K, Mikubo M1, Yamashita K2, Nishita M, Minami Y, Satoh Y1: Oncol Rep 2022/1; 47 (1): 19. (墍揷丂戝1, 徏旜桼婭巕1, 嶰孍彨巎1, 嶳壓宲巎2, 嵅摗擵弐1: 1屇媧婍奜, 2怴悽婭堛椕丒墶抐揑堛椕)
110286. [尨挊] Selection of preoperative stress electrocardiography test for appropriate patients with non-small cell lung cancer. Tamagawa S1, Sonoda D1, Mitsui A1, Matsushima K1, Hayashi S1, Naito M1, Matsui Y1, Shiomi K1, Satoh Y1: Gen Thorac Cardiovasc Surg 2022/2; 70 (2): 139-43. (嬍愳丂払1, 墍揷丂戝1, 嶰堜丂垽1, 徏搰孿屷1, 椦丂徦巕1, 撪摗夒恗1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1: 1屇媧婍奜)
110287. [尨挊] Cytology Reporting System for Lung Cancer from the Japan Lung Cancer Society and the Japanese Society of Clinical Cytology: An Extensive Study Containing More Benign Lesions. Yoshizawa A, Hiroshima K, Takenaka A, Hba R, Kawahara K, Minami Y, Kakinuma H, Shibuki Y, Miyake S, Kajio K, Kiyonaga K, Nagatomo M, Nishimura S, Mano M, Matsubayashi J, Motoi N, Nagao T, Nakatsuka S, Yoshida T1,2, Satoh Y3: Acta Cytol 2022/3; 66 (2): 124-33. (媑揷丂岟1,2, 嵅摗擵弐3: 1怴悽婭堛椕丒墶抐揑堛椕, 2昦棟, 3屇媧婍奜)
310033. [徢椺曬崘] Two Cases of Lower Lobe Pneumatoceles Following Upper Lobectomy. Kondo Y1, Nakao M, Hashimoto K, Ichinose J, Matsuura Y, Ninomiya H, Okumura S, Satoh Y1, Mun M: Ann Thorac Surg 2021/12; 112 (6): e403-6. (嬤摗懽恖1, 嵅摗擵弐1: 1屇媧婍奜)
320004. [徢椺曬崘] 枬惈擽嫻偵懳偡傞嫻峯撪愻忩屻偺姤摦柆嬻婥嵡愷偵怱憻僇僥乕僥儖帯椕偑憈岟偟偨1椺. 曅嬎丂擡, 墦摗廏婭, 媖丂尗淎, 惣郪墑岹, 嵅摗擵弐1, 嶳杮椇暯 (1屇媧婍奜): 擔屇奜夛帍 2021/5; 35 (4): 337-43.
510018. [憤愢] Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy. Mikubo M1, Inoue Y, Liu G, Tsao MS: J Thorac Oncol 2021/11; 16 (11): 1798-809. (嶰孍彨巎1: 1屇媧婍奜)
540027. [偦偺懠 (彺榐)] 攛娻偺嵶朎恌. 嵅摗擵弐 (屇媧婍奜): 攛娻 2021/11; 61 (supple): 869-871.
[挊丂彂]
621001. [妛弍彂 (曇廤)]亂屇媧婍奜壢僥僉僗僩 夵掶戞2斉亃嵅摗擵弐1,2 (1曇廤埾堳挿, 2屇媧婍奜), 曇: 擔杮屇媧婍奜壢妛夛, 屇媧婍奜壢愱栧堛崌摨埾堳夛, 撿峕摪, 搶嫗, 2021/4敪峴.
621002. [妛弍彂 (曇廤)]亂攛娻姵幰偵偍偗傞ALK梈崌堚揱巕専嵏偺庤堷偒 (戞4斉)亃嶰孍彨巎1,2 (1擔杮攛娻妛夛僶僀僆儅乕僇乕埾堳夛, 2屇媧婍奜), 擔杮攛娻妛夛, 搶嫗, 2021/10敪峴.
621003. [妛弍彂 (曇廤)]亂攛娻姵幰偵偍偗傞 師悽戙僔乕僋僄儞僒乕傪梡偄偨堚揱巕僷僱儖専嵏偺庤堷偒 (戞2斉)亃嶰孍彨巎1,2 (1擔杮攛娻妛夛僶僀僆儅乕僇乕埾堳夛, 2屇媧婍奜), 擔杮攛娻妛夛, 搶嫗, 2021/10敪峴.
[妛夛丒尋媶夛摍]
713043. [妛夛 (崙嵺)] (堦斒島墘) Combination of EGFR mutation and presence of high-grade subtype predicts recurrence in resected stage I lung adenocarcinoma. Ichinose J, Kondo Y1, Ninomiya H, Yamamichi T, Omura K, Hashimoto K, Matsuura Y, Nakao M, Ishikawa Y, Okumura S, Satoh Y1, Mun M: IASLC 2021 World Conference on Lung Cancer (2021/9/8-14), Web奐嵜. (嬤摗懽恖1, 嵅摗擵弐1: 1屇媧婍奜)
713044. [妛夛 (崙嵺)] (堦斒島墘) Molecular and cellular dynamics of drug-tolerant persister (DTP) cells during osimertinib therapy in EGFR mutant lung adenocarcinoma. Mikubo M1, Li Q, Filho S, Inoue Y, Pham N, Moghal N, Tsao M: IASLC 2021 World Conference on Lung Cancer (2021/9/8-14), Web奐嵜. (嶰孍彨巎1: 1屇媧婍奜)
713045. [妛夛 (崙嵺)] (堦斒島墘) A new cytology reporting system for lung cancer from Japan Lung Cancer Society and Japanese Society of Clinical Cytology. Minami Y, Satoh Y1: Europian Congress of Cytology 2021 (2021/10/3), Wroc_aw, Poland. (嵅摗擵弐1: 1屇媧婍奜)
721011. [妛夛 (慡崙)] (摿暿島墘) 怴偟偄屇媧婍嵶朎恌偺曬崘條幃. 郌栘峃梇, 奰徖淎朚, 壨尨朚岝, 抾拞柧旤, 塇応楃師, 淎搰寬嶰, 撿丂桪巕, 嶰戭恀巌, 媑郪柧旻, 嵅摗擵弐1 (1屇媧婍奜): 戞62夞擔杮椪彴嵶朎妛夛憤夛弔婜戝夛 (2021/6/5), 愮梩 (僴僀僽儕僢僪奐嵜).
722122. [妛夛 (慡崙)] (僔儞億僕僂儉) 屇媧婍嵶朎恌偺怴偟偄曬崘條幃偺栤戣揰. 奰徖淎朚, 壨尨朚岝, 郌栘峃梇, 抾拞柧旤, 塇応楃師, 淎搰寬嶰, 撿丂桪巕, 嶰戭恀巌, 媑郪柧旻, 嵅摗擵弐1 (1屇媧婍奜): 戞60夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2021/11/20), 暷巕.
722123. [妛夛 (慡崙)] (僔儞億僕僂儉) 怴攛娻嵶朎恌敾掕曬崘條幃偵偍偗傞乬atypical cells乭偵偮偄偰. 壨尨朚岝, 淎搰寬嶰, 抾拞柧旤, 塇応楃師, 媑郪柧旻, 撿丂桪巕, 郌栘峃梇, 奰徖淎朚, 嶰戭恀巌, 嵅摗擵弐1 (1屇媧婍奜): 戞60夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2021/11/20), 暷巕.
722124. [妛夛 (慡崙)] (僔儞億僕僂儉) 屇媧婍嵶朎恌偺怴偟偄曬崘條幃: 嵶朎恌敾掕嬫暘偺娤嶡幰娫偺堦抳. 淎搰寬嶰, 媑郪柧旻, 抾拞柧旤, 塇応楃師, 壨尨朚岝, 撿丂桪巕, 奰徖淎朚, 郌栘峃梇, 嶰戭恀巌, 妬旜寬懢, 惔塱壛嵷, 挿桭丂朑, 惣懞憗嵷巕, 嵅摗擵弐1 (1屇媧婍奜): 戞60夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2021/11/20), 暷巕.
722125. [妛夛 (慡崙)] (僔儞億僕僂儉) 屇媧婍嵶朎恌偺怴偟偄曬崘條幃: 椙惈昦曄偵懳偡傞JLCC-JSCC暘椶偺桳梡惈. 媑郪柧旻, 淎搰寬嶰, 抾拞柧旤, 塇応楃師, 壨尨朚岝, 撿丂桪巕, 奰徖淎朚, 郌栘峃梇, 嶰戭怣巌, 惔塱壛嵷, 妬旜寬懢, 嵅摗擵弐1 (1屇媧婍奜): 戞60夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2021/11/20), 暷巕.
722126. [妛夛 (慡崙)] (嫵堢島墘) 攛娻偺嵶朎恌. 嵅摗擵弐 (屇媧婍奜): 戞62夞擔杮攛娻妛夛妛弍廤夛 (2021/11/27), 墶昹.
723369. [妛夛 (慡崙)] (堦斒島墘) 攛態娻嵶朎姅偺塼忬壔専懱嵶朎恌 (LBC) 専懱偐傜拪弌偟偨僎僲儉DNA昳幙偺曐帩曽朄. 徏旜桼婭巕1, 嶳壓榓栫2, 媑揷丂岟3, 嵅摗擵弐4 (1昦懺丒恌椕宯, 2昦棟晹, 3昦棟, 4屇媧婍奜): 戞110夞擔杮昦棟妛夛憤夛 (2021/4/22-24), 搶嫗 (僴僀僽儕僢僪奐嵜).
723370. [妛夛 (慡崙)] (堦斒島墘) 埆惈崟怓庮偺攛揮堏傪愗彍偟偨4徢椺偺専摙. 椦丂徦巕1, 嶰堜丂垽2, 嬍愳丂払2, 徏搰孿屷2, 撪摗夒恗2, 徏堜孾晇2, 墫尒丂榓2, 嵅摗擵弐2 (1戝妛堾堛椕宯尋媶壢, 2屇媧婍奜): 戞38夞擔杮屇媧婍奜壢妛夛妛弍廤夛 (2021/5/20), 挿嶈 (僴僀僽儕僢僪奐嵜).
723371. [妛夛 (慡崙)] (堦斒島墘) Characterization of morphological and invasive alterations in lung micropapillary adenocarcinoma using a cell line. 墍揷丂戝1, 嵅摗擵弐2 (1戝妛堾堛椕宯尋媶壢, 2屇媧婍奜): 戞80夞擔杮娻妛夛妛弍憤夛 (2021/10/1), 墶昹 (僴僀僽儕僢僪奐嵜).
723372. [妛夛 (慡崙)] (堦斒島墘) 尨敪惈攛娻弍屻偵掅Na寣徢傪棃偟偨8椺偺専摙. 嬤摗懽恖1, 嶰嫶弐夘1, 娵嶳棃婸1, 椦丂徦巕2, 墍揷丂戝2, 嶰孍彨巎1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1 (1屇媧婍奜, 2戝妛堾堛椕宯尋媶壢): 戞62夞擔杮攛娻妛夛妛弍廤夛 (2021/11/26), 墶昹.
723373. [妛夛 (慡崙)] (堦斒島墘) 攛滸暯忋旂娻偵偍偗傞庮釃怹, CD8梲惈嵶朎悢偲弍屻嵞敪偺娭楢惈偺専摙. 墫尒丂榓1, 堦屗徆柧2, 椦丂徦巕3, 嶰孍彨巎1, 墍揷丂戝3, 嬤摗懽恖1, 娵嶳棃婸1, 徏堜孾晇1, 徲丂悽埉, 懞塤朏庽2, 嵅摗擵弐1 (1屇媧婍奜, 2昦棟, 3戝妛堾堛椕宯尋媶壢): 戞62夞擔杮攛娻妛夛妛弍廤夛 (2021/11/27), 墶昹.
731007. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 攛娻恌椕偲屇媧婍嵶朎恌偺揥朷. 嵅摗擵弐 (屇媧婍奜): 戞39夞惵怷導椪彴嵶朎妛夛憤夛暲傃偵妛弍廤夛 (2022/3/5), 峅慜.
733112. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 懡敪攛撪擷朎惈儕儞僷娗庮偺堦椺. 嶰嫶弐夘1, 娵嶳棃婸1, 嶰堜丂垽1, 嬤摗懽恖1, 嬍愳丂払1, 徏搰孿屷1, 椦丂徦巕2, 撪摗夒恗1, 嶰孍彨巎1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1 (1屇媧婍奜, 2戝妛堾堛椕宯尋媶壢): 戞186夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/6/5), 搶嫗.
733113. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 懕敪惈婥嫻傪掓偟偨摢旂尨敪寣娗擏庮攛揮堏偺2椺. 娵嶳棃婸1, 嶰嫶弐夘1, 嬤摗懽恖1, 嶰孍彨巎1, 徏堜孾晇1, 墫尒丂榓1, 憹郪恀幚巕2, 嵅摗擵弐1 (1屇媧婍奜, 2旂晢): 戞177夞擔杮屇媧婍撪帇嬀妛夛娭搶巟晹夛 (2021/6/19), Web奐嵜.
733114. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嫻態擲昞旂娻庤弍偐傜21擭屻偵嫻枌攄庬嵞敪傪偒偨偟偨1椺. 椦丂徦巕1, 嶰嫶弐夘2, 娵嶳棃婸2, 嬤摗懽恖2, 嶰孍彨巎2, 徏堜孾晇2, 墫尒丂榓2, 撊杮徆岶3, 堦屗徆柧3, 嵅摗擵弐2 (1戝妛堾堛椕宯尋媶壢, 2屇媧婍奜, 3昦棟): 戞41夞擔杮嫻態尋媶夛 (2022/2/11), Web奐嵜.
733115. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怱枌拞旂庮偺1椺. 嶰嫶弐夘1, 娵嶳棃婸1, 嬤摗懽恖1, 椦丂徦巕2, 墍揷丂戝2, 嶰孍彨巎1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1, 惎栰徍朏3, 懞塤朏庽3 (1屇媧婍奜, 2戝妛堾堛椕宯尋媶壢, 3昦棟): 戞192夞擔杮攛娻妛夛娭搶巟晹妛弍廤夛 (2022/3/5), 搶嫗 (僴僀僽儕僢僪奐嵜).
733116. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僇僥僐儔儈儞桿敪惈怱幒昿攺偵懳偟偰椉懁嫻峯嬀壓嫻晹岎姶恄宱幷抐弍傪巤峴偟偨1椺. 娵嶳棃婸1, 嶰嫶弐夘1, 嬤摗懽恖1, 嶰孍彨巎1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1 (1屇媧婍奜): 戞188夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2022/3/19), 搶嫗 (僴僀僽儕僢僪奐嵜).
擼恄宱奜壢妛
[妛弍榑暥]
110288. [尨挊] Long-term follow-up after BCNU wafer implantation in patients with newly diagnosed glioblastoma. Shibahara I1, Miyasaka K1, Sekiguchi A2, Ishiyama H2, Inukai M1, Yaui Y3, Watanabe T, Sato S1, Hide T1, Kumabe T1: J Clin Neurosci 2021/4; 86: 202-10. (幠尨堦梲1, 媨嶁榓峅1, 娭岥埄堖2, 愇嶳攷瀶2, 將帞丂墌1, 埨堜旤峕3, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1: 1擼奜, 2曻幩慄 (庮釃), 3宍懺宯)
110289. [尨挊] Postcentral gyrus resection of opercular gliomas is a risk factor for motor deficits caused by damaging the radiologically invisible arteries supplying the descending motor pathway. Shibahara I1, Sato S1, Hide T1, Saito R, Kanamori M, Sonoda Y, Tominaga T, Kumabe T1: Acta Neurochir (Wien) 2021/5; 163 (5): 1269-78. (幠尨堦梲1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1: 1擼奜)
110290. [尨挊] Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversy. Kanamori M, Takami H, Suzuki T, Tominaga T, Kurihara J, Tanaka S, Hatazaki S, Nagane M, Matsuda M, Yoshino A, Natsumeda M, Yamaoka M, Kagawa N, Akiyama Y, Fukai J, Negoto T, Shibahara I1, Tanaka K, Inoue A, Mase M, Tomita T, Kuga D, Kijima N, Fukami T, Nakahara Y, Natsume A, Yoshimoto K, Keino D, Tokuyama T, Asano K, Ujifuku K, Abe H, Nakada M, Matsuda K, Arakawa Y, Ikeda N, Narita Y, Shinojima N, Kambe A, Nonaka M, Izumoto S, Kawanishi Y, Kanaya K, Nomura S, Nakajima K, Yamamoto S, Terashima K, Ichimura K, Nishikawa R: Neurooncol Adv 2021/6; 3 (1): vdab086. (幠尨堦梲1: 1擼奜)
110291. [尨挊] Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma. Osada Y, Saito R, Miyata S, Shoji T, Shibahara I1, Kanamori M, Sonoda Y, Kumabe T1, Watanabe M, Tominaga T: Brain Tumor Pathol 2021/7; 38 (3): 218-27. (幠尨堦梲1, 孏晹弐岹1: 1擼奜)
110292. [尨挊] Low tumor cell content predicts favorable prognosis in germinoma patients. Takami H, Satomi K, Fukuoka K, Fukushima S, Matsushita Y, Yamasaki K, Nakamura T, Tanaka S, Mukasa A, Saito N, Suzuki T, Yanagisawa T, Nakamura H, Sugiyama K, Tamura K, Maehara T, Nakada M, Nonaka M, Asai A, Yokogami K, Takeshima H, Iuchi T, Kanemura Y, Kobayashi K, Nagane M, Kurozumi K, Yoshimoto K, Matsuda M, Matsumura A, Hirose Y, Tokuyama T, Kumabe T1, Narita Y, Shibui S, Nakazato Y, Nishikawa R, Matsutani M, Ichimura K: Neurooncol Adv 2021/8; 3 (1): vdab110. (孏晹弐岹1: 1擼奜)
110293. [尨挊] Ventricular opening and cerebrospinal fluid circulation accelerate the biodegradation process of carmustine wafers suggesting their immunomodulation potential in the human brain. Shibahara I1, Shibahara Y2, Hagiwara H, Watanabe T, Orihashi Y, Handa H1, Inukai M1, Hide T1, Yasui Y, Kumabe T1: J Neurooncol 2022/9; 159 (2): 425-35. (幠尨堦梲1, 幠尨桾婭巕2, 敿揷丂敚1, 將帞丂墌1, 廏戱堦榊1, 孏晹弐岹1: 1擼奜, 2昦棟)
110294. [尨挊] Role of the parietooccipital fissure and its implications in the pathophysiology of posterior medial temporal gliomas. Shibahara I1, Saito R, Kanamori M, Sonoda Y, Sato S1, Hide T1, Tominaga T, Kumabe T1: J Neurosurg 2021/12; 137 (2): 505-14. (幠尨堦梲1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1: 1擼奜)
110295. [尨挊] Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial. Narita Y, Muragaki Y, Kagawa N, Asai K, Nagane M, Matsuda M, Ueki K, Kuroda J, Date I, Kobayashi H, Kumabe T1, Beppu T, Kanamori M, Kasai S, Nishimura Y, Xiong H, Ocampo C, Yamada M, Mishima K: Cancer Sci 2021/12; 112 (12): 5020-33. (孏晹弐岹1: 1擼奜)
110296. [尨挊] Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan. Iuchi T, Inoue A, Hirose Y, Morioka M, Horiguchi K, Natsume A, Arakawa Y, Iwasaki K, Fujiki M, Kumabe T1, Sakata Y: Neurooncol Adv 2022/1; 4 (1): vdab189. (孏晹弐岹1: 1擼奜)
110297. [尨挊] Influence of hospital capabilities and prehospital time on outcomes of thrombectomy for stroke in Japan from 2013 to 2016. Kurogi A, Onozuka D, Hagihara A, Nishimura K, Kada A, Hasegawa M, Higashi T, Kitazono T, Ohta T, Sakai N, Arai H, Miyamoto S, Sakamoto T, Iihara K, J-ASPECT Study Collaborators (Kumabe T1, etc):Sci Rep 2022/2; 12 (1): 3252. (孏晹弐岹1: 1擼奜)
120009. [尨挊] 崅埵崢捙 (L1/2, L2/3) 捙娫斅僿儖僯傾偺椪彴憸偲帯椕朄偺専摙. 墡揷榓婱巕1, 壴杒弴嵠, 孏晹弐岹1, 撿丂丂妛, 寭徏丂棿, 搰撪姲栫, 戝捤椇懢楴, 崅嫶晀峴: 擼恄宱奜壢僕儍乕僫儖 2022/5; 31 (5): 324-32.
220002. [弨尨挊] 娫擼壓悅懱庮釃偺宱旲撪帇嬀庤弍偵偍偗傞ICG撪帇嬀偺桳梡惈. 廏戱堦榊1, 幠尨堦梲1, 廳巬椚懢1, 嶳杮戝曘1, 彫愹姲擵1, 姍揷桾擇2, 栘懞崄棦2, 埳搶偟偍傝2, 崅栰岾楬2, 孏晹弐岹1 (1擼奜, 2撪暘斿戙幱撪): 擔杮撪暘斿妛夛嶨帍僒僾儕儊儞僩 2021/9; 97 (S.HPT): 19-22.
310034. [徢椺曬崘] Leber's hereditary optic neuropathy with diffuse white matter changes mimicking gliomatosis cerebri: illustrative case. Saruta W1, Shibahara I1, Handa H1, Inukai M1, Kanayama S2, Yasumoto R3, Sakurai K3, Akiyama H, Ishikawa H4, Sato S1, Hide T1, Kumabe T1: J Neurosurg Case Lessons 2021/6; 1 (26): CASE21161. (墡揷榓婱巕1, 幠尨堦梲1, 敿揷丂敚1, 將帞丂墌1, 嬥嶳弐夘2, 埨杮棿攏3, 烴堜宑憿3, 愇愳丂嬒4, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1: 1擼奜, 2娽壢, 3椪専晹, 4堛椕塹惗妛晹)
310035. [徢椺曬崘] Cortical Neural Damage Associated with Cerebral Hyperperfusion after Reperfusion Therapy for Acute Ischemic Stroke: 123I-iomazenil Single-photon Emission Computed Tomography Findings. Kuroda H1, Yamamoto D1, Koizumi H1, Shimizu S1, Kumabe T1: NMC Case Rep J 2021/7; 8 (1): 367-30. (崟揷攷婭1, 嶳杮戝曘1, 彫愹姲擵1, 惔悈丂濟1, 孏晹弐岹1: 1擼奜)
310036. [徢椺曬崘] Transdural reduction of a bone fragment protruding into the spinal canal during surgical treatment of lumbar burst fracture: A case report. Saruta W1, Takahashi T, Kumabe T1, Minami M, Kanematsu R, Shimauchi-Ohtaki H, Otsuka R, Hanakita J: Surg Neurol Int 2021/8; 12: 406. (墡揷榓婱巕1, 孏晹弐岹1: 1擼奜)
310037. [徢椺曬崘] A Case of Synchronous Occurrence of Intracranial Germinoma and Systemic Sarcoidosis. Hyakutake Y1, Shibahara I1, Inukai M1, Koizumi H1, Hide T1, Morota N1, Yoshida T2, Sasaki J2, Kumabe T1: NMC Case Rep J 2021/9; 8 (1): 645-50. (昐晲桟棟1, 幠尨堦梲1, 將帞丂墌1, 彫愹姲擵1, 廏戱堦榊1, 巘揷怣恖1, 媑揷丂岟2, 嵅乆栘帯堦榊2, 孏晹弐岹1: 1擼奜, 2怴悽婭堛椕丒墶抐揑堛椕)
310038. [徢椺曬崘] Aneurysms Arising from Persistent Arteries in the Vertebrobasilar Paramedian Longitudinal Axis: Two Case Reports. Shimizu S1, Mochizuki T, Inukai M1, Osawa S, Kuroda H1, Amari K, Nakai Y, Kumabe T1: NMC Case Rep J 2021/10; 8 (1): 665-71. (惔悈丂濟1, 將帞丂墌1, 崟揷攷婭1, 孏晹弐岹1: 1擼奜)
310039. [徢椺曬崘] Long-term survival of a patient with diffuse midline glioma in the pineal region: A case report and literature review. Ono T, Kuwashige H, Adachi J, Takahashi M, Oda M, Kumabe T1, Shimizu H: Surg Neurol Int 2021/12; 12: 612. (孏晹弐岹1: 1擼奜)
310040. [徢椺曬崘] Strategic neuronavigation-guided emergent endoscopic evacuation of the hematoma caused by ruptured brain arteriovenous malformation: Technical note and retrospective case series. Koizumi H1, Yamamoto D1, Hide T1, Asari Y2, Kumabe T1: J Clin Neurosci 2022/2; 96: 61-7. (彫愹姲擵1, 嶳杮戝曘1, 廏戱堦榊1, 愺棙丂桋2, 孏晹弐岹1: 1擼奜, 2媬柦)
310041. [徢椺曬崘] Coexistence of anterior cranial fossa dural arteriovenous fistula and arteriovenous malformation with the same drainage system: illustrative case. Yamamoto D1, Shibahara I1, Inukai M1, Koizumi H1, Hyakutake Y1, Ishima D2, Usui R2, Kimura A2, Hide T1, Kumabe T1: J Neurosurg Case Lessons 2022/3; 3 (13): CASE2222. (嶳杮戝曘1, 幠尨堦梲1, 將帞丂墌1, 彫愹姲擵1, 昐晲桟棟1, 恗栘丂弤1, 堜搰戝曘2, 塐堜丂椛2, 栘懞暥彨2, 廏戱堦榊1, 孏晹弐岹1: 1擼奜, 2擼恄宱撪)
522076. [島嵗]亂愱栧堛偵媮傔傜傟傞嵟怴偺抦幆亃[擼庮釃] 擼椑恑揥偟偰偄傞恄宱銹庮偵懳偡傞揈弌弍. 幠尨堦梲1, 孏晹弐岹1 (擼奜): 擼恄宱奜壢懍曬 2021/7; 31 (4): 700-9.
[妛夛丒尋媶夛摍]
722127. [妛夛 (慡崙)] (僔儞億僕僂儉) 75嵨埲忋偺崅楊幰銹夎庮偵懳偡傞儀僶僔僘儅僽椕朄偵傛傞帯椕岠壥. 幠尨堦梲1, 敿揷丂敚1, 朙揷錆棞巕1, 昐晲桟棟1, 將帞丂墌1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞34夞擔杮榁擭擼恄宱奜壢妛夛 (2021/4/17), Web奐嵜.
722128. [妛夛 (慡崙)] (僔儞億僕僂儉) 90嵨埲忋偺挻崅楊幰媫惈婜擼峓嵡姵幰偵懳偡傞婡夿揑寣愷夞廂椕朄屻偺帯椕揮婣. 嶳杮戝曘1, 彫愹姲擵1,2, 恗栘丂弤1, 幠尨堦梲1, 媨嶁榓峅1, 堜搰戝曘3, 塐堜丂椛3, 栘懞暥彨3, 惣嶳榓棙3, 孏晹弐岹1 (1擼奜, 2媬柦, 3擼恄宱撪): 戞34夞擔杮榁擭擼恄宱奜壢妛夛 (2021/4/17), Web奐嵜.
722129. [妛夛 (慡崙)] (僔儞億僕僂儉) 僶僀僷僗弍栰傪愺偔偟傑偭偡偖偺摴嬶傪巊梡偡傞岺晇. 媣恵旤恀棟1, 壀丂廏岹1, 嬤摗岹帯1, 堃懞岞堣1, 孏晹弐岹1 (1擼奜): 戞30夞擼恄宱奜壢庤弍偲婡婍妛夛 (CNTT2021) (2021/4/23), Web奐嵜.
722130. [妛夛 (慡崙)] (僔儞億僕僂儉) Dural scoring: 奐摢弍偵偍偗傞峝枌堦師暵嵔偺曗彆庤媄. 惔悈丂濟1, 朷寧悞峅, 崟揷攷婭1, 娭岥朁巕1, 彫愹姲擵1,2, 孏晹弐岹1 (1擼奜, 2媬柦): 戞14夞擔杮惍梕擼恄宱奜壢妛夛 (JSAN2021) (2021/4/24), Web奐嵜.
722131. [妛夛 (慡崙)] (僔儞億僕僂儉) 慜摢懁摢奐摢帪偺摢敮慄傪柍帇偟偨昁梫嵟掅尷偺旂愗曽朄偺専摙. 幠尨堦梲1, 敿揷丂敚1, 朙揷錆棞巕1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞14夞擔杮惍梕擼恄宱奜壢妛夛 (JSAN2021) (2021/4/24), Web奐嵜.
722132. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 宱旲撪帇嬀庤弍偵偍偗傞ICG撪帇嬀偺崱屻偺揥奐. 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞41夞擔杮擼恄宱奜壢僐儞僌儗僗憤夛 (2021/5/15), 墶昹 (僴僀僽儕僢僪奐嵜).
722133. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 戝岥宎媧堷僇僥乕僥儖偺愴崙帪戙乣 SOFIA傪巊偄偙側偣!乣. 嶳杮戝曘1, 彫愹姲擵1,2, 恗栘丂弤1, 幠尨堦梲1, 媨嶁榓峅1, 堜搰戝曘3, 塐堜丂椛3, 栘懞暥彨3, 惣嶳榓棙3, 孏晹弐岹1 (1擼奜, 2媬柦, 3擼恄宱撪): 戞41夞擔杮擼恄宱奜壢僐儞僌儗僗憤夛 (2021/5/16), 墶昹 (僴僀僽儕僢僪奐嵜).
722134. [妛夛 (慡崙)] (僔儞億僕僂儉) 儕儃僝乕儉偼銹夎庮嵶朎偵姴嵶朎惈傪桿摫偡傞. 廏戱堦榊1, 敀愳桾婱, 忛栰攷巎, 幠尨堦梲1, 將帞丂墌1, 幝搰捈庽, 晲妢峎忎, 孏晹弐岹1 (1擼奜): 戞39夞擔杮擼庮釃昦棟妛夛妛弍廤夛 (2021/5/21), 嫗搒 (僴僀僽儕僢僪奐嵜).
722135. [妛夛 (慡崙)] (僔儞億僕僂儉) ICG撪帇嬀傪巊梡偟偨嬀帇壓庤弍偺尰忬偲揥朷. 廏戱堦榊1, 廳巬椚懢1, 幠尨堦梲1, 嶳杮戝曘1, 彫愹姲擵1,2, 孏晹弐岹1 (1擼奜, 2媬柦): 戞26夞擔杮擼庮釃偺奜壢妛夛 (2021/9/9), 搶嫗 (僴僀僽儕僢僪奐嵜).
722136. [妛夛 (慡崙)] (僔儞億僕僂儉) 摢捀屻摢峚偵婯掕偝傟傞懁摢梩撪懁屻曽恄宱銹庮偺恑揥條幃偲偦傟傪娪傒偨庤弍愴棯. 幠尨堦梲1, 嵅摗悷恖1, 廏戱堦榊1, 釼摗棾懢, 嬥怷惌擵, 墍揷弴旻, 晊塱掝擇, 孏晹弐岹1 (1擼奜): 戞26夞擔杮擼庮釃偺奜壢妛夛 (2021/9/10), 搶嫗 (僴僀僽儕僢僪奐嵜).
722137. [妛夛 (慡崙)] (僔儞億僕僂儉) 屻摢奧鈢庮釃媦傃擼摦惷柆婏宍偵懳偡傞屻摢奧鈢丒屻摢奐摢暪梡偵傛傞揈弌弍. 孏晹弐岹1, 幠尨堦梲1, 嶳杮戝曘1, 彫愹姲擵1,2, 廏戱堦榊1 (1擼奜, 2媬柦): 戞26夞擔杮擼庮釃偺奜壢妛夛 (2021/9/10), 搶嫗 (僴僀僽儕僢僪奐嵜).
722138. [妛夛 (慡崙)] (僔儞億僕僂儉) 銹夎庮偺奜壢帯椕. 孏晹弐岹1, 幠尨堦梲1 (1擼奜): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/27), 墶昹 (僴僀僽儕僢僪奐嵜).
722139. [妛夛 (慡崙)] (僔儞億僕僂儉) 彫帣擼庮釃暘巕恌抐僱僢僩儚乕僋偺峔抸偲墳梡. 嬥懞暷攷, 惓嶥抭巕, 媑壀奊杻, 巗懞岾堦, 拞栰壝巕, 暯屗弮巕, 嵅乆栘撜, 媊壀岶巕, 嶳嶈壞堐, 尨丂弮堦, 孏晹弐岹1, 埳払丂孧, 塱崻婎梇, 惣愳丂椇 (1擼奜): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/27), 墶昹 (僴僀僽儕僢僪奐嵜).
722140. [妛夛 (慡崙)] (僔儞億僕僂儉) 泱庮偵偍偗傞挿婜婡擻梊屻. 嬥怷惌擵, 壓揷桼婸, 釼摗棾懢, 墍揷弴旻, 孏晹弐岹1, 敒憅弐巌, 楅栘嫥巕, 晊塱掝擇 (1擼奜): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/27), 墶昹 (僴僀僽儕僢僪奐嵜).
722141. [妛夛 (慡崙)] (僔儞億僕僂儉) 嵞敪壓悅懱態庮揈弌偺庤弍庤媄. 媣恵旤恀棟1, 壀丂廏岹1, 嬤摗岹帯1, 堃懞岞堣1, 孏晹弐岹1 (1擼奜): 戞28夞堦斒幮抍朄恖擔杮恄宱撪帇嬀妛夛 (2021/11/18), 柤屆壆 (僴僀僽儕僢僪奐嵜).
722142. [妛夛 (慡崙)] (僔儞億僕僂儉) 媫惈婜惉恖弌寣宆傕傗傕傗昦徢椺偵懳偡傞撪帇嬀壓寣庮彍嫀弍偺桳梡惈偲栤戣揰. 彫愹姲擵1,2, 嶳杮戝曘2, 廏戱堦榊2, 墡揷榓婱巕2, 昐晲桟棟2, 愺棙丂桋1, 孏晹弐岹2 (1媬柦, 2擼奜): 戞28夞堦斒幮抍朄恖擔杮恄宱撪帇嬀妛夛 (2021/11/18), 柤屆壆 (僴僀僽儕僢僪奐嵜).
722143. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) ICG撪帇嬀傪庤弍偵妶偐偡乣儕傾儖僞僀儉偵摼傜傟傞忣曬乣. 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞28夞堦斒幮抍朄恖擔杮恄宱撪帇嬀妛夛 (2021/11/19), 柤屆壆 (僴僀僽儕僢僪奐嵜).
722144. [妛夛 (慡崙)] (嫵堢僙僢僔儑儞) 忋堖庮偺帯椕偲栤戣揰: 忋堖庮偺庤弍偲偼壗側偺偐? 孏晹弐岹 (擼奜): 戞63夞擔杮彫帣寣塼丒偑傫妛夛妛弍廤夛 (2021/11/25), Web奐嵜.
722145. [妛夛 (慡崙)] (僔儞億僕僂儉) 婏宍庮惉暘傪娷傓泱嵶朎庮偵懳偡傞曻幩慄丒壔妛椕朄偺昁梫惈. 嬥怷惌擵, 壓揷桼婸, 幠尨堦梲1, 釼摗棾懢, 墍揷弴旻, 孏晹弐岹1, 晊塱掝擇 (1擼奜): 戞39夞擔杮擼庮釃妛夛妛弍廤夛 (2021/12/5), 恄屗 (僴僀僽儕僢僪奐嵜).
722146. [妛夛 (慡崙)] (僔儞億僕僂儉) 恄宱銹庮偺夝朥妛揑恑揥條幃夝愅: 摢捀屻摢峚偵拲栚偟偨懁摢梩撪懁屻曽恄宱銹庮偺専摙. 幠尨堦梲1, 嵅摗悷恖1, 廏戱堦榊1, 釼摗棾懢, 嬥怷惌擵, 墍揷弴旻, 晊塱掝擇, 孏晹弐岹1 (1擼奜): 戞39夞擔杮擼庮釃妛夛妛弍廤夛 (2021/12/6), 恄屗 (僴僀僽儕僢僪奐嵜).
722147. [妛夛 (慡崙)] (僔儞億僕僂儉) 揈弌搙傪揔奿婎弨偲偟偰弍拞儔儞僟儉壔傪峴偆銹夎庮偵懳偡傞斾妑椪彴帋尡. 釼摗棾懢, 栘壓丂妛, 嶳嶈暥擵, 妏旤撧巕, 堜奯丂峗, 廰扟丂惤, 嵅乆栘撜, 彫怷棽巌, 峳愳朏婸, 惉揷慞岶, 惣愳丂椇, 娭栰梇懢, 嵅乆栘孾懢, 孏晹弐岹1 (1擼奜): 戞39夞擔杮擼庮釃妛夛妛弍廤夛 (2021/12/6), 恄屗 (僴僀僽儕僢僪奐嵜).
722148. [妛夛 (慡崙)] (僔儞億僕僂儉) 4K ICG撪帇嬀傊偺堏峴偲弍屻壓悅懱婡擻. 廏戱堦榊1, 廳巬椚懢1, 幠尨堦梲1, 彫愹姲擵1,2, 孏晹弐岹1 (1擼奜, 2媬柦): 戞32夞堦斒幮抍朄恖擔杮娫擼壓悅懱庮釃妛夛 (2022/2/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
722149. [妛夛 (慡崙)] (僔儞億僕僂儉) 崅埵寊晹撪栩摦柆嫹嶓徢偵懳偡傞CEA偵偍偗傞埨慡側摓払尷奅偲墦埵僔儍儞僩憓擖崲擄帪偺懳張朄. 媣恵旤恀棟1, 壀丂廏岹1, 嬤摗岹帯1 (1擼奜): STROKE 2022 (2022/3/19), 戝嶃 (僴僀僽儕僢僪奐嵜).
723374. [妛夛 (慡崙)] (堦斒島墘) 撪帇嬀揑戞嶰擼幒掙奐憢弍偑挊岠偟偨斢惉惈拞擼悈摴嫹嶓徢偺2椺亅昦懺揑峫嶡亅. 嵅摗悷恖1, 彫愹姲擵1,2, 敿揷丂敚1, 堜忋抭晇, 娭岥朁巕1, 巘揷怣恖, 廏戱堦榊1, 孏晹弐岹1 (1擼奜, 2媬柦): 戞62夞擔杮恄宱妛夛妛弍戝夛 (2021/5/21), 嫗搒 (僴僀僽儕僢僪奐嵜).
723375. [妛夛 (慡崙)] (堦斒島墘) 旕揟宆揑夋憸強尒傪帵偡尨敪惈拞悤恄宱宯埆惈儕儞僷庮偺昦棟慻怐妛揑摿挜. 將帞丂墌1, 幠尨堦梲1, 敿揷丂敚1, 墡揷榓婱巕1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞39夞擔杮擼庮釃昦棟妛夛妛弍廤夛 (2021/5/21), 嫗搒 (僴僀僽儕僢僪奐嵜).
723376. [妛夛 (慡崙)] (堦斒島墘) 摢奧撪泱庮偵偍偗傞擼愐悜塼傪梡偄偨堚揱巕恌抐. 朙揷錆棞巕1, 幠尨堦梲1, 昐晲桟棟1, 敿揷丂敚1, 摗扟榓巕2, 將帞丂墌1, 彫愹姲擵1,3, 巘揷怣恖, 廏戱堦榊1, 孏晹弐岹1 (1擼奜, 2DNA幚尡僙, 3媬柦): 戞39夞擔杮擼庮釃昦棟妛夛妛弍廤夛 (2021/5/22), 嫗搒 (僴僀僽儕僢僪奐嵜).
723377. [妛夛 (慡崙)] (堦斒島墘) Gliomatosis cerebri條偺擼敀幙昦曄傪掓偟偨Leber堚揱惈帇恄宱徢偺堦椺. 墡揷榓婱巕1, 幠尨堦梲1, 將帞丂墌1, 嬥嶳弐夘2, 廐嶳媣彯, 愇愳丂嬒3, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹): 戞39夞擔杮擼庮釃昦棟妛夛妛弍廤夛 (2021/5/22), 嫗搒 (僴僀僽儕僢僪奐嵜).
723378. [妛夛 (慡崙)] (堦斒島墘) 摢奧撪germinoma偵慡恎惈sarcoidosis傪崌暪偟偨堦椺. 昐晲桟棟1, 幠尨堦梲1, 彫愹姲擵1,2, 巘揷怣恖, 廏戱堦榊1, 媑揷丂岟3, 嵅乆栘帯堦榊4, 孏晹弐岹1 (1擼奜, 2媬柦, 3昦棟, 4怴悽婭堛椕丒墶抐揑堛椕): 戞39夞擔杮擼庮釃昦棟妛夛妛弍廤夛 (2021/5/22), 嫗搒 (僴僀僽儕僢僪奐嵜).
723379. [妛夛 (慡崙)] (堦斒島墘) 拞擼幚幙撪攚懁晹庮釃偵懳偡傞occipital transtentorial approach偵傛傞揈弌弍. 孏晹弐岹1, 幠尨堦梲1, 敿揷丂敚1, 堫懞彶婭, 忹尨岝恖, 嶳杮戝曘1, 將帞丂墌1, 嵅摗悷恖1, 廏戱堦榊1 (1擼奜): 戞49夞擔杮彫帣恄宱奜壢妛夛 (2021/6/5), 暉搰 (僴僀僽儕僢僪奐嵜).
723380. [妛夛 (慡崙)] (堦斒島墘) 懁擼幒壓妏偵懚嵼偡傞柆棈憄庮釃偵懳偡傞搰壓嫬奅峚傪夘偟偨揈弌弍. 幠尨堦梲1, 昐晲桟棟1, 朙揷錆棞巕1, 敿揷丂敚1, 墡揷榓婱巕1, 將帞丂墌1, 嵅摗悷恖1, 廏戱堦榊1, 釼摗棾懢, 嬥怷惌擵, 墍揷弴旻, 晊塱掝擇, 孏晹弐岹1 (1擼奜): 戞49夞擔杮彫帣恄宱奜壢妛夛 (2021/6/5), 暉搰 (僴僀僽儕僢僪奐嵜).
723381. [妛夛 (慡崙)] (堦斒島墘) 摢奧撪germinoma偵慡恎惈sarcoidosis傪崌暪偟偨堦椺. 昐晲桟棟1, 幠尨堦梲1, 彫愹姲擵1,2, 巘揷怣恖, 廏戱堦榊1, 媑揷丂岟3, 嵅乆栘帯堦榊4, 孏晹弐岹1 (1擼奜, 2媬柦, 3昦棟, 4怴悽婭堛椕丒墶抐揑堛椕): 戞49夞擔杮彫帣恄宱奜壢妛夛 (2021/6/5), 暉搰 (僴僀僽儕僢僪奐嵜).
723382. [妛夛 (慡崙)] (堦斒島墘) 擼幒乗嫻峯僔儍儞僩弍傪宱尡偟偨悈摢徢偺堦椺. 朙揷錆棞巕1, 巘揷怣恖, 恄栰悞惗, 敿揷丂敚1, 昐晲桟棟1, 孏晹弐岹1 (1擼奜): 戞49夞擔杮彫帣恄宱奜壢妛夛 (2021/6/5), 暉搰 (僴僀僽儕僢僪奐嵜).
723373. [妛夛 (慡崙)] (堦斒島墘) 摿敪惈愐悜僿儖僯傾偺廋暅弍屻偵double-barreled dural theca傪惗偠偨1椺. 惔悈丂濟1, 彫椦梞夘, 惵揷梞堦, 孏晹弐岹1 (1擼奜): 戞28夞擔杮愐捙丒愐悜恄宱庤弍庤媄妛夛妛弍廤夛 (2021/9/3), 嫗搒 (僴僀僽儕僢僪奐嵜).
723384. [妛夛 (慡崙)] (堦斒島墘) 摢奧掙庤弍偵偍偗傞ICG撪帇嬀偺尰忬偲枹棃. 廏戱堦榊1, 敿揷丂敚1, 幠尨堦梲1, 堜忋抭晇, 彫愹姲擵1,2, 孏晹弐岹1 (1擼奜, 2媬柦): 戞32夞擔杮摢奧掙奜壢妛夛 (2021/10/26), 暉搰.
723385. [妛夛 (慡崙)] (堦斒島墘) 崅楊幰偺枹攋楐擼摦柆釒宱夁娤嶡拞偵敪徢偟偨偔傕枌壓弌寣徢椺偺屻曽帇揑専摙: 攋楐儕僗僋僗僐傾偵傛傞帯椕夘擖偺懨摉惈昡壙. 彫愹姲擵1,2, 嶳杮戝曘2, 敿揷丂敚2, 墡揷榓婱巕2, 幠尨堦梲2, 媨嶁榓峅2, 昐晲桟棟2, 朙揷錆棞巕2, 嵅摗悷恖2, 廏戱堦榊2, 愺棙丂桋1, 孏晹弐岹2 (1媬柦, 2擼奜): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/27), 墶昹 (僴僀僽儕僢僪奐嵜).
723386. [妛夛 (慡崙)] (堦斒島墘) 戝宆壓悅懱態庮揈弌偺庤弍庤媄: 弶敪偲嵞敪偵偍偗傞奺乆偺僐僣偵偮偄偰. 媣恵旤恀棟1, 壀丂廏岹1, 嬤摗岹帯1, 堃懞岞堣1, 孏晹弐岹1 (1擼奜): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/27), 墶昹 (僴僀僽儕僢僪奐嵜).
723387. [妛夛 (慡崙)] (堦斒島墘) 嬼敪揑偵敪尒偝傟偨戞巐擼幒撪恄宱銹庮3徢椺偺専摙. 朙揷錆棞巕1, 幠尨堦梲1, 將帞丂墌1, 墡揷榓婱巕1, 敿揷丂敚1, 昐晲桟棟1, 嬵堜塸恖1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/27), 墶昹 (僴僀僽儕僢僪奐嵜).
723388. [妛夛 (慡崙)] (堦斒島墘) 摢奧撪泱庮帯椕屻偵偰傫偐傫傪敪徢偟偨徢椺孮偺専摙. 壓揷桼婸, 嬥怷惌擵, 戝戲怢堦榊, 釼摗棾懢, 墍揷弴旻, 孏晹弐岹1, 拞棦怣榓, 晊塱掝擇 (1擼奜): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/27), 墶昹 (僴僀僽儕僢僪奐嵜).
723389. [妛夛 (慡崙)] (堦斒島墘) 摢捀屻摢峚偵婯掕偝傟傞懁摢梩撪懁屻曽恄宱銹庮偺恑揥條幃偲偦偺庤弍愴棯. 幠尨堦梲1, 嵅摗悷恖1, 廏戱堦榊1, 釼摗棾懢, 嬥怷惌擵, 墍揷弴旻, 晊塱掝擇, 孏晹弐岹1 (1擼奜): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/27), 墶昹 (僴僀僽儕僢僪奐嵜).
723390. [妛夛 (慡崙)] (堦斒島墘) 恄宱慄堐庮徢I宆偵崌暪偟偨栄條嵶朎宍懺傪桳偡傞彫擼戅宍惉惈惎嵶朎庮偺1椺. 拞搰嵤壺, 幠尨堦梲1, 將帞丂墌1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/27), 墶昹 (僴僀僽儕僢僪奐嵜).
723391. [妛夛 (慡崙)] (堦斒島墘) ICG撪帇嬀帪戙偺娫擼壓悅懱庮釃偺庤弍愴棯. 廏戱堦榊1, 廳巬椚懢1, 幠尨堦梲1, 嶳杮戝曘1, 彫愹姲擵1,2, 孏晹弐岹1 (1擼奜, 2媬柦): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/28), 墶昹 (僴僀僽儕僢僪奐嵜).
723392. [妛夛 (慡崙)] (堦斒島墘) 90嵨埲忋偺挻崅楊幰偵懳偡傞寣愷夞廂椕朄屻偺帯椕揮婣. 嶳杮戝曘1, 彫愹姲擵1,2, 恗栘丂弤1, 幠尨堦梲1, 廳巬椚懢1, 媨嶁榓峅1, 墡揷榓婱巕1, 敿揷丂敚1, 昐晲桟棟1, 朙揷錆棞巕1, 嬵堜塸恖1, 堜搰戝曘3, 塐堜丂椛3, 栘懞暥彨3, 惣嶳榓棙3, 孏晹弐岹1 (1擼奜, 2媬柦, 3擼恄宱撪): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/29), 墶昹 (僴僀僽儕僢僪奐嵜).
723393. [妛夛 (慡崙)] (堦斒島墘) 擼幒嫻峯僔儍儞僩弍偺宱尡偲桳梡惈. 堃懞岞堣1, 媣恵旤恀棟1, 嬤摗岹帯1, 壀丂廏岹1, 孏晹弐岹1 (1擼奜): 戞80夞擔杮擼恄宱奜壢妛夛憤夛 (2021/10/29), 墶昹 (僴僀僽儕僢僪奐嵜).
723394. [妛夛 (慡崙)] (堦斒島墘) 戝擼姍晹悜枌庮庤弍偵偍偗傞4K ICG撪帇嬀暪梡偺桳梡惈. 廳巬椚懢1, 廏戱堦榊1, 彫愹姲擵1, 嶳杮戝曘1, 昐晲桟棟1, 孏晹弐岹1 (1擼奜): 戞28夞堦斒幮抍朄恖擔杮恄宱撪帇嬀妛夛 (2021/11/19), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723395. [妛夛 (慡崙)] (堦斒島墘) 摢奧撪泱庮偵偍偗傞擼愐悜塼傪梡偄偨堚揱巕恌抐. 朙揷錆棞巕1, 幠尨堦梲1, 昐晲桟棟1, 敿揷丂敚1, 摗扟榓巕2, 將帞丂墌1, 彫愹姲擵1,3, 巘揷怣恖, 廏戱堦榊1, 孏晹弐岹1 (1擼奜, 2DNA幚尡僙, 3媬柦): 戞39夞擔杮擼庮釃妛夛妛弍廤夛 (2021/12/5), 恄屗 (僴僀僽儕僢僪奐嵜).
723396. [妛夛 (慡崙)] (堦斒島墘) 銹夎庮弍屻巆懚T2崅怣崋堟偲嵞敪. 壓揷桼婸, 嬥怷惌擵, 釼摗棾懢, 墍揷弴旻, 孏晹弐岹1, 敒憅弐巌 (1擼奜): 戞39夞擔杮擼庮釃妛夛妛弍廤夛 (2021/12/5), 恄屗 (僴僀僽儕僢僪奐嵜).
723397. [妛夛 (慡崙)] (堦斒島墘) Gliomatosis cerebri條偺擼敀幙昦曄傪掓偟偨Leber堚揱惈帇恄宱徢偺堦椺. 墡揷榓婱巕1, 幠尨堦梲1, 將帞丂墌1, 嬥嶳弐夘2, 廐嶳媣彯, 愇愳丂嬒3, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹): 戞39夞擔杮擼庮釃妛夛妛弍廤夛 (2021/12/6), 恄屗 (僴僀僽儕僢僪奐嵜).
723398. [妛夛 (慡崙)] (堦斒島墘) 婡擻揑屻崻愗抐弍 (functional posterior rhizotomy: FPR) 偵偍偗傞弍拞F攇偺曄壔偲嵞尰惈. 嬵堜塸恖1, 嵅摗悷恖1, 將帞丂墌1, 墴揷岲旤2, 彫栰郪桾栫, 巘揷怣恖, 孏晹弐岹1 (1擼奜, 2椪専晹): 戞51夞擔杮椪彴恄宱惗棟妛夛妛弍戝夛丒戞58夞擔杮椪彴恄宱惗棟妛夛媄弍島廗夛 (2021/12/16), 愬戜 (僴僀僽儕僢僪奐嵜).
723399. [妛夛 (慡崙)] (堦斒島墘) 曅懁婄柺偗偄傟傫偵懳偡傞揔愗側infrafloccular approach. 媣恵旤恀棟1, 壀丂廏岹1, 堃懞岞堣1, 嬤摗岹帯1, 孏晹弐岹1 (1擼奜): 戞24夞擔杮擼恄宱尭埑弍妛夛 (2022/1/27), 戝嶃 (僴僀僽儕僢僪奐嵜).
723400. [妛夛 (慡崙)] (堦斒島墘) 怴宆僐儘僫僂僀儖僗姶愼徢傪崌暪偟帯椕偑抶傟偨摢晹奜彎偺1椺. 昐晲桟棟1, 彫愹姲擵1,2, 嶳杮戝曘1, 廏戱堦榊1, 愺棙丂桋2, 孏晹弐岹1 (1擼奜, 2媬柦): 戞45夞擔杮擼恄宱奜彎妛夛 (2022/2/25), 撧椙 (僴僀僽儕僢僪奐嵜).
723401. [妛夛 (慡崙)] (堦斒島墘) 旕憿塭MRI/CT fusion夋憸傪梡偄偨CEA弍慜昡壙. 崟揷攷婭1, 拞嫃峃揥, 嶰戭栁懢, 惔悈丂濟1, 孏晹弐岹1 (1擼奜): STROKE 2022 (戞47夞擔杮擼懖拞妛夛妛弍廤夛) (2022/3/17), 戝嶃 (僴僀僽儕僢僪奐嵜).
723402. [妛夛 (慡崙)] (堦斒島墘) 摢旂惷柆傪摢旂摦柆偲岆擣偟儅乕僉儞僌偟偨偨傔偵僶僀僷僗弍偑暋嶨壔偟偨2徢椺. 惔悈丂濟1, 崟揷攷婭1, 嶰戭栁懢, 朷寧悞峅, 拞嫃峃揥, 孏晹弐岹1 (1擼奜): STROKE 2022 (戞47夞擔杮擼懖拞妛夛妛弍廤夛) (2022/3/17), 戝嶃 (僴僀僽儕僢僪奐嵜).
731008. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) Occipital & transtentorial approach偵傛傞庮釃揈弌弍: 弍屻偺偰傫偐傫敪嶌傪娷傔偨崌暪徢夞旔. 孏晹弐岹 (擼奜): Neuro-oncology in Hiroshima 2021 (2021/9/3), 峀搰 (僴僀僽儕僢僪奐嵜).
731009. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) Choroidal arteries anatomy & surgery related complications. 孏晹弐岹 (擼奜): 掃晳擼庮釃web僇儞僼傽儗儞僗 (2021/9/16), Web奐嵜.
732047. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 偮傑偢偄偰傕棫偪忋偑傟!乣寣愷夞廂偵偍偗傞嵞奐捠崲擄丒婋尟徢椺偺孹岦偲懳嶔乣. 嶳杮戝曘1, 彫愹姲擵1,2, 幠尨堦梲1, 恗栘丂弤1, 媨嶁榓峅1, 堜搰戝曘3, 塐堜丂椛3, 孏晹弐岹1 (1擼奜, 2媬柦, 3擼恄宱撪): 戞20夞NPO朄恖擔杮擼恄宱寣娗撪帯椕妛夛娭搶抧曽夛妛弍廤夛 (2021/8/21), 搶嫗.
732048. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 寣愷夞廂乣媧堷僇僥乕僥儖偺巊梡朄乣. 嶳杮戝曘1, 堜搰戝曘2, 塐堜丂椛2, 栘懞暥彨2, 彫愹姲擵1,3, 幠尨堦梲1, 恗栘丂弤1, 媨嶁榓峅1, 惣嶳榓棙2, 孏晹弐岹1 (1擼奜, 2擼恄宱撪, 3媬柦): 戞1夞搶嫗擼恄宱寣娗撪帯椕嫵堢僙儈僫乕 (2021/9/24), 墶昹.
732049. [妛夛 (抧曽夛丒尋媶夛)] (儔儞僠儑儞僙儈僫乕) 銹夎庮偺庤弍揈弌: 嵞峫. 孏晹弐岹 (擼奜): 戞87夞擔杮擼恄宱奜壢妛夛杒奀摴巟晹夛 (2022/3/26), 嶥杫 (僴僀僽儕僢僪奐嵜).
733117. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Bevacizumab搳梌屻偵揈弌弍傪峴偭偨懁摢梩撪懁偵庡嵗傪桳偡傞嵞敪銹夎庮揈弌弍. 幠尨堦梲1, 昐晲桟棟1, 將帞丂墌1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞144夞堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛娭搶巟晹妛弍廤夛 (2021/4/3), 搶嫗 (僴僀僽儕僢僪奐嵜).
733118. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 8屄偺擼摦柆釒傪桳偡傞拞偱弶夞僐僀儖嵡愷弍傪峴偭偨墦埵屻戝擼摦柆釒偐傜7擭屻偵嵞弌寣傪惗偠偨1椺. 昐晲桟棟1, 嶳杮戝曘1, 恄栰悞惗, 恗栘丂弤1, 堜搰戝曘2, 塐堜丂椛2, 栘懞暥彨2, 塒堜峩懢榊2, 彫愹姲擵1,3, 孏晹弐岹1 (1擼奜, 2擼恄宱撪, 3媬柦): 戞144夞堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛娭搶巟晹妛弍廤夛 (2021/4/3), 搶嫗 (僴僀僽儕僢僪奐嵜).
733119. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Gliomatosis cerebri條偺擼敀幙昦曄傪掓偟偨Leber堚揱惈帇恄宱徢偺堦椺. 墡揷榓婱巕1, 幠尨堦梲1, 將帞丂墌1, 嬥嶳弐夘2, 廐嶳媣彯, 愇愳丂嬒3, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹): 戞40夞搶嫗擼庮釃帯椕崸榖夛 (2021/6/18), Web奐嵜.
733120. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 堦擭偺宱夁偱埆惈悜枌庮傊偲揮壔偟媬偊側偐偭偨堦椺. 廏戱堦榊1, 將帞丂墌1, 朙揷錆棞巕1, 廳巬椚懢1, 敿揷丂敚1, 幠尨堦梲1, 孏晹弐岹1 (1擼奜): 戞39夞恄撧愳擼庮釃僼僅乕儔儉 (2021/6/18), 愳嶈.
733121. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 婡擻揑屻崻愗抐弍 (functional posterior rhizotomy: FPR) 偵偍偗傞弍拞F攇偺曄壔偲嵞尰惈. 嬵堜塸恖1, 嵅摗悷恖1, 將帞丂墌1, 昐晲桟棟1, 朙揷錆棞巕1, 敿揷丂敚1, 墡揷榓婱巕1, 廳巬椚懢1, 墴揷岲旤2, 彫栰郪桾栫2, 巘揷怣恖, 孏晹弐岹1 (1擼奜, 2椪専晹): 戞145夞堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛娭搶巟晹妛弍廤夛 (2021/9/4), 搶嫗 (僴僀僽儕僢僪奐嵜).
'20擭搙埲慜暘
[妛夛丒尋媶夛摍]
'20-731001. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 庒庤擼寣娗撪帯椕堛偵抦偭偰傎偟偄!乣杒棦戝妛幃丒寣愷夞廂椕朄惉岟偺偨傔偺抦幆偲媄弍乣. 嶳杮戝曘1, 彫愹姲擵1,2, 幠尨堦梲1, 恗栘丂弤1, 媨嶁榓峅1, 堜搰戝曘3, 塐堜丂椛3, 栘懞暥彨3, 惣嶳榓棙3, 孏晹弐岹1 (1擼奜, 2媬柦, 3擼恄宱撪): 戞19夞NPO朄恖擔杮擼恄宱寣娗撪帯椕妛夛娭搶抧曽夛妛弍廤夛 (2021/2/20), Web奐嵜.
彫帣壢妛
[妛弍榑暥]
110298. [尨挊] Perinatal factors contributing to chronic kidney disease in a cohort of Japanese children with very low birth weight. Uemura O, Ishikura K1, Kaneko T, Hirano D, Hamasaki Y, Ogura M, Mikami N, Gotoh Y, Sahashi T, Fujita N, Yamamoto M, Hibino S, Nakano M, Wakano Y, Honda M: Pediatr Nephrol 2021/5; 36 (4): 953-60. (愇憅寬巌1: 1彫帣)
110299. [尨挊] Inhibition of Glucose-6-Phosphate Dehydrogenase Activity Attenuates Right Ventricle Pressure and Hypertrophy Elicited by VEGFR Inhibitor + Hypoxia. Kitagawa A1, Jacob C, Jordan A, Waddell I, McMurtry IF, Gupte SA: J Pharmacol Exp Ther 2021/5; 377 (2): 284-92. (杒愳撃巎1: 1彫帣)
110300. [尨挊] Live attenuated vaccines under immunosuppressive agents or biological agents: survey and clinical data from Japan. Kamei K, Miyairi I, Shoji K, Arai K, Kawai T, Ogura M, Ishikura K1, Sako M, Nakamura H: Eur J Pediatr 2021/6; 180 (6): 1847-54. (愇憅寬巌1: 1彫帣)
110301. [尨挊] Dietary Potassium Intake and Mortality in a Prospective Hemodialysis Cohort. Narasaki Y, Okuda Y1, Kalantar SS, You AS, Novoa A, Nguyen T, Streja E, Nakata T, Colman S, Kalantar-Zadeh K, Nguyen DV, Rhee CM: J Ren Nutr 2021/7; 31 (4): 411-20. (墱揷梇夘1: 1彫帣)
110302. [尨挊] Study on the Causes, Types, and Mechanisms of Childhood Injuries-Age and Disease Specificity. Matsuura N, Nishida Y, Harada S, Takahashi K, Koshikawa K, Konn S1, Hosoda N, Deguchi K, Hotta U, Oka T: JMA J 2021/7; 4 (3): 246-53. (崺丂怢栫1: 1彫帣)
110303. [尨挊] Dietary protein intake, kidney function, and survival in a nationally representative cohort. Narasaki Y, Okuda Y1, Moore LW, You AS, Tantisattamo E, Inrig JK, Miyagi T, Nakata T, Kovesdy CP, Nguyen DV, Kalantar-Zadeh K, Rhee CM: Am J Clin Nutr 2021/7; 114 (1): 303-13. (墱揷梇夘1: 1彫帣)
110304. [尨挊] Association Between Eosinophilia and Late-onset Circulatory Collapse in Preterm Infants: A case-Control Study, Okamura T, Washio Y, Watanabe H, Nakanishi H1,2, Uchiyama A, Tsukahara H, Kusuda S: Acta Med Okayama 2021/8; 75 (4): 505-9. (拞惣廏旻1,2: 1怴悽婭堛椕丒愭抂堛椕, 2彫帣)
110305. [尨挊] Glucocorticoid discontinuation in pediatric-onset systemic lupus erythematosus: a single-center experience. Nishi K, Ogura M, Ishiwa S, Kanamori T, Okutsu M, Yokota S, Nada T, Sato M, Kamei K, Ishikura K1, Ito S: Pediatr Nephrol 2022/9; 37 (9): 2131-9. (愇憅寬巌1: 1彫帣)
110306. [尨挊] Mean of creatinine clearance and urea clearance examined over 1 h estimates glomerular filtration rate accurately and precisely in children. Okuda Y1, Hamada R, Uemura O, Sakai T, Sawai T, Harada R, Hamasaki Y, Ishikura K1, Hataya H, Honda M: Nephrology (Carlton) 2021/10; 26 (10): 763-71. (墱揷梇夘1, 愇憅寬巌1: 1彫帣)
110307. [尨挊] Ultrasonography as a Diagnostic Support Tool for Childhood Takayasu Arteritis Referred to as Fever of Unknown Origin: Case Series and Literature Review. Nozawa H, Ogura M, Miyasaka M, Suzuki H, Ishikura K1, Ishiguro A, Ito S: JMA J 2021/10; 4 (4): 358-66. (愇憅寬巌1: 1彫帣)
110308. [尨挊] Risk factors for post-nephrectomy hypotension in pediatric patients. Nishi K, Kamei K, Ogura M, Sato M, Ishiwa S, Shioda Y, Kiyotani C, Matsumoto K, Nozu K, Ishikura K1, Ito S: Pediatr Nephrol 2021/11; 36 (11): 3699-709. (愇憅寬巌1: 1彫帣)
110309. [尨挊] Influenza virus vaccination in pediatric nephrotic syndrome significantly reduces rate of relapse and influenza virus infection as assessed in a nationwide survey. Ishimori S, Ando T, Kikunaga K, Terano C, Sato M, Komaki F, Hamada R, Hamasaki Y, Araki Y, Gotoh Y, Nakanishi K, Nakazato H, Matsuyama T, Iijima K, Yoshikawa N, Ito S, Honda M, Ishikura K1: Sci Rep 2021/12; 11 (1): 23305. (愇憅寬巌1: 1彫帣)
110310. [尨挊] Evaluation of postoperative complications for patent ductus arteriosus in extremely-low-birthweight infants. Ishida S1, Yamaguchi A1, Ooka M1, Kenmochi M1, Nakanishi H1,2: Pediatr Int 2022/1; 64 (1): e14759. (愇揷廆巌1, 嶳岥埢擳1, 戝壀杻棟1, 櫅帩丂妛1, 拞惣廏旻1,2: 1彫帣, 2怴悽婭堛椕丒愭抂堛椕)
110311. [尨挊] Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20. Toyofuku E, Takeshita K, Ohnishi H, Kiridoshi Y, Masuoka H, Kadowaki T, Nishikomori R, Nishimura K, Kobayashi C, Ebato T1, Shigemura T, Inoue Y, Suda W, Hattori M, Morio T, Honda K, Kanegane H: Front Cell Infect Microbiol 2022/1; 11: 787667. (峕攇屗岶曘1: 1彫帣)
110312. [尨挊] Medical, welfare, and educational challenges and psychological distress in parents caring for an individual with 22q11.2 deletion syndrome: A cross-sectional survey in Japan. Morishima R, Kumakura Y, Usami S, Kanehara A, Tanaka M, Okochi N, Nakajima N, Hamada J, Ogawa T, Ando S, Tamune H, Nakahara M, Jinde S, Kano Y, Tanaka K, Hirata Y1, Oka A, Kasai K: Am J Med Genet A 2022/1; 188 (1): 37-45. (暯揷梲堦榊1: 1彫帣)
110313. [尨挊] Comparison of inulin clearance with 2-h creatinine clearance in Japanese pediatric patients with renal disease: open-label phase 3 study of inulin. Uemura O, Ishikura K1, Kamei K, Hamada R, Yamamoto M, Gotoh Y, Fujita N, Sakai T, Sano T, Fushimi M, Iijima K: Clin Exp Nephrol 2022/2; 26 (2): 132-9. (愇憅寬巌1: 1彫帣)
110314. [尨挊] Respiratory management for extremely premature infants born at 22 to 23 weeks of gestation in proactive centers in Sweden, Japan, and USA. Sindelar R, Nakanishi H1,2, Stanford AH, Colaizy TT, Klein JM: Semin Perinatol 2022/2; 46 (1): 151540. (拞惣廏旻1,2: 1怴悽婭堛椕丒愭抂堛椕, 2彫帣)
110315. [尨挊] Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome. Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinouchi T, Konishi A, Omori T, Nakanishi K, Ishikura K1, Ito S, Nakamura H, Nozu K, Japanese Study Group of Kidney Disease in Children: J Am Soc Nephrol 2022/2; 33 (2): 401-19. (愇憅寬巌1: 1彫帣)
110316. [尨挊] Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study. Myojin S, Pak K, Sako M, Kobayashi T, Takahashi T, Sunagawa T, Tsuboi N, Ishikura K1, Kubota M, Kubota M, Igarashi T, Morioka I, Miyairi I: PLoS One 2022/2; 17 (2): e0263349. (愇憅寬巌1: 1彫帣)
110317. [尨挊] Comparison of inulin clearance with 2-h creatinine clearance in Japanese pediatric patients with renal disease: open-label phase 3 study of inulin. Uemura O, Ishikura K1, Kamei K, Hamada R, Yamamoto M, Gotoh Y, Fujita N, Sakai T, Sano T, Fushimi M, Iijima K: Clin Exp Nephrol 2022/2; 26 (2): 132-9. (愇憅寬巌1: 1彫帣)
110318. [尨挊] Incidence of malignancy after pediatric kidney transplantation: a single-center experience over the past three decades in Japan. Aoki Y, Satoh H, Hamasaki Y, Hamada R, Harada R, Hataya H, Ishikura K1, Muramatsu M, Shishido S, Sakai K: Clin Exp Nephrol 2022/3; 26 (3): 294-302. (愇憅寬巌1: 1彫帣)
110319. [尨挊] Validation of the estimated glomerular filtration rate equation for Japanese children younger than 2 years. Gotoh Y, Uemura O, Fujita N, Hamasaki Y, Honda M, Ishikura K1, Pediatric CKD Study Group in Japan in conjunction with the Committee of Measures for Pediatric CKD of the Japanese Society of Pediatric Nephrology: Clin Exp Nephrol 2022/3; 26 (3): 266-71. (愇憅寬巌1: 1彫帣)
110320. [尨挊] Efficacy of a Transitional Support Program Among Adolescent Patients With Childhood-Onset Chronic Diseases: A Randomized Controlled Trial. Morisaki-Nakamura M, Suzuki S, Kobayashi A, Kita S, Sato I, Iwasaki M, Hirata Y1, Sato A, Oka A, Kamibeppu K: Front Pediatr 2022/3; 10: 829602. (暯揷梲堦榊1: 1彫帣)
110321. [尨挊] Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study. Chan EYH, Yu ELM, Angeletti A, Arslan Z, Basu B, Boyer O, Chan CY, Colucci M, Dorval G, Dossier C, Drovandi S, Ghiggeri GM, Gipson DS, Hamada R, Hogan J, Ishikura K1, Kamei K, Kemper MJ, Ma ALT, Parekh R, Radhakrishnan S, Saini P, Shen Q, Sinha R, Subun C, Teo S, Vivarelli M, Webb H, Xu H, Kim H, Yap HK, Tullus K: J Am Soc Nephrol 2022/6; 33 (6): 1193-207. doi: 10.1681/ASN.2021111472. Epub 2022 Mar 30. (愇憅寬巌1: 1彫帣)
110322. [尨挊] Risks and renal outcomes of severe acute kidney injury in children with steroid-resistant nephrotic syndrome. Ishiwa S, Sato M, Kamei K, Nishi K, Kanamori T, Okutsu M, Ogura M, Sako M, Ito S, Orihashi Y, Ishikura K1: Clin Exp Nephrol 2022/7; 26 (7): 700-8. doi: 10.1007/s10157-022-02198-w. Epub 2022 Mar 7. (愇憅寬巌1: 1彫帣)
110323. [尨挊] Glucose-6-phosphate dehydrogenase and MEG3 controls hypoxia-induced expression of serum response factor (SRF) and SRF-dependent genes in pulmonary smooth muscle cell. Kitagawa A1, Jacob C, Gupte SA: J Smooth Muscle Res 2022; 58 (0): 34-49. Published online: April 29, 2022; doi: 10.1540/jsmr.58.34 (杒愳撃巎1: 1彫帣)
120010. [尨挊] 妛摱婜偵摓払偟偨挻憗嶻帣偺廇妛忬嫷丒崌暪徢偵偮偄偰偺傾儞働乕僩挷嵏寢壥. 巛帩丂妛1, 戝壀杻棟1, 愇揷廆巌1, 嶳岥埢擳1, 彫嶃桾壚巕1, 墶娭桽堦榊1,栰搉惓旻, 拞惣廏旻1,2, 愇憅寬巌1 (1彫帣, 2怴悽婭堛椕丒愭抂堛椕): 擔杮廃嶻婜丒怴惗帣堛妛夛嶨帍 2021/5; 57 (1): 66-72.
120011. [尨挊] 嵼戀26廡枹枮偺帣偱偺帯椕夘擖偵傛傞摦柆娗暵嵔慜屻偺弞娐摦懺偺曄壔. 愇揷廆巌1, 拞惣廏旻1,2, 嶳岥埢擳1, 戝壀杻棟1, 巛帩丂妛1 (1彫帣, 2怴悽婭堛椕丒愭抂堛椕): 擔杮廃嶻婜丒怴惗帣堛妛夛嶨帍 2021/9; 57 (2): 269-74.
310042. [徢椺曬崘] Tocilizumab for juvenile Takayasu arteritis complicated with acute heart failure at onset. Kanamori K, Ogura M, Ishikura K1, Ishiguro A, Ito S: Mod Rheumatol Case Rep 2022/6; 6 (2): 226-9. (愇憅寬巌1: 1彫帣)
310043. [徢椺曬崘] Contradiction between genetic analysis and diuretic loading test in type I Bartter syndrome: a case report. Kuroda J, Harada R, Hamada R, Okuda Y, Yoshida Y, Hataya H, Nozu K, Iijima K, Honda M, Ishikura K1: BMC Nephrol 2021/8; 22 (1): 295. (愇憅寬巌1: 1彫帣)
310044. [徢椺曬崘] Venous Properties in a Fontan Patient with Successful Remission of Protein-Losing Enteropathy. Kuwata S, Saiki H, Takanashi M1, Fukunishi T2, Miyaji K2, Senzaki H: Int Heart J 2021; 62 (3): 710-4. (崅棞丂妛1, 暉惣戶恀2, 媨抧丂娪2: 1彫帣, 2怱憻寣娗奜)
510019. [憤愢] Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies. Harada R, Hamasaki Y, Okuda Y1, Hamada R, Ishikura K1: Pediatr Nephrol 2022/6; 37 (6): 1215-29. (墱揷梇夘1, 愇憅寬巌1: 1彫帣)
522077. [島嵗]亂僔儞億僕僂儉12: 怴惗帣椞堟偺NO媧擖椕朄亃嵗挿偺傑偲傔. 拞惣廏旻1,2, 朏杮惤巌 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 擔杮廃嶻婜怴惗帣堛妛夛嶨帍 2021/4; 57 (4): 708-9.
522078. [島嵗]亂僔儞億僕僂儉12: 怴惗帣椞堟偺NO媧擖椕朄亃怴惗帣椞堟偵偍偗傞NO媧擖椕朄偺婜懸偝傟傞岠壥 (婎慴揑傾僾儘乕僠). 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 擔杮廃嶻婜怴惗帣堛妛夛嶨帍 2021/4; 57 (4): 718-21.
522079. [島嵗]亂摿廤: 擕梒帣寬恌幚慔僈僀僪亃愱栧壠偐傜偺傾僪僶僀僗乣椞堟暿偵乣丂弞娐婍. 杒愳撃巎1, 暯揷梲堦榊1 (1彫帣): 彫帣壢恌椕 2021/4; 84 (5): 663-7.
522080. [島嵗]亂摿廤: NEO Speciality亃with僐儘僫帪戙偵嵞峫偡傞丂尰応偱巊偊傞!NICU偱偺姶愼懳嶔Q&A丂憤榑 昗弨梊杊嶔偲姶愼宱楬暿梊杊嶔. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): with NEO 2021/6; 34 (3): 408-11.
522081. [島嵗]亂摿廤: NEO Speciality亃with僐儘僫帪戙偵嵞峫偡傞丂尰応偱巊偊傞! NICU偱偺姶愼懳嶔Q&A丂巤愝暿僐儘僫僂僀儖僗姶愼懳嶔Q&A丂懠偺巤愝偼偳偆偟偰傞? (杒棦戝妛昦堾偺応崌). 戝壀杻棟 (彫帣): with NEO 2021/6; 34 (3): 427-38.
522082. [島嵗]亂摿廤: 敪惗妛偐傜峫偊偰傒傛偆! 彫帣偺愭揤幘姵亃II. 奺榑丂愭揤惈恡擜楬堎忢, 鵑朎惈恡幘姵. 惣寬懢楴, 愇憅寬巌1 (1彫帣): 彫帣壢恌椕 2021/7; 84 (8): 1089-96.
522083. [島嵗]亂摿廤: 惉恖堏峴巟墖偺擇柺惈亃[奺榑] 惉恖堛椕偲偺楢実偺応丂彫帣壢偲惉恖恌椕壢偲偺楢実丂憤崌昦堾撪偱偺楢実亅堾撪徯夘偺嵺偵昁梫側乽帺棫巟墖乿偲偼. 暯揷梲堦榊 (彫帣): 彫帣撪壢 2022/8; 53 (8): 1271-4.
522084. [島嵗]亂摿廤: 恡幘姵偺堏峴婜堛椕亃堏峴婜堛椕偺恑傔曽. 崺丂怢栫1, 戝捤丂崄2, 暯揷梲堦榊1, 栰乆揷朙1, 墱揷梇夘1, 抾撪峃梇3, 愇憅寬巌1 (1彫帣, 2娕岇晹, 3恡憻撪): 恡憻撪壢 2021/8; 14 (2): 132-7.
522085. [島嵗]亂摿廤: 嵼戀22乣23廡偺挻憗嶻傪傔偖傞壽戣偲揥朷亃NICU擖堾拞偺崌暪徢偲梊杊愴棯丂崌暪徢偺懳墳偲梊杊愴棯丂斢婜弞娐晄慡. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 廃嶻婜堛妛 2021/8; 51 (8): 1140-5.
522086. [島嵗]亂帩昦偑偁傞帣摱傊偺妛峑堛偺懳墳亃妛峑堛偵媮傔傜傟傞彫帣弞娐婍幘姵偵懳偡傞棟夝偲懳墳. 杒愳撃巎1, 暯揷梲堦榊1 (1彫帣): 抧堟堛妛 2022/1; 36 (1): 20-6.
522087. [島嵗]亂摿廤: 廃嶻婜偺僗僥儘僀僪亃椪彴曇: 怴惗帣丂斢婜弞娐晄慡偵懳偡傞僗僥儘僀僪椕朄. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 廃嶻婜堛妛 2022/1; 52 (1): 92-6.
522088. [島嵗]亂Onco-nephrology: 埆惈庮釃帯椕偲恡婡擻忈奞亃[憤榑] 彫帣CKD姵幰偵偍偗傞偑傫敪惗偺塽妛偲摿挜. 墱揷梇夘1, 堦壀憦巕, 愇憅寬巌1 (1彫帣): 恡偲摟愅 2022/3; 92 (3): 529-32.
530010. [偦偺懠 (Comment)] Outcomes of infants born at periviable gestations in Japan. Kono Y, Rysavy MA, Nakanishi H1, Kusuda S: Acta Paediatr 2021/5; 110 (5): 1694-5. (拞惣廏旻1,2: 1怴悽婭堛椕丒愭抂堛椕, 2彫帣)
540028. [偦偺懠 (尋媶曬崘彂)]亂彫帣枬惈恡憻昦姵幰偺偨傔偺堏峴婜堛椕巟墖僣乕儖乽岤惗楯摥峴惌悇恑挷嵏旓曗彆嬥 (恡幘姵惌嶔尋媶帠嬈)乿亃偍偟偭偙 (擜) 偲恡憻偺晄巚媍. 攼尨捈庽1, 暈晹尦巎1, 愇憅寬巌1,2, 恄揷徦堦榊1, 帥栰愮崄巕1, 挿壀桼廋1, 嶰塝寬堦榊1, 桍尨丂崉1, 嬥巕徆峅1, 媏塱壚怐1,2, 彫椦岝堦1, 崺丂怢栫1,2 (1乽恡幘姵懳嶔専摙夛曬崘彂偵婎偯偔懳嶔偺恑捇娗棟偍傛傃怴偨側懳嶔偺採尵偵偟偡傞僄價僨儞僗峔抸乿斍, 2彫帣), 彫帣枬惈恡憻昦姵幰偺偨傔偺堏峴婜堛椕巟墖僣乕儖乽岤惗楯摥峴惌悇恑挷嵏旓曗彆嬥 (恡幘姵惌嶔尋媶帠嬈)乿尋媶曬崘彂, 2021/9.
[挊丂彂]
610001. [妛弍彂 (暘扴幏昅)]亂Pediatric dialysis, third edition亃Outcome of Chronic Dialysis丂Long-Term Outcome of Chronic Dialysis in Children, p.745-83. Honda M, Terano C, Inoguchi T, Kikunaga K1, Harada R, Groothof JW, Editors: Warady BA, Alexander SR, Schaefer F, SpringerSwitzerland AG, 2021. (媏塱壚怐1: 1彫帣)
620083. [妛弍彂 (暘扴幏昅)]亂幚慔?彫帣偺桝塼 (彫帣撪壢4寧憹戝崋)亃[奺昦懺偵偍偗傞桝塼偺峫偊曽] 弞娐婍幘姵丂枬惈怱晄慡, p.574-7. 暯揷梲堦榊 (彫帣), 搶嫗堛妛幮, 搶嫗, 2022/4敪峴.
620084. [妛弍彂 (暘扴幏昅)]亂乣僄僉僗僷乕僩偺宱尡偵妛傇乣彫帣壢Decision Making (彫帣壢恌椕Vol.84憹姧崋)亃15. 儂儖儌儞丒戙幱丒揹夝幙偵娭偡傞昦懺丂掅僫僩儕僂儉寣徢, 崅僫僩儕僂儉寣徢, p.393-7. 墱揷梇夘1, 崺丂怢栫1, 愇憅寬巌1 (1彫帣), 恌抐偲帯椕幮, 搶嫗, 2021/4敪峴.
620085. [妛弍彂 (暘扴幏昅)]亂恡憻昦恌椕Q&A丂AKI乣CKD乣恡擄昦傑偱亃5) 帯椕丂彫帣CKD丂姵幰偺怘帠椕朄傪嫵偊偰偔偩偝偄, p.115-6. 墱揷梇夘1, 崺丂怢栫1, 愇憅寬巌1 (1彫帣), 娔廋: 嶳鉷朚峅, 曇: 塒堜忎堦, 嵵摗抦塰, 搶嫗堛妛幮, 搶嫗, 2021/6敪峴.
620086. [妛弍彂 (暘扴幏昅)]亂彫帣RS僂僀儖僗屇媧婍姶愼徢恌椕僈僀僪儔僀儞2021亃Clinical Question CQ1丂憗嶻帣偺RS僂僀儖僗嵶婥娗巟墛偺梊杊偵僷儕價僘儅僽偼桳岠偐?, p.2-5. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣), 娔廋: 媑尨廳旤, 怷壀堦楴, 壀揷朚擵, 屗愇屽巌, 嶌惉: 擔杮彫帣屇媧婍妛夛, 擔杮怴惗帣惉堢堛妛夛, 嫤榓婇夋, 搶嫗, 2021/6敪峴.
620087. [妛弍彂 (暘扴幏昅)]亂昗弨揑堛椕愢柧丂僀儞僼僅乕儉僪丒僐儞僙儞僩偺嵟慜慄亃彫帣幘姵丂廳徢愭揤惈幘姵偺恌椕 (憗嶻帣傪拞怱偵), p.255-7. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣), 曇: 堦斒幮抍朄恖 撪壢宯妛夛幮夛曐尟楢崌, 堛妛彂堾, 搶嫗, 2021/8敪峴.
620088. [妛弍彂 (暘扴幏昅)]亂昗弨揑堛椕愢柧丂僀儞僼僅乕儉僪丒僐儞僙儞僩偺嵟慜慄亃彫帣幘姵丂彫帣僱僼儘乕僛徢岓孮偵娭偡傞柶塽梷惂栻 (僔僋儘僗億儕儞) 偺巊梡, p.258-9. 愇憅寬巌 (彫帣), 曇: 堦斒幮抍朄恖 撪壢宯妛夛幮夛曐尟楢崌, 堛妛彂堾, 搶嫗, 2021/8敪峴.
620089. [妛弍彂 (暘扴幏昅)]亂怴惗帣偺屇媧丒弞娐丂敾抐椡丒幚慔椡UP偺偨傔偺働乕僗71 (with NEO (2021擭廐婫憹姧)亃 曇挊: 愮梩梞晇, 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣), 儊僨傿僇弌斉, 搶嫗, 2021/9敪峴.
620090. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓乣巹偼偙偆帯椕偟偰偄傞乣2022擭斉亃22 怴惗帣幘姵丂擼幒撪弌寣, 擼幒廃埻敀幙擃壔徢, 1430-1. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒 堦惉, 堛妛彂堾, 搶嫗, 2022/1敪峴.
620091. [妛弍彂 (暘扴幏昅)]亂廃嶻婜堛妛昁廋抦幆 戞9斉 (廃嶻婜堛妛51姫憹姧崋)亃帒椏摑寁丒梡岅曇丂VII 帒椏摑寁丒梡岅丂375 曣巕曐寬摑寁, p.1312-9. 拞惣廏旻1,2 (1悽婭堛椕丒愭抂堛椕, 2彫帣), 搶嫗堛妛幮, 搶嫗, 2022/1敪峴.
620092. [妛弍彂 (暘扴幏昅)]亂偙傫側偲偒偳偆偡傞?懠壢偲偺僐儈儏僯働乕僔儑儞僈僀僪 (嶻壢偲晈恖壢2022擭Vol.89 No.憹姧崋)亃戞1復 怴惗帣壢丒彫帣壢丒怴惗帣奜壢丂11. 側傫偲側偔尦婥偺側偄怴惗帣, p.63-6. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣), 恌抐偲帯椕幮, 搶嫗, 2022/3敪峴.
[妛夛丒尋媶夛摍]
712008. [妛夛 (崙嵺)] (嫵堢島墘) CKD in children (CME Cat A 1 point). Ishikura K1 Hong Kong Paediatric Nephrology Society (2021/8/2), Web奐嵜. (愇憅寬巌1: 1彫帣)
713044. [妛夛 (崙嵺)] (堦斒島墘) Nephronophthisis: case report of an adolescent girl and up-to-date results of a national survey in Japanese children. Okuda Y1, Hamasaki Y, Sugimoto K, Okutsu M, Kon S1,2, Hamada R, Kaneko T, Ishikura K1 The 18th Japan-Korea-China Pediatric Nephrology Seminar 2021 (2021/4/25), Web奐嵜. (墱揷梇夘1, 崺丂怢栫1,2, 愇憅寬巌1: 1彫帣, 2媬柦)
722150. [妛夛 (慡崙)] (僔儞億僕僂儉) 偙傟偐傜偺惉恖堏峴巟墖. 暯揷梲堦1, 嵅摗弤巙, 壀丂丂柧, 愇憅寬巌1 (1彫帣): 戞124夞擔杮彫帣壢妛夛妛弍廤夛 (2021/4/17), 嫗搒 (僴僀僽儕僢僪奐嵜).
722151. [妛夛 (慡崙)] (僷僱僗僨傿僗僇僢僔儑儞) CAKUT: 彫帣恡憻撪壢堛偺娗棟. 愇憅寬巌 (彫帣): 戞58夞擔杮彫帣奜壢妛夛妛弍廤夛 (2021/4/29), 墶昹 (僴僀僽儕僢僪奐嵜),
722152. [妛夛 (慡崙)] (嫵堢島墘) 怴偟偄帯椕昗揑偲偟偰偺僌儖僐乕僗-6-儕儞巁扙悈慺峺慺偺壜擻惈. 杒愳撃巎1, Sachin Gupte, 崅棞丂妛1, 杮揷丂悞1, 暯揷梲堦榊1, 愇憅寬巌1 (1彫帣): 戞6夞擔杮攛崅寣埑丒攛弞娐妛夛妛弍廤夛 (2021/5/6-8), 搶嫗 (僴僀僽儕僢僪奐嵜).
722153. [妛夛 (慡崙)] (嫵堢島墘) 媫惈婜偐傜巒傔傞HFOV娗棟乣22-24廡帣偺屇媧帯椕愴棯乣. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 戞65夞擔杮怴惗帣惉堢堛妛夛丒妛弍廤夛 (2021/5/7), Web奐嵜.
722154. [妛夛 (慡崙)] (嫵堢島墘) 払恖偐傜妛傇, 尋媶偺幚嵺偲榑暥偺彂偒曽. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 戞65夞擔杮怴惗帣惉堢堛妛夛丒妛弍廤夛 (2021/5/7), Web奐嵜.
722155. [妛夛 (慡崙)] (嫵堢島墘) 怴惗帣椞堟偵偍偗傞NO媧擖椕朄偺婜懸偝傟傞岠壥 (婎慴揑傾僾儘乕僠). 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/12), 媨嶈 (僴僀僽儕僢僪奐嵜).
722156. [妛夛 (慡崙)] (僔儞億僕僂儉) 嵍攛摦柆撪寣愷宍惉偵傛傞媫寖側徢忬恑峴傪擣傔偨怴惗帣摦柆娗釒偺堦椺. 堫栘廏塸1, 拞惣廏旻1,2, 彫嶃桾壚巕1, 嶳岥埢擳1, 愇揷廆巌1, 戝壀杻棟1, 媨抧丂娪3 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕, 3怱憻寣娗奜): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/11-13), 媨嶈 (僴僀僽儕僢僪奐嵜).
722157. [妛夛 (慡崙)] (僔儞億僕僂儉) Medication Withdrawal in JIA乽慡恎宆丒庒擭惈摿敪惈娭愡墛乿帯椕栻尭検偵娭偡傞慡崙彫帣儕僂儅僠堛挷嵏. 峕攇屗岶曘 (彫帣): 戞30夞擔杮彫帣儕僂儅僠妛夛妛弍廤夛 (2021/10/16), 搶嫗 (僴僀僽儕僢僪奐嵜).
723403. [妛夛 (慡崙)] (堦斒岥墘) 屻揤惈TTP敪徢屻偵SLE偲恌抐偝傟偨13嵨抝帣椺. 搉绯椱旤1, 峕攇屗岶曘1, 嬥巕夒婭1, 墱揷梇夘1, 崺丂怢栫1,2, 暯揷梲堦榊1, 愇憅寬巌1 (1彫帣, 2媬柦): 戞124夞擔杮彫帣壢妛夛妛弍廤夛 (2021/4/16-18), 嫗搒 (僴僀僽儕僢僪奐嵜).
723404. [妛夛 (慡崙)] (堦斒岥墘) 恄撧愳導憡柾尨抧堟偵偍偗傞彫帣COVID-19恌椕楢実偺帋傒. 杮揷丂悞1, 埳摗彯巙1, 埨摗丂庻1, 埦惗峩懢, 埳摗丂椇, 崱堜弮岲1, 栧堜怢嬇, 嵅摗壛戙巕1, 敀堜岹岾, 嵒墴丂徛, 拞懞怣栫, 栰懞夒姲, 桍揷婭擵, 嶳嶈夒旻, 愇憅寬巌1 (1彫帣): 戞124夞擔杮彫帣壢妛夛妛弍廤夛 (2021/4/16-18), 嫗搒 (僴僀僽儕僢僪奐嵜).
723405. [妛夛 (慡崙)] (堦斒岥墘) 庮釃揈弌偵傛傝廳撃側擕巁傾僔僪乕僔僗偺夵慞傪摼偨怴惗帣恄宱夎庮偺堦椺. 拞懞恀婭1, 愇揷廆巌1, 彫嶃桾壚巕1, 嶳岥埢擳1, 戝壀杻棟1, 巛帩丂妛1, 拞惣廏旻1,2, 暯揷梲堦榊1, 愇憅寬巌1 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕): 戞124夞擔杮彫帣壢妛夛妛弍廤夛 (2021/4/16-18), 嫗搒 (僴僀僽儕僢僪奐嵜).
723406. [妛夛 (慡崙)] (堦斒島墘) TTP傪崌暪偟偨弶敪SLE偺1椺. 搉绯椱旤1, 嬥巕夒婭1, 峕攇屗岶曘1, 墱揷梇夘1, 崺丂怢栫1,2, 暯揷梲堦榊1, 愇憅寬巌1 (1彫帣, 2媬柦): 戞124夞擔杮彫帣壢妛夛妛弍廤夛 (2021/4/16-18), 嫗搒 (僴僀僽儕僢僪奐嵜).
723407. [妛夛 (慡崙)] (堦斒島墘) 僱僼儘乕僛徢岓孮嵞敪拞偵柍徢岓惈偺攛寣愷嵡愷徢傪敪徢偟偨巚弔婜抝巕椺. 擔壓晹埱幯孿, 崺丂怢栫1,2, 娭扟棦壚2, 墱揷梇夘2, 暯揷梲堦榊2, 愇憅寬巌2 (1媬柦, 2彫帣): 戞124夞擔杮彫帣壢妛夛妛弍廤夛 (2021/4/16-18), 嫗搒 (僴僀僽儕僢僪奐嵜).
723408. [妛夛 (慡崙)] (堦斒岥墘) Microgeodic disease偲恌抐偟偨6徢椺偺椪彴揑摿挜. 峕攇屗岶曘 (彫帣): 戞65夞擔杮儕僂儅僠妛夛憤夛丒妛弍廤夛 (2021/4/26-28), Web奐嵜.
723409. [妛夛 (慡崙)] (堦斒岥墘) 僗僥儘僀僪椕朄偺傒偱椙岲側宱夁傪扝偭偨峈MDA5峈懱梲惈庒擭惈旂晢嬝墛偺1椺. 戝搱丂柧, 峕攇屗岶曘1 (1彫帣): 戞65夞擔杮儕僂儅僠妛夛憤夛丒妛弍廤夛 (2021/4/26-28), Web奐嵜.
723410. [妛夛 (慡崙)] (堦斒岥墘) 挻憗嶻帣丒嫻峯嬀壓摦柆娗暵嵔弍 (VATS-PDA) 偺挿婜梊屻丂廇妛帣偺傾儞働乕僩挷嵏偱傢偐偭偨偙偲. 巛帩丂妛1, 戝壀杻棟1, 愇揷廆巌1, 嶳岥埢擳1, 墶娭桽堦榊1, 拞惣廏旻1,2 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕): 戞65夞擔杮怴惗帣惉堢堛妛夛丒妛弍廤夛 (2021/5/7-9), Web奐嵜.
723411. [妛夛 (慡崙)] (堦斒島墘) 彫帣僱僼儘儞釘偵偍偗傞枛婜恡晄慡恑峴傊偺儕僗僋場巕. 墱揷梇夘1, 郷嶈桽巕, 悪杮孿憡, 墱捗旤壞, 郷揷丂棨, 嬥巕揙帯, 愇憅寬巌1 (1彫帣): 戞64夞擔杮恡憻妛夛妛弍憤夛 (2021/6/18-20), 墶昹 (僴僀僽儕僢僪奐嵜).
723412. [妛夛 (慡崙)] (堦斒島墘) Clinical characteristics of nephronophthisis in Japanese children: a national survey. 墱揷梇夘1, 郷嶈桽巕, 悪杮孿憡, 墱捗旤壞, 郷揷丂棨, 嬥巕揙帯, 愇憅寬巌1 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/9), 崅抦.
723413. [妛夛 (慡崙)] (堦斒岥墘) 彫帣摿敪惈僱僼儘乕僛徢岓孮慡崙塽妛挷嵏 (JP-SHINE study) 僀儞僼儖僄儞僓僂僀儖僗儚僋僠儞偺桳岠惈偲僱僼儘乕僛嵞敪傊偺塭嬁. 愇怷恀屷, 埨摗崅巙, 媏塱壚怐1, 帥栰愮崄巕, 嵅摗丂晳, 郷嶈桽巕, 埳摗廏堦, 杮揷夒宧, 愇憅寬巌1 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 93.
723414. [妛夛 (慡崙)] (堦斒岥墘) Lowe徢岓孮偺恡婡擻偲椪彴堚揱妛揑強尒偲偺娭楢惈偺専摙. 埨摗懢榊, 嶰塝寬堦榊, 愇捤婌悽怢, 桏撪抭楴, 愇榓丂隳, 挘揷丂朙, 恄揷徦堦榊, 嵅摗撝巎, 堥搰丂崑, 郷揷丂棨, 愇憅寬巌1, 屲廫棐棽, 暈晹尦巎 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 94.
723415. [妛夛 (慡崙)] (堦斒岥墘) 昿夞嵞敪宆/僗僥儘僀僪埶懚惈僱僼儘乕僛徢岓孮偵懳偡傞僔僋儘僼僅僗僼傽儈僪偲僔僋儘僗億儕儞偺昿夞嵞敪壔慾巭岠壥偵嵎偼側偄. 帥栰愮崄巕, 郷揷丂棨, 彫杚暥戙, 塭嶳偁偝巕, 鉷丂堦巙, 杮揷丂嬆, 晊妦桬恖, 惔悈曕旤, 愒曯宧帯, 尨揷椓巕, 郷嶈桽巕, 杮揷夒宧, 敠扟峗巎, 愇憅寬巌1 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 94.
723416. [妛夛 (慡崙)] (堦斒島墘) 彫帣婜敪徢擄帯惈摿敪惈僱僼儘乕僛徢岓孮 (INS) 偵偍偗傞儕僣僉僔儅僽 (RTX) 搳梌屻慗墑惈掅IgG寣徢偺儕僗僋場巕偺専摙. 杮揷丂嬆, 郷揷丂棨, 鉷丂堦巙, 塭嶳偁偝巕, 晊妦桬恖, 惔悈曕旤, 堜岥抭梞, 嶰忋捈楴, 愒曯宧帯, 帥栰愮崄巕, 尨揷椓巕, 郷嶈桽巕, 愇憅寬巌1, 杮揷夒宧, 敠扟峗巎 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 105.
723417. [妛夛 (慡崙)] (堦斒島墘) 彫帣僗僥儘僀僪掞峈惈僱僼儘乕僛徢岓孮偺晄姰慡姲夝徢椺偵偍偗傞挿婜梊屻偺専摙. 塭嶳偁偝巕, 郷揷丂棨, 堫梩丂嵤, 鉷丂堦巙, 惔悈曕旤, 晊妦桬恖, 杮揷丂嬆, 愒曯宧帯, 帥栰愮崄巕, 尨揷椓巕, 郷嶈桽巕, 愇憅寬巌1, 杮揷夒宧, 敠扟峗巎 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 107.
723418. [妛夛 (慡崙)] (堦斒島墘) 擜嵶娗娫幙惈恡墛偺夵慞傑偱偺宱夁偲擜嵶娗儅乕僇乕偺悇堏. 堦悾恀旤, 尨揷椓巕, 郷揷丂棨, 晊妦桬恖, 杮揷丂嬆, 鉷丂堦巙, 塭嶳偁偝巕, 惔悈曕旤, 愒曯宧帯, 帥栰愮崄巕, 郷嶈桽巕, 愇憅寬巌1, 杮揷夒宧, 敠扟峗巎 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 119.
723419. [妛夛 (慡崙)] (堦斒島墘) 僱僼儘儞釘偵偍偗傞恡奜徢忬偺崌暪昿搙側傜傃偵帪婜偺専摙. 晊妦桬恖, 郷揷丂棨, 埨擺偁偮偙, 鉷丂堦巙, 塭嶳偁偝巕, 惔悈曕旤, 杮揷丂嬆, 愒曯宧帯, 帥栰愮崄巕, 尨揷椓巕, 郷嶈桽巕, 愇憅寬巌1, 杮揷夒宧, 敠扟峗巎 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 126.
723420. [妛夛 (慡崙)] (堦斒島墘) 僄僾僗僞僀儞徢岓孮偺恡惗専強尒偲椪彴宱夁. 嶰塝寬堦榊, 敀堜梲巕, 戝捤懽巎, 戝榓揷梩巕, 媑揷丂峎, 搶丂媊恖, 惣嶳丂宑, 崯尦棽梇, 彅嫶丂娐, 郷揷丂棨, 愇憅寬巌1, 暈晹尦巎 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 127.
723421. [妛夛 (慡崙)] (堦斒島墘) 恡堏怉屻嵞敪傪擣傔偨憙忬暘愡惈巺媴懱峝壔徢 (FSGS) 徢椺偺嵞敪帯椕斀墳偲挿婜恡梊屻偺専摙. 鉷丂堦巙, 郷揷丂棨, 嵅摗桾擵, 帥栰愮崄巕, 尨揷椓巕, 惵栘桾師榊, 郷嶈桽巕, 愇憅寬巌1, 幊屗惔堦榊, 杮揷夒宧, 敠扟峗巎 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 131.
723422. [妛夛 (慡崙)] (堦斒島墘) 僱僼儘乕僛徢岓孮偵崌暪偟偨攛寣愷嵡愷徢偺捈愙宱岥峈嬅屌栻 (DOAC) 偵傛傞帯椕愴棯. 崺丂怢栫1,2, 嵅摗怢梞1, 墶撪嬇巕2, 墱揷梇夘2, 娾攇捈旤, 戝孎峗峕, 庣壆弐夘, 拞懞怣栫, 壨惣婭徍, 愇憅寬巌2 (1媬柦, 2彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 144.
723423. [妛夛 (慡崙)] (堦斒島墘) 愳嶈昦僔儑僢僋徢岓孮滊姵屻偵恡婡擻掅壓懍搙偑2.8攞偵壛懍偟偨愭揤惈恡擜楬堎忢偺抝帣椺. 晊妦桬恖, 尨揷椓巕, 郷揷丂棨, 鉷丂堦巙, 塭嶳偁偝巕, 惔悈曕旤, 杮揷丂嬆, 愒曯宧帯, 帥栰愮崄巕, 杮揷夒宧, 愇憅寬巌1, 敠扟峗巎 (1彫帣): 戞56夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/7/10), 崅抦, 擔杮彫帣恡憻昦妛夛嶨帍 2021/5; 34 (1 Suppl): 169.
723424. [妛夛 (慡崙)] (堦斒島墘) Fontan弍屻偺擄帯惈抈敀楻弌惈堓挵徢傊偺怴偨側帯椕愴棯: 僔儘僗僞僝乕儖偵傛傞怱朳挷棩傊偺夘擖. 搉绯椱旤1, 杮揷丂悞1, 崅棞丂妛1, 杒愳撃巎1, 栘懞弮恖1, 暯揷梲堦榊1, 媨抧丂娪2, 愇憅寬巌1 (1彫帣, 2怱憻寣娗奜): 戞57夞擔杮彫帣弞娐婍妛夛憤夛丒妛弍廤夛 (2021/7/9-11), 撧椙 (僴僀僽儕僢僪奐嵜), 擔杮彫帣弞娐婍妛夛憤夛丒妛弍廤夛彺榐廤 2021/7; 57: OR24-2.
723425. [妛夛 (慡崙)] (堦斒島墘) 媫懍偵憹戝偟偨寣愷偵傛傝嬞媫庤弍偵帄偭偨摦柆娗釒偺怴惗帣椺. 堫栘廏塸1, 杒愳撃巎1, 杮揷丂悞1, 壀杮丂払1, 暯揷梲堦榊1, 拞惣塸旻1,2, 媨抧丂娪3, 愇憅寬巌1 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕, 3怱憻寣娗奜): 戞57夞擔杮彫帣弞娐婍妛夛憤夛丒妛弍廤夛 (2021/7/9-11), 撧椙 (僴僀僽儕僢僪奐嵜), 擔杮彫帣弞娐婍妛夛憤夛丒妛弍廤夛彺榐廤 2021/7; 57: P1-3.
723426. [妛夛 (慡崙)] (堦斒島墘) 嶰愲曎銯嶕抐楐傪崌暪偟偨擕帣摿敪惈憁朮曎銯嶕抐楐椺偺昦懺峫嶡. 崅棞丂妛1, 恑摗峫梞, 崅尒郪岾堦, 彫郪桼堖, 椦丂懽桟, 嶰嶈懽巙, 嬥巕岾桾, 彫栰丂攷, 夑摗丂嬒 (1彫帣): 戞57夞擔杮彫帣弞娐婍妛夛憤夛丒妛弍廤夛 (2021/7/9-11), 撧椙 (僴僀僽儕僢僪奐嵜).
723427. [妛夛 (慡崙)] (堦斒岥墘) 夁嫀8擭娫偺恄撧愳導導墰杒憡抧堟撪偵偍偗傞怴惗帣斃憲偺傑偲傔. 戝壀杻棟1, 拞惣廏旻1,2, 彫嶃桾壚巕1, 嶳岥埢擳1, 愇揷廆巌1, 墶娭桽堦榊1, 巛帩丂妛1 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/11-13), 媨嶈 (僴僀僽儕僢僪奐嵜).
723428. [妛夛 (慡崙)] (堦斒岥墘) 妛摱婜偵払偟偨挻憗嶻帣偺廇妛忬嫷丒崌暪徢偵偮偄偰偺傾儞働乕僩寢壥. 巛帩丂妛1, 戝壀杻棟1, 愇揷廆巌1, 嶳岥埢擳1, 彫嶃桾壚巕1, 墶娭桽堦榊1, 栰搉惓旻, 拞惣廏旻1,2 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/11-13), 媨嶈 (僴僀僽儕僢僪奐嵜).
723429. [妛夛 (慡崙)] (堦斒岥墘) 擕帣寣娗庮偵懳偟偰廋惓34廡偱僾儘僾儔僲儘乕儖傪巊梡偟偨挻憗嶻帣椺. 擔壓晹埱幯孿, 拞惣廏旻1,2, 彫嶃桾壚巕2, 嶳岥埢擳2, 愇揷廆巌2, 戝壀杻棟2, 巛帩丂妛2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/11-13), 媨嶈 (僴僀僽儕僢僪奐嵜).
723430. [妛夛 (慡崙)] (堦斒岥墘) 惗屻72帪娫埲崀偵敪徢偟偨嬌掅弌惗懱廳帣偺擼幒撪弌寣偵偮偄偰72帪娫枹枮敪徢椺偲偺斾妑. 嶳岥埢擳1, 拞惣廏旻1,2, 彫嶃桾壚巕1, 愇揷廆巌1, 戝壀杻棟1, 墶娭桽堦榊1, 巛帩丂妛1 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/11-13), 媨嶈 (僴僀僽儕僢僪奐嵜).
723431. [妛夛 (慡崙)] (堦斒岥墘) 嵼戀26廡枹枮偺挻憗嶻帣偺摦柆娗暵嵔慜屻偺弞娐摦懺偺曄壔. 愇揷廆巌1, 彫嶃桾壚巕1, 嶳岥埢擳1, 戝壀杻棟1, 巛帩丂妛1, 拞惣廏旻1,2 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/11-13), 媨嶈 (僴僀僽儕僢僪奐嵜).
723432. [妛夛 (慡崙)] (堦斒岥墘) 摉堾偵偍偗傞怴惗帣巰朣徢椺偵娭偡傞専摙丂恄撧愳導怴惗帣巰朣搊榐帠嬈偺奐巒偵岦偗偨庢傝慻傒. 彫嶃桾壚巕1, 嶳岥埢擳1, 愇揷廆巌1, 戝壀杻棟1, 巛帩丂妛1, 拞惣廏旻1,2 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/11-13), 媨嶈 (僴僀僽儕僢僪奐嵜).
723433. [妛夛 (慡崙)] (堦斒岥墘) 懡嵤側徢忬傪掓偟, 恌抐偵擄廰偟偨僔僃乕僌儗儞徢岓孮偺14嵨偺彈帣椺. 峕攇屗岶曘 (彫帣): 戞30夞擔杮彫帣儕僂儅僠妛夛妛弍廤夛 (2021/10/15), 搶嫗 (僴僀僽儕僢僪奐嵜).
723434. [妛夛 (慡崙)] (堦斒島墘) 屻揤惈TTP傪弶敪徢忬偲偟偨SLE偺2徢椺. 嬥巕夒婭1, 峕攇屗岶曘1, 墱揷梇夘1, 崺丂怢栫1,2, 嶁搶桼婭1, 愇憅寬巌1 (1彫帣, 2媬柦): 戞30夞擔杮彫帣儕僂儅僠妛夛妛弍廤夛 (2021/10/15-17), 搶嫗 (僴僀僽儕僢僪奐嵜).
723435. [妛夛 (慡崙)] (堦斒島墘) EIEE44: UBA5曄堎偵傛傞忢愼怓懱楎惈堚揱惈偰傫偐傫惈擼徢偺巓枀椺. 敀堜岹捈1, 搚婒丂暯1, 栰乆揷朙1, 杧偁偡偐2, 塃揷墹夘, 恅寬堦榊, 愇憅寬巌1, 崅揷巎抝2 (1彫帣, 2戝妛堾堛椕宯尋媶壢): 擔杮恖椶堚揱妛夛戞66夞戝夛/戞28夞擔杮堚揱巕恌椕妛夛戝夛崌摨奐嵜 (2021/10/13-16), 墶昹 (僴僀僽儕僢僪奐嵜).
723436. [妛夛 (慡崙)] (堦斒島墘) 數嫻偲壓巿峉弅偵傛傝攔醾僪儗僫乕僕偵擄廰偟偨1徢椺. 戝嬋惓庽, 撿栰弶崄1 (1彫帣): 戞53夞擔杮彫帣屇媧婍妛夛 (2021/10/22-23), Web奐嵜.
723437. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞愭揤惈拞悤惈柍屇媧徢岓孮徢椺偵懳偡傞CCHS屇媧儈僯僪僢僋. 撿栰弶崄 (彫帣): 戞53夞擔杮彫帣屇媧婍妛夛 (2021/10/22-23), Web奐嵜.
723438. [妛夛 (慡崙)] (堦斒岥墘) ECMO摫擖帪僈僀僪儚僀儎偑柪擖偟懸婡揑偵彍嫀傪峴偭偨媫惈怱嬝墛1彈帣椺. 揷懞桟暯1, 惣懞嵷曚, 奀榁尨捈庽, 捹堜攲旻, 摗栰柧峗, 拞愳丂憦 (1彫帣): 戞49夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2021/11/21-23), 搶嫗.
723439. [妛夛 (慡崙)] (堦斒島墘) 杮朚偵偍偗傞夁嫀10擭娫偺彫帣摟愅怴婯摫擖棪偲桳昦棪亅暷崙, 墷廈, 僆僙傾僯傾偲偺斾妑亅. 墱揷梇夘1, 尨揷椓巕, 郷揷丂棨, 郷嶈桽巕, 愇憅寬巌1 (1彫帣): 戞42夞擔杮彫帣恡晄慡妛夛妛弍廤夛 (2021/12/9-10), Web奐嵜.
723440. [妛夛 (慡崙)] (堦斒岥墘) Fontan弞娐偵偍偗傞戝摦柆曎暵嵔晄慡偺弞娐摦懺偵梌偊傞塭嬁. 杒愳撃巎1, 暯揷梲堦榊1, 崅棞丂妛1, 杮揷丂悞1, 媨抧丂娪2, 愇憅寬巌1 (1彫帣, 2怱憻寣娗奜): 戞23夞擔杮惉恖愭揤惈怱幘姵妛夛憤夛丒妛弍廤夛 (2022/1/7-9), 暉壀.
723441. [妛夛 (慡崙)] (堦斒島墘) 帯椕偵擄廰偟偰偄傞HA20偵懳偡傞JAK慾奞栻偺巊梡宱尡. 峕攇屗岶曘 (彫帣): 戞5夞擔杮柶塽晄慡丒帺屓墛徢妛夛憤夛丒妛弍廤夛 (2022/2/12), Web奐嵜.
723442. [妛夛 (慡崙)] (堦斒島墘) 戀帣婜偺彊柆傪宊婡偵敪尒偝傟偨儈僩僐儞僪儕傾怱嬝徢偺1椺. 搉绯椱旤1, 杮揷丂悞1, 暯揷梲堦榊1 (1彫帣): 堦斒幮抍朄恖擔杮戀帣怱憻昦妛夛戞28夞妛弍廤夛 (2022/2/18-19), 徏杮 (僴僀僽儕僢僪奐嵜).
723443. [妛夛 (慡崙)] (堦斒島墘) 彫帣怱憻弍屻偵偍偗傞暊枌摟愅偲PICU傾僂僩僇儉偺娭楢. 曯旜宐棞1, 墱揷梇夘1, 埨摗丂庻1, 暯揷梲堦榊1, 媨抧丂娪2, 愇憅寬巌1 (1彫帣, 2怱憻寣娗奜): 戞49夞擔杮廤拞帯椕堛妛夛妛弍廤夛 (2021/3/18), Web奐嵜.
731010. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 堏峴婜巟墖偺尰忬偲壽戣2021乣僐儘僫壭傪挻偊偰乣. 暯揷梲堦榊 (彫帣): 戞12夞愳嶈彫帣弞娐婍僇儞僼傽儗儞僗 (2021/6/4), Web奐嵜.
731011. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 彫帣弞娐婍撪壢偲傕嫟桳偟偨偄乣怴惗帣恌椕Up to Date乣. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 戞25夞嶃恄彫帣弞娐婍幘姵尋媶夛 (2021/9/11), Web奐嵜.
731012. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 杮朚彫帣CKD偺幚懱亅恡堏怉傕娷傔偰亅. 愇憅寬巌 (彫帣): 戞122夞杒棦弞娐婍僙儈僫乕 (2021/10/21), Web奐嵜.
732050. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 尒摝偟偰偼偄偗側偄彫帣偺恄宱嬝幘姵. 栰乆揷朙 (彫帣): 戞449夞憡柾尨巗彫帣壢堛夛寧椺崸榖夛 (2021/6/16), 憡柾尨.
732051. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) SARS-CoV-2棳峴壓偵偍偗傞RS僂僀儖僗傪娷傓NICU姶愼懳嶔偺曄慗亅摉堾偺庢傝慻傒亅. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 傾僗僩儔僛僱僇庡嵜Pediatric TV Symposium (2021/10/26), 搶嫗.
732052. [妛夛 (抧曽夛丒尋媶夛)] (巗柉岞奐島嵗) 梒抰墍丒妛峑側偳偵偍偗傞偰傫偐傫敪嶌偺懳墳. 栰乆揷朙 (彫帣): 恄撧愳導偰傫偐傫堛椕丒幮夛楢実嫤媍夛偰傫偐傫偺尋廋夛 (2021/11/7), Web奐嵜.
732053. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 愳嶈昦. 峕攇屗岶曘 (彫帣): 娾庤堛壢戝妛昦堾彫帣壢偵偰愳嶈昦偺島墘 (2021/11/9), Web奐嵜.
732054. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 宱挵塰梴娗棟拞偵垷墧寚朢徢傪掓偟偨廳徢怱恎忈奞帣幰偺堦椺. 搉绯枩梩1, 搚婒丂暯1, 媖揷堦婸1, 摗晲媊堦, 栰乆揷朙1, 暯揷梲堦榊1, 愇憅寬巌1 (1彫帣): 戞451夞憡柾尨巗堛巘夛彫帣壢堛夛寧椺崸榖夛 (2021/11/10), 憡柾尨, Web.
732055. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 彫帣偺僱僼儘乕僛徢岓孮偺恌椕亅嵟怴偺僈僀僪儔僀儞偵婎偯偄偰亅. 愇憅寬巌 (彫帣): 戞46夞搶擔杮彫帣壢妛夛 (2021/11/23), Web奐嵜.
732056. [妛夛 (抧曽夛丒尋媶夛)] (嫵庼廇擟島墘) 彫帣摿敪惈僱僼儘乕僛徢岓孮: 杮朚偵偍偗傞帯椕奐敪尋媶偲Registry. 愇憅寬巌 (彫帣): 戞47夞杒棦堛妛夛憤夛 (2021/11/26), Web奐嵜.
732057. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 慡斒偰傫偐傫偵偮偄偰. 搚婒丂暯1, 栰乆揷朙1, 愇憅寬巌1 (1彫帣): 恄撧愳偰傫偐傫恌椕僱僢僩儚乕僋 (2021/12/3), 墶昹.
732058. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) NICU Webinar PI僇僥乕僥儖徢椺曬崘夛. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): CardinalHealth庡嵜 NICU Webinar PI僇僥乕僥儖徢椺曬崘夛 (2021/12/4), Web奐嵜.
732059. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 摉堾NICU偵偍偗傞PI僇僥乕僥儖暵嵡偵偮偄偰: 嬌掅弌惗懱廳帣偱偺専摙. 嶳岥埢擳1, 拞惣廏旻1,2, 彫嶃桾壚巕1, 愇揷廆巌1, 戝壀杻棟1 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕): CardinalHealth庡嵜 NICU Webinar PI僇僥乕僥儖徢椺曬崘夛 (2021/12/4), Web奐嵜.
732060. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) Neuromyelitis optca spectrum disorder (NMOSD) 彫帣椺偵懳偡傞僒僩儔儕僘儅僽偺巊梡宱尡. 栰乆揷朙1, 搚婒丂暯1, 愇憅寬巌1 (1彫帣): 戞63夞恄撧愳彫帣恄宱崸榖夛 (2021/12/11), 愳嶈.
732061. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 杮朚彫帣CKD 悽奅偲偺斾妑偱尒偊偰偒偨壽戣. 愇憅寬巌 (彫帣): 戞5夞壂撽彫帣恡丒銹尨昦尋媶夛 (2022/2/17), Web奐嵜.
732062. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 柶塽幘姵偺峫偊曽. 峕攇屗岶曘 (彫帣): 擔杮怴栻庡嵜幮撪曌嫮夛 (2022/3/1), Web奐嵜.
732063. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 彫帣柶塽幘姵傪峫偊傞夛in KANAGAWA. 峕攇屗岶曘 (彫帣): abbie崌摨夛幮庡嵜JIA偺恌抐丒帯椕 (2022/3/22), Web奐嵜.
732064. [妛夛 (抧曽夛丒尋媶夛)] (僷僱僗僨傿僗僇僢僔儑儞) 恄撧愳導偺擄昦堛椕楢実嫆揰昦堾偺尰忬偲庴偗擖傟懱惂. 愇憅寬巌 (彫帣): 堏峴婜堛椕尋廋夛 (偐側偑傢堏峴婜堛椕巟墖僙儞僞乕庡嵜) (2022/3/23), Web奐嵜.
733122. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 婾惈掅傾儖僪僗僥儘儞徢偑媈傢傟偨1憗嶻帣椺. 惣揷彯巎 (彫帣): 戞448夞憡柾尨巗彫帣壢堛夛寧椺崸榖夛 (2021/5/19), Web奐嵜.
733123. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嶰愲曎銯嶕抐楐傪崌暪偟偨擕帣摿敪惈憁朮曎銯嶕抐楐椺偺昦懺峫嶡. 杮揷丂悞1, 杒愳撃巎1, 栘懞弮恖1, 暯揷梲堦榊1, 彫栰丂攷, 愇憅寬巌1 (1彫帣): 戞12夞愳嶈彫帣弞娐婍僇儞僼傽儗儞僗 (2021/6/4), Web奐嵜.
733124. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嬛墝傪悇恑偟偰偄傞尰戙偵偍偗傞僞僶僐岆堸徢椺偺尰忬. 惸摗尦婯, 撿栰弶崄1 (1彫帣): 戞152夞擔杮彫帣壢妛夛惷壀抧曽夛 (2021/6/6), 惷壀 (僴僀僽儕僢僪奐嵜).
733125. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 捵釃惈戝挵墛偺嵞擱偲娪暿傪梫偟偨婾枌惈挵墛偺13嵨彈帣椺. 堫栘廏塸1, 峕攇屗岶曘1 (1彫帣): 戞365夞擔杮彫帣壢妛夛恄撧愳導抧曽夛 (2021/6/12), Web奐嵜.
733126. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Bartter徢岓孮. 墱揷梇夘 (彫帣): 戞56夞彫帣恡憻昦僙儈僫乕 (2021/7/9-10), 崅抦.
733127. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嫄戝悈醰傪宍惉偟偨旕揟宆揑懡宍燌弌惈峠斄偺1椺. 塝揷夎媣旤1,2, 堫栘廏塸1, 嵅攲晀椇2, 嶁搶桼婭1,2 (1彫帣, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞184夞擔杮彫帣壢妛嶉嬍抧曽夛妛弍廤夛 (2021/9/12), Web奐嵜.
733128. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 1儢寧寬恌帪偺慼惗帠徾傪宊婡偵恌抐偝傟偨憤攛惷柆娨棳堎忢徢偺1椺. 搉绯椱旤1, 杮揷丂悞1, 暯揷梲堦榊1 (1彫帣): 戞366夞擔杮彫帣壢妛夛恄撧愳導抧曽夛 (2021/9/18), Web奐嵜.
733129. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擔楊28枬惈攛幘姵傪崌暪偟偨挻憗嶻帣偵偍偗傞媫惈婜埲崀偺堦巁壔拏慺媧擖椕朄偺岠壥: 2003-2016擭偵偍偗傞廃嶻婜怴惗帣僱僢僩儚乕僋僨乕僞儀乕僗傪梡偄偨屻曽帇揑僐儂乕僩尋媶. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 戞33夞擔杮怴惗帣枬惈攛幘姵尋媶夛 (2021/10/9), Web奐嵜.
733130. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 夝朥妛揑廋暅庤弍傪巤峴偟偨廋惓戝寣娗揮埵偺2椺. 杒愳撃巎1, 崅棞丂妛1, 杮揷丂悞1, 幁揷暥徍1, 暯揷梲堦榊1, 媨抧丂娪2, 愇憅寬巌1 (1彫帣, 2怱憻寣娗奜): 戞17夞恄撧愳彫帣弞娐婍尋媶夛 (2021/11/6), 墶昹.
733131. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 妛峑寬恌傪偒偭偐偗偵壠懓惈庒擭敪徢摐擜昦5宆 (MODY5) 傪媈偭偨1椺. 愳岥桽巏, 墱揷梇夘1, 媖揷堦婸1, 崺丂怢栫1,2, 暯揷梲堦榊1, 愇憅寬巌1 (1彫帣, 2媬柦): 戞367夞擔杮彫帣壢妛夛恄撧愳抧曽夛 (2021/11/20), Web奐嵜.
733132. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 僱僼儘儞釘. 墱揷梇夘 (彫帣): 彫帣恡憻昦僙儈僫乕 (2021/12/4), 昹徏.
733133. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 屻揤惈TTP偱敪徢偟偨SLE彈巕偺堦椺. 懢揷傑傝1, 峕攇屗岶曘1 (1彫帣): 搶嫗恄撧愳彫帣恡僙儞僞乕偺夛 (2022/1/6), Web奐嵜.
733134. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 彫帣恡椞堟偺婓彮丒擄帯惈幘姵孮偺恌椕丒尋媶懱惂偺敪揥. 愇憅寬巌 (彫帣): 椷榓3擭搙JSN岞揑尋媶斍尋媶惉壥崌摨敪昞夛 (2022/1/30), Web奐嵜.
733135. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僕傾僲僢僥傿徢岓孮偲娪暿偵擄廰偟偨愳嶈昦偺1抝帣椺. 捈媨嬁暯1, 峕攇屗岶曘1 (1彫帣): 戞17夞恄撧愳愳嶈昦尋媶夛 (2022/2/5), Web奐嵜.
733136. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 揮憲斃憲庴偗擖傟偵偍偗傞埨慡娗棟. 搉绯枩梩1, 曯旜宐棞1, 愇憅寬巌1 (1彫帣): 戞368夞擔杮彫帣妛夛恄撧愳抧曽夛 (2022/2/19), Web奐嵜.
733137. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擕帣婜偵懱廳憹壛晄椙偐傜恌抐偝傟偨Lesh-Nyhan徢岓孮偺堦抝帣椺. 捈媨嬁暯1, 媖揷堦婸1, 栘懞弮恖1, 拞懞恀婭1, 嵁栰丂庻1, 摗杮傑備1, 櫅帩丂妛1 (1彫帣): 戞369夞擔杮彫帣壢妛夛恄撧愳導抧曽夛 (2022/3/12), Web奐嵜.
733138. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 懱廳憹壛晄椙偐傜敪尒偝傟偨Lesch-Nyhan徢岓孮偺堦椺. 捈媨嬁暯1, 媖揷堦婸1, 栘懞弮恖1, 拞懞恀婭1, 嵁栰丂庻1, 摗杮傑備1, 巛帩丂妛1 (1彫帣): 戞369夞擔杮彫帣壢妛夛恄撧愳導抧曽夛 (2022/3/12), 墶昹.
'20擭搙埲慜暘
[妛弍榑暥]
'18-530001. [偦偺懠 (Correction)] Correction to: Validation of estimated glomerular filtration rate equations for Japanese children. Gotoh Y, Uemura O, Ishikura K1, Sakai T, Hamasaki Y, Araki Y, Hamada R, Honda M, Pediatric CKD Study Group in Japan in conjunction with the Committee of Measures for Pediatric CKD of the Japanese Society of Pediatric Nephrology: Clin Exp Nephrol 2018/12; 22 (6): 1477. (愇憅寬巌1: 1彫帣)
'20-320002. [徢椺曬崘] 彫帣婜偵敪徢偟偨microgeodric disease偺2徢椺. 峕攇屗岶曘 (彫帣): 旂晢昦恌椕 2021/3; 43 (3): 260-3.
[妛夛丒尋媶夛摍]
'20-723027. [妛夛 (慡崙)] (堦斒岥墘) 偣傫栂偵懳偟偰摦暔夘嵼椕朄傪妶梡偟偨堦椺. 愇郷抭撧旤1, 嶳杮岹柧1, 嬂掚彯巕1, 忋丂悙曚1, 孠尨宑懢1, 戝娧杻旤1, 嶁搶桼婭1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2彫帣): 戞40夞擔杮幮夛惛恄堛妛夛 (2021/3/4-5), Web奐嵜, 擔杮幮夛惛恄堛妛夛嶨帍 2021; 30 (3): 295.
'20-732004. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) RAISE study偵婎偯偄偨PSL摫擖屻偵擄帯惗宱夁傪偨偳偭偨愳嶈昦傊偺夘擖. 嬥巕夒婭1, 峕攇屗岶曘1 (1彫帣): 戞16夞恄撧愳導愳嶈昦尋媶夛 (2021/2/13), 挰揷.
'20-733011. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 揮憲斃憲庴偗擖傟偵偍偗傞埨慡娗棟. 搉绯枩梩1, 曯旜宐棞1, 愇憅寬巌1 (1彫帣): 戞368夞擔杮彫帣妛夛恄撧愳抧曽夛 (2021/2/19), Web奐嵜.
嶻壢妛
[妛弍榑暥]
120012. [尨挊] 抩娚弌寣徢椺偵偍偗傞戝検桝寣偺梊應場巕偵娭偡傞専摙. 拞嬥楴巕1, 朷寧弮巕1, 戝惣梖巕1, 暈晹嬁巕1, 媑懞壝峀1, 娭岥榓婇1, 嬥堜梇擇1, 奀栰怣栫1 (1嶻壢): 擔杮廃嶻婜丒怴惗帣堛妛夛嶨帍 2021/5; 57 (1): 19-25.
522522. [島嵗]亂摿廤: 徢椺偵儅僢僠偡傞暘曍桿敪傾僾儘乕僠亃8. 柍捝寁夋暘曍偵偍偗傞暘曍桿敪偺棷堄揰. 嬥堜梇擇 (嶻壢): 嶻晈恖壢偺幚嵺 2021/4; 70 (4): 407-13.
522523. [島嵗]亂摿廤NEO Speciality: with僐儘僫帪戙偵嵞峫偡傞丂尰応偱巊偊傞! NICU偱偺姶愼懳嶔Q仌A亃1. 僐儘僫僂僀儖僗嵟怴偺僄價僨儞僗Q&A: 嶻壢曇. 暈晹嬁巕 (嶻壢): with NEO 2021/6; 34 (3): 412-9.
522524. [島嵗]亂摿廤: 嶻晈恖壢? 摥偒曽夵妚傊偺儘乕僪儅僢僾亃乽堛椕夵妚埾堳夛乿偲偟偰尒偰偒偨偙偲. 奀栰怣栫 (嶻壢): 嶻晈恖壢偺幚嵺 2022/1; 71 (1): 9-2.
[挊丂彂]
620093. [妛弍彂 (暘扴幏昅)]亂廃嶻婜堛妛昁廋抦幆 戞9斉 (廃嶻婜堛妛2021擭51姫憹姧崋)亃III 暘曍丒嶻羼丂[嶻壢堎忢丒幘姵]丂096 崪斦埵, p.325-7. 嬥堜梇擇 (嶻壢), 搶嫗堛妛幮, 搶嫗, 2022/1敪峴.
[妛夛丒尋媶夛摍]
721012. [妛夛 (慡崙)] (摿暿島墘) 怴宆僐儘僫僂僀儖僗姶愼徢傪摜傑偊偨嵭奞懳墳. 奀栰怣栫 (嶻壢): 戞73夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2021/4/22-25), 怴妰 (僴僀僽儕僢僪奐嵜).
721013. [妛夛 (慡崙)] (摿暿島墘) 柍捝暘曍偺埨慡惈岦忋偺偨傔偵-柍捝暘曍娭學妛夛丒抍懱楢棈嫤媍夛 (JALA) 偺妶摦曬崘 (2021擭搙)-. 奀栰怣栫 (嶻壢): 戞125夞擔杮嶻壢杻悓妛夛妛弍廤夛 (2021/12/4), 柤屆壆 (僴僀僽儕僢僩奐嵜).
722158. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嶻壢媬媫WG婇夋亃嶻壢婋婡揑弌寣偵懳偡傞帯椕愴棯偺堄巚寛掕偲偦偺幚慔. 戝惣梖巕1, 嶳嶈丂桪1, 媑懞壝峀1, 娭岥榓婇1, 嬥堜梇擇1, 奀栰怣栫1 (1嶻壢): 戞125夞擔杮嶻壢杻悓妛夛妛弍廤夛 (2021/12/4), 柤屆壆 (僴僀僽儕僢僩奐嵜).
723444. [妛夛 (慡崙)] (億僗僞乕) TAFRO徢岓孮滊姵屻偵帺慠擠怭偟偨1椺. 嶳嶈丂桪1, 戝惣梖巕1, 媑懞壝峀1, 暈晹嬁巕1, 拞嬥楴巕1, 娭岥榓婇1, 愇愳棽嶰1, 嬥堜梇擇1, 朷寧弮巕, 奀栰怣栫1 (1嶻壢): 戞73夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2021/4/22-25), 怴妰 (僴僀僽儕僢僪奐嵜).
723445. [妛夛 (慡崙)] (億僗僞乕) 巕媨撪枌徢偵偍偗傞儕儞僷娗怴惗傪惂屼偡傞VEGFR1僔僌僫儖偺栶妱. 暈晹嬁巕1, 埳摗媊栫2, 杮揷夒巕3, 娭岥榓婇1, 奀栰怣栫1 (1嶻壢, 2栻棟, 3晈恖): 戞73夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2021/4/22-25), 怴妰 (僴僀僽儕僢僪奐嵜).
723446. [妛夛 (慡崙)] (億僗僞乕) 摉巤愝偵偍偗傞憗嶻怴惗帣偺梊屻 (The prognosis of preterm infants at our institution). 屲搰桾擵1, 朷寧弮巕, 徏郪峎戙1, 惣嶳崄怐1, 怴堜惓廏2, 朷寧垽榊, 媑尨丂堦, 奀栰怣栫1 (1嶻壢, 2晈恖): 戞73夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2021/4/22-25), 怴妰 (僴僀僽儕僢僪奐嵜).
723447. [妛夛 (慡崙)] (億僗僞乕) 擠怭拞偵敪徢偟偨媫惈敀寣昦偺3椺. 嶳嶈丂桪1, 娭岥榓婇1, 媑懞壝峀1, 暈晹嬁巕1, 拞嬥楴巕1, 戝惣梖巕1, 愇愳棽嶰1, 嬥堜梇擇1, 奀栰怣栫1 (1嶻壢): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/11-13), 媨嶈 (僴僀僽儕僢僪奐嵜).
723448. [妛夛 (慡崙)] (億僗僞乕) 弌惗懱廳偵塭嬁傪梌偊傞曣懱梫場偺専摙. 惣嶳崄怐1, 媑尨丂堦, 屲搰桾擵1, 嶳嶈丂桪1, 徏郪峎戙1, 朷寧弮巕, 奀栰怣栫1 (1嶻壢): 戞57夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2021/7/11-13), 媨嶈 (僴僀僽儕僢僪奐嵜).
731013. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 杒棦戝妛偱偺17擭娫偱妛傫偩偙偲. 奀栰怣栫 (嶻壢): 憡柾尨巗嶻晈恖壢堛夛丒巕媨偑傫専恌晹夛崌摨尋廋夛 (2022/2/15), Web奐嵜.
732065. [妛夛 (抧曽夛丒尋媶夛)] (島廗夛庡嵜) J-CIMELS岞擣島廗夛B. 暈晹嬁巕 (嶻壢): J-CIMELS岞擣島廗夛B (2021/11/7), 憡柾尨.
732066. [妛夛 (抧曽夛丒尋媶夛)] (僗億儞僒-僪僙儈僫乕) 寁夋暘曍, 柍捝暘曍, 掗墹愗奐弍-愭恖偺抦宐偲尰戙媄弍偺梈崌-. 嬥堜梇擇 (嶻壢): 戞142夞娭搶楢崌嶻壢晈恖壢妛夛憤夛丒妛弍廤夛 (2021/11/21), 墶昹.
733139. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怴宆僐儘僫僂僀儖僗姶愼偵偍偗傞擠嶻晈傊偺懳墳忬嫷偵偮偄偰. 暈晹嬁巕 (嶻壢): 導墰杒憡僽儘僢僋戞106夞廃嶻婜媬媫楢棈夛 (2021/6/10), Web奐嵜.
733140. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嶻壢媬媫斃憲徢椺曬崘. 屲搰桾擵 (嶻壢): 導墰丒杒憡抧嬫廃嶻婜媬媫専摙夛 (2021/6/17), Web奐嵜.
733141. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怴宆僐儘僫僂僀儖僗姶愼擠晈傊偺懳墳偺尰忬偵偮偄偰. 奀栰怣栫 (嶻壢): 導墰丒杒憡抧嬫廃嶻婜媬媫専摙夛 (2021/6/17), Web奐嵜.
733142. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉堾偱偺COVID-19擠晈傊偺懳墳. 帪擟愹屛1, 暈晹嬁巕1, 屲摗桾擵1, 嶳嶈丂桪1, 拞嬥楴巕1, 娭岥榓婇1, 愇愳棽嶰1, 戝惣梖巕1, 嬥堜梇擇1, 奀栰怣栫1 (1嶻壢): 戞384夞巐悈夛 (2021/6/23), Web奐嵜.
733143. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 棳嶻婜偐傜偺慜婜攋悈偱惗帣傪摼偨堦椺. 壀嶈壚撧巕, 嶳嶈丂桪1, 屲搰桾擵1, 暈晹嬁巕1, 拞嬥楴巕1, 娭岥榓婇1, 愇愳棽嶰1, 戝惣梖巕1, 嬥堜梇擇1, 奀栰怣栫1 (1嶻壢): 戞433夞恄撧愳嶻壢晈恖壢妛夛憤夛妛弍島墘夛 (2021/7/3-9), Web奐嵜.
733144. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 憓娗娗棟慜偵曍弌傪峫椂偟偨擠怭26廡偺堦椺. 郷揷撧旤1, 戝惣梖巕1, 垻晹丂悏1, 娭岥榓婇1, 嬥堜梇擇1, 奀栰怣栫1 (1嶻壢): 戞385夞巐悈夛 (2021/11/17), Web奐嵜.
733145. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擠怭26廡偵婥娗憓娗娗棟偲側傝, 摨擔偵掗墹愗奐傪巤峴偟偨COVID-19廳徢椺. 娭岥榓婇 (嶻壢): 戞107夞恄撧愳導廃嶻婜媬媫楢棈夛 (2021/11/18), Web奐嵜.
733146. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 峈MDA5峈懱梲惈旂晢嬝墛崌暪擠怭偺堦椺. 屲搰桾擵1, 嶳嶈丂桪1, 暈晹嬁巕1, 拞嬥楴巕1, 娭岥榓婇1, 愇愳棽嶰1, 戝惣梖巕1, 嬥堜梇擇1, 奀栰怣栫1 (1嶻壢): 戞142夞娭搶楢崌嶻壢晈恖壢妛夛憤夛丒妛弍廤夛 (2021/11/20), 墶昹.
733147. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 掅恎挿擠晈偼掗墹愗奐偵側傞偙偲偑懡偄偺偐? 暯揷妜巎1, 朷寧弮巕, 媑懞壝峀1, 徏郪峎戙1, 惣嶳崄怐1, 朷寧垽榊, 戝栰丂曌, 怴堜惓廏2, 忋朧晀巕, 媑尨丂堦, 奀栰怣栫1 (1嶻壢, 2晈恖): 戞142夞娭搶楢崌嶻壢晈恖壢妛夛憤夛丒妛弍廤夛 (2021/11/20), 墶昹.
晈恖壢妛
[妛弍榑暥]
110324. [尨挊] A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis. Ishikawa M, Shibata T, Iwata T, Nishio S, Takada T1, Suzuki S, Horie K, Kudaka W, Kagabu M, Tanikawa M, Kitagawa R, Takekuma M, Kobayashi H, Yaegashi N, Japan Clinical Oncology Group: Gynecol Oncol 2021/8; 162 (2): 292-8. (崅揷嫳恇1: 1晈恖)
320005. [徢椺曬崘] 棏憙娻嵞敪壔妛椕朄拞偵敪徢偟偨僯儏乕儌僔僗僠僗攛墛偺堦椺. 帪擟愹屛1, 娾悾弔巕1, 拞懞婎姲1, 墦摗恀堦1, 屆愳惓媊1, 戝惣尗恖1, 揷嶨桳婭1, 崅揷嫳恇1, 怴堜惓廏1, 媑栰丂廋1, 壎揷婱巙1 (1晈恖): 擔杮晈恖壢庮釃妛夛嶨帍 2021/4; 39 (2): 549-56.
320006. [徢椺曬崘] 銷泖宔幒偺偨傔捠忢偲偼堎側傞埵抲偺擜娗偵廫暘側拲堄傪暐偭偰姰悑偱偒偨暊峯嬀壓巕媨慡揈弍 (TLH) 偺1椺. 扟丂戩栫1,2, 搰壀嫕惗1,2, 塱堜丂悞1, 媑揷峎戝1, 埳摗幚崄1,3, 娾抂弐曘1,3, 媣搱懃峴1, 嶰栘柧摽1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2嶻壢, 3晈恖): 嶉嬍嶻壢晈恖壢妛夛嶨帍 2022; 52 (1): 1-7.
521004. [夝愢] 棏憙娻丒棏娗娻丒暊枌娻偺庤弍偵娭偡傞嵟嬤偺僄價僨儞僗. 娾悾弔巕 (晈恖): 擔杮晈恖壢庮釃妛夛嶨帍 2021/10; 39 (4): 723-33.
522525. [島嵗]亂摿廤: 彮巕壔帪戙偵偍偗傞廇楯彈惈偺晄擠帯椕亃3. 廇楯彈惈偺堦斒晄擠専嵏丒帯椕僗働僕儏乕儖. 壃栰媩婓巕, 娾抂弐曘1, 媑栰丂廋1,2 (1晈恖, 2嶻壢): 嶻壢偲晈恖壢 2021/12; 88 (12): 1407-14.
[妛夛丒尋媶夛摍]
723449. [妛夛 (慡崙)] (堦斒島墘) Distinct functions of uterine epithelial and stromal STAT3 orchestrate uterine receptivity and embryo attachment. 暯壀婤戝1, Hirota Y, Fukui Y, Hirata T, Akaeda S, Matsuo M, 娾悾弔巕1, 媑栰丂廋1,2, 奀栰怣栫2, Fujii T, Osuga Y (1晈恖, 2嶻壢): 戞73夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2021/4/22-25), 怴妰 (僴僀僽儕僢僪奐嵜).
723450. [妛夛 (慡崙)] (堦斒島墘) 巕媨撪枌徢惈擷朎偺娪暿偵偍偗傞MRI IDEAL IQ偺桳梡惗偵偮偄偰偺専摙. 屆峕柧巕1, 暯揷婤戝1, 杮揷夒巕1, 娾抂弐曘1, 媑栰丂廋1,2, 娾悾弔巕1, 奀栰怣栫2 (1晈恖, 2嶻壢): 戞73夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2021/4/22-25), 怴妰 (僴僀僽儕僢僪奐嵜).
723451. [妛夛 (慡崙)] (堦斒島墘) RAMP1庴梕懱僔僌僫儖偵傛傞巕媨撪枌徢恑揥惂屼婡峔. 杮揷夒巕1, 埳摗媊栫2, 暈晹嬁巕3, 娭岥榓婇3, 媑栰丂廋1,3, 娾悾弔巕1, 奀栰怣栫3 (1晈恖, 2栻棟, 3嶻壢): 戞73夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2021/4/22-25), 怴妰 (僴僀僽儕僢僪奐嵜).
723452. [妛夛 (慡崙)] (堦斒島墘) 弍屻偵嵞敪拞儕僗僋孮偲昡壙偝傟偨巕媨栩娻徢椺偺椪彴揑専摙. 屆愳惓媊1, 拞懞婎姲1, 墦摗恀堦1, 戝惣尗恖1, 揷嶨桳婭1, 崅揷嫳恇1, 媑栰丂廋1,2, 娾悾弔巕1 (1晈恖, 2嶻壢): 戞63夞擔杮晈恖壢庮釃妛夛妛弍島墘夛 (2021/7/16-18), 戝嶃 (僴僀僽儕僢僪奐嵜).
723453. [妛夛 (慡崙)] (堦斒島墘) 摉堾偱Olaparib傪搳梌偟偨僾儔僠僫姶庴惈嵞敪棏憙娻姵幰偺桳奞帠徾偺専摙. 拞懞婎姲1, 崅揷嫳恇1, 扟丂戩栫1, 墦摗恀堦1, 屆愳惓媊1, 戝惣尗恖1, 揷嶨桳婭1, 媑栰丂廋1,2, 娾悾弔巕1 (1晈恖, 2嶻壢): 戞63夞擔杮晈恖壢庮釃妛夛妛弍島墘夛 (2021/7/16-18), 戝嶃 (僴僀僽儕僢僪奐嵜).
723454. [妛夛 (慡崙)] (堦斒島墘) 摉堾偺崅楊晈恖壢庮釃姵幰偵懳偡傞崅楊幰婡擻昡壙偺摫擖. 墦摗恀堦1, 拞懞婎姲1, 屆愳惓媊1, 戝惣尗恖1, 揷嶨桳婭1, 崅揷嫳恇1, 媑栰丂廋1,2, 娾悾弔巕1 (1晈恖, 2嶻壢): 戞63夞擔杮晈恖壢庮釃妛夛妛弍島墘夛 (2021/7/16-18), 戝嶃 (僴僀僽儕僢僪奐嵜).
723455. [妛夛 (慡崙)] (堦斒島墘) 摉堾偺儘儃僢僩巟墖壓巕媨懱娻庤弍摫擖弶婜10徢椺偵偍偗傞埨慡惈偺昡壙. 娾悾弔巕1, 戝惣尗恖1, 拞懞婎姲1, 墦摗恀堦1, 屆愳惓媊1, 崅揷嫳恇1, 媑栰丂廋1,2, 壛摗堦婌1 (1晈恖, 2嶻壢): 戞14夞擔杮儘儃僢僩奜壢妛夛妛弍廤夛 (2022/2/26-27), Web奐嵜.
723456. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞晈恖壢椙惈幘姵偵懳偡傞儘儃僢僩巟墖壓庤弍偺摫擖. 屆愳惓媊1, 娾悾弔巕1, 拞懞婎姲1, 墦摗恀堦1, 戝惣尗恖1, 崅揷嫳恇1, 媑栰丂廋1,2, 壛摗堦婌1 (1晈恖, 2嶻壢): 戞14夞擔杮儘儃僢僩奜壢妛夛妛弍廤夛 (2022/2/26-27), Web奐嵜.
731014. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 晈恖壢偑傫帯椕偺崱屻偺揥奐. 壛摗堦婌 (晈恖): 憡柾尨巗嶻晈恖壢堛夛妛弍島墘夛 (2021/9/16), Web奐嵜.
731015. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 晈恖壢椙埆惈庮釃偵懳偡傞嬀帇壓庤弍偺揥朷. 壛摗堦婌 (晈恖): 憡柾尨巗嶻晈恖壢堛夛妛弍島墘夛 (2021/12/9), Web奐嵜.
731016. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 椷榓2擭搙敪尒巕媨偑傫徢椺. 壛摗堦婌 (晈恖): 憡柾尨巗嶻晈恖壢堛夛丒巕媨偑傫専恌晹夛崌摨尋廋夛 (2022/2/15), Web奐嵜.
733148. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 巕媨撪枌渖敄偵懳偟PRP (Platelet Rich Plasma懡寣彫斅寣燋) 椕朄傪峴偄擠怭宲懕偱偒偨2徢椺. 壓揷棽恗 (晈恖): 戞62夞嶉嬍導嶻晈恖壢堛夛儂儖儌儞偲惗怋堛妛尋媶夛 (2021/7/10), 嶉嬍.
733149. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 崅搙偵愇奃壔偟偨燋枌壓嬝庮偑尨場偲峫偊傜傟偨巕媨擯揮偺1椺. 郷揷撧旤1, 屆愳惓媊1, 旜曽嵐寧1, 垻晹丂悏1, 拞懞婎姲1, 墦摗恀堦1, 娾悾弔巕1, 壛摗堦婌1 (1晈恖): 戞142夞娭搶楢崌嶻壢晈恖壢妛夛憤夛丒妛弍廤夛 (2021/11/20), 墶昹.
733150. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 崻帯弍偐傜6儠寧屻偵暊枌攄庬嵞敪傪棃偟偨巕媨栩晹滸暯忋旂娻IB1婜偺1椺. 埳摗戝婤1, 墦摗恀堦1, 彫搰丂堣1, 屲廫敤恗巙1, 垻晹丂悏1, 拞懞婎姲1, 屆愳惓媊1, 娾悾弔巕1, 壛摗堦婌1 (1晈恖): 戞434夞恄撧愳嶻壢晈恖壢妛夛妛弍島墘夛 (2021/10/9-10/15), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-120001. [尨挊] 擕娻擇師専恌偱偺慂巋媧堷嵶朎恌 (FNA) 偺惛搙岦忋偵岦偗偰亅摉嫤夛巤愝偱偺5擭娫偺専徹 (戞2曬)亅. 悰尨丂棽, 嶁栰傒偳傝, 杧恀恵巕, 壛摗偪偯戙, 媨愳丂弫, 悪杮捈巕, 媑揷丂柧, 棿丂旤幯, 錟杮攷峴1 (1杒棦戝妛柤梍嫵庼): 恄撧愳導梊杊堛妛嫤夛帠嬈擭曬 椷榓尦擭搙斉 2021/1; p.118-24.
'20-120002. [尨挊] 椷榓尦擭搙恄撧愳嶻壢晈恖壢堛夛晈恖壢埆惈庮釃搊榐廤寁曬崘. 堥嶈懢堦, 徖嶈椷巕, 怴堜丂搘1, 儖僀僘墶揷撧朁, 媑揷丂峗, 悪塝丂尗, 戝尨丂庽, 崅揷嫳恇1, 栘斠峷帨, 嵅乆栘峃, 暷嶳崉堦, 椦丂峃巕, 暯郪丂栆, 敧戙棔巕, 搚壆丂憦, 拞揷偝偔傜, 怷壀丂姴, 嶰忋姴抝, 壛摗媣惙, 拞栰崃嵅抝, 媨忛墄巕, 崅嫶峆抝 (1晈恖): 擔杮嶻壢晈恖壢妛夛恄撧愳抧曽晹夛夛帍 2021/3; 57 (2): 129-36.
惍宍奜壢妛
[妛弍榑暥]
110325. [尨挊] Gender-specific analysis for the association between trunk muscle mass and spinal pathologies. Hori Y, Hoshino M, Inage K, Miyagi M1, Takahashi S, Ohyama S, Suzuki A, Tsujio T, Terai H, Dohzono S, Sasaoka R, Toyoda H, Kato M, Matsumura A, Namikawa T, Seki M, Yamada K, Habibi H, Salimi H, Yamashita M, Yamauchi T, Furuya T, Orita S, Maki S, Shiga Y, Inoue M, Inoue G1, Fujimaki H, Murata K2, Kawakubo A1, Kabata D, Shintani A, Ohtori S, Takaso M1, Nakamura H: Sci Rep 2021/4; 11 (1): 7816. (堜忋丂尯1, 懞揷岾桟2, 愳媣曐曕1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
110326. [尨挊] Efficacy and safety of arthroscopic treatment for native acute septic arthritis of the hip joint in adult patients. Fukushima K1, Uekusa Y, Koyama T2, Ohashi Y2, Uchiyama K1,3, Takahira N4, Takaso M1: BMC Musculoskelet Disord 2021/4; 22 (1): 318. (暉搰寬夘1, 彫嶳抭媣2, 戝嫶宑媣2, 撪嶳彑暥1,3, 崅暯彯怢4, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
110327. [尨挊] Relationships Between Spinal Alignment and Muscle Mass in Osteoporosis Patients Over 75 Years of Age Who Were Independent and Maintained Their Activities of Daily Living. Kawakubo A1, Miyagi M1, Fujimaki H, Inoue G1, Nakazawa T1, Imura T1, Saito W1, Uchida K1, Ohtori S, Takaso M1: Cureus 2021/5; 13 (5): e15130. (愳媣曐曕1, 媨忛惓峴1, 堜忋丂尯1, 拞郪弐擵1, 堜懞婱擵1, 釼摗丂榡1, 撪揷寬懢榊1, 崅憡徎巑1: 1惍奜)
110328. [尨挊] Risk Factor for Poor Patient Satisfaction After Lumbar Spine Surgery in Elderly Patients Aged Over 80 years. Hikata T, Ishii K, Matsumoto M, Kobayashi K, Imagama S, Ando K, Ishiguro N, Yamashita M, Seki S, Terai H, Suzuki A, Tamai K, Aramomi M, Ishikawa T, Kimura A, Inoue H, Inoue G1, Miyagi M1, Saito W1, Yamada K, Hongo M, Endo K, Suzuki H, Nakano A, Watanabe K, Ohya J, Chikuda H, Aoki Y, Shimizu M, Futatsugi T, Mukaiyama K, Hasegawa M, Kiyasu K, Iizuka H, Kobayashi R, Iizuka Y, Nishida K, Kakutani K, Nakajima H, Murakami H, Demura S, Kato S, Yoshioka K, Namikawa T, Watanabe K, Nakanishi K, Nakagawa Y, Yoshimoto M, Fujiwara H, Nishida N, Imajo Y, Yamazaki M, Abe T, Fujii K, Kaito T, Eguchi Y, Furuya T, Orita S, Ohtori S: Clin Spine Surg 2021/5; 34 (4): E223-8. (堜忋丂尯1, 媨忛惓峴1, 釼摗丂榡1: 1惍奜)
110329. [尨挊] Prevalence and Characteristics of Spinal Sagittal Malalignment in Patients with Osteoporosis. Matsunaga T1, Miyagi M1, Nakazawa T1, Murata K1, Kawakubo A1, Fujimaki H, Koyama T2, Kuroda A2, Yokozeki Y, Mimura Y1, Shirasawa E1, Saito W1, Imura T1, Uchida K1, Nanri Y3, Inage K, Akazawa T, Ohtori S, Takaso M1, Inoue G1: J Clin Med 2021/6; 10 (13): 2827. (徏塱峍擵1, 媨忛惓峴1, 拞郪弐擵1, 懞揷岾桟1, 愳媣曐曕1, 彫嶳抭媣2, 崟揷峎媊2, 嶰懞桰桽1, 敀郪塰庽1, 釼摗丂榡1, 堜懞婱擵1, 撪揷寬懢榊1, 撿棦桟懢3, 崅憡徎巑1, 堜忋丂尯1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3儕僴價儕晹)
110330. [尨挊] Neurological improvement is associated with neck pain attenuation after surgery for cervical ossification of the posterior longitudinal ligament. Koda M, Yoshii T, Egawa S, Sakai K, Kusano K, Nakagawa Y, Hirai T, Wada K, Katsumi K, Kimura A, Furuya T, Maki S, Nagoshi N, Watanabe K, Kanchiku T, Nagamoto Y, Oshima Y, Ando K, Nakashima H, Takahata M, Mori K, Nakajima H, Murata K, Matsunaga S, Kaito T, Yamada K, Kobayashi S, Kato S, Ohba T, Inami S, Fujibayashi S, Katoh H, Kanno H, Takahashi H, Fujii K, Miyagi M1, Inoue G1, Takaso M1, Imagama S, Kawaguchi Y, Takeshita K, Nakamura M, Matsumoto M, Okawa A, Yamazaki M: Sci Rep 2021/6; 11 (1): 11910. (媨忛惓峴1, 堜忋丂尯1, 崅憡徎巑1: 1惍奜)
110331. [尨挊] Automated detection of cervical ossification of the posterior longitudinal ligament in plain lateral radiographs of the cervical spine using a convolutional neural network. Miura M, Maki S, Miura K, Takahashi H, Miyagi M1, Inoue G1, Murata K, Konishi T, Furuya T, Koda M, Takaso M1, Endo K, Ohtori S, Yamazaki M: Sci Rep 2021/6; 11 (1): 12702. (媨忛惓峴1, 堜忋丂尯1, 崅憡徎巑1: 1惍奜)
110332. [尨挊] Differential Synovial CGRP/RAMP1 Expression in Men and Women With Knee Osteoarthritis. Uchida K1, Takano S1, Takata K, Mukai M2, Koyama T2, Ohashi Y2, Saito H2, Takaso M1, Miyagi M1, Inoue G1: Cureus 2021/6; 13 (6): e15483. (撪揷寬懢榊1, 崅栰徃懢榊1, 寎丂丂妛2, 彫嶳抭媣2, 戝嫶宑媣2, 釼摗峀庽2, 崅憡徎巑1, 媨忛惓峴1, 堜忋丂尯1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
110333. [尨挊] The Mechanical Strength of Side-to-Side Tendon Repair Using a Modified Krackow Technique. Ueno K, Suzuki T, Matsuura Y, Sukegawa K1, Ohtori S, Kuniyoshi K: J Hand Surg Asian Pac Vol 2021/6; 26 (2): 188-193. (彆愳峗巑1,2: 1椪彴夝朥嫵堢尋, 2惍奜)
110334. [尨挊] Somnolence and Dizziness During Mirogabalin Treatment in Patients With Neuropathic Pain Related to Lumbar Disease Who Switched From Pregabalin: A Retrospective Study. Akazawa T, Inoue G1, Tanaka M, Umehara T, Nagai T, Oshita Y, Imura T1, Miyagi M1, Saito W1, Sako K, Nomura S, Hiyama A, Katoh H, Sakai D, Sato M, Yoshida A, Iinuma M, Niki H, Takaso M1, Watanabe M: Global Spine J 2021/7; 21925682211031185. (堜忋丂尯1, 堜懞婱擵1, 媨忛惓峴1, 釼摗丂榡1, 崅憡徎巑1: 1惍奜)
110335. [尨挊] Possible Regulation of bFGF Expression by Mast Cells in Osteoarthritis Patients with Obesity: A Cross-Sectional Study. Takata K, Uchida K1, Takano S1, Muaki M2, Inoue G1, Sekiguchi H1, Aikawa J1, Miyagi M1, Iwase D1, Takaso M1: Diabetes Metab Syndr Obes 2021/7; 14: 3291-7. (撪揷寬懢榊1, 崅栰徃懢榊1, 寎丂丂妛2, 堜忋丂尯1, 娭岥桾擵1, 憡愳丂弤1, 媨忛惓峴1, 娾悾丂戝1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
110336. [尨挊] TGF-兝 regulates nerve growth factor expression in a mouse intervertebral disc injury model. Yokozeki Y1, Uchida K2, Kawakubo A2, Nakawaki M2, Okubo T3, Miyagi M2, Inoue G2, Itakura M4, Sekiguchi H2, Takaso M2: BMC Musculoskelet Disord 2021/7; 22 (1): 634. (墶娭梇巌1, 撪揷寬懢榊2, 愳媣曐曕2, 拞榚廩復2, 戝媣曐捈3, 媨忛惓峴2, 堜忋丂尯2, 斅憅丂惤4, 娭岥桾擵2, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜, 3幚摦, 4惗壔)
110337. [尨挊] Reduced TGF-兝 Expression and CD206-Positive Resident Macrophages in the Intervertebral Discs of Aged Mice. Yokozeki Y1, Kawakubo A2, Miyagi M2, Kuroda A1, Sekiguchi H2, Inoue G2, Takaso M2, Uchida K2: Biomed Res Int 2021/7; 2021: 7988320. (墶娭梇巌1, 愳媣曐曕2, 媨忛惓峴2, 崟揷峎媊1, 娭岥桾擵2, 堜忋丂尯2, 崅憡徎巑2, 撪揷寬懢榊2: 1戝妛堾堛椕宯尋媶壢, 2惍奜)
110338. [尨挊] Regulation of Tumor Necrosis Factor-兛 by Peptide Lv in Bone Marrow Macrophages and Synovium. Mukai M1, Uchida K2, Okubo T3, Takano S2, Matsumoto T4, Satoh M5, Inoue G2, Takaso M2: Front Med (Lausanne) 2021/7; 8: 702126. (寎丂丂妛1, 撪揷寬懢榊2, 戝媣曐捈3, 崅栰徃懢榊2, 徏杮弐塸4, 嵅摗丂夒5, 堜忋丂尯2, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜, 3幚摦, 4堛椕塹惗妛晹, 5柶塽)
110339. [尨挊] Influence of different energy patterns on efficacy of radial shock wave therapy. Kenmoku T1, Iwakura N, Ochiai N, Saisu T, Ohtori S, Takahashi K, Nakazawa T1, Fukuda M2, Takaso M1: J Orthop Sci 2021/7; 26 (4): 698-703. (尒栚抭婭1, 拞郪弐擵1, 暉揷椣栫2, 崅憡徎巑1: 1惍奜, 2堛椕塹惗妛晹)
110340. [尨挊] Investigating interest in orthopedic surgery within an entire medical faculty: A cross-sectional study. Kenmoku T, Sho S, Suzuki T, Suzuki A, Suzuki R, Sakaguchi K, Saito A, Kohata A, Takaso M1: J Orthop Sci 2021/7; 26 (4): 704-8. (尒栚抭婭1, 崅憡徎巑1: 1惍奜)
110341. [尨挊] Increasing transforming growth factor-beta concentrations with age decrease apelin in the rat rotator cuff. Tazawa R1, Uchida K1, Kenmoku T1, Nakawaki M1, Muneshige K2, Ishii D2, Inoue G1, Takaso M1: J Orthop Surg Res 2021/8; 16 (1): 539. (揷郪丂椚1, 撪揷寬懢榊1, 尒栚抭婭1, 拞榚堯復1, 廆廳嬁巕2, 愇堜戝曘2, 堜忋丂尯1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
110342. [尨挊] Role of CD14-positive cells in inflammatory cytokine and pain-related molecule expression in human degenerated intervertebral discs. Miyagi M1, Uchida K1, Takano S1, Nakawaki M1, Sekiguchi H1, Nakazawa T1, Imura T1, Saito W1, Shirasawa E1, Kawakubo A1, Akazawa T, Inoue G1, Takaso M1: J Orthop Res 2021/8; 39 (8): 1755-62. (媨忛惓峴1, 撪揷寬懢榊1, 崅栰徃懢榊1, 拞榚堯復1, 娭岥桾擵1, 拞郪弐擵1, 堜懞婱擵1, 釼摗丂榡1, 敀郪塰庽1, 愳媣曐曕1, 堜忋丂尯1, 崅憡徎巑1: 1惍奜)
110343. [尨挊] Incidences of deep vein thrombosis and major bleeding under the administration of fondaparinux for thromboprophylaxis after periacetabular osteotomy: a retrospective observational study. Fukushima K1, Saito H2, Koyama T2, Ohashi, Y2, Uchiyama K1,3, Takahira N4, TakasoM1: J Hip Preserv Surg 2021/8; 8 (3): 293-7. (暉搰寬夘1, 釼摗峀庽2, 彫嶳抭媣2, 戝嫶宑媣2, 撪嶳彑暥1,3, 崅暯彯怢4, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
110344. [尨挊] NGF Expression and Elevation in Hip Osteoarthritis Patients with Pain and Central Sensitization. Ohashi Y1, Uchida K2, Fukushima K2, Satoh M3, Koyama T1, Tsuchiya M1, Saito H1, Takahira N4, Inoue G2, Takaso M2: Biomed Res Int 2021/9; 2021: 9212585. (戝嫶宑媣1, 撪揷寬懢榊2, 暉搰寬夘2, 嵅摗丂夒3, 彫嶳抭媣1, 搚壆恀曚1, 釼摗峀庽1, 崅暯彯怢4, 堜忋丂尯2, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜, 3柶塽, 4堛椕塹惗妛晹)
110345. [尨挊] Factors Significantly Associated with Postoperative Neck Pain Deterioration after Surgery for Cervical Ossification of the Posterior Longitudinal Ligament: Study of a Cohort Using a Prospective Registry. Koda M, Yoshii T, Egawa S, Sakai K, Kusano K, Nakagawa Y, Hirai T, Wada K, Katsumi K, Kimura A, Furuya T, Maki S, Nagoshi N, Watanabe K, Kanchiku T, Nagamoto Y, Oshima Y, Ando K, Nakashima H, Takahata M, Mori K, Nakajima H, Murata K, Matsunaga S, Kaito T, Yamada K, Kobayashi S, Kato S, Ohba T, Inami S, Fujibayashi S, Katoh H, Kanno H, Takahashi H, Fujii K, Miyagi M1, Inoue G1, Takaso M1, Imagama S, Kawaguchi Y, Takeshita K, Nakamura M, Matsumoto M, Okawa A, Yamazaki M: J Clin Med 2021/10; 10 (21): 5026. (媨忛惓峴1, 堜忋丂尯1, 崅憡徎巑1: 1惍奜)
110346. [尨挊] Prevalence and location of endplate fracture and subsidence after oblique lumbar interbody fusion for adult spinal deformity. Inoue G1, Saito W1, Miyagi M1, Imura 1, Shirasawa E1, Ikeda S1, Mimura Y1, Kuroda A2, Yokozeki Y2, Inoue S2, Akazawa T, Nakazawa T1, Uchida K1, Takaso M1: BMC Musculoskelet Disord 2021/10; 22 (1): 880. (堜忋丂尯1, 釼摗丂榡1, 媨忛惓峴1, 堜懞婱擵1, 敀郪塰庽1, 抮揷怣夘1, 懞揷岾桟1, 崟揷峎媊2, 墶娭梇巌2, 堜忋丂隳2, 拞郪弐擵1, 撪揷寬懢榊1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
110347. [尨挊] Adverse Effects of Higher Preoperative Pain at Rest, a Central Sensitization-Related Symptom, on Outcomes After Total Hip Arthroplasty in Patients with Osteoarthritis. Ohashi Y1, Fukushima K2, Uchida K2, Koyama T1, Tsuchiya M1, Saito H1, Uchiyama K2,3, Takahira N4, Inoue G2, Takaso M2: J Pain Res 2021/20; 14: 3345-52. (戝嫶宑媣1, 暉搰寬夘2, 撪揷寬懢榊2, 彫嶳抭媣1, 搚壆恀曚1, 釼摗峀庽1, 撪嶳彑暥2,3, 崅暯彯怢4, 堜忋丂尯2, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
110348. [尨挊] Increased nerve growth factor expression in the synovial tissues of patients with rotator cuff tears. Tazawa R1, Kenmoku T1, Uchida K1, Arendt-Nielsen L, Nagura N, Nakawaki M1, Matsumoto T2, Inoue G1, Takeuchi H3, Jimbo T3, Nakazawa T1, Fukuda M2, Takaso M1: Mol Pain 2021/1-12; 17: 17448069211021252. (揷郪丂椚1, 尒栚抭婭1, 撪揷寬懢榊1, 拞榚堯復1, 徏杮弐塸2, 堜忋丂尯1, 抾撪姲恖3, 恄曐晲懃3, 拞郪弐擵1, 暉揷椣栫2, 崅憡徎巑1: 1惍奜, 2堛椕塹惗妛晹, 3儕僴價儕晹)
110349. [尨挊] Factors associated with pain-related disorders and gait disturbance scores from the Japanese orthopedic association back pain evaluation questionnaire and Oswestry Disability Index in patients with osteoporosis. Miyagi M1, Inoue G1, Murata K1, Koyama T2, Kuroda A2, Kawakubo A1, Yokozeki Y2, Mimura Y1, Nannri Y3, Inage K, Akazawa T, Ohtori S, Uchida K1, Takaso M1: Arch Osteoporos 2021/12; 17 (1): 1. (媨忛惓峴1, 堜忋丂尯1, 懞揷岾桟1, 彫嶳抭媣2, 崟揷峎媊2, 愳媣曐曕1, 墶娭梇巌2, 嶰懞桰桽1, 撿棦桟懢3, 撪揷寬懢榊1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3儕僴價儕晹)
110350. [尨挊] Elevated macrophage-inducible C-type lectin expression in the synovial tissue of patients with rheumatoid arthritis. Takata K, Takano S1, Miyagi M1, Mukai M2, Iwase D1, Aikawa J1, Ohashi Y2, Inoue G1, Takaso M1, Uchida K1: Cent Eur J Immunol 2021/12; 46 (4): 470-3. (崅栰徃懢榊1, 媨忛惓峴1, 寎丂丂妛2, 娾悾丂戝1, 憡愳丂弤1, 戝嫶宑媣2, 堜忋丂尯1, 崅憡徎巑1, 撪揷寬懢榊1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
110351. [尨挊] Management of regional bone bank during declaration of a state of emergency concerning the COVID-19 in Japan. Uchida K1, Mukai M2, Miyagi M1, Fukushima K1, Uchiyama K1,3, Nakayama A, Matsumoto M, Takahira N4, Urabe K1, Takaso M1, Inoue G1: Cell Tissue Bank 2021/12; 22 (4): 703-9. (撪揷寬懢榊1, 寎丂丂妛2, 媨忛惓峴1, 暉搰寬夘1, 撪嶳彑暥1,3, 崅暯彯怢4, 愯晹丂寷1, 崅憡徎巑1, 堜忋丂尯1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
110352. [尨挊] Femoral varus derotational osteotomy without pelvic osteotomy in nonambulatory children with cerebral palsy: Minimum 5 years follow-up. Iwase D1, Fukushima K1, Kusumoto Y, Metoki Y2, Aikawa J1, Kenmoku T1, Minato S1, Takaso M1: Medicine (Baltimore) 2022/1; 101 (3): e28604. (娾悾丂戝1, 暉搰寬夘1, 栚帪桳婓宐2, 憡愳丂弤1, 尒栚抭婭1, 柀嵅戙巕1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
110353. [尨挊] Long-term antibacterial activity of vancomycin from calcium phosphate cement in vivo. Mukai M1, Uchida K2, Sugo K, Nakasu M, Nakajima T, Takata K, Takaso M2, Urabe K2: Biomed Mater Eng 2022; 33 (1): 41-50. (寎丂丂妛1, 撪揷寬懢榊2, 崅憡徎巑2, 愯晹丂寷2: 1戝妛堾堛椕宯尋媶壢, 2惍奜)
120013. [尨挊] 崅楊崪慹闋徢姵幰偵偍偗傞堓怘摴媡棳徢偺徢忬偲愐拰栴忬柺傾儔僀儊儞僩. 敀郪塰庽1, 晲堜惓堦榊1, 徏杮岝孿1, 媨忛惓峴1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜): 搶擔杮惍宍嵭奞奜壢妛夛嶨帍 2021/5; 33 (1): 1-6.
120014. [尨挊] 僒儖僐儁僯傾傪崌暪偟偨尨敪惈崪慹闋徢姵幰偺摿挜. 栴栰攷擵1, 媨忛惓峴1, 懞揷岾桟1, 戝捁惛巌1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜): 搶擔杮惍宍嵭奞奜壢妛夛嶨帍 2021/5; 33 (1): 22-7.
120015. [尨挊] 崅僄僱儖僊乕奜彎偵敽偆愬崪晄埨掕宆崪愜偵懳偡傞掅怤廝屻曽屌掕弍偺帯椕惉愌偺専摙. 拞郪弐擵1, 媨忛惓峴1, 敀郪塰庽1, 堜懞婱擵1, 釼摗丂榡1, 摗栰彲懢榊1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜): 杒棦堛妛 2021/6; 51 (1): 17-23.
120016. [尨挊] 姲崪塒旐暍搙偑僙儊儞僩儗僗姲崪塒僔僃儖偺弶婜屌掕椡傊梌偊傞塭嬁. 媑揷榓峅1, 暉搰寬夘2, 庰堜棙撧1, 撪嶳彑暥2,3, 崅暯彯怢1, 巵暯惌怢1 (1堛椕塹惗妛晹, 2惍奜, 3堛椕埨慡丒娗棟): 椪彴僶僀僆儊僇僯僋僗 2021/10; 42: 137-44.
310045. [徢椺曬崘] Hip Dislocation After Correction for Scoliosis in an Adolescent with Angelman Syndrome: A Case Report. Metoki Y1, Iwase D1, Fukushima K1, Uchiyama K1,2, Saito W1, Takao M1: JBJS Case Connect 2021/4; 11 (2). doi: 10.2106/JBJS.CC.20.00959. (栚帪桳婓宐1, 娾悾丂戝1, 暉搰寬夘1, 撪嶳彑暥1,2, 釼摗丂榡1, 崅憡徎巑1: 1惍奜, 2堛椕埨慡丒娗棟)
310046. [徢椺曬崘] Disseminated nocardiosis complicated by multiple abscesses of the brain and lower limbs diagnosed by the melting temperature mapping method: A case report. Ikeda S1, Uchiyama K1,2, Moriya M, Sakurai K3, Nihonyanagi S3,4, Niimi H, Takaso M1: J Orthop Sci 2021/8; S0949-2658 (21) 00232-3. (抮揷怣夘1, 撪嶳彑暥1,2, 烴堜宑憿3, 擇杮桍怢3,4, 崅憡徎巑1: 1惍奜, 2堛椕埨慡丒娗棟, 3椪専晹, 4姶愼娗棟幒)
320007. [徢椺曬崘] III. 奜彎丒奜彎崌暪徢丂旾娭愡屻奜懁夞慁晄埨掕徢傪敽偭偨彫帣忋榬崪奜懁梓sleeve崪愜偺1椺. 崱栰梇懢1, 彆愳峗巑1,2, 彫徖尗帯1, 戝抾桰嵠1, 崅憡徎巑1 (1惍奜, 2椪彴夝朥嫵堢尋): 擔杮旾娭愡妛夛嶨帍 2021/11; 28 (2): 7-10.
320008. [徢椺曬崘] VII. 墛徢丒姶愼丂摨庬崪傪巊梡偟偨Impaction bone grafting朄偵傛傞恖岺旾娭愡嵞抲姺弍傪巤峴偟偨娭愡儕僂儅僠偺1椺. 崅壀弮堦1, 彫徖尗帯1, 彆愳峗巑1,2, 戝抾桰嵠1, 崅憡徎巑1 (1惍奜, 2椪彴夝朥嫵堢尋): 擔杮旾娭愡妛夛嶨帍 2021/11; 28 (2): 163-6.
521005. [夝愢] TKA屻偺旼娭愡偭偰慜廫帤恱懷婡擻晄慡旼偠傖側偄偺? 偦傟偱偄偄偺? 愯晹丂寷 (惍奜): 嶉嬍導堛巘夛帍 2021/6; (855): 46-50.
521006. [夝愢]亂楢嵹: 揱傢傜側偄僐僩僶偨偪 (戞2夞)亃DDH偲CDH. 暉搰寬夘 (惍奜): 娭愡奜壢 2022/1; 41 (1): 95.
521007. [夝愢]亂楢嵹: 揱傢傜側偄僐僩僶偨偪 (戞3夞)亃塣摦婍晄埨掕徢偲儘僐儌僥傿僽僔儞僪儘乕儉, 僼儗僀儖. 暉搰寬夘 (惍奜): 娭愡奜壢 2022/3; 41 (3): 312-3.
522526. [島嵗]亂戞93夞擔杮惍宍奜壢妛夛妛弍憤夛僔儞億僕僂儉乽崢捝偺昦懺夝柧偵岦偗偨怴偟偄傾僾儘乕僠乿亃崢捝偺昦懺夝柧偵岦偗偨怴偟偄傾僾儘乕僠亅崪慹闋徢姵幰偺崢捝偲曕峴婡擻忈奞丂愐拰栴忬柺傾儔僀儊儞僩堎忢偲懱姴嬝検掅壓偑媦傏偡塭嬁亅. 崅憡徎巑1, 媨忛惓峴1 (1惍奜): 擔杮惍宍奜壢妛夛帍 2021/4; 95 (4): 224-8.
522527. [島嵗]亂Debate亃曣巜CM娭愡徢亅娭愡屌掕弍 vs. 娭愡宍惉弍. 彆愳峗巑1,2, 忋尨峗夘 (1椪彴夝朥嫵堢, 2惍奜): 椪彴惍宍奜壢 2021/4; 56 (4): 393-6.
522528. [島嵗]亂摿廤: 崪慹闋徢惈捙懱崪愜亅擄帯椺偺恌抐丒帯椕傪拞怱偵亅亃崪慹闋徢惈捙懱崪愜偵偍偗傞屻淽曄宍亅擄帯椺偺恌抐丒帯椕傪拞怱偵亅. 媨忛惓峴1, 拞郪弐擵1, 堜懞婱擵1, 釼摗丂榡1, 敀郪塰庽1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜): 娭愡奜壢 2021/5; 40 (5): 514-20.
522529. [島嵗]亂惍宍僩僺僢僋僗亃娭愡儕僂儅僠姵幰偺妸枌儅僋儘僼傽乕僕偵偍偄偰槾恑傪擣傔傞C宆儗僋僠儞庴梕懱 (macrophage inducible C-type lectin) 偺敪尰. 怷扟岝弐1, 撪揷寬懢榊1, 崅憡徎巑1 (1惍奜): 惍宍奜壢 2021/5; 72 (5): 462.
522530. [島嵗]亂摿廤: FAI拞婜惉愌偺峫嶡偲揥朷亃FAI偺塽妛. 暉搰寬夘1, 崅暯彯怢2, 崅憡徎巑1 (1惍奜, 2堛椕塹惗妛晹): Monthly Book Ortrhopaedics 2021/12; 34 (13): 1-5.
522531. [島嵗]亂摿廤: 僐儞僶乕僕儑儞THA 偺偡傋偰亅擄堈搙偺崅偄primary THA亅亃戝戁崪奜斀崪愗傝弍屻偺THA. 暉搰寬夘1, 崅暯彯怢2, 撪嶳彑暥1,3, 崅憡徎巑1 (1惍奜, 2堛椕塹惗妛晹, 3堛椕埨慡丒娗棟): 娭愡奜壢 2022/2; 41 (2): 66-72.
522532. [島嵗]亂摿廤: 恌抐丒帯椕偵擄廰偟偨Periprosthetic Joint Infection傊偺懳墳亃仭帯椕曇丂嫄戝崪寚懝傪敽偆徢椺傊偺懳墳. 撪嶳彑暥1,2, 暉搰寬夘2, 怷扟岝弐2, 彫嶳抭媣3, 戝嫶宑媣3, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): 椪彴惍宍奜壢 2022/3; 57 (3): 241-8.
[挊丂彂]
620094. [妛弍彂 (暘扴幏昅)]亂僗儁僔儍儕僗僩偑偡偡傔傞恖岺娭愡庤弍崌暪徢懳嶔亃憤榑丂戞II復 恖岺娭愡廃埻姶愼丂3 崅儕僗僋徢椺偵懳偡傞廃弍婜娗棟. 4 弍慜惔怈丒徚撆偺曽朄偲僞僀儈儞僌, p.35-8. 撪嶳彑暥1,2 (1堛椕埨慡丒娗棟妛, 2惍奜), 曇: 嶳杮尓屷, 撿峕摪, 搶嫗, 2021/4敪峴.
620095. [妛弍彂 (暘扴幏昅)]亂僀儞僾儔儞僩廃埻姶愼偺懳張朄亅恖岺娭愡丒愐捙丒崪愜亅 (娭愡奜壢2021擭4寧憹姧崋)亃II. 奺榑丂抶敪惈恖岺崪摢丒恖岺屢娭愡廃埻姶愼偺懳張朄, p.88-94. 撪嶳彑暥1,2, 暉搰寬夘2, 怷扟岝弐2, 彫嶳抭媣3, 戝嫶宑媣3, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): 曇: 揷拞峃恗, 儊僕僇儖價儏乕幮, 搶嫗, 2021/4敪峴.
620096. [妛弍彂 (暘扴幏昅)]亂旼娭愡奜壢妛亃II 奺榑 丂3 墛徢丂D 愐捙娭愡墛, p.415-26. 愯晹丂寷 (惍奜), 曇: 捗懞丂峅, 嶰塝桾惓, 徏揷廏堦, 壀嶈丂尗, 撿峕摪, 搶嫗, 2021/8敪峴.
620097. [妛弍彂 (暘扴幏昅)]亂Save the Athlete 屢娭愡僗億乕僣懝彎亃II 屢娭愡丒崪斦偺僗億乕僣懝彎丂B. 懳徾曇丂5 僩僢僾傾僗儕乕僩: 栰媴偲屢娭愡偺娭楢惈, p.185-8 尒栚抭婭1, 暉搰寬夘1 (1惍奜), 曇: 崅暯彯怢, 儊僕僇儖價儏乕幮, 搶嫗, 2020/10敪峴.
620098. [妛弍彂 (暘扴幏昅)]亂擖堾偐傜戅堾傑偱偺僠儍乕僩偱妛傇丂惍宍奜壢昦搹偺弍幃暿働傾儅僯儏傾儖 (惍宍奜壢娕岇2021擭廐婫憹姧)亃戞3復 忋巿丂烎崪墦埵抂崪愜, p.109-18. 広崪恄宱堏峴弍, p.119-26. 庤巜崪愜偺惍暅屌掕弍, p.127-33. 恄宱懝彎偵懳偡傞恄宱朌崌弍, p.134-41. 彆愳峗巑1,2 (1椪彴夝朥嫵堢, 2惍奜), 曇: 崅暯彯怢, 儊僨傿僇弌斉, 2021/11敪峴.
621004. [妛弍彂 (曇廤)]亂惍宍奜壢堛偺偨傔偺屢娭愡僗億乕僣恌椕偺偡傋偰亃曇: 暉搰寬夘, 擔杮堛帠怴曬幮, 搶嫗, 2021/12敪峴.
[妛夛丒尋媶夛摍]
712009. [妛夛 (崙嵺)] (僔儞億僕僂儉) Surgical treatment for neuromuscular disease patients with severe scoliosis whose Cobb angle was over 100 degrees. Miyagi M1, Saito W1, Mimura Y1, Inoue G1, Nakazawa T1, Imura T1, Shirasawa E1, Ikeda S1, Kuroda A2, Yokozeki Y2, Takaso M1: 13th Combined Meeting of Asia Pacific Spine Society and Asia Pacific Paediatric Orthopaedic Society (2021/6/9-12), Kobe, Japan. (媨忛惓峴1, 釼摗丂榡1, 嶰懞桰桽1, 堜忋丂尯1, 拞郪弐擵1, 堜懞婱擵1, 敀郪塰庽1, 抮揷怣夘1, 崟揷峎媊2, 墶娭梇巌2, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
712010. [妛夛 (崙嵺)] (僔儞億僕僂儉) Residual neuropathic pain in postoperative patients for cervical ossification of posterior longitudinal ligament. Miyagi M1, Yoshii T, Koda M, Furuya T, Kimura A, Nagoshi N, Nakashima H, Sakai K, Ikeda S1, Inoue G1, Imagama S, Takeshita K, Matsumoto M1, Okawa A, Yamazaki M, Takaso M1: Spine Across the Sea 2021 (2021/7/5-8), Hawaii, USA. (媨忛惓峴1, 抮揷怣夘1, 堜忋丂尯1, 徏杮岝孿1, 崅憡徎巑1: 1惍奜)
722159. [妛夛 (慡崙)] (僔儞億僕僂儉) 屢娭愡PJI帯椕偺尰忬偲枹棃. 撪嶳彑暥1,2, 抮揷怣夘2, 暉搰寬夘2, 彫嶳抭媣3, 戝嫶宑媣3, 怷扟岝弐2, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): 戞94夞擔杮惍宍奜壢妛夛妛弍憤夛 (2021/5/20-21), 搶嫗 (僴僀僽儕僢僪奐嵜).
722160. [妛夛 (慡崙)] (彽懸島墘摍) FAI偵懳偡傞屢娭愡嬀帯椕偺尰忬. 暉搰寬夘1, 戝嫶宑媣2, 彫嶳抭媣2, 撪嶳彑暥1,3, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞94夞擔杮惍宍奜壢妛夛妛弍憤夛 (2021/5/21), 搶嫗.
722161. [妛夛 (慡崙)] (僔儞億僕僂儉) 屢娭愡嬀帇壓庤弍偵偍偗傞, 妸枌墛偍傛傃妸枌撪墛徢惈僒僀僩僇僀儞敪尰偺塭嬁. 暉搰寬夘1, 堜忋丂尯1, 撪揷寬懢榊1, 戝嫶宑媣2, 彫嶳抭媣2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): JOSKAS/JOSSM meeting 2021 (2021/6/18), Web奐嵜.
722162. [妛夛 (慡崙)] (僔儞億僕僂儉) 庤弍晹埵姶愼偺杘柵傪栚巜偟偰亅THA廃埻姶愼偵懳偡傞擇婜揑嵞抲姺弍偺岺晇亅. 撪嶳彑暥1,2, 暉搰寬夘2, 怷扟岝弐2, 彫嶳抭媣3, 戝嫶宑媣3, 抮揷怣夘2, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): 戞44夞擔杮崪丒娭愡姶愼徢妛夛 (2021/6/25), 墶昹 (僴僀僽儕僢僪奐嵜).
722163. [妛夛 (慡崙)] (僔儞億僕僂儉) 摉堾偱偺恖岺屢娭愡廃埻姶愼偺帯椕慡斒亅僗儁乕僒乕丒嵞抲姺丒峈嬠栻亅. 撪嶳彑暥1,2, 暉搰寬夘2, 抮揷怣夘2, 彫嶳抭媣3, 戝嫶宑媣3, 怷扟岝弐2, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): 戞51夞擔杮恖岺娭愡妛夛 (2021/7/8), 墶昹 (僴僀僽儕僢僪奐嵜), 彺榐廤 p.244.
722164. [妛夛 (慡崙)] (僔儞億僕僂儉) 晄椙徢椺偐傜妛傫偩屢娭愡嬀帇壓庤弍偺揔墳偲庤媄偺曄慗. 暉搰寬夘1, 戝嫶宑媣2, 彫嶳抭媣2, 釼摗峀庽2, 搚壆恀曚2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞48夞擔杮屢娭愡妛夛妛弍廤夛 (2021/10/22), 撧椙 (僴僀僽儕僢僪奐嵜).
722165. [妛夛 (慡崙)] (嫵堢尋廋島墘) 戝戁崪嬤埵崪愗傝弍偺揔墳偲尷奅. 撪嶳彑暥1,2 (1堛椕埨慡丒娗棟, 2惍奜): 戞48夞擔杮屢娭愡妛夛妛弍廤夛 (2021/10/22-23), 撧椙 (僴僀僽儕僢僪奐嵜).
722166. [妛夛 (慡崙)] (僔儞億僕僂儉) Avenir Complete stem (Zimmer-Biomet幮). 暉搰寬夘1, 彫嶳抭媣2, 戝嫶宑媣2, 釼摗峀庽2, 搚壆恀曚2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞48夞擔杮屢娭愡妛夛妛弍廤夛 (2021/10/23), 撧椙 (僴僀僽儕僢僪奐嵜).
722167. [妛夛 (慡崙)] (僔儞億僕僂儉) 恖岺屢娭愡廃埻姶愼偵懳偡傞帯椕偺婎杮. 撪嶳彑暥1,2, 暉搰寬夘2, 抮揷怣夘2, 彫嶳抭媣3, 戝嫶宑媣3, 怷扟岝弐2, 崅嶳梲巕4, 惎嶳棽峴5, 榓揷払旻5, 拞懞惓庽6, 崅暯彯怢6, 崅憡徎巑2, 恗堜尒塸庽7, 壴栘廏柧8 (1堛椕埨慡丒娗棟, 2惍奜, 3戝妛堾堛椕宯尋媶壢, 4怴悽婭堛椕丒墶抐揑堛椕, 5銹尨昦丒姶愼撪, 6堛椕塹惗妛晹, 7晉嶳戝妛, 8杒棦惗柦壢妛尋媶強): 戞70夞擔杮姶愼徢妛夛搶擔杮抧曽夛妛弍廤夛/戞68夞擔杮壔妛椕朄妛夛搶擔杮巟晹憤夛 崌摨妛夛 (2021/10/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722168. [妛夛 (慡崙)] (僔儞億僕僂儉) 捙崪摦柆懝彎. 媨忛惓峴1, 堜懞婱擵1, 敀郪塰庽1, 嶰懞桰桽1, 抮揷怣夘1, 拞郪弐擵1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜): 戞11夞嵟彫怤廝愐捙帯椕妛夛 (2021/10/29-30), 搶嫗.
722169. [妛夛 (慡崙)] (僔儞億僕僂儉) 曻幩慄旐敇掅尭僨僶僀僗摫擖奼戝傪栚巜偟偨峴惌傊偺傾僾儘乕僠奣梫. 媨忛惓峴1, 戝捁惛巌, 墦摗寬巌, 庬巗丂梞 (1惍奜): 戞11夞嵟彫怤廝愐捙帯椕妛夛 (2021/10/29-30), 搶嫗.
722170. [妛夛 (慡崙)] (僔儞億僕僂儉) 恄宱嬝惈愐拰懁淽徢偵懳偡傞庤弍帯椕. 媨忛惓峴1, 釼摗丂榡1, 嶰懞桰桽1, 堜忋丂尯1, 拞郪弐擵1, 堜懞婱擵1, 敀郪塰庽1, 抮揷怣夘1, 崅憡徎巑1 (1惍奜): 戞55夞擔杮懁淽徢妛夛妛弍廤夛 (2021/11/5-6), 昹徏 (僴僀僽儕僢僪奐嵜).
722171. [妛夛 (慡崙)] (僔儞億僕僂儉) 恖岺屢娭愡廃埻姶愼偵懳偡傞帩懕揑嬊強峈嬠栻燇棳 (CLAP). 撪嶳彑暥1,2, 暉搰寬夘2, 怷扟岝弐2, 彫嶳抭媣3, 戝嫶宑媣3, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): 戞34夞擔杮奜壢姶愼徢妛夛憤夛妛弍廤夛 (2021/12/17), Web奐嵜.
723457. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞曣巜CM娭愡徢偵懳偡傞憰嬶椕朄偲庤弍椕朄. 彫徖尗帯1, 嵅乆栘廏堦2, 彆愳峗巑1, 戝抾桰嵠1, 崅憡徎巑1 (1惍奜, 2儕僴價儕晹): 戞64夞擔杮庤奜壢妛夛妛弍廤夛 (2021/4/23), 挿嶈 (僴僀僽儕僢僪奐嵜).
723458. [妛夛 (慡崙)] (堦斒島墘) 彫帣丒惵擭婜偵偍偗傞晄埨掕宆旾娭愡扙塒崪愜偺帯椕宱尡. 彆愳峗巑1,2, 彫徖尗帯2, 戝抾桰嵠2, 挰揷廃暯2, 崱栰梇懢2, 崅憡徎巑2 (1椪彴夝朥嫵堢, 2惍奜): 戞64夞擔杮庤奜壢妛夛妛弍廤夛 (2021/4/23), 挿嶈 (僴僀僽儕僢僪奐嵜).
723459. [妛夛 (慡崙)] (堦斒島墘) 怷桭暘椶Type 1-B3廙忬崪崪愜偵懳偡傞攚懁恑擖偵傛傞墦埵崪曅偐傜嬤埵崪曅偵岦偗偰僗僋儕儏乕傪憓擖偡傞崪愜晹屌掕朄. 彫徖尗帯1, 懡揷戱栴1, 彆愳峗巑1,2, 戝抾桰嵠1, 崅憡徎巑1 (1惍奜, 2椪彴夝朥嫵堢): 戞64夞擔杮庤奜壢妛夛妛弍廤夛 (2021/4/23), 挿嶈 (僴僀僽儕僢僪奐嵜).
723460. [妛夛 (慡崙)] (堦斒島墘) 僑乕儖僉乕僷乕偑儃乕儖傪庤彾晹偱僙乕僽偟偨嵺偵庴彎偟偨偲峫偊傜傟偨廙忬崪崪愜偺2椺. 懡揷戱栴1, 彫徖尗帯1, 彆愳峗巑1,2, 戝抾桰嵠1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜, 2椪彴夝朥嫵堢): 戞94夞擔杮惍宍奜壢妛夛妛弍憤夛 (2021/5/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723461. [妛夛 (慡崙)] (堦斒島墘) 彫帣丒惵擭婜偵偍偗傞晄埨掕宆旾娭愡扙塒崪愜. 彆愳峗巑1,2, 彫徖尗帯2, 戝抾桰嵠2, 崱栰梇懢2, 栚帪桳婓宐2, 挰揷廃暯2, 尒栚抭婭2, 崅憡徎巑2 (1椪彴夝朥嫵堢, 2惍奜): 戞94夞擔杮惍宍奜壢妛夛妛弍憤夛 (2021/5/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723462. [妛夛 (慡崙)] (堦斒島墘) COVID-19僷儞僨儈僢僋壓偵偍偗傞摉堾嶰師媬媫偵斃憲偝傟偨奜彎姵幰偍傛傃惍宍奜彎庤弍悢偺悇堏偺専摙. 壨懞丂捈1, 徏塝峎惓2, 彲巌恀懢榊1, 曯尨岹徆, 崅憡徎巑1 (1惍奜, 2媬柦): 戞47夞擔杮崪愜帯椕妛夛妛弍廤夛 (2021/7/3), 恄屗.
723463. [妛夛 (慡崙)] (堦斒島墘) 曄宍惈屢娭愡徢偵偍偗傞拞悤惈姶嶌娭楢捝偑恖岺屢娭愡抲姺弍屻偵媦傏偡塭嬁. 戝嫶宑媣1, 暉搰寬夘2, 撪揷寬懢榊2, 彫嶳抭媣1, 搚壆恀曚1, 釼摗峀庽1, 撪嶳彑暥2,3, 崅暯彯怢4, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞51夞擔杮恖岺娭愡妛夛 (2021/7/7), 墶昹 (僴僀僽儕僢僪奐嵜), 彺榐廤 p.339.
723464. [妛夛 (慡崙)] (堦斒島墘) 帀幙戙幱堎忢偵敽偆嬝僞僀僾挷愡場巕偺曄壔. 彫嶳抭媣1, 撪揷寬懢榊2, 揷郪丂椚2, 淎郪捈栫, 戝嫶宑媣1, 暉搰寬夘2, 娭岥桾擵2, 媨忛惓峴2, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723465. [妛夛 (慡崙)] (堦斒島墘) 嬞媫帠懺愰尵偵敽偆崪慹闋徢姵幰偺妶摦惈掅壓偑崪枾搙, 崪戙幱儅乕僇乕偵媦傏偡塭嬁偵偮偄偰. 墶娭梇巌1, 撪揷寬懢榊2, 愳媣曐曕2, 崟揷峎媊1, 彫嶳抭媣1, 懞揷岾桟1, 媨忛惓峴2, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723466. [妛夛 (慡崙)] (堦斒島墘) 捙娫斅彎奞屻偺Apelin偍傛傃偦偺庴梕懱APJ偺敪尰摦懺偵娭偡傞専摙. 崟揷峎媊1, 撪揷寬懢榊2, 媨忛惓峴2, 拞榚廩復2, 愳媣曐曕2, 堜忋丂尯2, 娭岥桾擵2, 釼摗丂榡2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723467. [妛夛 (慡崙)] (堦斒島墘) 旍枮曄宍惈旼娭愡徢姵幰偺妸枌慻怐偵偍偗傞墫婎惈慄堐夎嵶朎憹怋場巕bFGF敪尰憹壛婡峔偺専摙. 崅揷丂尋1, 撪揷寬懢榊2, 寎丂丂妛1, 憡愳丂弤2, 娾悾丂戝2, 媨忛惓峴2, 堜忋丂尯2, 戝娧桾巕3, 娭岥桾擵2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3昦懺丒恌椕宯): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723468. [妛夛 (慡崙)] (堦斒島墘) 旍枮曄宍惈旼娭愡徢姵幰偺妸枌慻怐偵偍偄偰憹壛偡傞旍枮嵶朎偺昞尰宆偺専摙偲墛徢惈僒僀僩僇僀儞嶻惗傊偺娭梌偺専摙. 崅揷丂尋1, 撪揷寬懢榊2, 憡愳丂弤2, 娾悾丂戝2, 寎丂丂妛1, 媨忛惓峴2, 堜忋丂尯2, 娭岥桾擵2, 戝娧桾巕3, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3昦懺丒恌椕宯): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723469. [妛夛 (慡崙)] (堦斒島墘) 僸傾儖儘儞巁峝壔僎儖傪梡偄偰BMP-2傪摫擖偟偨恖岺崪偺屻懁曽屌掕弍偵偍偗傞崪宍惉懀恑岠壥偺専摙. 崟揷峎媊1, 撪揷寬懢榊2, 彲巌恀懢榊2, 墶娭梇巌1, 媨忛惓峴2, 釼摗丂榡2, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723470. [妛夛 (慡崙)] (堦斒島墘) 曄宍惈娭愡徢偺妸枌慻怐偵偍偗傞旍枮嵶朎桼棃恄宱儁僾僠僪偺専摙. 崅揷丂尋1, 撪揷寬懢榊2, 寎丂丂妛1, 憡愳丂弤2, 娾悾丂戝2, 媨忛惓峴2, 堜忋丂尯2, 娭岥桾擵2, 戝娧桾巕3, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3昦懺丒恌椕宯): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723471. [妛夛 (慡崙)] (堦斒島墘) 尨敪惈崪慹闋徢儌僨儖偺嬝慻怐偵偍偗傞UCP2偺敪尰掅壓偲偦偺掅壓儊僇僯僘儉偺専摙. 彫嶳抭媣1, 撪揷寬懢榊2, 媨忛惓峴2, 揷郪丂椚2, 堜忋丂尯2, 摗姫庻巕, 戝嫶宑媣1, 娭岥桾擵2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723472. [妛夛 (慡崙)] (堦斒島墘) BMP-2娷桳嬊強峝壔僸傾儖儘儞巁僎儖傪梡偄偨峀斖埻崪寚懝廋暅朄偺桳梡惈. 彲巌恀懢榊1, 撪揷寬懢榊1, 揷郪丂椚1, 娭岥桾擵1, 堜忋丂尯1, 釼摗丂榡1, 媨忛惓峴1, 崟揷峎媊2, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723473. [妛夛 (慡崙)] (堦斒島墘) 儅僂僗戝戁崪擄帯惈崪愜儌僨儖偵偍偗傞BMP-2娷桳崅擹搙Poly (POG) n僎儖偺崪宍惉懀恑岠壥偺専摙. 崟揷峎媊1, 撪揷寬懢榊2, 彲巌恀懢榊2, 娭岥桾擵2, 媨忛惓峴2, 釼摗丂榡2, 懞揷岾桟1, 墶娭梇巌1, 彫嶳抭媣1, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723474. [妛夛 (慡崙)] (堦斒島墘) 壛楊偵敽偆TGF-兝偺敪尰尭彮偲CD206梲惈捙娫斅撪嵼惈儅僋儘僼傽乕僕偺尭彮偲偺娭楢惈偺専摙. 撪揷寬懢榊1, 愳媣曐曕1, 墶娭梇巌2, 媨忛惓峴1, 崟揷峎媊2, 堜忋丂尯1, 釼摗丂榡1, 娭岥桾擵1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723475. [妛夛 (慡崙)] (堦斒島墘) TGF-兝傪夘偟偨捙娫斅慻怐撪恄宱惉挿場巕偺敪尰忋徃婡峔偺専摙. 墶娭梇巌1, 撪揷寬懢榊2, 愳媣曐曕2, 媨忛惓峴2, 崟揷峎媊1, 堜忋丂尯2, 釼摗丂榡2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723476. [妛夛 (慡崙)] (堦斒島墘) M2儅僋儘僼傽乕僕暘壔偵偍偗傞TGF-兝偺栶妱偺専摙. 崟揷峎媊1, 撪揷寬懢榊2, 愳媣曐曕2, 媨忛惓峴2, 堜忋丂尯2, 墶娭梇巌1, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723477. [妛夛 (慡崙)] (堦斒島墘) 娭愡怬懝彎姵幰偺妸枌慻怐偵偍偗傞墛徢惈僒僀僩僇僀儞偺敪尰忋徃: 枛婜曄宍惈屢娭愡徢偲偺斾妑. 彫嶳抭媣1, 撪揷寬懢榊2, 暉搰寬夘2, 戝嫶宑媣1, 撪嶳彑暥3, 堜忋丂尯2, 戝娧桾巕4, 崅暯彯怢5, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3堛椕埨慡丒娗棟, 4昦懺丒恌椕宯, 5堛椕塹惗妛晹): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723478. [妛夛 (慡崙)] (堦斒島墘) 椉懁壓巿CT夋憸傪梡偄偨曄宍惈旼娭愡徢偵偍偗傞曅懁惈偺嬝検曄壔偲嬝椡曄壔偲偺娭楢惈偺専摙. 寎丂丂妛1, 撪揷寬懢榊2, 捤揷垷桾旤2, 憡愳丂弤2, 娾悾丂戝2, 崅栰徃懢榊2, 媨忛惓峴2, 娭岥桾擵2, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723479. [妛夛 (慡崙)] (堦斒島墘) 暃峛忬態儂儖儌儞偵傛傞墛徢惈僒僀僩僒僀僩僇僀儞, 恄宱惉挿場巕梷惂岠壥偺専摙亅扨夞搳梌偲斀暅搳梌偺嶌梡斾妑亅. 懞揷岾桟1, 撪揷寬懢榊2, 媨忛惓峴2, 揷郪丂椚2, 堜忋丂尯2, 彫嶳抭媣1, 愳媣曐曕2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723480. [妛夛 (慡崙)] (堦斒島墘) 擕娻嬊強崪揮堏儌僨儖偵懳偡傞acridine orange寣娗撪搳梌偲bisphosphonate偺岠壥. 搶奀椦椚, 媨崢彯媣, 杮嫿摴惗, 敂愳梇巌, 塱郪攷岾, 搚峕攷岾, 撪揷寬懢榊1, 憡愳丂弤1, 搰揷梞堦 (1惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723481. [妛夛 (慡崙)] (堦斒島墘) 儔僢僩恄宱懝彎儌僨儖偵懳偡傞僩儘儞價儞揧壛, 旕揧壛platelet-rich plasma偺捝妎夁晀梷惂岠壥偺斾妑. 岦堜柋峎, 撪揷寬懢榊1, 淎郪捈栫, 巙夑峃峗, 堫栄堦廏, 愜揷弮媣, 峕岥丂榓, 徏塝桟夘, 堜忋丂尯1, 崅憡徎巑1, 戝捁惛巌 (1惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723482. [妛夛 (慡崙)] (堦斒島墘) 枛徑恄宱忈奞偵偍偗傞V-set and transmembrane domain containing 4偺栶妱偺専摙. 墶娭梇巌1, 撪揷寬懢榊2, 岦堜柋峎, 寎丂丂妛1, 堜忋丂尯2, 媨忛惓峴2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723483. [妛夛 (慡崙)] (堦斒島墘) V-set and transmembrane domain containing 4偵傛傞儅僋儘僼傽乕僕妶惈惂屼婡峔偲妸枌墛傊偺娭梌偺専摙. 寎丂丂妛1, 撪揷寬懢榊2, 戝媣曐捈3, 徏杮弐塸4, 崅栰徃懢榊2, 崅揷丂尋1, 娾悾丂戝2, 憡愳丂弤2, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3幚摦, 4堛椕塹惗妛晹): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723484. [妛夛 (慡崙)] (堦斒島墘) 尐娭愡晄埨掕徢姵幰偺尐峛忋榬娭愡妸枌慻怐偱偼墛徢惈僒僀僩僇僀儞, 儅僋儘僼傽乕僕儅乕僇乕偺敪尰偑槾恑偟偰偄傞. 廆廳嬁巕1, 尒栚抭婭2, 撪揷寬懢榊2, 揷郪丂椚2, 拞榚廩復2, 愇堜戝曘1, 嵅摗丂夒3, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3柶塽): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723485. [妛夛 (慡崙)] (堦斒島墘) 壛楊偵敽偆銯斅TGF-兝嶻惗忋徃偼峈巁壔娭楢堚揱巕偺敪尰傪掅壓偝偣傞. 揷郪丂椚1, 撪揷寬懢榊1, 尒栚抭婭1, 拞榚廩復1, 廆廳嬁巕2, 愇堜戝曘2, 戝娧桾巕3, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3昦懺丒恌椕宯): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
723486. [妛夛 (慡崙)] (堦斒島墘) 銯斅抐楐姵幰偺妸枌慻怐偵偍偗傞NGF敪尰偲醬捝偺娭楢惈. 揷郪丂椚1, 尒栚抭婭1, 撪揷寬懢榊1, 柤憅捈廳, 拞榚廩復1, 廆廳嬁巕2, 愇堜戝曘2, 戝娧桾巕3, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3昦懺丒恌椕宯): 戞36夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2021/10/14-15), 嶰廳.
731017. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) Avenir Complete stem偺抁婜椪彴宱尡偲庤弍庤媄偺億僀儞僩. 暉搰寬夘 (惍奜): Zimmer Biomet Webinar (2021/4/8), Web奐嵜.
731018. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) Femoroacetabular impingement (FAI) 偺恌抐偲帯椕. 暉搰寬夘 (惍奜): 戞29夞憡柾尨崪慹闋徢尋媶夛 (2021/6/5), Web奐嵜.
731019. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 壔擽惈屢娭愡墛偵懳偡傞屢娭愡嬀帇壓庤弍. 暉搰寬夘 (惍奜): 戞36夞恄撧愳惍宍庤弍庤媄尋媶夛 (2021/7/9), Web奐嵜.
731020. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) Full HA coated Corail stem偺僐儞僙僾僩偲巊梡偵偍偗傞拲堄揰. 暉搰寬夘 (惍奜): 戞28夞Hip Forum (2021/7/30), 昹徏.
731021. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) Avenir stem偲偺堘偄. 暉搰寬夘 (惍奜): Salon de Corail (2021/7/31), Web奐嵜.
731022. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 惍宍奜壢偵偍偗傞MRSA姶愼徢帯椕-屢娭愡奜壢偺幚嵺. 撪嶳彑暥1,2 (1堛椕埨慡丒娗棟, 2惍奜): 姶愼徢 Virtual Meeting (2021/9/16), Web奐嵜.
731023. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 惍宍奜壢偵偍偗傞SSI懳嶔慡斒亅AST妶摦偐傜庤弍幒傑偱亅. 撪嶳彑暥1,2 (1堛椕埨慡丒娗棟, 2惍奜): 戞2夞擔杮奜壢姶愼徢妛夛摿暿僙儈僫乕 (2021/9/28), Web奐嵜.
731024. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 姲崪塒嵞抲姺偺帯椕愴棯. 撪嶳彑暥1,2 (1堛椕埨慡丒娗棟, 2惍奜): Zimmer Biomet RTCD THA 偍偗傞 Dual Mobility (2021/10/12), Web奐嵜.
731025. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 夞暅婜儕僴價儕僥乕僔儑儞昦堾偵偍偗傞崪慹闋徢恌椕. 暉搰寬夘 (惍奜): 埉壔惉僼傽乕儅婇嬈撪尋廋 (2022/1/20), Web奐嵜.
731026. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 僙儔僺僗僩偵揱偊偨偄亅屢娭愡幘姵偺恌抐偲帯椕亅昦懺夝庍偐傜抦偭偰偍偔傋偒庤弍傑偱亅. 暉搰寬夘 (惍奜): Professional Therapy Seminars (2022/2/5), Web奐嵜.
731027. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 挻壒攇偵傛傞崪愜帯椕偺婎慴偲椪彴. 愯晹丂寷 (惍奜): 戞159夞惙壀椪彴惍宍奜壢堛夛 (2022/3/10), Web奐嵜.
731028. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 愐捙曄宍偵懳偡傞帯椕愴棯亅醬捝傊偺懳張傪娷傔偰亅. 堜忋丂尯 (惍奜): Pain Expert Meeting (2022/3/22), Web奐嵜.
732067. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 愐捙庤弍偵偍偗傞庤弍晹埵姶愼儕僗僋偺梊應僣乕儖. 抮揷怣夘1, 堜忋丂尯1, 媨忛惓峴1, 拞郪弐擵1, 堜懞婱擵1, 敀郪塰庽1, 嶰懞桰桽1, 崅憡徎巑1, 擄攇岶摽 (1惍奜): 戞172夞恄撧愳惍宍嵭奞奜壢尋媶夛 (2021/7/10), 墶昹 (僴僀僽儕僢僪奐嵜).
732068. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 屢娭愡嬀偲THA. 暉搰寬夘1, 彫嶳抭媣1, 戝嫶宑媣2, 搚壆恀曚2, 釼摗峀庽2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞16夞擔杮屢娭愡嬀尋媶夛 (2021/9/4), Web奐嵜.
732069. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 崅搙崪寚懝傪桳偡傞恖岺屢娭愡嵞抲姺弍偺帯椕愴棯: 摨庬崪傪梡偄偨懳墳. 暉搰寬夘1, 撪嶳彑暥2, 崅暯彯怢3, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2堛椕埨慡丒娗棟, 3堛椕塹惗妛晹): 戞70夞搶擔杮惍宍嵭奞奜壢妛夛 (2021/9/18), 娾庤 (僴僀僽儕僢僪奐嵜).
732070. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 惉恖忋榬崪墦埵晹崪愜偺帯椕: 旾娭愡廃埻崪愜弍屻偵崌暪偟偨奜彎惈旾娭愡峉弅偺帯椕宱尡. 彆愳峗巑1,2, 彫徖尗帯2, 戝抾桰嵠2, 挰揷廃暯2, 崅憡徎巑2 (1椪彴夝朥嫵堢, 2惍奜): 173夞恄撧愳惍宍嵭奞奜壢尋媶夛 (2021/11/20), 墶昹 (僴僀僽儕僢僪奐嵜).
732071. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) Avenir Complete stem傪巊梡偟偨報徾 (悇偟億僀儞僩). 暉搰寬夘 (惍奜): 戞6夞HIT尋媶夛 (2022/2/26), 嫗搒 (僴僀僽儕僢僪奐嵜).
733151. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 戝戁崪暋崌崪愜偵偍偗傞嶰廳崪愜偺2椺 戝嶈桾搇1, 彲巌恀懢榊1, 徏塝峎惓2, 壨懞丂捈1, 嶰懞桰桽1, 曯尨岹徆, 崅憡徎巑1 (1惍奜, 2媬柦): 戞172夞恄撧愳惍宍嵭奞奜壢尋媶夛 (2021/7/10), 墶昹 (僴僀僽儕僢僪奐嵜).
733152. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 泺崪銫崪崪姴晹崪愜弍屻偵懌娭愡壥晹崪愜PER stage 4偺崌暪偑敾柧偟偨1椺. 徏尨巎朁1, 徏塝峎惓2, 壨懞丂捈1, 彲巌恀懢榊1, 曯尨岹徆, 崅憡徎巑1 (1惍奜, 2媬柦): 戞70夞搶擔杮惍宍嵭奞奜壢妛夛 (2021/9/17), 惙壀 (僴僀僽儕僢僪奐嵜).
733153. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摨庬崪傪梡偄偨Impaction bone grafting朄偵偰Coonrad-Morrey宆恖岺旾娭愡偺嵞抲姺弍傪巤峴偟偨娭愡儕僂儅僠偺1椺. 崅壀弮堦1, 彫徖尗帯1, 撪嶳彑暥1,2, 彆愳峗巑1,3, 戝抾桰嵠1, 崅憡徎巑1 (1惍奜, 2堛椕埨慡丒娗棟, 3椪彴夝朥嫵堢): 戞27夞恄撧愳忋巿奜壢尋媶夛 (2021/10/23), Web奐嵜.
733154. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 敪徢婡彉偺堎側傞摛忬嶰妏崪娭愡徢偺帯椕宱尡. 戝抾桰嵠1, 彆愳峗巑1,2, 彫徖尗帯1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜, 2椪彴夝朥嫵堢): 戞27夞恄撧愳忋巿尋媶夛 (2021/10/23), Web奐嵜.
733155. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 彫帣丒惵擭婜偵偍偗傞晄埨掕宆旾娭愡扙塒崪愜偺帯椕宱尡. 彆愳峗巑1,2, 彫徖尗帯2, 戝抾桰嵠2, 挰揷廃暯2, 尒栚抭婭2, 崅憡徎巑2 (1椪彴夝朥嫵堢, 2惍奜): 戞27夞恄撧愳忋巿尋媶夛 (2021/10/23), Web奐嵜.
733156. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 弍屻憗婜偵梊憐奜偺崪斀墳傪帵偟偨Full HA stem偺1椺. 暉搰寬夘1, 彫嶳抭媣2, 戝嫶宑媣2, 釼摗峀庽2, 搚壆恀曚2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞56夞娭搶屢娭愡崸榖夛 (2022/3/5), 搶嫗 (僴僀僽儕僢僪奐嵜).
733157. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 婎慴幘姵偺側偄惉恖偵敪惗偟偨椉懁拞巜怺巜孅嬝銯旂壓抐楐偺1椺. 栴栰攷擵1, 彫徖尗帯1, 彆愳峗巑1, 戝抾桰嵠1, 尒栚抭婭1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜): 戞62夞娭搶惍宍嵭奞奜壢妛夛 (2022/3/12), 搶嫗 (僴僀僽儕僢僪奐嵜).
'20擭搙埲慜暘
[妛弍榑暥]
'20-110020. [尨挊] Acceleration of bone formation using in situ-formed hyaluronan-hydrogel containing bone morphogenetic protein-2 in a mouse critical size bone defect model. Shoji S1, Uchida K1, Tazawa R1, Saito W1, Kuroda A2, Sekiguchi H1, Ishii D2, Inoue S2, Inoue G1, Takaso M1: Biomed Mater Eng 2021/1; 32 (4): 207-15. (彲巌恀懢榊1, 撪揷寬懢榊1, 揷郪丂椚1, 釼摗丂榡1, 崟揷峎媊2, 娭岥桾擵1, 愇堜戝曘2, 堜忋丂隳2, 堜忋丂尯1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
'20-110021. [尨挊] Limitation of the external glenohumeral joint rotation is associated with subacromial impingement syndrome, especially pain. Ishi D1, Kenmoku T2, Tazawa R2, Nakawaki M2, Nagura N, Muneshige K1, Saito K, Takaso M2: JSES Int 2021/3; 5 (3): 430-8. (愇堜戝曘1, 尒栚抭婭2, 揷郪丂椚2 拞榚堯復2, 廆廳嬁巕1, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜)
'20-310003. [徢椺曬崘] Polymicrobial Extensor Tenosynovitis Including Mycobacterium chelonae Caused by a Dog Bite: A Case Report. Minato S1, Sukegawa K2,3, Onuma K3, Otake Y1, Iida R, Takaso M3: JBJS Case Connect 2021/2; 11 (1): e20.00608. (柀嵅戙巕1, 彆愳峗巑2,3, 彫徖尗帯3, 戝抾桰嵠1, 崅憡徎巑3: 1戝妛堾堛椕宯尋媶壢, 2椪彴夝朥嫵堢尋, 3惍奜)
'20-310004. [徢椺曬崘] Displaced Isolated Coronal Shearing Fracture of theDisplaced isolated coronal shearing fracture of the trapezoid: a case report. Otake Y1, Sukegawa K1,2, Onuma K1, Machida S1, Iida R, Takaso M1: Case Reports Plast Surg Hand Surg 2021/3; 8 (1): 50-5. (戝抾桰嵠1, 彆愳峗巑1,2, 彫徖尗帯1, 挰揷廃暯1, 崅憡徎巑1: 1惍奜, 2椪彴夝朥嫵堢尋)
'20-320003. [徢椺曬崘] 娭愡儕僂儅僠偺娪暿偵偍偔傋偒旕寢妀惈峈巁嬠徢亅帯椕奐巒傑偱婜娫傪梫偟偨嫵堢揑側2徢椺亅. 戝抾桰嵠1, 彆愳峗巑1,2, 懡揷戱栴1, 彫徖尗帯1, 崅憡徎巑1 (1惍奜, 2椪彴夝朥嫵堢尋): 擔杮庤奜壢妛夛嶨帍 2020/9; 37 (5): 743-7.
'20-522004. [島嵗]亂摿廤: 崪愜偵懳偡傞愊嬌揑曐懚椕朄亃仭婎慴曇丂墫婎惈慄堐夎嵶朎憹怋場巕偺崪愜帯桙夁掱傊偺塭嬁. 撪揷寬懢榊 (惍奜): 椪彴惍宍奜壢 20213/; 56 (3): 247-51.
[挊丂彂]
'15-620001. [妛弍彂 (暘扴幏昅)]亂庡梫幘姵丒慡恎栐梾! 懱憖椕朄僆乕儖僽僢僋 傂偲傔偱傢偐傞岠壥揑側嬝偺巊偄曽亃3復 幚慔 偄偞懱憖偺巜摫亅幘姵丒徢忬偵偁傢偣偨懱憖亅丂02 尐偙傝丒尐捝丒旾捝偺懱憖, p.50-7. 尒栚抭婭 (惍奜), 曇: 崅暯彯怢, 儊僕僇儖價儏乕幮, 搶嫗, 2016/3敪峴.
'19-620001. [妛弍彂 (暘扴幏昅)]亂惍宍奜壢幘姵偺儕僴價儕僥乕僔儑儞嵟慜慄 (Journal of Clinical Rehabilitation 28姫椪帪憹姧崋)亃尐娭愡廃埻墛, p.613-620. 尒栚抭婭 (惍奜), 堛帟栻弌斉, 搶嫗, 2019/6敪峴.
'19-620002. [妛弍彂 (暘扴幏昅)]亂崱擔偺幘姵帿揟 Current Decision Support亃銯抐楐 (庤晹). 彆愳峗巑1,2 (1椪彴夝朥嫵堢, 2惍奜), 僾儗僔僕儑儞, 2019敪峴.
'19-620003. [妛弍彂 (暘扴幏昅)]亂崱擔偺幘姵帿揟 Current Decision Support亃扙塒偲垷扙塒 (庤晹). 彆愳峗巑1,2 (1椪彴夝朥嫵堢, 2惍奜), 僾儗僔僕儑儞, 2019敪峴.
'20-620002. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓 2021亃18. 惍宍奜壢幘姵丂旾娭愡晄埨掕徢, p.1142-3. 尒栚抭婭 (惍奜), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2021/1敪峴.
[妛夛丒尋媶夛摍]
'20-723028. [妛夛 (慡崙)] (堦斒島墘) 旾娭愡屻奜懁夞慁晄埨掕惈傪桳偟偨彫帣忋榬崪奜懁梓sleeve崪愜偺1椺. 崱栰梇懢1, 彆愳峗巑1,2, 彫徖尗帯1, 戝抾桰嵠1, 挰揷廃暯1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜, 2椪彴夝朥嫵堢): 戞33夞擔杮旾娭愡妛夛妛弍廤夛 (2021/2/12), 戝嶃 (僴僀僽儕僢僪奐嵜).
'20-733012. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 愺巜孅嬝銯旂壓抐楐傪崌暪偟偨Type 5a彫巜怺巜孅嬝銯楐棧懝彎偺1椺亅晄埨掕側枛愡崪墶崪愜偲楐棧崪愜偵懳偡傞hook plate朄亅. 斞揷浠梌, 彆愳峗巑1,2, 彫徖尗帯2, 戝抾桰嵠2, 崅憡徎巑2 (1椪彴夝朥嫵堢, 2惍奜): 戞35夞搶擔杮庤奜壢尋媶夛 (2021/1/30), 塅搒媨.
'20-733013. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 將欩彎屻偵敪徢偟偨Mycobacterium chelonae偵傛傞庤晹怢嬝銯銯忊妸枌墛偺1椺. 柀嵅戙巕2, 彆愳峗巑1,2, 彫徖尗帯2, 戝抾桰嵠2, 挰揷廃暯2, 尒栚抭婭2, 崅憡徎巑2 (1惍奜, 2椪彴夝朥嫵堢): 戞35夞搶擔杮庤奜壢尋媶夛 (2021/1/30), 塅搒媨.
'20-733014. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 惍暅屻偺晄埨掕惈偵懳偟APTUS Hand 偵傛傞堦婜揑憂撪屌掕傪峴偭偨捖媽惈寧忬崪廃埻扙塒偺堦椺. 旍棷愳峆暯2, 戝抾桰嵠2, 彆愳峗巑1,2, 彫徖尗帯2, 崅憡徎巑2 (1惍奜, 2椪彴夝朥嫵堢): 戞26夞杒棦丒摗偑媢塣摦婍幘姵僼僅乕儔儉 (2021/3/7), 憡柾尨.
'20-733015. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恌抐丒帯椕偵擄廰偟偨庤奜壢椞堟偍偗傞旕寢妀惈峈巁嬠徢亅3椺曬崘亅. 崱栰梇懢2, 彆愳峗巑1,2, 彫徖尗帯2, 戝抾桰嵠2, 柀嵅戙巕2, 墶娭梇巌3, 崅憡徎巑2 (1惍奜, 2椪彴夝朥嫵堢, 3戝妛堾堛椕宯尋媶壢): 戞26夞杒棦丒摗偑媢塣摦婍幘姵僼僅乕儔儉 (2021/3/7), 憡柾尨.
宍惉奜壢丒旤梕奜壢妛
[妛弍榑暥]
110354. [尨挊] Evaluation of elastin fibres in young and aged eyelids and abdominal skin using computational 3D structural analysis. Tohgasaki T, Kondo S, Nishizawa S, Ishiwatari S, Sakurai T, Ishikawa S1, Takeda A1: Skin Health Dis 2021/6; 1 (4): e58. (愇愳怱夘1, 晲揷丂孾1: 1宍惉丒旤奜)
110355. [尨挊] Differentiation and proliferation potencies of human bone tissue-derived mesenchymal stromal cells (hBT-MSCs) after long-term cryopreservation 亅Comparison among cells stored for 1, 5, 10, 15, and 20 years. Sugimoto Y1, Yamazaki Y1, Moriyama K1, Sugimoto T1, Kumazawa K2, Baba K1,3, Sone Y4, Takeda A1: Regen Ther 2021/9; 18: 363-71. (悪杮壚崄1, 嶳嶈埨惏1, 怷嶳榓偺1, 悪杮岶擵1, 孎郪寷堦2, 攏応崄巕1,3, 慮崻桼旤巕4, 晲揷丂孾1: 1宍惉丒旤奜, 2媬柦, 3杒棦戝妛儊僨傿僇儖僙儞僞乕, 4恌椕丒昦懺宯)
110356. [尨挊] Elastin microfibril interface-located protein 1 and its catabolic enzyme, cathepsin K, regulate the age-related structure of elastic fibers in the skin. Kondo S, Tohgasaki T, Shiga S, Nishizawa S, Ishiwatari S, Ishikawa S1, Takeda A1, Sakurai T: J Cosmet Dermatol 2022/10; 21 (10): 4796-804. doi: 10.1111/jocd.14789. Epub 2022 Feb 1. (愇愳怱夘1, 晲揷丂孾1: 1宍惉丒旤奜)
120017. [尨挊] 儊僨傿僇儖僜儚儞僄僗僥僥傿僢僋偺栶妱偲偦偺桳岠惈偵偮偄偰亅杒棦戝妛宍惉奜壢丒旤梕奜壢偱偺庢傝慻傒亅. 悪杮壚崄1, 搰憅峃恖1, 崅嶳撝巕, 悪杮岶擵1, 搰忋榓懃, 娳撪孨巬, 埨戭儖儈巕, 晲揷丂孾1 (1宍惉丒旤奜): 擔旤奜曬 2021/9; 43 (3): 107-19.
310047. [徢椺曬崘] Clinical pitfall with Chievitz's organ: A case report of tongue cancer patient. Kimizuka S1, Fijihara H, Ito Y, Takeda A1, Yamada H, Hamada Y: J Oral Maxillofac Surg, Med, Pathol 2021/5; 33 (3): 272-5. (孨捤岾巕1, 晲揷丂孾1: 1宍惉丒旤奜)
310048. [徢椺曬崘] A patient with macrodystrophia lipomatosa bilaterally affecting the entire upper extremity: reporting of a rare case and literature review. Baba K1,2, Kashiwagi S2, Nemoto M2, Takeda A2, Fukumoto K, Uchinuma E: Case Reports Plast Surg Hand Surg 2021/6; 8 (1): 1-7. (攏応崄巕1,2, 攼栘怲栫2, 崻杮丂廩2, 晲揷丂孾2: 1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜)
310049. [徢椺曬崘] A Histological Evaluation of Artificial Dermal Scaffold Used in Micrograft Treatment: A Case Study of Micrograft and NPWT Performed on a Postoperative Ulcer Formation after Tumor Resection. Niimi Y1, Baba K1,2, Tsuchida M1, Takeda A1: Medicina (Kaunas) 2022/1; 58 (1): 73. (怴旤梇戝1, 攏応崄巕1,2, 搚揷棟巕1, 晲揷丂孾1: 1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕)
310050. [徢椺曬崘] Devised coronoidectomy with zygomaplasty for coronoid process hyperplasia of the mandible. Kimizuka S1, Fijihara H, Takeda A1, Hamada Y: Oral Maxillofac Surg 2022/1-3; 5: 100233. (孨捤岾巕1, 晲揷丂孾1: 1宍惉丒旤奜)
320009. [徢椺曬崘] 壓妠垷慡揈屻偵僇僗僞儉儊僀僪僠僞儞僩儗乕偲PCBM偵傛傞壓妠崪嵞寶偲帟壢僀儞僾儔儞僩偵傛傞欩崌嵞寶傪峴偭偨1椺. 杒瀶廏庽, 拞壀堦晀, 孨捤岾巕1, 嶳揷廏揟, 挿扟晹廩旻, 愇捤拤棙, 愳岥峗巌, 郷揷椙庽 (1宍惉丒旤奜): 擔杮妠婄柺僀儞僾儔儞僩妛夛帍 2021/4; 20 (1): 45-50.
320010. [徢椺曬崘] Van der Wonde徢岓孮偺4椺. 塅夑恄姁旤1, 悪杮岶擵1, 廐杮曯崕, 悪杮壚崄1, 孨捤岾巕1, 晲揷丂孾1 (1宍惉丒旤奜): 宍惉奜壢 2021/5; 64 (5): 583-9.
320011. [徢椺曬崘] 暊枌摟愅僇僥乕僥儖旂壓僩儞僱儖姶愼偵懳偟僇僥乕僥儖傪壏懚偟偊偨1椺亅暊捈嬝丒嬝枌曎偲廃婜揑帩懕燇棳暪梡嬊強堿埑暵嵔椕朄傪梡偄偨怴偨側帯椕朄亅. 揷拞悙婓1,2, 攏応崄巕1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜): 擔杮怑嬈丒嵭奞堛妛夛帍 2021/11; 69 (6): 285-9.
320012. [徢椺曬崘] 扙棊偟偨姤摦柆僗僥儞僩偑烎崪摦柆暻偵慂捠偟巆棷偟偨徢椺偵懳偡傞奜壢揑帯椕宱尡. 搚揷棟巕1, 怴旤梇戝1, 攏応崄巕1, 嵅摗擵弐2 (1宍惉丒旤奜, 2屇媧婍奜): 嶉嬍導堛妛夛嶨帍 2022/3; 56 (2): 471-5.
522533. [島嵗]亂摿廤: 儁僢僩欩憂傊偺弶婜帯椕偲婡擻丒惍梕偺夵慞 [3]亅婄柺偺慻怐寚懝傪敽偆僀僰欩憂 (2) 岥怬埲奜亅亃旲梼寚懝傪敽偆僀僰欩憂偵懳偟偰旲怬峚旂曎偵傛傞嵞寶傪峴偭偨1椺. 忋尨棟宐1, 崻杮丂廩1, 悾嶈峎堦楴1, 攏応崄巕1, 忛壓丂峎1, 晲揷丂孾1 (1宍惉丒旤奜): 宍惉奜壢 2021/4; 64 (4): 403-8.
[妛夛丒尋媶夛摍]
713045. [妛夛 (崙嵺)] (堦斒島墘) Effectiveness of W-plasty scar revision after self-harm scars of arms. Takeda A1, Suzuki T, Sakata Y1, Sukegawa H1: The 2nd World Congress of Global Scar Society with Scar Academy and Japan Scar Workshop (2021/12/19), Yokohama, Japan. (晲揷丂孾1, 嶁揷朏梞1, 彆愳桾榓1: 1宍惉丒旤奜)
722172. [妛夛 (慡崙)] (僔儞億僕僂儉) 暋悢庤巜懝彎偵懳偡傞捛壛帯椕偺岠壥偲尷奅. 崻杮丂廩1, 孎郪寷堦1, 攼栘怲栫1, 榓搨弮暯1, 娾愳偝偍傝2, 晲揷丂孾1 (1宍惉丒旤奜, 2媬柦): 戞64夞擔杮宍惉奜壢妛夛憤夛丒妛弍廤夛 (2021/4/14), 搶嫗 (僴僀僽儕僢僪奐嵜).
722173. [妛夛 (慡崙)] (僔儞億僕僂儉) 嵙柵庤偵偍偗傞懳棫婡擻忈奞偲2師庤弍. 崻杮丂廩1, 孎郪寷堦1, 攼栘怲栫1, 彆愳桾榓1, 嶁揷朏梞1, 晲揷丂孾1 (1宍惉丒旤奜): 戞64夞擔杮庤奜壢妛夛妛弍廤夛 (2021/4/23), 挿嶈 (僴僀僽儕僢僪奐嵜).
722174. [妛夛 (慡崙)] (僷僱儖) 弍拞挷惍偵傛傞弍屻奐豳埵抲偺悇掕偲幚嵺. 戝帨栱桾擵, 崅栘惤巌, 屆嶳搊棽, 晲揷丂孾1 (1宍惉丒旤奜): 擔杮旤梕奜壢妛夛 (JSAPS) 戞141夞妛弍廤夛 (2021/7/3), 恄屗.
723487. [妛夛 (慡崙)] (堦斒島墘) 儊僨傿僇儖僜儚儞僄僗僥僥傿僢僋奜棃偺庢傝慻傒偵偮偄偰. 悪杮壚崄1, 搰憅峃恖1, 崅嶳撝巕, 悪杮岶擵1, 搰忋榓懃, 娳撪孨巬, 埨戭儖儈巕, 晲揷丂孾1 (1宍惉丒旤奜): 戞64夞擔杮宍惉奜壢妛夛憤夛丒妛弍廤夛 (2021/4/14), 搶嫗 (僴僀僽儕僢僪奐嵜).
723488. [妛夛 (慡崙)] (堦斒島墘) 懡敪婄柺崪崪愜偵偍偗傞懸婡揑椫忬峛忬娫枌愗奐偺桳梡惈. 孨捤岾巕1, 孎郪寷堦1, 娾愳偝偍傝2, 悪杮岶擵1, 悪杮壚崄1, 晲揷丂孾1 (1宍惉丒旤奜, 2媬柦): 戞64夞擔杮宍惉奜壢妛夛憤夛丒妛弍廤夛 (2021/4/14), 搶嫗 (僴僀僽儕僢僪奐嵜).
723489. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞婄柺懡敪崪愜偺帯椕愴棯亅恌椕懱惂丒庤弍曽朄偺尰忬亅. 孎郪寷堦1, 榓搨弮暯1, 娾愳偝偍傝2, 悪杮岶擵1, 悪杮壚崄1, 孨捤岾巕1, 晲揷丂孾1 (1宍惉丒旤奜, 2媬柦): 戞64夞擔杮宍惉奜壢妛夛憤夛丒妛弍廤夛 (2021/4/14), 搶嫗 (僴僀僽儕僢僪奐嵜).
723490. [妛夛 (慡崙)] (億僗僞乕) 嵍壓戁偵敪徢偟偨埆惈擃晹庮釃偺1椺. 堦巵弐悽, 嶳揷捈恖1, 晲揷丂孾1 (1宍惉丒旤奜): 戞64夞擔杮宍惉奜壢妛夛憤夛丒妛弍廤夛 (2021/4/14), 搶嫗 (僴僀僽儕僢僪奐嵜).
723491. [妛夛 (慡崙)] (億僗僞乕) 擄帯惈捵釃偵懳偡傞micrograft偺帯椕宱尡亅13椺偺専摙. 攏応崄巕1,2, 搚揷棟巕2, 怴旤梇戝2, 崻杮丂廩2, 愇崟嫥巎, 晲揷丂孾2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜): 戞64夞擔杮宍惉奜壢妛夛憤夛丒妛弍廤夛 (2021/4/14), 搶嫗 (僴僀僽儕僢僪奐嵜).
723492. [妛夛 (慡崙)] (億僗僞乕) 宱旂揑姤摦柆僀儞僞乕儀儞僔儑儞屻烎崪摦柆堎暔巆懚徢椺傊偺奜壢揑帯椕夘擖偺宱尡. 搚揷棟巕1, 怴旤梇戝1, 攏応崄巕1,2, 崻杮丂廩1, 晲揷丂孾1 (1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞64夞擔杮宍惉奜壢妛夛憤夛丒妛弍廤夛 (2021/4/14), 搶嫗 (僴僀僽儕僢僪奐嵜).
723493. [妛夛 (慡崙)] (堦斒島墘) 庤巜旂晢擃晹慻怐寚懝偵懳偡傞屻泺崪摦柆傪寣娗宻偲偡傞梀棧旂曎偺桳梡惈. 孎郪寷堦1, 桘堜嵅宐巕1, 怴旤桾戝1, 彆愳桾榓1, 幝嶈抭岞, 攼栘怲栫1, 崻杮丂廩1, 晲揷丂孾1 (1宍惉丒旤奜): 戞64夞擔杮庤奜壢妛夛妛弍廤夛 (2021/4/23), 挿嶈 (僴僀僽儕僢僪奐嵜).
723494. [妛夛 (慡崙)] (堦斒島墘) 杒棦戝妛宍惉奜壢丒旤梕奜壢偺怬妠岥奧楐怴婯姵幰偺椪彴摑寁揑専摙, 愭揤堎忢偺崌暪偵娭偟偰. 嶁揷朏梞1, 悪杮岶擵1, 悪杮壚崄1, 孨捤岾巕1, 愇搉桋晇, 崅嫶堦惤, 悾嶈峎堦榊1, 嶳嶈埨惏, 彆愳桾榓1, 搚揷棟巕1, 桘堜嵅宐巕1, 晲揷丂孾1 (1宍惉丒旤奜): 戞45夞擔杮岥奧楐妛夛憤夛丒妛弍廤夛 (2021/5/20), Web奐嵜.
723495. [妛夛 (慡崙)] (堦斒島墘) 杒棦戝妛宍惉奜壢丒旤梕奜壢偺怬妠岥奧楐怴婯姵幰10擭娫偺摦岦. 悪杮岶擵1, 悪杮壚崄1, 孨捤岾巕1, 愇搉桋晇, 崅嫶堦惤, 悾嶈峎堦榊1, 嶳嶈埨惏1, 嶁揷朏梞1, 彆愳桾榓1, 搚揷棟巕1, 桘堜嵅宐巕1, 晲揷丂孾1 (1宍惉丒旤奜): 戞45夞擔杮岥奧楐妛夛憤夛丒妛弍廤夛 (2021/5/20), Web奐嵜.
723496. [妛夛 (慡崙)] (堦斒島墘) 杒棦戝妛宍惉奜壢丒旤梕奜壢偵偍偗傞夁嫀1擭娫偺岥怬楐丒岥奧楐姵幰偺挷嵏. 孨捤岾巕1, 悪杮岶擵1, 悪杮壚崄1, 嶁揷朏梞1, 彆愳桾榓1, 搚揷棟巕1, 桘堜嵅宐巕1, 晲揷丂孾1 (1宍惉丒旤奜): 戞45夞擔杮岥奧楐妛夛憤夛丒妛弍廤夛 (2021/5/20), Web奐嵜.
723497. [妛夛 (慡崙)] (堦斒島墘) 椉懁將帟偺奐憢尅堷傪峴偭偨嵍懁怬妠岥奧楐徢椺. 愇搉桋晇, 崅嫶堦惤, 孨捤岾巕1, 嶳嶈埨惏1, 悪杮壚崄1, 悪杮岶擵1, 晲揷丂孾1, 悾嶈峎堦榊1 (1宍惉丒旤奜): 戞45夞擔杮岥奧楐妛夛丒妛弍廤夛 (2021/5/20), Web奐嵜.
723498. [妛夛 (慡崙)] (堦斒島墘) 曅懁惈怬妠岥奧楐姵幰偵妠嫺惓庤弍傪峴偭偨1椺. 孨捤岾巕1, 悪杮岶擵1, 愇搉桋晇, 崅嫶堦惤, 悪杮壚崄1, 晲揷丂孾1 (1宍惉丒旤奜): 戞31夞擔杮妠曄宍徢妛夛憤夛丒妛弍戝夛 (2021/6/11), 愬戜 (僴僀僽儕僢僪奐嵜).
723499. [妛夛 (慡崙)] (堦斒島墘) Cloud based telemedicine and telementorning using extended reality in orthognathic surgery. 晉揷戝夘, 嵅屗愳愮斂, 栰拞嵤壛, 孨捤岾巕1, 媨嶈朚晇, 悰尨棾桟, 拞栰椱旤, 搚壆悡柧, 晉揷桼旤巕, 嶳杮悞峅, 悪杮恀庽 (1宍惉丒旤奜): 戞31夞擔杮妠曄宍徢妛夛憤夛丒妛弍戝夛 (2021/6/11), 愬戜 (僴僀僽儕僢僪奐嵜).
723500. [妛夛 (慡崙)] (堦斒島墘) 僐儔乕僎儞廋忺儕億僜乕儉娷桳旂晢壔徬椏偺憂彎摍帯椕屻敡夞暅曗彆岠壥偵傛傞柍嶌堊壔僾儔僙儃懳徠擇廳栍専僴乕僼僒僀僪斾妑帋尡. 悪杮壚崄1, 悪杮岶擵1, 彫椦惓峗, 堜忋塱夘, 晲揷丂孾1 (1宍惉丒旤奜): 戞21夞擔杮峈壛楊堛妛夛憤夛 (2021/6/25), 嫗搒 (僴僀僽儕僢僪奐嵜).
723501. [妛夛 (慡崙)] (堦斒島墘) 妠崪桼棃偍傛傃挵崪桼棃娫梩宯嵶朎偺懡暘壔擻偺嵎堎偵偮偄偰. 怷嶳榓偺1, 嶳嶈埨惏1, 慮崻桼旤巕2, 悪杮壚崄1, 悪杮岶擵1, 孎郪寷堦1, 攏応崄巕1,3, 晲揷丂孾1 (1宍惉丒旤奜, 2昦懺丒恌椕宯, 3杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞30夞擔杮宍惉奜壢妛夛婎慴妛弍廤夛 (2021/10/7), 怴廻 (僴僀僽儕僢僪奐嵜).
723502. [妛夛 (慡崙)] (堦斒島墘) 鋊懷桼棃娫梩宯嵶朎偺慻怐宍惉擻偺専摙亅摉嫵幒偵偍偗傞夁嫀10擭娫偺憤妵亅. 攏応崄巕1,2, 嶳嶈埨惏2, 慮崻桼旤巕3, 悪杮壚崄2, 怷嶳榓偺2, 悪杮岶擵2, 孎郪寷堦2, 晲揷丂孾2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜, 3昦懺丒恌椕宯): 戞30夞擔杮宍惉奜壢妛夛婎慴妛弍廤夛 (2021/10/8), 怴廻 (僴僀僽儕僢僪奐嵜).
723503. [妛夛 (慡崙)] (堦斒島墘) 摉壢偵偍偗傞擄帯惈捵釃偵懳偡傞micro graft偺帯椕宱尡亅25徢椺偺曬崘亅. 桘堜嵅宐巕1, 怴旤梇戝1, 攏応崄巕1 (1宍惉丒旤奜): 戞30夞擔杮宍惉奜壢妛夛婎慴妛弍廤夛 (2021/10/7-8), 搶嫗.
723504. [妛夛 (慡崙)] (堦斒島墘) 峀斖埻側忋妠崪寚懝偵懳偟偰, 挵崪僽儘僢僋堏怉偲僀儞僾儔儞僩偵傛傞妠崪欩崌嵞寶傪峴偭偨1椺. 孨捤岾巕1, 悪杮岶擵1, 孎郪寷堦1, 晲揷丂孾1 (1宍惉丒旤奜): 戞39夞擔杮摢奧妠婄柺奜壢妛夛妛弍廤夛 (2021/11/11), 搶嫗 (僴僀僽儕僢僪奐嵜).
723505. [妛夛 (慡崙)] (堦斒島墘) Swinging Eyelid Approach偲宱椳媢愗奐偵傛傞娽鈢廃埻崪愜庤弍偺桳梡惈. 孎郪寷堦1, 彆愳桾榓1, 嶁揷朏梞1, 怴旤梇戝1, 悪杮壚崄1, 悪杮岶擵1, 孨捤岾巕1, 晲揷丂孾1 (1宍惉丒旤奜): 戞39夞擔杮摢奧妠婄柺奜壢妛夛妛弍廤夛 (2021/11/11), 搶嫗 (僴僀僽儕僢僪奐嵜).
723506. [妛夛 (慡崙)] (堦斒島墘) 杒棦戝妛昦堾宍惉奜壢丒旤梕奜壢偵偍偗傞夁嫀1擭娫偺岥怬楐丒岥奧楐姵幰偺挷嵏. 孨捤岾巕1, 孎郪寷堦1 (1宍惉丒旤奜): 戞66夞岞塿幮抍朄恖擔杮岥峯奜壢妛夛憤夛丒妛弍戝夛 (2021/11/12), 愮梩 (僴僀僽儕僢僪奐嵜).
723507. [妛夛 (慡崙)] (堦斒島墘) 崪墑挿婍傪梡偄偨婄柺懡敪崪愜徢椺偺帯椕宱尡. 孨捤岾巕1, 孎郪寷堦1 (1宍惉丒旤奜): 戞66夞岞塿幮抍朄恖擔杮岥峯奜壢妛夛憤夛丒妛弍戝夛 (2021/11/12), 愮梩 (僴僀僽儕僢僪奐嵜).
723508. [妛夛 (慡崙)] (堦斒島墘) 尨敪惈泓鈢懡娋徢偵懳偡傞僜僼僺儘僯僂儉廘壔暔奜梡嵻偺巊梡宱尡. 攏応崄巕1, 桘堜嵅宐巕1, 揷拞悙婓1 (1宍惉丒旤奜): 戞69夞擔杮怑嬈丒嵭奞堛妛夛妛弍戝夛 (2021/11/27-28), Web奐嵜.
723509. [妛夛 (慡崙)] (堦斒島墘) micrograft傪梡偄偨壓巿擄帯惈捵釃偺帯椕宱尡. 桘堜嵅宐巕1, 揷拞悙婓1, 攏応崄巕1 (1宍惉丒旤奜): 戞69夞擔杮怑嬈丒嵭奞堛妛夛妛弍戝夛 (2021/11/27-28), Web奐嵜.
733158. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 寢挵慂岴暊暻慂攋偵傛傝惗偠偨暊暻擽釃偺帯椕宱尡亅NPWTid偲micrograft傪梡偄偰帯桙偟偊偨1椺亅. 桘堜嵅宐巕1, 怴旤梇戝1, 攏応崄巕1 (1宍惉丒旤奜): 娭搶宍惉奜壢妛夛戞300夞搶嫗抧曽夛 (2021/7/3), Web奐嵜.
733159. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 婄柺旕懳徧徢椺偵懳偟偰椫妔宍懺傪峫椂偟偰妠嫺惓庤弍傪峴偭偨1椺. 孨捤岾巕 (宍惉丒旤奜): 戞24夞杒棦宍惉奜壢僼僅乕儔儉 (2021/7/17), 憡柾尨.
733160. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Dingman朄偲椫妔宍惉傪暪jaw surgery偱椙岲側寢壥偑摼傜傟偨廳搙壓妠旍戝偺徢椺. 拞杒怣徍, 嶳嶈埨惏, 暫摢揙栫, 屆嶳搊棽, 孨捤岾巕1, 悪杮岶擵1, 晲揷丂孾1, 暉嶳塸帯 (1宍惉丒旤奜): 戞24夞杒棦宍惉奜壢僼僅乕儔儉 (2021/7/17), 憡柾尨.
733161. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恌抐偵嬯椂偟偨奜彎惈忋娽鈢楐徢岓孮1椺. 崅丂怳壠, 娾愳偝偍傝1, 怴旤梇戝2, 孎郪寷堦2, 晲揷丂孾2 (1媬柦, 2宍惉丒旤奜): 戞24夞杒棦宍惉奜壢僼僅乕儔儉 (2021/7/17), 憡柾尨.
733162. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 栚傕偲偺僄僀僕儞僌傊偺傾僾儘乕僠. 晲揷丂孾 (宍惉丒旤奜): 戞14夞恄撧愳僋儘僗僆乕僶乕僔儞億僕僂儉 (2022/2/5), 墶昹 (僴僀僽儕僢僪奐嵜).
733163. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 媫惈斈敪惈暊枌墛弍屻憂姶愼 (SSI) 偱惗偠偨捵釃偵懳偡傞micrograft偺帯椕宱尡. 崱懞丂弜1, 桘堜嵅宐巕1, 枼塝岹擵2, 攏応崄巕1, 崅嫶掯恖3, 嵅摗擵弐4 (1宍惉丒旤奜, 2壓晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4屇媧婍奜): 戞59夞嶉嬍導堛妛夛憤夛 (2022/2/27), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110022. [尨挊] RNA-sequencing reveals positional memory of multipotent mesenchymal stromal cells from oral and maxillofacial tissue transcriptomes. Onizuka S, Yamazaki Y1, Park SJ, Sugimoto T1, Sone Y2, Sj歲vist S, Usui M, Takeda A1, Nakai K, Nakashima K, Iwata T: BMC Genomics 2020/6; 21 (1): 417. (嶳嶈埨惏1, 悪杮岶擵1, 慮崻桼旤巕2, 晲揷丂孾1: 1宍惉丒旤奜, 2昦懺丒恌椕宯)
'20-320004. [徢椺曬崘] 婄柺旕懳徧徢椺偵懳偟偰椫妔宍懺傪峫椂偟偰妠嫺惓庤弍傪峴偭偨1椺. 孨捤岾巕1, 拞杒怣徍, 嶳嶈埨惏1, 晎愳弐旻, 悪杮壚崄1, 悪杮岶擵1, 晲揷丂孾1 (1宍惉丒旤奜): 擔旤奜曬 2021/3; 43 (1): 12-9.
[妛夛丒尋媶夛摍]
'20-722004. [妛夛 (慡崙)] (僔儞億僕僂儉)栄敮偺惍梕惈偵偮偄偰: 宍惉奜壢堛偺棫応偐傜. 晲揷丂孾1, 悪杮岶擵1 (1宍惉丒旤奜): 戞13夞擔杮惍梕擼恄宱奜壢妛夛 (JSAN2020) (2020/9/30), 墶昹 (僴僀僽儕僢僪奐嵜).
'20-722005. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 抝惈宆扙栄徢偺帯椕尷奅傪嵞惗堛椕媄弍偱挧愴偡傞. 嵅摗柧抝, 桍郪惓擵, 搰憅峃恖1, 愇愳怱夘1, 怷嶳榓偺1, 壛摗払栫, 婱巙榓惗, 晲揷丂孾1 (1宍惉丒旤奜): 戞38夞擔杮摢奧妠婄柺奜壢妛夛妛弍廤夛 (2020/11/12-13), 搶嫗 (僴僀僽儕僢僪奐嵜).
'20-722006. [妛夛 (慡崙)] (僔儞億僕僂儉) 娽鈢帀朾愗彍傪暪梡偟偨杽杤幃廳豳弍偺桳梡惈偺専摙. 庰堜捈旻, 栴戲宑巎, 晲揷丂孾1 (1宍惉丒旤奜): 戞43夞擔杮旤梕奜壢妛夛憤夛 (2021/2/25), 杒嬨廈.
'20-723029. [妛夛 (慡崙)] (堦斒島墘) 堿晹擕朳奜Paget昦弍屻偵敪惗偟偨曻幩慄桿敪擏庮偺1椺. 幝嶈抭岞, 攼栘怲栫1, 晲揷丂孾1 (1宍惉丒旤奜): 戞53夞擔杮惍宍奜壢妛夛崪丒擃晹庮釃妛弍廤夛 (2020/9/11), Web奐嵜.
'20-733016. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嫻妔弌岥徢岓孮條徢忬傪掓偟偨嵍戞1榏崪愭揤堎忢偺1椺. 崻杮丂廩 (宍惉丒旤奜): 戞17夞娭搶忋巿愭揤堎忢徢椺専摙夛 (2021/1/21), Web奐嵜.
旂晢壢妛
[妛弍榑暥]
110357. [尨挊] Hair-Follicle-Associated Pluripotent (HAP) Stem Cells Can Extensively Differentiate to Tyrosine-Hydroxylase-Expressing Dopamine-Secreting Neurons. Yamane M, Takaoka N1, Obara K1, Shirai K1, Aki R1, Hamada Y2, Arakawa N, Hoffman RM, Amoh Y1: Cells 2021/4; 10 (4): 864. (崅壀撧撨巕1, 彫尨岹嵠1, 敀堜嫗旤1, 埨錣椙堦1, 昹揷桽巕2, 揤塇峃擵1: 1旂晢, 2昦懺丒恌椕宯)
120018. [尨挊] 摢晹寣娗擏庮嬊強嵞敪椺偵懳偡傞僪僉僜儖價僔儞扨撈椕朄. 帞徖幚桪1, 憹郪恀幚巕1, 崅壀撧撨巕1, 敀堜嫗旤1, 憗揷丂奿2, 桍郪岹恖, 揤塇峃擵1 (1旂晢, 2曻幩慄 (庮釃)): 擔杮旂晢壢妛夛嶨帍 2021/11; 131 (12): 2589-93.
210002. [弨尨挊] Successful treatment of non-AIDS Kaposi's sarcoma with eribulin. Masuzawa M1, Yamashita K2, Horigome Y3, Amoh Y1: J Dermatol 2021/7; 48 (7): e345-6. (憹郪恀幚巕1, 嶳壓榓栫2, 杧暷桟堦3, 揤塇峃擵1: 1旂晢, 2昦棟晹, 3寣塼撪)
320013. [徢椺曬崘]亂摿廤: 忋旂宯庮釃亃HPV16宆偑専弌偝傟偨Queyrat峠怓旍岤徢偺1椺. 奆愳戝曘1, 彫尨岹嵠1, 敀堜嫗旤1, 揷曈寬堦1, 揤塇峃擵1 (1旂晢): 旂晢壢偺椪彴 2021/4; 63 (4): 445-8.
522534. [島嵗]亂摿廤: 寣娗惈庮釃亃摢晹寣娗擏庮攛揮堏偵傛傞嵞敪惈婥嫻偺帯椕愴棯亅僷僝僷僯僽偲嫻峯嬀壓攛晹暘愗彍弍偑憈岠偟偨徢椺亅. 憹郪恀幚巕1, 嶰堜丂垽2, 椦丂徦巕2, 墫尒丂榓2, 憹揷抭惉3, 揤塇峃擵1 (1旂晢, 2屇媧婍奜, 3媬柦): 旂晢昦恌椕 2021/4; 43 (4): 348-51.
530011. [偦偺懠 (LETTER TO THE EDITOR)] Successful treatment of non-AIDS Kaposi's sarcoma with eribulin. Masuzawa M1, Yamashita K2, Horigome Y3, Amoh Y1: J Dermatol 2021;48 (7): e345-6. (憹郪恀旤巕1, 嶳壓榓栫2, 杧崬桟堦3, 揤塇峃擵1: 1旂晢, 2昦棟晹, 3寣塼撪)
[妛夛丒尋媶夛摍]
722175. [妛夛 (慡崙)] (僔儞億僕僂儉) 懳墳偵崲傞愙怗旂晢墛: 偦偺恌抐偲懳嶔亅儗僕儞傾儗儖僊乕偲偦偺懳墳亅. 憹郪恀幚巕 (旂晢): 戞51夞擔杮旂晢柶塽傾儗儖僊乕妛夛憤夛妛弍戝夛 (2021/11/26), 搶嫗.
723510. [妛夛 (慡崙)] (堦斒島墘) 娽媴寢枌廩寣偲岥峯撪擲枌怾傪敽偭偨屻揤惈昞旂悈醰徢偺1椺. 斾棷娫壚撧1, 敀堜嫗旤1, 釼摗嫳巕1, 嬥暎桪庽1, 嵅乆栘埐1, 抮懞桳妿2, 搧崻丂婤, 愇堜暥恖, 屆夑峗巏, 揤塇峃擵1 (1旂晢, 2娽壢): 戞120夞擔杮旂晢壢妛夛憤夛 (2021/6/10-13), 墶昹 (僴僀僽儕僢僪奐嵜).
723511. [妛夛 (慡崙)] (堦斒島墘) 戙幱堎忢徢偵敽偆旂晢昦曄: 揹夝幙堎忢, 價僞儈儞寚朢, 撪暘斿宯幘姵偵敽偆旂晢徢忬摍. 敀堜嫗旤 (旂晢): 戞120夞擔杮旂晢壢妛夛憤夛 (2021/6/10-13), 墶昹 (僴僀僽儕僢僪奐嵜).
723512. [妛夛 (慡崙)] (堦斒島墘) The potencial of hair-follicle-associated pluripotennt (HAP) stem cells for heart regeneration. 崅壀撧撨巕, 嶳崻旤抭巕1, 彫尨岹嵠2, 敀堜嫗旤2, 昹揷桽巕3, 峳愳怣巕3, 埨錣椙堦2, Robert M Hoffman, 揤塇峃擵2 (1戝妛堾堛椕宯尋媶壢, 2旂晢, 3昦懺丒恌椕宯): 擔杮尋媶旂晢壢妛夛戞46夞擭師妛弍戝夛丒憤夛 (2021/12/3-5), Web奐嵜.
733164. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 悈醰惈僄儕僥儅僩乕僨僗偺堦椺. 挿扟愳嵤尒, 宩丂桭棟1, 崅栰揘榊1, 敀堜嫗旤1, 桳徖椙岾2, 屆夑峗巏3, 愇堜暥恖3, 揤塇峃擵1 (1旂晢, 2銹尨昦丒姶愼撪, 3媣棷暷戝): 擔杮旂晢壢妛夛戞897夞搶嫗抧曽夛 (2021/7/17), 恄撧愳.
733165. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 塃慜榬朓鈢怐墛帯椕拞偵敪惗偟偨僙僼僃僺儉擼徢. 嬥嶳傑傝偐1, 嬥暎桪庽1, 暷嶳庻巕1, 敀堜嫗旤1, 摽揷丂隳2, 揤塇峃擵1 (1旂晢, 2擼恄宱撪): 擔杮旂晢壢妛夛戞897夞搶嫗抧曽夛 (2021/7/17), 恄撧愳.
733166. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 儁儉僽儘儕僘儅僽偵傛傞irAE偲峫偊偨岲巁媴惈嬝枌墛偺堦椺. 嵅乆栘埐1, 憹郪恀幚巕1, 暷嶳庻巕1, 敀堜嫗旤1, 揤塇峃擵1 (1旂晢): 戞85夞擔杮旂晢壢妛夛搶嫗巟晹妛弍戝夛 (2021/11/13-14), 搶嫗 (僴僀僽儕僢僪奐嵜).
733167. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 梓棻媴媧拝椕朄偑憈岟偟偨IL-36RN堚揱巕曄堎傪桳偡傞斈敪惈擽醰惈姡釢偺1椺. 悈岥棾擵夘1, 敀堜嫗旤1, 埨錣椙堦1, 嵅乆栘埐1, 愳懞嵐桼旤2, 壀搰岝栫, 揤塇峃擵1 (1旂晢, 2恡憻撪): 戞85夞擔杮旂晢壢妛夛搶嫗巟晹妛弍戝夛 (2021/11/13-14), 搶嫗 (僴僀僽儕僢僪奐嵜).
733168. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 梊屻晄椙側宱夁傪偨偳偭偨僄僢僋儕儞娋岴娻偺1椺 嬍堜埢巕1, 暷嶳庻巕1, 敄堜棙戝1, 彫尨岹嵠1, 敀堜嫗旤1, 媏抮朁巕, 揤塇峃擵1 (1旂晢): 擔杮旂晢壢妛夛戞899夞搶嫗抧曽夛 (2021/12/18), Web奐嵜.
733169. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 懡敪擼揮堏傪偒偨偟偨摢晹寣娗擏庮偺1椺 墇屻娧宒1, 憹郪恀幚巕1, 敄堜棙戝1, 暷嶳庻巕1, 敀堜嫗旤1, 摽揷丂隳2, 娵嶳棃婸3, 揤塇峃擵1 (1旂晢, 2擼恄宱撪, 3屇媧婍奜): 擔杮旂晢壢妛夛戞899夞搶嫗抧曽夛 (2021/12/18), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110023. [尨挊] Gray-edged line sign of scabies burrow. Ueda T, Katsura Y, Sasaki A, Minagawa D, Amoh Y1, Shirai K1: J Dermatol 2021/2; 48 (2): 190-8. (揤塇峃擵1, 敀堜嫗旤1: 1旂晢)
'20-320005. [徢椺曬崘] NUDT15堚揱巕懡宆偺偨傔傾僓僠僆僾儕儞偵傛傞嵞惗晄椙惈昻寣傪偒偨偟偨悈醰惈椶揤醰釋. 帞徖幚桪1, 敀堜嫗旤1, 揷帥斖峴2, 揤塇峃擵1 (1旂晢, 2寣塼撪): 旂晢壢偺椪彴 2021/3; 63 (3): 356-9.
'20-540002. [偦偺懠 (僈僀僪儔僀儞)] 旂晢埆惈庮釃恌椕僈僀僪儔僀儞戞3斉丂旂晢寣娗擏庮恌椕僈僀僪儔僀儞2021. 摗郪峃峅, 愺墇寬帯, 憹郪恀幚巕1, 戝捤撃巌, 撪丂攷巎, 徏壓栁恖, 恅丂梞榊, 憗愳榓廳, 屆夑峅巙, 悰扟丂惤 (1旂晢): 擔杮旂晢壢妛夛嶨帍 2021/2; 131 (2): 245-77.
'20擭搙埲慜暘
[妛夛丒尋媶夛摍]
'20-723030. [妛夛 (慡崙)] (堦斒島墘) IL36RN堚揱巕曄堎傪擣傔偨嵞敪惈娐忬峠斄條姡釢偺1椺. 嬥暎桪庽1, 憹郪恀幚巕1, 昹揷桽巕2, 埨錣椙堦1, 揤塇峃擵1 (1旂晢, 2昦懺丒恌椕宯): 戞84夞擔杮旂晢壢妛夛搶嫗巟晹妛弍戝夛 (2020/11/21), Web奐嵜.
'20-733017. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 屻揤惈寣桭昦傪崌暪偟偨悈醰惈椶揤醰釋偺1椺. 廰扟椇懢1, 嵅乆栘埐1, 敀堜嫗旤1, 墶嶳恀婌2, 摽塱愮弔3, 揤塇峃擵1 (1旂晢, 2寣塼撪, 3榓巗棫昦堾): 擔杮旂晢壢妛夛戞895夞搶嫗抧曽夛 (2021/2/20), 搶嫗.
'20-733018. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 廃曈晹妏枌捵釃傪崌暪偟偨岲巁媴惈懡敪寣娗墛惈擏夎庮偺1椺. 悈岥棾擵夘1, 敀堜嫗旤1, 埨錣椙堦1, 暷嶳庻巕1, 嬥暎桪庽1, 揷拞抦庽2, 壨栰梇椇3, 栘懞庨棦4, 揤塇峃擵1 (1旂晢, 2銹尨昦丒姶愼撪, 3娽壢, 4帹旲堲岮丒摢栩奜): 擔杮旂晢壢妛夛戞895夞搶嫗抧曽夛 (2021/2/20), 搶嫗.
斿擜婍壢妛
[妛弍榑暥]
110358. [尨挊] Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy. Koguchi D1, Matsumoto K1, Shimizu Y, Kobayashi M1, Hirano S1, Ikeda M1, Sato Y, Iwamura M1: Cancers (Basel) 2021/4; 13 (8): 1748. (崅岥丂戝1, 徏杮榓彨1, 彫椦搷巕1, 暯栰廋暯1, 抮揷彑恇1, 娾懞惓巏1: 1斿擜婍)
110359. [尨挊] Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial. Yokomizo A, Koga H, Ito K, Takezawa Y, Komiyama M, Nishimura K, Yonese J, Hashine K, Masumori N, Arai G, Saito S, Shinohara M, Shimizu N, Yamauchi A, Satoh T1, Tochigi T, Kobayashi M, Fujimoto H, Kakimoto K, Fukui I, Tsukamoto T, Nozaki M, Karasawa K, Hasumi M, Ohtani M, Ishiyama H2, Kuwahara M, Harada M, Ohashi Y, Kotake T, Kakizoe T, Suzuki K, Naito S, Yamanaka H, National Research Project on Endocrine-Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators: Cancer Med 2021/5; 10 (10): 3240-8. (嵅摗埿暥1, 愇嶳攷瀶2: 1斿擜婍, 2曻幩慄 (庮釃))
110360. [尨挊] Correcting anemia and native vitamin D supplementation in kidney transplant recipients: a multicenter, 2 亊 2 factorial, open-label, randomized clinical trial. Obi Y, Ichimaru N, Sakaguchi Y, Iwadoh K, Ishii D1, Sakai K, Iwami D, Harada H, Sumida K, Sekine A, Masutani K, Akutsu N, Inoue T, Nishihira M, Yoneda T, Ito S, Araki M, Kaimori J, Yoshida K, Satoh S, Ubara Y, Isaka Y, Yoshida K1,2, Tsubakihara Y, Takahara S, Hamano T, CANDLE-KIT Trial Investigators: Transpl Int 2021/7; 34 (7): 1212-25. (愇堜戝曘1, 媑揷堦惉1,2: 1斿擜婍, 2怴悽婭堛椕丒墶抐揑堛椕)
110361. [尨挊] Cytopathic effects and local immune responses in repeated neoadjuvant HSV- tk + ganciclovir gene therapy for prostate cancer. Yanagisawa N, Satoh T1, Tabata K1, Tsumura H1, Nasu Y, Watanabe M, Thompson TC, Okayasu I2, Murakumo Y2, Baba S1, Iwamura M1: Asian J Urol 2021/7; 8 (3): 280-8. (嵅摗埿暥1, 揷敤寬堦1, 捗懞廏峃1, 壀埨丂孧2, 懞塤朏庽2, 攏応巙榊1, 娾懞惓巏1: 1斿擜婍, 2昦棟)
110362. [尨挊] A novel prognostic model for Japanese patients with newly diagnosed bone-metastatic hormone-na_ve prostate cancer. Miyoshi Y, Yasui M, Yoneyama S, Kawahara T, Nakagami Y, Ohno Y, Iizuka J, Tanabe K, Hashimoto Y, Tsumura H1, Tabata K1, Iwamura M1, Yano A, Kawakami S, Uemura H: BJUI Compass 2020/9; 2 (2): 105-14. (捗懞廏峃1, 揷敤寬堦1, 娾懞惓巏1: 1斿擜婍)
110363. [尨挊] Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer. Shimura S1, Matsumoto K1, Shimizu Y, Mochizuki K1, Shiono Y1, Hirano S1, Koguchi D1, Ikeda M1, Sato Y, Iwamura M1: Cancers (Basel) 2021/10; 13 (20): 5150. (巙懞憇堦楴1, 徏杮榓彨1, 朷寧峃暯1, 墫栰丂桾1, 暯栰廋暯1, 崅岥丂戝1, 抮揷彑恇1, 娾懞惓巏1: 1斿擜婍)
110364. [尨挊] Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report. Takahashi S, Yasuda M, Wada K, Matsumoto M, Hayami H, Kobayashi K, Miyazaki J, Kiyota H, Matsumoto T, Yotsuyanagi H, Tateda K, Sato J, Hanaki H, Masumori N, Hiyama Y, Egawa S, Yamada H, Matsumoto K1, Ishikawa K, Yamamoto S, Togo Y, Tanaka K, Shigemura K, Uehara S, Kitano H, Kiyoshima K, Hamasuna R, Ito K, Hirayama H, Kawai S, Shiono Y, Maruyama T, Ito S, Yoh M, Ito M, Hatano K, Ihara H, Uno S, Monden K, Yokoyama T, Takayama K, Sumii T, Kadena H, Kawahara M, Hosobe T, Izumitani M, Kano M, Nishimura H, Fujita R, Kaji S, Hayashi K, Tojo T, Matumura M: J Infect Chemother 2022/1; 28 (1): 1-5. (徏杮榓彨1: 1斿擜婍)
120019. [尨挊] 摉壢偵偍偗傞儘儃僢僩巟墖恡岜宍惉弍偺弶婜惉愌偲暊峯嬀壓恡岜宍惉弍偲偺斾妑専摙. 怷丂榡暯1, 惣丂惙岹1, 暯栰廋暯1, 杒搰榓庽1, 抮揷彑恇1, 愇堜戝曘1, 娾懞惓巏1 (1斿擜婍): Japanese Journal of Endourology and ESWL 2021/12; 34 (2): 323-7.
120020. [尨挊] 35嵨枹枮偵敪惗偟偨銷泖娻偺椪彴揑摿挜偺専摙. 暯栰廋暯1, 徏杮榓彨1, 墫栰丂桾1, 拞懞恀棙峕1, 彑枖梞庽1, 彫椦搷巕1, 抮揷彑恇1, 捗懞廏峃1, 娾懞惓巏1 (1斿擜婍): 斿擜婍壢婭梫 2021/6; 67 (6): 221-4.
310051. [徢椺曬崘] Effect of cisplatin on metastatic castration-resistant prostate cancer with BRCA2 mutation: A case report. Koguchi D1, Tabata K1, Tsumura H1, Mori K1, Koh H, Iwamura M1: Urol Case Rep 2021/5; 38: 101712. (崅岥丂戝1, 揷敤寬堦1, 捗懞廏峃1, 怷丂榡暯1, 娾懞惓巏1: 1斿擜婍)
520009. [憤愢] COVID-19偲恡堏怉堛椕. 嶳塱惉旤, 媑愳旤婌巕, 憼枮丂孫, 擔斾懽憿, 戝郪椙夘, 昰巕梞夘, 彫栰丂柅, 廫愳丂攷, 柤庢梞堦榊, 栴栰惏旤, 朏愳朙巎, 媑揷堦惉1,2, 彫愳捈巕, 寱帩丂宧, 搾戲尗帯, 峕愳桾恖 (1怴悽婭堛椕丒墶抐揑堛椕, 2斿擜婍): 擔杮椪彴恡堏怉妛夛嶨帍 2021/7; 9 (1): 62-72.
522535. [島嵗]亂摿廤: 慜棫態娻偺奜壢帯椕亃15. 揮堏偺偁傞徢椺偵懳偡傞慜棫態慡揈偺堄媊. 揷敤寬堦 (斿擜婍): Prostate Journal 2021/4; 8 (1): 88-93.
522536. [島嵗]亂摿廤: 恑壔偡傞嫀惃掞峈惈慜棫態偑傫偺恌抐偲帯椕偺嵟怴抦尒亃mCRPC偺壔妛椕朄亅僞僉僒儞宯峈偑傫嵻偺僄價僨儞僗偲巊梡曽朄亅. 揷敤寬堦 (斿擜婍): 斿擜婍奜壢 2021/8; 34 (8): 945-50.
522537. [島嵗]亂憻婍採嫙丒憻婍堏怉偺慡懱憸亃憻婍堏怉偺奣梫偲揔墳, 徢椺悢, 惉愌. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍): 媬媫堛妛 2021/9; 45 (10): 1236-46.
[挊丂彂]
620099. [妛弍彂 (暘扴幏昅)]亂寣塼摟愅恌椕巜恓亃摟愅娭楢庤弍丒庤媄偲娗棟丂廃弍婜娗棟, p.349-52. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍), 娔廋: 壀揷堦媊, 曇: 壀揷堦媊, 堜忋朁巕, 揷戙丂妛, 悈岥丂弫, 搶嫗堛妛幮, 搶嫗, 2021/6敪峴.
620100. [妛弍彂 (暘扴幏昅)]亂恡幘姵帯椕栻update (恡偲摟愅2021擭91姫憹姧崋)亃戞3復 斿擜婍壢幘姵丂2. 恡堏怉偵巊傢傟偰偄傞柶塽梷惂栻丂戙幱漢峈栻丂儈僝儕價儞, p.606-8. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍), 搶嫗堛妛幮 搶嫗, 2021/8敪峴.
620101. [妛弍彂 (暘扴幏昅)]亂恡幘姵帯椕栻update (恡偲摟愅2021擭91姫憹姧崋)亃戞3復 斿擜婍壢幘姵丂2. 恡堏怉偵巊傢傟偰偄傞柶塽梷惂栻丂戙幱漢峈栻丂儈僝儕價儞, p.606-8. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍): 搶嫗堛妛幮, 搶嫗, 2021/9敪峴.
620102. [妛弍彂 (暘扴幏昅)]亂偍栻棫偪BOOK 2022丂夝朥惗棟丒昦懺惗棟偐傜栻妛娗棟傊 (栻嬊2022擭憹姧Vol. 73 No.4)亃仭偑傫丒巟帩椕朄丂66 慜棫態娻, p.927-32. 抮揷彑恇1, 擖峕丂孾 (1斿擜婍) 撿嶳摪, 搶嫗, 2022/3敪峴.
[妛夛丒尋媶夛摍]
721014. [妛夛 (慡崙)] (摿暿島墘) 恡堏怉偵偍偗傞僠乕儉堛椕僗僞僢僼乣恡堏怉堛椕偺幙偺岦忋傪巟偊傞僗僞僢僼払乣. 媑揷堦惉1,2, 栰岥暥擳2, 愇堜戝曘2, 堜懞梉昉3 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍, 3娕岇晹): 戞25夞擔杮摟愅傾僋僙僗堛妛夛妛弍廤夛丒憤夛 (2021/11/28), Web奐嵜.
722176. [妛夛 (慡崙)] (僔儞億僕僂儉) 斈梡e-learning僔僗僥儉偲AI壒惡崌惉僔僗僥儉傪妶梡偟偨嵼戭寣塼摟愅尋廋梡僣乕儖偺嶌惉. 垻晹撧捗旤, 庒堜梲婓, 暫摗丂摟, 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂抐揑堛椕, 2斿擜婍): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4), 墶昹 (僴僀僽儕僢僪奐嵜).
722177. [妛夛 (慡崙)] (嫵堢島墘) 摟愅姵幰偱偺斿擜婍壢庤弍偲偦偺娗棟. 媑揷堦惉1,2, 愇堜戝曘2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/6), 墶昹 (僴僀僽儕僢僪奐嵜).
722178. [妛夛 (慡崙)] (僔儞億僕僂儉) 恡堏怉堛椕偱摥偔RTC乣奆偱偙傟偐傜偺10擭傪曄偊傞偨傔偵乣. 栰岥暥擳1, 拠媨桪巕, 壨栰丂宐, 愇堜戝曘1, 娾懞惓巏1, 媑揷堦惉1,2 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞57夞擔杮堏怉妛夛憤夛 (2021/9/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
722179. [妛夛 (慡崙)] (僨傿儀乕僩僙僢僔儑儞) 儁儞僽儘儕僘儅僽偵懳偡傞儅僀僋儘僒僥儔僀僩晄埨掕惈専嵏偲偦偺梲惈幰偵懳偡傞堚揱僇僂儞僙儕儞僌偺幚懺挷嵏. 捗懞廏峃1,2, 巙懞憇堦楴1, 搰捗丂彨2, 彫嶁桖尗, 敀堜岹捈2,3, 榤扟旤撧2,4, 杧撪宐旤巕, 愳揷浠壚2, 峳栘彯旤2, 峳栘惓梇2, 嶰奒婱巎2,4, 崅揷巎抝2,5 (1斿擜婍, 2昦堾堚揱恌椕晹, 3彫帣, 4擕態丒峛忬態奜, 5戝妛堾堛椕宯尋媶壢): 擔杮恖椶堚揱妛夛戞66夞戝夛/戞28夞擔杮堚揱巕恌椕妛夛戝夛 (2021/10/13-16), 墶昹 (僴僀僽儕僢僪奐嵜).
722180. [妛夛 (慡崙)] (巗柉岞奐島嵗) 慜棫態偑傫偺曻幩慄椕朄. 捗懞廏峃 (斿擜婍): 擔杮斿擜婍庮釃妛夛戞7夞妛弍廤夛 (2021/10/23), 墶昹 (僴僀僽儕僢僪奐嵜).
722181. [妛夛 (慡崙)] (僔儞億僕僂儉) RLPP乣晛媦偺偨傔偵昁梫側偙偲乣Pros and Cons: LPP偺宱尡偼昁梫側偄. 怷丂榡暯1, 暯栰廋暯1, 杒搰榓庽1, 抮揷彑恇1, 愇堜戝曘1, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
722182. [妛夛 (慡崙)] (僔儞億僕僂儉) 庒庤彈惈斿擜婍壢堛偺棫応偐傜Endourology媄弍偺廗摼偲堐帩. 崅揷帯巕1, 暯堜徦巌, 墱栰婭旻, 墿丂塸栁, 擖峕丂孾, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/12), 墶昹 (僴僀僽儕僢僪奐嵜).
722183. [妛夛 (慡崙)] (僔儞億僕僂儉) 慜棫態偺戝偒偝傗宍忬偵傛傞崅擄搙徢椺偵懳偡傞RARP庤媄. 揷敤寬堦1, 捗懞廏峃1, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/13), 墶昹 (僴僀僽儕僢僪奐嵜).
722184. [妛夛 (慡崙)] (僔儞億僕僂儉) 嬊強恑峴丒僆儕僑揮堏傪桳偡傞怴婯恌抐慜棫態偑傫偵懳偡傞HDR僽儔僉僙儔僺乕偺桪埵惈. 捗懞廏峃1, 揷敤寬堦1, 抮揷彑恇1, 暯栰廋暯1, 愇堜戝曘1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/13), 墶昹 (僴僀僽儕僢僪奐嵜).
722185. [妛夛 (慡崙)] (僔儞億僕僂儉) 僫價僎乕僔儑儞僔僗僥儉偺摫擖偵岦偗偨傾僾儘乕僠. 抮揷彑恇 (斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11-13), 墶昹 (僴僀僽儕僢僪奐嵜).
722186. [妛夛 (慡崙)] (僔儞億僕僂儉) 恡堏怉偺尰忬偲栤戣揰乣儗僔僐偼壗傪偡傞恖偧!?乣. 栰岥暥擳1, 堜懞梉昉2, 垻晹揘栫3, 杒搰榓庽1, 愇堜戝曘1, 娾懞惓巏1, 媑揷堦惉1,4 (1斿擜婍, 2娕岇晹, 3恡憻撪, 4怴悽婭堛椕丒愭抂堛椕): 戞30夞擔杮恡晄慡奜壢尋媶夛妛弍廤夛 (2021/12/4), 壂撽 (僴僀僽儕僢僪奐嵜).
722187. [妛夛 (慡崙)] (僔儞億僕僂儉) 堏怉偑惉棫偟側偄応崌偺RTC偺栶妱. 栰岥暥擳1, 堜懞梉昉2, 垻晹揘栫3, 愇堜戝曘1, 娾懞惓巏1, 媑揷堦惉1,4 (1斿擜婍, 2娕岇晹, 3恡憻撪, 4怴悽婭堛椕丒愭抂堛椕): 戞32夞擔杮僒僀僐僱僼儘儘僕乕妛夛妛弍廤夛丒憤夛 (2021/12/12), Web奐嵜.
723513. [妛夛 (慡崙)] (億僗僞乕) 擔杮嶻晈恖壢堛夛愭揤堎忢儌僯僞儕儞僌偵偍偗傞愭揤堎忢僨乕僞儀乕僗傪婎偵偟偨彫帣斿擜婍娭楢愭揤堎忢敪惗摦岦偺専摙. 怷丂榡暯 (斿擜婍): 戞30夞擔杮彫帣斿擜婍壢妛夛憤夛丒妛弍廤夛 (2021/7/2), 戝嶃 (僴僀僽儕僢僪奐嵜).
723514. [妛夛 (慡崙)] (億僗僞乕) 摉堾偺愭峴揑恡堏怉偵偮偄偰偺専摙. 愇堜戝曘1, 墫栰丂桾1, 拞懞恀棙峕1, 徏杮榓彨1, 娾懞惓巏1, 栰岥暥擳1, 堜懞梉昉2, 垻晹揘栫3, 抾撪峃梇3, 媑揷堦惉1,4 (1斿擜婍, 2娕岇晹, 3恡憻撪, 4怴悽婭堛椕丒愭抂堛椕): 戞57夞擔杮堏怉妛夛憤夛 (2021/9/20), 搶嫗.
723515. [妛夛 (慡崙)] (堦斒島墘) 恡堏怉屻嵞敪憙忬巺媴懱峝壔徢偵懳偡傞寣燋岎姺椕朄偺帯椕岠壥偺専摙. 杒搰榓庽1, 奀忋峩暯, 愇堜岹懢, 戝栘棦壴巕, 摗尨桾栫, 椦丂愮桾, 柂揷丂椇, 敧栘郪棽巎, 恄郪懢堦, 旜杮榓栫, 搚扟丂寬, 愇揷塸庽, 揷绮堦惉, 崅栘晀抝 (1斿擜婍): 戞57夞擔杮堏怉妛夛憤夛 (2021/9/20), 搶嫗.
723516. [妛夛 (慡崙)] (億僗僞乕) 儁儞僽儘儕僘儅僽偵懳偡傞儅僀僋儘僒僥儔僀僩晄埨掕惈専嵏偲偦偺梲惈幰偵懳偡傞堚揱僇僂儞僙儕儞僌偺幚懺挷嵏. 捗懞廏峃1, 巙懞憇堦楴1, 搰捗丂彨, 彫嶁桖尗, 敀堜岹捈2, 榤扟旤撧3, 杧撪宐旤巕, 愳揷浠壚, 峳栘彯旤, 峳栘惓梇, 嶰奒婱巎3, 崅揷巎抝4 (1斿擜婍, 2彫帣, 3擕態丒峛忬態奜, 4戝妛堾堛椕宯尋媶壢): 擔杮恖椶堚揱妛夛戞66夞/戝夛戞28夞擔杮堚揱巕恌椕妛夛戝夛崌摨奐嵜 (2021/10/15), 墶昹 (僴僀僽儕僢僪奐嵜).
723517. [妛夛 (慡崙)] (堦斒島墘) 銷泖娻偵偍偗傞寣惔偍傛傃昦棟慻怐偱偺Epiplakin敪尰偺専摙. 巙懞憇堦楴1, 徏杮榓彨1, 揤栰摑擵2, 惔悈儐儕巕, 暯栰廋暯1, 揷敤寬堦1, 嵅摗梇堦3, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹): 擔杮斿擜婍庮釃妛夛戞7夞妛弍廤夛 (2021/10/23), 墶昹 (僴僀僽儕僢僪奐嵜).
723518. [妛夛 (慡崙)] (堦斒島墘) 擄帯惈惛憙庮釃偵懳偡傞TIP椕朄偺嵞搳梌偑挊岠偟偨1椺. 巙懞憇堦楴1, 揷敤寬堦1, 烴堜丂梫1, 墫栰丂桾1, 揤栰摑擵2, 抮揷彑恇1, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢): 擔杮斿擜婍庮釃妛夛戞7夞妛弍廤夛 (2021/10/23), 墶昹 (僴僀僽儕僢僪奐嵜).
723519. [妛夛 (慡崙)] (堦斒島墘) 愙怗幃儗乕僓乕慜棫態忲嶶弍 (CVP) 偺弶婜帯椕宱尡. 峚岥廏擵, 恵嶳堦曚, 巙懞丂揘, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723520. [妛夛 (慡崙)] (億僗僞乕) 儘儃僢僩巟墖暊峯嬀壓崻帯揑銷泖揈彍弍偲懠弍幃偺惂娻岠壥偵偮偄偰偺斾妑専摙. 徏杮榓彨1, 抮揷彑恇1, 暯嶳婱攷1, 懞忋懽惔1, 暯栰廋暯1, 捗懞廏峃1, 揷敤寬堦1, 愇堜戝曘1, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723521. [妛夛 (慡崙)] (億僗僞乕) BPH偵懳偡傞宱擜摴揑慜棫態庤弍屻偺巆懚夁妶摦銷泖徢忬偵娭楢偡傞場巕偺専摙. 懞忋懽惔1, 暯嶳婱攷1, 墱揷抦巎1, 擖峕丂孾, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723522. [妛夛 (慡崙)] (億僗僞乕) 3擭娫曻抲偝傟偨擜娗僗僥儞僩, 擜楬寢愇偵懳偡傞攋嵱帯椕偺1椺. 攱尨惓攷1, 戝怷庨榓擳1, 朙揷徆旤1, 彑枖梞庽2, 埨摗枤旤1, 墱栰婭旻, 娵丂揟晇, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723523. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞HoLEP弍慜偺慜棫態MRI専嵏偵偮偄偰偺専摙. 暯栰廋暯1, 徏壓堦庽1, 彫椦搷巕1, 巙懞憇堦楴1, 抮揷彑恇1, 暯嶳婱攷1, 愇堜戝曘1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723524. [妛夛 (慡崙)] (億僗僞乕) 儘儃僢僩巟墖壓崻帯揑銷泖慡揈弍偺摫擖婜帯椕惉愌. 抮揷彑恇1, 徏杮榓彨1, 暯嶳婱攷1, 暯栰廋暯1, 懞忋懽惔1, 拞懞恀棙峕1, 彫椦搷巕1, 杒搰榓庽1, 愇堜戝曘1, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723525. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞儘儃僢僩巟墖壓恡晹暘愗彍弍屻偺嵞敪揮堏徢椺偵懳偡傞専摙. 墫栰丂桾1, 愇堜戝曘1, 拞懞恀棙峕1, 彫椦搷巕1, 暯栰廋暯1, 杒搰榓庽1, 摗揷揘晇1, 徏杮榓彨1, 媑揷堦惉1,2, 娾懞惓巏1 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723526. [妛夛 (慡崙)] (憤夛徿億僗僞乕) 暊峯嬀壓恄宱壏懚崻帯揑慜棫態慡揈彍弍偑愗彍抐抂偵梌偊傞塭嬁偵娭偡傞専摙. 尨栰婱峅1, 揷敤寬堦1, 愇愳桾榓1, 徏壓堦庽1, 媨郪柧巕1, 彫椦搷巕1, 巙懞憇堦楴1, 捗懞廏峃1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723527. [妛夛 (慡崙)] (憤夛徿億僗僞乕) 嵍擜娗娻偵懳偟偰僣儕僂儉儗乕僓乕忲嶶愗彍弍傪巤峴偟偨堦椺. 朙揷徆旤1, 彑枖梞庽2, 墱栰婭旻, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723528. [妛夛 (慡崙)] (堦斒島墘) 惗懱恡堏怉屻偺堏怉恡擜娗寢愇偵懳偟偰, 宱擜摴揑寢愇攋嵱弍傪巤峴偟偨堦椺. 戝怷庨榓擳1, 娵丂揟晇, 攱尨惓攷1, 埨摗枤旤1, 愇堜戝曘1, 媑揷堦惉1,2, 娾懞惓巏1 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723529. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞儘儃僢僩巟墖恡岜宍惉弍偺弶婜惉愌偲暊峯嬀壓恡岜宍惉弍偲偺斾妑専摙. 怷丂榡暯1, 暯栰廋暯1, 杒搰榓庽1, 抮揷彑恇1, 惣丂惙岹, 愇堜戝曘1, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11), 墶昹 (僴僀僽儕僢僪奐嵜).
723530. [妛夛 (慡崙)] (億僗僞乕)摉壢偵偍偗傞暊峯嬀壓擜枌娗揈彍弍偺宱尡. 徏壓堦庽1, 暯栰廋暯1, 拞懞恀棙峕1, 彫椦搷巕1, 杒搰榓庽1, 抮揷彑恇1, 愇堜戝曘1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11-13), 墶昹 (僴僀僽儕僢僪奐嵜).
723531. [妛夛 (慡崙)] (億僗僞乕) Glenn-Anderson朄偵傛傞婥銷泖壓銷泖擜娗媡棳徢庤弍偺1椺. 愇愳桾榓1, 怷丂榡暯1, 惣丂惙岹, 娾懞惓巏1 (1斿擜婍): 戞35夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2021/11/11-13), 墶昹 (僴僀僽儕僢僪奐嵜).
723532. [妛夛 (慡崙)] (堦斒島墘) 帯椕偵擄廰偟偨恡堏怉屻暊枌摟愅嵞摫擖姵幰偺僇僥乕僥儖僩儞僱儖姶愼偺堦椺. 戝怷庨榓擳1, 愇堜戝曘1, 尨栰婱峅1, 墫栰丂桾1, 拞懞恀棙峕1, 杒搰榓庽1, 栰岥暥擳1, 娾懞惓巏1, 媑揷堦惉1,2 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞30夞擔杮恡晄慡奜壢尋媶夛妛弍廤夛 (2021/12/4), 壂撽 (僴僀僽儕僢僪奐嵜).
723533. [妛夛 (慡崙)] (堦斒島墘) 銷泖娻姵幰偵偍偗傞DJ-1敪尰偺昦棟慻怐妛揑専摙. 暯栰廋暯1, 徏杮榓彨1, 拞懞恀棙峕1, 彫椦搷巕1, 杒搰榓庽1, 抮揷彑恇1, 揷敤寬堦1, 嵅摗梇堦2, 娾懞惓巏1 (1斿擜婍, 2堛椕塹惗妛晹): 戞109夞擔杮斿擜婍壢妛夛憤夛 (JUA2021) (2021/12/7), 墶昹.
723534. [妛夛 (慡崙)] (堦斒島墘) 揮堏惈恡娻偵懳偡傞尨敪憙揈彍偺桳岠惈偺専摙. 杒搰榓庽1, 愇堜戝曘1, 摗揷揘晇1, 彑枖梞庽2, 彫椦搷巕1, 拞懞恀棙峕1, 墫栰丂桾1, 暯栰廋暯1, 抮揷彑恇1, 媑揷堦惉1,3, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒愭抂堛椕): 戞109夞擔杮斿擜婍壢妛夛憤夛 (JUA2021) (2021/12/7), 墶昹.
723535. [妛夛 (慡崙)] (堦斒島墘) 銷泖娻偵偍偗傞寣惔偍傛傃昦棟慻怐偱偺Epiplakin敪尰偺専摙. 巙懞憇堦楴1, 徏杮榓彨1, 惔悈儐儕巕, 朷寧峃暯1, 杒搰榓庽1, 揷敤寬堦1, 媑揷堦惉1,2, 娾懞惓巏1 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞109夞擔杮斿擜婍壢妛夛憤夛 (JUA2021) (2021/12/7), 墶昹.
723536. [妛夛 (慡崙)] (堦斒島墘) 忋晹擜楬忋旂娻弍屻銷泖嵞敪偵懳偡傞BCG銷泖撪拲擖椕朄偺帯椕惉愌. 慜嶳椙懢1, 抮揷彑恇1, 巙懞憇堦楴1, 揤栰摑擵2, 懞忋懽惔1, 嶳揷懽巎1, 崅岥丂戝1, 棫壴婱巎1, 愳懞悙曚1, 嶁揷桽夘1, 攱尨惓攷1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢): 戞109夞擔杮斿擜婍壢妛夛憤夛 (JUA2021) (2021/12/8), 墶昹.
723537. [妛夛 (慡崙)] (堦斒島墘) 嬝憌旕怹弫惈銷泖娻偵懳偡傞掅梡検BCG銷泖撪拲擖椕朄偺帯椕惉愌. 棫壴婱巎1, 抮揷彑恇1, 巙懞憇堦楴1, 揤栰摑擵2, 懞忋懽惔1, 嶳揷懽巎1, 崅岥丂戝1, 慜嶳椙懢1, 愳懞悙曚1, 嶁揷桽夘1, 攱尨惓攷1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢): 戞109夞擔杮斿擜婍壢妛夛憤夛 (JUA2021) (2021/12/8), 墶昹.
723538. [妛夛 (慡崙)] (堦斒島墘) 銷泖慡揈彍弍徢椺偵偍偗傞AHNAK2敪尰偲梊屻偵娭偡傞専摙. 崅岥丂戝1, 徏杮榓彨1, 巙懞憇堦榊1, 惔悈儐儕巕, 怷丂榡暯1, 捗懞廏峃1, 墿丂塸栁, 媑揷堦惉1,2, 嵅摗梇堦3, 娾懞惓巏1 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕, 3堛椕塹惗妛晹): 戞109夞擔杮斿擜婍壢妛夛憤夛 (JUA2021) (2021/12/9), 墶昹.
723539. [妛夛 (慡崙)] (堦斒岥墘) 拞娫儕僗僋孮偵偍偗傞儓僂慺125枾晻彫慄尮椕朄扨撈偲奜徠幩暪梡枾晻彫慄尮椕朄偺斾妑. 捗懞廏峃1, 揷拞愰摴2, 彫岥抭旻3, 旜挘戱栫2,4, 拞堜丂桋2, 愺愳桬梇2, 斞搰榓朏3, 壛摗惏楴3, 嫶揷丂娹3, 揷敤寬堦1, 嵅摗埿暥1, 愇嶳攷瀶5, 娾懞惓巏1 (1斿擜婍, 2撧椙導棫堛壢戝妛, 3挿栰巗柉昦堾, 4戝榓崅揷巗棫昦堾, 5曻幩慄 (庮釃)): 戞109夞擔杮斿擜婍壢妛夛憤夛 (JUA2021) (2021/12/7-10), 恄撧愳, 擔杮斿擜婍壢妛夛憤夛 2021/12; 109: OP82-05.
723540. [妛夛 (慡崙)] (堦斒島墘) 擄帯惈惛憙庮釃偵懳偟TIP椕朄偺嵞搳梌偑挊岠偟偨堦椺. 巙懞憇堦楴1, 揷敤寬堦1, 抮揷彑恇1, 娾懞惓巏1 (1斿擜婍): 戞19夞擔杮椪彴庮釃妛夛妛弍廤夛 (2022/2/17), 嫗搒 (僴僀僽儕僢僪奐嵜).
731029. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mCRPC偺屄暿壔帯椕偲儕儉僷乕僓偺巊梡宱尡. 揷敤寬堦 (斿擜婍): CRPC Precision Medicine Expert meeting 恄撧愳杒惣晹 (2021/4/9), Web奐嵜.
731030. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 慜棫態偑傫恌椕偺怴偨側傞挭棳. 揷敤寬堦 (斿擜婍): mCRPC僾儗僔僕儑儞儊僨傿僔儞島墘夛 (2021/4/23), Web奐嵜.
731031. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mHSPC偺儀僗僩僾儔僋僥傿僗傪峫偊傞. 揷敤寬堦 (斿擜婍): 慜棫態娻帯椕崸榖夛 (2021/6/4), Web奐嵜.
731032. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mHSPC偺儀僗僩僾儔僋僥傿僗傪峫偊傞. 揷敤寬堦 (斿擜婍): 嶳岥導墰抧嬫慜棫態娻僙儈僫乕 (2021/6/10), Web奐嵜.
731033. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mCRPC偺屄暿壔帯椕偲儕儉僷乕僓偺巊梡宱尡. 揷敤寬堦 (斿擜婍): Tokyo West Prostate Cancer Seminar (2021/6/11), Web奐嵜.
731034. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mCRPC偺屄暿壔帯椕偲儕儉僷乕僓偺僀儞僷僋僩. 揷敤寬堦 (斿擜婍): 憡柾尨CRPC Seminar柧擔偐傜妶偐偣傞慜棫態偑傫偺屄暿壔帯椕 (2021/6/17), Web奐嵜.
731035. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 暘偐傝傗偡偄! 慜棫態偑傫偺僎僲儉恌椕亅椪彴偱栶棫偮婎慴抦幆亅. 捗懞廏峃 (斿擜婍): 憡柾尨CRPC Seminar柧擔偐傜妶偐偣傞慜棫態偑傫偺屄暿壔帯椕 (2021/6/17), Web奐嵜.
731036. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 攔擜帺棫僒億乕僩偵懳偡傞杒棦戝妛昦堾偺庢傝慻傒. 暯嶳婱攷 (斿擜婍): K-NUC Kanagawa Network of Urination Care (2021/6/18), Web奐嵜.
731037. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mCRPC偺屄暿壔帯椕偲儕儉僷乕僓偺巊梡宱尡. 揷敤寬堦 (斿擜婍): 戞317夞壀嶳斿擜婍壢僇儞僼傽儗儞僗 (2021/6/22), Web奐嵜.
731038. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 梊屻夵慞傪栚巜偟偨慜棫態娻偵偍偗傞曻幩慄帯椕乣枾晻彫慄尮椕朄偲揮堏憙徠幩傪梡偄偨帯椕愴棯乣. 捗懞廏峃 (斿擜婍): Prostate Cancer Expert Meeting (2021/6/29), Web奐嵜.
731039. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 斿擜婍壢椞堟偺儘儃僢僩庤弍娭楢. 娾懞惓巏 (斿擜婍): 搶嫗恄撧愳彫帣恡僙儞僞乕偺夛 (2021/7/1), Web奐嵜.
731040. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mHSPC帯椕偺嵟怴挭棳 -偪傚偆偳椙偄帯椕傪扵傞-. 揷敤寬堦 (斿擜婍): 柧擔偺慜棫態偑傫傪峫偊傞夛 (2021/7/3), Web奐嵜.
731041. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) M1慜棫態娻偺僄價僨儞僗亅杮朚偱偺偪傚偆偳椙偄帯椕傪扵傞亅. 揷敤寬堦 (斿擜婍): Both Surgery and Drug therapy conference for young urologist at HYOGO (2021/7/12), Web奐嵜.
731042. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mHSPC帯椕偺僷儔僟僀儉僔僼僩亅偪傚偆偳椙偄帯椕傪媮傔偰亅. 揷敤寬堦 (斿擜婍): Prostate Cancer Consensus Conference (2021/7/21), Web奐嵜.
731043. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mCRPC偵偍偗傞屄暿壔帯椕偺壜擻惈偲儕儉僷乕僓偺巊梡宱尡. 揷敤寬堦 (斿擜婍): 戝揷嬫慜棫態娻僎僲儉島墘夛 (2021/7/30), Web奐嵜.
731044. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 亅upfront偲僎僲儉堛椕偺帪戙亅CRPC偵偍偗傞傾價儔僥儘儞傪嵞峫偡傞亅. 捗懞廏峃 (斿擜婍): 揮堏惈慜棫態偑傫帯椕愴棯傪峫偊傞慜棫態偑傫Web僙儈僫乕 (2021/8/30), Web奐嵜.
731045. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 僐儘僫壭偱偺慜棫態娻栻暔椕朄傪峫偊傞. 捗懞廏峃 (斿擜婍): 慜棫態娻Web僙儈僫乕 (2021/9/7), Web奐嵜.
731046. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mHSPC帯椕偺僷儔僟僀儉僔僼僩; 偪傚偆偳椙偄帯椕傪峫偊傞. 揷敤寬堦 (斿擜婍): 嶉嬍斿擜婍埆惈庮釃島墘夛 (2021/9/10), Web奐嵜.
731047. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 慜棫態偑傫偵偍偗傞栻暔椕朄偲曻幩慄帯椕-偙偺悢擭偵偍偗傞帯椕慖戰巿偺曄慗-. 捗懞廏峃 (斿擜婍): 斿擜婍幘姵楢実僙儈僫乕 (2021/9/17), Web奐嵜.
731048. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mHSPC帯椕偵偍偗傞儀僗僩僾儔僋僥傿僗偲偼? 揷敤寬堦 (斿擜婍): 戞5夞庒庤堛巘 Prostate Cancer Forum (2021/9/30), Web奐嵜.
731049. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 恑峴惈慜棫態娻帯椕偵壔妛椕朄偼峷專偟偰偄傞偺偐?乣僄價僨儞僗偐傜昍夝偔乣mHSPC偵偍偗傞壔妛椕朄偺栶妱. 揷敤寬堦 (斿擜婍): JEVTANA WEB僇儞僼傽儗儞僗 (2021/10/13), Web奐嵜.
731050. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) M0CRPC偵僀儞僥儞僔僽側帯椕偼昁梫偐? 揷敤寬堦 (斿擜婍): 僯儏儀僋僆敪攧1廃擭&僝乕僼傿僑敪攧5廃擭婰擮島墘夛 in 墶恵夑 (2021/10/28), Web奐嵜.
731051. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 斿擜婍暊峯嬀庤弍偺枹棃: 儘儃僢僩偺弌尰偼怑恖寍傪廔鄟偵摫偔偐? 娾懞惓巏 (斿擜婍): 媨嶈斿擜婍壢堛夛僒僥儔僀僩僙儈僫乕 5 (2021/11/6), Web奐嵜.
731052. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 慜棫態娻栻暔椕朄娭楢偛墘戣. 揷敤寬堦 (斿擜婍): 斿擜婍偑傫Meet the Expert in KANAGAWA (埬) (2021/12/3), Web奐嵜.
732072. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 屄暿壔恌椕偺庢傝慻傒偲幚嵺. 揷敤寬堦 (斿擜婍): CRPC Precision Medicine Expert meeting 恄撧愳杒惣晹 (2021/4/9), Web奐嵜.
732073. [妛夛 (抧曽夛丒尋媶夛)] (嶲壛宆僨傿僗僇僢僔儑儞) 寖榑!BRCA堚揱巕曄堎専嵏乣庡帯堛偲偟偰壗傪偳偆偡傋偒? 媈栤傪惏傜偡宱尡嫙棗乣. 揷敤寬堦 (斿擜婍): Japan REAL Experience Symposium 乣廤寢, BRCA堚揱巕曄堎専嵏偺幚慔乣 (2021/5/26), Web奐嵜.
732074. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 恡堏怉偵偍偗傞傾僋僙僗, 媄弍偺揱彸. 愇堜戝曘1, 杒搰榓庽1, 媑揷堦惉1,2 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞36夞恡堏怉丒寣娗奜壢尋媶夛 (2021/6/11), Web奐嵜.
732075. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 僶儀儞僠僆堐帩椕朄偺巊偄偳偙傠傪峫偊傞. 崟嶁崃擇 (斿擜婍): UC Internet Symposium DUAL in Sagamihara (2021/8/3), Web奐嵜.
732076. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 僶儀儞僠僆堐帩椕朄偺巊偄偳偙傠傪峫偊傞. 抮揷彑恇 (斿擜婍): UC Internet Symposium DUAL in Sagamihara (2021/8/3), Web奐嵜.
732077. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) mHSPC偵懳偡傞慜棫態嬊強曻幩慄帯椕偲揮堏憙徠幩偵傛傞梊屻夵慞傪栚巜偟偨帯椕愴棯. 捗懞廏峃1, 揷敤寬堦1, 拞懞恀棙峕1, 彫椦搷巕1, 巙懞憇堦楴1, 揤栰摑擵2, 抮揷彑恇1, 徏杮榓彨1, 嵅摗埿暥, 愇嶳攷瀶3, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3曻幩慄 (庮釃)): 戞86夞擔杮斿擜婍壢妛夛搶晹憤夛 (2021/9/4), Web奐嵜.
732078. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 僐儘僫壭偵偍偗傞慜棫態娻壔妛椕朄偲暃嶌梡懳嶔. 崟嶁崃擇 (斿擜婍): 慜棫態娻Web僙儈僫乕 (2021/9/7), Web奐嵜.
732079. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 壔妛椕朄: 僔僗僾儔僠儞巊梡偺幚嵺. 徏杮榓彨 (斿擜婍): Hybrid Internet Symposium in 恄撧愳導墰/導惣 (2021/9/16), Web奐嵜.
732080. [妛夛 (抧曽夛丒尋媶夛)] (巗柉岞奐島嵗) 慜棫態偑傫偵懳偡傞曻幩慄帯椕. 捗懞廏峃 (斿擜婍): 偙偙傑偱偒偨! 慜棫態偑傫曻幩慄帯椕乣僐儘僫壭偺尰嫷傕摜傑偊偰乣 (2021/10/3), Web奐嵜.
732081. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢僙儈僫乕) Pros and Cons偱峫偊傞mHSPC帯椕偵偍偗傞ARATs. 揷敤寬堦 (斿擜婍): 戞71夞擔杮斿擜婍壢妛夛拞晹憤夛 (2021/10/7), 柤屆壆 (僴僀僽儕僢僪奐嵜).
732082. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) mCSPC偺娤揰傛傝. 揷敤寬堦 (斿擜婍): 椪彴斿擜婍僙儈僫乕 (2021/10/20), Web奐嵜.
732083. [妛夛 (尋媶夛丒抧曽夛)] (僔儞億僕僂儉) 恡堏怋偺尰嫷偲栤戣揰亅恡堏怉偵偍偗傞僠乕儉堛椕偺廳梫惈亅. 媑揷堦惉1,2, 愇堜戝曘2, 栰岥暥擳3, 杒搰榓庽2, 垻晹揘栫4, 堜懞梉昉3 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍, 3娕岇晹, 4恡憻撪): 戞30夞擔杮恡晄慡奜壢尋媶夛妛弍廤夛 (2021/12/4-5), 壂撽 (僴僀僽儕僢僪奐嵜)
733170. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 憙忬巺媴懱峝壔徢傪尨幘姵偲偡傞儗僔僺僄儞僩16椺偺専摙. 墫栰丂桾1, 杒搰榓庽1, 愇堜戝曘1, 垻晹揘栫2, 栰岥暥擳1, 堜懞梉昉3, 抾撪峃梇2, 媑揷堦惉1,4, 娾懞惓巏1 (1斿擜婍, 2恡憻撪, 3娕岇晹, 4怴悽婭堛椕丒愭抂堛椕): 戞100夞恄撧愳恡尋媶夛憤夛丒尋媶廤夛 (2021/5/29), 墶昹 (僴僀僽儕僢僪奐嵜).
733171. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 弍屻偵堏怉擜娗-銷泖怴暙崌傪梫偟偨專恡堏怉偺1椺. 杒搰榓庽1, 愇堜戝曘1, 墱揷抦巎1, 彑枖梞庽2, 巙懞憇堦楴1, 垻晹揘栫3, 崺丂怢栫4, 娾懞惓巏1, 媑揷堦惉1,5 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3恡憻撪, 4媬柦, 5怴悽婭堛椕丒愭抂堛椕): 戞36夞恡堏怉丒寣娗奜壢尋媶夛 (2021/6/11), Web奐嵜.
733172. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嵞椕朄慖戰. 愇堜戝曘 (斿擜婍): 戞4夞恡晄慡僠乕儉堛椕嫤媍夛妛弍戝夛 (2021/8/22), Web奐嵜.
733173. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 銷泖娻偱偺HNRNPA3敪尰偍傛傃梊屻偵娭偡傞専摙. 揤栰摑擵1, 徏杮榓彨2, 惔悈儐儕巕, 杒搰榓庽2, 抮揷彑恇2, 揷敤寬堦2, 媑揷堦惉2,3, 嵅摗梇堦, 娾懞惓巏2 (1戝妛堾堛椕宯尋媶壢, 2斿擜婍, 3怴悽婭堛椕丒愭抂堛椕): 戞86夞擔杮斿擜婍壢妛夛搶晹憤夛 (2021/9/3), Web奐嵜.
733174. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) BCG銷泖撪拲擖椕朄偺忋晹擜楬忋旂娻婛墲偺桳柍偵偍偗傞帯椕惉愌. 慜嶳椙懢1, 抮揷彑恇1, 巙懞憇堦楴1, 揤栰摑擵2, 懞忋懽惔1, 嶳揷懽巎1, 崅岥丂戝1, 棫壴婱巎1, 愳懞悙曚1, 嶁揷桾夘1, 攱尨惓攷1, 徏揷戝夘1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢): 戞86夞擔杮斿擜婍壢妛夛搶晹憤夛 (2021/9/3), Web奐嵜.
733175. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 恡岜擜娗嬀専嵏偑恡擜娗慡揈弍偵媦傏偡塭嬁偵偮偄偰偺専摙. 朷寧峃暯1, 嶁揷桾夘1, 愇堜弤堦榊 (1斿擜婍): 戞86夞擔杮斿擜婍壢妛夛搶晹憤夛 (2021/9/3), Web奐嵜.
733176. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 銷泖娻姵幰偵偍偗傞寣惔拞DJ-1僞儞僷僋幙敪尰儗儀儖偺専摙. 暯栰廋暯1, 徏杮榓彨1, 揤栰摑擵2, 墫栰丂桾1, 拞懞恀棙峕1, 彫椦搷巕1, 巙懞憇堦楴1, 嵅摗梇堦3, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹): 戞86夞擔杮斿擜婍壢妛夛搶晹憤夛 (2021/9/3), Web奐嵜.
733177. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 摉堾偵偍偗傞嫀惃掞峈惈慜棫態娻 (CRPC), 崪揮堏徢椺偵懳偡傞223Ra (僝乕僼傿僑) 偺桳岠惈偵偮偄偰偺専摙. 彑枖梞庽1, 朙揷徆旤2, 尨栰婱峅2, 庒揷晹梲巌, 杒栰夒巎, 墱栰婭旻, 娾懞惓巏2 (1戝妛堾堛椕宯尋媶壢, 2斿擜婍): 戞86夞擔杮斿擜婍壢妛夛搶晹憤夛 (2021/9/3), Web奐嵜.
733178. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 嫀惃掞峈惈慜棫態娻偵懳偡傞Cabazitaxel椕朄: 搳梌検暿偺僋儕僯僇儖傾僂僩僇儉. 墫栰丂桾1, 揷敤寬堦1, 捗懞廏峃1, 拞懞恀棙峕1, 彫椦搷巕1, 尨栰婱峅1, 懞栘晀榊1, 烴堜丂梫1, 媨郪柧巕1, 愇愳桾榓1, 徏壓堦庽1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍): 戞86夞擔杮斿擜婍壢妛夛搶晹憤夛 (2021/9/3), Web奐嵜.
733179. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 儘儃僢僩巟墖暊峯嬀壓恡晹暘愗彍弍147椺偵偍偗傞弍屻姵懁恡婡擻偺専摙. 杒搰榓庽1, 愇堜戝曘1, 摗揷揘晇1, 抮揷彑恇1, 暯栰廋暯1, 徏杮榓彨1, 媑揷堦惉1,2, 娾懞惓巏1 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞86夞擔杮斿擜婍壢妛夛搶晹憤夛 (2021/9/3), Web奐嵜.
733180. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 銷泖慡揈彍弍昗杮傪梡偄偨Epiplakin敪尰偺専摙. 巙懞憇堦楴1, 徏杮榓彨1, 惔悈儐儕巕1, 怷丂榡暯1, 暯栰廋暯1, 抮揷彑恇1, 嵅摗梇堦2, 娾懞惓巏1 (1斿擜婍, 2堛椕塹惗妛晹): 戞86夞擔杮斿擜婍壢妛夛搶晹憤夛 (2021/9/3), Web奐嵜.
733181. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 崻帯揑銷泖娻慡揈彍弍昗杮偵偍偗傞億儕僆僂僀儖僗庴梕懱 (CD155) 敪尰偺専摙. 怷丂榡暯1, 徏杮榓彨1, 揤栰摑擵2, 惔悈儐儕巕, 攱尨惓攷1, 捗懞廏峃1, 愇堜戝曘1, 嵅摗梇堦3, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹): 戞86夞擔杮斿擜婍壢妛夛搶晹憤夛 (2021/9/4), Web奐嵜.
733182. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 椪彴恌抐偵嬯椂偟偨憀宎晹庮釒偺堦椺. 朙揷徆旤1, 彑枖梞庽2, 杧揷埢巕, 釼摗惗楴, 墱栰婭旻, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢): 戞63夞擔杮斿擜婍壢妛夛恄撧愳抧曽夛 (2021/9/16), Web奐嵜.
733183. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擄帯惈惛憙庮釃偵懳偟TIP椕朄偺嵞搳梌偑挊岠偟偨堦椺. 愇愳桾榓1, 巙懞憇堦楴1, 墫栰丂桾1, 彫椦搷巕1, 揤栰摑擵2, 抮揷彑恇1, 揷敤寬堦1, 徏杮榓彨1, 媑揷堦惉1,3, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒愭抂堛椕): 戞63夞擔杮斿擜婍壢妛夛恄撧愳抧曽夛 (2021/9/16), Web奐嵜.
733184. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 儘儃僢僩巟墖暊峯嬀壓恡岜宍惉弍乣柧擔偐傜偺椪彴偵岦偗偰乣. 愇堜戝曘 (斿擜婍): 斿擜婍庮釃幚慔弇 in 庱搒寳乣柧擔偐傜偺椪彴偵岦偗偰乣 (2021/10/13), Web奐嵜.
733185. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 揮堏惈慜棫態娻帯椕偺嵟慜慄乣low volume mCSPC偺帯椕偼偳偆曄傢傞偐乣. 敥嶳恀屷, 揷敤寬堦1 (1斿擜婍): 慜棫態偑傫Web僙儈僫乕 (2021/10/18), Web奐嵜.
733186. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 慜棫態偑傫帯椕愴棯偵偮偄偰. 巙懞憇堦楴1, 鋙嵗捈棙, 攡杮払嵠, 怉懞岞堦 (1斿擜婍): SKYT 2021 Extend meeting (2021/11/24), Web奐嵜.
733187. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) mHSPC偺恌抐丒帯椕偵偮偄偰 (壖). 揷敤寬堦 (斿擜婍): 搶妺杒晹 Prostate Cancer WEB Forum (2021/11/26), Web奐嵜.
733188. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 揮堏惈慜棫態娻偺嵟怴帯椕偵偮偄偰 (壖). 揷敤寬堦 (斿擜婍): Metropolitan Oncology Seminar (2021/12/2), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110024. [尨挊] Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort. Ito K, Kobayashi T, Kojima T, Hikami K, Yamada T, Ogawa K, Nakamura K, Sassa N, Yokomizo A, Abe T, Tsuchihashi K, Tatarano S, Inokuchi J, Tomida R, Fujiwara M, Takahashi A, Matsumoto K1, Shimizu K, Araki H, Kurahashi R, Osaki Y, Tashiro Y, Uegaki M, Ogawa O 4, KitamuraH, Nishiyama H: Cancer Med 2021/3; 10 (10): 3188-96. (徏杮榓彨1: 1斿擜婍)
娽壢妛
[妛弍榑暥]
110365. [尨挊] Clinical Features of Crowded Orbital Syndrome on Magnetic Resonance Imaging. Iwasa M, Wakakura M, Kohmoto H, Tatsui S1, Ishikawa H2: Neuroophthalmology 2021; 45 (2): 87-91. (棿堜墤巕1, 愇愳丂嬒2: 1娽壢, 2堛椕塹惗妛晹)
110366. [尨挊] Factors Influencing Contrast Sensitivity Function in Eyes with Mild Cataract. Kamiya K1, Fujimura F1, Kawamorita T1, Ando W2, Iida Y2, Shoji N2: J Clin Med 2021/4; 10 (7): 1506. (恄扟榓岶1, 摗懞晣幯巕1, 愳庣揷戱巙1, 埨摗榓壧巕2, 斞揷壝旻2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110367. [尨挊] Clinical outcomes of simultaneous phototherapeutic keratectomy and photoastigmatic keratectomy. Kamiya K1, Yazaki K2, Ando W2, Takahashi M2, Shoji N2: Sci Rep 2021/5; 11 (1) :9504. (恄扟榓岶1, 栴嶈崄嵷2, 埨摗榓壧巕2, _嫶惓塸2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110368. [尨挊] Comparison of Mean and Centroid of Surgically Induced Astigmatism After Standard Cataract Surgery. Kamiya K1, Iijima K2, Ando W2 , Shoji N2: Front Med (Lausanne) 2021/6; 8: 670337. (恄扟榓岶1, 斞搰丂宧2, 埨摗榓壧巕2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110369. [尨挊] Prediction of Phakic Intraocular Lens Vault Using Machine Learning of Anterior Segment Optical Coherence Tomography Metrics. Kamiya K1, Ando W2, Shoji N2: Am J Ophthalmol 2021/6; 226: 90-9. (恄扟榓岶1, 埨摗榓壧巕2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110370. [尨挊] Fovea-Sparing as Opposed to Total Peeling of Internal Limiting Membrane for Myopic Foveoschisis: A Systematic Review and Meta-analysis. Azuma K, Hirasawa K1, Araki F, Shiraya T, Yashiro S, Kato S, Nagahara M, Ueta T: Ophthalmol Retina 2021/7; 5 (7): 670-9. (暯郪堦朄1: 1娽壢)
110371. [尨挊] Sagging eye syndrome. Goseki T1,2: Jpn J Ophthalmol 2021/7; 65 (4): 448-53. (屻娭棙柧1,2: 1娽壢, 2崙嵺堛椕暉巸戝妛擬奀昦堾)
110372. [尨挊] Prediction of keratoconus progression using deep learning of anterior segment optical coherence tomography maps. Kamiya K1, Ayatsuka Y, Kato Y, Shoji N2, Miyai T, Ishii H, Mori Y, Miyata K: Ann Transl Med 2021/8; 9 (16): 1287. (恄扟榓岶1, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110373. [尨挊] High Visibility Conditions in a Sunset Environment. Iizuka T1, Kawamorita T2, Handa T2, Ishikawa H2: Appl Sci 2021/8; 11 (16): 7229; (斞捤払栫1, 愳庣揷戱巙2, 敿揷抦栫2, 愇愳丂嬒2: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹)
110374. [尨挊] Clinical evaluation of flat peripheral curve design with aspherical-curve and multi-curve hard contact lenses for keratoconus. Kumanomido T1, Kamiya K2, Takahashi M1, Tsujisawa T1, Hayakawa H1, Ando W1, Utsumi Y1, Shoji N1: PLoS One 2022/8; 17 (2): e0263506. (孎擶屼摪棽1, 恄扟榓岶2, 崅嫶惓塸1, 捯戲扖旻1, 憗愳廏婸1, 埨摗榓壧巕1, 塅捗尒媊堦1, 彲巌怣峴1: 1娽壢, 2堛椕塹惗妛晹)
110375. [尨挊] Comparison of magnitude and summated vector mean of surgically induced astigmatism vector according to incision site after phakic intraocular lens implantation. Kamiya K1, Ando W2, Takahashi M2, Shoji N2: Eye Vis (Lond) 2021/9; 8 (1): 32. (恄扟榓岶1, 埨摗榓壧巕2, 崅嫶惓塸2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110376. [尨挊] Diagnosability of Keratoconus Using Deep Learning With Placido Disk-Based Corneal Topography. Kamiya K1, Ayatsuka Y, Kato Y, Shoji N2, Mori Y, Miyata K: Front Med (Lausanne) 2021/10; 8: 724902. (恄扟榓岶1, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110377. [尨挊] Effect of Platelet-Rich Plasma on Corneal Epithelial Healing after Phototherapeutic Keratectomy: An Intraindividual Contralateral Randomized Study. Kamiya K1, Takahashi M2, Shoji N2: Biomed Res Int 2021/11; 2021: 5752248. (恄扟榓岶1, 崅嫶惓塸2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110378. [尨挊] Eight-Year Outcomes of Implantation of Posterior Chamber Phakic Intraocular Lens With a Central Port for Moderate to High Ametropia. Kamiya K1, Shimizu K, Takahashi M2, Ando W2, Hayakawa H2, Shoji N2: Front Med (Lausanne) 2021/12; 8: 799078. (恄扟榓岶1, 崅嫶惓塸2, 埨摗榓壧巕2, 憗愳廏婸2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110379. [尨挊] Effect of Trabeculectomy on Mean and Centroid Surgically Induced Astigmatism. Ando W1, Kamiya K2, Kasahara M1, Shoji N1: J Clin Med 2022/1; 11 (1): 240. (埨摗榓壧巕1, 恄扟榓岶2, 妢尨惓峴1, 彲巌怣峴1: 1娽壢, 2堛椕塹惗妛晹)
110380. [尨挊] Characteristics of glaucoma patients with intraocular pressure elevation early after trabectome surgery. Kono Y1, Kasahara M1, Hirasawa K1, Matsumura K1,2, Morita T1,3, Shoji N1: Graefes Arch Clin Exp Ophthalmol 2022/2; 260 (2): 537-43. (壨栰梇椇1, 妢尨惓峴1, 暯郪堦朄1, 徏懞堦峅1,2, 怷揷揘栫1,3, 彲巌怣峴1: 1娽壢, 2挰揷傑偮傓傜娽壢, 3怷揷傾僀僋儕僯僢僋)
110381. [尨挊] New device for taking nine-directional ocular photographs: ""9Gaze"" application. Toshiaki Goseki T1,2, Kunimi K1,2: J Eye Mov Res 2022/3; 15 (1): 10.16910/jemr.15.1.5. (屻娭棙柧1,2, 殸尒宧巕1,2: 1娽壢, 2崙嵺堛椕暉巸戝妛擬奀昦堾)
110382. [尨挊] Hyperopia-Correcting Phototherapeutic Keratectomy and Its Comparison With Conventional Phototherapeutic Keratectomy. Hayakawa H1, Kamiya K2, Tsujisawa T1, Takahashi M1, Shoji N1: Front Med (Lausanne) 2022/3; 9: 708188. (憗愳廏婗1, 恄扟榓岶2, 捯戲扖旻1, 崅嫶惓塸1, 彲巌怣峴1: 1娽壢, 2堛椕塹惗妛晹)
120021. [尨挊] 墌悕妏枌娽偵偍偗傞IOLMaster700偺2庬椶偺妏枌孅愜椡傪梡偄偨梊應孅愜岆嵎偺斾妑. 愺堜桪撧1, 彫搰棽巌2, 嬍抲柧栰1, 嫶捾椙懢1, 庰堜岾峅3, 壛夑払巙1,4, 巗愳堦晇3,4 (1拞嫗昦堾, 2宑墳媊弇戝妛, 3拞嫗娽壢, 4娽壢): 偁偨傜偟偄娽壢 2021/4; 38 (4): 459-63.
120022. [尨挊] 擼愐悜塼尭彮徢徢椺偺娽徢忬偺専摙. 嶳忋柧巕1,2, 娾嵅恀媩1, 堜忋尗帯1, 庒憅夒搊1, 棿堜墤巕2, 愇愳丂嬒3, 崅嫶峗堦4 (1堜忋娽壢昦堾, 2娽壢, 3堛椕塹惗妛晹, 4嶳墹昦堾擼恄宱奜壢): 恄宱娽壢 2021/6; 38 (2): 162-71.
120023. [尨挊]亂戞74夞擔杮椪彴娽壢妛夛島墘廤 [7] 島墘40-5亃僸僩悈徎懱偺愒摴晹埵抲傪惗懱娽偵偍偄偰専弌偡傞怴偟偄夝愅朄. 攏搱惔擛1, 巗愳丂宑2, 庰堜岾峅2, 曅壀悡攷3, 堥扟彯婸3, 拞懞桭徍3, 嬍抲柧栰4, 巗愳堦晇2,5 (1娽壢柧娽堾, 2拞嫗娽壢, 3柤屆壆傾僀僋儕僯僢僋, 4JCHO拞嫗昦堾娽壢, 5娽壢): 椪彴娽壢 2021/9; 75 (9): 1190-8.
120024. [尨挊] 妏枌僩億僌儔僼傿偲慜娽晹OCT偺堎側傞妏枌宍忬夝愅憰抲偵傛傞妏枌棎帇検偺斾妑. 壛摗岾恗1, 彫搰棽巌2, 嬍抲柧栰3, 庰堜岾峅1, 巗愳堦晇1,4 (1拞嫗娽壢, 2宑滀媊弇戝妛, 3拞嫗昦堾, 4娽壢): 偁偨傜偟偄娽壢 2021/10; 38 (10): 1207-11.
120025. [尨挊] 奜幬帇傪敽偆姵幰偺敀撪忈庤弍慜屻偺娽埵曄壔. 愒愇戲抭斂1, 姳愳棦奊2, 斞揷壝旻1, 愇愳丂嬒2, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 擔杮帇擻孭楙巑嫤夛帍 2021/12; 50: 123-8.
120026. [尨挊]亂戞60夞擔杮帇擻嫺惓妛夛堦斒島墘亃儗乕僓乕僗儁僢僋儖僼儘乕僌儔僼傿乕偵偍偗傞帇恄宱擕摢寣棳偺嵞尰惈偍傛傃堦抳惂. 彫愳浠撧1, 嵵摗丂嵤1, 峕崟桭弔2, 塱栰岾堦1, 嶳岥丂弮1, 彲巌怣峴1 (1娽壢, 2嶰僣嫬娽壢): 擔杮帇擻孭楙巑嫤夛帍 2021/12; 50: 129-34.
120027. [尨挊] 僆儈僨僱僷僌丒僀僜僾儘僺儖揰娽塼0.002%偺娽埑壓崀岠壥偍傛傃埨慡惈偺屻曽揑専摙. 崅栘寴懢榊1, 妢尨惓峴1, 暯郪堦朄1, 壨栰梇椇1, 暷嶳丂椚1, 捯戲扖旻1, 彲巌怣峴1 (1娽壢): 擔杮娽壢妛夛嶨帍 2022/1; 126 (1): 19-26.
120028. [尨挊 (妛夛尨挊)]亂戞77夞擔杮庛帇幬帇妛夛憤夛亃惣揷朄偑挊岠偟偨Duane徢岓孮厽宆偺3椺. 抮揷峃恗1, 愇愳宐棦1, 崅嫶怲栫1, 揷拞桾堦楴1, 彫戲拤旻1, 屻娭棙柧1,2,3 (1彫戲娽壢撪壢昦堾, 2崙嵺堛椕暉巸戝妛擬奀昦堾, 3娽壢): 娽壢椪彴婭梫 2022/1; 15 (1): 56-9.
120029. [尨挊] 寬峃惉恖傪懳徾偲偟偨價儖儀儕乕/徏庽旂拪弌暔攝崌怘昳愙庬偵傛傞娽埑傊偺塭嬁偺専摙. 崅栘懽岶1, 搰揷媣惗1, 壂忋桾旤1, 彲巌怣峴2 (1嶲揤惢栻, 2娽壢): 偁偨傜偟偄娽壢 2022/2; 39 (2): 251-7.
120030. [尨挊 (妛夛尨挊)]亂戞77夞擔杮庛帇幬帇妛夛憤夛亃僨僕僞儖僨僶僀僗偑尨場偲巚傢傟傞屻揤嫟摨惈撪幬帇偺帯椕宱夁. 埨摗桭婭1, 屻娭棙柧1,2,3, 屗捤榓巕1, 孨搰恀弮1, 姉惗恀棦1, 烴堜棔巕1,2, 巗绯媊復1,2 (1恄撧愳帟壢戝妛晬懏墶昹僋儕僯僢僋, 2娽壢, 3崙嵺堛椕暉巸戝妛擬奀昦堾): 娽壢椪彴婭梫 2022/2; 15 (2): 110-6.
120031. [尨挊 (妛夛尨挊)]亂戞77夞擔杮庛帇幬帇妛夛憤夛亃惗嶻擭楊傪懳徾偲偟偨娽埵偲孅愜搙悢偺娭學. 崅嫶怲栫1, 屻娭棙柧1,2,3, 栰揷怣屷1, 挿扟愳弜1, 愇愳宐棦1, 揷拞桾堦楴1, 彫戲拤旻1 (1彫戲娽壢撪壢昦堾, 2崙嵺堛椕暉巸戝妛擬奀昦堾, 3娽壢): 娽壢椪彴婭梫 2022/2; 15 (2): 122-6.
120032. [尨挊] 挻壒攇惗懱尠旝嬀偲慜娽晹岝姳徛抐憌寁偱嶣塭偟偨悈徎懱愒摴晹埵抲偺斾妑. 攏搱惔擛1, 巗愳丂宑2, 庰堜岾峅2, 曅壀悡攷3, 堥扟彯婸3, 拞懞桭徍3, 嬍抲柧栰4, 巗愳堦晇2,5 (1娽壢柧娽堾, 2拞嫗娽壢, 3柤屆壆傾僀僋儕僯僢僋, 4JCHO拞嫗昦堾娽壢, 5娽壢): IOL&RS 2022/3; 36 (1): 77-85.
320014. [徢椺曬崘] 價僲儗儖價儞搳梌拞偵帇恄宱徢傪敪徢偟偨堦椺. 愳恄奊棞巕1, 彫惣梕巕1, 娾嵅恀媩1, 嶳忋柧巕1,2, 堜忋尗帯1, 庒憅夒搊1 (1堜忋娽壢昦堾, 2娽壢): 恄宱娽壢 2021/9; 38 (3): 298-303.
320015. [徢椺曬崘] 僎乕儉偺夁忚巊梡偵娭楢偟偰敪徢偟偨偲峫偊傜傟傞妛摱婜偺媫惈撪幬帇2徢椺偺椪彴揑摿挜. 峕捤嵤夎1, 尨丂捈恖1,2,3, 壀栰恀媩2, 怷丂孿夘1, 怴堜揷岶桾1,2,3 (1崙嵺堛椕暉巸戝妛昦堾娽壢, 2崙嵺堛椕暉巸戝妛曐寬堛椕妛晹帇婡擻椕朄妛壢, 3娽壢): 娽壢 2021/11; 63 (11): 1107-12.
320016. [徢椺曬崘] 憗婜帯椕偵傛傝帇婡擻偑堐帩偱偒偨峝枌摦惷柆釕偵傛傞椉懁帇恄宱擕摢庮挴偺1椺. 掃揷嵷揈1, 巗绯媊復1,4, 尨丂捈恖1,2,4, 孨搰恀弮1, 姉惗恀棦1, 屗捤榓巕1, 岦栰榓梇1,4, 娫拞丂峗3 (1恄撧愳帟壢戝妛晬懏墶昹僋儕僯僢僋, 2崙嵺堛椕暉巸戝妛曐寬堛椕妛晹, 3墶昹巗棫戝妛晬懏巗柉憤崌堛椕僙儞僞乕擼恄宱奜壢, 4娽壢): 恄宱娽壢 2021/12; 38 (4): 366-72.
320017. [徢椺曬崘] 偆偭寣傪偒偨偟偨Camurati-Engelmann昦偺1椺. 戝峕垻巕1, 屻娭棙柧1,2, 棿堜墤巕1, 愇愳丂嬒3, 彲巌怣峴1 (1娽壢, 2崙嵺堛椕暉巸戝妛擬奀昦堾, 3堛椕塹惗妛晹): 恄宱娽壢 2021/12; 38 (4): 387-93.
320018. [徢椺曬崘] 儗乕僓乕僗儁僢僋儖僼儘乕僌儔僼傿乕傪梡偄偨帇恄宱墛媈偄徢椺偵偍偗傞Uhthoff挜岓弌尰慜屻偺娽寣棳應掕. 郷撧弿巕1,2, 徏杮丂捈2, 晉揷嫥旻2, 岟搧梩巕2, 壛摗宩巕2, 杧丂桾堦2, 愇愳丂嬒3 (1搶嫗昳愳昦堾, 2搶朚戝妛堛椕僙儞僞乕戝怷昦堾, 3堛椕塹惗妛晹) 恄宱娽壢 2022/3; 39 (1): 34-9.
320019. [徢椺曬崘] 峛忬態娽徢偲廳徢嬝柍椡徢偺帯椕傪摨帪偵梫偟偨1椺. 嶳嶈旤崄1, 嶳忋柧巕1.3, 娾嵅恀媩1, 堜忋尗帯1, 庒憅夒搊1, 幁搰丂屽2, 崃栘擇梩3 (1堜忋娽壢昦堾, 2惞儅儕傾儞僫堛壢戝妛擼恄宱撪壢, 3娽壢): 恄宱娽壢 2022/3; 39 (1): 53-8.
420001. [椪彴曬崘] 敀撪忈弍屻偺暋帇偺敪惗昿搙偲偦偺摿挜. 栴嶈崄嵷1, 屻娭棙柧1,2, 屗捤丂屽1, 棿堜墤巕1, 彲巌怣峴1 (1娽壢, 2崙嵺堛椕暉巸戝妛擬奀昦堾): 椪彴娽壢 2021/4; 75 (4): 479-84.
420002. [椪彴曬崘] 帇恄宱擕摢庮挴偲擕摢廃埻偺慄忬弌寣傪擣傔偨Weber-Christian昦偺1椺. 懞忋嵐曚1, 搉绮揤隳2, 愇揷惌峅3, 鴚栰壝峅4, 愳杒揘栫1, 崱懞丂桾1,2 (1杒棦戝妛尋媶強, 2掗嫗戝妛堛妛晹晬懏峚岥昦堾娽壢, 3搶朚戝妛堛椕僙儞僞乕戝嫶昦堾, 4掗嫗戝妛堛妛晹晬懏峚岥昦堾旂晢壢): 椪彴娽壢 2021/6; 75 (6): 753-60.
510020. [憤愢] Sagging eye syndrome. Goseki T1,2: Jpn J Ophthalmol 2021/7; 65 (4): 448-53. (屻娭棙柧1,2: 1娽壢, 2崙嵺堛椕暉巸戝妛擬奀昦堾)
520010. [憤愢] 憤愢丂拞嫗僌儖乕僾偺奀奜堛椕峷專 巗愳堦晇1,2,3 (1JSCRS棟帠挿, 2拞嫗僌儖乕僾夛挿, 3娽壢): IOL&RS 2021/6; 35 (2): 247-52.
520011. [憤愢] 尨場偺傛偔傢偐傜側偄愕柧偺峫偊曽. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 娽壢 2021/7; 63 (7): 645-9.
520012. [憤愢] 2021 JSCRS Clinical Survey. 嵅摗惓庽1, 恄扟榓岶1,2, 彫搰棽巌1, 屻摗寷恗1, 揷暎恗巙1, 弶嶁撧捗巕1, 椦丂丂尋1 (1JSCRS僨乕僞夝愅埾堳夛, 2堛椕塹惗妛晹): IOL&RS 2021/9; 35 (3): 427-48.
520013. [憤愢] 娽鈢pulley偲偦偺堎忢. 殸尒宧巕1, 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 娽壢 2021/12; 63 (12): 1179-83.
520014. [憤愢] 敀撪忈弍慜惗懱寁應僨乕僞丒嵟揔娽撪儗儞僘搙悢寁嶼幃偺懠巤愝斾妑尋媶. 恄扟榓岶1,2, 椦丂丂尋2, 嵅摗惓庽2, 彫搰棽巌2, 屻摗寷恗2, 弶嶁撧捗巕2, 揷绯恀惗3, 揷暎恗巙2, 巗愳堦晇2,4 (1堛椕塹惗妛晹, 2JSCRS僨乕僞夝愅埾堳夛, 3僣僇僓僉昦堾, 4娽壢): IOL&RS 2022/3; 36 (1): 51-6.
521008. [夝愢]亂娽壢堛偺庤堷<982>亃AI傪梡偄偨墌悕妏枌偺恌抐. 恄扟榓岶 (堛椕塹惗妛晹): 擔杮偺娽壢 2021/4; 92 (4): 46-7.
521009. [夝愢]亂孅愜嫺惓庤弍僙儈僫乕亃僗僉儖傾僢僾島嵗亅楢嵹252: 僇僗僞儉妏枌僋儘僗儕儞僉儞僌. 恄扟榓岶 (堛椕塹惗妛晹): 偁偨傜偟偄娽壢 2021/5; 38 (5): 547-8.
521010. [夝愢]亂堛夛Pick Up亃彫帣偺張曽獬側偟偱偺娽嬀嶌惉偺栤戣揰. 媨撪丂廋1, 嵅栰尋擇2, 塅捗尒媊堦3,4, 怴揷戩栫5, 楅栘寬巎6, 壃栰岞巏7, 桭婑峀巑8, 媨懞徆岶9, 媨杮桾巕10, 暯徏朚晇11, 晲怣弴巕12, 忋巬岹榓13, 擇媨丂尦14, 弌悈惤擇15 (1傒傗偆偪娽壢, 2偁偡傒偑媢嵅栰娽壢, 3塅捗尒娽壢堛堾, 4娽壢, 5夞柧摪娽壢丒帟壢, 6楅栘娽壢堛堾, 7壃栰娽壢堛堾, 8偲傕傛傝娽壢, 9徏嶃媨懞娽壢, 10傾僀傾僀娽壢堛堾, 11暯徏娽壢堛堾, 12晲怣娽壢, 13偆偊偩娽壢, 14嫑挰娽壢恌椕強, 15弌悈娽壢): 擔杮偺娽壢 2021/5; 92 (5): 535-40.
521011. [夝愢]亂僐儞僒儖僥乕僔儑儞僐乕僫乕: 僄僉僗僷乕僩偵暦偔亃夞摎4. 斞揷壝旻 (娽壢): IOL&RS 2021/9; 35 (3): 526-7.
521012. [夝愢]亂庤弍庤媄偺僐僣亃MIGS屻偺MIGS嵞庤弍. 妢尨惓峴1, 彲巌怣峴1 (1娽壢): 娽壢庤弍 2021/10; 34 (4): 581-5.
521013. [夝愢]亂僄僉僗僷乕僩偵妛傇: 娽壢庤弍偺幙栤敔19亃Q敀撪忈庤弍拞偵Zinn彫懷惼庛丒抐楐傪惗偠偨嵺偵偳偺傛偆側懳墳傗娽撪儗儞僘傪慖戰偡傋偒偱偡偐. 斞揷壝旻 (娽壢): 娽壢庤弍 2021/10; 34 (4): 608-9.
521014. [夝愢]亂敀撪忈丒孅愜庤弍偺榑揰亃LASIK屻娽偵懳偡傞IOL慖戰 (扨徟揰IOL). 斞揷壝旻 (娽壢): IOL&RS 2021/12; 35 (4): 651-4.
521015. [夝愢]亂庤弍婍嬶亃Zepto覀饤p偄偨precision pulse capsulotomy偵偮偄偰. 巗愳丂宑1, 巗愳堦晇2,3 (1憤崌惵嶳昦堾, 2拞嫗娽壢, 3娽壢): IOL&RS 2021/12; 35 (4): 659-64.
521016. [夝愢]亂孅愜嫺惓庤弍僙儈僫乕亃僗僉儖傾僢僾島嵗亅楢嵹259: 敀撪忈弍屻孅愜岆嵎偺幚嵺. 恄扟榓岶 (堛椕塹惗妛晹): 偁偨傜偟偄娽壢 2021/12; 38 (12): 1479-80.
521017. [夝愢]亂孅愜嫺惓庤弍僙儈僫乕亃僗僉儖傾僢僾島嵗亅楢嵹262: ICL偵偍偗傞棎帇嫺惓. 屲廫棐復巎1,2 (1僗僇僀價儖娽壢, 2娽壢): 偁偨傜偟偄娽壢 2022/3; 39 (3): 325-6.
522538. [島嵗]亂儊僀儞摿廤: 姵幰枮懌搙傪崅傔傞! 娽撪儗儞僘娭楢抦幆傾僢僾僨乕僩亃1. 嵟怴偺敀撪忈庤弍偺枮懌搙偵塭嬁傪偁偨偊傞場巕. 愳庣揷戱巙 (堛椕塹惗妛晹): 娽壢僌儔僼傿僢僋 2021/4; 10 (2): 134-41.
522539. [島嵗]亂儊僀儞摿廤: 姵幰枮懌搙傪崅傔傞! 娽撪儗儞僘娭楢抦幆傾僢僾僨乕僩亃2. 嵟怴偺娽撪儗儞僘搙悢寁嶼. 恄扟榓岶 (堛椕塹惗妛晹): 娽壢僌儔僼傿僢僋 2021/4; 10 (2): 142-6.
522540. [島嵗]亂摿廤: ICL偺偙偙偑抦傝偨偄亅婎杮偐傜椪彴傑偱亅亃Hole ICL偺奐敪偲拞怱岴偺栶妱. 惔悈岞栫1,2 (1嶳墹昦堾, 2娽壢): OCULISTA 2021/4; 97: 1-9.
522541. [島嵗]亂摿廤: ICL偺偙偙偑抦傝偨偄亅婎杮偐傜椪彴傑偱亅亃慜娽晹OCT傪梡偄偨ICL偺僒僀僘寛掕曽朄亅KS幃亅. 屲廫棐復巎1,2 (1嶳墹昦堾, 2娽壢): OCULISTA 2021/4; 97: 31-6.
522542. [島嵗]亂摿廤: ICL偺偙偙偑抦傝偨偄亅婎杮偐傜椪彴傑偱亅亃ICL庤弍偺幚嵺偲弍拞僩儔僽儖偺懳張曽朄. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): OCULISTA 2021/4; 97: 37-43.
522543. [島嵗]亂摿廤: ICL偺偙偙偑抦傝偨偄亅婎杮偐傜椪彴傑偱亅亃ICL偺椪彴墳梡亅敀撪忈弍屻傗墌悕妏枌傊偺墳梡亅. 恄扟榓岶 (堛椕塹惗妛晹): OCULISTA 2021/4; 97: 61-6.
522544. [島嵗]亂摿廤: 幬帇偺儘僕僢僋宯摑揑恌嶡朄亃III. 奺榑丂娽媴塣摦忈奞偺帪偵峫偊傞傋偒幘姵偲専嵏. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): OCULISTA 2021/6; 99: 56-9.
522545. [島嵗]亂摿廤: 椢撪忈帯椕偺尰忬偲嬤枹棃亃嬤枹棃偺椢撪忈帯椕丂嬤枹棃偺椢撪忈庤弍. 彲巌怣峴 (娽壢): 偁偨傜偟偄娽壢 2021/6; 38 (6): 663-70.
522546. [島嵗]亂傢偐傝傗偡偄椪彴島嵗亃惉恖偺妀壓惈娽媴塣摦忈奞. 崅嫶梞暯1, 愇愳丂嬒2 (1搶嫗彈巕堛壢戝妛敧愮戙堛椕僙儞僞乕, 2堛椕塹惗妛晹): 擔杮偺娽壢 2021/6; 92 (6): 665-70.
522547. [島嵗]亂摿廤: 棎帇嫺惓傪偒傢傔傞亃僩乕儕僢僋桳悈徎懱娽撪儗儞僘偵傛傞棎帇嫺惓. 恄扟榓岶 (堛椕塹惗妛晹): 娽壢庤弍 2021/7; 34 (3): 328-33.
522548. [島嵗]亂摿廤: 悈徎懱扙塒丒曃埵偲擑嵤寚懝僩儔僽儖亃悈徎懱扙塒丒曃埵偺帯椕匘亅恑壔偡傞朌拝弍, 巹偺偙偩傢傝亅. 斞揷壝旻 (娽壢): OCULISTA 2021/9; 102: 43-51
522549. [島嵗]亂摿廤: 屻揤撪幬帇偲恄宱娽壢亃彉榑亅奺梡岅偺堘偄偵偮偄偰亅. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 恄宱娽壢 2021/9; 38 (3): 239-40.
522550. [島嵗]亂摿廤: 屻揤撪幬帇偲恄宱娽壢亃Sagging eye syndrome偲椶帡幘姵. 壨崌垽幚 (戝妛堾堛椕宯尋媶壢): 恄宱娽壢 2021/9; 38 (3): 263-8.
522551. [島嵗]亂摿廤: 屻揤撪幬帇偲恄宱娽壢亃娽鈢媷孅徢岓孮. 娾嵅恀媩1,2 (1堜忋娽壢昦堾, 2娽壢): 恄宱娽壢 2021/9; 38 (3): 269-75.
522552. [島嵗]亂摿廤: 椢撪忈娽埑旕埶懚場巕傾僢僾僨乕僩亃娽寣棳應掕. 彲巌怣峴 (娽壢): NANO OPHTHALMOLOGY 2021/9; 59: 5-11.
522553. [島嵗]亂摿廤: 娽壢堛偺偨傔偺妛峑曐寬僈僀僪亅嵟嬤偺摦岦亅亃妛峑偱偺ICT妶梡偲娽偵偮偄偰. 塅捗尒媊堦1,2 (1塅捗尒娽壢堛堾, 2娽壢): OCULISTA 2021/10; 103: 33-44.
522554. [島嵗]亂摿廤: 栻嵻偺壏屘抦怴亃娽偵暃嶌梡傪惗偠傗偡偄峈庮釃栻. 攼栘峀嵠1,2 (1惷壀導棫惷壀偑傫僙儞僞乕, 2娽壢): 偁偨傜偟偄娽壢 2021/11; 38 (11): 1291-19.
522555. [島嵗]亂摿廤: 墌悕妏枌帯椕偺嵟慜慄亃3. 妏枌僋儘僗儕儞僉儞僌. 崅嫶惓塸1,2 (1娽壢, 2嶳墹昦堾傾僀僙儞僞乕): 娽壢 2021/12; 63 (12): 1155-64.
522556. [島嵗]亂摿廤: 偁偨傜偟偄椢撪忈庤弍亅偳偆偄偆姵幰傪徯夘偡傞?亃1. 慖戰揑儗乕僓乕慇堐拰懷宍惉弍 (SLT). 壨栰梇椇1, 妢尨惓峴1 (1娽壢): 娽壢 2022/1; 64 (1): 3-10.
522557. [島嵗]亂傢偐傝傗偡偄椪彴島嵗丂恄宱娽壢偐傜傒偨娽捝丒愕柧偺娪暿恌抐偲帯椕, 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 擔杮偺娽壢 2022/1; 93 (1): 42-6.
522558. [島嵗]亂堛夛Pick Up <擔杮娽壢幮夛曐尟夛媍僔儞億僕僂儉曬崘>: 戞75夞擔杮椪彴娽壢妛夛丂擔杮娽壢幮夛曐尟夛媍僔儞億僕僂儉亃恌椕曬廣夵掕僸傾儕儞僌傪摜傑偊偰: 4. 擔杮椢撪忈妛夛偐傜偺梫朷. 彲巌怣峴 (娽壢): 擔杮偺娽壢 2022/2; 93 (2): 208-13.
522559. [島嵗]亂摿廤: 擼埑偺曄壔偲帇婡擻忈奞亃擼愐悜塼尭彮偵傛傞帇婡擻堎忢. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 恄宱娽壢 2022/3; 39 (1): 26-33.
522560. [島嵗]亂摿廤亃AI偵傛傞寁嶼幃. 斞搰丂宧 (娽壢): IOL&RS 2022/3; 36 (1): 19-25.
540029. [偦偺懠 (僙儈僫乕儕億乕僩)]亂ACUVUE丂SeminarReport亃戞124夞擔杮娽壢妛夛憤夛儔儞僠儑儞僙儈僫乕3:乬尒偊傞乭傪捛媮偡傞. 恄扟榓岶1, 愳庣揷戱巙1 (1堛椕塹惗妛晹): 僕儑儞僜儞丒僄儞僪丒僕儑儞僜儞SeminarReport 2021/6/1.
540030. [偦偺懠 (怴暦婰帠)] 僐儞僞僋僩儗儞僘丂廇怮帪偵憰拝偟帇椡嫺惓 (僆儖僜K). 塅捗尒媊堦1,2 (1塅捗尒娽壢堛堾, 2娽壢): 撉攧怴暦 2021/6/22; P.16.
540031. [偦偺懠 (姫摢尵)]亂姫摢尵亃AI尋媶偲榑棟揑巚峫. 恄扟榓岶 (堛椕塹惗妛晹): IOL&RS 2021/6; 35 (2): 191.
540032. [偦偺懠 (僩僺僢僋僗)]亂僩僺僢僋僗亃僇僗僞儅僀僘僪妏枌僋儘僗儕儞僉儞僌. 恄扟榓岶 (堛椕塹惗妛晹): IOL&RS 2021/6; 35 (2): 253-8.
540033. [偦偺懠] 偙偺恖偵拲栚. 斞搰丂宧 (娽壢): IOL&RS 2021/6; 35 (2): 328-33.
540034. [偦偺懠 (彉榑)]亂摿廤: 帇恄宱幘姵偲椢撪忈惈帇恄宱徢偺娪暿亃彉榑. 愇愳丂嬒 (堛椕塹惗妛晹): 娽壢 2021/7; 63 (7): 613.
540035. [偦偺懠 (崱寧偺昞巻)]亂崱寧偺昞巻亃妏枌僀儞儗乕KAMRATM. 塱栰岾堦1, 堜忋岾師2 (1娽壢, 2捁庢戝妛): 椪彴娽壢 2021/9; 75 (9): 1140.
540036. [偦偺懠] 巹偲敀撪忈庤弍亅愭攜偐傜偺儊僢僙乕僕亅. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): IOL&RS 2021/9; 35 (3): 528-33.
540037. [偦偺懠] 朄恖偐傜偺偍抦傜偣: 僐儘僫壭偵巚偆偙偲. 巗愳堦晇1,2,3 (1JSCRS棟帠挿, 2拞嫗娽壢, 3娽壢): IOL&RS 2021/9; 35 (3): 538.
540038. [偦偺懠]亂CL僶僩儖儘僀儎儖僒乕僪僗僥乕僕戞66夞亃榁帇偵懳偡傞懳墳: CL偲IOL. 恄扟榓岶 (堛椕塹惗妛晹): 擔杮僐儞僞僋僩儗儞僘妛夛帍 2021/9; 63 (4): 148-55.
540039. [偦偺懠 (怴暦婰帠)] 娽嬀偵僒儓僫儔丂嬤帇偵ICL, 儗乕僔僢僋偲偺堘偄偼乽嶍傜側偄乿. 恄扟榓岶 (堛椕塹惗妛晹): 挬擔怴暦DIGITAL 2021/10/3.
540040. [偦偺懠 (奜崙帍梫棗)] 慜娽晹岝姳徛抐憌寁偺僶僀僆儊僩儕乕傪梡偄偨婡夿妛廗偵傛傞桳悈徎懱娽撪儗儞僘偺vault 梊應. 恄扟榓岶1, Ik Hee Ryu2,3, Tae Keun Yoo2,3,4, Jung Sub Kim2,3, In Sik Lee2,3, Jin Kook Kim2,3, 埨摗榓壧巕3, 彲巌怣峴3, 嶳撪抦朳5, 揷暎恗巙5 (1堛椕塹惗妛晹, 2B & VIIT Eye Center, 3娽壢, 4Aerospace Medical Center, 5幮夛堛椕朄恖嶰塰夛僣僇僓僉昦堾娽壢): 擔杮娽壢妛夛嶨帍 2021/10; 125 (10): 971-5.
540041. [偦偺懠 (姫摢尵)] 姫摢尵亅僐儘僫壭偑傕偨傜偟偨傕偺亅. 斞揷壝旻 (娽壢): 娽壢庤弍 2021/10; 34 (4): 477-8.
540042. [偦偺懠 (庤弍憡択幒)]亂庤弍憡択幒亃徢椺採帵: 弍屻暋悢夞儗儞僘夞揮偡傞toric ICL徢椺. 屲廫棐復巎1,2 (1嶳墹昦堾, 2娽壢): 娽壢庤弍 2021/10; 34 (4): 601-6.
540043. [偦偺懠 (報徾婰)] 幬帇偲暋帇, 儘僕僢僋偲傾乕僩. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 擔杮庛帇幬帇妛夛夛曬 2021/10; 57 (1): 69-70.
540044. [偦偺懠 (彉榑)] 摿廤: 彉榑. 栄捤崉巌1,2, 愇愳丂嬒3 (1栄捤娽壢昦堾, 2搶嫗堛壢戝妛, 3堛椕塹惗妛晹): 恄宱娽壢 2021/12; 38 (4): 339.
540045. [偦偺懠] 朄恖偐傜偺偍抦傜偣: 庤弍妛夛偺廂榐傪廔偊偰. 巗愳堦晇1,2,3 (1JSCRS棟帠挿, 2拞嫗娽壢, 3娽壢): IOL&RS 2021/12; 35 (4): 173.
540046. [偦偺懠] 摿廤偵偁偨偭偰. 恄扟榓岶1, 暉壀嵅抦巕2 (1堛椕塹惗妛晹, 2傆偔偍偐娽壢僋儕僯僢僋拞栰): IOL&RS 2021/12; 35 (4): 577.
540047. [偦偺懠] 偙偺恖偵拲栚: 嵟桪廏嵗挿徿庴徿幰. 忋嶳丂晼 (娽壢): IOL&RS 2021/12; 35 (4): 691-2.
540048. [偦偺懠] 巹偲敀撪忈庤弍亅愭攜偐傜偺儊僢僙乕僕亅. 惔悈岞栫1,2,3 (1嶳墹昦堾傾僀僙儞僞乕, 2崙嵺堛椕暉巸戝妛, 3娽壢): IOL&RS 2021/12; 35 (4): 708-12.
[挊丂彂]
620103. [妛弍彂 (暘扴幏昅)]亂崙帋115夝愢彂 (戞115夞堛巘崙壠帋尡栤戣夝愢彂)亃A-31 壛楊墿斄曄惈偺恌抐, p.42-3. A-67 摰岴撪堎忢偑傒傜傟傞幘姵, p.105-6. A-70 怴惗寣娗椢撪忈傪偒偨偡幘姵, p.110-1. C-39 夁擬敀撪忈, 悈徎懱梈夝惈傇偳偆枌墛偺帯椕, p.219-20. D-3 娽壢媬媫幘姵偲弶婜懳墳偺慻崌偣, p.276-7. D-19 栐枌惷柆暘婒暵嵡徢偵傛傞墿斄晜庮偵峴偆帯椕, p.292-4. 屻娭棙柧1,2, 巗绮媊復2,3 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢, 3恄撧愳帟壢戝妛晬懏墶昹僋儕僯僢僋), 曇: 堛巘崙壠帋尡栤戣夝愢彂曇廤埾堳夛, 僥僐儉, 搶嫗, 2021/4敪峴.
620104. [妛弍彂 (暘扴幏昅)]亂偙偺徢椺偺傑傑偱恌偰偄偰戝忎晇?丂昦恌楢実偵傕偲偯偔幘姵暿娽壢恌椕僈僀僪 (椪彴娽壢2021擭憹姧崋亃5 椢撪忈丂敀撪忈崌暪偺椢撪忈, p.174-9. 彲巌怣峴 (娽壢), 堛妛彂堾, 搶嫗, 2021/10敪峴.
620105. [妛弍彂 (暘扴幏昅)]亂娽壢庤弍Q&A (偁偨傜偟偄娽壢椪帪憹姧崋)亃II 妏枌丂Q2 孅愜偺掱搙傗娽偺忬懺偵傛偭偰慖戰偡傋偒孅愜庤弍偲偦偺嬶懱揑曽朄偵偮偄偰嫵偊偰偔偩偝偄, p.41-6. 恄扟榓岶 (堛椕塹惗妛晹), 儊僨傿僇儖埁弌斉, 搶嫗, 2021/12敪峴.
620106. [妛弍彂 (暘扴幏昅)]亂娽壢庤弍Q&A (偁偨傜偟偄娽壢椪帪憹姧崋)亃IV 椢撪忈丂Q6 偝傑偞傑側MIGS僨僶僀僗偑奐敪偝傟偰偄傑偡偑, 崱屻傢偑崙傊偺摫擖偑婜懸偝傟傞僨僶僀僗偵偮偄偰嫵偊偰偔偩偝偄, p.163-7. 彲巌怣峴 (娽壢), 儊僨傿僇儖埁弌斉, 搶嫗, 2021/12敪峴.
620107. [妛弍彂 (暘扴幏昅)]亂妎偊偰偍偒偨偄恄宱娽壢幘姵 (2021擭12寧椪帪憹姧崋)亃I. 帇恄宱幘姵丂11. 栻嵻惈帇恄宱徢, 1311-7. 崅堜峃峴1, 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢), 嬥尨弌斉, 搶嫗, 2021/12, 敪峴.
620108. [妛弍彂 (暘扴幏昅)]亂妎偊偰偍偒偨偄恄宱娽壢幘姵 (2021擭12寧椪帪憹姧崋)亃III. 幬帇丒娽怳丂3. Sagging eye syndrome, p.1419-24. 殸尒宧巕1, 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢), 嬥尨弌斉, 搶嫗, 2021/12, 敪峴.
620109. [妛弍彂 (暘扴幏昅)]亂妎偊偰偍偒偨偄恄宱娽壢幘姵 (2021擭12寧椪帪憹姧崋)亃IV. 摰岴堎忢丂2. 摰岴嬞挘徢丒Adie徢岓孮, p.1443-5. 愇愳丂嬒 (堛椕塹惗妛晹), 嬥尨弌斉, 搶嫗, 2021/12, 敪峴.
620110. [妛弍彂 (暘扴幏昅)]亂帇擻妛 戞3斉亃[1] 婎慴堛妛戝梫丂I. 帇婍偺峔憿偲婡擻丂D. 娽偺帺棩恄宱/摰岴丒挷愡丒鐃柀, p.39-45. 愇愳丂嬒 (堛椕塹惗妛晹), 曇: 彫椦媊帯, 徏壀媣旤巕, 塒堜愮湪, 壀恀桼旤, 暥岝摪, 搶嫗, 2022/1, 敪峴.
620111. [妛弍彂 (暘扴幏昅)]亂帇擻妛 戞3斉亃[1] 婎慴堛妛戝梫丂I. 帇婍偺峔憿偲婡擻丂E. 娽埑丒朳悈, p.46-8. 彲巌怣峴 (娽壢), 曇: 彫椦媊帯, 徏壀媣旤巕, 塒堜愮湪, 壀恀桼旤, 暥岝摪, 搶嫗, 2022/1, 敪峴.
620112. [妛弍彂 (暘扴幏昅)]亂帇擻妛 戞3斉亃[2] 婎慴帇擻嫺惓妛丂I. 帇妎惗棟妛丂E. 怓妎, p.76-85. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢), 曇: 彫椦媊帯, 徏壀媣旤巕, 塒堜愮湪, 壀恀桼旤, 暥岝摪, 搶嫗, 2022/1, 敪峴.
620113. [妛弍彂 (暘扴幏昅)]亂帇擻妛 戞3斉亃[2] 婎慴帇擻嫺惓妛丂I. 帇妎惗棟妛丂G. 揹婥惗棟妛, p.90-105. 怴堜揷岶桾1,2 (1崙嵺堛椕暉巸戝妛, 2娽壢), 曇: 彫椦媊帯, 徏壀媣旤巕, 塒堜愮湪, 壀恀桼旤, 暥岝摪, 搶嫗, 2022/1, 敪峴.
620114. [妛弍彂 (暘扴幏昅)]亂帇擻妛 戞3斉亃[4] 帇擻忈奞妛丂II. 恄宱娽壢妛丂B. 妀忋惈娽媴塣摦堎忢, p.301-8. 岦栰榓梇 (娽壢), 曇: 彫椦媊帯, 徏壀媣旤巕, 塒堜愮湪, 壀恀桼旤, 暥岝摪, 搶嫗, 2022/1, 敪峴.
620115. [妛弍彂 (暘扴幏昅)]亂娽壢幘姵嵟怴偺帯椕2022-2024亃[姫摢僩僺僢僋僗] 8 孅愜嫺惓庤弍僈僀僪儔僀儞 (戞幍師摎怽), p.29-31. 恄扟榓岶 (堛椕塹惗妛晹), 曇: 懞忋丂徎, 敀愇丂撝 捯愳柧岶, 撿峕摪, 搶嫗, 2022/1敪峴.
620116. [妛弍彂 (暘扴幏昅)]亂娽壢幘姵嵟怴偺帯椕2022-2024亃IV 偦偺懠偺幘姵丂匓幬帇, 庛帇丂4 愭揤忋幬嬝杻醿, p.302. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢), 曇: 懞忋丂徎, 敀愇丂撝 捯愳柧岶, 撿峕摪, 搶嫗, 2022/1敪峴.
620117. [妛弍彂 (暘扴幏昅)]亂娽壢専嵏僈僀僪 戞3斉亃2. 孅愜専嵏丂1) 懠妎揑孅愜専嵏丂匑僆乕僩儗僼儔僋僩 (働儔僩) 儊乕僞, 匒億乕僞僽儖僆乕僩儗僼儔僋僩 (働儔僩) 儊乕僞, p.52-9. 愳庣揷戱巙1, 敿揷抦栫1 (1堛椕塹惗妛晹), 娔廋: 崻栘丂徍, 曇: 斞揷抦峅, 嬤摗曯惗, 拞懞丂惤, 嶳揷徆榓, 暥岝摪, 搶嫗, 2022/2, 敪峴.
620118. [妛弍彂 (暘扴幏昅)]亂娽壢専嵏僈僀僪 戞3斉亃5. 娽埵丒娽媴撍弌丒娽媴塣摦専嵏丂7) 懠妎揑帇婡擻専嵏, p.182-3. 敿揷抦栫 (堛椕塹惗妛晹), 娔廋: 崻栘丂徍, 曇: 斞揷抦峅, 嬤摗曯惗, 拞懞丂惤, 嶳揷徆榓, 暥岝摪, 搶嫗, 2022/2, 敪峴.
620119. [妛弍彂 (暘扴幏昅)]亂娽壢専嵏僈僀僪 戞3斉亃8. 怓妎専嵏丂5) 傾僲儅儘僗僐乕僾, p.230-5. 揷拞朏庽, 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢), 娔廋: 崻栘丂徍, 曇: 斞揷抦峅, 嬤摗曯惗, 拞懞丂惤, 嶳揷徆榓, 暥岝摪, 搶嫗, 2022/2, 敪峴.
620120. [妛弍彂 (暘扴幏昅)]亂娽壢専嵏僈僀僪 戞3斉亃9. 帇栰専嵏丂2) 帺摦帇栰寁 (惷揑帇栰専嵏)丂匒Octopus帇栰寁 (Pulsar帇栰), p.253-61. 暯郪堦朄1, 彲巌怣峴1 (1娽壢), 娔廋: 崻栘丂徍, 曇: 斞揷抦峅, 嬤摗曯惗, 拞懞丂惤, 嶳揷徆榓, 暥岝摪, 搶嫗, 2022/2, 敪峴.
620121. [妛弍彂 (暘扴幏昅)]亂娽壢専嵏僈僀僪 戞3斉亃10. 娽豳専嵏丂3) 傾僀僗僷僢僋僥僗僩, 僥儞僔儘儞僥僗僩 (恄宱丒嬝晧壸僥僗僩), p.334-5. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢), 娔廋: 崻栘丂徍, 曇: 斞揷抦峅, 嬤摗曯惗, 拞懞丂惤, 嶳揷徆榓, 暥岝摪, 搶嫗, 2022/2, 敪峴.
620122. [妛弍彂 (暘扴幏昅)]亂娽壢専嵏僈僀僪 戞3斉亃12. 妏枌丒寢枌丒悈徎懱専嵏丂11) 妏枌僸僗僥儕僔僗應掕, p402-3. 恄扟榓岶 (堛椕塹惗妛晹), 娔廋: 崻栘丂徍, 曇: 斞揷抦峅, 嬤摗曯惗, 拞懞丂惤, 嶳揷徆榓, 暥岝摪, 搶嫗, 2022/2, 敪峴.
620123. [妛弍彂 (暘扴幏昅)]亂娽壢専嵏僈僀僪 戞3斉亃13. 摰岴専嵏丂1) 摰岴宎寁應, 2) 摰岴斀墳専嵏, 3) 揰娽帋尡 (摰岴栻暔晧壸僥僗僩), 4) 愒奜慄摰岴寁, p.404-20. 愺愳丂尗1, 愇愳丂嬒1 (1堛椕塹惗妛晹), 娔廋: 崻栘丂徍, 曇: 斞揷抦峅, 嬤摗曯惗, 拞懞丂惤, 嶳揷徆榓, 暥岝摪, 搶嫗, 2022/2, 敪峴.
620124. [妛弍彂 (暘扴幏昅)]亂娽壢専嵏僈僀僪 戞3斉亃14. 娽撪儗儞僘搙悢寁應丂1) 娽撪儗儞僘搙悢寛掕偺棟榑, 2) 挻壒攇A儌乕僪娽幉挿寁應, 3) 岝妛幃娽幉挿寁應, p.421-30. 恄扟榓岶 (堛椕塹惗妛晹), 娔廋: 崻栘丂徍, 曇: 斞揷抦峅, 嬤摗曯惗, 拞懞丂惤, 嶳揷徆榓, 暥岝摪, 搶嫗, 2022/2, 敪峴.
620125. [妛弍彂 (暘扴幏昅)]亂娽壢専嵏僈僀僪 戞3斉亃21. 揹婥惗棟専嵏丂2) 恄宱娽壢幘姵偺揹婥惗棟妛揑専嵏丂匓懡嬊強EMG, p.674-5. 怴堜揷岶桾1,2 (1崙嵺堛椕暉巸戝妛, 2娽壢), 娔廋: 崻栘丂徍, 曇: 斞揷抦峅, 嬤摗曯惗, 拞懞丂惤, 嶳揷徆榓, 暥岝摪, 搶嫗, 2022/2, 敪峴.
[妛夛丒尋媶夛摍]
713046. [妛夛 (崙嵺)] (億僗僞乕) THREE-MONTH RESULTS OF OMIDENEPAG ISOPROPYL OPHTHALMIC SOLUTION 0.002%. Kasahara M1, Hirasawa K1, Kono Y1, Yoneyama R1, Shoji N1: 9th World Glaucoma Congress (2021/6/30), Web奐嵜. (妢尨惓峴1, 暯郪堦朄1, 壨栰梇椇1, 暷嶳丂椚1, 彲巌怣峴1: 1娽壢)
713047. [妛夛 (崙嵺)] (億僗僞乕) CHARACTERISTICS OF GLAUCOMA PATIENTS WITH INTRAOCULAR PRESSURE ELEVATION EARLY AFTER TRABECTOME SURGERY. Kono Y1, Kasahara M1, Hirasawa K1, Yoneyama R1, Ito A1, Ueyama K1, Shoji N1: 9th World Glaucoma Congress (2021/6/30), Web奐嵜. (壨栰梇椇1, 妢尨惓峴1, 暯郪堦朄1, 暷嶳丂椚1, 埳摗庨棟1, 忋嶳丂晼1, 彲巌怣峴1: 1娽壢)
713048. [妛夛 (崙嵺)] (億僗僞乕) EFFECT OF TRABECULECTOMY ON MEAN SURGICAL INDUCED丂ASTIGMATISM AND CENTROID VALUE. Ando W1, Kamiya K2, Iida Y1, Iijima K1, Tsujisawa T1, Fujimura F2, Kawamorita T2, Hoshikawa R2, Kasahara M1, Shoji N1: 9th World Glaucoma Congress (2021/6/30), Web奐嵜. (埨摗榓壧巕1, 恄扟榓岶2, 斞揷壝旻1, 斞搰丂宧1, 捯戲扖旻1, 摗懞晣幯巕2, 愳庣揷戱巙2, 姳愳棦奊2, 妢尨惓峴1, 彲巌怣峴1: 1娽壢, 2堛椕塹惗妛晹)
713049. [妛夛 (崙嵺)] (億僗僞乕) TWO YEAR RESULTS OF TRABECTOME SURGERY FOR CASES WITH PREOPERATIVE INTRAOCULAR PRESSURE OF LESS THAN 20 MMHG. Yoneyama R1, Kasahara M1, Hirasawa K1, Kono Y1, Shoji N1: 9th World Glaucoma Congress (2021/6/30), Web奐嵜. (暷嶳丂椚1, 妢尨惓峴1, 暯郪堦朄1, 壨栰梇椇1, 彲巌怣峴1: 1娽壢)
713050. [妛夛 (崙嵺)] (億僗僞乕) Comparison between the time required to take nine-direction ocular photographs using conventional method and a novel convenient application. Kunimi K1,2, Goseki T1,2, Shioya N1, Iijima Y1, Sebe M1, Fukaya K1, Hosoya K1: AAPOS2022 (2022/3/23), Web奐嵜. (殸尒宧巕1,2, 屻娭棙柧1,2: 1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢)
721015. [妛夛 (慡崙)] (摿暿島墘)亂嵗挿亃The Light Adjustable Lens: Implications for Patients and Doctors. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
721016. [妛夛 (慡崙)] (摿暿島墘)亂嵗挿亃敀撪忈庤弍帪婜偺椢撪忈娗棟. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
721017. [妛夛 (慡崙)] (摿暿島墘)亂嵗挿亃摿暿島墘. 恄扟榓岶 (堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/27), 墶昹 (僴僀僽儕僢僪奐嵜).
721018. [妛夛 (慡崙)] (摿暿島墘) 懡徟揰娽撪儗儞僘偲偺晅偒崌偄曽. 惔悈岞栫1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2崙嵺堛椕暉巸戝妛): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/27), 墶昹 (僴僀僽儕僢僪奐嵜).
722188. [妛夛 (慡崙)] (僔儞億僕僂儉) 抜奒揑悅捈捈嬝愗銯弍GVRT (graded vertical rectus tenotomy). 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/8), 戝嶃 (僴僀僽儕僢僪奐嵜).
722189. [妛夛 (慡崙)] (僔儞億僕僂儉) 傇偳偆枌埆惈崟怓庮偺椪彴宱夁偲僎僲儉夝愅 (Clinical course and genomic analysis findings of uveal melanoma). 攼栘峀嵠1,2, 尨丂徦晇1, 媑愳廃嵅1, 戝捤惓庽1, 埳摗埲抦榊1, 搉绮楉巕1, 屻摗孾夘1, 挬憅峅堣1, 悈岥杺屓1, 塝忋尋堦1, 廐嶳桋恖1, 嶳岥丂寶1 (1惷壀導棫惷壀偑傫僙儞僞乕, 2娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/8), 戝嶃 (僴僀僽儕僢僪奐嵜).
722190. [妛夛 (慡崙)] (嫵堢僙儈僫乕)亂嵗挿亃嫵堢僙儈僫乕1崅師廂嵎偲娽幘姵. 恄扟榓岶 (堛椕塹惗妛晹): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/9), 戝嶃 (僴僀僽儕僢僪奐嵜).
722191. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 悈徎懱偺壛楊曄壔丒敀撪忈偲崅師廂嵎 Age-related changes in crystalline lens, cataracts and higher order aberrations. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/9), 戝嶃 (僴僀僽儕僢僪奐嵜).
722192. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 妏枌幘姵偵偍偗傞庤弍揔墳偺峫偊曽 How to determine surgical indication for corneal diseases. 恄扟榓岶 (堛椕塹惗妛晹): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/9), 戝嶃 (僴僀僽儕僢僪奐嵜).
722193. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃僗儁僔儍儕僗僩偺娽撪儗儞僘 乣偙偩傢傝偺婎弨偲IOL慖戰乣. 彲巌怣峴 (娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/9), 戝嶃 (僴僀僽儕僢僪奐嵜).
722194. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕)亂嵗挿亃娽埑擔撪曄摦傪柧傜偐偵偡傞 乣怴偟偄専嵏婡婍傪巊偄偙側偦偆!乣. 彲巌怣峴 (娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/10), 戝嶃 (僴僀僽儕僢僪奐嵜).
722195. [妛夛 (慡崙)] (僒僽僗儁僔儍儕僥傿僒儞僨乕) 擼愐悜塼尭彮偵傛傞帇婡擻忈奞 (Visual disturbance of cerebrospinal fluid leakage). 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/11), 戝嶃 (僴僀僽儕僢僪奐嵜).
722196. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕) 棎帇嫺惓偺堄媊乣惓妋側棎帇嫺惓偑姁偊傞傕偺乣. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/11), 戝嶃 (僴僀僽儕僢僪奐嵜).
722197. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕) 棎帇嫺惓偺堄媊乣惓妋側棎帇嫺惓偑姁偊傞傕偺乣. 恄扟榓岶 (堛椕塹惗妛晹): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/11), 戝嶃 (僴僀僽儕僢僪奐嵜).
722198. [妛夛 (慡崙)] (島廗夛) 孅愜嫺惓庤弍丒崙撪奜偺尰忬偲崱屻偺揥朷. 恄扟榓岶 (堛椕塹惗妛晹): 戞125夞擔杮娽壢妛夛憤夛 (擔杮娽壢妛夛孅愜嫺惓庤弍島廗夛) (2021/4/26), Web奐嵜.
722199. [妛夛 (慡崙)] (島廗夛) 幬帇恌椕偺僺僢僩僼僅乕儖. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞125夞擔杮娽壢妛夛憤夛 (擔杮娽壢妛夛愱栧堛惂搙戞73夞島廗夛僾儘僌儔儉) (2021/4/26), Web奐嵜.
722200. [妛夛 (慡崙)] (JIPS僐乕僠儞僌僙儈僫乕)亂嵗挿亃柧擔偐傜栶棫偮帇栰専嵏: 尰応偺僲僂僴僂. 彲巌怣峴 (娽壢): 戞10夞擔杮帇栰夋憸妛夛妛弍廤夛 (2021/4/25), Web奐嵜.
722201. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃椢撪忈姵幰偝傫偺枹棃傊偺壦偗嫶. 彲巌怣峴 (娽壢): 戞10夞擔杮帇栰夋憸妛夛妛弍廤夛 (2021/4/25), Web奐嵜.
722202. [妛夛 (慡崙)] (夛挿婇夋) 3D價僕儏傾儖僔僗僥儉偺桳梡惈偵偮偄偰. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722203. [妛夛 (慡崙)] (摿暿曬崘) 僩乕儕僢僋娽撪儗儞僘傪巊偭偨棎帇惂屼敀撪忈庤弍. 巗愳堦晇1,2, 巗愳丂宑1, 庰堜岾峅1, 壛摗岾恗1, 摯堜棦奊1, 忢斦惞巌1, 彫搰棽巌3, 嬍抲柧栰4 (1拞嫗娽壢, 2娽壢, 3宑滀戝, 4JCHO拞嫗昦堾): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722204. [妛夛 (慡崙)] (僔儞億僕僂儉) 摰岴偲棎帇. 恄扟榓岶 (堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722205. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃敀撪忈庤弍乣媶嬌偺帇婡擻傪栚巜偟偰乣. 恄扟榓岶 (堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722206. [妛夛 (慡崙)] (僔儞億僕僂儉) 摿庩徢椺 (孅愜嫺惓庤弍屻, 墌悕妏枌, 僺僊乕僶僢僌) 傪嬌傔傞. 斞搰丂宧1, 恄扟榓岶2, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722207. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 慜娽晹岝姳徛抐憌寁偺夋憸偐傜悈徎懱偺愒摴晹埵抲傪梊應偡傞怴偟偄夝愅朄. 攏搱惔擛1, 巗愳丂宑2, 庰堜岾峅2, 曅壀悡攷3, 堥扟彯婸3, 拞懞桭徍3, 嬍抲柧栰4, 巗愳堦晇2,5 (1娽壢柧娽堾, 2拞嫗娽壢, 3柤屆壆傾僀僋儕僯僢僋, 4JCHO拞嫗昦堾, 5娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722208. [妛夛 (慡崙)] (嫵堢僙儈僫乕) ICL. 屲廫棐復巎 (嶳墹昦堾): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722209. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 恑峴惈墌悕妏枌偵懳偡傞Customized妏枌僋儘僗儕儞僉儞僌. 崅嫶惓塸1,2 (1娽壢, 2嶳墹昦堾傾僀僙儞僞乕): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722210. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 棎帇偺専嵏偲嫺惓朄. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722211. [妛夛 (慡崙)] (働乕僗儕億乕僩) IC-8?憓擖娽偵惗偠偨栐枌攳棧偵偍偄偰, 娽撪帇嬀暪梡徤巕懱庤弍偱栐枌暅埵傪摼偨堦椺. 媑壀榓庽1, 壛夑払巙1,3, 墶嶳丂隳1, 徏揷懽曘1, 彫搰棽巌2, 巗愳堦晇2,3 (1JCHO拞嫗昦堾, 2拞嫗娽壢, 3娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722212. [妛夛 (慡崙)] (働乕僗儕億乕僩) 儅儖僼傽儞徢岓孮偵傛傞悈徎懱曃埵偵偰掅擭楊帣偵庤弍傪巤峴偟偨徢椺. 墶嶳媑旤1, 壛夑払巙1,3, 巗愳堦晇2,3 (1JCHO拞嫗昦堾, 2拞嫗娽壢, 3娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722213. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃僗儁僔儍儕僗僩偺愭尒擵柧乣敀撪忈庤弍偲AMD帯椕乣. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722214. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 巹偼偙偙傪尒夁偛偝側偄!乣弍慜専嵏偲儗儞僘慖戰乣. 斞揷壝旻 (娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722215. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃敀撪忈孅愜嫺惓庤弍偵偍偗傞CASIA2偺桳梡惈. 恄扟榓岶 (堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722216. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) ATA傪梡偄偨ICL僒僀僘梊應幃 (KS幃). 屲廫棐復巎 (嶳墹昦堾): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
722217. [妛夛 (慡崙)] (夛挿婇夋) 嫮枌屌掕弍偵揔偟偨娽撪儗儞僘. 媑揷懃旻1, 巗愳堦晇2,3 (1婒晫愒廫帤昦堾, 2拞嫗娽壢, 3娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722218. [妛夛 (慡崙)] (摿暿曬崘) 敀撪忈弍慜惗懱寁應僨乕僞丒嵟揔娽撪儗儞僘搙悢寁嶼幃偺懡巤愝斾妑尋媶. 恄扟榓岶1, 椦丂丂尋2, 嵅摗惓庽3, 彫搰棽巌4, 屻摗寷恗5, 弶嶁撧捗巕6, 揷绯恀惗7, 揷暎恗巙7 (1堛椕塹惗妛晹, 2椦娽壢昦堾, 3僒僩僂娽壢, 4宑墳戝, 5屗揷偛偲偆娽壢, 6嬥戲堛戝, 7僣僇僓僉昦堾): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722219. [妛夛 (慡崙)] (摿暿曬崘) 娽撪儗儞僘曃埵丒棊壓偺懡巤愝嫟摨尋媶 (拞娫曬崘). 屻摗寷恗1, 恄扟榓岶2, 彫搰棽巌3, 嵅摗惓庽4, 揷暎恗巙5,6, 弶嶁撧捗巕7, 椦丂丂尋8 (1屗揷偛偲偆娽壢, 2堛椕塹惗妛晹, 3宑墳戝, 4僒僩僂娽壢, 5峀搰戝丒婑晬島嵗DT2M, 6僣僇僓僉昦堾, 7嬥戲堛戝, 8椦娽壢昦堾): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722220. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃懡徟揰IOL偺堿偺懳嶔. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722221. [妛夛 (慡崙)] (僔儞億僕僂儉) 嫮搙嬤帇娽偺棎帇嫺惓. 恄扟榓岶 (堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722222. [妛夛 (慡崙)] (僔儞億僕僂儉) 桳悈徎懱娽撪儗儞僘偺尰忬偲崱屻. 惔悈岞栫1,2 (1嶳墹昦堾, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722223. [妛夛 (慡崙)] (僔儞億僕僂儉) ICL偺枹棃 (榁帇懳墳ICL側偳). 屲廫棐復巎1,2 (1嶳墹昦堾, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722224. [妛夛 (慡崙)] (嫵堢僙儈僫乕)亂嵗挿亃帇婡擻丒慜娽晹昡壙傾僢僾僨乕僩. 恄扟榓岶 (堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722225. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 慜娽晹夋憸夝愅. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722226. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 懡徟揰娽撪儗儞僘偺揔惓巊梡. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722227. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗)亂僆乕僈僫僀僓乕亃悽奅偺嵟怴僩儗儞僪傪抦傠偆!乬What's New in 2021乭. 恄扟榓岶 (堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722228. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕) TECNIS僾儔僢僩僼僅乕儉偲TECNIS Simplicity偺巊梡宱尡. 斞揷壝旻 (娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722229. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕)亂嵗挿亃偙傟偐傜偺敀撪忈庤弍偼偙傟偱寛傑傝! 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722230. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃ZEISS Cataract Solution Part嘦. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722231. [妛夛 (慡崙)] (僀僽僯儞僌僙儈僫乕)亂嵗挿亃弍屻QOV丒QOL岦忋偺偨傔偺庢傝慻傒. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
722232. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃懡徟揰娽撪儗儞僘憓擖娽偺帇婡擻傊偺塭嬁場巕. 恄扟榓岶 (堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722233. [妛夛 (慡崙)] (僔儞億僕僂儉) 娽撪儗儞僘曃埵偲兩妏偺塭嬁. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722234. [妛夛 (慡崙)] (働乕僗儕億乕僩) 徟揰怺搙奼挘宆桳悈徎懱屻朳儗儞僘傪梡偄偨僴僀僽儕僢僪儌僲價僕儑儞. 屲廫棐復巎1,2, 惔悈岞栫1,2, 忢淎弐懢榊1,2 (1嶳墹昦堾, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722235. [妛夛 (慡崙)] (働乕僗儕億乕僩) 娧捠岴晅偒桳悈徎懱屻朳儗儞僘憓擖弍屻偵媫惈椢撪忈敪嶌傪棃偟偨1椺. 愇愳宐棦1, 屲廫棐復巎2,3, 峕攇屗旤榓1, 揷拞桽堦楴1, 彫郪拤旻1 (1彫戲娽壢撪壢昦堾, 2嶳墹昦堾, 3娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722236. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕)亂嵗挿亃Intense Pulsed Light (IPL) 帯椕亅弍屻惉愌仌枮懌搙岦忋偺怴偨側庤抜亅. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
722237. [妛夛 (慡崙)] (僀僽僯儞僌僙儈僫乕) A宆儃僣儕僰僗撆慺惢嵻儃僩僢僋僗?丂島廗丒幚媄僙儈僫乕乽幬帇乿幘姵曇. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞77夞擔杮庛帇幬帇妛夛憤夛 (2021/7/2), 恄撧愳 (僴僀僽儕僢僪奐嵜).
722238. [妛夛 (慡崙)] (島廗夛)亂嵗挿亃庛帇偲暋帇, 儘僕僢僋偲傾乕僩. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞77夞擔杮庛帇幬帇妛夛憤夛 (戞37夞擔杮庛帇幬帇妛夛島廗夛) (2021/7/3), 恄撧愳 (僴僀僽儕僢僪奐嵜).
722239. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕) 棎帇嫺惓偺乽幙乿傪壢妛偡傞. 敿揷抦栫 (堛椕塹惗妛晹): 僼僅乕僒儉2021愬戜 (2021/7/24), 愬戜 (僴僀僽儕僢僪奐嵜).
722240. [妛夛 (慡崙)] (婰擮島墘)亂嵗挿亃妛弍彠椼徿庴徿婰擮島墘. 恄扟榓岶 (堛椕塹惗妛晹): 戞57夞擔杮娽岝妛妛夛憤夛 (2021/9/4), Web奐嵜.
722241. [妛夛 (慡崙)] (僔儞億僕僂儉) 堦昩帇椡. 屲廫棐復巎1,2 (1嶳墹昦堾, 2娽壢): 戞57夞擔杮娽岝妛妛夛憤夛 (2021/9/4), Web奐嵜.
722242. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃孅愜傪嵞峫偡傞. 恄扟榓岶 (堛椕塹惗妛晹): 戞57夞擔杮娽岝妛妛夛憤夛 (2021/9/4), Web奐嵜.
722243. [妛夛 (慡崙)] (僔儞億僕僂儉) 擔杮恖柾宆娽偺廳梫惈. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞57夞擔杮娽岝妛妛夛憤夛 (2021/9/4), Web奐嵜.
722244. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 娽撪儗儞僘傪惗棟揑偵峫偊傞. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞57夞擔杮娽岝妛妛夛憤夛 (2021/9/4), Web奐嵜.
722245. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 張曽惉岟棪94%傪巟偊傞墦嬤CL偺岝妛摿惈. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞57夞擔杮娽岝妛妛夛憤夛 (2021/9/5), Web奐嵜.
722246. [妛夛 (慡崙)] (僨乕僞夝愅埾堳夛摿暿僙僢僔儑儞) Report from Glaucoma Blood Flow Research Group 椢撪忈寣棳尋媶斍曬崘. 彲巌怣峴 (娽壢): 戞32夞擔杮椢撪忈妛夛 (2021/9/10), 嫗搒 (僴僀僽儕僢僪奐嵜).
722247. [妛夛 (慡崙)] (JGS special session) Current Status and Issues of MIGS MIGS偺尰忬偲壽戣. 彲巌怣峴 (娽壢): 戞32夞擔杮椢撪忈妛夛 (2021/9/11), 嫗搒 (僴僀僽儕僢僪奐嵜).
722248. [妛夛 (慡崙)] (尋廋堛丒僐儊僨傿僇儖僾儘僌儔儉) How to use the kinetic perimetry in glaucoma diagnosis 椢撪忈恌抐偵偍偗傞摦揑帇栰寁偺億僀儞僩. 摗懞晣幯巕 (堛椕塹惗妛晹): 戞32夞擔杮椢撪忈妛夛 (2021/9/11), 嫗搒 (僴僀僽儕僢僪奐嵜).
722249. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃庡棳弌楬傪媶傔傞. 彲巌怣峴 (娽壢): 戞32夞擔杮椢撪忈妛夛 (2021/9/11), 嫗搒 (僴僀僽儕僢僪奐嵜).
722250. [妛夛 (慡崙)] (恵揷婰擮島墘) To protect visual acuity in glaucoma surgery 椢撪忈庤弍偱帇椡傪庣傞偨傔偵. 彲巌怣峴 (娽壢): 戞32夞擔杮椢撪忈妛夛 (2021/9/12), 嫗搒 (僴僀僽儕僢僪奐嵜).
722251. [妛夛 (慡崙)] (嫵堢僙儈僫乕)亂嵗挿亃椢撪忈偲暣傜傢偟偄幘姵. 彲巌怣峴 (娽壢): 戞32夞擔杮椢撪忈妛夛 (2021/9/12), 嫗搒 (僴僀僽儕僢僪奐嵜).
722252. [妛夛 (慡崙)] (嫵堢僙儈僫乕) Optic nerve disease confusing with glaucoma 椢撪忈偲傑偓傜傢偟偄帇恄宱幘姵. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 戞32夞擔杮椢撪忈妛夛 (2021/9/12), 嫗搒 (僴僀僽儕僢僪奐嵜).
722253. [妛夛 (慡崙)] (彽懸島墘摍)亂儌僨儗乕僞乕亃敀撪忈庤弍偵偍偗傞榁帇嫺惓偺嵟慜慄. 恄扟榓岶1, 愳庣揷戱巙1 (1堛椕塹惗妛晹): The 24th IRSJ (2021)/戞20夞娽壢椪彴婡婍尋媶夛 (2021/10/16), Web奐嵜.
722254. [妛夛 (慡崙)] (婎挷島墘) 揹巕孅愜椡壜曄娽嬀TouchFocus? 斞搰丂宧 (娽壢): The 24th IRSJ (2021)/戞20夞娽壢椪彴婡婍尋媶夛 (2021/10/16), Web奐嵜.
722255. [妛夛 (慡崙)] (傾僼僞僰乕儞僙儈僫乕)亂嵗挿亃椢撪忈栻暔帯椕傾僢僾僨乕僩. 彲巌怣峴 (娽壢): The 24th IRSJ (2021)/戞20夞娽壢椪彴婡婍尋媶夛 (2021/10/16), Web奐嵜.
722256. [妛夛 (慡崙)] (彽懸島墘摍)亂儌僨儗乕僞乕亃島墘嘥慜娽晹OCT: 傾儞僥儕僆儞. 妢尨惓峴 (娽壢): The 24th IRSJ (2021)/戞20夞娽壢椪彴婡婍尋媶夛 (2021/10/16), Web奐嵜.
722257. [妛夛 (慡崙)] (彽懸島墘摍) 椢撪忈娽偵懳偡傞傾儞僥儕僆儞偺墳梡. 暷嶳丂椚 (娽壢): The 24th IRSJ (2021)/戞20夞娽壢椪彴婡婍尋媶夛 (2021/10/16), Web奐嵜.
722258. [妛夛 (慡崙)] (彽懸島墘摍)亂儌僨儗乕僞乕亃島墘II ZEISS ARTEVO 800. 桍揷抭旻 (娽壢): The 24th IRSJ (2021)/戞20夞娽壢椪彴婡婍尋媶夛 (2021/10/16), Web奐嵜.
722259. [妛夛 (慡崙)] (彽懸島墘摍) ZEISS ARTEVO 800偺巊梡宱尡. 壨栰梇椇 (娽壢): The 24th IRSJ (2021)/戞20夞娽壢椪彴婡婍尋媶夛 (2021/10/16), Web奐嵜.
722260. [妛夛 (慡崙)] (彽懸島墘摍)亂儌僨儗乕僞乕亃島墘III 僼僃僀僐儅僔乕儞嵟慜慄. 斞揷壝旻 (娽壢): The 24th IRSJ (2021)/戞20夞娽壢椪彴婡婍尋媶夛 (2021/10/16), Web奐嵜.
722261. [妛夛 (慡崙)] (僔儞億僕僂儉) 栚偺捝傒偺僒僀僄儞僗: New Insight of Ocular Pain. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
722262. [妛夛 (慡崙)] (僔儞億僕僂儉) 娽晹埆惈庮釃帯椕偺怴偨側挭棳 (New trend of treatment for ocular malignant tumors). 攼栘峀嵠1,2 (1導棫惷壀偑傫僙儞僞乕, 2娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
722263. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗) 幬帇庤弍偺僌儘乕僶儖僗僞儞僟乕僪傪峫偊傞丂偦偺3. 挿扟晹憦1, 屻娭棙柧2,3, 栴儢嶈掝巌4, 椦丂岶梇5, 崻娸婱巙6 (1愳嶈堛戝, 2崙嵺堛椕暉巸戝妛擬奀昦堾, 3娽壢, 4娽壢傗偑偝偒堛堾, 5掗嫗戝堛椕媄弍, 6弴揤戝): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
722264. [妛夛 (慡崙)] (僔儞億僕僂儉)亂僆乕僈僫僀僓乕亃嵟怴偺岝攇挿偺峫偊曽 (Eye-opening Perspectives on Light Wavelengths). 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/29), 暉壀 (僴僀僽儕僢僪奐嵜).
722265. [妛夛 (慡崙)] (僔儞億僕僂儉) 棟憐偺娽撪儗儞僘暘岝摟夁摿惈. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/29), 暉壀 (僴僀僽儕僢僪奐嵜).
722266. [妛夛 (慡崙)] (僔儞億僕僂儉) 晄惓棎帇娽偵懳偡傞棎帇嫺惓偵僼僅乕僇僗! 恄扟榓岶 (堛椕塹惗妛晹): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/29), 暉壀 (僴僀僽儕僢僪奐嵜).
722267. [妛夛 (慡崙)] (僀僽僯儞僌僙儈僫乕)亂嵗挿亃嵤傝備偨偐偱岾偣側枹棃傪栚巜偟偰乣栐枌曇惉帯椕偺嵟慜慄偲怓嵤怱棟妛乣. 屲廫棐復巎1,2 (1嶳墹昦堾, 2娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/29), 暉壀 (僴僀僽儕僢僪奐嵜).
722268. [妛夛 (慡崙)] (僀僽僯儞僌僙儈僫乕) 僀僽僯儞僌僙儈僫乕丂僋儘乕僕儞僌儕儅乕僋僗. 惔悈岞栫1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/29), 暉壀 (僴僀僽儕僢僪奐嵜).
722269. [妛夛 (慡崙)] (僀僽僯儞僌僙儈僫乕) A宆儃僣儕僰僗撆慺惢嵻儃僩僢僋僗島廗丒幚媄僙儈僫乕乽娽豳醶澒/曅懁婄柺醶澒乿幘姵曇. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/29), 暉壀 (僴僀僽儕僢僪奐嵜).
722270. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗) 怓妎堎忢偺恌抐偲巜摫. 巗愳堦晇1,2, 拞懞塸庽3, 娾嵅恀婭4, 栛栰媣旤巕5, 拞懞偐偍傞6, 懞栘憗昪7, 攼堜恀棟巕8 (1拞嫗娽壢, 2娽壢, 3柤搶娽壢, 4帬夑堛戝, 5姞扟朙揷憤崌昦堾, 6彈巕堛戝, 7傓傜偒娽壢, 8娽壢攼堜堛堾): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/30), 暉壀 (僴僀僽儕僢僪奐嵜).
722271. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 摰岴堎忢娽偺敀撪忈庤弍丂摰岴偲帇婡擻, 懡徟揰IOL偺塭嬁. 恄扟榓岶 (堛椕塹惗妛晹): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/30), 暉壀 (僴僀僽儕僢僪奐嵜).
722272. [妛夛 (慡崙)] (傾僼僞僰乕儞僙儈僫乕) 敀撪忈庤弍偵媮傔傜傟傞3A乣埨怱丒埨慡丒埨掕乣娽幉挿應掕婍偑傕偨傜偡埨怱丒埨慡丒埨掕. 恄扟榓岶 (堛椕塹惗妛晹): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/30), 暉壀 (僴僀僽儕僢僪奐嵜).
722273. [妛夛 (慡崙)] (僔儞億僕僂儉) 擔杮椢撪忈妛夛偐傜偺梫朷. 彲巌怣峴 (娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/30), 暉壀 (僴僀僽儕僢僪奐嵜).
722274. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗) CT丒MRI偱傕偭偲傢偐傞!丂幬帇偺昦懺偲帯椕. 崻娸婱巙1, 嵅摗旤曐2, 悪嶳擻巕3, 旻扟柧巕3, 惣懞崄悷4,5, 屻娭棙柧6,7, 恄慜偁偄8 (1弴揤戝, 2昹徏堛戝, 3嬥戲戝, 4忋栰娽壢, 5惞楆昹徏昦堾, 6崙嵺堛椕暉巸戝妛擬奀昦堾, 7娽壢, 8僆儕儞僺傾娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/11/22), 僆儞僨儅儞僪攝怣.
722275. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗) 幚慔偐傜妛傇桳悈徎懱娽撪儗儞僘. 惔悈岞栫1,2, 恄扟榓岶3, 巗愳堦晇2,4, 拞懞桭徍5, 杒郪悽巙攷6, 崅嫶惓塸1,4, 恅惤堦榊7 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢, 3堛椕塹惗妛晹, 4拞嫗娽壢, 5柤屆壆傾僀僋儕僯僢僋, 6僒僺傾僞儚乕傾僀僋儕僯僢僋搶嫗, 7僗僇僀價儖娽壢堛堾): 戞75夞擔杮椪彴娽壢妛夛 (2021/11/22), 僆儞僨儅儞僪攝怣.
722276. [妛夛 (慡崙)] (島廗夛) 乽嵟嬤偺恑曕僔儕乕僘43乿IOL (揔墳丒弍幃丒崌暪徢丒挿婜梊屻) 揔墳偲弍慜専嵏. 恄扟榓岶 (堛椕塹惗妛晹): 戞75夞擔杮椪彴娽壢妛夛 (擔杮娽壢妛夛愱栧堛惂搙戞74夞島廗夛) (2021/11/22), 僆儞僨儅儞僪攝怣.
722277. [妛夛 (慡崙)] (島廗夛) 孅愜嫺惓庤弍丒崙撪奜偺尰忬偲崱屻偺揥朷. 恄扟榓岶 (堛椕塹惗妛晹): 戞75夞擔杮椪彴娽壢妛夛 (擔杮娽壢妛夛孅愜嫺惓庤弍島廗夛) (2021/11/22), 僆儞僨儅儞僪攝怣.
722278. [妛夛 (慡崙)] (僔儞億僕僂儉) 懖慠嫵堢偺棫応偐傜. 怴堜揷岶桾1,2,3 (1崙嵺堛椕暉巸戝妛, 2慡崙帇擻孭楙巑妛峑嫤夛夛挿, 3娽壢): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
722279. [妛夛 (慡崙)] (僆儞僨儅儞僪僙儈僫乕) 3嵨帣寬恌偵偍偗傞帇妎専嵏偺幚嵺. 摗懞晣幯巕 (堛椕塹惗妛晹): 戞62夞擔杮帇擻嫺惓妛夛 (2021/12/3), 僆儞僨儅儞僪攝怣.
722280. [妛夛 (慡崙)] (夛挿垾嶢) 夛挿垾嶢. 恄扟榓岶 (堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/26), 墶昹 (僴僀僽儕僢僪奐嵜).
722281. [妛夛 (慡崙)] (僀僽僯儞僌僙儈僫乕)亂嵗挿亃僌儗乕僪傾僢僾!丂弍屻娗棟 椢撪忈偑傜傒偺弍屻娗棟傪僌儗乕僪傾僢僾! 彲巌怣峴 (娽壢): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/26), 墶昹 (僴僀僽儕僢僪奐嵜).
722282. [妛夛 (慡崙)] (僀僽僯儞僌僙儈僫乕)亂嵗挿亃僌儗乕僪傾僢僾!丂弍屻娗棟丂敀撪忈弍屻娗棟偺億僀儞僩. 恄扟榓岶 (堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/26), 墶昹 (僴僀僽儕僢僪奐嵜).
722283. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕)亂嵗挿亃弍屻帇婡擻傪捛媮偡傞敀撪忈帯椕. 恄扟榓岶 (堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/27), 墶昹 (僴僀僽儕僢僪奐嵜).
722284. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕) 崅師旕媴柺宍忬傪桳偡傞怴偟偄扨徟揰娽撪儗儞僘乬TECNIS Eyhance乭偺岝妛摿惈. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/27), 墶昹 (僴僀僽儕僢僪奐嵜).
722285. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃庤弍儕僗僋偲敀撪忈庤弍愴棯. 恄扟榓岶 (堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/27), 墶昹 (僴僀僽儕僢僪奐嵜).
722286. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃塅拡堛妛偲恄宱娽壢. 愇愳丂嬒 (堛椕塹惗妛晹): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
722287. [妛夛 (慡崙)] (嫟嵜僙儈僫乕)亂嵗挿亃擔忢恌椕偑儚儞儔儞僋傾僢僾偡傞恄宱娽壢岥嵗. 愇愳丂嬒 (堛椕塹惗妛晹): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
722288. [妛夛 (慡崙)] (嫟嵜僙儈僫乕) 幬帇恌椕乣枹抦側傞椞堟傊乣. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
722289. [妛夛 (慡崙)] (嫟嵜僙儈僫乕) 帇恄宱墛偺媫惈婜帯椕偟偰偄傑偡偐?丂Before NMO偐傜with NMO傊. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
722290. [妛夛 (慡崙)] (帇擻孭楙巑僙儈僫乕) 摰岴専嵏. 愺愳丂尗 (堛椕塹惗妛晹): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
722291. [妛夛 (慡崙)] (憡択徢椺) Hysterical hemianopia條曅懁帹懁敿栍傪掓偟偨摿敪惈帇恄宱墛傪媈偆1椺. 墌扟峃桟1, 棿堜墤巕1, 嬥嶳弐夘1, 崅嫶梞暯1, 彲巌怣峴1, 愇愳丂嬒2 (1娽壢, 2堛椕塹惗妛晹): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
722292. [妛夛 (慡崙)] (憡択徢椺) 堦夁惈偵帇椡掅壓傪棃偟偨彫帣偺婾擕摢晜庮偺堦椺. 惓堜抭巕1, 娾嵅恀媩1,2, 嶳忋柧巕1,2, 庒憅夒搊1 (1堜忋娽壢昦堾, 2娽壢): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
722293. [妛夛 (慡崙)] (憡択徢椺) 尨場晄柧偺椉娽惈帇恄宱埾弅偺1椺. 惵嶳桽棦崄1, 郪懞桾惓1, 嶳忋柧巕2,3, 憡尨丂堦1 (1搶戝昦堾, 2堜忋娽壢昦堾, 3娽壢): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
722294. [妛夛 (慡崙)] (嫟嵜僙儈僫乕)亂嵗挿亃帇恄宱愐悜墛偲IL-6乣擼恄宱撪壢堛偺帇揰, 僒僩儔儕僘儅僽傪拞怱偵乣. 愇愳丂嬒 (堛椕塹惗妛晹): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723541. [妛夛 (慡崙)] (堦斒島墘) 敀撪忈庤弍偵偍偗傞暯嬒庝婲棎帇検偲僙儞僩儘僀僪抣偺斾妑 (Comparison of mean induced astigmatism and centroid value after cataract surgery). 恄扟榓岶1, 斞搰丂宧2, 埨摗榓壧巕2, 憗愳廏婸2, 崅嫶惓塸2, 彲巌怣峴2 (1堛椕塹惗妛晹, 2娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/8), 戝嶃 (僴僀僽儕僢僪奐嵜).
723542. [妛夛 (慡崙)] (堦斒島墘) Waterclefts偺僒僀僘丒嬊嵼偲帇婡擻亅岝妛僔儈儏儗乕僔儑儞偵傛傞夝愅亅(Impact of Waterclefts on visual function by optical simulation). 娭丂桽夘1, 愳庣揷戱巙2, 嶰揷揘戝1, 嶳嶈丂晳1, 媣曐峕棟1, 嵅乆栘梞1 (1嬥戲堛戝, 2堛椕塹惗妛晹): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/8), 戝嶃 (僴僀僽儕僢僪奐嵜).
723543. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃恄宱娽壢. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/8), 戝嶃 (僴僀僽儕僢僪奐嵜).
723544. [妛夛 (慡崙)] (堦斒島墘) 儗乕儀儖堚揱惈帇恄宱徢偺夞暅椺偺専摙 (Clinical feature of visual recovery cases in Leber hereditary optic neuropathy). 暉揷杻撧1, 嶳忋柧巕1,2, 墫愳旤嵷巕1, 娾嵅恀媩1, 堜忋尗帯1, 庒憅夒搊1, 愇愳丂嬒3, 埨杮棿攏4, 烴堜宑憿4 (1堜忋娽壢昦堾, 2娽壢, 3堛椕塹惗妛晹, 4椪専晹): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/8), 戝嶃 (僴僀僽儕僢僪奐嵜).
723545. [妛夛 (慡崙)] (妛弍揥帵) 慜娽晹岝姳徛抐憌寁偱嶣塭偝傟偨夋憸傪巊梡偟偨怴偟偄僸僩敀撪忈悈徎懱妀偺暘椶 (Classification as to the opacification of nucleus of human cataractous lens). 攏搱惔擛1, 巗愳丂宑2, 壛摗岾恗2, 庰堜岾峅2, 嬍抲柧栰3, 巗愳堦晇2,4 (1娽壢柧娽堾, 2拞嫗娽壢, 3JCHO拞嫗昦堾, 4娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/8), 戝嶃 (僴僀僽儕僢僪奐嵜).
723546. [妛夛 (慡崙)] (妛弍揥帵) 岝妛幃娽幉挿應掕憰抲偵偍偗傞媫惈嬿妏暵嵡徢偵娭楢偡傞場巕 (Factors related to acute primary angle closure in IOLmaster�700). 壨栰梇椇1, 妢尨惓峴1, 捯戲扖旻1, 暷嶳丂椚1, 暯郪堦朄1, 彲巌怣峴1 (1娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/8), 戝嶃 (僴僀僽儕僢僪奐嵜).
723547. [妛夛 (慡崙)] (妛弍揥帵) 娽撪儗儞僘曃埵傪敽傢偢偵悈徎懱屻曽場巕偵傛偭偰惗偠偨懕敪嬿妏暵嵡偺1椺 (A case of angle closure by retrolenticular mechanism without IOL dislocation). 憗愳廏婸1, 桍揷抭旻1, 彲巌怣峴1 (1娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/8), 戝嶃 (僴僀僽儕僢僪奐嵜).
723548. [妛夛 (慡崙)] (妛弍揥帵) 0.002%僆儈僨僱僷僌僀僜僾儘僺儖揰娽塼偺抁婜惉愌 (Short-term results of Omidenepag Isopropyl Ophthalmic Solution 0.002%). 妢尨惓峴 (娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/8), 戝嶃 (僴僀僽儕僢僪奐嵜).
723549. [妛夛 (慡崙)] (堦斒島墘) Hill-RBF朄Version 2.0偲Beta Version 3.0偺梊應惈偺斾妑 (Comparison of Predictability of the Hill-RBF method Version 2.0 and 3.0). 斞搰丂宧1, 恄扟榓岶2, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/9), 戝嶃 (僴僀僽儕僢僪奐嵜).
723550. [妛夛 (慡崙)] (堦斒島墘) 挻壒攇僠僢僾愭抂偺嵽幙偺堘偄偵傛傞攋擷儕僗僋偺昡壙 (Evaluation of capsule rupture risk by difference of material of ultrasonic tip). 巗愳丂宑1,2, 揷拞朏庽2, 忢斦惞巌2, 撪摗垽棟2, 巗愳楁巕2, 巗愳堦晇2,3 (1憤崌惵嶳昦堾, 2拞嫗娽壢, 3娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/9), 戝嶃 (僴僀僽儕僢僪奐嵜).
723551. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃桳悈徎懱娽撪儗儞僘. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/10), 戝嶃 (僴僀僽儕僢僪奐嵜).
723552. [妛夛 (慡崙)] (堦斒島墘) 娧捠岴晅偒屻朳宆桳悈徎懱娽撪儗儞僘偺挿婜椪彴惉愌 (Long-term clinical results of posterior-chamber phakic lens with central hole). 崅嫶惓塸1, 恄扟榓岶2, 憗愳廏婸1, 埨摗榓壧巕1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/10), 戝嶃 (僴僀僽儕僢僪奐嵜).
723553. [妛夛 (慡崙)] (堦斒島墘) 桳悈徎懱娽撪儗儞僘庤弍偍偗傞愗奐晹埵暿偺庝婲棎帇偺斾妑 (Comparison of surgical induced astigmatism after phakic intraocular lens surgery). 埨摗榓壧巕1, 恄扟榓岶2, 崅嫶惓塸1, 憗愳廏婸1, 屲廫棐復巎1,3, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹, 3嶳墹昦堾傾僀僙儞僞乕): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/10), 戝嶃 (僴僀僽儕僢僪奐嵜).
723554. [妛夛 (慡崙)] (堦斒島墘) 惓忢娽偵偍偗傞怓帇椡偺壛楊惈曄壔 Aging change of color visual acuity in normal eyes. 墶嶳丂隳1, 揷拞朏庽2, 摯堜棦奊2, 彫憼戱奀3, 拞懞塸庽4, 揷拞丂惔3, 巗愳堦晇2,5 (1JCHO拞嫗昦堾, 2拞嫗娽壢, 3怣廈戝, 4柤搶娽壢, 5娽壢): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/10), 戝嶃 (僴僀僽儕僢僪奐嵜).
723555. [妛夛 (慡崙)] (堦斒島墘) 僄僺僫僗僠儞墫巁墫0.1%偺摰岴偵懳偡傞嶌梡 Effect of epinastine hydrochloride 0.1% eye-drops on pupil diameter. 棿堜墤巕1, 暯郪堦朄1, 愺愳丂尗2, 愇愳丂嬒2, 媑晊寬巙3, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹, 3暉壀崙嵺堛椕暉巸戝): 戞125夞擔杮娽壢妛夛憤夛 (2021/4/10), 戝嶃 (僴僀僽儕僢僪奐嵜).
723556. [妛夛 (慡崙)] (堦斒島墘) 僩儔儀僋僩乕儉庤弍慜屻偺帇栰曄壔. 妢尨惓峴1, 壨栰梇椇1, 暯郪堦朄1, 暷嶳丂椚1, 彲巌怣峴1 (1娽壢): 戞10夞擔杮帇栰夋憸妛夛妛弍廤夛 (2021/4/24), Web奐嵜.
723557. [妛夛 (慡崙)] (堦斒島墘) 徠柧愝寁夝愅僜僼僩傪梡偄偨娽撪儗儞僘幉奜擖幩岝偺柪岝夝愅. 愳庣揷戱巙1, 敿揷抦栫1, 彲巌怣峴2 (1堛椕塹惗妛晹, 2娽壢): 戞10夞擔杮帇栰夋憸妛夛妛弍廤夛 (2021/4/24), Web奐嵜.
723558. [妛夛 (慡崙)] (堦斒島墘) 擼幘姵偵偍偗傞僿僢僪儅僂儞僩宆帇栰寁乽傾僀儌乿偲僴儞僼儕乕帇栰寁偺帇栰偺堦抳惈偺専摙. 嶁杮杻棦1, 郪懞桾惓2, 憡尨丂堦2, 屻娭棙柧3,4, 抮揷揘栫5, 愇愳丂嬒6, 拞懞丂惤1 (1恄屗戝, 2搶嫗戝, 3娽壢, 4崙嵺堛椕暉巸戝丒擬奀, 5嶳墹昦堾, 6堛椕塹惗妛晹): 戞10夞擔杮帇栰夋憸妛夛妛弍廤夛 (2021/4/24), Web奐嵜.
723559. [妛夛 (慡崙)] (堦斒島墘) 僀儊乕僕僈僀僪僔僗僥儉傪梡偄偨僩乕儕僢僋娽撪儗儞僘355T弍屻惉愌. 庰堜岾峅1, 彫搰棽巌2, 嬍抲柧栰3, 郪栘埢巕3, 塅懮宐巕1, 摯堜棦奊1, 壨栰鷘怢1, 巗愳堦晇1,4 (1拞嫗娽壢, 2宑滀戝, 3JCHO拞嫗昦堾, 4娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
723560. [妛夛 (慡崙)] (堦斒島墘) 庒擭憌偺嬤帇娽偵偍偗傞棁娽帇椡偲孅愜搙悢偺娭學. 忋嶳丂晼1, 恄扟榓岶2, 姳愳棦奊2, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
723561. [妛夛 (慡崙)] (堦斒島墘) 扨徟揰娽撪儗儞僘憓擖娽偺墦拞嬤嫍棧棁娽帇椡偺専摙. 壛摗岾恗1, 彫搰棽巌2, 嬍抲柧栰3, 揷拞朏庽1, 嶰揷懞杻棦1,4, 巗愳堦晇1,5 (1拞嫗娽壢, 2宑滀戝, 3JCHO拞嫗昦堾, 4婒晫愒廫帤昦堾, 5娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
723562. [妛夛 (慡崙)] (堦斒島墘) MiLoop傪巊梡偟偨敀撪忈庤弍偺弶婜庤弍巊梡帪偺昡壙. 巗愳丂宑1,2, 彫搰棽巌3, 庰堜岾峅2, 忢斦惞巌2, 巗愳楁巕2, 巗愳堦晇2,4 (1憤崌惵嶳昦堾, 2拞嫗娽壢, 3宑墳戝, 4娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
723563. [妛夛 (慡崙)] (堦斒島墘) 慄堐拰懷愗彍弍偑暯嬒庝婲棎帇傗廳怱抣偵媦傏偡塭嬁. 埨摗榓壧巕1, 恄扟榓岶2, 斞揷壝旻1, 斞搰丂宧1, 捯戲扖旻1, 摗懞晣嵅巕2, 姳愳棦奊2, 妢尨惓峴1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞36夞JSCRS妛弍憤夛 (2021/6/25), 搶嫗 (僴僀僽儕僢僪奐嵜).
723564. [妛夛 (慡崙)] (堦斒島墘) Zepto規⿹畱O鵑愗奐憰抲傪梡偄偨娽壢愱峌堛偵傛傞敀撪忈庤弍偺抁婜惉愌. 巙夑丂桪1, 彫搰棽巌2, 巗愳丂宑3, 嶰揷懞杻棦3, 揷拞朏庽3, 媑揷懃旻1, 巗愳堦晇3,4 (1婒晫愒廫帤昦堾, 2宑滀戝, 3拞嫗娽壢, 4娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723565. [妛夛 (慡崙)] (堦斒島墘) 敀撪忈庤弍偵偍偗傞ACTIVE CENTRY?僴儞僪僺乕僗偺巊梡偵傛傞塭嬁偺専摙. 郪栘埢巕1, 彫搰棽巌2,3, 撪摗垽棟3, 摯堜棦奊3, 巗愳堦晇3,4 (1JCHO拞嫗昦堾, 2宑滀戝, 3拞嫗娽壢, 4娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723566. [妛夛 (慡崙)] (堦斒島墘) 奜彎惈嶶摰媦傃擑嵤埾弅偵懳偟偰僔儕僐儞惢恖岥擑嵤堏怉弍傪巤峴偟偨2椺. 栰岥夽搇1, 郪栘埢巕1, 摯堜棦奊2, 彫搰棽巌2,3, 巗愳堦晇2,4 (1JCHO拞嫗昦堾, 2拞嫗娽壢, 3宑滀戝, 4娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723567. [妛夛 (慡崙)] (堦斒島墘) 敀撪忈庤弍拞偵梡偄偨堎側傞摰岴奼挘僨僶僀僗偵傛傞弍屻惉愌偺専摙. 嶰揷懞杻棦1,2, 彫搰棽巌1,3, 塅懮宐巕1, 嫶捾椙懢4, 郪栘埢巕4, 巗愳丂宑5, 巗愳堦晇1,6 (1拞嫗娽壢, 2婒晫愒廫帤昦堾, 3宑滀戝, 4JCHO拞嫗昦堾, 5憤崌惵嶳昦堾, 6娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723568. [妛夛 (慡崙)] (堦斒島墘) 寬忢娽偵偍偗傞Angle-to-Angle偺専摙. 塱悾弜婯1, 埳摗旤嵐奊1, 抮揷揘栫1, 惔悈岞栫1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723569. [妛夛 (慡崙)] (堦斒島墘) 墌悕妏枌梡Kane幃傪巊梡偟偨敀撪忈弍屻孅愜岆嵎偺懡巤愝尋媶. 壨栰愰怢1, 彫搰棽巌2, 嬍抲柧栰3, 壛摗岾恗1, 庰堜岾峅1, 摯堜棦奊1, 揷拞朏庽1, 巗愳堦晇1,4 (1拞嫗娽壢, 2宑滀戝, 3JCHO拞嫗昦堾, 4娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723570. [妛夛 (慡崙)] (堦斒島墘) 嬫暘孅愜棪傪梡偄偨挿丒抁娽幉挿娽偺敀撪忈弍屻梊應孅愜岆嵎偵娭偡傞専摙. 嬍抲柧栰1, 彫搰棽巌2, 嵅摗桾栫3, 棷庣椙懢4, 搉绮宧嶰5, 挿扟愳垷棦1, 郪栘埢巕1, 壛夑払巙1,7, 巗愳丂宑6, 巗愳堦晇6,7 (1JCHO拞嫗昦堾, 2宑滀戝, 3嵅摗桾栫娽壢, 4僩儊儌儕娽壢丒宍惉奜壢, 5撿戝嶃傾僀僋儕僯僢僋, 6拞嫗昦堾, 7娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723571. [妛夛 (慡崙)] (妛弍揥帵) 恑峴惈墌悕妏枌偵懳偡傞崅懍妏枌僋儘僗儕儞僉儞僌偺弍屻4擭娫偺惉愌. 挿扟愳垷棦1,2, 彫搰棽巌1,2,3, 惣揷抦栫2, 拞懞桭徍2, 壛夑払巙1,5, 巗愳堦晇4,5 (1JCHO拞嫗昦堾, 2柤屆壆傾僀僋儕僯僢僋, 3宑滀戝, 4拞嫗娽壢, 5娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/26), 搶嫗 (僴僀僽儕僢僪奐嵜).
723572. [妛夛 (慡崙)] (堦斒島墘) ICL偺僒僀僘曄峏屻偺Vault偺曄壔検. 拞懞桭徍1, 媑揷梲巕1, 悈栰懽巕1, 堥扟彯婸1, 惣揷抦栫1, 彫搰棽巌1,2, 巗愳堦晇3,4 (1柤屆壆傾僀僋儕僯僢僋, 2宑滀戝, 3拞嫗娽壢, 4娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
723573. [妛夛 (慡崙)] (堦斒島墘) Implantable collamer lens庤弍慜専嵏偵偍偗傞孅愜専嵏偵偮偄偰偺専摙. 摯堜棦奊1, 惣揷抦栫2, 彫搰棽巌3, 拞懞桭徍2, 巗愳堦晇1,4 (1拞嫗娽壢, 2柤屆壆傾僀僋儕僯僢僋, 3宑滀戝, 4娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
723574. [妛夛 (慡崙)] (堦斒島墘) 墌悕妏枌姵幰偵偍偗傞擔忢惗妶廗姷傾儞働乕僩挷嵏寢壥. 彫搰棽巌1, 惣揷抦栫2, 楅栘撧墰2, 拞懞桭徍2, 敀堜桪懢3, 搉晹丂娐3, 嵅摗桾栫3, 巗愳堦晇4,5 (1宑墳戝, 2柤屆壆傾僀僋儕僯僢僋, 3嵅摗桾栫娽壢堛堾, 4拞嫗娽壢, 5娽壢): 戞36夞JSCRS妛弍憤夛 (2021/6/27), 搶嫗 (僴僀僽儕僢僪奐嵜).
723575. [妛夛 (慡崙)] (堦斒島墘) 僆儞儔僀儞庼嬈偵傛傞嬤尒斀墳偺曄壔偲娽徢忬丒恎懱旀楯偺専摙. 尨丂捈恖1, 姍揷懽彶1, 巗栄棦曕1, 嵅摗晳栱1, 嵒尨塱棦巕1, 戧揷瀤嵷1, 忢斦桞崄1, 旘揷愮桾1, 崻杮抦揟1, 柸娧浠嵷1, 怴堜揷岶桾1,2 (1崙嵺堛椕暉巸戝妛曐寬堛椕妛晹, 2娽壢): 戞77夞擔杮庛帇幬帇妛夛憤夛 (2021/7/2), 恄撧愳 (僴僀僽儕僢僪奐嵜).
723576. [妛夛 (慡崙)] (堦斒島墘) 惣揷朄偑挊岠偟偨Duane徢岓孮1宆偺3椺. 抮揷峃恗1, 屻娭棙柧2,3, 愇愳宐棦1, 揷拞桾堦楴1, 彫戲拤旻1 (1彫戲娽壢撪壢昦堾, 2崙嵺堛椕暉巸戝妛擬奀昦堾, 3娽壢): 戞77夞擔杮庛帇幬帇妛夛憤夛 (2021/7/2), 恄撧愳 (僴僀僽儕僢僪奐嵜).
723577. [妛夛 (慡崙)] (堦斒島墘) 僨僕僞儖僨僶僀僗偑尨場偲巚傢傟傞屻揤嫟摨惈撪幬帇偺帯椕宱夁. 埨摗桭婭1, 屻娭棙柧1,2,3, 孨搰恀弮1, 姉惗恀棦1, 掃揷嵷揈1, 屗捤榓巕1, 烴堜棔巕1,2, 巗绯媊復1,2 (1恄撧愳帟戝丒墶昹, 2娽壢, 3崙嵺堛椕暉巸戝妛擬奀昦堾): 戞77夞擔杮庛帇幬帇妛夛憤夛 (2021/7/2), 恄撧愳 (僴僀僽儕僢僪奐嵜).
723578. [妛夛 (慡崙)] (堦斒島墘) 惗嶻擭楊傪懳徾偲偟偨娽埵偲孅愜堎忢偺娭學. 崅嫶怲栫1, 屻娭棙柧2,3, 栰揷怣屷1, 挿扟愳弜1, 愇愳宐棦1, 揷拞桾堦楴1, 彫戲拤旻1 (1彫戲娽壢撪壢昦堾, 2崙嵺堛椕暉巸戝妛擬奀昦堾, 3娽壢): 戞77夞擔杮庛帇幬帇妛夛憤夛 (2021/7/2), 恄撧愳 (僴僀僽儕僢僪奐嵜).
723579. [妛夛 (慡崙)] (堦斒島墘) 墦曽帇, 嬤曽帇偱撪幬帇傪掓偡傞Distance-independent esotropia偺娽鈢MRI夋憸偺摿挜. 壨崌垽幚1,2, 屻娭棙柧2,3, 愇愳丂嬒1,4, 棿堜墤巕2, 棝丂峠梲5, 晜廎棿懢榊6, 彲巌怣峴1,2 (1戝妛堾堛椕宯尋媶壢, 2娽壢, 3崙嵺堛椕暉巸戝妛擬奀昦堾, 4堛椕塹惗妛晹, 5庱搒堛壢戝杒嫗桭媌堛堾, 6曻幩慄 (夋憸)): 戞77夞擔杮庛帇幬帇妛夛憤夛 (2021/7/2), 恄撧愳 (僴僀僽儕僢僪奐嵜).
723580. [妛夛 (慡崙)] (妛弍揥帵) 摢埵堎忢偑Spot vision Screener偺應掕寢壥偵梌偊傞塭嬁. 悾晹垽旤1, 屻娭棙柧1,2, 墫扟捈巕1, 惎丂尓惉3 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢, 3崙嵺堛椕暉巸戝妛惉揷昦堾): 戞77夞擔杮庛帇幬帇妛夛憤夛 (2021/7/2), 恄撧愳 (僴僀僽儕僢僪奐嵜).
723581. [妛夛 (慡崙)] (妛弍揥帵) 夝棧惈擼摦柆釒偑尨場偱敪徢偟偨屻揤惈妸幵恄宱杻醿偺堦椺. 戝怷愮惞1,2, 屻娭棙柧1,3, 搉曈堦榊1, 挿扟愳塸柅1,2, 慞愊揘栫4 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2挿扟愳娽壢, 3娽壢, 4崙嵺堛椕暉巸戝妛擬奀昦堾擼恄宱奜壢): 戞77夞擔杮庛帇幬帇妛夛憤夛 (2021/7/3), 恄撧愳 (僴僀僽儕僢僪奐嵜).
723582. [妛夛 (慡崙)] (堦斒島墘) 僋儘僗儕儞僉儞僌巤峴屻僴乕僪僐儞僞僋僩儗儞僘傪憰梡偟偨墌悕妏枌偺妏枌宍忬. 孎擶屼摪棽1, 埳摗庨棟1, 崅嫶惓塸1, 嬥嶳弐夘1, 埨摗榓壧巕1, 塅捗尒媊堦1, 恄扟榓岶2, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 僼僅乕僒儉2021 (戞63夞擔杮僐儞僞僋僩儗儞僘妛夛憤夛) (2021/7/24), 愬戜 (僴僀僽儕僢僪奐嵜).
723583. [妛夛 (慡崙)] (堦斒島墘) 扨徟揰娽撪儗儞僘弍屻偺懡徟揰僐儞僞僋僩儗儞僘偲懡徟揰娽撪儗儞僘偺帇婡擻斾妑. 恄扟榓岶1, 怷丂梞惸2, 媨揷榓揟2, 暯壀岶峗3 (1堛椕塹惗妛晹, 2媨揷娽壢, 3拀攇戝): 僼僅乕僒儉2021 (戞63夞擔杮僐儞僞僋僩儗儞僘妛夛憤夛) (2021/7/24), 愬戜 (僴僀僽儕僢僪奐嵜).
723584. [妛夛 (慡崙)] (堦斒島墘) 敄柧壓偵偍偗傞孅愜媦傃帇婡擻曄壔. 斞捤払栫1, 愳庣揷戱巙2, 敿揷抦栫2, 愇愳丂嬒2 (1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹): 戞57夞擔杮娽岝妛妛夛憤夛 (2021/9/4), Web奐嵜.
723585. [妛夛 (慡崙)] (堦斒島墘) 岝攇挿惂屼儗儞僘傪梡偄偨庛帇娽偺僐儞僩儔僗僩姶搙岦忋岠壥偺専摙. 拞捤廏巌1, 敿揷抦栫2, 埳摗攷棽1, 搉绮抭恖1, 栛栰媣旤巕1 (1姞扟朙揷憤崌昦堾, 2堛椕塹惗妛晹): 戞57夞擔杮娽岝妛妛夛憤夛 (2021/9/5), Web奐嵜.
723586. [妛夛 (慡崙)] (堦斒岥墘)亂嵗挿亃娽弞娐. 彲巌怣峴 (娽壢): 戞32夞擔杮椢撪忈妛夛 (2021/9/10), 嫗搒 (僴僀僽儕僢僪奐嵜).
723587. [妛夛 (慡崙)] (堦斒岥墘) 曄暘嬤帡儀僀僘慄宍夞婣傪梡偄偨2偮偺怴偟偄帇栰應掕傾儖僑儕僘儉偲SITA-Fast偺斾妑 (Comparing new algorithms based on the variational Bayes linear regression and SITA-Fast). 徖郪桬婸1, 懞揷攷巎2, 挬壀丂椇3,4, 暯郪堦朄1, 徏栰朑堖1, 搰揷丂尗, 彲巌怣峴1 (1娽壢, 2搶嫗戝, 3惞楆昹徏昦堾, 4惞楆僋儕僗僩僼傽乕戝): 戞32夞擔杮椢撪忈妛夛 (2021/9/10), 嫗搒 (僴僀僽儕僢僪奐嵜).
723588. [妛夛 (慡崙)] (堦斒岥墘) 僩儔儀僋儘僩儈乕娽撪朄偵偍偗傞弍拞朳悈惷柆摦懺暿偺惉愌 (Evaluation of the effectiveness of ab internotrabeculotomy by aqueous humor outflow). 暷嶳丂椚1, 妢尨惓峴1, 壨栰梇椇1, 彲巌怣峴1 (1娽壢): 戞32夞擔杮椢撪忈妛夛 (2021/9/11), 嫗搒 (僴僀僽儕僢僪奐嵜).
723589. [妛夛 (慡崙)] (堦斒岥墘) Trabectome偲Microhook慄堐拰懷愗奐弍弍屻惉愌傪斾妑偡傞懡巤愝屻傠岦偒娤嶡尋媶 (Trabectome vs. Microhook Trabeculotomy Comparative Study; TramTrac Study). 惙悞懢楴1, 彲巌怣峴2, 扟屗惓庽3, 墶嶳丂桰4, 婽揷棽斖5, 彲巌戱暯6, 峚忋巙楴7, 釼摗梇懢8, 愇揷嫳巕9,10, 怉揷弐旻11, 拞懞丂惤1 (1恄屗戝, 2娽壢, 3搰崻戝, 4搶杒戝, 5嫗搒戝, 6嶉嬍堛戝, 7垽昋戝, 8徍榓戝, 9堜忋娽壢昦堾, 10搶朚戝丒戝嫶, 11擇杮徏娽壢昦堾): 戞32夞擔杮椢撪忈妛夛 (2021/9/11), 嫗搒 (僴僀僽儕僢僪奐嵜).
723590. [妛夛 (慡崙)] (堦斒岥墘) 椢撪忈姵幰偵偍偗傞愕柧傊偺塭嬁場巕偺専摙 (Factors affecting photophobia in glaucoma patients). 愒愇戲抭斂1, 摗懞晣嵅巕2, 奆愳桭寷1, 嵅摗怣擵1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞32夞擔杮椢撪忈妛夛 (2021/9/11), 嫗搒 (僴僀僽儕僢僪奐嵜).
723591. [妛夛 (慡崙)] (堦斒岥墘) 峈寣愷栻暈梡偺桳柍偵傛傞僩儔儀僋僩乕儉庤弍偺惉愌 (The effect of antithrombotic therapy in trabectome surgery). 壨栰梇椇1, 妢尨惓峴1, 暯郪堦朄1, 暷嶳丂椚1, 彲巌怣峴1 (1娽壢): 戞32夞擔杮椢撪忈妛夛 (2021/9/12), 嫗搒 (僴僀僽儕僢僪奐嵜).
723592. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃鄅夁庤弍2丂Filtration surgery 2. 彲巌怣峴 (娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
723593. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃墌悕妏枌/奼挘徢 1 Keratoconus/ectasia. 恄扟榓岶 (堛椕塹惗妛晹): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
723594. [妛夛 (慡崙)] (堦斒島墘) 恑峴惈儁儖乕僔僪妏枌曈墢曄惈偵懳偡傞僇僗僞儅僀僘僪妏枌僋儘僗儕儞僉儞僌偺椪彴惉愌. 崅嫶惓塸1,2, 恄扟榓岶3, 憗愳廏婸2, 捯戲扖旻2, 埨摗榓壧巕2, 彲巌怣峴2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢, 3堛椕塹惗妛晹): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
723595. [妛夛 (慡崙)] (堦斒島墘) 椢撪忈惈拞怱帇栰忈奞傪崌暪偟帇恄宱墛偲偺娪暿偵嬯椂偟偨Leber堚揱惈帇恄宱徢椺. 惵嶳桽棦崄1, 嶳忋柧巕2,3, 憡尨丂堦1, 郪懞桾惓1 (1搶嫗戝, 2堜忋娽壢昦堾, 3娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
723596. [妛夛 (慡崙)] (堦斒島墘) 崙撪懡巤愝嫟摨尋媶偵傛傞棊孄徢岓孮偵偍偗傞敀撪忈庤弍偺専摙 (戞1曬: 姵幰攚宨). 恄扟榓岶1, 嫿塃嬤攷峃2, 怷丂梞惸3, 媨揷榓揟3, 幠丂戶栫4, 彫搰棽巌5 (1堛椕塹惗妛晹, 2娽壢, 3媨揷娽壢, 4榋杮栘幠昦堾, 5宑墳戝): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
723597. [妛夛 (慡崙)] (堦斒島墘) 崙撪懡巤愝嫟摨尋媶偵傛傞棊孄徢岓孮偺敀撪忈庤弍偺専摙 (戞2曬: 庤弍傾僂僩僇儉). 怷丂梞惸1, 恄扟榓岶2, 嫿塃嬤攷峃3, 彫搰棽巌4, 幠丂戶栫5, 媨揷榓揟1 (1媨揷娽壢昦堾, 2堛椕塹惗妛晹, 3娽壢, 4宑滀戝, 5榋杮栘幠娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
723598. [妛夛 (慡崙)] (堦斒島墘) 慜娽晹岝姳徛抐憌嶣塭偵傛傞屻朳宆桳悈徎懱娽撪儗儞僘僒僀僘梊應幃 (KS幃ver.4). 屲廫棐復巎1,2, 壛摗幯栴崄1, 塱悾弜婯1, 惔悈岞栫1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
723599. [妛夛 (慡崙)] (堦斒島墘) Photorefractive Intrastromal Corneal Collagen Cross-Linking (PiXL) 偺椪彴惉愌. 彫搰棽巌1,2, 曅壀悡攷1, 惣揷抦栫1, 堥扟彯婸1, 媑揷梲巕1, 拞懞桭徍1, 巗愳堦晇3,4 (1柤屆壆傾僀僋儕僯僢僋, 2宑滀戝, 3拞嫗娽壢, 4娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
723600. [妛夛 (慡崙)] (堦斒島墘) 掅壛擖搙悢暘愡宆娽撪儗儞僘憓擖娽偺儗儞僘埵抲偲弍屻帇婡擻. 梎悈丂妛1,2, 惔悈岞栫1,2, 塱悾弜婯1, 屲廫棐復巎1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/28), 暉壀 (僴僀僽儕僢僪奐嵜).
723601. [妛夛 (慡崙)] (堦斒島墘) 擭楊暿偺懠妎揑夞慁曃埵搙偺専摙. 崅嫶怲栫1, 屻娭棙柧2,3, 栰揷怣屷1, 挿扟晹弜1, 愳栰曈揙1, 徏嶈戱栫1, 抮揷楑恗1, 愇愳宐棦1, 揷拞桾堦楴1, 彫戲拤旻1 (1彫戲娽壢撪壢昦堾, 2崙嵺堛椕暉巸戝妛擬奀昦堾, 3娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/29), 暉壀 (僴僀僽儕僢僪奐嵜).
723602. [妛夛 (慡崙)] (堦斒島墘) 嬥懏傾儗儖僊乕姵幰偵徤巕懱庤弍傪峴偭偨2徢椺. 奆愳桭寷1, 桍揷抭旻1, 弔栘悞岹1, 嵅摗怣擵1, 彲巌怣峴1 (1娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/30), 暉壀 (僴僀僽儕僢僪奐嵜).
723603. [妛夛 (慡崙)] (堦斒島墘) 娫寚惈奜幬帇偵懳偡傞撪捈嬝plication弍屻偺孅愜曄壔. 烴堜棔巕1,2, 屻娭棙柧1,2,3, 孨搰恀弮1, 巗绯媊復1,2, 彲巌怣峴2 (1恄撧愳帟戝墶昹僋儕僯僢僋, 2娽壢, 3崙嵺堛椕暉巸戝妛擬奀昦堾): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/30), 暉壀 (僴僀僽儕僢僪奐嵜).
723604. [妛夛 (慡崙)] (堦斒島墘) 僗僥傿乕僾妏枌娽偵懳偡傞娽撪儗儞僘搙悢寁嶼幃偺梊應惈偺斾妑. 斞搰丂宧1, 恄扟榓岶2, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/31), 暉壀 (僴僀僽儕僢僪奐嵜).
723605. [妛夛 (慡崙)] (堦斒島墘) 嬤帇LASIK屻偺娽撪儗儞僘搙悢寁嶼幃偺斾妑. 忢淎弐懢榊1,2,3, 惔悈岞栫1,2, 嵅摗丂巌2, 抮揷揘栫1,2,3, 屲廫棐復巎1,2, 梎悈丂妛1,2,3 (1嶳墹昦堾傾僀僙儞僞乕, 2崙嵺堛椕暉巸戝, 3娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/10/31), 暉壀 (僴僀僽儕僢僪奐嵜).
723606. [妛夛 (慡崙)] (妛弍揥帵) 儅僀僋儘僷儖僗栄條懱岝嬅屌弍, 偍傛傃捛壛椢撪忈庤弍偺惉愌. 捯戲扖旻1, 彲巌怣峴1, 妢尨惓峴1, 壨栰梇椇1 (1娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/11/22), 僆儞僨儅儞僪攝怣.
723607. [妛夛 (慡崙)] (妛弍揥帵) 屻朳宆桳悈徎懱娽撪儗儞僘悅捈屌掕偵偍偗傞vault偺宱帪曄壔偲孅愜傊偺塭嬁. 埨摗榓壧巕1, 恄扟榓岶2, 憗愳廏婸1, 捯戲扖旻1, 崅嫶惓塸1,3, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹, 3嶳墹昦堾傾僀僙儞僞乕): 戞75夞擔杮椪彴娽壢妛夛 (2021/11/22), 僆儞僨儅儞僪攝怣.
723608. [妛夛 (慡崙)] (妛弍揥帵) 墦帇梷惂帯椕揑妏枌愗彍弍 (HC-PTK) 偲廬棃PTK偺帇椡丒孅愜曄壔偺斾妑. 憗愳廏婸1, 恄扟榓岶2, 埨摗榓壧巕1, 捯戲扖旻1, 崅嫶惓塸1,3, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹, 3嶳墹昦堾傾僀僙儞僞乕): 戞75夞擔杮椪彴娽壢妛夛 (2021/11/22), 僆儞僨儅儞僪攝怣.
723609. [妛夛 (慡崙)] (妛弍揥帵) Soemmering椫傪敽偆栄條懱僽儘僢僋偵傛傞懕敪暵嵡嬿妏偺1椺. 抮懞桳妿1, 斞揷壝旻1, 崅栘寴懢榊1, 桍揷抭旻1, 彲巌怣峴1 (1娽壢): 戞75夞擔杮椪彴娽壢妛夛 (2021/11/22), 僆儞僨儅儞僪攝怣.
723610. [妛夛 (慡崙)] (堦斒島墘) 嬤帇偺夁嫺惓娽嬀憰梡壓偱偺僗儅乕僩僼僅儞偺巊梡偑撪幬帇偺桿場偲側偭偨1徢椺. 旸揷嵷墰1, 栴栰丂棽1, 憡郪戝曘2,3, 恄嶳偲傛傒2,3 (1奀榁柤僾儔僓, 2奀榁柤憤崌昦堾, 3娽壢): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723611. [妛夛 (慡崙)] (堦斒島墘) Total Keratometry傪梡偄偨LASIK屻娽偵偍偗傞敀撪忈弍屻孅愜岆嵎偺専摙. 惣懞偁偐偹1, 彫搰棽巌2, 嬍抲柧栰3, 庰堜岾峅1, 巗愳堦晇1,4 (1拞嫗娽壢, 2宑墳媊弇戝妛, 3JHCO拞嫗昦堾, 4娽壢): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723612. [妛夛 (慡崙)] (億僗僞乕) 擭挿帣偵偍偗傞撉傒擻椡偲帇婡擻堎忢偲偺娭學. 壀栰恀媩1, 崅嫶桼巏1, 嵅摗丂巌1, 幗尨旤婓1, 撪愳媊榓1, 怴堜揷岶桾1,2 (1崙嵺堛椕暉巸戝丒帇婡擻椕朄, 2娽壢): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723613. [妛夛 (慡崙)] (億僗僞乕) 惷揑棫埵帪偵偍偗傞妸摦惈捛廬娽媴塣摦晧壸帪偺廳怱摦梙偺廃攇悢摿惈偵偮偄偰偺専摙. 撪愳媊榓1, 峳堜旤曚1, 崟愳垽栱擳1, 嵅摗墌崄1, 帥嶳旤曚1, 惗揷栚旤奀1, 搉绯丂戝1, 壀栰恀媩1, 崅嫶桼巏1, 怴堜揷岶桾1,2 (1崙嵺堛椕暉巸戝丒帇婡擻椕朄, 2娽壢): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723614. [妛夛 (慡崙)] (億僗僞乕) 挿娽幉娽偵偍偗傞娽幉挿應掕帪偺屌帇忬懺偲孅愜岆嵎偺娭楢惈偺専摙. 塅懮宐巕1, 彫搰棽巌2, 摯堜棦奊1, 墶嶳丂隳3, 揷拞朏庽1, 庰堜岾峅1, 梋揷愮宐1, 嬍抲柧栰3, 巗愳堦晇1,4 (1拞嫗娽壢, 2宑墳媊弇戝妛, 3JHCO拞嫗昦堾, 4娽壢): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723615. [妛夛 (慡崙)] (億僗僞乕) 娽豳醶澒姵幰傊偺幷岝娽嬀張曽. 拞懞廐曚1, 搚巘偐偝偹1, 幠揷戱栫2, 埳摗桾旤3, 堫堜棽懢4, 愇堜桽巕1, 撿塤丂姴1, 嶳忋柧巕1,5, 堜忋尗帯1 (1堜忋娽壢昦堾, 2惣妺惣丒堜忋娽壢昦堾, 3戝媨丒堜忋娽壢僋儕僯僢僋, 4嶥杫丒堜忋娽壢僋儕僯僢僋, 5娽壢): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723616. [妛夛 (慡崙)] (億僗僞乕) 娽壢専嵏寢壥偺昞婰曽朄偵娭偡傞傾儞働乕僩挷嵏. 暷揷丂崉1,2, 墶揷晀巕2,3, 揷栰忋嫳巕2,4, 嫑廧榓戙2,5, 怴堜揷岶桾2,6,7 (1愳嶈堛暉戝, 2慡崙帇擻孭楙巑妛峑嫤夛, 3戝嶃堛暈, 4戝暘帇擻愱, 5惣嫵堛, 6崙嵺堛暉戝, 7娽壢) 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723617. [妛夛 (慡崙)] (億僗僞乕) 堎側傞慜娽晹OCT偺ICL僒僀僘寛掕偵娭梌偡傞僷儔儊乕僞偺斾妑. 揷懞尗惗1, 彫搰棽巌2, 嬍抲柧栰3, 壛摗岾恗1, 摯堜棦奊1, 巗愳丂宑4, 巗愳堦晇1,5 (1拞嫗娽壢, 2宑墳戝, 3JCHO拞嫗昦堾, 4憤崌惵嶳昦堾, 5娽壢): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723618. [妛夛 (慡崙)] (億僗僞乕) 9曽岦娽埵幨恀偺嶣塭曽朄偺堘偄偵傛傞強梫帪娫偺斾妑. 墫扟捈巕1, 屻娭棙柧1,2, 斞搰桼壚1, 悾晹垽旤1, 怺扟丂嫗1, 嵶扟壴椩1 (1崙嵺堛椕暉巸戝擬奀, 2娽壢): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723619. [妛夛 (慡崙)] (堦斒島墘) 帇妎桿敪揹埵傪梡偄偨儌僲價僕儑儞偵偍偗傞椉娽壛廳偺昡壙. 幗尨旤婓1, 嵅摗丂巌1, 怴堜揷岶桾1,2 (1崙嵺堛椕暉巸戝, 2娽壢): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/21), 搶嫗 (僴僀僽儕僢僪奐嵜).
723620. [妛夛 (慡崙)] (堦斒島墘) 懠妎揑帇婡擻専嵏憰抲ORTeEYENAC傪梡偄偨AI帺摦敾掕曗彆偺帋傒. 埳摗庨棟1, 屗捤丂屽1, 敿揷抦栫2, 愇愳丂嬒2, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞62夞擔杮帇擻嫺惓妛夛 (2021/11/21), 搶嫗 (僴僀僽儕僢僪奐嵜).
723621. [妛夛 (慡崙)] (堦斒島墘) 棊孄徢岓孮偺敀撪忈庤弍慜屻偵偍偗傞悈徎懱偲娽撪儗儞僘偺曃怱偲孹幬偺掕検揑専摙. 嫿塃嬤攷峃1, 恄扟榓岶2, 斞揷壝旻1, 斞搰丂宧1, 墶娭桽壚巕1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/26), 墶昹 (僴僀僽儕僢僪奐嵜).
723622. [妛夛 (慡崙)] (堦斒島墘) 敀撪忈弍慜惗懱寁應憰抲ANTERION偲IOL Master700偺斾妑. 彫愳浠撧1, 恄扟榓岶2, 埨摗榓壧巕1, 愒愇戲抭斂1, 斞搰丂宧1, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/26), 墶昹 (僴僀僽儕僢僪奐嵜).
723623. [妛夛 (慡崙)] (堦斒島墘) IOLMaster700偲OA-2000偵傛傞惗懱寁應抣偲敀撪忈弍屻偺孅愜岆嵎偺斾妑. 徏栰朑堖1, 恄扟榓岶2, 摗懞晣幯巕2, 斞搰丂宧1, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/26), 墶昹 (僴僀僽儕僢僪奐嵜).
723624. [妛夛 (慡崙)] (堦斒島墘) Waterclefts偺宍忬偑帇婡擻偵媦傏偡塭嬁亅岝妛僔儈儏儗乕僔儑儞偵傛傞夝愅亅. 娭丂桽夘1, 愳庣揷戱巙2, 塋帞桽婸1, 嶰揷揘戝1, 嶳嶈丂晳1, 媣曐峕棦1, 嵅乆栘梞1 (1嬥戲堛戝, 2堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/26), 墶昹 (僴僀僽儕僢僪奐嵜).
723625. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃庤弍傾僂僩僇儉. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/26), 墶昹 (僴僀僽儕僢僪奐嵜).
723626. [妛夛 (慡崙)] (堦斒島墘) 挻娽幉挿娽偵懳偡傞掅搙悢娽撪儗儞僘偺梊應惈偺専摙. 斞搰丂宧1, 恄扟榓岶2, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/26), 墶昹 (僴僀僽儕僢僪奐嵜).
723627. [妛夛 (慡崙)] (堦斒島墘) 懡巤愝偱僀儊乕僕僈僀僪僔僗僥儉傪巊梡偟偨僩乕儕僢僋娽撪儗儞僘偺弍屻憗婜惉愌. 巗愳丂宑1,2, 彫搰棽巌3, 嵅摗桾擵4, 媑揷懃旻5, 庰堜岾峅2, 摯堜棦奊2, 屻摗丂廋1, 巗愳楁巕2, 巗愳堦晇2,6 (1憤崌惵嶳昦堾, 2拞嫗娽壢, 3宑滀戝, 4嵅摗桾栫娽壢, 5婒晫愒廫帤昦堾, 6娽壢): 戞60夞擔杮敀撪忈妛夛憤夛丒戞47夞悈徎懱尋媶夛 (2021/11/26), 墶昹 (僴僀僽儕僢僪奐嵜).
723628. [妛夛 (慡崙)] (堦斒岥墘) 2019擭偺儗乕儀儖堚揱惈帇恄宱徢偺怴婯敪徢幰悢偵娭偡傞塽妛挷嵏. 崅栰巎惗1, 忋揷崄怐1, 嶳忋柧巕2,3, 愇愳桾恖4, 拞攏廏庽5, 愇愳丂嬒6, 抮揷峃攷5, 拞懞丂惤1 (1恄屗戝妛, 2堜忋娽壢昦堾, 3娽壢, 4暫屔堛壢戝妛昦堾, 5媨嶈戝妛, 6堛椕塹惗妛晹): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
723629. [妛夛 (慡崙)] (堦斒岥墘) m.12811T>C儈僩僐儞僪儕傾堚揱巕曄堎傪擣傔偨帯椕掞峈惈帇恄宱墛偺堦椺. 崅嫶梞暯1,2, 愇愳丂嬒3, 棿堜墤巕2, 嬥嶳弐夘2, 埨杮棿攏4, 嶗堜宑憿4, 彲巌怣峴2 (1搶嫗彈巕堛壢戝妛敧愮戙堛椕僙儞僞乕, 2娽壢, 3堛椕塹惗妛晹, 4椪専晹): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
723630. [妛夛 (慡崙)] (堦斒岥墘) 寣塼忩壔椕朄屻偵儗乕儀儖昦偲恌抐偝傟偨3椺. 媨扟桽庽1, 娾嵅恀媩1,2, 嶳忋柧巕1,2, 堜忋尗帯1, 庒憅夒搊1, 愇愳丂嬒3, 埨杮棿攏4, 嶗堜宑憿4 (1堜忋娽壢昦堾, 2娽壢, 3堛椕塹惗妛晹, 4椪専晹): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/17), 搶嫗 (僴僀僽儕僢僪奐嵜).
723631. [妛夛 (慡崙)] (堦斒岥墘)亂嵗挿亃帇恄宱嘨. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723632. [妛夛 (慡崙)] (堦斒岥墘) 杒棦戝妛偵偍偗傞帇恄宱幘姵偺椪彴揑摿挜. 嬥嶳弐夘1,2, 愇愳丂嬒3, 棿堜墤巕2, 壨崌垽幚1,2, 崅嫶梞暯2,4, 彲巌怣峴2 (1戝妛堾堛椕宯尋媶壢, 2娽壢, 3堛椕塹惗妛晹, 4搶嫗彈巕堛壢戝妛敧愮戙堛椕僙儞僞乕): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723633. [妛夛 (慡崙)] (堦斒岥墘) COVID-19偺mRNA儚僋僠儞愙庬屻偵敪徢偟偨椉娽惈帇恄宱墛偺堦椺. 嶳嶈旤崄1, 娾嵅恀媩1,2, 嶳忋柧巕1, 墫愳旤嵷巕1, 堜忋尗帯1, 庒憅夒搊1 (1堜忋娽壢昦堾, 2娽壢): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723634. [妛夛 (慡崙)] (堦斒岥墘) 昿斏側堦夁惈曅娽惈帇妎忈奞傪棃偡庒擭偺挬婄徢岓孮偺堦椺. 娾嵅恀媩1,2, 嶳忋柧巕1,2, 堜忋尗帯1, 庒憅夒搊1 (1堜忋娽壢昦堾, 2娽壢): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723635. [妛夛 (慡崙)] (堦斒岥墘) 慡恎杻悓偵傛傞懠妎揑孅愜抣傊偺塭嬁. 壨崌垽幚1,2, 愇愳丂嬒3, 棿堜墤巕2, 嬥嶳弐夘1,2, 拞郪埢擳4, 徏揷峅旤4, 壀杮峗巏4, 彲巌怣峴2 (1戝妛堾堛椕宯尋媶壢, 2娽壢, 3堛椕塹惗妛晹, 4杻悓): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723636. [妛夛 (慡崙)] (堦斒岥墘) 椢撪忈姵幰偵偍偗傞愒奜慄摰岴寁傪梡偄偨懳岝斀幩偺専摙. 斞捤払栫1, 愇愳丂嬒2, 徖郪桬婸3, 愺愳丂尗2, 彲巌怣峴3 (1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3娽壢): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723637. [妛夛 (慡崙)] (堦斒岥墘)亂嵗挿亃娽鈢. 攼栘峀嵠1,2 (1惷壀導棫惷壀偑傫僙儞僞乕, 2娽壢): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
723638. [妛夛 (慡崙)] (堦斒岥墘) 埑敆惈帇恄宱徢偱敪尒偝傟偨歬恄宱夎嵶朎庮偺庒擭彈惈椺. 奆愳桭寷1, 愇愳丂嬒2, 棿堜墤巕1, 嬥嶳弐夘1, 崅嫶梞暯1, 拞愳錆桽3, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹, 3昦棟): 戞59夞擔杮恄宱娽壢妛夛憤夛 (2021/12/18), 搶嫗 (僴僀僽儕僢僪奐嵜).
731053. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) MIGS偺尰忬偲婜懸. 彲巌怣峴 (娽壢): 椷榓3擭搙惷壀導搶晹娽壢僼僅乕儔儉 (2021/5/27), Web奐嵜.
731054. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 懍峌棟夝丒嵟怴偺帇恄宱墛. 愇愳丂嬒 (堛椕塹惗妛晹): 戞12夞搶奀摴娽壢尋媶夛 (2021/6/19), Web奐嵜.
731055. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 椢撪忈庤弍偲帇婡擻. 彲巌怣峴 (娽壢): 戞152夞峀搰導娽壢堛夛島廗夛 (2021/10/3), Web奐嵜.
731056. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)亂嵗挿亃摿暿島墘. 彲巌怣峴 (娽壢): 戞57夞杒棦戝妛丒恄撧愳導娽壢堛夛崌摨儕僒乕僠僇儞僼傽儗儞僗 (2021/10/7), Web奐嵜.
731057. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 椢撪忈庤弍偲帇婡擻. 彲巌怣峴 (娽壢): 戞2夞Yokohama Ophthalmic Meeting (2021/11/2), Web奐嵜.
731058. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)亂夝愢亃Sagging Eye Syndrome. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 峅慜娽幘姵僼僅乕儔儉2021 (2021/11/6), 惵怷 (僴僀僽儕僢僪奐嵜).
731059. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 椢撪忈庤弍偲庤弍. 彲巌怣峴 (娽壢): 帇妎傪岇傞丒庢傝栠偡2021 (2021/11/14), 媨忛 (僴僀僽儕僢僪奐嵜).
731060. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 偙偙傑偱曄傢偭偨!丂墌悕妏枌偺嵟怴帯椕乣CuRV, PiXL偐傜AI恌抐傑偱乣. 恄扟榓岶 (堛椕塹惗妛晹): 戞41夞嬥戲堛壢戝妛娽壢尋媶夛 (2021/11/14), Web奐嵜.
731061. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 椢撪忈庤弍偺僞僀儈儞僌傪峫偊傞. 彲巌怣峴 (娽壢): 戞42夞偝偞側傒娽壢尋媶夛 (2021/11/20), 帬夑.
731062. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)亂嵗挿亃摿暿島墘2. 恄扟榓岶 (堛椕塹惗妛晹): 戞18夞徝撿娽壢嬩妝晹 (2022/1/13), 姍憅.
731063. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)亂嵗挿亃摿暿島墘. 彲巌怣峴 (娽壢): 戞19夞杒棦娽壢昦恌楢実夛 (2022/1/20), Web奐嵜.
731064. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 僩儔儀僋儗僋僩儈乕屻偺帇婡擻. 妢尨惓峴 (娽壢): 戞19夞杒棦娽壢昦恌楢実夛 (2022/1/20), Web奐嵜.
731065. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 徢椺偐傜妛傫偩巹偺恄宱娽壢亅変擼棤偵崗傑傟偟徢椺亅. 愇愳丂嬒 (堛椕塹惗妛晹): 戞6夞傂偲傒僱僢僩偺夛 (2022/1/22), 柤屆壆 (僴僀僽儕僢僪奐嵜).
731066. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)亂嵗挿亃摿暿島墘. 彲巌怣峴 (娽壢): 戞14夞恄撧愳僋儘僗僆乕僶乕僔儞億僕僂儉 (2022/2/5), Web奐嵜.
731067. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 恄宱娽壢専嵏偺棊偲偟寠偲戝愗側偙偲. 愺愳丂尗 (堛椕塹惗妛晹): 傒傗偓帇擻孭楙巑偺夛 (2022/2/13), Web奐嵜.
731068. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 巹偺恄宱娽壢-擼棤偵崗傑傟偨朰傟傜傟側偄徢椺偲偦偙偐傜妛傫偩傕偺. 愇愳丂嬒 (堛椕塹惗妛晹): YOKOHAMA RETINA NIGHT season6 (2022/2/17), 墶昹 (僴僀僽儕僢僪奐嵜).
731069. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)亂嵗挿亃摿暿島墘. 彲巌怣峴 (娽壢): 戝捤椢撪忈WEB僙儈僫乕 (2022/2/25), Web奐嵜.
731070. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)亂嵗挿亃摿暿島墘嘥. 彲巌怣峴 (娽壢): 戞3夞SENJU Glaucoma Seminar (2022/3/9), Web奐嵜.
731071. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 椢撪忈偺帇婡擻傪峫偊傞. 彲巌怣峴 (娽壢): 戞4夞Visual Function Seminar in Saitama (2022/3/11), Web奐嵜.
731072. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 戞擇偺榁娽乣僒僊儞僌傾僀徢岓孮乣. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞115夞晉嶳戝妛娽壢椪彴僇儞僼傽儗儞僗 44632 Web奐嵜.
732084. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 棳弌楬嵞寶弍屻偺崌暪徢娗棟偲栻暔娗棟乣嵟嬤偺僌儔僫僥僢僋偺榖戣傕娷傔偰乣. 妢尨惓峴 (娽壢): Kowa Web Conference (2021/4/20), Web奐嵜.
732085. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘2. 彲巌怣峴 (娽壢): 戞15夞偝偑傒娽壢尋媶夛 (2021/6/17), Web奐嵜.
732086. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 椢撪忈帯椕偺傾僢僾僨乕僩. 妢尨惓峴 (娽壢): 戞15夞偝偑傒娽壢尋媶夛 (2021/6/17), Web奐嵜.
732087. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 姵幰偝傫偺偨傔偵乬抦偭偰偍偔傋偒偦偺抦幆乭偲乬偦偺弨旛乭乣儗儞僘偺惈擻, 摿挜偐傜峫偊偰偄偔乣. 愳庣揷戱巙 (堛椕塹惗妛晹): 嶲揤惢栻WEB島墘夛 (2021/7/15), Web奐嵜.
732088. [妛夛 (抧曽夛丒尋媶夛)] (婎挷島墘)亂嵗挿亃婎挷島墘1. 桍揷抭旻 (娽壢): 戞3夞杒棦戝妛娽壢拑榖夛 (2021/7/17), Web奐嵜.
732089. [妛夛 (抧曽夛丒尋媶夛)] (婎挷島墘) 娽壢堛11擭栚, 彫帣堛椕偲娽豳庤弍. 棿堜墤巕 (娽壢): 戞3夞杒棦戝妛娽壢拑榖夛 (2021/7/17), Web奐嵜.
732090. [妛夛 (抧曽夛丒尋媶夛)] (婎挷島墘)亂嵗挿亃婎挷島墘2. 恄扟榓岶 (堛椕塹惗妛晹): 戞3夞杒棦戝妛娽壢拑榖夛 (2021/7/17), Web奐嵜.
732091. [妛夛 (抧曽夛丒尋媶夛)] (婎挷島墘) 梤枌堏怉偺楌巎偲崱屻偺揥朷. 愳杒揘栫 (娽壢): 戞3夞杒棦戝妛娽壢拑榖夛 (2021/7/17), Web奐嵜.
732092. [妛夛 (抧曽夛丒尋媶夛)] (擣掕島廗夛) 娽豳醶澒丂恌抐偲帯椕. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛娽壢, 2娽壢): 戞36夞恀掃僙儈僫乕 (2021/8/21), Web奐嵜.
732093. [妛夛 (抧曽夛丒尋媶夛)] (傾僪僶僀僓乕) 椢撪忈栻暔帯椕偵偮偄偰. 妢尨惓峴1, 壨栰梇椇1 (1娽壢): 傾僪僶僀僓乕Dr.彽阗婇夋 (愮庻) (2021/9/16), 恄撧愳.
732094. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂夝愢亃Sagging Eye Syndrome. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛娽壢, 2娽壢): 戝嶃堛壢栻壢戝妛娽壢僆乕僾儞僇儞僼傽儗儞僗 (2021/9/16), Web奐嵜.
732095. [妛夛 (抧曽夛丒尋媶夛)] (幮撪尋廋夛) 徤巕懱庤弍. 桍揷抭旻 (娽壢): 嶲揤惢栻幮撪尋廋夛 (2021/9/22), Web奐嵜.
732096. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 寣娗怴惗椢撪忈偺庤弍惉愌. 妢尨惓峴 (娽壢): 徝撿FRONTIER TODAY乣柧擔偐傜巊偊傞娽壢帯椕傪傾僢僾僨乕僩乣 (2021/9/28), Web奐嵜.
732097. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) JCHO憡柾栰昦堾丂娽壢偺徯夘. 弔擔堜峢巕1,2 (1憡柾栰昦堾, 2娽壢): 徝惣娽壢島廗夛 (2021/10/2), Web奐嵜.
732098. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 暘偐傝傗偡偄娽岝妛乣椪彴偱偺帇椡丒孅愜偵娭偡傞媈栤偵偮偄偰峫偊傞乣. 愳庣揷戱巙 (堛椕塹惗妛晹): 徝惣娽壢島廗夛 (2021/10/2), Web奐嵜.
732099. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂夝愢亃Sagging Eye Syndrome. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛娽壢, 2娽壢): 嶉嬍導娽壢嫵堢島墘夛 (2021/10/3), Web奐嵜.
732100. [妛夛 (抧曽夛丒尋媶夛)] (徢椺敪昞)亂嵗挿亃僩儔儀僋儗僋僩儈乕偺奺戝妛偺庤媄偺億僀儞僩偵偮偄偰. 彲巌怣峴 (娽壢): 戞37夞NG夛 (2021/10/5), Web奐嵜.
732101. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘)亂嵗挿亃嫵堢島墘. 桍揷抭旻 (娽壢): 戞57夞杒棦戝妛丒恄撧愳導娽壢堛夛崌摨儕僒乕僠僇儞僼傽儗儞僗 (2021/10/7), Web奐嵜.
732102. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 徤巕懱庤弍偺揔墳偲帯椕. 奆愳桭寷 (娽壢): 戞57夞杒棦戝妛丒恄撧愳導娽壢堛夛崌摨儕僒乕僠僇儞僼傽儗儞僗 (2021/10/7), Web奐嵜.
732103. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃庤弍徢椺偺峫嶡. 斞揷壝旻 (娽壢): 戞13夞僐儖僯傾僼僃僀僐僙儈僫乕 (2021/10/21), Web奐嵜.
732104. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) Marfan徢岓孮偺悈徎懱曃埵偵懳偟, 悈徎懱鵑奼挘儕儞僌暪梡Sulcus-Subcapsular fixation傪巤峴偟偨1椺. 墶娭桽壚巕 (娽壢): 戞13夞僐儖僯傾僼僃僀僐僙儈僫乕 (2021/10/21), Web奐嵜.
732105. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃RVO偺娽掙僀儊乕僕儞僌偲帯椕愴棯. 桍揷抭旻 (娽壢): 戞12夞徝惣娽壢傾僇僨儈乕 (2021/11/11), Web奐嵜.
732106. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃娽庮釃偵懳偡傞奜壢揑帯椕偺幚嵺. 愇愳丂嬒 (堛椕塹惗妛晹): 戞12夞徝惣娽壢傾僇僨儈乕 (2021/11/11), Web奐嵜.
732107. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 徢椺偐傜妛傇帇恄宱墛亅帇恄宱墛敪嶌梊杊惗暔惢嵻2020亅. 愇愳丂嬒 (堛椕塹惗妛晹): 戞1夞帇恄宱愐悜墛Web僙儈僫乕 (2021/11/29), Web奐嵜.
732108. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘)亂嵗挿亃嫵堢島墘. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞31夞彫帣娽壢 (幬帇丒庛帇) 徢椺専摙夛丒曌嫮夛 (2021/12/9), Web奐嵜.
732109. [妛夛 (抧曽夛丒尋媶夛)] (徢椺専摙)亂嵗挿亃徢椺専摙. 愇愳丂嬒 (堛椕塹惗妛晹): 戞31夞彫帣娽壢 (幬帇丒庛帇) 徢椺専摙夛丒曌嫮夛 (2021/12/9), Web奐嵜.
732110. [妛夛 (抧曽夛丒尋媶夛)] (徢椺専摙) 桳悈徎懱娽撪儗儞僘憓擖屻撪幬帇偲挷愡醶澒傪敪徢偟偨1椺. 愒愇戲抭斂 (娽壢): 戞31夞彫帣娽壢 (幬帇丒庛帇) 徢椺専摙夛丒曌嫮夛 (2021/12/9), Web奐嵜.
732111. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 奜娽嬝媦傃奜娽嬝巟帩慻怐偺堎忢偲僗億乕僣帇妎. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞12夞擔杮僗億乕僣帇妎尋媶夛 (2021/12/12), Web奐嵜.
732112. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘1. 恄扟榓岶 (堛椕塹惗妛晹): 戞67夞徝惣娽壢椪彴僼僅乕儔儉 (2021/12/16), 挰揷 (僴僀僽儕僢僪奐嵜).
732113. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘2. 彲巌怣峴 (娽壢): 戞67夞徝惣娽壢椪彴僼僅乕儔儉 (2021/12/16), 挰揷 (僴僀僽儕僢僪奐嵜).
732114. [妛夛 (抧曽夛丒尋媶夛)] (幮撪尋廋夛) 崅楊幰偺暋帇亅Sagging Eye Syndrome傪棟夝偡傞亅. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 愮庻惢栻幮撪島墘夛 (2022/1/7), 惷壀 (僴僀僽儕僢僪奐嵜).
732115. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 摐擜昦偵傛傞, 栐枌徢埲奜偺娽崌暪徢偵偮偄偰. 桍揷抭旻 (娽壢): 戞97夞偝偑傒摐擜昦僇儞僼傽儗儞僗 (2022/1/21), Web奐嵜.
732116. [妛夛 (抧曽夛丒尋媶夛)] (僨傿僗僇僢僔儑儞)亂巌夛亃僨傿僗僇僢僔儑儞. 愇愳丂嬒 (堛椕塹惗妛晹): NMOSD崌摨僇儞僼傽儗儞僗 (2022/1/26), Web奐嵜.
732117. [妛夛 (抧曽夛丒尋媶夛)] (僨傿僗僇僢僔儑儞) NMOSD偺恌椕壢楢実偲偦傟偧傟偺帇揰嫟桳丂僨傿僗僇僢僒儞僩. 屻娭棙柧11,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): NMOSD崌摨僇儞僼傽儗儞僗 (2022/1/26), Web奐嵜.
732118. [妛夛 (抧曽夛丒尋媶夛)] (徢椺曬崘) 娽鈢撪懁暻崪愜屻偵奐嶶杻醿條偺撪幬帇傪偒偨偟偨1椺. 愇揷丂嬇1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞14夞恄撧愳僋儘僗僆乕僶乕僔儞億僕僂儉 (2022/2/5), Web奐嵜.
732119. [妛夛 (抧曽夛丒尋媶夛)] (徢椺採帵) 椢偺僉僘僫匓擄帯惈椢撪忈偺懳墳. 彲巌怣峴 (娽壢): 椢偺鉐2022 (2022/2/15), Web奐嵜.
732120. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃師悽戙偺帇栰専嵏傾儖僑儕僘儉. 彲巌怣峴 (娽壢): AP-7700Web僇儞僼傽儗儞僗 (2022/2/18), Web奐嵜.
732121. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 嵗挿. 彲巌怣峴 (娽壢): 戞7夞帇妎惗棟妛婎慴僙儈僫乕 (2022/2/20), Web奐嵜.
732122. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘1. 彲巌怣峴 (娽壢): 戞68夞徝惣娽壢椪彴僼僅乕儔儉 (2022/3/3), Web奐嵜.
732123. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘2. 恄扟榓岶 (堛椕塹惗妛晹): 戞68夞徝惣娽壢椪彴僼僅乕儔儉 (2022/3/3), Web奐嵜.
732124. [妛夛 (抧曽夛丒尋媶夛)] (徢椺専摙)亂嵗挿亃徢椺専摙. 愳杒揘栫 (娽壢): 戞21夞傔偞偣!僐儖僱傾偺揝恖 (2022/3/4), 搶嫗.
732125. [妛夛 (抧曽夛丒尋媶夛)] (徢椺専摙) 恑峴惈墌悕妏枌偵懳偡傞Customized妏枌僋儘僗儕儞僉儞僌偺擭楊暿弍屻帇婡擻丒枮懌搙偺専摙. 屻摗揷揘巎1,2 (1娽壢, 2搶朚戝妛堛椕僙儞僞乕戝怷昦堾): 戞21夞傔偞偣!僐儖僱傾偺揝恖 (2022/3/4), 搶嫗.
732126. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 孅愜嫺惓庤弍偺揔墳偲慖戰. 恄扟榓岶 (堛椕塹惗妛晹): 戞20夞娽壢恌椕傾僢僾僨乕僩僙儈僫乕 2022 in Kyoto (2022/3/13), 嫗搒 (僴僀僽儕僢僪奐嵜).
732127. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 孅愜嫺惓庤弍傾僢僾僨乕僩2022. 恄扟榓岶 (堛椕塹惗妛晹): 戞31夞柖搰娽壢尋鑢夛 (2022/3/19), Web奐嵜.
733189. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 媠懸偵傛傞擕梒帣摢晹奜彎 (AHT=Abusive Head Trauma in Infants and Children) 偐傜栐枌弌寣傪擣傔偨1椺. 墌扟峃桟1,2, 嶰戭弐擵1,2, 抮揷揘栫1,2,3, 惣杮峗擵1,2, 彲巌怣峴1 (1娽壢, 2墶恵夑巗棫偆傢傑偪昦堾, 3嶳墹昦堾): 戞13夞恄撧愳娽壢妛夛丒戞134夞恄撧愳導娽壢廤択夛 (2021/5/30), Web奐嵜.
733190. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 偆偭寣擕摢偺帯椕偵嬯椂偟偨恑峴惈崪姴堎宍惉徢偺1椺. 戝峕垻巕1,2, 屻娭棙柧1,3, 棿堜墤巕1, 愇愳丂嬒4, 彲巌怣峴1 (1娽壢, 2奀榁柤憤崌昦堾, 3崙嵺堛椕暉巸戝妛擬奀昦堾, 4堛椕塹惗妛晹): 戞13夞恄撧愳娽壢妛夛丒戞134夞恄撧愳導娽壢廤択夛 (2021/5/30), Web奐嵜.
733191. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) Vogt-彫桍-尨揷昦偵懳偡傞僗僥儘僀僪僷儖僗椕朄7擭屻偵曅娽嵞敪傪偒偨偟偨1椺. 烴堜棔巕1, 嵅摗怣擵1, 桍揷抭旻1, 弔栘悞岹1, 奆愳桭寷1, 彲巌怣峴1 (1娽壢): 戞13夞恄撧愳娽壢妛夛丒戞134夞恄撧愳導娽壢廤択夛 (2021/5/30), Web奐嵜.
733192. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) Hill-RBF朄Version3.0偺梊應惈偲Barrett Universal II幃丒SRK/T幃偲偺斾妑. 斞搰丂宧1, 恄扟榓岶2, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞13夞恄撧愳娽壢妛夛丒戞134夞恄撧愳導娽壢廤択夛 (2021/5/30), Web奐嵜.
733193. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 昿斏側堦夁惈帇妎忈奞傪婲偙偟偨挬婄徢岓孮偺堦椺. 娾嵅恀媩1,2 (1堜忋娽壢, 2娽壢): 戞36夞恀掃僙儈僫乕 (2021/8/21), Web奐嵜.
733194. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 埑敆惈帇恄宱徢偱敪尒偝傟偨歬恄宱夎嵶朎庮偺庒擭彈惈椺. 奆愳桭寷1, 愇愳丂嬒2, 棿堜墤巕1, 嬥嶳弐夘1,3, 崅嫶梞暯1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢): 戞36夞恀掃僙儈僫乕 (2021/8/21), Web奐嵜.
733195. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) Hysterical hemianopia條曅懁帹懁敿栍傪掓偟偨摿敪惈帇恄宱墛傪媈偆1椺. 墌扟峃桟 (娽壢): 戞36夞恀掃僙儈僫乕 (2021/8/21), Web奐嵜.
733196. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 帇恄宱墛? 嫊寣惈帇恄宱徢? 嶳忋柧巕1,2 (1堜忋娽壢, 2娽壢): 戞36夞恀掃僙儈僫乕 (2021/8/21), Web奐嵜.
733197. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣)亂嵗挿亃堦斒墘戣. 妢尨惓峴 (娽壢): 戞57夞杒棦戝妛丒恄撧愳導娽壢堛夛崌摨儕僒乕僠僇儞僼傽儗儞僗 (2021/10/7), Web奐嵜.
733198. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 椉懁娽豳庮挴傪掓偟偨挻崅楊幰偺娽鈢傾儈儘僀僪乕僔僗偺堦椺. 戝夑怲暯1, 愇愳丂嬒2, 棿堜墤巕1, 嬥嶳弐夘1,3, 墶娭桽壚巕1, 惎栰徍朏4, 悪杮壚崄5, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢, 4昦棟, 5宍惉丒旤奜): 戞57夞杒棦戝妛丒恄撧愳導娽壢堛夛崌摨儕僒乕僠僇儞僼傽儗儞僗 (2021/10/7), Web奐嵜.
733199. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 僽儕儌僯僕儞乛僽儕儞僝儔儈僪攝崌揰娽栻偺帯椕惉愌. 墌扟峃桟1, 妢尨惓峴1, 壨栰梇椇1, 暷嶳丂椚1, 堜尨錆撨旤1, 彲巌怣峴1 (1娽壢): 戞57夞杒棦戝妛丒恄撧愳導娽壢堛夛崌摨儕僒乕僠僇儞僼傽儗儞僗 (2021/10/7), Web奐嵜.
733200. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 撦揑奜彎屻偵悈徎懱屻鵑偑攋楐偟悈徎懱妀偑扙塒偟偨1椺. 抮懞桳妿1, 奆愳桭寷1, 嵅摗怣擵1, 桍揷抭旻1, 彲巌怣峴1 (1娽壢): 戞57夞杒棦戝妛丒恄撧愳導娽壢堛夛崌摨儕僒乕僠僇儞僼傽儗儞僗 (2021/10/7), Web奐嵜.
733201. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 墌悕妏枌偵懳偡傞妏枌撪儕儞僌偑椉娽偲傕偵帺慠扙弌偟偨1椺. 屻摗揷揘巎1,2, 崅嫶惓塸1, 憗愳廏婸1, 恄扟榓岶3, 彲巌怣峴1 (1娽壢, 2搶朚戝妛堛椕僙儞僞乕戝怷昦堾, 3堛椕塹惗妛晹): 戞57夞杒棦戝妛丒恄撧愳導娽壢堛夛崌摨儕僒乕僠僇儞僼傽儗儞僗 (2021/10/7), Web奐嵜.
733202. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) Marfan徢岓孮偺悈徎懱曃埵偵懳偟, 悈徎懱鵑奼挘儕儞僌暪梡Sulcus-Subcapsular fixation傪巤峴偟偨1椺. 墶娭桽壚巕1, 斞揷壝旻1, 斞搰丂宧1, 抮懞桳妿1, 戝夑怲暯1, 彲巌怣峴1 (1娽壢): 戞57夞杒棦戝妛丒恄撧愳導娽壢堛夛崌摨儕僒乕僠僇儞僼傽儗儞僗 (2021/10/7), Web奐嵜.
733203. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣)亂嵗挿亃堦斒墘戣. 愇愳丂嬒 (堛椕塹惗妛晹): 戞19夞杒棦娽壢昦恌楢実夛 (2022/1/20), Web奐嵜.
733204. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 杒棦戝妛昦堾娽壢愱栧奜棃偺徯夘丂妏枌丒孅愜嫺惓斍. 憗愳廏婸 (娽壢): 戞19夞杒棦娽壢昦恌楢実夛 (2022/1/20), Web奐嵜.
733205. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 杒棦戝妛昦堾娽壢愱栧奜棃偺徯夘丂幬帇丒恄宱斍. 棿堜墤巕 (娽壢): 戞19夞杒棦娽壢昦恌楢実夛 (2022/1/20), Web奐嵜.
733206. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 杒棦戝妛昦堾娽壢愱栧奜棃偺徯夘丂栐枌徤巕懱斍. 桍揷抭旻 (娽壢): 戞19夞杒棦娽壢昦恌楢実夛 (2022/1/20), Web奐嵜.
733207. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 杒棦戝妛昦堾娽壢愱栧奜棃偺徯夘丂敀撪忈斍. 斞揷壝旻 (娽壢): 戞19夞杒棦娽壢昦恌楢実夛 (2022/1/20), Web奐嵜.
733208. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣)亂嵗挿亃堦斒島墘. 彲巌怣峴 (娽壢): 戝捤椢撪忈WEB僙儈僫乕 (2022/2/25), Web奐嵜.
733209. [妛夛 (抧曽夛丒尋媶夛)] (堦斒墘戣) 杒棦戝妛偵偍偗傞儈働儖僫規脨瑦褌﹤鐐虓l嶡. 壨栰梇椇 (娽壢): 戝捤椢撪忈WEB僙儈僫乕 (2022/2/25), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110025. [尨挊] Visual performance and patient satisfaction of multifocal contact lenses in eyes undergoing monofocal intraocular Lens implantation. Kamiya K1, Fujimura F1, Ando W2, Iijima K2, Shoji N2: Cont Lens Anterior Eye 2020/6; 43 (3): 218-21. (恄扟榓岶1, 摗懞晣嵅巕1, 埨摗榓壧巕2, 斞搰丂宧2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
'20-110026. [尨挊] The Relationship Between Corneal Hysteresis and Progression of Glaucoma After Trabeculectomy. FujinoY, Murata H, Matsuura M, Nakakura S, Shoji N1, Nakao Y, Kiuchi Y, Asaoka R: J Glaucoma 2020/10; 29 (10): 912-7. (彲巌怣峴1: 1娽壢)
'20-110027. [尨挊] Regional comparison of preoperative biometry for cataract surgery between two domestic institutions. Kamiya K1, Fujimura F1, Iijima K2, Shoji N2, Mori Y, Miyata K: Int Ophthalmol 2020/11; 40 (11): 2923-30. (恄扟榓岶1, 摗懞晣嵅巕1, 斞搰丂宧2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
'20-110028. [尨挊] Characterization of laser speckle flowgraphy pulse waveform parameters for the evaluation of the optic nerve head and retinal circulation. Enomoto N, Anraku A, Tomita G, Iwase A, Sato T, Shoji N1, Shiba T, Nakazawa T, Sugiyama K, Nitta K, Araie M: Sci Rep 2021/3; 11 (1): 6847. (彲巌怣峴1: 1娽壢)
帹旲堲岮壢丒摢栩晹奜壢妛
[妛弍榑暥]
110383. [尨挊] Evaluation of the usefulness of upper gastrointestinal endoscopy and the Valsamouth_ by an otolaryngologist in patients with Hypopharyngeal cancer. Hosono H1, Katada C2, Kano K1, Kimura A1, Tsutsumi S3, Miyamoto S1, Ichinoe M4, Furue Y2, Tanabe S2,5, Koizumi W2, Yamashita T1: Auris Nasus Larynx 2021/4; 48 (2): 265-73. (嵶栰峗巎1, 寴揷恊棙2, 壛擺岶堦1, 栘懞庨棦1, 掔丂隳暯3, 媨杮弐曘1, 堦屗徆柧4, 屆峕峃柧2, 揷绯丂憦2,5, 彫愹榓嶰榊2, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜, 2徚壔婍撪, 3戝妛堾堛椕宯尋媶壢, 4昦棟, 5怴悽婭堛椕丒愭抂堛椕)
110384. [尨挊] Resection of Parapharyngeal Space Tumors Located in the Prestyloid Compartment: Efficacy of the Cervical Approach. Matsuki T1, Okamoto I, Tada Y, Masubuchi T, Fushimi C, Kamata S, Miyamoto S1, Yamashita T1, Miura K: Ann Surg Oncol 2021/6; 28 (6): 3066-72. (徏栘丂悞1, 媨杮弐曘1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110385. [尨挊] The effect of laryngeal elevation training on swallowing function in patients with dysphagia. Sugaya N, Goto F, Seino Y1, Nishiyama K, Okami K: J Laryngol Otol 2021/7; 135 (7): 574-8. (惔栰桼攜1: 1帹旲堲岮丒摢栩奜)
110386. [尨挊] A report on patients with vertigo seen at a specialized vertigo outpatient clinic Ochiai A1: Kitasato Med J 2021/9; 51 (2): 102-8. (棊崌丂撝1: 1帹旲堲岮丒摢栩奜)
110387. [尨挊] Characteristics that predict penetration - aspiration in elderly patients following supracricoid laryngectomy with cricohyoidoepiglottopexy - a videofluoroscopic study. Seino Y1, Miyamoto S1, Nakayama M, Yamashita T1, Miles A, Allen JE: J Laryngol Otol 2021/11; 1-24. (惔栰桼攜1, 媨杮弐曘1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110388. [尨挊] The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy. Saigusa N, Hirai H, Tada Y, Kawakita D, Nakaguro M, Tsukahara K, Kano S, Ozawa H, Kondo T, Okami K, Togashi T, Sato Y, Urano M, Kajiwara M, Shimura T, Fushimi C, Shimizu A, Okamoto I, Okada T, Suzuki T, Imanishi Y, Watanabe Y, Sakai A, Ebisumoto K, Sato Y, Honma Y, Yamazaki K, Ueki Y, Hanazawa T, Saito Y, Takahashi H, Ando M, Kohsaka S, Matsuki T1, Nagao T: Front Oncol 2022/2; 11: 779882. (徏栘丂悞1: 1帹旲堲岮丒摢栩奜)
110389. [尨挊] Postoperative Complications and Swallowing Function after Jejunal and Skin Flap Reconstruction for Hypopharyngeal Carcinoma-A Multicenter Retrospective Study. Tokashiki K, Okamoto I, Okada T, Sato H, Yamashita T1, Matsuki T1, Kondo T, Fushimi C, Masubuchi T, Miura K, Omura G, Tsukahara K: J Clin Med 2022/3; 11 (5): 1464. (嶳壓丂戱1, 徏栘丂悞1: 1帹旲堲岮丒摢栩奜)
110390. [尨挊] Comparison of Dosage of Nivolumab in Efficacy and Safety for Recurrent Metastatic Squamous Cell Carcinoma. Okada T, Fushimi C, Matsuki T1, Okamoto I, Sato H, Kondo T, Tokashiki K, Kishida T, Ito T, Yamashita G, Aihara Y, Hanyu K, Kushihashi Y, Masubuchi T, Tada Y, Miura K, Harada Y1, Momiyama K1, Yamashita T1, Omura G, Takahashi H, Oridate N, Tsukahara K: Anticancer Res 2022/3; 42 (3): 1607-13. (徏栘丂悞1, 尨揷梇婎1, 栢嶳崄曐1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
120033. [尨挊] 慡恎惈僄儕僥儅僩乕僨僗 (SLE) 偺恄宱帹壢妛揑専摙. 棊崌丂撝 (帹旲堲岮丒摢栩奜): 帹旲堲岮壢丒摢栩晹奜壢 2021/4; 93 (4): 367-72.
120034. [尨挊] 摢栩晹奜壢堛偑巤峴偟偨梀棧慻怐偵傛傞嵞寶庤弍偺専摙. 徏栘丂悞1, 媨杮弐曘1, 壛擺岶堦1, 掔丂隳暯2, 屆栘埢巕1, 栢嶳崄曐1, 尨揷梇婎1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 擔杮摢栩晹娻妛夛帍 2021/6; 47 (1): 15-20.
120035. [尨挊] 憗婜殝壓儕僴價儕僥乕僔儑儞夘擖偵傛傞岮摢垷慡揈弌弍偺帯椕婜娫抁弅偺帋傒. 媨杮弐曘1, 徏栘丂悞1, 壛擺岶堦1, 掔丂隳暯2, 屆栘埢巕1, 栢嶳崄曐1, 尨揷梇婎1, 惔栰桼攜1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 擔杮摢栩晹娻妛夛帍 2021/6; 47 (1): 65-70.
310052. [徢椺曬崘] Endolymphatic sac tumor followed as Meniere's disease Ochiai A1, Seino Y1: International Journal of Clinical and Medical Case Reports 2021; OPEN ACCESS. DOI: 10.46998/UCMCR.2021.14.000334. (棊崌丂撝1, 惔栰桼攜1: 1帹旲堲岮丒摢栩奜)
310053. [徢椺曬崘] Removal of a Giant Parapharyngeal Space Oncocytoma Without Osteotomy. Matsuki T1, Tsutsumi S2, Miyamoto S1, Kano K1, Momiyama K1, Asako Y1, Yamashita T1:
Ear Nose Throat J 2021/10; 1455613211048973. (徏栘丂悞1, 掔丂隳暯2, 媨杮弐曘1, 壛擺岶堦1, 栢嶳崄曐1, 愺屆桼婭巕1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢)
320020. [徢椺曬崘] 妠娭愡柍嬠惈擽釃傪愭峴敪徢偟偨墛徢惈幘姵偺1椺. 愺屆桳婭巕1, 媨杮弐曘1, 摗愳捈栫1, 屆栘徣屷1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 擔杮帹旲堲岮壢妛夛夛曬 2021/6; 124 (6): 897-902.
320021. [徢椺曬崘] 懁栩晹偵惗偠偨嫄戝朼悗宍嵶朎帀朾庮椺. 揷懞徆栫1, 徏栘丂悞1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 帹旲椪彴 2021/10; 114 (10): 771-6.
[妛夛丒尋媶夛摍]
723639. [妛夛 (慡崙)] (堦斒島墘) Supracricoid Laryngectomy偵偍偗傞怴惡栧嫹嶓偺昿搙偲梊應場巕. 媨杮弐曘1, 徏栘丂悞1, 壛擺岶堦1, 掔丂隳暯2, 栢嶳崄曐1, 尨揷梇婎1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 戞45夞擔杮摢栩晹娻妛夛 (2021/6/17), 愮梩 (僴僀僽儕僢僪奐嵜).
723640. [妛夛 (慡崙)] (堦斒島墘) 崻帯揑徠幩屻偺嬊強堚巆嵞敪偵懳偡傞ELPS. 壛擺岶堦1, 寴揷恊棙2, 堦屗徆柧3, 尨揷梇婎1, 屆峕峃柧2, 媨杮弐曘1, 徏栘丂悞1, 掔丂隳暯4, 栢嶳崄曐1, 揷绯丂憦2,5, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2徚壔婍撪, 3昦棟, 4戝妛堾堛椕宯尋媶壢, 5怴悽婭堛椕丒愭抂堛椕): 戞45夞擔杮摢栩晹娻妛夛 (2021/6/18), 愮梩 (僴僀僽儕僢僪奐嵜).
723641. [妛夛 (慡崙)] (堦斒島墘) TS-1覀獟穵鷤虠L岠惈傪帵偟偨庤弍嫅斲恑峴岥峯掙娻偺堦椺. 栢嶳崄曐1, 徏栘丂悞1, 媨杮弐曘1, 壛擺岶堦1, 掔丂隳暯2, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 戞45夞擔杮摢栩晹娻妛夛 (2021/6/18), 愮梩 (僴僀僽儕僢僪奐嵜).
723642. [妛夛 (慡崙)] (堦斒島墘) 岮摢揈弌屻偺枬惈曋旈徢偵娭偡傞椪彴尋媶. 尨揷梇婎1, 徏栘丂悞1, 媨杮弐曘1, 壛擺岶堦1, 掔丂隳暯2, 栢嶳崄曐1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 戞45夞擔杮摢栩晹娻妛夛 (2021/6/18), 愮梩 (僴僀僽儕僢僪奐嵜).
723643. [妛夛 (慡崙)] (堦斒島墘) Nivolumab傪搳梌偟偨嵞敪揮堏摢栩晹滸暯忋旂娻88椺偵偍偗傞Real-world偺挿婜惉愌亅懡巤愝嫟摨尋媶亅. 徏栘丂悞1, 壀杮埳嶌, 暁尒愮拡, 崅嫶廏憦, 壀揷戱楴, 嬤摗婱恗, 嵅摗岹庽, 埳摗払嵠, 搉壝晘朚旻, 捤尨惔彶, 塇惗寬帯, 憹暎払晇, 懡揷梇堦榊, 嶰塝峅婯, 彫懞丂崑, 郪晹丂椣, 愳杒戝夘, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 戞45夞擔杮摢栩晹娻妛夛 (2021/6/17), 愮梩 (僴僀僽儕僢僪奐嵜).
723644. [妛夛 (慡崙)] (堦斒島墘) 儊僯僄乕儖昦偺椉懁挳椡偵偍偗傞摨挷惈偵偮偄偰偺専摙亅戞3曬亅. 怴揷媊梞1, 挿徖塸柧1,2 (1帹旲堲岮丒摢栩奜, 2怴悽婭堛椕丒愭抂堛椕): 戞80夞擔杮傔傑偄暯峵堛妛夛憤夛丒妛弍島墘夛 (2021/11/11), 搶嫗 (僴僀僽儕僢僪奐嵜), 梊峞廤: Equilibrium Res 2021; 80 (5): p.447.
723645. [妛夛 (慡崙)] (堦斒島墘) 傔傑偄敪嶌偺姵懁偺敾掕偑崲擄偱偁偭偨椉懁儊僯僄乕儖昦偺1徢椺. 拞愳婱擵1, 棊崌丂撝1, 挿徖塸柧1,2 (1帹旲堲岮丒摢栩奜, 2怴悽婭堛椕丒愭抂堛椕): 戞80夞擔杮傔傑偄暯峵堛妛夛憤夛丒妛弍島墘夛 (2021/11/11), 搶嫗 (僴僀僽儕僢僪奐嵜), 梊峞廤: Equilibrium Res 2021; 80 (5): p.449.
723646. [妛夛 (慡崙)] (堦斒島墘) 壛楊惈暯峵忈奞偵懳偡傞廤抍偱偺暯峵嬝椡僩儗乕僯儞僌. 棊崌丂撝 (帹旲堲岮丒摢栩奜): 戞80夞擔杮傔傑偄暯峵堛妛夛憤夛丒妛弍島墘夛 (2021/11/12), 搶嫗 (僴僀僽儕僢僪奐嵜).
723647. [妛夛 (慡崙)] (堦斒島墘) 宱岥揑儘儃僢僩巟墖壓庤弍摫擖弶婜偵偁偨偭偰偺摉壢偺庢傝慻傒. 嶳壓丂戱1, 媨杮弐曘1 (1帹旲堲岮丒摢栩奜): 戞31夞擔杮摢栩晹奜壢妛夛憤夛側傜傃偵妛弍島墘夛 (2022/3/3), 戝嶃 (僴僀僽儕僢僪奐嵜).
723648. [妛夛 (慡崙)] (堦斒島墘) 忋妠摯偵惗偠偨intravascular papillary endothelial hyperplasia偺1椺. 尨揷梇婎1, 媨杮弐曘1, 嶳杮尗屷1, 嶳壓丂戱1, 戝栘姴暥2 (1帹旲堲岮丒摢栩奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞31夞擔杮摢栩晹奜壢妛夛憤夛側傜傃偵妛弍島墘夛 (2022/3/3), 戝嶃 (僴僀僽儕僢僪奐嵜).
723649. [妛夛 (慡崙)] (堦斒島墘) 崅楊摢栩晹娻姵幰偺擣抦婡擻偲弍屻偣傫栂偺娭學偺専摙. 栢嶳崄曐1, 媨杮弐曘1, 徏栘丂悞1, 壛擺岶堦1, 掔丂隳暯2, 尨揷梇婎1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 戞31夞擔杮摢栩晹奜壢妛夛憤夛側傜傃偵妛弍島墘夛 (2022/3/3), 戝嶃 (僴僀僽儕僢僪奐嵜).
723650. [妛夛 (慡崙)] (堦斒島墘) 梊杊揑栩晹妔惔偑岮摢垷慡揈偵媦傏偡塭嬁. 媨杮弐曘1, 徏栘丂悞1, 壛擺岶堦1, 掔丂隳暯2, 栢嶳崄曐1, 尨揷梇婎1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 戞31夞擔杮摢栩晹奜壢妛夛憤夛側傜傃偵妛弍島墘夛 (2022/3/4), 戝嶃 (僴僀僽儕僢僪奐嵜).
惛恄壢妛
[妛弍榑暥]
110391. 尨挊 Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study. Numata S, Nakataki M, Hasegawa N, Takaesu Y, Takeshima M, Onitsuka T, Nakamura T, Edagawa R, Edo H, Miura K, Matsumoto J, Yasui乚Furukori N, Kishimoto T, Hori H, Tsuboi T, Yasuda Y, Furihata R, Muraoka H, Ochi S, Nagasawa T, Kyou Y1, Murata A, Katsumoto E, Ohi K, Hishimoto A, Inada K1, Watanabe K, Hashimoto R: Neuropsychopharmacol Rep 2021/6; 41 (2): 199-206. (汭丂慞婱1, 堫揷丂寬1: 1惛恄)
110392. [尨挊] Factors associated with blood carnitine levels in adult epilepsy patients with chronic valproic acid therapy. Saito M1, Takizawa T1, Miyaoka H1: Epilepsy Research 2021/9; 175: 106697. (釼摗惓斖1, 戧郪婤栴1, 媨壀丂摍1: 1惛恄)
110393. [尨挊] Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project. Hashimoto N, Yasui-Furukori N, Hasegawa N, Ishikawa S, Numata S, Horie H, Iida H, Ichihashi K, Furihata R, Murata A, Tsuboi T, Takeshima M, Kyou Y1, Komatsu H, Kubota C, Ochi S, Takaesu Y, Usami M, Nagasawa T, Hishimoto A, Miura K, Matsumoto J, Ohi K, Yamada H, Inada K1, Watanabe K, Shimoda K, Hashimoto R: Asian Journal of Psychiatry 2021/9; 63: 102744. (汭丂慞婱1, 堫揷丂寬1: 1惛恄)
320022. [徢椺曬崘] 媫惈婜帯椕屻3擭娫擣抦婡擻偺悇堏傪捛愓偟偨恄宱攡撆偺堦椺. 媑懞桳婓1, 汭丂慞婱1, 弿曽宑嶰榊2, 戧郪婤栴1, 戝愇丂抭1, 媨壀丂摍1 (1惛恄, 2椪彴怱棟幒): 惛恄壢帯椕妛 2021/4; 36 (4): 461-6.
320023. [徢椺曬崘] 惈揑堩扙峴堊傪孞傝曉偟偨擣抦婡擻忈奞傪敽偆崅楊幰偺堦椺. 彫栰丂崉1, 汭丂慞婱1, 栘懞桭旻1, 拞棦桭崄1, 弌悈楁撧1, 戧郪婤栴1, 戝愇丂抭1, 媨壀丂摍1 (1惛恄): 惛恄壢帯椕妛 2021/7; 36 (7): 841-7.
320024. [徢椺曬崘] 扽巁儕僠僂儉偱帯椕拞偵拞悤惈擜曵徢傪敪徢偟儕儞僷媴惈楻搇壓悅懱屻梩墛偑媈傢傟偨1椺. 栘懞桭旻1, 嫶杮丂庽1, 怴堜媣柅1, 彫栰丂崉1, 弌悈楁撧1, 戝愇丂抭1, 釼摗惓斖1, 媨壀丂摍1 (1惛恄): 搶嫗惛恄堛妛夛帍 2021/7; 35: 44752.
522561. [島嵗]亂摿廤: 惛恄壢偵偍偗傞傾僂僩儕乕僠偺姪傔亃戝妛昦堾偵偍偗傞懡怑庬傾僂僩儕乕僠僠乕儉偺僗僗儊. 愇揷嫥岹1, 惎栰奣擮1 (1惛恄): 惛恄壢帯椕妛 2021/4; 36 (4): 419-24.
522562. [島嵗]亂摿廤I: 僗億乕僣偲惛恄堛妛亃傾僗儕乕僩偵偍偗傞悋柊忈奞. 嶳杮岹柧 (惛恄): 惛恄壢 2021/4; 38 (4): 401-7.
522563. [島嵗]亂摿廤: 埶懚徢 儗僕僨儞僩偑抦偭偰偍偒偨偄恌抐傗帯椕偺僐僣! 摿廤偵偁偨偭偰亃怱棟丒幮夛揑帯椕 <暔幙娭楢忈奞孮傾儖僐乕儖埶懚丒栻暔埶懚怱棟丒幮夛揑帯椕. 懞悾壺巕1, 挬憅悞暥2 (1堛椕塹惗妛晹, 2惛恄): 惛恄壢Resident 2021/4; 2 (2): 96-8.
522564. [島嵗]亂摿暿婇夋: 巚弔婜偺偙偙傠偲偐傜偩亃仴巚弔婜偺偙偙傠偲偐傜偩傪恌傞丂婲棫惈挷愡忈奞偲晄搊峑亅帣摱惛恄壢堛偐傜揱偊偨偄偙偲. 堜忋彑晇 (惛恄): 偙偙傠偺壢妛 2021/5; 217: 67-72.
522565. [島嵗]亂摿廤: 崅楊幰偺曢傜偟丒偙偙傠丒嫃応強亃崅楊偺恖偺偙偙傠偵曄壔偑惗傑傟傞帪. 戝愇丂抭 (惛恄): 偙偙傠偺壢妛 2021/7; 218: 18-22.
522566. [島嵗]亂摿廤: 崅楊幰偺曢傜偟丒偙偙傠丒嫃応強亃崅楊偺恖傊偺巟墖偲朘栤恌椕. 惎栰奣擮 (惛恄): 偙偙傠偺壢妛 2021/7; 218: 59-64.
522567. [島嵗]亂摿廤: 怴宆僐儘僫僂僀儖僗1擭傪怳傝曉偭偰亃COVID-19偙偙傠偺働傾. 戝愇丂抭 (惛恄): 椪彴偲僂僀儖僗 2021/8; 49 (3): 106-11.
522568. [島嵗]亂摿廤: 巹偺偙傕傝曽亃敧忎搰偺巚偄弌偲YouTube. 惎栰奣擮 (惛恄): 摑崌幐挷徢偺傂傠偽 2021/9; 18: 49-54.
522569. [島嵗]亂摿廤: 擣抦徢偺幘姵奣擮偵偮偄偰峫偊傞;楌巎揑帠崁偐傜彨棃傑偱亃擣抦徢偺峴摦丒怱棟徢忬(BPSD)奣擮偺岟嵾. 戝愇丂抭 (惛恄): 榁擭惛恄堛妛嶨帍 2021/10; 32 (10): 1046-50.
530012. [偦偺懠 (Letter to the Editor)] Mental health services at the Tokyo 2020 Olympic and Paralympic Games during the COVID-19 pandemic. Nishida M, Takagi S, Yamaguchi T, Yamamoto H1, Yoshino S, Yagishita K, Akama T: Sports Psychiatry 2022/2; 1 (2): 36-8. (嶳杮岹柧1: 1惛恄)
530013. [偦偺懠 (Letter to the Editor)] Administration of a small dose of perampanel improves walking ability in a case of Lance-Adams Syndrome. Saita D1, Oishi S1, Saito M1: Psychiatry Clin Neurosci 2022/3; 76 (3): 89. (嵶揷戝帯1, 戝愇丂抭1, 釼摗惓斖1: 1惛恄)
540049. [偦偺懠 (嶨帍摿廤曇廤)]亂摿廤: 崅楊幰偺曢傜偟丒偙偙傠丒嫃応強亃戝愇丂抭 (惛恄): 偙偙傠偺壢妛 2021/7; 218.
540050. [偦偺懠 (彺榐)] 媬柦媬媫僙儞僞乕偵斃憲偝傟傞帺嶦婇恾幰偵懳偡傞惛恄壢堛偺栶妱丂帺嶦婇恾偱斃憲偝傟傞媫惈栻暔拞撆姵幰偺嵟嬤偺孹岦偲懳墳. 怴堜媣柅1, 惎栰弐栱1, 愇揷嫥岹1, 媨壀丂摍1 (1惛恄): 惛恄恄宱妛嶨帍 2021/9; 摿暿崋: S411.
540051. [偦偺懠 (嶨帍摿廤曇廤)]亂摿暿婇夋: 扤偐傪働傾偡傞恖偺働傾亅巟墖幰巟墖傪峫偊傞亃戝愇丂抭 (惛恄): 偙偙傠偺壢妛 2022/3; 222.
[挊丂彂]
620126. [妛弍彂 (扨挊)]亂嫵堳偺儊儞僞儖僿儖僗 : 愭惗偺偙偙傠偑夡傟側偄偨傔偺僸儞僩亃戝愇丂抭 (惛恄), 戝廋娰彂揦, 搶嫗, 2021/5敪峴.
620127. [妛弍彂 (暘扴幏昅)]亂傗偭偰傒偨偔側傞傾僨傿僋僔儑儞恌椕丒巟墖僈僀僪丂傾儖僐乕儖丒栻暔丒僊儍儞僽儖偐傜僎乕儉埶懚傑偱亃姉惗桾巌 (惛恄), 曇: 徏杮弐旻, 嵅媣娫姲擵, 姉惗桾巌, 暥岝摪, 搶嫗, 2021/9敪峴.
620128. [妛弍彂 (暘扴幏昅)]亂乽怱乿偺偍巇帠丂崱擔傕扤偐偺偦偽偵棫偮24恖偺暔岅亃Chapter 1 乬怱偺偍堛幰偝傫乭偭偰壗傪偟偰偄傞偺?丂偖傞偖傞偟側偑傜怱偲偐偐傢傞, p.54-64. 惎栰奣擮 (惛恄), 曇: 壨弌彂朳怴幮, 壨弌彂朳怴幮, 搶嫗, 2021/10敪峴.
620129. [妛弍彂 (暘扴幏昅)]亂摝偘側偄撪壢恌椕丂乽愱栧奜側偺偱乧乿偐傜乽慡恎傪恌傞!乿傊亃椞堟匧 偦偺懠丂傾儖僐乕儖埶懚徢乣戝愗側偺偼栤戣偺嫟桳偲偦偺夝寛嶔傪堦弿偵峫偊傞偙偲, p.331-5. 挬憅悞暥 (惛恄), 曇: 愒堜桋岹, 搶丂岝媣, 敧揷丂崘, 楅栘丂憦, 惣嶳戝抧, 尨丂彨擵, 梤搚幮, 搶嫗, 2021/10敪峴.
[妛夛丒尋媶夛摍]
722295. [妛夛 (慡崙)] (彽懸島墘摍) 乽悋柊丒惗懱儕僘儉偲僗億乕僣乿僆乕僶乕僩儗乕僯儞僌徢岓孮偲悋柊. 嶳杮岹柧 (惛恄): 戞32夞擔杮椪彴僗億乕僣堛妛夛妛弍廤夛 (2021/11/14), Web奐嵜, 擔杮椪彴僗億乕僣堛妛夛帍 2021/10; 29 (4): S91.
722296. [妛夛 (慡崙)] (彽懸島墘摍) 擣抦徢偺偁傞恖偑, 杮摉偵抧堟偱惗偒惗偒偲曢傜偟偰偄偔偨傔偵偱偒傞偙偲偲偼乣僋儕僯僇儖僷僗偺帇揰偐傜乣. 汭丂慞婱1, 壓懞桾尒巕2, 嶰尨旤愥3, 戝愇丂抭1, 晉妦愮戙旤4, 拞懞岝惉5, 壛摗拤憡6 (1惛恄, 2戝妛堾堛椕宯尋媶壢, 3彲撪撿晹抧堟楢実僷僗嫤媍夛, 4掃壀巗棫憫撪昦堾, 5惣尨僋儕僯僢僋, 6(姅) 偁偍偄偗偁): 戞21夞擔杮僋儕僯僇儖僷僗妛夛妛弍廤夛 (2021/11/27), 嶳宍 (僴僀僽儕僢僪奐嵜).
722297. [妛夛 (慡崙)] (彽懸島墘摍) 揹婥偗偄傟傫椕朄 (ECT) 偺敪嶌偑100%偱廫暘桿敪偱偒側偄偲偒乣敪嶌鑷抣傪僐儞僩儘乕儖偡傞乣. 郪嶳宐攇 (惛恄): 戞34夞擔杮憤崌昦堾惛恄堛妛夛憤夛 (2021/12/7-31), Web奐嵜.
722298. [妛夛 (慡崙)] (僔儞億僕僂儉) 敪嶌鑷抣傪僐儞僩儘乕儖偡傞. 郪嶳宐攇 (惛恄): 戞34夞擔杮憤崌昦堾惛恄堛妛夛憤夛 (2021/12/7-31), Web奐嵜.
723651. [妛夛 (慡崙)] (堦斒島墘) 彈惈傾僗儕乕僩斉愛怘忈奞僗僋儕乕僯儞僌僥僗僩 (TA-EDQ) 偲SCOFF偲偺斾妑. 娭岥朚巕, 憣扟旤棩, 塅捗栰嵤, 拞懞姲峕, 彫惔悈岶巕, 愮梩梲巕, 峕揷崄怐, 嶳杮岹柧1, 嶳岥払栫, 擻悾偝傗偐 (1惛恄): 戞32夞擔杮椪彴僗億乕僣堛妛夛妛弍廤夛 (2021/11/13-12/6), Web奐嵜, 擔杮椪彴僗億乕僣堛妛夛帍 2021/10; 29 (4): S220.
723652. [妛夛 (慡崙)] (堦斒島墘) 憤崌昦撪偐傜揥奐偡傞條乆側埶懚徢帯椕. 挬憅悞暥1, 敀嶁抦旻, 庤捤岾梇, 摗愳柧婓, 忢壀弐徍 (1惛恄): 戞34夞擔杮憤崌昦堾惛恄堛妛夛憤夛 (2021/12/7-31), Web奐嵜.
723653. [妛夛 (慡崙)] (堦斒島墘) 揹婥偗偄傟傫椕朄偵偍偗傞嬝抩娚栻儘僋儘僯僂儉偺巊梡偵娭偡傞屻曽帇揑挷嵏. 搚揷惞懢1, 郪嶳宐攇1, 搰栰朁栫1, 怴旤桾懢1, 戝愇丂抭1, 抾楺柉峕2, 釼摗惓斖1 (1惛恄, 2杻悓): 戞34夞擔杮憤崌昦堾惛恄堛妛夛憤夛 (2021/12/7-31), Web奐嵜.
731073. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 帣摱惛恄壢堛偐傜偐偐傝偮偗彫帣壢堛傊揱偊偨偄偙偲. 堜忋彑晇 (惛恄): 戞23夞乽巕偳傕偺怱乿尋廋夛 (2021/5/9), 搶嫗 (僴僀僽儕僢僪奐嵜).
733210. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 夝棧惈忈奞偺恌抐偱壛椕拞偵庮釒條懡敪惈峝壔徢傪敪徢偟偨1椺. 弌悈楁撧1, 怴堜媣柅1, 嫶杮丂庽1, 栘懞桭旻1, 彫栰丂崉1, 惓栘崄椦1, 戝愇丂抭1, 釼摗惓斖1, 媨壀丂摍1 (1惛恄): 搶嫗惛恄堛妛夛戞122夞妛弍憤夛 (2021/7/3), 搶嫗.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110029. [尨挊] A reliable method to reduce electrode impedances during electroconvulsive therapy. Shimano T1, Sawayama E, Oishi S1, Natsuyama T1, Takizawa T1, Saito M1, Tanaka K2, Miyaoka H1: Kitasato Med J 2021/3; 51 (1): 19-23. (搰栰朁栫1, 郪嶳宐攇1, 戝愇丂抭1, 壞嶳丂戩1, 戧郪婤栴1, 釼摗惓斖1, 揷拞崕弐2, 媨壀丂摍1: 1惛恄, 2戝妛堾堛椕宯尋媶壢)
'20-110030. [尨挊] A comparative study of the outcomes of individual psychotherapy alone and that in conjunction with group psychotherapy for gambling disorder. Asakura T1, Oishi S1, Ogata K2, Takizawa T1, Kyou Y1, Demizu R1, Imayuki H1, Gamo Y1: Kitasato Med J 2021/3; 51 (1): 49-55. (挬憅悞暥1, 戝愇丂抭1, 弿曽宑嶰榊2, 戧郪婤栴1, 汭丂慞婱1, 弌悈楁撧1, 崱愥岹悞1, 姉惗桾巌1: 1惛恄, 2椪彴怱棟幒)
'20-120003. [尨挊] 擣抦徢偺偁傞恖偺壠懓夘岇幰偵懳偡傞怱棟嫵堢僾儘僌儔儉偺桳岠惈偺専摙. 汭丂慞婱1, 戝愇丂抭1, 戧郪婤栴1, 媨壀丂摍1 (1惛恄): 惛恄壢帯椕妛 2021/3; 36 (3): 357-62.
曻幩慄壢妛 (夋憸恌抐妛)
[妛弍榑暥]
110394. [尨挊] Effects of negativity bias on amygdala and anterior cingulate cortex activity in short and long emotional stimulation paradigms. Yoshida N, Kotani Y, Ohgami Y, Kunimatsu A, Inoue Y1, Kiryu S, Okada Y: Neuroreport 2021/4; 32 (6): 531-9. (堜忋桪夘1: 1曻幩慄 (夋憸))
110395. [尨挊] Childhood trauma affects autobiographical memory deficits through basal cortisol and prefrontal-extrastriate functional connectivity. Hakamata Y, Mizukami S1, Izawa S, Moriguchi Y, Hori H, Matsumoto N, Hanakawa T, Inoue Y2, Tagaya H1: Psychoneuroendocrinology 2021/5; 127: 105172. (悈忋怲栫1, 堜忋桪夘2, 揷儢扟峗朚1: 1堛椕塹惗妛晹, 2曻幩慄 (夋憸))
110396. [尨挊] The membrane-linked adaptor FRS2兝 fashions a cytokine-rich inflammatory microenvironment that promotes breast cancer carcinogenesis. Takeuchi Y, Kimura N, Murayama T, Machida Y, Iejima D, Nishimura T, Terashima M, Wang Y, Li M, Sakamoto R, Yamamoto M, Itano N, Inoue Y1, Ito M, Yoshida N, Inoue J, Akashi K, Saya H, Fujita K, Kuroda M, Kitabayashi I, Voon D, Suzuki T, Tojo A, Gotoh N: Proc Natl Acad Sci U S A 2021/10; 118 (43): e2103658118. (堜忋桪夘1: 1曻幩慄 (夋憸))
110397. [尨挊] Effects of Gadolinium Deposition in the Brain on Motor or Behavioral Function: A Mouse Model. Akai H, Miyagawa K, Takahashi K, Mochida-Saito A, Kurokawa K, Takeda H, Tsuji M, Sugawara H, Yasaka K, Kunimatsu A, Inoue Y1, Abe O, Ohtomo K, Kiryu S: Radiology 2021/11; 301 (2): 409-16. (堜忋桪夘1: 1曻幩慄 (夋憸))
110398. [尨挊] Conversion from dose-length product to effective dose in computed tomography venography of the lower extremities. Inoue Y1, Yonekura Y1, Nagahara K2, Uehara A2, Ikuma H2: J Radiol Prot 2022/1; 42 (1). doi: 10.1088/1361-6498/ac49d6. (堜忋桪夘1, 暷憅桼壚1, 塱尨榓寷2, 忋尨曕壞2, 埳孎廏婰2: 1曻幩慄 (夋憸), 2曻幩慄晹)
110399. [尨挊] Implicit and explicit emotional memory recall in anxiety and depression: Role of basolateral amygdala and cortisol-norepinephrine interaction. Hakamata Y, Mizukami S, Izawa S, Okamura H, Mihara K, Marusak H, Moriguchi Y, Hori H, Hanakawa T, Inoue Y1, Tagaya H2: Psychoneuroendocrinology 2022/2; 136: 105598. (堜忋桪夘1, 揷儢扟峗朚2: 1曻幩慄 (夋憸), 2堛椕塹惗妛晹)
110400. [尨挊] Association of childhood maltreatment history with salivary interleukin-6 diurnal patterns and C-reactive protein in healthy adults. Hori H, Izawa S, Yoshida F, Kunugi H, Kim Y, Mizukami S1, Inoue Y2, Tagaya H, Hakamata Y: Brain Behav Immun 2022/3; 101: 377-82. (悈忋怲栫1, 堜忋桪夘2: 1堛椕塹惗妛晹, 2曻幩慄 (夋憸))
310054. [徢椺曬崘] A case of solid-type pancreatic hamartoma presenting high apparent diffusion coefficient value: histopathological correlation and literature review. Woo J, Haradome H1,2, Adachi K3, Iwai T4, Nishizawa N5, Murakumo Y6, Kusano C4, Kumamoto Y5, Inoue Y2, Ojiri H: Abdom Radiol (NY) 2022/6; 47 (6): 1939-47. (尨棷峅庽1,2, 埨払丂夣3 娾堜抦媣4, 惣郪怢嫳5, 懞塤朏庽6, 憪栰丂墰4, 孏尦梇夘5, 堜忋桪夘2: 1怴悽婭堛椕丒愭抂堛椕, 2曻幩慄 (夋憸), 3戝妛堾堛椕宯尋媶壢, 4徚壔婍撪, 5堦斒丒彫帣丒娞抇鋁奜, 6昦棟)
510021. [憤愢] Radiation Dose Modulation of Computed Tomography Component in Positron Emission Tomography/Computed Tomography. Inoue Y1: Semin Nucl Med 2022/3; 52 (2): 157-66. (堜忋桪夘1: 1曻幩慄 (夋憸))
520015. [憤愢]亂Refresher Course亃恌椕梡曻幩慄偺偨傔偺埨慡娗棟丂1. 夵惓朄椷偵婎偯偔恌椕梡曻幩慄偺埨慡娗棟懱惂. 堜忋桪夘 (曻幩慄 (夋憸)): 夋憸恌抐 2021/4; 41 (5): 512-6.
522570. [島嵗] 嶌昳敪昞1: 娽鈢壓暻偺悂偒敳偗崪愜傪棟夝偡傞偨傔偺2枃偺僀儔僗僩. 晜廎棿懢榊 (曻幩慄 (夋憸): 擔杮儊僨傿僇儖僀儔僗僩儗乕僔儑儞妛夛嶨帍 2021/9; 3 (1): 81-3.
522571. [島嵗]亂摿廤: 恌抐偺寛傔庤偲側偭偨夋憸丒強尒II亅徚壔婍亅亃娞抇摴亅傃傑傫惈娞幘姵. 尨棷峅庽1,2 (1怴悽婭堛椕丒愭抂堛椕, 2曻幩慄 (夋憸)): 椪彴曻幩慄 2021/11; 66 (12): 1391-413.
530014. [偦偺懠 (Published Erratum)] Correction to: Predictive factors of truncation artifacts in the arterial phase of Gd-EOB-DTPA-enhanced MRI: a nationwide multicenter study. Tsurusaki M, Sofue K, Onishi H, Goshima S, Higaki A, Isoda H, Haradome H1,2, Ishii K, Murakami T: Jpn J Radiol 2021/4; 39 (4): 405. (尨棷峅庽1,2: 1怴悽婭堛椕丒愭抂堛椕, 2曻幩慄 (夋憸))
540052. [偦偺懠 (僈僀僪儔僀儞)]亂擔杮IVR妛夛僈僀僪儔僀儞亃CT僈僀僪壓攛惗専偺庤媄偵娭偡傞僈僀僪儔僀儞2020. 擔杮IVR妛夛 (僂僢僪僴儉僗楁巕1, 懠) (1曻幩慄 (夋憸)): 擔杮僀儞僞乕儀儞僔儑僫儖儔僕僆儘僕乕妛夛嶨帍 2021/9; 36 (1): 82-98.
[挊丂彂]
620130. [妛弍彂 (暘扴幏昅)]亂摢寊晹扨弮CT偙偲巒傔亅師偺僗僥僢僾傑偱偮側偘傛偆亅 (夋憸恌抐2021擭憹姧崋)亃IV復 摢奧奜偺扨弮CT丂1. 摢奧掙夝朥, A166-77. 晜廎棿懢榊 (曻幩慄 (夋憸), 曇: 惵栘栁庽, 徏栘丂廩, 怷丂丂崵, Gakken, 搶嫗, 2021/8敪峴.
620131. [妛弍彂 (暘扴幏昅)]亂懄愴椡偑恎偵偮偔摢栩晹偺夋憸恌抐亃幚椡曇丂徢椺L2-32 ,10嵨戜抝惈, 慜堛偱巚弔婜抶敪傪巜揈, p.265-7. 徢椺L2-44, 40嵨戜彈惈, 傕偲傕偲嵍娽偼庛帇偱掅恎挿, 寬恌偱塃娽偺帇栰忈奞傪巜揈偝傟偨, p.309-11. 徢椺L2-60, 70嵨戜抝惈, 慜堛帹旲壢偵偰, 忋堲摢庮釒傪巜揈偝傟偨, p.362-4. 挧愴曇丂徢椺L3-1, 30嵨戜彈惈, 栺3擭慜偐傜殝壓崲擄姶, 10偐寧慜偐傜歮惡傪帺妎, p.366-9. 挧愴曇丂徢椺L3-24, 60嵨戜彈惈, 尨幘姵偵懳偟帯椕拞, p439-42. 庪栰梞曘, 晜廎棿懢榊1 (1曻幩慄 (夋憸)), 曇: 旜怟攷栫, 壛摗攷婎, 媣栰攷暥, 儊僨傿僇儖僒僀僄儞僗僀儞僞乕僫僔儑僫儖, 搶嫗, 2021/9敪峴.
620132. [妛弍彂 (暘扴幏昅)]亂夋憸恌抐僈僀僪儔僀儞 2021擭斉丂戞3斉亃2 摢栩晹, p.70-97. 晜廎棿懢榊 (曻幩慄 (夋憸)), 曇: 擔杮堛妛曻幩慄妛夛, 嬥尨弌斉, 搶嫗, 2021/9敪峴.
620133. [妛弍彂 (暘扴幏昅)]亂僇儞僎僉偡傞傎偳傢偐傞摢栩晹娫寗偺夋憸恌抐亃II 娫寗傪撉傓丂愩崪忋栩晹偵偁傞娫寗丂帹壓態娫寗, p.118-29. 晜廎棿懢榊 (曻幩慄 (夋憸)), 曇: 釼摗彯巕, 儊僕僇儖價儏乕幮, 搶嫗, 2021/10敪峴.
620134. [妛弍彂 (暘扴幏昅)]亂僇儞僎僉偡傞傎偳傢偐傞摢栩晹娫寗偺夋憸恌抐亃II 娫寗傪撉傓丂愩崪壓栩晹偵偁傞娫寗丂憻婍娫寗, p.192-204. 庪栰梞曘, 晜廎棿懢榊1 (1曻幩慄 (夋憸)), 曇: 釼摗彯巕, 儊僕僇儖價儏乕幮, 搶嫗, 2021/10敪峴.
620135. [妛弍彂 (暘扴幏昅)]亂娞娻恌椕僈僀僪儔僀儞2021擭搙斉 戞5斉亃娞娻恌椕僈僀僪儔僀儞2021擭搙斉偺奜晹昡壙, p.286-92. 嵅栰孿擇, 埳嵅嶳峗捠, 殸暘栁攷, 嶁姫尠懢榊, 悪尨寬堦, 尨棷峅庽1,2 (1怴悽婭堛椕丒愭抂堛椕, 2曻幩慄 (夋憸)), 曇: 擔杮娞憻妛夛, 嬥尨弌斉, 搶嫗, 2021/10敪峴.
[妛夛丒尋媶夛摍]
712010. [妛夛 (崙嵺)] (僔儞億僕僂儉) Stimulus modality and contents differently affect SPN cortical distributions and components, Symposium (Functional correlates of the stimulus-preceding negativity). Kotani Y, Ohgami Y, Yoshida N, Kunimatsu A, Kiryu S, Inoue Y1: 2021 Virtual Annual Meeting of Society for Psychophysiological Research (2021/10/10-18), Web奐嵜, Psychophysiology 2021; 58 (Suppl 1): S13. (堜忋桪夘1: 1曻幩慄 (夋憸))
712011. [妛夛 (崙嵺)] (僔儞億僕僂儉) Principal Component Analysis of Subtracted SPN before auditory stimuli. Ohgami Y, Kotani Y, Yoshida N, Akai H, Kunimatsu A, Kiryu S, Inoue Y1: 2021 Virtual Annual Meeting of Society for Psychophysiological Research (2021/10/10-18), Web奐嵜, Psychophysiology 2021; 58 (Suppl 1): S47. (堜忋桪夘1: 1曻幩慄 (夋憸))
712012. [妛夛 (崙嵺)] (僔儞億僕僂儉) Radiation safety issues in clinical practice in Japan. In Radiation monitoring with patients and in medicine. Inoue Y1: IAEA Technical Meeting (2021/11/10), Web奐嵜. (堜忋桪夘1: 1曻幩慄 (夋憸))
713051. [妛夛 (崙嵺)] (億僗僞乕) Hemifield Auditory Stimulation and the Right Hemisphere Dominance of Stimulus-Preceding Negativity. Kotani Y, Ohgami Y, Yoshida N, Kunimatsu A, Kiryu S, Inoue Y1: Annual Meeting of the Organization of Human Brain Mapping (OHBM) 2021 The 27th Annual Meeting (2021/6/21-25), Web奐嵜, Abstract Book 2021; p.22. (堜忋桪夘1: 1曻幩慄 (夋憸))
713052. [妛夛 (崙嵺)] (億僗僞乕) The Two-component Structure of Cortical Slow Waves in Anticipation of Auditory Stimuli. Ohgami Y, Kotani Y, Yoshida N, Kunimatsu A, Kiryu S, Inoue Y1: Annual Meeting of the Organization of Human Brain Mapping (OHBM) 2021 The 27th Annual Meeting (2021/6/21-25), Web奐嵜, Abstract Book 2021; p. 23. (堜忋桪夘1: 1曻幩慄 (夋憸))
722299. [妛夛 (慡崙)] (摿暿婇夋) 嶻壢婋婡揑弌寣偵懳偡傞IVR: 巭寣惉岟偺偨傔偺僈僀僪儔僀儞偵婎偯偄偨庤媄偲偦偺墳梡. 僂僢僪僴儉僗楁巕1, 摗堜丂奭1, 嬥堜梇擇2, 堜忋桪夘1 (1曻幩慄 (夋憸), 2嶻壢): 戞50夞擔杮IVR妛夛憤夛 (2021/5/21), Web奐嵜, 擔杮僀儞僞乕儀儞僔儑僫儖儔僕僆儘僕乕妛夛嶨帍 2021; 36 (Suppl): 100.
722300. [妛夛 (慡崙)] (尋廋堛丒堛妛惗僙儈僫乕) 峛忬態丒暃峛忬態幘姵偺夋憸恌抐. 晜廎棿懢榊 (曻幩慄 (夋憸)): 戞57夞擔杮堛妛曻幩慄妛夛廐婫椪彴戝夛 (2021/10/4-31), Web奐嵜, 戞57夞擔杮堛妛曻幩慄妛夛廐婫椪彴戝夛彺榐廤 2021; p.384.
722301. [妛夛 (慡崙)] (彽懸島墘) 媫惈暊徢偺帯椕愴棯亅椙惈挵幘姵偺恌抐偲帯椕亅. 僂僢僪僴儉僗楁巕 (曻幩慄 (夋憸): 戞58夞擔杮暊晹媬媫堛妛夛憤夛 (2022/3/24-25), 搶嫗.
723654. [妛夛 (慡崙)] (堦斒島墘) 崅ADC抣傪帵偟偨鋁夁岆庮偺1椺. 鈀丂丂弫, 尨棷峅庽1,2, 娾堜抦媣3, 惣郪怢嫳4, 埨払丂夣5, 堜忋桪夘2 (1怴悽婭堛椕丒愭抂堛椕, 2曻幩慄 (夋憸), 3徚壔婍撪, 4堦斒丒彫帣丒娞抇鋁奜, 5戝妛堾堛椕宯尋媶壢): 戞34夞擔杮暊晹曻幩慄妛夛 (2021/6/19), 暉壀 (僴僀僽儕僢僪奐嵜).
723655. [妛夛 (慡崙)] (堦斒岥墘) 慡恎PET/CT偵偍偗傞慄検挿偝愊偐傜幚岠慄検傊偺曄姺. 戝媣曐桰1, 堜忋桪夘1, 塱尨榓寷2, 忋尨曕壞2, 崅栰惤恖2, 媨晲斾楥庽2 (1曻幩慄 (夋憸), 2曻幩慄晹): 戞61夞擔杮妀堛妛夛妛弍憤夛 (2021/11/4-6), 柤屆壆 (僴僀僽儕僢僪奐嵜), 妀堛妛 2021; 58 (Suppl): S222.
731074. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 堛椕旐偽偔偺揔惓壔偵岦偗偰亅恌椕梡曻幩慄偺埨慡娗棟偺朄惂壔亅. 堜忋桪夘 (曻幩慄 (夋憸)): 擔杮妛弍怳嫽夛乽曻幩慄偺棙梡偲惗懱塭嬁乿戞195埾堳夛 (2021/7/17), Web奐嵜.
731075. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 恌椕梡曻幩慄偺埨慡棙梡偺偨傔偺尋廋偺幚巤亅擔杮堛妛曻幩慄妛夛偺庢傝慻傒亅. 堜忋桪夘 (曻幩慄 (夋憸)): 椷榓3擭搙乽堛椕曻幩慄埨慡娗棟島廗夛乿 (2021/10/24), Web奐嵜.
731076. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 恌椕梡曻幩慄偺埨慡棙梡偲埨慡娗棟亅堛椕朄巤峴婯懃傊偺懳墳亅. 堜忋桪夘 (曻幩慄 (夋憸)): 憡柾尨巗堛巘夛堛椕埨慡島廗夛 (2021/10/25), 憡柾尨.
731077. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 恌椕梡曻幩慄偺埨慡娗棟: 堛椕朄巤峴婯懃夵惓屻偺堛椕尰応偵偍偗傞懳墳偺幚嵺. 堜忋桪夘 (曻幩慄 (夋憸)): 幁帣搰巗棫昦堾恌椕曻幩慄埨慡娗棟尋廋夛 (2021/11/2), Web奐嵜.
731078. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 恌椕梡曻幩慄偺埨慡棙梡偺偨傔偺尋廋偲堛椕婡娭偱偺COVID-19懳墳. 堜忋桪夘 (曻幩慄 (夋憸)): 崙棫曐寬堛椕壢妛堾 椷榓3擭搙抁婜尋廋 堛椕曻幩慄偺揔惓娗棟偵娭偡傞尋廋 (2021/11/24), Web奐嵜.
731079. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 曻幩慄埨慡娗棟偵娭偡傞杒棦戝妛偺庢傝慻傒. 堜忋桪夘 (曻幩慄 (夋憸)): 戞10夞憡柾尨婡擻夋憸僙儈僫乕 (2021/11/25), Web奐嵜.
733211. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 嵍峝岥奧尨敪偲峫偊傜傟偨傃傑傫惈戝嵶朎宆B嵶朎儕儞僷庮. 暷憅桼壚1, 晜廎棿懢榊1, 堜忋桪夘1, 屆栘埢巕2, 嶳壓丂戱2, 惎栰徍朏3 (1曻幩慄 (夋憸), 2帹旲堲岮丒摢栩晹奜, 3昦棟): 戞34夞摢栩晹曻幩慄尋媶夛 (2021/9/18), Web奐嵜, 戞57夞擔杮堛妛曻幩慄妛夛廐婫椪彴戝夛彺榐廤 2021; p. S454.
733212. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 旲暵姶傪宊婡偵敪尒偝傟偨 glomangiopericytoma. 棿揷傕傕偙1, 晜廎棿懢榊1, 堜忋桪夘1, 媨杮弐曘2, 嶳壓丂戱2, 崃嶳丂摓3, 撊杮徆岶4 (1曻幩慄 (夋憸), 2帹旲堲岮丒摢栩晹奜, 3昦棟, 4戝妛堾堛椕宯尋媶壢): 戞34夞摢栩晹曻幩慄尋媶夛 (2021/9/18), Web奐嵜, 戞57夞擔杮堛妛曻幩慄妛夛廐婫椪彴戝夛彺榐廤 2021; p. S455-6.
733213. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 僀儊乕僕僀儞僞乕僾儕僥乕僔儑儞僙僢僔儑儞丂Session匑1 [夞摎]. 暷憅桼壚1, 晜廎棿懢榊1, 堜忋桪夘1, 屆栘埢巕2, 嶳壓丂戱2, 惎栰徍朏3 (1曻幩慄 (夋憸), 2帹旲堲岮丒摢栩晹奜, 3昦棟): 戞34夞摢栩晹曻幩慄尋媶夛 (2021/9/18), Web奐嵜.
733214. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僀儊乕僕僀儞僞乕僾儕僥乕僔儑儞僙僢僔儑儞丂Session匑2 [弌戣].
棿揷傕傕偙1, 晜廎棿懢榊1, 堜忋桪夘1, 媨杮弐曘2, 嶳壓丂戱2, 崃嶳丂摓3, 撊栘徆峫4 (1曻幩慄 (夋憸), 2帹旲堲岮丒摢栩晹奜, 3昦棟, 4戝妛堾堛椕宯尋媶壢): 戞34夞摢栩晹曻幩慄尋媶夛 (2021/9/18), Web奐嵜.
733215. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 旲暵姶媦傃旲弌寣傪庡慽偵敪尒偝傟偨恡嵶朎娻. 埨払傒偢傎1, 晜廎棿懢榊1, 堜忋桪夘1, 惔栰桼攜2, 媨杮弐夘2, 攇懡栰塴懢2, 嶳壓丂戱2, 崃嶳丂摓3 (1曻幩慄 (夋憸), 2帹旲堲岮丒摢栩晹奜, 3昦棟): 2021擭搙恄撧愳導曻幩慄堛夛憤夛媦傃戞61夞椺夛 (2021/10/30), Web奐嵜, 2021擭搙恄撧愳導曻幩慄堛夛憤夛丒戞61夞椺夛僾儘僌儔儉丒彺榐廤 2021; p. 10.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110031. [尨挊] Predictive factors of truncation artifacts in the arterial phase of Gd-EOB-DTPA-enhanced MRI: a nationwide multicenter study. Tsurusaki M, Sofue K, Onishi H, Goshima S, Higaki A, Isoda H, Haradome H1,2, Ishii K, Murakami T: Jpn J Radiol 2021/2; 39 (2): 165-77. (尨棷峅庽1,2: 1怴悽婭堛椕丒愭抂堛椕, 1曻幩慄 (夋憸))
'20-310005. [徢椺曬崘] Pulmonary Artery-Bronchus Fistula Treated with a Combination of Bare Metal Stent, Metallic Coil, and N-Butyl Cyanoacrylate. Woodhams R1, Fujii K1, Takigawa M, Inoue Y1: J Vasc Interv Radiol 2021/1; 32 (1): 152-5. (僂僢僪僴儉僗楁巕1, 摗堜丂奭1, 堜忋桪夘1: 1曻幩慄 (夋憸))
'20-520001. [憤愢] 堛椕朄巤峴婯懃夵惓屻偺堛椕尰応偵偍偗傞懳墳偺幚嵺. 堜忋桪夘 (曻幩慄 (夋憸)): 堛椕曻幩慄杊岇Newsletter 2021/3; 84: 5-18.
'20-540003. [偦偺懠 (僈僀僪儔僀儞)]亂擔杮IVR妛夛僈僀僪儔僀儞亃愐捙揮堏偺宱旂揑捙懱宍惉弍 (PVP) 僈僀僪儔僀儞2019. 擔杮IVR妛夛 (僂僢僪僴儉僗楁巕1, 懠) (1曻幩慄 (夋憸)): 擔杮僀儞僞乕儀儞僔儑僫儖儔僕僆儘僕乕妛夛嶨帍 2021/2; 35 (3): 290-309.
曻幩慄壢妛 (曻幩慄庮釃妛)
[妛弍榑暥]
110401. [尨挊] Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients. Ishiyama H1, Tsumura H2, Nagano H, Watanabe M, Mizuno E, Taka M, Kobayashi H, Eriguchi T, Imada H, Inaba K, Nakamura K: Sci Rep 2021/6; 11 (1): 13194. (愇嶳攷瀶1, 捗懞廏峃2: 1曻幩慄 (庮釃), 2斿擜婍)
110402. [尨挊] Protective Effects of Amino Acids on Plasmid DNA Damage Induced by Therapeutic Carbon Ions. Yogo K, Murayama C, Hirayama R, Matsumoto K, Nakanishi I, Ishiyama H1, Yasuda H: Radiat Res 2021/8; 196 (2): 197-203. (愇嶳攷瀶1: 1曻幩慄 (庮釃))
110403. [尨挊] Three-dimensional dose-distribution measurement of therapeutic carbon-ion beams using a ZnS scintillator sheet. Yogo K, Tsuneda M, Horita R, Souda H , Matsumura A, Ishiyama H1, Hayakawa K, Kanai T, SYamamoto S: J Radiat Res 2021/9; 62 (5): 825-32. (愇嶳攷瀶1: 1曻幩慄 (庮釃))
110404. [尨挊] Quality of life score as a prognosticator for pharyngeal cancer patients treated with radiotherapy. Ishiyama H1, Kawakami S1, Sekiguchi A1, Kainuma T1, Miyamoto S2, Yamashita T2, Nakano M1: Sci Rep 2022/2; 12 (1): 2387. (愇嶳攷瀶1, 愳忋惓屽1, 娭岥埄堖1, 帞徖戩楴1, 媨杮弐曘2, 嶳壓丂戱2, 拞栰惓姲1: 1曻幩慄 (庮釃), 2帹旲堲岮丒摢栩奜)
110405. [尨挊] Radiosensitization Effect of Gold Nanoparticles on Plasmid DNA Damage Induced by Therapeutic MV X-rays. Yogo K, Misawa M, Shimizu H, Kitagawa T, Hirayama R, Ishiyama H1, Yasuda H, Kametaka S, Takami S: Nanomaterials (Basel) 2022/2; 12 (5): 771. (愇嶳攷瀶1: 1曻幩慄 (庮釃))
[妛夛丒尋媶夛摍]
723656. [妛夛 (慡崙)] (堦斒岥墘) 挻夝憸媄弍傪梡偄偨怺憌妛廗偵傛傞憻婍帺摦拪弌僔僗僥儉偺奐敪. 烴掚寬懢楴1, 媨撪丂婸2, 揷拞桰堦2, 拞栰惓姲3, 愇嶳攷瀶3, 挿扟愳抭擵2, 嫶杮惉悽2 (1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3曻幩慄 (庮釃)): 戞77夞擔杮曻幩慄媄弍妛夛憤夛妛弍戝夛 (2021/4/15-18), 恄撧愳, 擔杮曻幩慄媄弍妛夛嶨帍 2021/9; 77 (9): 1115.
杻悓壢妛
[妛弍榑暥]
110406. [尨挊] The characteristics, types of intervention, and outcomes of postoperative patients who required rapid response system intervention: a nationwide database analysis. Sento Y, Arai M1,2, Yamamori Y, Fujiwara S, Tamashiro M, Kawamoto E, Naito T, Atagi K, Fujitani S, Osaga S, Sobue K; In-Hospital Emergency Study Group: J Anesth 2021/4; 35 (2): 222-31. (怴堜惓峃1,2: 1怴悽婭堛椕奐丒墶抐揑堛椕, 2杻悓)
110407. [尨挊] Incidence of accidental events during anesthesia from 2012 to 2016: survey on anesthesia-related events by the Japanese Society of Anesthesiologists. Morimatsu H; Accidental Event (Pulmonary Embolism) Working Group, Safety Committee of the Japanese Society of Anesthesiologists (Collaborators: Hirota K, Hagihira S, Masui K, Yokota M, Sawa T, Yamauchi M, Kuroiwa M1): J Anesth 2021/4; 35 (2): 206-12. (崟娾惌擵1: 1杻悓)
110026. [尨挊] Roles of Thromboxane Receptor Signaling in Enhancement of Lipopolysaccharide-Induced Lymphangiogenesis and Lymphatic Drainage Function in Diaphragm. Matsuda H1, Ito Y2, Hosono K2, Tsuru S1, Inoue T3, Nakamoto S4, Kurashige C1, Hirashima M, Narumiya S, Okamoto H1, Majima M2: Arterioscler Thromb Vasc Biol 2021/4; 41 (4): 1390-407. (徏揷峅旤1, 埳摗媊栫2, 嵶栰壛撧巕2, 捗棷悽棦1, 堜忋抭恗3, 拞杮廋巌4, 錟廳愮奊1, 攏搱惓棽2: 1杻悓, 2栻棟, 3徚壔婍撪, 4堦斒丒彫帣丒娞抇鋁奜)
110408. [尨挊] Validation of National Early Warning Score for predicting 30-day mortality after rapid response system activation in Japan. Naito T, Hayashi K, Hsu HC, Aoki K, Nagata K, Arai M1,2, Nakada T, Suzaki S, Hayashi Y, Fujitani S; In乚Hospital Emergency Study Group: Acute Med Surg 2021/5; 8 (1): e666. (怴堜惓峃1,2: 1怴悽婭堛椕奐丒墶抐揑堛椕, 2杻悓)
110409. [尨挊] Use of electrical muscle stimulation body massager (EMS-BMs) improves deep venous blood flow. Sakai M1, Otsuka T1, Sugimura K1, Nishizawa Y1, Nagai A1, Yamamoto S1, Okamoto H1, Kuroiwa M1: Med Eng Phys 2021/6; 92: 110-4. (嶃堜錆桳巕1, 戝捤抭媣1, 悪懞寷椇1, 惣郪媊擵1, 塱堜垷埶1, 嶳杮恀栫1, 壀杮峗巏1, 崟娾惌擵1: 1杻悓)
110410. [尨挊] Prevalence and predictors of direct discharge home following hospitalization of patients with serious adverse events managed by the rapid response system in Japan: a multicenter, retrospective, observational study. Hongo T, Naito H, Fujiwara T, Naito T, Homma Y, Fujimoto Y, Takaya M, Yamamori Y, Nakada T, Nojima T, Nakao A, Fujitani S; In乚Hospital Emergency Study Group (Arai M1,2, et al): Acute Med Surg 2021/8; 8 (1): e690. (怴堜惓峃1,2: 1怴悽婭堛椕奐丒墶抐揑堛椕, 2杻悓)
110411. [尨挊] Six-Minute Walk Test Predicts Postoperative Delirium After Transcatheter Aortic Valve Replacement. Yamashita A1 ,Suzuki S2, Otsuka T2, Matsuda H2, Ando H2, Sugimura K2, Maekawa E3, Meguro K3, Ako J3, Okamoto H2: J Cardiothorac Vasc Anesth 2021/9; 35 (9): 2613-7. (嶳壓丂撝1, 楅栘洅巏2, 戝捤抭媣2, 徏揷峅旤2, 埨摗庻宐2, 悪懞寷椇2, 慜愳宐旤3, 栚崟寬懢榊3, 垻屆弫嵠3, 壀杮峗巏2: 1戝妛堾堛椕宯尋媶壢, 2杻悓, 3弞娐婍撪)
110412. [尨挊] Effectiveness of anti-slip dots on the soles of elastic compression stockings. Kuroiwa M1, Sakai M1, Otsuka T1, Nishizawa Y1, Sugimura K1, Nagai A1, Yamamoto S1: Kitasato Med J 2021/9; 51 (2): 97-101. (崟娾惌擵1, 嶃堜錆桳巕1, 戝捤抭媣1, 惣郪媊擵1, 悪懞寷椇1, 塱堜垷埶1, 嶳杮恀栫1: 1杻悓)
110007. [尨挊] Cytohesin-2 mediates group I metabotropic glutamate receptor-dependent mechanical allodynia through the activation of ADP ribosylation factor 6 in the spinal cord. Ito A1, Fukaya M2, Sugawara T2, Hara Y2, Okamoto H1, Yamauchi J, Sakagami H2: Neurobiol Dis 2021/11; 159: 105466. (埳摗桜巕1, 怺扟徆峅2, 悰尨寬擵2, 尨丂朏怢2, 壀杮峗巏1, 嶃忋梞峴2: 1杻悓, 2夝朥)
320025. [徢椺曬崘] 壔妛椕朄桿敪惈枛徑恄宱忈奞捝偵懳偡傞僼僃儞僞僯儖惷拲帋尡偲嫮僆僺僆僀僪捔捝栻偺桳梡惈偺専摙. 峳丂彨抭1, 椦丂宱恖1, 壨懞捈庽, 嬥堜徍暥1,2 (1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕): 儁僀儞僋儕僯僢僋 2021/5; 42 (5): 641-5.
522572. [島嵗]亂摿廤: 姶愼徢偍傛傃墛徢惈幘姵傪桳偡傞姵幰偺杻悓娗棟亃怱嬝墛偍傛傃姶愼惈怱撪枌墛偲杻悓娗棟. 埨摗庻宐1, 旜嶈丂壏1, 壀杮峗巏1 (1杻悓): 杻悓 2021/5; 70 (5): 512-6.
[挊丂彂]
620136. [妛弍彂 (暘扴幏昅)]亂崅楊幰杻悓偺億僀儞僩50亃Q40. 挿婜夌彴姵幰偺廃弍婜攛嵡愷徢偺梊杊偵偮偄偰嫵偊偰偔偩偝偄, p.155-8. 崟娾惌擵 (杻悓), 娔廋: 彫斅嫶弐嵠, 曇: 愳岥徆旻, 愳屢抦擵, 崕惤摪弌斉, 搶嫗, 2021/5敪峴.
620137. [妛弍彂 (暘扴幏昅)]亂杻悓壢堛側傜抦偭偰偍偒偨偄寣愷徢丒嵡愷徢 (LiSA 2021擭暿嶜廐崋)亃PART 4 惷柆惈寣愷丂23 廃弍婜攛寣愷嵡愷徢, p.171-8. 拞郪埡擳, 崟娾惌擵1 (1杻悓), 愑擟曇廤: 捸愳峆媣, 儊僨傿僇儖丒僒僀僄儞僗丒僀儞僞乕僫僔儑僫儖, 搶嫗, 2021/9敪峴.
620138. [妛弍彂 (暘扴幏昅)]亂杻悓壢堛側傜抦偭偰偍偒偨偄 寣愷徢丒嵡愷徢 (LiSA 2021擭暿嶜廐崋)亃PART 5 偦偺懠偺嵡愷徢丂嬠夠嵡愷, 庮釃夠嵡愷, p.221-5. 埨摗庻宐1, 壀杮峗巏1 (1杻悓), 曇: 捸愳峆媣, 儊僨傿僇儖僒僀僄儞僗, 搶嫗, 2021/9敪峴.
[妛夛丒尋媶夛摍]
722302. [妛夛 (慡崙)] (僔儞億僕僂儉) 怱憻寣娗杻悓椞堟偱宷偑傠偆. 壀杮峗巏 (杻悓): 擔杮杻悓壢妛夛戞68夞妛弍廤夛 (2021/6/4), Web奐嵜.
722303. [妛夛 (慡崙)] (僔儞億僕僂儉) 怱憻庤弍偵偍偗傞攛摦柆僇僥乕僥儖偺揔墳偲埨慡側憓擖偲巊梡朄乕杻悓壢堛偺棫応偐傜. 壀杮峗巏 (杻悓): 戞52夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2022/3/4), 墶昹 (僴僀僽儕僢僪奐嵜).
723657. [妛夛 (慡崙)] (堦斒島墘) 岮摢娻偵懳偡傞宱岥揑撪帇嬀庤弍偺弍拞弍屻偵梊婜偣偢嬞媫婥娗愗奐傪梫偟偨16徢椺偺専摙. 嶳楬桾峅1, 嶃堜錆桳巕1, 抾楺柉峕1, 壀杮峗巏1 (1杻悓): 擔杮杻悓壢妛夛戞68夞妛弍廤夛 (2021/6/3), Web奐嵜.
723658. [妛夛 (慡崙)] (堦斒島墘) COVID19姶愼梊杊懳嶔偲偟偰偺敳娗屻僒乕僕僇儖儅僗僋憰拝偑梌偊傞塭嬁偵偮偄偰. 捗棷悽棦1, 彫嶁峃惏1, 嵅摗崕旻1, 墶嶳桭崄, 杧嵐桭壞1, 壀杮峗巏1 (1杻悓): 擔杮杻悓壢妛夛戞68夞妛弍廤夛 (2021/6/3), Web奐嵜.
723659. [妛夛 (慡崙)] (堦斒島墘) 僶僋儘僼僃儞偔傕枌壓峯搳梌偺慻怐妛揑埨慡惈偺専摙. 抾楺柉峕1, 撧椙壚梞, 戝媣曐挬巕, 嶳壓丂隳1, 埳摗宐埲1, 壀杮峗巏1 (1杻悓): 擔杮杻悓壢妛夛戞68夞妛弍廤夛 (2021/6/3), Web奐嵜.
723660. [妛夛 (慡崙)] (堦斒島墘) 彫帣恄宱嬝幘姵偵傛傞徢岓惈懁淾徢偵懳偡傞屻曽屌掕弍偺廃弍婜屇媧婍崌暪徢偺専摙. 嶳壓恀栫, 嶳壓丂撝1, 徏揷峅旤2, 拞郪埡擳, 嶳壓丂隳2, 壀杮峗巏2 (1戝妛堾堛椕宯尋媶壢, 2杻悓): 擔杮杻悓壢妛夛戞68夞妛弍廤夛 (2021/6/3), Web奐嵜.
723661. [妛夛 (慡崙)] (堦斒島墘) 戝検僆僺僆僀僪巊梡拞偺偑傫醬捝姵幰偵偍偗傞揹棳抦妎鑷抣偺挷嵏. 旜嶈丂壏1, 嬥堜徍暥1,2, 壀杮峗巏1 (1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮杻悓壢妛夛戞68夞妛弍廤夛 (2021/6/3), Web奐嵜.
723662. [妛夛 (慡崙)] (堦斒島墘) 掅怤廝怱憻庤弍偵偍偗傞壓巿燇棳偺巜昗偲偟偰偺嬤愒奜慄暘岝朄偺桳梡惈. 嶳壓丂隳1, 埨摗庻宐1, 埳摗宐埲1, 杮揷悞峢1, 壀杮峗巏1 (1杻悓): 擔杮杻悓壢妛夛戞68夞妛弍廤夛 (2021/6/3), Web奐嵜.
723663. [妛夛 (慡崙)] (堦斒島墘) 彫帣偺幬帇庤弍偵偍偗傞娽擃峱揾晍偵傛傞妏枌捝杊巭岠壥偺専摙. 埳摗宐埲1, 徏揷峅旤1, 拞郪埡擳1, 嶳壓丂隳1, 壀杮峗巏1 (1杻悓): 擔杮杻悓壢妛夛戞68夞妛弍廤夛 (2021/6/3), Web奐嵜.
723664. [妛夛 (慡崙)] (堦斒島墘) 儘僋儘僯僂儉偵傛傞傾僫僼傿儔僉僔乕偺婛墲偺偁傞姵幰偵懳偟, 屻擔慡恎杻悓壓偵暊晹庤弍傪巤峴偟偨堦椺. 塱壜撧巕1, 壀杮峗巏1 (1杻悓): 擔杮椪彴杻悓妛夛戞41夞戝夛 (2021/11/5), 嶥杫 (僴僀僽儕僢僪奐嵜).
723665. [妛夛 (慡崙)] (堦斒島墘) DHA丒EPA娷桳僒僾儕儊儞僩愛庢拞偺擠晈傊偺嬫堟杻悓巤峴徢椺偺専摙. 摗揷撨宐1, 嬤摗峅峎1, 擔岦弐曘1, 娭崻嵐桼旤1, 墱晉弐擵1, 壀杮峗巏1 (1杻悓): 戞125夞擔杮嶻壢杻悓妛夛妛弍廤夛 (2021/12/4), 柤屆壆 (僴僀僽儕僢僪奐嵜).
733216. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) i-gel覒}擖帪偵枹恌抐偺傾僨僲僀僪懝彎偵傛傞堲摢弌寣傪偒偨偟偨堦椺. 塱壜撧巕1, 嶳楬桾峅1, 埳摗桜巕1, 徏揷峅旤徏1, 壀杮峗巏1 (1杻悓): 擔杮杻悓壢妛夛2021擭搙巟晹妛弍廤夛 (娭搶峛怣墇丒搶嫗巟晹戞61夞崌摨妛弍廤夛) (2021/9/4), Web奐嵜.
733217. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 忋峴戝摦柆抲姺弍屻偺ARDS偵懳偟偰暊夌埵椕朄偑挊岠偟偨1椺. 杧幯桭壞1, 惣郪媊擵1, 崟娾惌擵1, 怴堜惓峃1,2, 壀杮峗巏1 (1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮杻悓壢妛夛2021擭搙巟晹妛弍廤夛 (娭搶峛怣墇丒搶嫗巟晹戞61夞崌摨妛弍廤夛) (2021/9/4), Web奐嵜.
733218. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 暊峯嬀壓娞晹暘愗彍弍偺敳娗屻, 梊婜偣偸攛悈庮傪棃偨偟偨1椺. 嶳壓丂隳1, 娭揷徍旻1, 惣郪媊擵1, 抾楺柉峕1, 崟娾惌擵1, 壀杮峗巏1 (1杻悓): 擔杮杻悓壢妛夛2021擭搙巟晹妛弍廤夛 (娭搶峛怣墇丒搶嫗巟晹戞61夞崌摨妛弍廤夛) (2021/9/4), Web奐嵜.
733219. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 塃堓戝栐摦柆傪梡偄偨姤摦柆僶僀僷僗弍屻偺憗婜堓娻偵懳偟, 暊峯嬀壓堓慡揈弍傪巤峴偟偨1椺. 庰堜垷婓巕1, 娭揷徍旻1, 恴朘愮棦, 埨摗庻宐1, 挿揷愰巕1, 壀杮峗巏1 (1杻悓): 擔杮杻悓壢妛夛2021擭搙巟晹妛弍廤夛 (娭搶峛怣墇丒搶嫗巟晹戞61夞崌摨妛弍廤夛) (2021/9/4), Web奐嵜.
733220. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 愭揤惈嬝柍椡徢岓孮偺愐捙懁淾徢庤弍偺廃弍婜屇媧娗棟. 懞徏桰壺1, 嶳壓丂撝2, 徏揷峅旤1, 彫栰愮恞1, 杧幯桭壞1, 壀杮峗巏1 (1杻悓, 2戝妛堾堛椕宯尋媶壢): 擔杮杻悓壢妛夛2021擭搙巟晹妛弍廤夛 (娭搶峛怣墇丒搶嫗巟晹戞61夞崌摨妛弍廤夛) (2021/9/4), Web奐嵜.
733221. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 尠旝嬀揑懡敪寣娗墛偵敽偆嫊寣捝偵懳偟偰, 嫮僆僺僆僀僪捔捝栻傪梡偄傞偙偲偱椙岲側捔捝娗棟偑壜擻偲側偭偨1椺. 彫栰愮恞1, 峳丂彨抭1, 崅嫶桟堦楴1, 懞徏桰壺1, 嬥堜徍暥1,2, 壀杮峗巏1 (1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮杻悓壢妛夛2021擭搙巟晹妛弍廤夛 (娭搶峛怣墇丒搶嫗巟晹戞61夞崌摨妛弍廤夛) (2021/9/4), Web奐嵜.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110032. [尨挊] Rapid response system in Japanese outpatient departments based on online registry: Multicentre observational study. Aoyama T, Tsuneyoshi I, Otake T, Ouchi K, Kawase Y, Arai M1,2, Shibata N, Fujiwara S, Fujitani S; In-Hospital Emergency Registry in Japan collaborators: Resusc Plus 2021/1; 5: 100065. (怴堜惓峃1,2: 1怴悽婭堛椕奐丒墶抐揑堛椕, 2杻悓)
[妛夛丒尋媶夛摍]
'20-723031. [妛夛 (慡崙)] (堦斒島墘) 怴宆僐儘僫僂僀儖僗姶愼徢 (COVID-19) 傪崌暪偟偨擠晈偺崙撪弶弌嶻椺偺廃弍婜娗棟. 埨摗庻宐1, 擔岦弐曘1, 埨払恀棞巕, 杮揷悞峢1, 屗揷夒栫1, 壀杮峗巏1, 墱晉弐擵1 (1杻悓): 擔杮椪彴杻悓妛夛戞40夞戝夛 (2020/11/6), Web奐嵜.
椪彴専嵏恌抐妛
[妛弍榑暥]
110413. [尨挊] Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution. Hayama K1, Abe Y2, Kamata H3, Okina S3, Murakami Y, Kanoh Y4, Suzuki T3: Int J Hematol 2022/4; 115 (4): 508-14. doi: 10.1007/s12185-021-03278-5. Epub 2022 Jan 22. (塇嶳宒埲1, 垻晹桳崄2, 姍揷峗柅3, 墺丂慶惤3, 庪栰桳嶌4, 楅栘棽峗3: 1戝妛堾堛椕宯尋媶壢, 2椪専晹, 3寣塼撪, 4椪専妛)
120036. [尨挊] 杒棦戝妛昦堾偵偍偗傞僇儖僶儁僱儉懴惈挵撪嵶嬠栚嵶嬠偺専弌忬嫷偵偮偄偰偺扨巤愝屻曽帇揑尋媶. 擇杮桍怢1, 崅嶳梲巕2, 悾屗椙嫵1, 埨払丂忳3, 彫娧抭悽3, 嵅摗梙桽1, 曐嶁奊浠1, 媨嶈岻夘1, 嵅乆栘尠巕1, 崅栘桼旤巕1, 惎嶳棽峴4, 拞懞惓庽5, 椦丂揘斖6, 庪栰桳嶌6 (1姶愼娗棟幒, 2怴悽婭堛椕丒墶抐揑堛椕, 3椪専晹, 4銹尨昦丒姶愼撪, 5堛椕塹惗妛晹, 6椪専妛): 杒棦堛妛 2021/12; 51 (2): 83-94.
220003. [弨尨挊] C宆娞墛杘柵偵岦偗偨椪彴専嵏晹偺庢傝慻傒乣杒棦戝妛昦堾偵偍偗傞娞墛懳嶔偵偍偗傞恌椕晹栧偲偺楢実懱惂乣 庪栰桳嶌 (椪専妛): 搶嫗搒堛妛専嵏 2022/1; 50 (1): 53-5.
[挊丂彂]
620139. [妛弍彂 (暘扴幏昅)]亂嵟怴 専嵏丒夋憸恌抐帠揟 2022-23擭斉亃億儖僼傿儕儞徢僗僋儕乕僯儞僌僥僗僩, p.10. 庪栰桳嶌 (椪専妛), 曇: 擔杮椪彴専嵏堛妛夛, 堛妛捠怣幮, 搶嫗, 2021/5敪峴.
620140. [妛弍彂 (暘扴幏昅)]亂嵟怴 専嵏丒夋憸恌抐帠揟 2022-23擭斉亃N-傾僙僠儖僌儖僐僒儈僔僞乕僛 (NAG), p.10-1. 庪栰桳嶌 (椪専妛), 曇: 擔杮椪彴専嵏堛妛夛, 堛妛捠怣幮, 搶嫗, 2021/5敪峴.
620141. [妛弍彂 (暘扴幏昅)]亂嵟怴 専嵏丒夋憸恌抐帠揟 2022-23擭斉亃IV宆僐儔乕僎儞掕検惛枾應掕, p.13. 庪栰桳嶌 (椪専妛), 曇: 擔杮椪彴専嵏堛妛夛, 堛妛捠怣幮, 搶嫗, 2021/5敪峴.
620142. [妛弍彂 (暘扴幏昅)]亂嵟怴 専嵏丒夋憸恌抐帠揟 2022-23擭斉亃僔儏僂巁 (擜), p.13. 庪栰桳嶌 (椪専妛), 曇: 擔杮椪彴専嵏堛妛夛, 堛妛捠怣幮, 搶嫗, 2021/5敪峴.
620143. [妛弍彂 (暘扴幏昅)]亂嵟怴 専嵏丒夋憸恌抐帠揟 2022-23擭斉亃僼儘乕僒僀僩儊僩儕乕朄偵傛傞擜拞桳宍惉暘掕検應掕, p.15. 庪栰桳嶌 (椪専妛), 曇: 擔杮椪彴専嵏堛妛夛, 堛妛捠怣幮, 搶嫗, 2021/5敪峴.
620144. [妛弍彂 (暘扴幏昅)]亂嵟怴 専嵏丒夋憸恌抐帠揟 2022-23擭斉亃儈僄儕儞墫巁惈抈敀 (MPB), p.21. 庪栰桳嶌 (椪専妛), 曇: 擔杮椪彴専嵏堛妛夛, 堛妛捠怣幮, 搶嫗, 2021/5敪峴.
620145. [妛弍彂 (暘扴幏昅)]亂嵟怴 専嵏丒夋憸恌抐帠揟 2022-23擭斉亃僼傿僔儏僶乕僌帋尡, p.246. 庪栰桳嶌 (椪専妛), 曇: 擔杮椪彴専嵏堛妛夛, 堛妛捠怣幮, 搶嫗, 2021/5敪峴.
620146. [妛弍彂 (暘扴幏昅)]亂嵟怴 専嵏丒夋憸恌抐帠揟 2022-23擭斉亃傾僕僗僇僂儞僩 (addis擜捑熢掕検専嵏), p.305. 庪栰桳嶌 (椪専妛), 曇: 擔杮椪彴専嵏堛妛夛, 堛妛捠怣幮, 搶嫗, 2021/5敪峴.
[妛夛丒尋媶夛摍]
723666. [妛夛 (慡崙)] (堦斒島墘) 摉堾摐擜昦姵幰偵偍偗傞嵟戝撪枌拞枌暋崌懱岤偺4擭曄壔偲偦偺塭嬁場巕偺専摙. 嶄丂廏旤, 搉嬶抦杻堖巕, 嶳壓帊怐, 懞壀撧旤崄, 壛摗杻桽巕, 惣岥晲巙, 椦丂揘斖1, 懌棫攷婭 (1椪専妛): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20-22), Web奐嵜.
723667. [妛夛 (慡崙)] (堦斒島墘) 摟愅拞偺2宆摐擜昦姵幰偵偍偗傞娫焄僗僉儍儞帩懕寣摐應掕婍偺惛搙昡壙偵娭偡傞尋媶 (AIDT2H尋媶). 朙揷夒晇, 懞揷丂宧, 陰摗恗捠, 栘懞庣師, 愇揷捈恖, 杒懞丂恀, 旘揷旤曚, 椦丂揘斖1, 怷岥偄傇偒, 彫椦捈擵, 掁扟戝曘, 嶁旜岾弐, 徏壓棽嵠, 埳摗愥奊, 楅栘徛懢, 妢娫丂廃, 妢尨惓搊, 嶳愳丂惓, 怷丂崕恗, 崟揷嬇惗, 嶰塝弴擵彆, 淎揷桬巑, 垻晹夒婭, 怺愳夒巎, 嶁崻捈庽, 嵶揷岞懃 (1椪専妛): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20-22), Web奐嵜.
723668. [妛夛 (慡崙)] (堦斒島墘) 旍枮崌暪2宆摐擜昦寣塼摟愅 (DMHD) 姵幰2椺偵偍偗傞僙儅僌儖僠僪偺巊梡宱尡. 怷岥偄傇偒, 椦丂揘斖1, 彫椦捈擵, 抾拞丂惤, 戝媣曐廩恖, 庣壆棙壚2, 庣壆払旤3, 抾撪峃梇4 (1椪専妛, 2堛妛嫵堢, 3寬峃娗棟僙, 4恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4-6), 墶昹 (僴僀僽儕僢僪奐嵜).
723669. [妛夛 (慡崙)] (堦斒島墘) 杒棦戝妛昦堾偱暘棧偝傟偨MRSA嬠姅偵偍偗傞峈MRSA栻姶庴惈孹岦偵娭偡傞専摙. 拞懞惓庽1, 埨払丂忳2, 擇杮桍怢2,3, 椦丂揘斖1, 揑応寬懢1, 庪栰桳嶌1, 杒棦塸榊4 (1椪専妛, 2椪専晹, 3姶愼娗棟幒, 4堛椕塹惗妛晹): 戞68夞擔杮椪彴専嵏堛妛夛妛弍廤夛 (2021/11/11-14), 晉嶳 (僴僀僽儕僢僪奐嵜).
723670. [妛夛 (慡崙)] (堦斒島墘) 杒棦戝妛昦堾偵偍偗傞儕僽儗View塣梡偺庢傝慻傒偲椪彴専嵏媄巘偺栶妱. 椦丂揘斖1, 揑応寬懢1, 搚昅抭徎2, 嶰塝朏揟2, 拞懞惓庽1, 庪栰桳嶌1 (1椪専妛, 2椪専晹): 戞68夞擔杮椪彴専嵏堛妛夛妛弍廤夛 (2021/11/11-14), 晉嶳 (僴僀僽儕僢僪奐嵜), 擔杮椪彴専嵏堛妛夛帍 2021/10; 69: 112.
723671. [妛夛 (慡崙)] (堦斒島墘) 娫焄僗僉儍儞幃帩懕寣摐應掕 (isCGM) 傪梡偄偨怑偵娭偡傞椕梴巜摫偑桳岠偱偁偭偨1宆摐擜昦偺1椺. 搉绯帊斂浠, 嶳杮塸棦崄, 椦丂揘斖1, 懌棫攷婭 (1椪専妛): 戞24夞丒戞25夞擔杮昦懺塰梴妛夛擭師妛弍廤夛 (2022/1/28-30), 嫗搒 (僴僀僽儕僢僪奐嵜).
731080. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) C宆娞墛杘柵偵岦偗偨椪彴専嵏晹偺庢傝崬傒乣杒棦戝妛昦堾偺娞墛懳嶔偵偍偗傞恌椕晹栧偲偺楢実乣. 庪栰桳嶌 (椪専妛): 搶嫗搒椪彴専嵏媄巘夛戞3夞柶塽寣惔専嵏尋媶斍尋廋夛 (2021/11/18), 搶嫗.
733222. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉堾偵偍偗傞寣摐僐儞僩儘乕儖晄挷姵幰傊偺椕梴巜摫偺庢傝慻傒偵偮偄偰. 彫椦桭棦, 搉绯帊斂浠, 嶳杮塸棦崄, 娾悾恀婭, 崅栘棞壴, 壛摗杻桽巕, 懞堜垽朷, 椦丂揘斖1, 懌棫攷婭 (1椪専妛): 戞59夞擔杮摐擜昦妛夛娭搶峛怣墇抧曽夛 (2022/1/22), Web奐嵜.
733223. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉堾娗棟塰梴巑偲峴惌曐寬巘偲偺楢実偑寣摐僐儞僩儘乕儖偵憈岟偟偨堦椺. 崅栘棞壴, 搉绯帊斂浠, 椦丂揘斖1, 懌棫攷婭 (1椪専妛): 戞59夞擔杮摐擜昦妛夛娭搶峛怣墇抧曽夛 (2022/1/22), Web奐嵜.
733224. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 寣摐抣偺忋偑傝偵偔偄榓壻巕乽垽愳偮偮偠閈摢乿偺寣摐忋徃梷惂岠壥偺専摙. 娾悾恀婭, 懌棫攷婭, 椦丂揘斖1, 搉绯帊斂浠, 嶳杮塸棦崄, 惣榚垽朷, 彫椦桭棦, 崅栘棞壴 (1椪専妛): 戞59夞擔杮摐擜昦妛夛娭搶峛怣墇抧曽夛 (2022/1/22), Web奐嵜.
桝寣丒嵶朎堏怉妛
[妛弍榑暥]
110414. [尨挊] Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones. Uchiyama T, Takahashi S, Nakabayashi K, Okamura K, Edasawa K, Yamada M, Watanabe N, Mochizuki E, Yasuda T, Miura A, Kato M, Tomizawa D, Otsu M1, Ariga T, Onodera M: Mol Ther Methods Clin Dev 2021/10; 23: 424-33. (戝捗丂恀1: 1桝寣丒嵶朎堏怉)
110415. [尨挊] Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma. Nakazato T, Hagihara M, Sahara N, Tamai Y, Ishii R, Tamaki S, Wake A, Tajika K, Sakai R, Kobayashi T, Hua J, Inoue M, Aisa Y, Fujisawa S, Miyazaki K1, Irie S, Tanaka E, Higashihara M2: Ann Hematol 2021/11; 100 (11): 2745-54. (媨鴵峗擇1, 搶尨惓柧2: 1桝寣丒嵶朎堏怉, 2寣塼撪)
522573. [島嵗]亂摿廤: 崱抦偭偰偍偒偨偄丂僎僲儉堛椕偲堚揱巕帯椕亅婎慴偐傜椪彴傑偱亃[憤榑] 尰嵼彸擣偝傟偰偄傞堚揱巕帯椕栻亅傢偑崙偲奀奜. 戝捗丂恀 (桝寣丒嵶朎堏怉): 彫帣撪壢 2022/2; 54 (2): 288-93.
[妛夛丒尋媶夛摍]
722304. [妛夛 (慡崙)] (僔儞億僕僂儉) 昦堾忣曬僔僗僥儉8擭娫偺曕傒. 戝扟怲堦 (桝寣丒嵶朎堏怉): 戞69夞擔杮桝寣丒嵶朎帯椕妛夛妛弍憤夛 (2021/6/5), 搶嫗 (僴僀僽儕僢僪奐嵜).
'20擭搙埲慜暘
[妛弍榑暥]
'20-110033. [尨挊] EffEfficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study. Jang JH, Tomiyama Y, Miyazaki K1, Nagafuji K, Usuki K, Uoshima N, Fujisaki T, Kosugi H, Matsumura I, Sasaki K, Kizaki M, Sawa M, Hidaka M, Kobayashi N, Ichikawa S, Yonemura Y, Enokitani K, Matsuda A, Ozawa K, Mitani K, Lee JW, Nakao S: Br J Haematol 2021/1; 192 (1): 190-9. (媨鴵峗擇1: 1桝寣丒嵶朎堏怉)
[妛夛丒尋媶夛摍]
'20-722007. [妛夛 (慡崙)] (僔儞億僕僂儉) 寣彫斅尭彮徢偺娪暿恌抐偲寣彫斅僷儔儊乕僞. 媨鴵峗擇 (桝寣丒嵶朎堏怉): 戞15夞擔杮寣愷巭寣妛夛妛弍昗弨壔埾堳夛 (SSC) 2021僔儞億僕僂儉 (2021/2/27), Web奐嵜.
媬柦媬媫堛妛
[妛弍榑暥]
120037. [尨挊] Possible 僪僫乕偐傜憻婍採嫙偺壜擻惈偑幐傢傟傞梫場偲幚懺: 扨巤愝屻曽帇揑尋媶. 揷懞丂抭1, 崅嫶丂宐2,3, 忋懞桼帡3, 娭丂堦攏2,3, 嵅愳旤棦3, 捴旤抭攷4, 媑揷堦惉5, 暈晹丂弫1, 曅壀桽堦1, 愺棙丂桋1 (1媬柦, 2堏怉堛椕巟墖幒, 3娕岇晹, 4娕岇妛晹, 5怴悽婭堛椕丒愭抂堛椕): 堏怉 2021/11; 56 (4): 397-403.
310055. [徢椺曬崘] Detection of Rectal Artery Supply to Vaginal Postpartum Hemorrhage Using CO2. Kurihara Y1, Woodhams R2, Fujii K2, Mitsui K2, Maruhashi T1, Asari Y1, Inoue Y2: J Vasc Interv Radiol 2022/2; 33 (2): 207-9. (孖尨桽懢楴1, 僂僢僪僴儉僗楁巕2, 摗堜丂奭2, 嶰堜峃暯2, 娵嫶岶徍1, 愺棙丂桋1, 堜忋桪夘2: 1媬柦, 2曻幩慄 (夋憸))
522574. [島嵗]亂摿廤: 僽儔僀儞僪慂巋丒庤媄亃8. 戝戁摦柆慂巋偲REBOA僇僥乕僥儖憓擖. 孖尨桽懢楴1, 娵嫶岶徍1 (1媬柦): 媬媫堛妛 2021/6; 45 (6): 658-65.
[挊丂彂]
620147. [妛弍彂 (暘扴幏昅)]亂JRC慼惗僈僀僪儔僀儞2020亃戞2復 惉恖偺擇師媬柦張抲 (ALS), p.47-150. 壛摗惓嵠, 嵵摗怢峴, 帥嶁桬椇, 娵嫶岶徍1, 媨晹峗摴 (1媬柦): 娔廋: 擔杮慼惗嫤媍夛, 堛妛彂堾, 搶嫗, 2021/6敪峴.
[妛夛丒尋媶夛摍]
713053. [妛夛 (崙嵺)] (堦斒島墘) Direct Oral Anticoagulant is Associated with a Lower Prevalence of Thin-Cap Fibroatheroma in Patients with Coronary Artery Disease. Kinoshita D1, Minami Y2, Kakizaki R2, Ishida K2, Fujiyoshi K2, Sato T2, Kato A3, Nagata T3, Asakura K3, Katamine M3, Katsura A2, Ako J2: American Heart Association (AHA) 2021 Scientific Session (2021/11/13-15), Web奐嵜. (栘壓戝帒1, 撿丂彯尗2, 奰嶈椙懢2, 愇揷峅婤2, 摗媑榓攷2, 嵅摗弐廩2, 壛摗嵤旤3, 塱揷婱巕3, 挬憅惔巎3, 曅曯惓岍3, 宩丂桳抭2, 垻屆弫嵠2: 1媬柦, 2弞娐婍撪, 3戝妛堾堛椕宯尋媶壢)
723672. [妛夛 (慡崙)] (堦斒島墘) 嶻壢弌寣偵偍偗傞妶摦惈弌寣偺専弌偵懳偡傞扽巁僈僗憿塭偺桳梡惈偺専摙. 孖尨桽懢楴1, 僂僢僪僴儉僗楁巕2, 徏塱宧擇2, 摗堜丂奭2, 嶰堜峃暯2, 娵嫶岶徍1, 揷懞丂抭1, 堜忋桪夘2, 愺棙丂桋1 (1媬柦, 2曻幩慄 (夋憸)): 戞50夞擔杮IVR妛夛憤夛 (2021/5/20), Web奐嵜, 擔杮僀儞僞乕儀儞僔儑僫儖儔僕僆儘僕乕妛夛嶨帍 2021; 36 (Suppl): 146.
723673. [妛夛 (慡崙)] (堦斒島墘) 懌娭愡壥晹崪愜傪敽偆泺崪崪姴晹崪愜偺帯椕彫宱尡. 徏塝峎惓1, 壨懞丂捈2, 彲巌恀懢榊2, 曯尨岹徆, 崅憡徎巑2 (1媬柦, 2惍奜): 戞47夞擔杮崪愜帯椕妛夛妛弍廤夛 (2021/7/3), 恄屗.
723674. [妛夛 (慡崙)] (堦斒岥墘) possible donor偐傜憻婍採嫙偺壜擻惈偑幐傢傟傞梫場偲幚懺. 揷懞丂抭1, 崅嫶丂宐2, 娭丂堦攏2, 忋懞桼帡2, 嵅愳旤棦2, 媑揷堦惉3,4, 曅壀桽堦1, 愺棙丂桋1 (1媬柦, 2娕岇晹, 3怴悽婭堛椕丒愭抂堛椕, 4斿擜婍): 戞57夞擔杮堏怉妛夛憤夛 (2021/9/20), 搶嫗 (僴僀僽儕僢僪奐嵜), 堏怉 2021/9; 56 (憤夛椪帪): O22-4.
732128. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 摉堾偵偍偗傞揮堏惈戝戁崪崪庮釃偵懳偡傞帯椕偺尰忬. 徏塝峎惓1, 壨懞丂捈2, 彲巌恀懢榊2, 崅憡徎巑2 (1媬柦, 2惍奜): 戞174夞恄撧愳惍宍嵭奞奜壢尋媶夛 (2022/1/29), 墶昹 (僴僀僽儕僢僪奐嵜).
733161. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恌抐偵嬯椂偟偨奜彎惈忋娽鈢楐徢岓孮1椺. 崅丂怳壠, 娾愳偝偍傝1, 怴旤梇戝2, 孎郪寷堦2, 晲揷丂孾2 (1媬柦, 2宍惉丒旤奜): 戞24夞杒棦宍惉奜壢僼僅乕儔儉 (2021/7/17), 憡柾尨.
憤崌恌椕堛妛
[妛弍榑暥]
521018. [夝愢] 嫻晹晄夣姶偺徢忬摍傪妋擣偡傞媊柋傪懹傝, 媫惈姤徢岓孮偺娪暿傪懹偭偨偨傔, 姵幰偵梻擔怱攋楐偑惗偠偰巰朣偟偨偲偟偰懝奞攨彏傪媮傔偨帠椺. 惵嶳捈慞 (憤崌恌椕): 堛椕敾椺夝愢 2021/10; 94: 122-4.
堛妛晹晬懏堛妛嫵堢尋媶奐敪僙儞僞乕
堛妛嫵堢尋媶晹栧
[妛弍榑暥]
220004. [弨尨挊] 懳墳崲擄側姵幰傪憐掕偟偨柾媅姵幰偲偺堛椕柺愙墘廗偵娭偡傞幚慔曬崘. 巗憅壛撧巕1, 庣壆棙壚2, 愮梩岹婤, 堜忋彶恇, 搰捗柧恖, 掔丂柧弮3 (1堛椕塹惗妛晹, 2堛妛嫵堢, 3岞廜塹惗): 擔杮僿儖僗僐儈儏僯働乕僔儑儞妛夛嶨帍 2021/4; 12 (1): 51-5.
220005. [弨尨挊] [嫵嵽丒僔僫儕僆] 堛椕宯偺妛惗娫儘乕儖丒僾儗僀墘廗傪懀恑偡傞愊嬌揑孹挳妛廗偵娭偡傞摦夋嫵嵽偺奐敪. 愮梩岹婤1, 堜忋彶恇, 庣壆棙壚1, 搰捗柧恖, 巗憅壛撧巕2, 掔丂柧弮3 (1堛妛嫵堢, 2堛椕塹惗妛晹, 3岞廜塹惗): 擔杮僔儈儏儗乕僔儑儞堛椕嫵堢妛夛嶨帍 2021/10; 9: 64-71.
[挊丂彂]
620148. [妛弍彂 (暘扴幏昅)]亂旕偑傫幘姵偺僄儞僪僆僽儔僀僼丒働傾 (EOLC) 偵娭偡傞僈僀僪儔僀儞亃[廳梫椪彴壽戣9] 傾僪僶儞僗丒働傾丒僾儔儞僯儞僌 (ACP)丂CQ21, p77-9. 愮梩岹婤1, 嶰塝媣岾, 惣愳枮懃, 嶳岥懽峅, 妬堜暥巕 (1堛妛嫵堢), 曇: 擔宱儊僨傿僇儖, 擔宱BP, 搶嫗, 2021/9敪峴.
[妛夛丒尋媶夛摍]
723675. [妛夛 (慡崙)] (堦斒島墘) 僆儞儔僀儞島媊宆庼嬈偵偍偗傞僇僂儞僙儕儞僌摦夋傪妶梡偟偨僐儈儏僯働乕僔儑儞墘廗偺幚巤壜擻惈偍傛傃桳梡惈. 巗憅壛撧巕1, 庣壆棙壚2, 愮梩岹婤2, 堜忋彶恇, 搉曈榓峀3, 峳堜桳旤4, 搰捗柧恖, 怺悾桾巕1, 懞悾壺巕1, 揷儢扟峗朚1, 掔丂柧弮3 (1堛椕塹惗妛晹, 2堛妛嫵堢, 3岞廜塹惗, 4堛椕偺幙丒埨慡悇恑幒): 僿儖僗僐儈儏僯働乕僔儑儞僂傿乕僋2021乣峀搰乣 (2021/10/2), Web奐嵜.
723676. [妛夛 (慡崙)] (堦斒岥墘) 僄儞僪丒僆僽丒儔僀僼働傾偵娭傢傞愱栧怑傪懳徾偲偟偨僐儈儏僯働乕僔儑儞尋廋慜屻偺夛榖曄壔偲姵幰昡壙偵娭偡傞尋媶. 愮梩岹婤1, 庣壆棙壚1, 旜宍椣柧, 偨傜郪朚抝, 怷扟廇宑, 懢揷堦庽 (1堛妛嫵堢): 僿儖僗僐儈儏僯働乕僔儑儞僂傿乕僋2021乣峀搰乣 (2021/10/2), 峀搰 (僴僀僽儕僢僪奐嵜).
堛妛尨榑尋媶晹栧
[妛弍榑暥]
521019. [夝愢]亂楢嵹: 桪惗巚憐偵棫偪岦偐偆乻27乼亃乬宧堄傪敽偆乭姲梕偺偨傔偵. 釼摗桳婭巕 (堛妛尨榑): 偡傋偰偺恖偺幮夛 2021/10; 41 (7): 8-9.
[妛夛丒尋媶夛摍]
723677. [妛夛 (慡崙)] (堦斒島墘) 擠晈偺寣塼偵傛傞弌惗慜専嵏乣僈僀僪儔僀儞傪嶌惉偡傞愱栧怑偺椣棟乣. 釼摗桳婭巕 (堛妛尨榑): 戞11夞擔杮堚揱巕恌椕妛夛堚揱巕恌抐丒専嵏媄弍悇恑僼僅乕儔儉 (2021/12/2), 搶嫗 (僴僀僽儕僢僪奐嵜).
733225. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擼恄宱撪壢堛偵媮傔傜傟傞堚揱巕恌抐専嵏偵偍偗傞椣棟揑丒朄揑攝椂. 釼摗桳婭巕 (堛妛尨榑): 椷榓3擭搙恄宱曄惈幘姵椕堢偺婎斦揑挷嵏尋媶斍儚乕僋僔儑僢僾 (2021/7/9), Web奐嵜.
733226. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 弌惗慜恌抐偲椣棟. 釼摗桳婭巕 (堛妛尨榑): 擔杮壠懓寁夋嫤夛堚揱偺婎慴僆儞儔僀儞島嵗 (2021/11/22), Web奐嵜.
733227. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擔杮惛恄塹惗夛偲桪惗曐岇朄挷嵏曬崘. 釼摗桳婭巕 (堛妛尨榑): 擔杮惛恄塹惗夛 (2021/12/16), Web奐嵜.
733228. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 弌惗慜丒拝彴慜専嵏偑傕偨傜偡彈惈傊偺僗僥傿僌儅. 釼摗桳婭巕 (堛妛尨榑): 僎僲儉栤戣専摙夛媍 (2022/1/16), Web奐嵜.
733229. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 惈揑DV丒惈朶椡偲擠怭拞愨. 釼摗桳婭巕 (堛妛尨榑): #傕偭偲埨慡側拞愨傪傾僋僔儑儞 (2022/1/28), Web奐嵜.
733230. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 弌惗慜丒拝彴慜専嵏偲DSDs. 釼摗桳婭巕 (堛妛尨榑): 柧帯妛堾戝妛幮夛妛晹晅懏尋媶強堦斒僾儘僕僃僋僩 (2022/3/16), Web奐嵜.
733231. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 偒傚偆偩偄偺帇揰偐傜傒偨弌惗慜専嵏. 釼摗桳婭巕 (堛妛尨榑): 柧帯妛堾戝妛幮夛妛晹晅懏尋媶強堦斒僾儘僕僃僋僩 (2022/3/16), Web奐嵜.
堛椕埨慡丒娗棟妛尋媶晹栧
仸乽惍宍奜壢妛乿傪嶲徠
堛椕媄弍嫵堢尋媶晹栧
仸乽恡憻撪壢妛乿傪嶲徠
妛廗巟墖尋媶晹栧
堛椕忣曬嫵堢尋媶晹栧
[妛夛丒尋媶夛摍]
713054. [妛夛 (崙嵺)] (堦斒島墘) Multi-state structure determination and dynamics analysis reveals a new ubiquitin-recognition mechanism in yeast ubiquitin C-terminal hydrolase. Ikeya T, Okada M, Tateishi Y, Nojiri E, Mikawa T, Rajesh Sundaresan, Ogasa H, Ueda T, Yagi H, Kohno T1, Kigawa T, Shimada I, Guntert Peter, Ito Y ISMAR-APNMR-NMRSJ-SEST 2021 (2021/8/23), Osaka, Japan. (壨栰弐擵1: 1堛椕忣曬嫵堢)
713055. [妛夛 (崙嵺)] (堦斒島墘) Successful Analysis of the Interaction between a GPCR Peptide Fragment Having High Aggregating Tendency with a Modulator Protein of the GPCR. Kuzunuki E, Busujima I, Kurokawa Y, Sakamoto T, Kohno T1, Hosoda K, Terawaki S, Wakamatsu K ISMAR-APNMR-NMRSJ-SEST 2021 (2022/8/23), Osaka, Japan. (壨栰弐擵1: 1堛椕忣曬嫵堢)
搶梞堛妛嫵堢尋媶晹栧
[妛弍榑暥]
110416. [尨挊] The Relationship between ""Shofuku-Fujin"" (Abnormality of Abdominal Examination in Japanese Kampo Medicine) and Body Composition by Bioelectrical Impedance Analysis: A Cross-Sectional Study. Ishige T1, Odaguchi H1,2, Hanawa T1: Evid Based Complement Alternat Med 2021/4; 2021: 6610593. (彫揷岥峗1,2: 1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢)
110417. [尨挊] Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials. Takayama S, Namiki T, Odaguchi H1,2, Arita R, Hisanaga A, Mitani K, Takashi Ito T: Front Pharmacol 2021/6; 12: 656246. (彫揷岥峗1,2: 1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強)
110418. [尨挊] Preventive effect of a Kampo medicine, kososan, on recurrent depression in a mouse model of repeated social defeat stress. Ito N1, Sasaki K, Hirose E, Nagai T1, Isoda H, Odaguchi H1,2: Gene 2022/1; 806: 145920. (彫揷岥峗1,2: 1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢)
110419. [尨挊] Kampo formulas alleviate aging-related emotional disturbances and neuroinflammation in male senescence-accelerated mouse prone 8 mice. Ito N1, Maruko A, Oshima K, Yoshida M, Honma K, Sugiyama C, Nagai T1, Kobayashi Y1, Odaguchi H1,2, Okada N: Aging (Albany NY) 2022/1; 14 (1): 109-42. (彫揷岥峗1,2: 1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢)
120038. [尨挊] 崙嵺幘昦暘椶戞11夞夵掶斉 (ICD-11) 揱摑堛妛復怴愝偺堄媊. 埳摗丂棽, 搉丂嶰壚, 惸摗廆懃, 惎栰戩擵1,2, 墶杧桼婌巕, 栴媣曐廋巏, 庒嶳堢榊 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): 擔杮搶梞堛妛嶨帍 2021/10; 72 (4): 461-72.
320026. [徢椺曬崘] 晄埨恄宱徢偺彅徢忬偵楄宩娒灔搾壛峠壴偑桳岠偱偁偭偨1徢椺. 拞旜宩巕1, 惎栰戩擵1,2, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 娍曽偺椪彴 2021/5; 68 (5): 632-6.
320027. [徢椺曬崘] 鐸媱偲娍曽偺暪梡偑憈岠偟偨悋柊忈奞偺1椺. 堜揷崉恖1, 埳搶廏寷1, 楅栘朚旻1, 埳摗丂崉1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 娍曽偺椪彴 2022/1; 69 (1): 95-100.
522575. [島嵗]亂摿廤: 僕僃僱儔儕僗僩丒娍曽亅偲偭偰偍偒偺娍曽妶梡弍亃仭椞堟暿偍偡偡傔娍曽帯椕丂徚壔婍撪壢匑丂怘梸晄怳, 婡擻惈僨傿僗儁僾僔傾, 媡棳惈怘摴墛. 惎栰戩擵1,2 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): medicina 2021/7; 58 (8): 1140-3.
522576. [島嵗]亂摿廤: 僕僃僱儔儕僗僩丒娍曽亅偲偭偰偍偒偺娍曽妶梡弍亃仭椞堟暿偍偡偡傔娍曽帯椕丂嶻晈恖壢丂寧宱慜徢岓孮丆峏擭婜忈奞. 怷丂塴巕1, 彫揷岥峗2,3 (1戝妛堾堛椕宯尋媶壢, 2搶梞堛妛嫵堢, 3搶梞堛妛憤崌尋媶強): medicina 2021/7; 58 (8): 1202-6.
[挊丂彂]
620149. [妛弍彂 (曇廤丒娔廋)]亂愱栧壠偺僐儞僙儞僒僗偵婎偯偔億働僢僩娍曽栻僈僀僪34 1斉亃怴堜丂怣, 彫揷岥峗1,2, 幠尨捈棙, 搱揷丂朙, 暲栘棽梇, 壴椫氭旻2, 嶰鄈拤摴, 懞徏怲堦, 娭崻杻棟巕, 庒悪埨婓擳 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強), 挊: 億働僢僩娍曽栻僈僀僪曇廤埾堳夛, 撿嶳摪, 搶嫗, 2021/8敪峴.
[妛夛丒尋媶夛摍]
722305. [妛夛 (慡崙)] (僔儞億僕僂儉) 娍曽張曽偺屇媧婍僂僀儖僗姶愼徢偵懳偡傞岠壥: 曗拞塿婥搾, 幠妺夝敡搾, 妺崻搾偲彫幠層搾壛媕峓愇峱崌嵻偺婎慴尋媶. 塱堜棽擵1, 彫揷岥峗1,2, 惔尨姲復1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/5), Web奐嵜.
722306. [妛夛 (慡崙)] (僔儞億僕僂儉) 堛巘庡摫帯尡乬姶愼弶婜偺COVID-19姵幰偵懳偡傞EFE偺桳岠惈媦傃埨慡惈傪専摙偡傞扵嶕揑帋尡乭偺拞娫曬崘. 彫揷岥峗1,2 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): 擔杮栻妛夛戞142擭夛 (2022/3/26), Web奐嵜.
723678. [妛夛 (慡崙)] (堦斒島墘) 擄帯惈偺擕偑傫愗彍屻醬捝徢岓孮偵鐸媱帯椕偑桳岠偱偁偭偨堦徢椺. 崟娾撧乆巕1, 埳搶廏寷1, 埳摗丂崉1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞70夞 (岞幮) 慡擔杮鐸媱妛夛妛弍戝夛 (2021/6/4), Web奐嵜.
723679. [妛夛 (慡崙)] (堦斒島墘) 纟晹偺捝傒偵懳偟偰宱棈帯椕偲摟擬媱偑憈岠偟偨1徢椺. 搶愳楀墰1, 埳搶廏寷1, 埳摗丂崉1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞70夞 (岞幮) 慡擔杮鐸媱妛夛妛弍戝夛 (2021/6/4), Web奐嵜.
723680. [妛夛 (慡崙)] (堦斒島墘) 醤嬉偵懳偟偰鐸媱丆娍曽帯椕偑桳岠偲巚傢傟偨2徢椺. 埳搶廏寷1, 埳摗丂崉1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞70夞 (岞幮) 慡擔杮鐸媱妛夛妛弍戝夛 (2021/6/5), Web奐嵜.
723681. [妛夛 (慡崙)] (堦斒島墘) 娽豳醶澒偵鐸媱帯椕偑桳岠偱偁偭偨1徢椺. 堜揷崉恖1, 埳搶廏寷1, 埳摗丂崉1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞70夞 (岞幮) 慡擔杮鐸媱妛夛妛弍戝夛 (2021/6/5), Web奐嵜.
723682. [妛夛 (慡崙)] (堦斒島墘) ICD-11揱摑堛妛偺復偺崙撪揔梡乗梡岅媦傃昦柤暘椶埾堳夛妶摦曬崘. 惎栰戩擵1,2 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): 戞71夞擔杮搶梞堛妛夛妛弍憤夛 (2021/8/13), Web奐嵜.
723683. [妛夛 (慡崙)] (堦斒島墘) 旍枮傪廌慽偲偟偨庴恌姵幰偺娍曽張曽偵偮偄偰偺屻傠岦偒娤嶡偺専摙. 埳搶廏寷1, 壴椫氭旻1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞71夞擔杮搶梞堛妛夛妛弍憤夛 (2021/8/13), Web奐嵜.
723684. [妛夛 (慡崙)] (堦斒島墘) AI偵傛傞崗傒惗栻偺夋憸敾暿偺帋傒亅怺憌妛廗僯儏乕儔儖僱僢僩儚乕僋偵傛傞敾暿惛搙偺専徹亅. 埳摗梇堦1, 埳搶廏寷1, 埳摗丂崉1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞71夞擔杮搶梞堛妛夛妛弍憤夛 (2021/8/13), Web奐嵜.
723685. [妛夛 (慡崙)] (堦斒島墘) 娽偺晄掕廌慽偵瀴巕攼旂搾偑挊岠偟偨1椺. 怷桾婭巕1, 晽屗梲巕1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞71夞擔杮搶梞堛妛夛妛弍憤夛 (2021/8/14), Web奐嵜.
723686. [妛夛 (慡崙)] (堦斒島墘) 擕朳嵞寶弍屻偺尐娭愡峉弅偵宱嬝帯椕傪娷傓鐸帯椕偑桳岠偩偭偨堦徢椺. 嬤摗垷嵐1, 埳搶廏寷1, 埳摗丂崉1, 壴椫氭旻1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞71夞擔杮搶梞堛妛夛妛弍憤夛 (2021/8/14), Web奐嵜.
723687. [妛夛 (慡崙)] (堦斒島墘) 娍曽悘徹帯椕偵傛傝愩戂 (崟妼怓) 偺曄壔傪擣傔偨堦椺. 愳撶埳峎1, 壴椫氭旻1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞71夞擔杮搶梞堛妛夛妛弍憤夛 (2021/8/14), Web奐嵜.
723688. [妛夛 (慡崙)] (堦斒島墘) 報搙幹栘壛枴曽偱崀埑岠壥偑擣傔傜傟偨崅寣埑徢偺3椺. 彫揷岥峗1,2 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): 戞71夞擔杮搶梞堛妛夛妛弍憤夛 (2021/8/14), Web奐嵜.
723689. [妛夛 (慡崙)] (堦斒島墘) 椪彴尋媶僐乕僨傿僱乕僞乕 (CRC) 偐傜傒傞椪彴尋媶偺摦岦乣夁嫀10擭娫偺摦岦乣夁嫀10擭娫偺杮妛夛妛弍憤夛偺島墘梫巪廤傪傕偲偵乣. 娭崻杻棟巕1, 庒悪埨婓擳1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞71夞擔杮搶梞堛妛夛妛弍憤夛 (2021/8/15), Web奐嵜.
723690. [妛夛 (慡崙)] (堦斒島墘) 杒棦戝妛堛妛晹偵偍偗傞搶梞堛妛幚廗偺奣梫偍傛傃妛惗偵傛傞昡壙. 庒悪埨婓擳1, 娭崻杻棟巕1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞71夞擔杮搶梞堛妛夛妛弍憤夛 (2021/8/15), Web奐嵜.
723691. [妛夛 (慡崙)] (堦斒島墘) 旍枮徢傑偨偼儊僞儃儕僢僋徢岓孮姵幰偵懳偡傞娍曽栻偺桳岠惈偍傛傃埨慡惈偵偮偄偰偺屻曽帇揑尋媶. 埳搶廏寷1, 壴椫氭旻1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723692. [妛夛 (慡崙)] (堦斒島墘) 敀濹攝崌曗拞塿婥搾偺柶塽僠僃僢僋億僀儞僩慾奞嵻偵傛傞暃嶌梡敪尰梊杊傊偺墳梡偺壜擻惈偺専摙. 嶳岥榓婸1, 墦摗恀棟1, 惔尨姲復1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723693. [妛夛 (慡崙)] (堦斒島墘) SAMP8儅僂僗傪梡偄偨娍曽栻偺枹昦惂屼儊僇僯僘儉偺夝愅. 埳摗捈庽1, 杮娫寬屽1, 悪嶳愮壚1, 掕岝桽壚1, 挿扟愳埢撨1, 塱堜棽擵1, 惔尨姲復1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723694. [妛夛 (慡崙)] (堦斒島墘) 枹昦儌僨儖儅僂僗偵懳偡傞暉棃 (僼僋儗) 儈僇儞壥旂愛庢偺桳岠惈偺夝愅. 掕岝桽壚1, 埳摗捈庽1, 杮娫寬屽1, 悪嶳愮壚1, 朙揷丂弤1, 堜忋塰堦1, 彫揷岥峗1,2, 惔尨姲復1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723695. [妛夛 (慡崙)] (堦斒島墘) LPS桿敪sickness behavior儌僨儖儅僂僗偵懳偡傞娍曽栻偺嶌梡偺夝愅. 杮娫寬屽1, 掕岝桽壚1, 悪嶳愮壚1, 埳摗捈庽1, 彫揷岥峗1,2, 惔尨姲復1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723696. [妛夛 (慡崙)] (堦斒島墘) 怶闼-敀濹攝崌曗拞塿婥搾偺T儕儞僷媴夘嵼惈彫挵擲枌墛徢夵慞嶌梡偺婡彉偲桳岠惉暘偺夝柧. 墦摗恀棟1, 惔尨姲復1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723697. [妛夛 (慡崙)] (堦斒島墘) 杻埱丂娒搾偺捔捝嶌梡偵娭傢傞峔惉惗栻偺夝柧. 抾撪丂弮1, 拞怷弐曘1, 擔岦恵旤巕2, 媨搱捈婭1, 撪嶳撧曚巕, 擔岦徆巌, 揤憅媑復, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻2, 彫椦媊揟1 (1栻妛晹, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723698. [妛夛 (慡崙)] (堦斒島墘) 儅僂僗僐儘僫僂僀儖僗Murine hepatitis virus姶愼儅僂僗偵懳偡傞EFE偺岠壥. 惣丂柧婭1, 擔岦恵旤巕1, 擔岦徆巌, 忋娫丂嫥, 撪嶳撧曚巕, 峚岥榓恇, 彫揷岥峗1,2 崌揷岾峀 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723699. [妛夛 (慡崙)] (堦斒島墘) VeroE6/TMPRSS2嵶朎傪梡偄偨EFE偺峈SARS-CoV-2嶌梡偺夝愅. 忋娫丂嫥, 擔岦徆巌, 擔岦恵旤巕1, 揤憅媑復, 撪嶳撧曚巕, 峚岥榓恇, 挬憅丂岹, 彫揷岥峗1,2, 崌揷岾峀 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723700. [妛夛 (慡崙)] (堦斒島墘) 僄僼僃僪儕儞傾儖僇儘僀僪彍嫀杻墿僄僉僗 (EFE) 偺峈怴宆僐儘僫僂僀儖僗嶌梡偵偍偗傞暘巕婡峔. 擔岦徆巌, 擔岦恵旤巕1, 揤憅媑復, 忋娫丂嫥, 撪嶳撧曚巕, 峚岥榓恇, 彫揷岥峗1,2, 崌揷岾峀 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723701. [妛夛 (慡崙)] (堦斒島墘) Paclitaxel桿敪枛徑恄宱忈奞惈醬捝偵懳偡傞杻墿僄僉僗偲僄僼僃僪儕儞傾儖僇儘僀僪彍嫀杻墿僄僉僗偺捔捝嶌梡. 墿丂愥扥1,2, 擔岦恵旤巕2, 梜丂嬥堒, 撪嶳撧曚巕, 擔岦徆巌, 揤憅媑復, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻2, 彫椦媊揟1 (1栻妛晹, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢): 戞38夞榓娍堛栻妛夛妛弍戝夛 (2021/9/4), Web奐嵜.
723702. [妛夛 (慡崙)] (堦斒島墘) 専嶕岅偺嬤愙搙傪尷掕偱偒傞娍曽僥僉僗僩暋崌専嶕僨乕僞儀乕僗偺峔抸. 惎栰戩擵1,2, 廃杊堦暯2, 壛敤憦巕2, 彫揷岥峗1,2, 壴椫氭旻2 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): 戞122夞擔杮堛巎妛夛憤夛丒妛弍戝夛 (2021/9/18), Web奐嵜.
723703. [妛夛 (慡崙)] (堦斒島墘) 堜忋宐棟偺柆恌偵偮偄偰. 廃杊堦暯1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞122夞擔杮堛巎妛夛憤夛丒妛弍戝夛 (2021/9/18), Web奐嵜.
723704. [妛夛 (慡崙)] (堦斒島墘) 怴弌偺惣懞棳亀壠揱鐸媱旈榐亁偵偮偄偰. 壛敤憦巕1, 惎栰戩擵1,2, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞122夞擔杮堛巎妛夛憤夛丒妛弍戝夛 (2021/9/18), Web奐嵜.
723705. [妛夛 (慡崙)] (堦斒島墘) 敿壞岤杙搾偺弍屻挵娗杻醿儌僨儖儅僂僗偵懳偡傞峈墛徢嶌梡偺夝愅. 墦摗恀棟1, 惔尨姲復1, 杧丂惓晀, 媦愳揘榊1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞23夞擔杮恄宱徚壔婍昦妛夛 (2021/10/8), Web奐嵜.
723706. [妛夛 (慡崙)] (堦斒島墘) 榁壔懀恑儌僨儖摦暔傪梡偄偨娍曽栻偺枹昦惂屼尋媶乣壛楊惈偆偮偵懳偡傞桳岠惈乣. 埳摗捈庽1, 杮娫寬屽1, 掕岝桽壚1, 塱堜棽擵1, 壴椫氭旻1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 擔杮栻妛夛戞142擭夛 (2022/3/27), Web奐嵜.
723707. [妛夛 (慡崙)] (堦斒島墘) Paclitaxel桿敪枛徑恄宱忈奞惈醬捝偵懳偡傞僄僼僃僪儕儞傾儖僇儘僀僪彍嫀杻墿僄僉僗偺帯椕媦傃梊杊岠壥. 愇愳岾巙1, 廐娫旤媣1, 墿丂愥扥1,2, 擔岦恵旤巕2, 梜丂嬥堒, 撪嶳撧曚巕, 擔岦徆巌, 揤憅媑復, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻2, 彫椦媊揟2 (1栻妛晹, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢): 擔杮栻妛夛戞142擭夛 (2022/3/27), Web奐嵜.
723708. [妛夛 (慡崙)] (堦斒島墘) 1HNMR儊僞儃儕僢僋僾儘僼傽僀儕儞僌傪梡偄偨娍曽栻乽杻埱丂娒搾乿偺惉暘慻惉夝愅. 忋揷抭栫1, 敀敤扖栱1, 拞怷弐曘1, 擔岦恵旤巕2, 抾撪丂弮1, 撪嶳撧曚巕, 擔岦徆巌, 揤憅媑復, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻2, 彫椦媊揟2 (1栻妛晹, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢): 擔杮栻妛夛戞142擭夛 (2022/3/27), Web奐嵜.
723709. [妛夛 (慡崙)] (堦斒島墘) Formalin桿敪醬捝偵懳偡傞杻墿僄僉僗媦傃僄僼僃僪儕儞傾儖僇儘僀僪偺懄岠惈偺捔捝嶌梡偺儊僇僯僘儉. 堜弌棦壚1, 墿丂愥扥1,2, 擔岦恵旤巕2, 拞怷弐曘1, 撪嶳撧曚巕, 擔岦徆巌, 揤憅媑復, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻2, 彫椦媊揟2 (1栻妛晹, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢): 擔杮栻妛夛戞142擭夛 (2022/3/27), Web奐嵜.
733232. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 鐸媱偲娍曽偺暪梡偑憈岠偟偨悋柊忈奞偺1椺. 堜揷崉恖1, 愇尨丂晲1, 埳搶廏寷1, 楅栘朚旻1,2, 埳摗丂崉1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞31夞娍曽帯椕尋媶夛 (2021/9/26), Web奐嵜.
733233. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉巤愝偵偍偗傞擼懖拞屻堚徢姵幰偵懳偡傞娍曽帯椕偺幚懺挷嵏. 拞旜宩巕1, 愇栄払栫1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞77夞擔杮搶梞堛妛夛娭搶峛怣墇巟晹憤夛 (2021/10/24), Web奐嵜.
昦堾楢実嫵堢尋媶晹栧
仸乽壓晹徚壔娗奜壢妛乿傪嶲徠
椪彴夝朥嫵堢媶晹栧
仸乽夝朥妛乮彫愳扨埵乯乿傪嶲徠
抧堟堛椕妛嫵堢尋媶晹栧
仸乽怱憻寣娗奜壢妛乿傪嶲徠
堛妛晹晬懏椪彴尋媶僙儞僞乕
婇夋奐敪晹栧
[妛弍榑暥]
110417. [尨挊] How Community Pharmacists Perceive Ethics in Clinical Research: A Qualitative Study. Ogura M, Takehira R, Watanabe T1, Arita E: Healthcare (Basel) 2021/11; 9(11): 1496. (搉绯払栫1: 1椪彴尋媶丒婇夋)
110418. [尨挊] Status survey on research ethics education for physicians: toward proper clinical research. Watanabe T1, Arita E, Ogura M, Takehira R: Kitasato Med J 2022/3; 52 (1): 12-9. (搉绯払栫1: 1椪彴尋媶丒婇夋)
522577. [島嵗]亂僔儞億僕僂儉8: CRC丒帠柋嬊僗僞僢僼嫵堢偺尰忬偲偙傟偐傜亅杮幙偺棟夝偵偮側偑傞偐偐傢傝偲偼?亅亃擔杮昦堾栻嵻巘夛偵傛傞CRC丒帠柋嬊僗僞僢僼偺嫵堢尋廋偵偮偄偰. 庰堜棽峗, 嬤摗捈庽, 栘枔旤捗晇, 帥尦丂崉, 榁杮柤捗巕, 崟揷丂抭, 搉绯払栫1, 悈堜婱帉, 掃娵夒巕, 揷嶈壝堦 (1椪彴尋媶丒婇夋): 栻棟偲帯椕 2021/8; 49 (8): 1219-22.
522578. [島嵗]亂僼僅乕儔儉亃椣棟埾堳夛偼婯惂奜懳徾奜尋媶偵偳偺傛偆偵懳墳偟偰偄傞偐. 摪殰弐旻, 搉绯払栫1, 拞揷垷婓巕, 巵尨丂弤, 桳揷墄巕 (1椪彴尋媶丒婇夋): 椪彴栻棟 2021/9; 52 (5): 127-33.
[妛夛丒尋媶夛摍]
722307. [妛夛 (慡崙)] (堛椕椣棟僙儈僫乕) 尋媶椣棟偲朄婯惂乣怴偟偄堛妛宯巜恓偺夝愢乣. 搉绯払栫 (椪彴尋媶丒婇夋): 戞60夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2021/11/21), 捁庢 (僴僀僽儕僢僪奐嵜).
723710. [妛夛 (慡崙)] (堦斒島墘) 椣棟埾堳夛偼婯惂懳徾奜偺尋媶偵偳偺傛偆偵懳墳偟偰偄傞偐. 摪殰弐旻, 搉绯払栫1, 拞揷垷婓巕, 巵尨丂弤2, 桳揷墄巕3 (1椪彴尋媶丒婇夋, 2杒棦尋媶強昦堾, 3栻妛晹): 戞33夞擔杮惗柦椣棟妛夛擭師戝夛 (2021/11/28), Web奐嵜.
僾儘僕僃僋僩幚巤晹栧
[妛弍榑暥]
110419. [尨挊] Concentration-QTc analysis for single arm studies. Orihashi Y, Ohwada S, Kumagai Y1: J Pharmacokinet Pharmacodyn 2021/4; 48 (2): 203-11. (孎扟梇帯1: 1椪彴尋媶丒僾儘僕僃僋僩)
110420. [尨挊] Real-world evidence of population differences in allopurinol-related severe cutaneous adverse reactions in East Asians: A population-based cohort study. Sato T, Cheng CL, Park HW, Yang YHK, Yang MS, Fujita M, Kumagai Y1, Tohkin M, Saito Y, Sai K: Clin Transl Sci 2021/5; 14 (3): 1002-14. (孎扟梇帯1: 1椪彴尋媶丒僾儘僕僃僋僩)
110421. [尨挊] Concentration-QTc analysis with two or more correlated baselines. Orihashi Y, Kumagai Y1: J Pharmacokinet Pharmacodyn 2021/10; 48 (5): 615-22. (孎扟梇帯1: 1椪彴尋媶丒僾儘僕僃僋僩)
110422. [尨挊] The necessary conduct: Exploratory multiregional clinical trials in East Asia. Jeon I, Kim YK, Song I, Yoon DY, Huh KY, Jin X, Yu KS, Lee SH, Kumagai Y1, Jang IJ: Clin Transl Sci 2021/11; 14 (6): 2399-407. (孎扟梇帯1: 1椪彴尋媶丒僾儘僕僃僋僩)
[挊丂彂]
620150. [妛弍彂 (暘扴幏昅)]亂栻嵻塽妛偺婎慴偲幚慔 (夵掶戞3斉)亃6復 斕攧彸擣慜偺椪彴帋尡 (帯尡) 偲巗斕屻偺挷嵏丒帋尡丂2 崙嵺嫟摨帋尡偲僽儕僢僕儞僌僐儞僙僾僩, p.300-5. 宨嶳丂栁, 孎扟梇帯1, 塅嶳壚柧, 愇崟抭宐巕 (1椪彴尋媶丒僾儘僕僃僋僩), 曇: 宨嶳丂栁, 媣曐揷寜, 儔僀僼僒僀僄儞僗弌斉, 搶嫗, 2021/7敪峴.
[妛夛丒尋媶夛摍]
712013. [妛夛 (崙嵺)] (僔儞億僕僂儉) Recent development of clinical pharmacology in Japan. Kumagai Y1: Summit Forum on Innovative R&D Services 2021 CIFTIS (2021/9/4), Beijing, China. (孎扟梇帯1: 1椪彴尋媶丒僾儘僕僃僋僩)
722308. [妛夛 (慡崙)] (僔儞億僕僂儉) 嫆揰偵傛傞儘乕僇儖僱僢僩儚乕僋傊偺婜懸. 孎扟梇帯 (椪彴尋媶丒僾儘僕僃僋僩): ARO嫤媍夛戞8夞妛弍廤夛 (2021/9/11), Web奐嵜.
722309. [妛夛 (慡崙)] (僔儞億僕僂儉) 傾僕傾偵偍偗傞帯尡偺幚巤娐嫬. 孎扟梇帯 (椪彴尋媶丒僾儘僕僃僋僩): 戞42夞擔杮椪彴栻棟妛夛妛弍憤夛 (2021/12/11), 愬戜 (僴僀僽儕僢僪奐嵜).
723711. [妛夛 (慡崙)] (堦斒島墘) 捵釃惈戝挵墛帯椕栻carotegrast methyl偺thorough QT/QTc (TQT) 帋尡: ICH E14 Q&A偵婎偯偔懡柺揑夝愅. 恄椦棽堦, 屻摗丂垽, 拞悾屆 (愹) 姲巕, 晲堜媊懃, 徏杮柧榊, 愳崌崃堦, 孎扟梇帯1, 悪嶳丂撃 (1椪彴尋媶丒僾儘僕僃僋僩): 戞42夞擔杮椪彴栻棟妛夛妛弍憤夛 (2021/12/9), 愬戜 (僴僀僽儕僢僪奐嵜).
僶僀僆僄僔僢僋僗晹栧
憂栻僔乕僘尋媶奐敪晹栧
堛妛晹晬懏怴悽婭堛椕奐敪僙儞僞乕
愭抂堛椕椞堟奐敪晹栧
(媑揷堦惉)
仸乽斿擜婍壢妛乿傪嶲徠
(揷绯丂憦)
仸乽徚壔婍撪壢妛乿傪嶲徠
(挿徖塸柧)
仸乽帹旲堲岮壢丒摢栩晹奜壢妛乿傪嶲徠
(揷拞丂寜)
仸乽堦斒丒彫帣丒娞抇鋁奜壢妛乿傪嶲徠
(尨棷峅庽)
仸乽曻幩慄壢妛乮夋憸恌抐妛乯乿傪嶲徠
(愭嶈廏柧)
仸乽彫帣壢妛乿傪嶲徠
(拞惣廏旻)
仸乽彫帣壢妛乿傪嶲徠
墶抐揑堛椕椞堟奐敪晹栧
(嬥堜徍暥)
仸乽杻悓壢妛乿傪嶲徠
(嶳壓宲巎)
仸乽忋晹徚壔娗奜壢妛乿傪嶲徠
(怴堜惓峃)
仸乽杻悓壢妛乿傪嶲徠
(嵅乆栘帯堦榊)
仸乽屇媧婍撪壢妛乿傪嶲徠
(彫椦惔揟)
仸乽徚壔婍撪壢妛乿傪嶲徠
(崅嶳梲巕)
仸乽杒棦戝妛昦堾姶愼娗棟幒乿傕嶲徠
[妛夛丒尋媶夛摍]
722310. [妛夛 (慡崙)] (僔儞億僕僂儉) 摉堾偵偍偗傞SARS-CoV-2姶愼懳嶔乣恄撧愳儌僨儖 崅搙堛椕婡娭丒廳揰堛椕婡娭偲偟偰乣. 崅嶳梲巕 (怴悽婭堛椕丒墶抐揑堛椕): 戞30夞擔杮宍惉奜壢妛夛婎慴妛弍廤夛 (2021/10/8), 搶嫗 (僴僀僽儕僢僪奐嵜).
731081. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 怴宆僐儘僫僂僀儖僗姶愼徢乣暘偐偭偨偙偲偲暘偐偭偰偄側偄偙偲乣. 崅嶳梲巕 (怴悽婭堛椕丒墶抐揑堛椕): 戞19夞杒棦戝妛堛妛晹摨憢夛巗柉岞奐島嵗乽抦偭偰栶棫偮怴宆僐儘僫僂僀儖僗姶愼徢偺嵟怴忣曬乿(2021/10/9), Web奐嵜.
732129. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 杒棦戝妛昦堾偵偍偗傞姶愼懳嶔乣恄撧愳儌僨儖 崅搙堛椕婡娭丒廳揰堛椕婡娭偲偟偰乣. 崅嶳梲巕 (怴悽婭堛椕丒墶抐揑堛椕): 戞34夞僶僀僆僒僀僄儞僗僼僅乕儔儉丒戞23夞旝惗暔傾僇僨儈乕尋媶廤夛 (2021/8/18), Web奐嵜.
堛妛晹嫵堢宯媄弍怑堳
宍懺宯
惗暔暔棟宯
昦懺丒恌椕宯
[妛夛丒尋媶夛摍]
722311. [妛夛 (慡崙)] (僔儞億僕僂儉) 塼忬壔専懱嵶朎恌曐懚塼偱屌掕偟偨攛娻嵶朎偐傜拪弌偟偨DNA偺埨掕惈偵偮偄偰. 徏旜桼婭巕1, 媑揷丂岟2, 嶳壓榓栫3, 懞塤朏庽2, 嵅摗擵弐4 (1昦懺丒恌椕宯, 2昦棟, 3昦棟晹, 4屇媧婍奜): 戞62夞擔杮椪彴嵶朎妛夛憤夛弔婜戝夛 (2021/6/5), 愮梩 (僴僀僽儕僢僪奐嵜).
梊杊堛妛宯
暘巕堛壢妛丒惂屼宯
搶昦堾尋媶宯
慻怐攟梴僙儞僞乕
DNA幚尡僙儞僞乕
僶僀僆僀儊乕僕儞僌尋媶僙儞僞乕
堚揱巕崅師婡擻夝愅僙儞僞乕
寬峃娗棟僙儞僞乕
[妛弍榑暥]
110423. [尨挊] Arteriolar hyalinosis is related to rapid GFR decline and long-standing GFR changes observed on renal biopsies in normo-microalbuminuric type 2 diabetic patients. Moriya T1, Yamagishi T, Yoshida Y1, Matsubara M1, Ouchi M: J Diabetes and its Complications 2021/8; 35 (4): 107847. (庣壆払旤1, 媑揷桭婭1, 徏尨傑偳偐1: 1寬峃娗棟僙)
110424. [尨挊] Glucose control, diabetic retinopathy, and hemodialysis induction in subjects with normo-microalbuminuric type 2 diabetic patients with normal renal function followed for 15 years. Moriya M1, Hayashi A2, Matsubara M1, Suzuki A2, Ouchi M: J Diabetes and its Complications 2022/1; 36 (1): 108080. (庣壆払旤1, 椦丂揘斖2, 徏尨傑偳偐1, 楅栘梲旻2: 1寬峃娗棟僙, 2撪暘斿戙幱撪)
[挊丂彂]
620151. [妛弍彂 (暘扴幏昅)]亂島嵗丂惛恄幘姵偺椪彴丂4. 恎懱揑嬯捝徢孮丂夝棧徢孮丂怱恎徢丂怘峴摦徢傑偨偼愛怘徢孮亃1復 恎懱揑嬯捝徢孮傑偨偼恎懱揑懱尡徢孮丂恎懱揑嬯捝徢偲枬惈醬捝丂Topics 帟壢椞堟偺恎懱揑嬯捝徢, p.37-42. 媨抧塸梇 (寬峃娗棟僙), 娔廋: 徏壓惓柧, 曇廤庡姴: 恄掚廳怣, 扴摉曇廤: 媣廧堦榊, 拞嶳彂揦, 搶嫗, 2021/7敪峴.
[妛夛丒尋媶夛摍]
713056. [妛夛 (崙嵺)] (堦斒島墘) Arteriolar Hyalinosis Is Associated with the Rate of eGFR Decline and Predicts the Onset of Macroalbuminuria and eGFR. Moriya T1, Hayashi A2, Suzuki A2, Matsubara M1, Ouchi M: American Diabetes Association 81th Scientific Sessions (2021/6/25-29), Web奐嵜, Diabetes 2021/6; 70 (Suppl 1): 409-P. (庣壆払旤1, 椦丂揘斖2, 楅栘梲旻2, 徏尨傑偳偐1: 1寬峃娗棟僙, 2撪暘斿戙幱撪)
713057. [妛夛 (崙嵺)] (億僗僞乕) Sodium Intake and Incidence of Diabetes Retinopathy in Elderly Patients with Type 2 Diabetes: Analysis of Data from the Japanese Elderly Diabetes Intervention Study (J-EDIT). Horikawa C, Aida R, Tanaka S, Kamada C, Tanaka S, Yoshimura Y, Kodera R, Fujihara K, Kawasaki R, Moriya T1, Yamashita H, Ito H, Sone H, Araki A: The American Diabetes Association's 81st Scientific Sessions (2021/6/25-29), Web奐嵜, Diabetes 2021/6; 70 (Suppl 1): 432-P. (庣壆払旤1: 1寬峃娗棟僙)
723712. [妛夛 (慡崙)] (堦斒島墘) 嵶摦柆徤巕壔偼惓忢乣旝検傾儖僽儈儞擜婜2宆摐擜昦偺媫寖側恡婡擻掅壓傪梊應偡傞巜昗偱偁傞. 庣壆払旤1, 椦丂揘斖2, 徏尨傑偳偐1, 楅栘梲旻2, 戝撪婎巌 (1寬峃娗棟僙, 2撪暘斿戙幱撪): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20-22), Web奐嵜, 摐擜昦 2021/4; 64 (Suppl): S-233.
'20擭搙埲慜暘
[妛弍榑暥]
'20-110034. [尨挊] Sodium Intake and Incidence of Diabetes Complications in Elderly Patients with Type 2 Diabetes-Analysis of Data from the Japanese Elderly Diabetes Intervention Study (J-EDIT). Horikawa C, Aida R, Tanaka S, Kamada C, Tanaka S, Yoshimura Y, Kodera R, Fujihara K, Kawasaki R, Moriya T1, Yamashita H, Ito H, Sone H, Araki A: Nutrients 2021/2; 13 (2): 689. (庣壆払旤1: 1寬峃娗棟僙)
杒棦戝妛昦堾
娕岇晹
[妛弍榑暥]
110425. [尨挊] Evaluation of the usefulness of a nurse-centered delirium care program. Shirai N1, Nagata M1, Takubo M, Iwamitsu Y2: Jpn J Gen Hosp Psychiatry 2022/1; 33 (1): 44-56. (敀堜嫵巕1, 挿揷恀桼旤1, 娾熮桪旤2: 1娕岇晹, 2戝妛堾堛椕宯尋媶壢)
120039. [尨挊] 壠懓巟墖愱栧娕岇巘偵傛傞壠懓娕岇幚慔偺奣擮壔偵娭偡傞尋媶. 堜忋楁巕1, 烴堜戝曘1, 楅栘榓巕2, 埨晲丂埢3, 徏嶁桼崄棦4, 崅尒婭巕5, 嶰巬恀棟6, 彫愹怐奊1, 墍愳梇擇6, 埳撪偝備傝6 (1搶奀戝妛堛妛晹娕岇妛壢, 2徝撿儕僒乕僠僙儞僞乕, 3孎杮戝妛堛妛晹曐寬妛壢, 4恄撧愳導棫曐寬暉巸戝妛, 5娕岇晹, 6搶奀戝妛堛妛晹晅懏昦堾): 栘懞娕岇嫵堢怳嫽嵿抍娕岇尋媶廤榐 2021/7; 28崋: 1-17.
120040. [尨挊] 彫帣廤拞帯椕偵実傢傞彫帣壢堛巘偑偲傜偊偨End-of-Life傪寎偊傞姵帣壠懓偲偺憡屳嶌梡偺僾儘僙僗. 崅嫶丂宐1, 彫搰傂偱巕2 (1娕岇晹, 2娕岇妛晹): 擔杮彫帣娕岇妛夛帍 2021/12; 30: 115-21.
220006. [弨尨挊] 帺戭戅堾1儢寧屻偺撈嫃崅楊幰偺惗妶懱尡. 戝塱棦旤1, 彫嶳岾戙2 (1娕岇晹, 2徝撿姍憅堛椕戝妛娕岇妛晹): 榁擭娕岇妛 2021/7; 26 (1): 114-22.
320028. [徢椺曬崘] 怴宆僐儘僫僂僀儖僗姶愼徢姵幰偺儕儌乕僩柺夛偵傛傞廔枛婜娕岇: 働乕僗儗億乕僩. 塇惗揷桰1, 捴旤抭攷2, 挅庪椛巕1, 怷丂戱栫1, 墶峚堢旤1 (1娕岇晹, 2娕岇妛晹): 僌儕乕僼仌價儕乕僽儊儞僩尋媶 2021/12; 2崋: 87-93.
522579. [島嵗]亂摿廤: ""with NEO"" Update NCPR2020丂弌惗捈屻偺怴惗帣偺働傾丂僈僀僪儔僀儞夵掶億僀儞僩11亃10. 億僕僔儑僯儞僌丂忬懺傪惍偊傞働傾. 悰栰偝傗偐 (娕岇晹): with NEO 2021/4; 34 (2): 242-8.
522580. [島嵗]亂摿廤: 廳徢側巕偳傕偺儀僢僪僒僀僪働傾亃[庡側帯椕偲娕岇偺梫揰]丂嘇旕怤廝揑梲埑姺婥椕朄 (NPPV) 偲崅棳検旲僇僯儏儔巁慺椕朄 (HFNC). 愳忋戝曘1, 戝媣曐憈旤1 (1娕岇晹): 彫帣娕岇 2021/5; 44 (5): 535-43.
522581. [島嵗]亂摿廤: 僐儈儏僯働乕僔儑儞尭彮偵傛傞怱偺旀暰偐傜僗僞僢僼傪庣傞丂庒庤娕岇巘傊偺儊儞僞儖僼僅儘乕弍亃僐儘僫壭偱庢傝慻傑傟偨庒庤娕岇巘偺儊儞僞儖僿儖僗巟墖丂僐儘僫壭偵偍偗傞怴恖娕岇怑堳偺僜乕僔儍儖僒億乕僩亅廤崌尋廋丒僉儍儕傾僇僂儞僙儕儞僌傪妶梡偟偨儊儞僞儖僼僅儘乕亅. 扟岥梲巕 (娕岇晹): 娕岇揥朷 2021/7; 46 (8): 724-7.
522582. [島嵗]亂摿廤: With僐儘僫偵偍偗傞庤弍堛妛亃怴宆僐儘僫僂傿儖僗姶愼徢姵幰庴偗擖傟傪宱尡偟偰. 墶峚廆巕 (娕岇晹): 擔杮庤弍堛妛夛帍 2021/7; 42 (2): 156-60.
522583. [島嵗]亂摿廤: 偑傫姵幰偺僗僉儞僩儔僽儖丂帠椺偱傢偐傞傾僙僗儊儞僩偲働傾亃Part4 偑傫廔枛婜姵幰偺旂晢忈奞働傾丂晜庮偲儕儞僷楻偺傾僙僗儊儞僩偲働傾. 悾屗杚巕 (娕岇晹): 僫乕僔儞僌 2021/7; 41 (9): 88-95.
522584. [島嵗]亂摿廤1: 堛椕埨慡偺儚乕僉儞僌僌儖乕僾妶摦傪悇恑偟傛偆両亃揮搢揮棊杊巭儚乕僉儞僌僌儖乕僾妶摦偺幚嵺偲墌妸側悇恑偺億僀儞僩. 敔揷旤抦宐 (娕岇晹): 昦堾埨慡嫵堢 2021/10; 9 (2): 34-9.
522585. [島嵗]亂摿廤: 廳徢搙暿COVID-19亃廳徢壔傪杊偖働傾偺億僀儞僩. 怷埨宐幚1, 嵅乆栘尠巕2 (1娕岇晹, 2姶愼娗棟幒): Expert Nurse 2021/11; 37 (13): 18-23.
522586. [島嵗]亂摿廤: 僗僩儔僥僕僢僋丒僔儞僉儞僌丂乽愴棯揑巚峫乿偵婎偯偒, 恀偺壽戣偵敆傞僾儘僙僗亃[巹偺愴棯傪怳傝曉傞丂恀偺壽戣夝寛偵岦偗偨娗棟幚慔]丂娕岇曗嵅偺億僥儞僔儍儖傪妶偐偟偨娕岇娗棟. 暿晎愮宐 (娕岇晹): 娕岇娗棟 2021/12; 31 (12): 1090-3.
522587. [島嵗]亂摿廤: 懳榖偲怣棅丂壽戣傪嫟桳偟, 曄壔偵嫮偄慻怐傪偮偔傞亃僐儘僫壭偵偍偗傞娕岇學挿丒庡擟夛偺僆儞儔僀儞偵傛傞慻怐夵慞妶摦. 陰摗孿巕1, 惔悈洅摑1, 扟岥梲巕1 (1娕岇晹): 娕岇娗棟 2022/1; 32 (1): 18-23.
522588. [島嵗]亂摿廤: 崱偝傜暦偗側偄娕岇偺崻嫆丂巕偳傕偵傛偔偁傞昦婥偲婎杮働傾亃[巕偳傕偵傛偔偁傞昦婥乽撪壢宯幘姵乿]丂匑屇媧婍幘姵 (RS僂僀儖僗姶愼徢, 婥娗巟歜懅). 栘懞備傒巕 (娕岇晹): 彫帣娕岇 2022/2; 45 (2): 163-9.
522589. [島嵗]亂怺傔傞摿廤: 柊傜側偄! 柊傟側偄! 偳偆偟偰? 晄柊姵幰偝傫傊偺儀僗僩懳墳亃5. 徢椺:] 弍慜丒弍屻偺晄柊偲娕岇幚慔. 敀捁桭婎 (娕岇晹): 惍宍奜壢娕岇 2022/2; 27 (2): 201-2.
[挊丂彂]
620152. [妛弍彂 (暘扴幏昅)]亂帪婜丒忬嫷丒忬懺暿僗僩乕儅憿愝姵幰傊偺働傾偲巜摫丒嫵堢偺億僀儞僩 (寧娫僫乕僔儞僌2021擭10寧憹姧崋)亃2. 弍屻偐傜戅堾傑偱偺姵幰亅働傾偺幚嵺偲憰嬶慖戰傪拞怱偵丂僙儖僼働傾偵徚嬌揑側姵幰, p.77-81. 搉曈嵐怐 (娕岇晹), 妛尋儊僨傿僇儖廏弫幮, 搶嫗, 2021/10敪峴.
620153. [妛弍彂 (暘扴幏昅)]亂帪婜丒忬嫷丒忬懺暿僗僩乕儅憿愝姵幰傊偺働傾偲巜摫丒嫵堢偺億僀儞僩 (寧娫僫乕僔儞僌2021擭10寧憹姧崋)亃2. 弍屻偐傜戅堾傑偱偺姵幰亅働傾偺幚嵺偲憰嬶慖戰傪拞怱偵丂庤巜偺岻鉱惈偑掅壓偟偰偄傞姵幰, p.82-86. 搉曈嵐怐 (娕岇晹), 妛尋儊僨傿僇儖廏弫幮, 搶嫗, 2021/10敪峴.
620154. [妛弍彂 (暘扴幏昅)]亂娕岇恌抐偺偨傔偺傛偔傢偐傞拞斖埻棟榑 戞3斉亃戞4復 忣摦揑拞斖埻棟榑丂巰偺庴梕夁掱棟榑丂帠椺曇, p.342-54. 彫愹弮巕1, 惉堜旤曚2 (1屗揷拞墰憤崌昦堾娕岇晹, 2娕岇晹), 娔廋: 崟揷桾巕, 妛尋儊僨傿僇儖廏弫幮, 搶嫗, 2021/10敪峴.
620155. [妛弍彂 (暘扴幏昅)]亂尒傞偙偲丒傗傞偙偲偑傢偐傞! 擖堾偐傜戅堾傑偱偺僠儍乕僩偱妛傇丂惍宍奜壢昦搹偺弍幃暿働傾儅僯儏傾儖 (惍宍奜壢娕岇2021擭廐婫憹姧)亃[1復] 憤榑丂A. 惍宍奜壢偺庤弍偺摿挜, p.10-1. 嵅摗埡壞1, 壀搰杻堖1 (1娕岇晹), 曇: 崅暯彯怢2 (2堛椕塹惗妛晹), 儊僨傿僇弌斉, 戝嶃, 2021/11敪峴.
620156. [妛弍彂 (暘扴幏昅)]亂尒傞偙偲丒傗傞偙偲偑傢偐傞! 擖堾偐傜戅堾傑偱偺僠儍乕僩偱妛傇丂惍宍奜壢昦搹偺弍幃暿働傾儅僯儏傾儖 (惍宍奜壢娕岇2021擭廐婫憹姧)亃[1復] 憤榑丂C. 惍宍奜壢偺婥傪偮偗偨偄弍慜丒弍屻働傾p.16-22. 嵅摗埡壞1, 壀搰杻堖1 (1娕岇晹), 曇: 崅暯彯怢2 (2堛椕塹惗妛晹), 儊僨傿僇弌斉, 戝嶃, 2021/11敪峴.
620157. [妛弍彂 (暘扴幏昅)]亂尒傞偙偲丒傗傞偙偲偑傢偐傞! 擖堾偐傜戅堾傑偱偺僠儍乕僩偱妛傇丂惍宍奜壢昦搹偺弍幃暿働傾儅僯儏傾儖 (惍宍奜壢娕岇2021擭廐婫憹姧)亃[1復] 憤榑丂D. 惍宍奜壢偺婥傪偮偗偨偄庡側弍屻崌暪徢p.23-5. 嵅摗埡壞1, 壀搰杻堖1 (1娕岇晹), 曇: 崅暯彯怢2 (2堛椕塹惗妛晹), 儊僨傿僇弌斉, 戝嶃, 2021/11敪峴.
620158. [妛弍彂 (暘扴幏昅)]亂娕岇妛僥僉僗僩NICE丂惛恄娕岇妛I丂偙偙傠偺寬峃偲抧堟曪妵働傾 (夵掶戞3斉)亃戞IV復 堦斒昦彴偵偍偗傞惛恄娕岇丂1. 帠椺偐傜妛傇堦斒昦彴偱偺惛恄娕岇丂1-1. 恎懱徢忬徢, 昦婥晄埨徢, p.176-9. 敀堜嫵巕 (娕岇晹), 曇: 姙娫恀旤, 堫奯丂拞, 撿峕摪, 搶嫗, 2022/1敪峴.
620159. [妛弍彂 (暘扴幏昅)]亂娕岇妛僥僉僗僩NICE丂惛恄娕岇妛I丂偙偙傠偺寬峃偲抧堟曪妵働傾 (夵掶戞3斉)亃戞IV復 堦斒昦彴偵偍偗傞惛恄娕岇丂1. 帠椺偐傜妛傇堦斒昦彴偱偺惛恄娕岇丂1-3. 晄埨, p.185-9. 敀堜嫵巕 (娕岇晹), 曇: 姙娫恀旤, 堫奯丂拞, 撿峕摪, 搶嫗, 2022/1敪峴.
620160. [妛弍彂 (暘扴幏昅)]亂娕岇妛僥僉僗僩NICE丂惛恄娕岇妛I丂偙偙傠偺寬峃偲抧堟曪妵働傾 (夵掶戞3斉)亃戞IV復 堦斒昦彴偵偍偗傞惛恄娕岇丂俀. 儕僄僝儞惛恄娕岇偲偼, p.226-32. 敀堜嫵巕 (娕岇晹), 曇: 姙娫恀旤, 堫奯丂拞, 撿峕摪, 搶嫗, 2022/1敪峴.
620161. [妛弍彂 (暘扴幏昅)]亂娕岇偺婋婡娗棟丂僐儘僫壭偺宱尡傪惗偐偟偰 (娕岇2022擭3寧椪帪憹姧崋)亃2復 曬崘丂僐儘僫壭偵偍偗傞娕岇偺婋婡娗棟丂2-11. 杒棦戝妛昦堾丂僐儘僫壭偵偍偗傞妶摦偲婋婡娗棟偵偍偗傞乽怱棟揑埨慡惈乿偺妋曐, p.116-22. 搚壆巙曐 (娕岇晹), 擔杮娕岇嫤夛弌斉夛, 搶嫗, 2022/3敪峴.
[妛夛丒尋媶夛摍]
721019. [妛夛 (慡崙)] (摿暿島墘) 娕岇巘偺儊儞僞儖僿儖僗丂COVID-19壭偵偍偗傞儊儞僞儖僿儖僗巟墖丗 儕僄僝儞僫乕僗丆偙偙傠偺働傾僠乕儉偺庢傝慻傒. 敀堜嫵巕 (娕岇晹): 戞37夞擔杮僗僩儗僗妛夛妛弍憤夛 (2021/10/30), Web奐嵜, 僗僩儗僗壢妛 2021/10; 36 (2): 87.
722312. [妛夛 (慡崙)] (嫵堢島墘) COVID-19棳峴壓偱偺娕岇巘堢惉-僷儞僨儈僢僋偺宱尡傪娕岇巘堢惉偺敪揥偵偄偐偡-. 暿晎愮宐 (娕岇晹): 戞21夞擔杮姶愼娕岇妛夛妛弍廤夛 (2021/9/4), 壂撽 (僴僀僽儕僢僪奐嵜), 擔杮姶愼娕岇妛夛妛弍廤夛島墘廤 2021/9; 21: 12.
722313. [妛夛 (慡崙)] (僔儞億僕僂儉) COVID-19僷儞僨儈僢僋偵傛傞婋婡偲娕岇怑偺懳墳 乽昦堾偱偺COVID亅19姵幰庴偗擖傟懱惂偺惍旛乿. 妬嶳榓旤 (娕岇晹): 堦斒幮抍朄恖擔杮嵭奞娕岇妛夛戞23夞擭師戝夛 (2021/9/4-30), Web奐嵜.
722314. [妛夛 (慡崙)] (僔儞億僕僂儉) COVID-19棳峴婜丆偦偺屻偺憻婍採嫙丒堏怉丂僐儘僫壭偵偍偗傞憻婍採嫙婡夛偺懝幐偵偮偄偰. 娭丂堦攏1, 崅嫶丂宐1, 忋懞桼帡1, 嵅愳旤棦1, 揷懞丂抭2, 曅壀桽堦2, 媑揷堦惉3,4 (1娕岇晹, 2媬柦, 3怴悽婭堛椕丒愭抂堛椕, 4斿擜婍): 戞57夞擔杮堏怉妛夛憤夛 (2021/9/20), 搶嫗 (僴僀僽儕僢僪奐嵜), 堏怉 2021/9; 56 (憤夛椪帪): CSY1-6.
722315. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) ACP偺尰忬偲偙傟偐傜丂弞娐婍Advance Care Planning (ACP) 僇儞僼傽儗儞僗悇恑僾儘僙僗偺億僀儞僩亅僠乕儉偺忴惉偲昦搹娕岇巘偺堢惉亅. 鍌柤桼壛棦1, 嶳嶈堣旤1, 庣壆幍奀1, 孖揷婱巙巕1, 嶳拞塮棦撧1 (1娕岇晹): 戞18夞擔杮弞娐婍娕岇妛夛妛弍廤夛 (2021/10/10), Web奐嵜, 戞18夞擔杮弞娐婍娕岇妛夛妛弍廤夛彺榐 2021/10; p.26.
722316. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) VAD帯椕偵偍偗傞婡婍僩儗乕僯儞僌, 戅堾巜摫偺昗弨壔丂旕怱憻堏怉幚巤巤愝偵偍偗傞怉崬宆VAD姵幰偺嫵堢偵岦偗偨庢傝慻傒. 桍揷寬柧1, 拞搰愡巕1, 椦垷婓巕1, 搰栰壺撧1, 晲揷復悢2, 杒懞丂棩3, 愇堜弐曘4, 憹揷惓榓1 (1娕岇晹, 2ME晹, 3怱憻寣娗奜, 4弞娐婍撪): 戞59夞擔杮恖岺憻婍妛夛戝夛 (2021/11/26), 愮梩, 恖岺憻婍 2021/10; 50 (2): S-62.
722317. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 廤拞帯椕偵偍偗傞僄儞僪丒僆僽丒儔僀僼丒働傾-姵幰丒壠懓偲偺岦偒崌偄曽丂姵幰丒壠懓偲偺僐儈儏僯働乕僔儑儞. 炓徏媣旤巕 (娕岇晹): 戞49夞擔杮廤拞帯椕堛妛夛妛弍廤夛 (2022/3/19), Web奐嵜, 戞49夞擔杮廤拞帯椕堛妛夛妛弍廤夛WEB彺榐 2022/3; p.PD14-3.
723713. [妛夛 (慡崙)] (堦斒岥墘) EXIT偵偍偗傞僠乕儉堛椕偺幚慔乣NICU娕岇巘偺棫応偐傜乣. 悰栰偝傗偐1, 楅栘塸棟撧1, 嶳娸旤曐1 (1娕岇晹): 戞30夞擔杮怴惗帣娕岇妛夛妛弍廤夛 (2021/5/8-9), Web奐嵜, 擔杮怴惗帣娕岇妛夛島墘廤 2021/5; 30: 71.
723714. [妛夛 (慡崙)] (堦斒岥墘) 摐擜昦椕梴巜摫巟墖僠乕儉棫偪忋偘偲夘擖偐傜尒偊偨偙偲乣摐擜昦傪書偊傞擖堾姵幰偑帺戭偱摐擜昦娗棟傪墌妸偵峴偆偨傔偺庢傝慻傒乣. 嶁杮攡巕1, 姍揷桾擇2, 搚昅抭徎3, 堫栰丂姲4, 嶳郪桰巕5, 幝尨椇懢3, 塐堜桪棟1, 幍棦崃媊2 (1娕岇晹, 2撪暘斿戙幱撪, 3椪専晹, 4栻嵻晹, 5塰梴晹): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20), Web奐嵜, 摐擜昦 2021/5; 64 (Suppl 1): I-59-5.
723715. [妛夛 (慡崙)] (億僗僞乕) COVID-19帯椕娐嫬偵偍偗傞偣傫栂働傾丂僫儔僥傿僽傾僾儘乕僠偵傛傝憗婜夵慞傪擣傔偨1椺. 摗巬丂岾1, 敀堜嫵巕1, 嵅摗嵅搒旤1, 戝愇丂抭2 (1娕岇晹, 2惛恄): 戞22夞擔杮擣抦徢働傾妛夛戝夛 (2021/6/5-10/5), Web奐嵜, 擔杮擣抦徢働傾妛夛帍 2021/4; 20 (1): 141.
723716. [妛夛 (慡崙)] (堦斒岥墘) 偑傫姵幰傪恊偵傕偮巕偳傕傊偺彫丒拞妛峑扴擟嫵堳偺偐偐傢傝. 彫搰傂偱巕1, 捯嵅宐巕1, 埳摗怲栫1, 巗栄惓恗2, 棊崌夑捗巕2, 桘扟榓巕3, 崅尒婭巕4, 崅嫶丂宐4, 椦旤撧巕5 (1娕岇妛晹, 2嫵怑僙儞僞乕, 3尦娕岇晹, 4娕岇晹, 5尦栚敀戝妛娕岇妛晹): 戞26夞擔杮娚榓堛椕妛夛妛弍戝夛 (2021/6/18-19), 墶昹 (僴僀僽儕僢僪奐嵜), Palliative Care Research 2021/6; 16 (Suppl): S365.
723717. [妛夛 (慡崙)] (堦斒岥墘) 偑傫姵幰傪恊偵傕偮巕偳傕偵偐偐傢傞彫丒拞妛峑扴擟嫵堳偺堛椕幰偲偺楢実偵懳偡傞僯乕僘亅娭搶寳撪彫丒拞妛峑偺幚懺挷嵏亅. 捯嵅宐巕1, 彫搰傂偱巕1, 埳摗怲栫1, 巗栄惓恗2, 棊崌夑捗巕2, 桘扟榓巕3, 崅尒婭巕4, 崅嫶丂宐4, 椦旤撧巕5 (1娕岇妛晹, 2嫵怑僙儞僞乕, 3尦娕岇晹, 4娕岇晹, 5尦栚敀戝妛娕岇妛晹): 戞26夞擔杮娚榓堛椕妛夛妛弍戝夛 (2021/6/18-19), 墶昹 (僴僀僽儕僢僪奐嵜), Palliative Care Research 2021/6; 16 (Suppl): S365.
723718. [妛夛 (慡崙)] (堦斒岥墘) BCP傪堄幆偟偨戝婯柾嵭奞憐掕僔儈儏儗乕僔儑儞偺宱尡乣嵭奞嫆揰昦堾偺彫帣昦搹丒PICU偐傜偺曬崘乣. 彫惓峕棦撧1, 彑嶳旤棦2, 暯椦撧昪1, 愳忋戝曘1, 懞忋旤宐1, 曯旜宐棞3, 埨摗丂庻3 (1娕岇晹, 2尦娕岇晹, 3彫帣): 戞34夞擔杮彫帣媬媫堛妛夛妛弍廤夛 (2021/6/18-20), 撧椙 (僴僀僽儕僢僪奐嵜), 擔杮彫帣媬媫堛妛夛嶨帍 2021/5; 20 (2): 353.
723719. [妛夛 (慡崙)] (堦斒岥墘) 姵幰偺堄巚傪懜廳偟偨End of Life Care: 僋儕僥傿僇儖働傾椞堟偺娕岇巘偑岅傝崌偆偙偲傪捠偟偰. 扟丂岾堦1,2 (1娕岇晹, 2堛椕偺幙丒埨慡悇恑幒): 戞17夞擔杮僋儕僥傿僇儖働傾娕岇妛夛妛弍廤夛 (2021/7/1-31), Web奐嵜.
723720. [妛夛 (慡崙)] (堦斒岥墘) 廳徢媬媫姵幰偵偍偗傞塰梴忬懺偲旂晢僩儔僽儖敪惗偺娭楢惈. 懢揷峕棞壴1, 愇憅丂垽1, 媦愳偁偢偝2, 墦摗惉巕3, 墶峚堢旤1, 揷懞丂抭4, 曅壀桽堦4 (1娕岇晹, 2塰梴晹, 3椪専晹, 4媬柦): 戞36夞擔杮椪彴塰梴戙幱妛夛妛弍廤夛 (2021/7/21-22), 恄屗 (僴僀僽儕僢僪奐嵜), 妛夛帍JSPEN 2021/10; 3 (Suppl 1): 751.
723721. [妛夛 (慡崙)] (堦斒岥墘) 僐儘僫壭偱乽摨偠宍乿偱偼側偔乽摨偠壙抣乿傪捛媮偡傞慻怐妶摦亅杒棦戝妛昦堾偺僆儞儔僀儞帺庡婇夋傪戣嵽偵亅. 扟岥梲巕1, 崅嫶峃夘1, 惔悈洅摑1, 杧峕愮湪巕1, 媑晹宐棟巕1, 陰摗孿巕1, 戝扟彯栫1 (1娕岇晹): 戞25夞擔杮娕岇娗棟妛夛妛弍廤夛 (2021/8/29), 墶昹 (僴僀僽儕僢僪奐嵜), 戞25夞擔杮娕岇娗棟妛夛妛弍廤夛彺榐廤 2021/7; p.201.
723722. [妛夛 (慡崙)] (億僗僞乕) 摦夋帇挳偵傛傞怱棟嫵堢揑夘擖偵懳偡傞擕偑傫姵幰偺僗僩儗僗寉尭偵偮偄偰. 嵅摗柅巕1, 悾屗杚巕2, 嶰奒婱巎3,, 愬愇婭旻3, 惣媨梞巎3,4, 媏抮恀棟巕3,, 惔悈埡崄1, 嶳嶈宐旤1, 娾枮桪旤1 (1戝妛堾堛椕宯尋媶壢, 2娕岇晹, 3,擕態丒峛忬態奜, 4憡柾尨嫤摨昦堾): 戞34夞擔杮僒僀僐僆儞僐儘僕乕妛夛憤夛 (2021/9/18-19), Web奐嵜, 擔杮僒僀僐僆儞僐儘僕乕妛夛憤夛僾儘僌儔儉丒彺榐廤 2021; 34th: 201.
723723. [妛夛 (慡崙)] (堦斒岥墘) 擼巰壓憻婍採嫙偵偍偗傞僪僫乕壠懓傊偺働傾偺専摙丂壠懓偲偲傕偵採嫙偐傜1擭傪怳傝曉傞. 嵅愳旤棦1, 揷懞丂抭2, 崅嫶丂宐1, 娭丂堦攏1, 忋懞桼帡1, 曅壀桽堦2, 媑揷堦惉3,4 (1娕岇晹, 2媬柦, 3怴悽婭堛椕丒愭抂堛椕, 4斿擜婍): 戞57夞擔杮堏怉妛夛憤夛 (2021/9/20), 搶嫗 (僴僀僽儕僢僪奐嵜), 堏怉 2021/9; 56 (憤夛椪帪): O22-2.
723724. [妛夛 (慡崙)] (堦斒岥墘) 僐儘僫壭偱偺廔枛婜堄巚寛掕偺幚懺偲壠懓巟墖曽朄偺嵞峔抸偺昁梫惈. 崅嫶丂宐1, 揷懞丂抭2, 娭丂堦攏1, 忋懞桼帡1, 嵅愳旤棦1, 曅壀桽堦2, 媑揷堦惉3,4 (1娕岇晹, 2媬柦, 3怴悽婭堛椕丒愭抂堛椕, 4斿擜婍): 戞57夞擔杮堏怉妛夛憤夛 (2021/9/20), 搶嫗 (僴僀僽儕僢僪奐嵜), 堏怉 2021/9; 56 (憤夛椪帪): O25-4.
723725. [妛夛 (慡崙)] (堦斒岥墘) 摉堾偺媫曄懳墳尋廋偺嫵堢岠壥 (戞2曬). 扟丂岾堦1,2, 揷懞丂抭3, 敔揷旤抦宐1,2, 杧峕愮宐巕1, 恄丂堦柌2, 塱堜崄怐1, 媏抧峅旤2, 峳堜桳旤1,2, 撪嶳彑暥2,4 (1娕岇晹, 2堛椕偺幙丒埨慡悇恑幒, 3媬柦, 4堛椕埨慡丒娗棟): 戞16夞堛椕偺幙丒埨慡妛夛妛弍廤夛 (2021/11/27-28), Web奐嵜, 堛椕偺幙丒埨慡妛夛帍 2021/11; 16 (Suppl): 235.
723726. [妛夛 (慡崙)] (堦斒岥墘) 摉堾偵偍偗傞姵幰岆擣杊巭懳嶔偺岠壥偲崱屻偺壽戣 (戞2曬) 乣怑堳偺姵幰妋擣庤弴偺弲庣忬嫷挷嵏偲姵幰嫤椡偺屇傃偐偗傪幚巤偟偰乣. 敔揷旤抦宐1,2, 峳堜桳旤1,2, 扟丂岾堦1,2, 恄丂堦柌2, 庒椦椙梇2, 嶁憅抭巕2,3, 媏抧峅旤2, 嶳岥晳壴2, 撪嶳彑暥2,4 (1娕岇晹, 2堛椕偺幙丒埨慡悇恑幒, 3栻嵻晹, 4堛椕埨慡丒娗棟): 戞16夞堛椕偺幙丒埨慡妛夛妛弍廤夛 (2021/11/27-28), Web奐嵜, 堛椕偺幙丒埨慡妛夛帍 2021/11; 16 (Suppl): 254.
723727. [妛夛 (慡崙)] (堦斒岥墘) 戝妛昦堾偵偍偗傞帺嶦杊巭懳嶔僾儘僕僃僋僩偺庢傝慻傒 (戞2曬). 敔揷旤抦宐1,2, 峳堜桳旤1,2, 怴堜媣柅3, 惎栰弐栱4, 敀堜嫵巕1, 孎嶁恀桼旤1, 撪嶳彑暥2,5 (1娕岇晹, 2堛椕偺幙丒埨慡悇恑幒, 3嶉嬍堛壢戝妛惛恄恄宱壢, 4惛恄, 5堛椕埨慡丒娗棟): 戞16夞堛椕偺幙丒埨慡妛夛妛弍廤夛 (2021/11/27-28), Web奐嵜, 堛椕偺幙丒埨慡妛夛帍 2021/11; 16 (Suppl): 255.
723728. [妛夛 (慡崙)] (億僗僞乕) 埆惈擼庮釃姵幰偺堄巚寛掕巟墖偵偍偗傞娕岇偺幚嵺乣壠懓偲娕岇巘偺娭傢傝乣. 嶳杮丂杛1, 崅尒婭巕1 (1娕岇晹): 戞36夞擔杮偑傫娕岇妛夛妛弍廤夛 (2022/2/19), 墶昹 (僴僀僽儕僢僪奐嵜) 戞36夞擔杮偑傫娕岇妛夛妛弍廤夛彺榐 (僆儞儔僀儞) 2022/2; p.P42-246.
723729. [妛夛 (慡崙)] (堦斒岥墘) 捠堾帯椕幒偱偺峈偑傫栻搳梌娗棟偵偍偗傞暵嵔幃栻暔堏憲僔僗僥儉摫擖慜屻偺敇業尰忬挷嵏乣娐嫬挷嵏偲怑堳偺懥塼擹搙應掕傛傝乣. 敧桍愮弔1, 崅嫶偐偍傞1, 挿揷恀桼旤1, 堫栰丂姲2, 嵅乆栘庻巕2, 揷懞榓宧2, 嵅乆栘帯堦榊3 (1娕岇晹, 2栻嵻晹, 3怴悽婭堛椕丒墶抐揑堛椕): 戞36夞擔杮偑傫娕岇妛夛妛弍廤夛 (2022/2/19), 墶昹 (僴僀僽儕僢僪奐嵜) 戞36夞擔杮偑傫娕岇妛夛妛弍廤夛彺榐 (僆儞儔僀儞) 2022/2; p.O10-46.
723730. [妛夛 (慡崙)] (堦斒岥墘) 捠堾帯椕幒偱偺峈偑傫栻搳梌娗棟偵偍偗傞暵嵔幃栻暔堏憲僔僗僥儉摫擖慜屻偺挷嵏乣桝塼儃僩儖偺時恓敳偒嵎偟帪偺庤戃敇業乣. 崅嫶偐偍傞1, 敧桍愮弔1, 挿揷恀桼旤1, 堫栰丂姲2, 嵅乆栘庻巕2, 揷懞榓宧2, 嵅乆栘帯堦榊3 (1娕岇晹, 2栻嵻晹, 3怴悽婭堛椕丒墶抐揑堛椕): 戞36夞擔杮偑傫娕岇妛夛妛弍廤夛 (2022/2/19), 墶昹 (僴僀僽儕僢僪奐嵜) 戞36夞擔杮偑傫娕岇妛夛妛弍廤夛彺榐 (僆儞儔僀儞) 2022/2; p.O10-48.
732130. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 娕岇怑偼僐儘僫偵傛傞壽戣偵偳偺傛偆偵懳墳偟偨偐亅嫵堢揑側帇揰偐傜亅乽僐儘僫壭偱偺怴恖娕岇怑堳偺堢惉乿. 扟岥梲巕 (娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733234. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 怴宆僐儘僫僂僀儖僗姶愼徢偵傛傞廳徢屇媧晄慡偺帯椕偵偍偄偰宱挵塰梴偺彫挵搳梌偑桳梡偱偁偭偨1椺. 懢揷峕棞壴1, 愇憅垽1, 墶峚堣旤1, 媦愳偁偢偝2, 嵅摗徠巕2, 揷懞丂抭3, 曅壀桽堦3 (1娕岇晹, 2塰梴晹, 3媬柦): 戞12夞擔杮椪彴塰梴戙幱妛夛庱搒寳巟晹夛妛弍廤夛 (2021/5/15), Web奐嵜.
733235. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 恡憻昦SDM僙儈僫乕儀乕僔僢僋僐乕僗幚慔曇丂帠椺徯夘. 挿壀丂墌 (娕岇晹): 恡憻昦SDM僙儈僫乕 儀乕僔僢僋僐乕僗乣幚慔曇乣 (2021/5/30), Web奐嵜.
733236. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 斿擜婍壢僟償傿儞僠庤弍偵偍偗傞帠椺専摙亅RALP徢椺偵偍偗傞旂晢僩儔僽儖梊杊丒懱埑偵拝栚偟偰亅. 巙懞旤壒1, 渳揷惔崄1, 拞搱桼旤巕1, 拞搱峅旤1 (1娕岇晹): 戞32夞擔杮庤弍娕岇妛夛娭搶峛怣墇抧嬫妛夛 (2021/6/26) Web奐嵜, 戞32夞擔杮庤弍娕岇妛夛娭搶峛怣墇抧嬫廤榐 2021/6; p.52.
733237. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 憤崌庤弍僙儞僞乕撪偺羼釋懳嶔僠乕儉偺妶摦偵偮偄偰亅懠怑庬偺嫮傒傪妶偐偟, 楢実傪峴偆偨傔偺搚戜嶌傝亅. 媏抮敼搇1, 拞搱桼旤巕1, 拞搱峅旤1 (1娕岇晹): 戞32夞擔杮庤弍娕岇妛夛娭搶峛怣墇抧嬫妛夛 (2021/6/26) Web奐嵜, 戞32夞擔杮庤弍娕岇妛夛娭搶峛怣墇抧嬫廤榐 2021/6; p.54.
733238. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 廳徢COVID-19姵幰偵懳偡傞彫挵帩懕搳梌偵傛傞宱挵塰梴娗棟偺桳梡惈. 徖栰堜隳懢1, 愇憅丂垽1, 懢揷峕棞壴1, 曅壀桽堦2 (1娕岇晹, 2媬柦): 戞7夞恄撧愳媫惈婜塰梴娗棟尋媶夛 (2021/7/3), Web奐嵜, 妛夛帍JSPEN 2021/12; 3 (Suppl 2): 22.
733239. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 媬柦媬媫嵭奞堛椕僙儞僞乕偵偍偗傞僌儕乕僼僇乕僪偺桳梡惈偺専徹. 忋懞桼帡1, 崅嫶丂宐1, 栴晹峢巙1, 愳忋戝曘1, 惵栘棟旤1, 巗愳夑堦2, 捗嶈怱栫3, 曅壀桽堦4, 愺棙丂桋4 (1娕岇晹, 2僩乕僞儖僒億乕僩僙, 3椪彴怱棟幒, 4媬柦): 杒棦戝妛昦堾怑堳尋媶敪昞夛 (2021/7/8), 恄撧愳.
733240. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 僗僩乕儅偵嬤愙偟偨憂彎娗棟偵, 堿埑暵嵔椕朄傪梡偄偨堦帠椺. 搉曈嵐怐 (娕岇晹): 戞43夞恄撧愳僗僩乕儅尋媶夛 (2021/10/2), Web奐嵜, 戞43夞恄撧愳尋媶夛僾儘僌儔儉彺榐廤 2021/10; p.16.
733241. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 僋儕僯僇儖儔僟乕I偑枹廋摼偱偁偭偨怴恖娕岇怑堳偺偦偺屻偺惉挿偵偮偄偰偺峫嶡. 楅栘桞壺1, 塅揷愳旤婭1, 杧峕愮宐巕1, 扟岥梲巕1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733242. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) COVID-19枲墑偺拞偱丆帺屓偺僷僞乕儞傊偺婥偯偒乣M丒僯儏乕儅儞棟榑傪梡偄偰乣. 恄扟朏奊1, 媑尨愮宐1, 帣嬍旤桼婭1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733243. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) MRI傪埨慡偵巤峴偡傞偨傔偵庢傝慻傫偩嬈柋夵慞乣娕岇巘偵傛傞嬥懏扵抦婡揰専偺摫擖丒昡壙乣. 椦丂巙擳1, 惗扟旤曚1, 懞嶳桭旤1, 壨崌垷栴巕1, 崅揷抭巕1, 愮鴵旤搊巕1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733244. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 堦斒昦搹偵偍偗傞僀儞僔僨儞僩儗億乕僩曬崘偺尰忬偲堛椕埨慡懳嶔偺専摙. 鴚揷寢堖1, 搚壆巙曐1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733245. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 姵幰偺僯乕僘傪偲傜偊偨撪帇嬀専嵏偺庢傝慻傒乣嬯捝寉尭傪栚揑偲偟偨捔捝嵻扨撈搳梌偺塣梡妋棫乣. 幝嶈枩棦巕1, 摗揷杻旤巕1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733246. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 暊枌摟愅偺堛椕偺幙岦忋傪栚巜偟偨懱惂偯偔傝乣暊枌墛偺杊巭傊偺庢傝慻傒傪捠偟偰乣. 彫憅椱旤1, 嵅乆栘埣旤1, 搷墍丂擡1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733247. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 彫帣恄宱幘姵姵幰偺惉恖堏峴婜巟墖偵偍偗傞娕岇 (1)乣惉恖堏峴傪庴偗擖傟傞傑偱偺壠懓偺堄巚寛掕巟墖乣. 戝捤丂崄1, 戝扟楁巕1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733248. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 彫帣恄宱幘姵姵幰偺惉恖堏峴婜巟墖偵偍偗傞娕岇 (2) 乣惉恖堏峴堛椕偺墌妸壔傪恾傞偨傔偵桳岠側巟墖乣. 戝扟楁巕1, 戝捤丂崄1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733249. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 恌椕帪娫奜偺媬媫斃憲徢椺偺幚懺偲宲懕娕岇偺壽戣. 鈐晉撨撧1, 挅庪椛巕1, 惵栘棟旤1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733250. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 廳徢怱恎忈奞帣傪帩偮恊偺堄巚寛掕傊偺娕岇夘擖. 陰摗憦巕1, 撪摗栁岾1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733251. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 埆惈擼庮釃姵幰偺堄巚寛掕巟墖偵偍偗傞娕岇巘偺娭傢傝. 嶳杮丂杛1, 崅尒婭巕1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733252. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 偑傫僒僶僀僶乕僔僢僾媫惈婜偺惗懚偺帪婜偵偁傞廃弍婜姵幰傊偺娭傢傝乣娚榓働傾僗僋儕乕僯儞僌偺寢壥偐傜娕岇婎弨傪昡壙乣. 婌壆晲惗岾1, 塐堜丂寬1, 弌郪旤棦1, 曅栰杻浠嵷1, 愳抂朳奊1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733253. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 帺戭偱偺椕梴傪婓朷偟偨捙懱捙娫斅墛姵幰偺堄巚寛掕巟墖. 媨杮傔偖傒1, 嵅乆栘棞崄1, 惉堜旤曚1, 墶嶳棙崄1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733254. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 姵幰偺堄巚傪懜廳偟偨End of Life Care乣僋儕僥傿僇儖働傾椞堟偺娕岇巘偑岅傝崌偆偙偲傪捠偟偰乣. 扟丂岾堦1,2 (1娕岇晹, 2堛椕偺幙丒埨慡悇恑幒): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733255. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) A昦搹偵偍偗傞恎懱峉懇嵟彫壔偵岦偗偨庢傝慻傒乣恎懱峉懇嶰尨懃偵増偭偨僇儞僼傽儗儞僗偺悇恑乣. 嵅乆栘棞崄1, 媨杮傔偖傒1, 惉堜旤曚1, 墶嶳棙崄1 (1娕岇晹): 戞20夞杒棦娕岇尋媶夛 (2021/12/11-13), Web奐嵜.
733256. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 怴宆僐儘僫僂僀儖僗姶愼徢姵幰偵儕儌乕僩柺夛傪梡偄偨廔枛婜働傾. 塇惗揷桰1, 捴旤抭攷1, 挅庪椛巕1, 怷丂戱栫1, 墶峚堢旤1 (1娕岇晹): 戞72夞擔杮媬媫堛妛夛娭搶抧曽夛妛弍廤夛 (2022/2/26), Web奐嵜.
733257. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) COVID-19寉徢乣拞摍徢懳墳昦搹偵偍偗傞擣抦徢姵幰傊偺懳墳偱娕岇巘偑姶偠偨崲擄偲妺摗. 橈壆嶈埢婓1, 懢搧愳垷婭1, 摗堜旤壞1, 嵅栰丂枽1, 嵅摗嵅搒旤1 (1娕岇晹): 擔杮堛椕儅僱僕儊儞僩妛夛戞21夞恄撧愳導巟晹妛弍廤夛 (2022/3/12), 恄撧愳, 擔杮堛椕儅僱僕儊儞僩妛夛戞21夞恄撧愳導巟晹妛弍廤夛僾儘僌儔儉丒彺榐廤 2022/3; p.O1-4.
733258. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) COVID-19姵幰偺懱偲怱偺偮傜偝偵偮偄偰亅娚榓働傾嬯捝僗僋儕乕僯儞僌幙栤昜偐傜尒偊偰偔傞傕偺亅. 懢揷嵅抦巕1, 愇愳旤愥1, 嵅摗丂椢1, 嵅摗嵅搒旤1 (1娕岇晹): 擔杮堛椕儅僱僕儊儞僩妛夛戞21夞恄撧愳導巟晹妛弍廤夛 (2022/3/12), 恄撧愳, 擔杮堛椕儅僱僕儊儞僩妛夛戞21夞恄撧愳導巟晹妛弍廤夛僾儘僌儔儉丒彺榐廤 2022/3; p.O1-7.
733259. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) COVID-19昦搹偵偍偗傞崱屻偺壽戣亅婥帩偪偺偮傜偝偵拝栚偟偰亅. 嵅摗丂椢1, 愇愳旤愥1, 懢揷嵅抦巕1, 嵅摗嵅搒旤1 (1娕岇晹): 擔杮堛椕儅僱僕儊儞僩妛夛戞21夞恄撧愳導巟晹妛弍廤夛 (2022/3/12), 恄撧愳, 擔杮堛椕儅僱僕儊儞僩妛夛戞21夞恄撧愳導巟晹妛弍廤夛僾儘僌儔儉丒彺榐廤 2022/3; p.O2-2.
'20擭搙埲慜暘
[妛弍榑暥]
'20-120004. [尨挊] 偑傫堛椕偵実傢傞怱棟怑偺怱棟揑僗僩儗僗偲偦偺娭楢梫場偵娭偡傞専摙. 嶳嶈棦幯1, 懞忋彯旤2, 拞搰崄悷3, 敀堜嫵巕4, 娾熮桪旤2 (1崙棫偑傫尋媶僙儞僞乕偑傫懳嶔忣曬僙儞僞乕偑傫堛椕巟墖晹, 2戝妛戝妛堾堛椕宯尋媶壢, 3搶奀戝妛暥壔幮夛晹怱棟丒幮夛妛壢, 4娕岇晹): 杒棦戝妛晅懏椪彴怱棟憡択僙儞僞乕婭梫 2021/3; 戞9崋: 1-11.
椪彴専嵏晹
[妛弍榑暥]
120041. [尨挊] LHON擄昦擣掕婎弨偺恌抐嬫暘偵傛傞儈僩僐儞僪儕傾堚揱巕専嵏偵娭偡傞専摙. 烴堜宑憿1, 埨杮棿攏1, 妢堜埱巕1, 愇愳丂嬒2, 嶳忋柧巕3, 庒憅夒搊3, 庪栰桳嶌4 (1椪専晹, 2堛椕塹惗妛晹, 3庒憅娽壢昦堾, 4椪専妛): 堛妛専嵏 2021/10; 70 (4): 676-84.
120042. [尨挊] 杒棦戝妛昦堾偵偍偗傞儂儖僞乕怱揹恾偺僷僯僢僋抣曬崘偺奣梫偍傛傃憗婜恌抐丒帯椕偵峷專偱偒偨1徢椺偵偮偄偰. 奆愳丂曕1, 彫栰嶳巙怐1, 嵅嫶媣旤巕1, 媨撪榓旤1, 塅帯嫶慞彑1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 恄撧愳導椪彴専嵏媄巘夛嶨帍 2021/12; 56 (173): 12-8.
220007. [弨尨挊] 恖岺娭愡姶愼徢偵偍偗傞Tm mapping朄傪梡偄偨嵶嬠堚揱巕専嵏偺桳梡惈偵偮偄偰. 烴堜宑憿1, 埨杮棿攏1, 妢堜埱巕1, 撪嶳彑暥2, 庪栰桳嶌3 (1椪専晹, 2惍奜, 3椪専妛): 恄撧愳導椪彴専嵏媄巘夛嶨帍 2021/12; 56 (173): 7.
522590. [島嵗]亂摿廤: 偄傑偝傜暦偗側偄椪彴壔妛専嵏偺乽忢幆乿亃2. 偄傑偝傜暦偗側偄専懱晄旛僨乕僞偺摿挜丂匓峈嬅屌嵻傗桝塼偺崿擖. 摗懞慞峴 (椪彴専嵏晹): Medical Technology 2021/6; 48 (6): 560-3.
[妛夛丒尋媶夛摍]
721020. [妛夛 (慡崙)] (摿暿島墘) BNP僐儞僩儘乕儖丂僔僆僲僊偺婎慴揑惈擻昡壙偍傛傃惛搙娗棟偵偍偗傞桳梡惈偵偮偄偰. 幝尨椇懢 (椪専晹): 擔杮堛椕専嵏壢妛夛戞53夞戝夛 (2021/10/8), 墶昹 (僴僀僽儕僢僪奐嵜), 堛椕専嵏偲帺摦壔 擔杮堛椕専嵏壢妛夛戞53夞戝夛彺榐廤 2021/8; 46: 40.
722318. [妛夛 (慡崙)] (僔儞億僕僂儉) 堦斒専嵏椞堟偵偍偗傞僺僢僩僼僅乕儖亅擜掕惈専嵏亅. 搚昅抭徎 (椪専晹): 戞61夞擔杮椪彴壔妛夛擭師妛弍廤夛 (2021/11/7), 暉壀 (僴僀僽儕僢僪奐嵜), 椪彴壔妛 2021/10; 50 (suppl 1): 147.
722319. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 挵娗桼棃専懱偱曬崘偑昁梫側嵶嬠. 埨払丂忳 (椪専晹): 戞33夞擔杮椪彴旝惗暔妛夛憤夛丒妛弍廤夛 (2022/1/28-30), 愬戜, 擔杮椪彴旝惗暔妛夛嶨帍 2021/12; 32 (suppi 1): 176.
723731. [妛夛 (慡崙)] (堦斒島墘) 寣塼宆偺堎側傞帪揰偱偺擇廳僠僃僢僋傪揙掙偡傞庢傝慻傒. 彫杮旤撧1, 嶳杮枮棦撧1, 桳攏榓撧1, 撪嶳埱撧1, 揷晹桾擇1, 娾愗暥巕1, 嶳曈惏旤1, 墦摗丂梞1, 戝扟怲堦2, 媨鴵峗擇2 (1椪専晹, 2桝寣丒嵶朎堏怉): 戞69夞擔杮桝寣丒嵶朎帯椕妛夛妛弍憤夛 (2021/6/4-6), 搶嫗 (僴僀僽儕僢僪奐嵜), 擔杮桝寣嵶朎帯椕妛夛帍 2021/6; 67 (2): 353.
723732. [妛夛 (慡崙)] (堦斒島墘) 宍懺恌抐偺偨傔偺働乕僗僇儞僼傽儗儞僗. 拞惣丂孫 (椪専晹): 戞22夞擔杮専嵏寣塼妛夛妛弍廤夛 (2021/9/12), Web奐嵜, 擔杮専嵏寣塼妛夛嶨帍 2021/8; 22: S100.
723733. [妛夛 (慡崙)] (堦斒島墘) 寣惔ALP偼垷墧寚朢僗僋儕乕僯儞僌偵桳梡偐. 搚昅抭徎1, 幝尨椇懢1, 嬤摗棷旤巕2, 庣壆払旤3, 庪栰桳嶌1,4 (1椪専晹, 2栻嵻晹, 3寬峃娗棟僙, 4椪専妛): 戞61夞擔杮椪彴壔妛夛擭師妛弍廤夛 (2021/11/6), 暉壀 (僴僀僽儕僢僪奐嵜), 椪彴壔妛 2021/10; 50 (suppl 1): 215.
723734. [妛夛 (慡崙)] (堦斒島墘) 僸僩寣燋傪儀乕僗偲偟偨乽BNP僐儞僩儘乕儖僔僆僲僊乿偺桳梡惈偵娭偡傞専摙. 幝尨椇懢1, 搚昅抭徎1, 摗懞慞峴1, 拞嶈峀巕1, 撪揷堦峅1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 擔杮堛椕専嵏壢妛夛戞53夞戝夛 (2021/11/8-10), 墶昹 (僴僀僽儕僢僪奐嵜), 堛椕専嵏偲帺摦壔 2021/8; 46 (4): 440.
723735. [妛夛 (慡崙)] (堦斒島墘) 帀朾巁寢崌傾儖僽儈儞偼PKC妶惈壔傪夘偟偰嬤埵擜嵶娗忋旂嵶朎偺嵶朎憹怋偍傛傃嵶朎榁壔傪桿摫偡傞. 崟嶈徦巎1, 搚昅抭徎2, 楅栘塸柧3, 巗愳懜暥1, 曅嬎恀恖1, 愇堜捈恗1 (1堛椕塹惗妛晹, 2椪専晹, 3暉搰導棫堛壢戝妛): 戞68夞擔杮椪彴専嵏堛妛夛妛弍廤夛 (2021/11/11-14), 晉嶳 (僴僀僽儕僢僪奐嵜), 擔杮椪彴専嵏堛妛夛帍 2021/10; 69: 111.
731082. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 戞4夞儚儞僫僢僾僙儈僫乕: 峺慺. 幝尨椇懢 (椪専晹): 恄撧愳導惗暔壔妛暘愅専嵏尋媶斍 (戞4夞儚儞僫僢僾僙儈僫乕) (2022/2/19), Web奐嵜, 恄撧愳導椪彴専嵏媄巘夛HP -
732131. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 僐儞僺儏乕僞僋儘僗儅僢僠偺塣梡偵偮偄偰乣24帪娫埨慡偱岠棪揑側桝寣弨旛乣. 彫杮旤撧 (椪専晹): 戞152夞擔杮桝寣丒嵶朎帯椕妛夛娭搶峛怣墇巟晹椺夛 (2021/9/11), Web奐嵜, 擔杮桝寣嵶朎帯椕妛夛帍 2021/12; 67 (6): 637.
733260. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 幙検暘愅憰抲偵傛傝摨掕壜擻偱偁偭偨Candida auris偵傛傞枬惈拞帹墛偺堦椺. 埳郪峢婸1, 埨払丂忳1, 嬥栘丂梱1, 拞嶈怣旻1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 戞70夞恄撧愳導堛妛専嵏妛夛 (2021/12/28-2022/1/10), Web奐嵜, 戞70夞恄撧愳導堛妛専嵏妛夛僾儘僌儔儉廤 2021/12; p.13.
733261. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僐儘僫壭偵偍偗傞寣塼専嵏幒偱偺妛惗幚廗偺嵼傝曽. 撪嶳梇搇1, 墶揷桼壚棟1, 拞惣丂孫1, 垻晹桳崄1, 撪揷堦峅1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 戞70夞恄撧愳導堛妛専嵏妛夛 (2021/12/28-2022/1/10), Web奐嵜, 戞70夞恄撧愳導堛妛専嵏妛夛僾儘僌儔儉廤 2021/12; p.14.
曻幩慄晹
[妛弍榑暥]
110426. [尨挊] Clinical Evaluation of Left Ventricular Diastolic Function Using Phase-contrast Cine Cardiovascular Magnetic Resonance Imaging: A Comparison With Steady-state Free Precession Cine Cardiovascular Magnetic Resonance Imaging and Echocardiography. Komi S1, Inoue Y2, Hata H1, Miyatake H1: J Comput Assist Tomogr 2022/1-2; 46 (1): 56-63. (彫尒惓懢榊1, 堜忋桪夘2, 恅丂攷暥1, 媨晲斾楥庽1: 1曻幩慄晹, 2曻幩慄 (夋憸))
[妛夛丒尋媶夛摍]
722320. [妛夛 (慡崙)] (僔儞億僕僂儉) MR conditional僨僶僀僗傪巊梡偟偰偄傞姵幰偺MRI: GE幮MRI憰抲傪梡偄偨摢晹偍傛傃暊晹偺専嵏偵偮偄偰. 彫尒惓懢榊1, 恅丂攷暥1 (1曻幩慄晹): JSMRM2021丒ASMRM2021崌摨戝夛乮戞49夞擔杮帴婥嫟柭堛妛夛戝夛) (2021/9/12), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮帴婥嫟柭堛妛夛嶨帍 2021/9; 46: 136.
723736. [妛夛 (慡崙)] (億僗僞乕) Image non-uniformity correction in 3T EOB-MRI: Comparison of quantitative indices of liver parenchymal enhancement among different software versions. 拞搱丂棔1, 恅丂攷暥1, 堜忋桪夘2, 崅摗桪婸1 (1曻幩慄晹, 2曻幩慄 (夋憸)): JSMRM2021丒ASMRM2021崌摨戝夛乮戞49夞擔杮帴婥嫟柭堛妛夛戝夛) (2021/9/10-12), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮帴婥嫟柭堛妛夛嶨帍 2021/9; 46: 254.
733262. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 摨堦儀儞僟乕偺堎側傞CT憰抲娫偵偍偗傞CT Automatic Exposure Control偺嫇摦偺斾妑. 埈旤桭婭1, 枛淎捈庽1, 埳摗姲懽1, 恅丂攷暥1, 敺丂岹揟1 (1曻幩慄晹): 擔杮曻幩慄媄弍妛夛戞68夞娭搶巟晹尋媶敪昞戝夛 (2021/11/27), 墶恵夑 (僴僀僽儕僢僪奐嵜), 戞68夞娭搶晹夛尋媶敪昞戝夛彺榐廤 2021; p.57.
733263. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) Cone Beam CT帪偺僐儕儊乕僔儑儞偵傛傞嶶棎慄掅尭岠壥偺専徹. 墡堜梇夘1, 拞搱婯梕1, 幝尨壞奀1, 嶳壓椇桟1 (1曻幩慄晹): 擔杮曻幩慄媄弍妛夛戞68夞娭搶巟晹尋媶敪昞戝夛 (2021/11/27), 墶恵夑 (僴僀僽儕僢僪奐嵜), 戞68夞娭搶晹夛尋媶敪昞戝夛彺榐廤 2021; p.72.
733264. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 夋憸夝愅僜僼僩僂僃傾傪梡偄偨SPECT夋憸嵞峔惉帪偵偍偗傞Butterworth僼傿儖僞偺婎慴揑専摙. 嵅乆椇曘1, 媨晲斾楥庽1, 崅嫶宑懢1, 揷忋峗堦1, 恄媨巌岞擇1 (1曻幩慄晹): 擔杮曻幩慄媄弍妛夛戞68夞娭搶巟晹尋媶敪昞戝夛 (2021/11/27), 墶恵夑 (僴僀僽儕僢僪奐嵜), 戞68夞娭搶晹夛尋媶敪昞戝夛彺榐廤 2021; p.74-5.
733265. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 昗揑傪攝抲偟偨3師尦億儕儅乕僎儖慄検寁偺婎慴専摙. 峕岥丂峍1, 棿栘壛撨1, 堜忋姴懢2, 悈忋怲栫3, 慜嶳戱嵠4, 搉绯桽夘3 (1曻幩慄晹, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹, 4棟妛晹): 擔杮曻幩慄媄弍妛夛戞68夞娭搶巟晹尋媶敪昞戝夛 (2021/11/27), 墶恵夑 (僴僀僽儕僢僪奐嵜), 戞68夞娭搶晹夛尋媶敪昞戝夛彺榐廤 2021; p.82.
733266. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 嬻娫朞榓僷儖僗偺摿惈偵娭偡傞婎慴揑専摙. 嫶杮揘栫1, 彫尒惓懢榊1, 恅丂攷暥1 (1曻幩慄晹): 擔杮曻幩慄媄弍妛夛戞68夞娭搶巟晹尋媶敪昞戝夛 (2021/11/28), 墶恵夑 (僴僀僽儕僢僪奐嵜), 戞68夞娭搶巟晹尋媶敪昞戝夛彺榐廤 2021; p.112-3.
733267. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 憰抲儊乕僇偍傛傃惷帴応嫮搙偺堘偄偵偍偗傞嬻娫朞榓僷儖僗偺摿惈偵娭偡傞専摙. 嫶杮揘栫1, 彫尒惓懢榊1, 恅丂攷暥1 (1曻幩慄晹): 擔杮曻幩慄媄弍妛夛戞68夞娭搶巟晹尋媶敪昞戝夛 (2021/11/28), 墶恵夑 (僴僀僽儕僢僪奐嵜), 戞68夞娭搶巟晹尋媶敪昞戝夛彺榐廤 2021; p.113.
733268. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) MVCT徠崌偵偍偗傞嶣塭忦審偲帺摦徠崌惛搙偲偺娭學. 嬵懞懢婳1, 愇忋丂柅1, 屆夑梍巎1, 崅摗桪婸1, 戝栰惓抭1, 堫揷棿巌1 (1曻幩慄晹): 擔杮曻幩慄媄弍妛夛戞68夞娭搶巟晹尋媶敪昞戝夛 (2021/11/28), 墶恵夑 (僴僀僽儕僢僪奐嵜), 戞68夞娭搶晹夛尋媶敪昞戝夛彺榐廤 2021; p.114.
'20擭搙埲慜暘
[妛弍榑暥]
'20-522005. [島嵗]亂摿廤2: MRI幒偺僸儎儕丒僴僢僩傪偮傇偣!亃MRI嶣塭幒傊偺戝宆嫮帴惈懱偺帩偪崬傒傪杊偖偨傔偵. 恅丂攷暥1, 堜忋 桪夘2 (1曻幩慄晹, 2曻幩慄 (夋憸)): 椪彴夋憸 2021/3; 37 (3): 380-4.
栻嵻晹
[妛弍榑暥]
110427. [尨挊] Impact of overlapping risks of type 2 diabetes and obesity on coronavirus disease severity in the United States. Ando W1, Horii T1, Uematsu T2, Hanaki H3, Atsuda K1,4, Otori K1,2: Sci Rep 2021/9; 11 (1): 17968. (埨摗丂峲1, 杧堜崉巎1, 怉徏悞擵2, 壴栘廏柧3, 岤揷岾堦榊1,4, 旜捁彑栫1,2: 1栻妛晹, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3杒棦戝妛戝懞抭婰擮尋媶強, 4栻嵻晹)
110428. [尨挊] Development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan. Yamashita Y1, Inoue G1, Nozaki Y1, Kitajima R1, Matsubara K1,2, Horii T1, Mohri J1, Atsuda K1,3, Matsubara H1: BMC Res Notes 2021/11; 14 (1): 426. (嶳壓峃栫1, 堜忋丂妜1, 栰搰峗岾1, 杒搰棦撧1, 徏尨丂惞1,2, 杧堜崉巎1, 栄棙弴堦1, 岤揷岾堦榊1,3, 徏尨丂敚1: 1栻妛晹, 2AdvanceSoft Corporation, 3栻嵻晹)
110429. [尨挊] Acute kidney injury in Japanese type 2 diabetes patients receiving sodium-glucose cotransporter 2 inhibitors: A nationwide cohort study. Horii T1, Oikawa Y2, Kunisada N1, Shimada A2, Atsuda K1,3: J Diabetes Investig 2022/1; 13 (1): 42-6. (杧堜崉巎1, 媦愳梞堦2, 崙掑側傞傒1, 搰揷丂楴2, 岤揷岾堦榊1,3: 1栻妛晹, 2嶉嬍堛壢戝妛撪暘斿撪壢丒摐擜昦撪壢, 3栻嵻晹)
110430. [尨挊] Venous thromboembolism risk factors and usefulness of a risk scoring system in lower limb orthopedic surgery: A case-control study in Japan. Akamine A1,2, Takahira N2,3, Kuroiwa M4, Tomizawa A1, Atsuda K1,5: Medicine (Baltimore) 2022/1; 101 (4): e28622. (愒椾憦旻1,2, 崅暯彯怢2,3, 崟娾惌擵4, 晊郪丂弤1, 岤揷岾堦榊1,5: 1栻嵻晹, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹, 4杻悓, 5栻妛晹)
110431. [尨挊] Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia. Komatsu T1, Nakamura M1, Uchiyama K2,3, Inoue G3, Sakanoue K1, Kawamura A1, Hiratsuka K1, Takayama Y4, Takaso M3, Atsuda K1,5: J Chemother 2022/2; 1-6. doi: 10.1080/1120009X.2022.2043538. Online ahead of print. (彫徏晀彶1, 拞懞旤曚1, 撪嶳彑暥2,3, 堜忋丂尯3, 嶁擵忋榓幚1, 愳懞廩巎1, 暯捤岞屓1, 崅嶳梲巕4, 崅憡徎巑3, 岤揷岾堦榊1,5: 1栻嵻晹, 2堛椕埨慡丒娗棟, 3惍奜, 4怴悽婭堛椕丒墶抐揑堛椕, 5栻妛晹)
110432. [尨挊] Population Pharmacokinetic-Pharmacodynamic Target Attainment Analysis of Flomoxef in the Serum and Liver Tissue of Patients Undergoing Hepatic Resection. Komatsu T1, Tsumuraya S2, Takayama Y3, Kaizu T4, Okamoto M4, Tajima H4, Nishizawa N4, Kubo H4, Kumamoto Y4, Okamoto H5, Hanaki H6, Atsuda K1,2: Antimicrob Agents Chemother 2022/4; 66 (4): e0230321. doi: 10.1128/aac.02303-21. Epub 2022 Mar 21. (彫徏晀彶1, 殺扟抭旤2, 崅嶳梲巕3, 奀捗婱巎4, 壀杮岝婓巕4, 揷搰丂峅4, 惣郪怢嫳4, 媣曐擟巎4, 孏尦梇夘4, 壀杮峗巏5, 壴栘廏柧6, 岤揷岾堦榊1,2: 1栻嵻晹, 2栻妛晹, 3怴悽婭堛椕丒墶抐揑堛椕, 4堦斒丒彫帣丒娞抇鋁奜, 5杻悓, 6杒棦戝妛戝懞抭婰擮尋媶強)
110433. [尨挊] Evaluation of a carbapenem antimicrobial stewardship program and clinical outcomes in a Japanese hospital. Komatsu T1, Inagaki R2, Azuma S1, Mochida S1, Sato Y1, Seto Y1, Nihonyanagi S3, Hoshiyama T4, Wada T4, Takayama Y5, Atsuda K1,2: J Infect Chemother 2022/7; 28 (7): 884-9. doi: 10.1016/j.jiac.2022.03.006. Epub 2022 Mar 21. (彫徏晀彶1, 堫奯椇桽2, 搶怣懢楴1, 帩揷弐栫1, 嵅摗梱桽1, 悾屗椙嫵1, 擇杮桍怢3, 惎嶳棽峴4, 榓揷払旻4, 崅嶳梲巕5, 岤揷岾堦榊1,2: 1栻嵻晹, 2栻妛晹, 3姶愼娗棟幒, 4銹尨昦丒姶愼撪, 5怴悽婭堛椕丒墶抐揑堛椕)
120043. [尨挊] 戝婯柾儗僙僾僩僨乕僞儀乕僗傪梡偄偨2宆摐擜昦姵幰偵偍偗傞SGLT2慾奞栻偺惉暘暿偵傒偨桳奞帠徾敪徢儕僗僋偺専摙. 杧堜崉巎1, 殸掑側傞傒1, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹): 偔偡傝偲摐擜昦 2021/12; 10 (2): 197-208.
120044. [尨挊] 恖岺抦擻 (AI) 偺婡夿妛廗傪巊梡偟偨寣拞栻暔擹搙偺梊應惈亅NONMEM僒儞僾儖僨乕僞傪梡偄偨僷僀儘僢僩僗僞僨傿亅. 彫椦徆岹1, 桭揷媑懃1 (1栻妛晹): TDM尋媶 2021/12; 38 (4): 85-91.
220008. [弨尨挊]乽崅搙栻妛娗棟婡擻傪敪婗偡傞偨傔偺栻嬊栻嵻巘尋廋僾儘僌儔儉 (偑傫椞堟)乿尋廋擔曬偵懳偡傞僥僉僗僩儅僀僯儞僌暘愅偺帋傒. 晈愳婱攷1, 栄棙弴堦1, 嶁憅抭巕2, 搶嶳椣巕1, 堫栰丂姲2, 晊郪丂弤2, 杮娫夒巑2, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹): 擔杮栻嵻巘夛嶨帍 2021/4; 73 (4): 365-70.
220009. [弨尨挊] 昦堾栻嵻巘偺僩儗乕僔儞僌儗億乕僩妶梡偵娭偡傞堄幆挷嵏亅僩儗乕僔儞僌儗億乕僩偺妶梡悇恑偵岦偗偰亅. 晈愳婱攷1, 晊郪丂弤2, 捙丂丂悞2, 嵅乆栘慞怣2, 怴堜枩棟巕2, 媑揷彯旤3, 徏尨丂敚3, 墶揷孭抝4, 旜捁彑栫2, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹, 3杒棦戝妛杒棦尋媶強昦堾, 4杒棦戝妛儊僨傿僇儖僙儞僞乕): 擔杮栻嵻巘夛嶨帍 2021/5; 73 (8): 837-41.
320029. [徢椺曬崘] 僀僩儔僐僫僝乕儖暈梡壓偱僔僋儘僗億儕儞偲DPP-4慾奞栻偲偺憡屳嶌梡傪宱尡偟偨1徢椺. 媨搰棩巕1, 摴壓梇夘2, 墺丂慶惤2, 楅栘棽峗2, 岤揷岾堦榊1,3 (1栻嵻晹, 2寣塼撪, 3栻妛晹): 擔杮昦堾栻嵻巘夛嶨帍 2022/3; 58 (3): 313-7.
522591. [島嵗]亂摿廤: 僠乕儉堛椕偵傛傞摐擜昦姵幰偺巟墖乣偙傟傑偱偲偙傟偐傜乣亃II 愱栧怑偺棫応偐傜丂4. 栻嵻巘. 堫栰丂姲1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 寧姧摐擜昦 2021/4; 13 (4): 33-9.
522592. [島嵗]亂摿廤: 1宆摐擜昦傾僢僾僨乕僩乣偦偺惉場偐傜帯椕傑偱乣亃12. 1宆摐擜昦偵偍偗傞僀儞僗儕儞椕朄傊偺SGLT2慾奞栻暪梡偺堄媊偲幚嵺. 杧堜崉巎 (栻妛晹): 寧姧摐擜昦 2021/6; 13 (6): 75-80.
522593. [島嵗]亂Symposium [嵗択夛]亃CRC偺夁嫀丒尰嵼丒枹棃丂Vol.2:乽CRC偁傝曽夛媍乿偺偙傟傑偱傪拞怱偵. 拞栰廳峴1, 楅栘愮湪巕2, 埨摗岾巕3, 戝栰徆旤4, 慜揷幚壴5 (1戝暘戝妛, 2昹徏堛壢戝妛堛妛晹晬懏昦堾椪彴尋媶僙儞僞乕, 3(姅) 儈僯儅儖椪彴尋媶巟墖晹, 4僔儈僢僋僿儖僗働傾丒僀儞僗僥傿僥儏乕僩 (姅), 5栻嵻晹): Clinical Research Professionals 2021/11; 85: 14-27.
522594. [島嵗]亂摿廤: 栻妛揑娗棟偵妶偐偡! 椪彴栻棟UPDATE 2022亃2宆摐擜昦帯椕栻 (僀儊僌儕儈儞). 堫栰丂姲 (栻嵻晹): 挷嵻偲忣曬 2022/1; 28 (1): 16-21.
540053. [偦偺懠 (僈僀僪儔僀儞)] 峈嬠栻TDM椪彴幚慔僈僀僪儔僀儞2022 抾枛朏惗, 栘懞棙旤, 徏尦堦柧, 栁尒埄棦, 揧揷丂攷, 崅嫶壚巕, 捯丂懽峅, 拞攏恀岾, 扥塇丂棽, 壴堜梇婱, 摗嫃丂尗, 恀媩弐旻, 彲巌寬夘, 愳懞塸庽, 旜揷堦婱, 憹揷抭愭, 抮揷尗擇, 嶳揷抭擵, 壛摗棽帣, 嶳杮晲恖, 挅愳榓楴, 彫椦徆岹1, 昹揷岾岹, 帥揷抭桽 (1栻妛晹): 擔杮壔妛椕朄妛夛嶨帍 2022/1; 70 (1): 1-72.
540054. [偦偺懠 (僈僀僪儔僀儞)] 峈嬠栻TDM椪彴幚慔僈僀僪儔僀儞2022. 抾枛朏惗, 栘懞棙旤, 徏尦堦柧, 栁尒埄棦, 揧揷丂攷, 崅嫶壚巕, 捯丂懽峅, 拞攏恀岾, 扥塇丂棽, 壴堜梇婱, 丄摗嫃丂尗, 恀媩弐旻, 彲巌寬夘, 愳懞塸庽, 旜揷堦婱, 憹揷抭愭, 抮揷尗擇, 嶳揷抭擵, 壛摗棽帣,嶳杮晲恖, 挅愳榓楴, 彫椦徆岹1, 昹揷岾岹, 帥揷抭桽 (1栻妛晹): TDM尋媶 2022/3; 39 (1): 35-106.
[挊丂彂]
620162. [妛弍彂 (暘扴幏昅)]亂尰応偱巊偊傞偔偡傝偺抦幆 (僄僉僗僷乕僩僫乕僗憹姧崋)亃搳梌帪偺娤嶡偲僞僀儈儞僌丂僆僺僆僀僪捔捝栻 (偑傫惈醬捝), p.54-71. 暯嶳晲巌1,2, 愳栰愮恞1,2 (1栻嵻晹, 2栻妛晹), 徠椦幮, 搶嫗, 2021/4敪峴.
620163. [妛弍彂 (暘扴幏昅)]亂昦婥偲偔偡傝2021丂婎慴偲幚慔 Expert's Guide (栻嬊2021擭憹姧 Vol.72 No.4)亃1 惛恄丒恄宱宯偺昦婥偲偔偡傝丂B 拞悤宯幘姵丂丒晄柊, 晄柊徢亅帯椕栻偺栻棟偲栻妛娗棟忋偺拲堄揰亅, p.614-34. 愒椾偪偐峕1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹), 撿嶳摪, 搶嫗, 2021/4敪峴.
620164. [妛弍彂 (暘扴幏昅)]亂昦婥偲偔偡傝2021丂婎慴偲幚慔 Expert's Guide (栻嬊2021擭憹姧 Vol.72 No.4)亃7 戙幱撪暘斿宯偺昦婥偲偔偡傝丂A 戙幱宯幘姵丂摐擜昦 (崌暪徢傪娷傓)亅帯椕栻偺栻棟偲栻妛娗棟忋偺拲堄揰亅, p.918-33. 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹), 撿嶳摪, 搶嫗, 2021/4敪峴.
620165. [妛弍彂 (暘扴幏昅)]亂怴堘偄偑傢偐傞! 摨庬丒摨岠栻 (忋姫)亃Chapter 08 悋柊栻, p.107-21. 愒椾偪偐峕1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹), 曇廤丗崟嶳惌堦, 戝扟摴婸, 撿峕摪, 搶嫗, 2021/7敪峴.
620166. [妛弍彂 (暘扴幏昅)]亂怴堘偄偑傢偐傞! 摨庬丒摨岠栻 (忋姫)亃Chapter 10 峈偆偮栻, p.137-49. 旘揷梉婭 (栻嵻晹), 曇廤丗崟嶳惌堦, 戝扟摴婸, 撿峕摪, 搶嫗, 2021/7敪峴.
620167. [妛弍彂 (暘扴幏昅)]亂怴堘偄偑傢偐傞! 摨庬丒摨岠栻 (壓姫)亃Chapter 19 僷乕僉儞僜儞昦帯椕栻, p.65-77. 徏壀梲巕1, 暯嶳晲巌1,2 (1栻嵻晹, 2栻妛晹), 曇廤丗崟嶳惌堦, 戝扟摴婸, 撿峕摪, 搶嫗, 2021/7敪峴.
620168. [妛弍彂 (暘扴幏昅)]亂怴堘偄偑傢偐傞! 摨庬丒摨岠栻 (壓姫)亃Chapter 20 峈擣抦徢栻, p.78-87. 旘揷梉婭1, 暯嶳晲巌1,2 (1栻嵻晹, 2栻妛晹), 曇廤丗崟嶳惌堦, 戝扟摴婸, 撿峕摪, 搶嫗, 2021/7敪峴.
620169. [妛弍彂 (暘扴幏昅)]亂擄偟偄悢幃傕, TDM傕傢偐傜側偄!乽僯僈僥偝傫乿偺偨傔偺栻暔摦懺 (挷嵻偲忣曬2021擭7寧憹姧)亃戞4復 姵幰攚宨偵傛傞ADME偺曄壔偵拲栚偱偒傞!丂旍枮姵幰丒傞偄憠姵幰偺栻暔摦懺, p.79-87. 彫椦徆岹 (栻妛晹), 曇: 嶳杮晲恖, 偠傎偆, 搶嫗, 2021/7敪峴.
620170. [妛弍彂 (暘扴幏昅)]亂栻偺摿挜丒張曽偺億僀儞僩丒僀儞僗儕儞億儞僾椕朄偑傢偐傞!両丂摐擜昦偺偔偡傝 揙掙僫價僎乕僩BOOK (摐擜昦働傾2021擭廐婫憹姧)亃戞2復 僀儞僗儕儞惢嵻丂6 拞娫宆僀儞僗儕儞惢嵻偺巊偄偐偨, p.114-8. 彑楥旤崄1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹), 曇: 晲摗払栫, 儊僨傿僇弌斉, 戝嶃, 2021/9敪峴.
620171. [妛弍彂 (暘扴幏昅)]亂栻偺摿挜丒張曽偺億僀儞僩丒僀儞僗儕儞億儞僾椕朄偑傢偐傞!!丂摐擜昦偺偔偡傝 揙掙僫價僎乕僩BOOK (摐擜昦働傾2021擭廐婫憹姧)亃戞2復 僀儞僗儕儞惢嵻丂8 崿崌宆僀儞僗儕儞惢嵻偺巊偄偐偨, p.124-9. 彑楥旤崄1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹), 曇: 晲摗払栫, 儊僨傿僇弌斉, 戝嶃, 2021/9敪峴.
620172. [妛弍彂 (暘扴幏昅)]亂偙傟偑巹偺栻嵻巘儔僀僼乣6擭惗懖50恖偑僉儍儕傾傪岅傞乣 (擔宱DI僉儍儕傾)亃昦婥偺巕偳傕偲壠懓偺徫婄偺偨傔彫帣栻暔椕朄偺愱栧惈惗偐偟擔乆僠儍儗儞僕. 彫愳棽峅 (栻嵻晹), 擔宱HR, 搶嫗, 2021/9WEB宖嵹.
620173. [妛弍彂 (暘扴幏昅)]亂擖堾偐傜戅堾傑偱偺僠儍乕僩偱妛傇丂惍宍奜壢昦搹偺弍幃暿働傾儅僯儏傾儖 (惍宍奜壢娕岇2021擭廐婫憹姧)亃[1復] 憤榑丂B 惍宍奜壢姵幰偺婥傪偮偗偨偄帩嶲栻, p.12-5. 愒椾憦旻 (栻嵻晹), 曇: 崅暯彯怢 (堛椕塹惗妛晹), 儊僨傿僇弌斉, 搶嫗, 2021/10敪峴.
620174. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓2022擭斉亃憤榑丂11 戙幱幘姵, p.738, 744, 758. 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2022/1敪峴.
620175. [妛弍彂 (暘扴幏昅)]亂帯椕栻僴儞僪僽僢僋2022亃栻嵻儕僗僩曇, p.648-79. 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹), 娔廋: 崅媣巎枦, 曇: 杧惓擇, 悰栰寬懢榊, 栧榚丂岶, 姡丂尗堦, 椦丂徆梞, 偠傎偆, 搶嫗, 2022/1敪峴.
620176. [妛弍彂 (暘扴幏昅)]亂帯椕栻僴儞僪僽僢僋2022亃栻暔摦懺斾妑昞, p.23-5, p.50, p.80, p.107, p.140, p.156, p.198, p.326, p.377-80, p.464-5, p.489, p.536-7, p.647, p.686, p.768, p.806, p.820, p.924-5, p.1145, p.1160, p.1191-2, p.1244, p.1298. 暯嶳晲巌1, 旘揷梉婭2, 愳栰愮恞2, 崟嶳惌堦3 (1栻妛晹, 2栻嵻晹, 3尦搶昦堾栻嵻晹), 娔廋: 崅媣巎枦, 曇: 杧惓擇, 悰栰寬懢榊, 栧榚丂岶, 姡丂尗堦, 椦丂徆梞, 偠傎偆, 搶嫗, 2022/1敪峴.
620177. [妛弍彂 (暘扴幏昅)]亂僫乕僔儞僌僌儔僼傿僇丂幘昦偺惉傝棫偪丂椪彴栻棟妛亃4 擼丒拞悤恄宱宯幘姵偱巊梡偡傞栻, p.94-129. 恄丂堦柌 (栻嵻晹), 曇: 屆愳桾擵, 愒悾抭巕, 椦惓寬擇, 戝惣峅崅, 儊僨傿僇弌斉, 搶嫗, 2022/1敪峴.
620178. [妛弍彂 (暘扴幏昅)]亂Pocket Drugs 2022亃娻帯椕娭楢栻丂64 戙幱漢峈栻, p.504-18. 壀杮宐旤巕1, 彫愹榓嶰榊2 (1栻嵻晹, 2杒棦戝妛柤梍嫵庼), 娔廋: 暉堜師栴, 曇: 彫徏峃岹, 搉绯桾巌, 堛妛彂堾, 搶嫗, 2022/1敪峴.
620179. [妛弍彂 (暘扴幏昅)]亂巜摫億僀儞僩傪懆偊偨栻妛惗昦堾幚柋幚廗巜摫彂 2018夵掶斉亃戞8復 偑傫壔妛椕朄, p.225-42. 栄棙弴堦1,2 (1栻妛晹, 2栻嵻晹), 曇: 嬥揷岝惓, 搉绮丂揙, 栻帠擔曬幮, 搶嫗, 2022/2敪峴.
620180. [妛弍彂 (暘扴幏昅)]亂椪彴巟墖傾僾儕HOKUTO亃壔妛椕朄儗僕儊儞 (寣塼撪壢). 媨搰棩巕 (栻嵻晹), 娔廋: 愵壆戝曘, HOKUTO, 搶嫗, 2021/8-2022/1宖嵹.
620181. [妛弍彂 (暘扴幏昅)]亂偍栻棫偪BOOK2022丂夝朥惗棟丒昦懺惗棟偐傜栻妛娗棟傊 (栻嬊2022擭憹姧 Vol.73 No.4)亃仭戙幱宯, 撪暘斿幘姵丂30 摐擜昦 (1宆摐擜昦, 2宆摐擜昦, 擠怭摐擜昦, 崌暪徢), p.547-74. 堫栰丂姲1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹), 娔廋: 楅栘姴懢, 曇: 懞堜宐旤, 撿嶳摪, 搶嫗, 2022/3敪峴.
620182. [妛弍彂 (暘扴幏昅)]亂偍栻棫偪BOOK2022丂夝朥惗棟丒昦懺惗棟偐傜栻妛娗棟傊 (栻嬊2022擭憹姧 Vol.73 No.4)亃仭偑傫丒巟帩椕朄丂66 慜棫態娻, p.932-5. 嶳杮桰庽1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹), 娔廋: 楅栘姴懢, 曇: 懞堜宐旤, 撿嶳摪, 搶嫗, 2022/3敪峴.
620183. [妛弍彂 (暘扴幏昅)]亂椪彴岺妛媄巑昗弨僥僉僗僩 戞4斉亃戞1曇 愱栧婎慴壢栚丂I. 堛妛奣榑丂E. 栻棟妛, p.69-84. 嶁憅抭巕 (栻嵻晹), 曇: 彫栰揘復, 杧愳廆擵, 曯搰嶰愮抝, 媑栰廏楴, 嬥尨弌斉, 搶嫗, 2022/3敪峴.
[妛夛丒尋媶夛摍]
713058. [妛夛 (崙嵺)] (億僗僞乕) Risk Factor for COVID-19 Infection-Related Hospitalization in Patients with Type 2 Diabetes. Horii T1, Oikawa Y2, Shimada A2, Atsuda K1,3: ADA 81h Scientific Session (2021/6/25-29), Web奐嵜. (杧堜崉巎1, 媦愳梞堦2, 搰揷丂楴2, 岤揷岾堦榊1,3: 1栻妛晹, 2嶉嬍堛壢戝妛撪暘斿撪壢丒摐擜昦撪壢, 3栻嵻晹)
713059. [妛夛 (崙嵺)] (億僗僞乕) Placebo-controlled, double-blinded phase III study comparing dexamethasone on day 1 with dexamethasone on days 1 to 4, with combined neurokinin-1 receptor antagonist, palonosetron, and olanzapine in patients receiving cisplatin-containing highly emetogenic chemotherapy: SPARED Trial. Shimomura K, Minatogawa H, Mashiko T, Arioka H, Iihara H, Sugawara M1,2, Hida N, Akiyama K, Nawata S, Tsuboya A, Mishima K, Izawa N, Miyaji T, Honda K, Inada Y, Ohno Y, Katada C3, Morita H, Yamaguchi T, Nakajima TE: ESMO congress 2021 (2021/9/17), Web奐嵜. (悰尨廩峀1,2, 寴揷恊棙3: 1栻嵻晹, 2栻妛晹, 3徚壔婍撪)
722321. [妛夛 (慡崙)] (僔儞億僕僂儉) 擔杮奜壢姶愼徢妛夛徚壔婍奜壢SSI梊杊偺偨傔偺廃弍婜娗棟僈僀僪儔僀儞嶌惉夁掱. 恀媩弐旻1, 戝栄岹婌1, 撪栰丂婎1, 杒愳梇堦1, 彫椦徆岹1,2, 彫椦丂媮1, 嶁杮巎堖1, 惔悈弫嶰1, 楅栘崕揟1, 搚巘惤擇1, 悈岥丂揙1, 栄棙桋旻1, 嶳壓愮掃1, 媑揷夒攷1, 憪抧怣栫1 (1擔杮奜壢姶愼徢妛夛徚壔婍奜壢SSI梊杊偺偨傔偺廃弍婜娗棟僈僀僪儔僀儞嶌惉儚乕僉儞僌僌儖乕僾, 2栻妛晹): 戞46夞擔杮奜壢宯楢崌妛夛妛弍廤夛 (2021/6/18), Web奐嵜, 擔杮奜壢宯楢崌妛夛帍 2021/5; 46 (3): 321.
722322. [妛夛 (慡崙)] (僔儞億僕僂儉) 栻暔摦懺夝愅僜僼僩僂僃傾偺摿挜偲妶梡偵娭偡傞儕僥儔僔乕. 彫椦徆岹 (栻妛晹): 堛椕栻妛僼僅乕儔儉2021/戞29夞僋儕僯僇儖僼傽乕儅僔乕僔儞億僕僂儉 (2021/7/24), Web奐嵜, 堛椕栻妛僼僅乕儔儉島墘梫巪廤 2021/7; 29th: 120.
722323. [妛夛 (慡崙)] (僔儞億僕僂儉) 摐擜昦姵幰偵偍偗傞億儕僼傽乕儅僔乕夝徚偺幚慔亅梫場夝愅傪梡偄偨夘擖庤朄傪梡偄偰亅. 杧堜崉巎 (栻妛晹): 戞9夞擔杮偔偡傝偲摐擜昦妛夛妛弍廤夛 (2021/9/11-12), Web奐嵜.
722324. [妛夛 (慡崙)] (僔儞億僕僂儉) 戝婯柾堛椕僨乕僞傪妶梡偟偨摐擜昦僈僀僪儔僀儞偺専徹. 杧堜崉巎 (栻妛晹): 戞31夞擔杮堛椕栻妛夛擭夛 (2021/10/9-10), Web奐嵜.
722325. [妛夛 (慡崙)] (僔儞億僕僂儉) 椪彴専嵏抣偵婎偯偔摐擜昦帯椕栻偺揔惓巊梡. 杧堜崉巎 (栻妛晹): 戞31夞擔杮堛椕栻妛夛擭夛 (2021/10/9-10), Web奐嵜.
722326. [妛夛 (慡崙)] (僔儞億僕僂儉) 杒棦戝妛昦堾偵偍偗傞栻嵻巘儗僕僨儞僩嫵堢傊偺庢傝慻傒. 嶁憅抭巕 (栻嵻晹): 戞11夞擔杮栻嵻巘儗僕僨儞僩僼僅乕儔儉 (2021/11/6), Web奐嵜.
722327. [妛夛 (慡崙)] (僔儞億僕僂儉) 恡堏怉偺尰忬 柶塽梷惂栻偵傛傞娗棟. 彫椦徆岹 (栻妛晹): 戞30夞擔杮恡晄慡奜壢尋媶夛妛弍廤夛 (2021/12/4), 撨攅 (僴僀僽儕僢僪奐嵜), 戞30夞擔杮恡晄慡奜壢尋媶夛妛弍廤夛梫巪廤 2021/12; 30th: Web.
723737. [妛夛 (慡崙)] (堦斒岥墘) MRSA偵懳偡傞寣拞擹搙僔儈儏儗乕僞乕傪梡偄偨ST崌嵻儕僼傽儞僺僔儞暪梡椕朄偺専摙. 拞懞惓庽1, 桭揷媑懃2, 彫椦徆岹2, 壴栘廏柧3, 杒棦塸榊1 (1堛椕塹惗妛晹, 2栻妛晹, 3杒棦戝妛戝懞婰擮尋媶強姶愼惂屼尋媶僙儞僞乕): 戞95夞擔杮姶愼徢妛夛妛弍島墘夛乛戞69夞擔杮壔妛椕朄妛夛憤夛崌摨妛夛 (2021/5/7-9), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮壔妛椕朄妛夛嶨帍 2021/4; 69 (Suppl): 232.
723738. [妛夛 (慡崙)] (堦斒岥墘) 僾儗僈僶儕儞偐傜儈儘僈僶儕儞傊偺愗傝懼偊徢椺偵偍偗傞拞悤恄宱宯娭楢桳奞帠徾偵娭偡傞専摙. 晲摴椓暯1, 杮娫夒巑1, 暯捤岞屓1, 懢揷抭攷1, 暯嶳晲巌1,2, 椦丂宱恖3, 嬥堜徍暥3,4, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹, 3杻悓, 4怴悽婭堛椕丒墶抐揑堛椕): 戞14夞擔杮娚榓堛椕栻妛夛擭夛 (2021/5/13-16), Web奐嵜.
723739. [妛夛 (慡崙)] (堦斒岥墘) 戝婯柾儗僙僾僩僨乕僞儀乕僗傪梡偄偨SGLT2慾奞栻傪怴婯搳梌偟偨崅楊2宆摐擜昦姵幰偵偍偗傞廳徢掅寣摐敪徢儕僗僋偺専摙. 杧堜崉巎1, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20-22), Web奐嵜.
723740. [妛夛 (慡崙)] (堦斒岥墘) 戝婯柾儗僙僾僩僨乕僞儀乕僗偵傛傞SGLT2慾奞栻偑搳梌偝傟偨摐擜昦姵幰偵偍偗傞摐擜昦働僩傾僔僪乕僔僗敪徢儕僗僋偺専摙. 杧堜崉巎1, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹): 戞9夞擔杮偔偡傝偲摐擜昦妛夛妛弍廤夛 (2021/9/11-12), Web奐嵜.
723741. [妛夛 (慡崙)] (堦斒岥墘) Evaluation of bendamustine-induced CINV and efficacy of aprepitant. 媨搰棩巕1, 姍揷峗柅2, 楅栘棽峗2, 岤揷岾堦榊1,3 (1栻嵻晹, 2寣塼撪, 3栻妛晹): 戞83夞擔杮寣塼妛夛妛弍廤夛 (2021/9/23-25), Web奐嵜.
723742. [妛夛 (慡崙)] (堦斒岥墘) 壓晹徚壔娗庤弍偵偍偗傞僙僼儊僞僝乕儖偺寣拞擹搙偲挵娗帀朾擹搙偲偺娭學惈乣晹埵摿堎揑 PK-PD 夝愅傪摜傑偊偰乣. 彫徏晀彶1, 怷揷斳撿巕2, 崅嶳梲巕3,4, 壞栚桽堖5, 桭揷媑懃2, 拞懞棽弐6, 壴栘廏柧7, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹, 3姶愼娗棟幒, 4怴悽婭堛椕丒墶抐揑堛椕, 5搶嫗堛壢帟壢戝妛堛妛晹晬懏昦堾栻嵻晹, 6嗾嫤堛壢戝妛戞堦奜壢, 7杒棦惗柦壢妛尋媶強): 戞31夞擔杮堛椕栻妛夛擭夛 (2021/10/9-10), Web奐嵜.
723743. [妛夛 (慡崙)] (億僗僞乕) 昦堾栻嵻巘怑堳嫵堢僔僗僥儉偺峔抸 (戞2曬)亅栻嵻巘斉僋儕僯僇儖儔僟乕嶌惉偵偍偗傞僴僀僷乕僼僅乕儅乕憸偺専摙亅. 彫嶳堣旤1, 堫栰丂姲1, 晈愳婱攷2, 嶁憅抭巕1, 嬤摗棷旤巕1, 扟岥梲巕3, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹, 3娕岇晹): 戞31夞擔杮堛椕栻妛夛擭夛 (2021/10/9-10), Web奐嵜.
723744. [妛夛 (慡崙)] (億僗僞乕) 2宆摐擜昦姵幰偺姤摦柆惈怱幘姵敪徢棪梊應幃偺奐敪偍傛傃専徹. 嶳壓峃栫1, 堜忋丂妜1, 栰搰峗岾1, 杒搰棦撧1, 徏尨丂惞2, 杧堜崉巎1, 栄棙弴堦1,3, 岤揷岾堦榊1,3, 徏尨丂敚1 (1栻妛晹, 2AdvanceSoft Corporation, 3栻嵻晹): 戞31夞擔杮堛椕栻妛夛擭夛 (2021/10/9-10), Web奐嵜.
723745. [妛夛 (慡崙)] (堦斒岥墘) 栻撆暔偺暔棟壔妛揑惈幙偵婎偯偔妶惈扽偺揔墳梊應. 桭揷媑懃1, 彫椦徆岹1 (1栻妛晹): 戞43夞擔杮拞撆妛夛憤夛丒妛弍廤夛 (2021/10/15), 帍忋奐嵜, 拞撆尋媶 2021/1; 34 (3): 221.
723746. [妛夛 (慡崙)] (億僗僞乕) 愗彍晄擻側娞嵶朎娻偺Lenvatinib椕朄偵懳偡傞堦巁壔拏慺崌惉峺慺妶惈偺塭嬁. 愳懞廩巎1, 嫑搱惏婭2, 拞攏丂惤3 (1栻嵻晹, 2徚壔婍撪, 3墶昹巗棫戝妛晅懏巗柉憤崌堛椕僙儞僞乕): 戞29夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2021 KOBE) (2021/11/4-7), 恄屗 (僴僀僽儕僢僪奐嵜).
723747. [妛夛 (慡崙)] (億僗僞乕) 僆儞儔僀儞傪妶梡偟偨崙嵺岎棳僾儘僌儔儉偺帋傒. 堫栰丂姲1, 嶳杮桰庽1, 彫嶳堣旤1, 晈愳婱攷2, 栄棙弴堦1,2, 娾郪恀婭巕2, 嶁憅抭巕1, 嬤摗棷旤巕1, 忛屗榓旻3, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹, 3僂僄僗僩僶乕僕僯傾戝妛栻妛晹): 戞11夞擔杮栻嵻巘儗僕僨儞僩僼僅乕儔儉 (2021/11/6), Web奐嵜.
723748. [妛夛 (慡崙)] (堦斒岥墘) 杒棦戝妛昦堾偵偍偗傞堛椕梡杻栻偺攑婞忬嫷偲嵞棙梡偵傛傞宱嵪岠壥偺専徹. 彫尨嵷旤1, 嶁擵忋榓幚1, 媨嶁桪恖1, 堫栰丂姲1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 戞11夞擔杮栻嵻巘儗僕僨儞僩僼僅乕儔儉 (2021/11/6), Web奐嵜.
723749. [妛夛 (慡崙)] (堦斒岥墘) 偆偮昦姵幰偵偍偗傞儀儞僝僕傾僛僺儞宯栻嵻偺尭栻丒尭検偟偨徢椺偵偮偄偰. 廙尒昐戙1, 悷揷嫳暯1, 嬤摗棷旤巕1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 戞11夞擔杮栻嵻巘儗僕僨儞僩僼僅乕儔儉 (2021/11/6), Web奐嵜.
723750. [妛夛 (慡崙)] (堦斒岥墘) 擜楬忋旂娻姵幰偵偍偗傞GN椕朄偺Nedaplatin梡検懨摉惈偺昡壙. 嶳杮桰庽1, 堫栰丂姲1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 戞15夞擔杮恡憻昦栻暔椕朄妛夛妛弍廤夛丒憤夛2021 (2021/11/6-7), Web奐嵜.
723751. [妛夛 (慡崙)] (堦斒岥墘) 弍慜媥栻偺埨慡側塣梡偵岦偗偨庢傝慻傒 (戞2曬)亅Patient Flow Management (PFM) 傊偺杮塣梡偺慻傒崬傒亅. 恄丂堦柌1, 捗懞廏峃2, 壓昹岶榊3, 彫愹杻旤4, 晊郪丂弤5, 峳堜桳旤1, 撪嶳彑暥1,6, 垻屆弫嵠3 (1堛椕偺幙丒埨慡悇恑幒, 2斿擜婍, 3弞娐婍撪, 4恌椕忣曬娗棟幒, 5栻嵻晹, 6堛椕埨慡丒娗棟): 戞16夞堛椕偺幙丒埨慡妛夛妛弍廤夛 (2021/11/27-28), Web奐嵜, 堛椕偺幙丒埨慡妛夛帍 2021/11; 16 (Suppl): 262.
723752. [妛夛 (慡崙)] (億僗僞乕) 杒棦戝妛昦堾偵偍偗傞椪彴尋媶娗棟懱惂偺峔抸: 懠婡娭偺擣掕椪彴尋媶怰嵏埾堳夛/椣棟怰嵏埾堳夛偱 彸擣傪庴偗偨尋媶偺幚巤嫋壜懱惂偺専摙傪捠偟偰. 娭崻抭旤1,2, 慜揷幚壴1,2,3, 巙懞崙峀1, 愇愳弐峀1, 岤揷岾堦榊2,3, 愇憅寬巌1,4, 崅憡徎巑5 (1杒棦戝妛昦堾HRP (Human Research Protections) 幒, 2栻嵻晹, 3栻妛晹, 4彫帣, 5惍奜): 戞42夞擔杮椪彴栻棟妛夛妛弍憤夛 (2021/12/11), 愬戜 (僴僀僽儕僢僪奐嵜), 擔杮椪彴栻棟妛夛妛弍廤夛彺榐廤 (J-STAGE偺傒) 2021; 42: Web.
723753. [妛夛 (慡崙)] (億僗僞乕) Phase III study comparing DEX on day 1 to days 1-4 with combined NK-1-RA PALO and OLZ in CDDP-based chemotherapy: SPARED Trial. 桍尨晲巎1, 墶峚埢巕2, 愳岥丂悞3, 壓懞堦宨4, 斞尨戝柅5, 悰尨廩峀6,7, 嶰堜枮棦撧8, 愇愳丂姲9, 撽揷廋堦10, 捸扟埢巕11, 嶰搰孿夘12, 怷愳丂宑2, 彫嶳揷敼桟13, 杮懡榓揟4, 搾愳桾巕1, 戝栰丂峃5, 寴揷恊棙14, 瀢揷捈栫8, 嶳岥戱梞15, 拞搰婱巕16 (1墶昹楯嵭昦堾, 2惞儅儕傾儞僫堛壢戝妛昦堾, 3搶嫗栻壢戝妛, 4垽抦導偑傫僙儞僞乕, 5婒晫戝妛昦堾, 6栻妛晹, 7栻嵻晹, 8惞儅儕傾儞僫堛壢戝妛墶昹巗惣晹昦堾, 9惷壀導棫惷壀偑傫僙儞僞乕, 10徍榓戝妛墶昹巗杒晹昦堾, 11愳嶈巗棫懡杸昦堾, 12擔杮堛壢戝妛晲憼彫悪昦堾, 13NPO朄恖JORTC僨乕僞僙儞僞乕, 14徚壔婍撪, 15搶杒戝妛戝妛堾, 16嫗搒戝妛戝妛堾): 戞19夞擔杮椪彴庮釃妛夛妛弍廤夛 (2022/2/17-19), 嫗搒 (僴僀僽儕僢僪奐嵜).
723754. [妛夛 (慡崙)] (億僗僞乕) 怘摴娻弍慜丒摫擖DCF椕朄偵偍偗傞暃嶌梡敪尰偑峈娻嵻搳梌検偵媦傏偡塭嬁. 搶嶳椣巕1,2, 栄棙弴堦1,2, 怴妏堣曕1, 悰尨廩峀1,2, 寴揷恊棙3, 暯嶳晲巌1,2, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹, 3徚壔婍撪): 擔杮椪彴庮釃栻妛夛妛弍戝夛2022 (JASPO2022) (2022/3/12-13), 愬戜 (僴僀僽儕僢僪奐嵜).
723755. [妛夛 (慡崙)] (億僗僞乕) 傾僽儔僉僒儞覔_揌惷拲梡偵偍偗傞drug vial optimization偵娭偡傞庢傝慻傒偲惉壥. 彫尨丂桰1, 懢揷抭攷1, 堜忋浠崄1, 揷懞榓宧1, 嵅乆栘庻巕1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 擔杮椪彴庮釃栻妛夛妛弍戝夛2022 (JASPO2022) (2022/3/12-13), 愬戜 (僴僀僽儕僢僪奐嵜).
723756. [妛夛 (慡崙)] (億僗僞乕) 僞儁儞僞僪乕儖宱岥搳梌帪偺栻暔摦懺傊塭嬁傪媦傏偡場巕偵娭偡傞尋媶. 杮娫夒巑1, 崙暘廏栫2, 暯嶳晲巌1,3, 墱榚嫽夘4, 寴揷恊棙4, 椦丂宱恖5,6, 嬥堜徍暥6,7, 岤揷岾堦榊1,3 (1栻嵻晹, 2搶嫗栻壢戝妛栻妛晹栻妛幚柋幚廗嫵堢僙儞僞乕, 3栻妛晹, 4徚壔婍撪, 5憡柾尨嫤摨昦堾娚榓働傾壢, 6杻悓, 7怴悽婭堛椕丒墶抐揑堛椕): 擔杮椪彴庮釃栻妛夛妛弍戝夛2022 (JASPO2022) (2022/3/12-13), 愬戜 (僴僀僽儕僢僪奐嵜).
723757. [妛夛 (慡崙)] (億僗僞乕) Clostridioides dfficile姶愼徢 (CDI) 偺専嵏偲帯椕傪巟墖偡傞AI chatbot偺奐敪. 彫椦徆岹1, 墶嶳撧乆1 (1栻妛晹): 擔杮栻妛夛戞142擭夛 (2022/3/25-28), Web奐嵜, 擔杮栻妛夛擭夛戞142擭夛梫巪廤 (Web) 2022/3; 142th: Web.
723758. [妛夛 (慡崙)] (億僗僞乕) 娙堈寽戺朄傪梡偄偨寢妀昗弨帯椕偵偍偗傞儕僼傽儞僺僔儞偺埨掕惈. 墶嶳撧乆1, 彫椦徆岹1, 桭揷媑懃1 (1栻妛晹): 擔杮栻妛夛戞142擭夛 (2022/3/25-28), Web奐嵜, 擔杮栻妛夛擭夛戞142擭夛梫巪廤 (Web) 2022/3; 142th: Web.
723759. [妛夛 (慡崙)] (億僗僞乕) 媫惈傾僙僩傾儈僲僼僃儞拞撆偵偍偗傞N-傾僙僠儖僔僗僥僀儞偺揔墳敾抐傪巟墖偡傞AI chatbot偺奐敪. 桭揷媑懃1, 斞搰懣夒1, 岺摗戝庽1, 彫椦徆岹1 (1栻妛晹): 擔杮栻妛夛戞142擭夛 (2022/3/25-28), Web奐嵜, 擔杮栻妛夛擭夛戞142擭夛梫巪廤 (Web) 2022/3; 142th: Web.
723760. [妛夛 (慡崙)] (億僗僞乕) 僶儞僐儅僀僔儞偺弶婜搳梌愝寁偺偨傔偺AI Chatbot偺奐敪亅Tomson朄偺揔梡亅. 斞搰懣夒1, 岺摗戝庽1, 彫椦徆岹1, 桭揷媑懃1 (1栻妛晹): 擔杮栻妛夛戞142擭夛 (2022/3/25-28), Web奐嵜, 擔杮栻妛夛擭夛戞142擭夛梫巪廤 (Web) 2022/3; 142th: Web.
723761. [妛夛 (慡崙)] (億僗僞乕) 僶儞僐儅僀僔儞弶婜搳梌愝寁偺偨傔偺AI Chatbot偺奐敪亅Winter幃偺揔梡亅. 岺摗戝庽1, 斞搰懣夒1, 彫椦徆岹1, 桭揷媑懃1 (1栻妛晹): 擔杮栻妛夛戞142擭夛 (2022/3/25-28), Web奐嵜, 擔杮栻妛夛擭夛戞142擭夛梫巪廤 (Web) 2022/3; 142th: Web.
723762. [妛夛 (慡崙)] (億僗僞乕) 僐儘僫壭偵偍偗傞堛栻昳忣曬妛島媊偱偺帋傒偐傜尒偊偨墦妘庼嬈偺桳岠惈偲壽戣. 娾郪恀婭巕1, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹): 擔杮栻妛夛戞142擭夛 (2022/3/25-28), Web奐嵜, 擔杮栻妛夛擭夛戞142擭夛梫巪廤 (Web) 2022/3; 142th: Web.
733269. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 杒棦戝妛昦堾擖堾姵幰偵偍偗傞儃僲僾儔僓儞僼儅儖巁墫忶偺巊梡幚懺挷嵏. 斞揷恀桼1, 悰尨廩峀1,2, 娾郪恀婭巕1, 悾屗椙嫵2, 幝尨桽巕2, 彫尨旤峕2, 暷嶳戝巙2, 暯嶳晲巌1,2, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 擔杮昦堾栻嵻巘夛娭搶僽儘僢僋戞51夞妛弍戝夛 (2021/8/28-9/5), Web奐嵜.
733270. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 恄宱帹壢儊僯僄乕儖昦擖堾姵幰傪懳徾偲偟偨栻嵻巘偵傛傞廤抍巜摫偺岠壥偵娭偡傞挷嵏. 愹扟憗婭1, 愳栰愮恞1,2, 暯嶳晲巌1,2, 挿徖塸柧3,4, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹, 3帹旲堲岮丒摢栩奜, 4怴悽婭堛椕丒愭抂堛椕): 擔杮昦堾栻嵻巘夛娭搶僽儘僢僋戞51夞妛弍戝夛 (2021/8/28-9/5), Web奐嵜.
733271. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 僆儞儔僀儞偱偺KJ朄傪梡偄偨儚乕僋僔儑僢僾偺幚巤曬崘. 恵揷揘巎1, 晈愳婱攷1,2, 孖尨弴堦1, 曅嶳廃栫1, 愇愳媩巕1, 忋揷抦峅1, 擔壓晹媑抝1, 愇崟揘晇1, 嫶杮恀栫1, 嶁忋堩岶3, 敀堜桾擇3, 栧揷壚巕3, 嬵堜尦旻3, 暯柸梞巕3, 搉绮丂揙3 (1岞塿幮抍朄恖恄撧愳導栻嵻巘夛幚柋幚廗埾堳夛, 2栻妛晹, 3岞塿幮抍朄恖恄撧愳導昦堾栻嵻巘夛栻妛惗昦堾幚廗専摙埾堳夛): 戞19夞偐側偑傢栻嵻巘妛弍戝夛 (2021/11/21), Web奐嵜, 栻氣 2022/3; 4寧崋: p.38.
733272. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 栻梡扽柍岠暔幙偵懳偡傞挻妶惈扽偺桳梡惈偺専摙. 桭揷媑懃 (栻妛晹): 戞35夞擔杮拞撆妛夛搶擔杮抧曽夛 (2022/1/22), Web奐嵜, 拞撆尋媶 2022/3; 35 (1): 73.
儕僴價儕僥乕僔儑儞晹
[妛弍榑暥]
110434. [尨挊] Prognostic utility of dynapenia in patients with cardiovascular disease. Uchida S1, Kamiya K2, Hamazaki N3, Nozaki K3, Ichikawa T3, Nakamura T1, Yamashita M1, Maekawa E4, Reed JL Yamaoka-Tojo M2, Matsunaga A2, Ako J4: Clin Nutr 2021/4; 40 (4): 2210-8. (撪揷隳懢1, 恄扟寬懢榊2, 郷嶈怢柧3, 栰嶈峃暯3, 巗愳婱暥3, 拞懞妜巎1, 嶳壓恀巌1, 慜愳宐旤4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4弞娐婍撪)
110435. [尨挊] Clinical usefulness of oxygen uptake during usual gait in patients with cardiovascular disease. Hamazaki N1, Kamiya K2, Nozak K1, Yanagi N3, Ichikawa T1, Matsuzawa R, Nakamura T3, Yamashita M3, Uchida S3, Saito T, Maekawa E4, Meguro K4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: Int J Cardiol 2021/7; 335: 118-22. (郷嶈怢柧1, 恄扟寬懢榊2, 栰嶈峃暯1, 桍丂彯栱3, 巗愳婱暥1, 拞懞妜巎3, 嶳壓恀巌3, 撪揷隳懢3, 慜愳宐旤4, 栚崟寬懢榊4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢, 4弞娐婍撪)
110436. [尨挊] Modified Creatinine Index and Clinical Outcomes of Hemodialysis Patients: An Indicator of Sarcopenia? Yamamoto S1, Matsuzawa R, Hoshi K2, Suzuki Y1, Harada M, Watanabe T, Isobe Y, Imamura K1, Osada S, Yoshida A, Kamiya K3, Matsunaga A3: J Ren Nutr 2021/7; 31 (4): 370-9. (嶳杮彯暯1, 惎丂壚朏2, 楅栘桾懢1, 崱懞宑屷1, 恄扟寬懢榊3, 徏塱撃旻3: 1戝妛堾堛椕宯尋媶壢, 2塹惗, 3堛椕塹惗妛晹)
110437. [尨挊] Impact of Physical Activity on Dialysis and Nondialysis Days and Clinical Outcomes Among Patients on Hemodialysis. Yamamoto S1, Matsuzawa R, Hoshi K2, Harada M, Watanabe T, Suzuki Y1, Isobe Y, Imamura K1, Osada S, Yoshida A, Kamiya K3, Matsunaga A3: J Ren Nutr 2021/7; 31 (4): 380-8. (嶳杮彯暯1, 惎丂壚朏2, 楅栘桾懢1, 崱懞宑屷1, 恄扟寬懢榊3, 徏塱撃旻3: 1戝妛堾堛椕宯尋媶壢, 2塹惗, 3堛椕塹惗妛晹)
110438. [尨挊] Low skeletal muscle density combined with muscle dysfunction predicts adverse events after adult cardiovascular surgery. Yamashita M1, Kamiya K2, Matsunaga A2, Kitamura T3, Hamazaki N4, Nozaki K4, Ichikawa T4, Maekawa E5, Meguro K5, Yamaoka-Tojo M2, Ako J5, Miyaji K3: Nutr Metab Cardiovasc Dis 2021/7; 31 (6): 1782-90. (嶳壓恀巌1, 恄扟寬懢榊2, 徏塱撃旻2, 杒懞丂棩3, 郷嶈怢柧4, 栰嶈峃暯4, 巗愳婱暥4, 慜愳宐旤5, 栚崟寬懢榊5, 搶瀶旤撧巕2, 垻屆弫嵠5, 媨抧丂娪3: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3怱憻寣娗奜, 4儕僴價儕晹, 5弞娐婍撪)
110439. [尨挊] Validity and Utility of the Questionnaire-based FRAIL Scale in Older Patients with Heart Failure: Findings from the FRAGILE-HF. Nozaki K1, Kamiya K2, Hamazaki N1, Saito H, Saito K, Ogasahara Y, Maekawa E3, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Makino A, Oka K, Momomura S, Kagiyama N, Matsue Y: J Am Med Dir Assoc 2021/8; 22 (8): 1621-6.e2. (栰嶈峃暯1, 恄扟寬懢榊2, 郷嶈怢柧1, 慜愳宐旤3: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3弞娐婍撪)
110440. [尨挊] Standardized gait speed ratio in elderly patients with heart failure. Ozawa T, Yamashita M1, Seino S, Kamiya K2, Kagiyama N, Konishi M, Saito H, Saito K, Ogasahara Y, Maekawa E3, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Momomura S, Hamazaki N4, Nozaki K4, Kim H, Obuchi S, Kawai H, Kitamura A, Shinkai S, Matsue Y: ESC Heart Fail 2021/10; 8 (5): 3557-65. (嶳壓恀巌1, 恄扟寬懢榊2, 慜愳宐旤3, 郷嶈怢柧4, 栰嶈峃暯4: 1戝妛堾堛椕宯尋媶壢 2堛椕塹惗妛晹, 3弞娐婍撪, 4儕僴價儕晹)
110441. [尨挊] Increased medial laxity of the elbow in preadolescent baseball players with or without medial elbow apophysitis. Watanabe H1, Masuma H2, Kenmoku T3, Kudo H, Saito K, Nagami T, Sekita J, Matsunaga A1: JSES Int 2021/9; 5 (6): 1119-24. (搉绮桾擵1, 憹娫峅徦2, 尒栚抭婭3, 徏塱撃旻1: 1堛椕塹惗妛晹, 2儕僴價儕晹, 3惍奜)
110442. [尨挊] Effect of atrial fibrillation on response to exercise-based cardiac rehabilitation in older individuals with heart failure. Hamazaki N1, Kamiya K2, Fukaya H3, Nozaki K1, Ichikawa T1, Matsuzawa R, Yamashita M4, Uchida S4, Maekawa E3, Meguro K3, Yamaoka-Tojo M2, Matsunaga A2, Ako J3: Ann Phys Rehabil Med 2021/11; 64 (6): 101466. (郷嶈怢柧1, 恄扟寬懢榊2, 怺扟塸暯3, 栰嶈峃暯1, 巗愳婱暥1, 嶳壓恀巌4, 撪揷隳懢4, 慜愳宐旤3, 栚崟寬懢榊3, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠3: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3弞娐婍撪, 4戝妛堾堛椕宯尋媶壢)
110443. [尨挊] Relationship between high-sensitivity cardiac troponin T, B-type natriuretic peptide, and physical function in patients with heart failure. Ueno K1, Kamiya K2, Hamazaki N3, Nozaki K3, Ichikawa T3, Yamashita M1, Uchida S1, Yanagi N1, Maekawa E4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: ESC Heart Fail 2021/12; 8 (6): 5092-101. (忋栰寭曘1, 恄扟寬懢榊2, 郷嶈怢柧3, 栰嶈峃暯3, 巗愳婱暥3, 嶳壓恀巌1, 撪揷隳懢1, 桍丂彯栱1, 慜愳宐旤4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4弞娐婍撪)
110444. [尨挊] Preoperative malnutrition is a risk factor for delayed recovery of mobilization after total hip arthroplasty. Nanri Y1, Shibuya M1, Fukushima K2, Uchiyama K2,3, Takahira N4, Takaso M2: PM R 2021/12; 13 (12): 1331-9. (撿棦桟懢1, 郌扟恀崄1, 暉搰寬夘2, 撪嶳彑暥2,3, 崅暯彯怢4, 崅憡徎巑2: 1儕僴價儕晹, 2惍奜, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
110445. [尨挊] Physical activity and its trajectory over time and clinical outcomes in hemodialysis patients. Suzuki Y1, Matsuzawa R, Hoshi K2, Koh YM, Harada M, Yamamoto S1, Imamura K1, Kamiya K3, Matsunaga A3: Int Urol Nephrol 2022/1. doi: 10.1007/s11255-021-03098-w. Online ahead of print. (楅栘桾懢1, 惎丂壚朏2, 嶳杮彯暯1, 崱懞宑屷1, 恄扟寬懢榊3, 徏塱撃旻3: 1戝妛堾堛椕宯尋媶壢, 2塹惗, 3堛椕塹惗妛晹)
110446. [尨挊] Gait speed and 6-minute walking distance are useful for identifying difficulties in activities of daily living in patients with cardiovascular disease. Sato A, Kamiya K1, Hamazaki N2, Nozaki K2, Ichikawa T2, Yamashita M3, Uchida S3, Maekawa E4, Yamaoka-Tojo M1, Matsunaga A1, Ako J4: Heart Lung 2022/1-2; 51: 46-51. (恄扟寬懢榊1, 郷嶈怢柧2, 栰嶈峃暯2, 巗愳婱暥2, 嶳壓恀巌3, 撪揷隳懢3, 慜愳宐旤4, 搶瀶旤撧巕1, 徏塱撃旻1, 垻屆弫嵠4: 1堛椕塹惗妛晹, 2儕僴價儕晹, 3戝妛堾堛椕宯尋媶壢, 4弞娐婍撪)
110447. [尨挊] Features of trunk muscle wasting during acute care and physical function recovery with aortic disease. Yamashita M1, Kamiya K2, Matsunaga A2, Kitamura T3, Hamazaki N4, Ichikawa T4, Uchida S1, Noda T1, Yanagi N1, Maekawa E5, Yamaoka-Tojo M2, Ako J5, Miyaji K3: J Cachexia Sarcopenia Muscle 2022/4; 13 (2): 1054-63. doi: 10.1002/jcsm.12935. Epub 2022 Feb 17. (嶳壓恀巌1, 恄扟寬懢榊2, 徏塱撃旻2, 杒懞丂棩3, 郷嶈怢柧4, 巗愳婱暥4, 撪揷隳懢1, 栰揷丂彔1, 桍丂彯栱1, 慜愳宐旤5, 搶瀶旤撧巕2, 垻屆弫嵠5, 媨抧丂娪3: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3怱憻寣娗奜, 4儕僴價儕晹, 5弞娐婍撪)
110448. [尨挊] Associations between kidney function and outcomes of comprehensive cardiac rehabilitation in patients with heart failure. Hamazaki N1, Kamiya K2, Yamamoto S3, Nozak K1, Ichikawa T1, Matsuzawa R, Yamashita M3, Uchida S3, Maekawa E4, Meguro K4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: Clin Res Cardiol 2022/3; 111 (3): 253-63. (郷嶈怢柧1, 恄扟寬懢榊2, 嶳杮彯暯3, 栰嶈峃暯1, 巗愳婱暥1, 嶳壓恀巌3, 撪揷隳懢3, 慜愳宐旤4, 栚崟寬懢榊4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢, 4弞娐婍撪)
110449. [尨挊] Work status before admission relates to prognosis in older patients with heart failure partly through social frailty. Yamashita M1, Kamiya K2, Hamazaki N3, Nozaki K3, Saito H, Saito K, Ogasahara Y, Maekawa E4, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Shuhei Yamamoto Y, Aizawa N, Wakaume K, Oka K, Momomura S, Kagiyama N, Matsue Y: J Cardiol 2022/3; 79 (3): 439-45. (嶳壓恀巌1, 恄扟寬懢榊2, 郷嶈怢柧3, 栰嶈峃暯3, 慜愳宐旤4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4弞娐婍撪)
110450. [尨挊] Usefulness of physical function sub-item of SF-36 survey to predict exercise intolerance in patients with heart failure. Ueno K1, Kamiya K2, Hamazaki N3, Nozaki K3, Ichikawa T3, Yamashita M1, Uchida S1, Kawabata M2, Maekawa E4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: Eur J Cardiovasc Nurs 2022/3; 21 (2): 174-7. (忋栰寭曘1, 恄扟寬懢榊2, 郷嶈怢柧3, 栰嶈峃暯3, 巗愳婱暥3, 嶳壓恀巌1, 撪揷隳懢1, 壨抂彨巌2, 慜愳宐旤4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4弞娐婍撪)
110451. [尨挊] Acute-Phase Initiation of Cardiac Rehabilitation for Short-Term Improvement in Activities of Daily Living in Patients Hospitalized for Acute Heart Failure. Ueno K1, Kamiya K2, Kaneko H, Okada A, Itoh H, Fujiu K, Takeda N, Morita H, Michihata N, Jo T, Yasunaga H, Komuro I: J Cardiovasc Dev Dis 2022/3; 9 (4): 97. (忋栰寭曘1, 恄扟寬懢榊2: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹)
110452. [尨挊] The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome. Noda T1, Kamiya K2, Hamazaki N3, Nozaki K3, Ichikawa T3, Yamashita M1, Uchida S1, Maekawa E4, Terada T, Reed JR, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: J Clin Med 2022/3; 11 (7): 1847. (栰揷丂彔1, 恄扟寬懢榊2, 郷嶈怢柧3, 栰嶈峃暯3, 巗愳婱暥3, 嶳壓恀巌1, 撪揷隳懢1, 慜愳宐旤4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4弞娐婍撪)
110453. [尨挊] Pulmonary Rehabilitation for Patients After COPD Exacerbation. Shibuya M1, Yamamoto S, Kobayashi S1, Nishie K, Yamaga T, Kawachi S, Matsunaga A2: Respir Care 2022/3; 67 (3): 360-9. (郌扟恀崄1, 彫椦庡專1, 徏塱撃旻2: 1儕僴價儕晹, 2堛椕塹惗妛晹)
110454. [尨挊] Cross-sectional area of erector spinae muscles is associated with activities of daily living at discharge in middle- to older-aged patients with coronavirus disease 2019. Yamashita M1, Koike T, Hamazaki N2, Ueno K1, Uchida S1, Noda T1, Ogura K1, Nagumo D1, Miki T1, Shakuta S1, Wada T3, Kamiya K4: Exp Gerontol 2022/6; 163: 111774. doi: 10.1016/j.exger.2022.111774. Epub 2022 Mar 25. (嶳壓恀巌1, 郷嶈怢柧2, 忋栰寭曘1, 撪揷隳懢1, 栰揷丂彔1, 彫憅丂寬1, 撿塤掗撨1, 嶰栘棽巎1, 広揷嶇婫1, 榓揷払旻3, 恄扟寬懢榊4: 1戝妛堾堛椕宯尋媶壢, 2儕僴價儕晹, 3銹尨昦丒姶愼撪, 4堛椕塹惗妛晹)
310056. [徢椺曬崘] Hemodynamic Changes During Neuromuscular Electrical Stimulation and Mobility Therapy for an Advanced Heart Failure Patient with Impella 5.0 Device. Nozaki K1, Hamazaki N1, Ikeda Y2, Nihei M1, Kobayashi S1, Kamiya K3, Maekawa E2, Matsunaga A3, Yamaoka-Tojo M3, Ako J2: Int Heart J 2021/5; 62 (3): 695-9. (栰嶈峃暯1, 郷嶈怢柧1, 抮揷桽婤2, 擇時垽幚1, 彫椦庡專1, 恄扟寬懢榊3, 慜愳宐旤2, 徏塱撃旻3, 搶瀶旤撧巕3, 垻屆弫嵠2: 1儕僴價儕晹, 2弞娐婍撪, 3堛椕塹惗妛晹)
522595. [島嵗]亂摿廤: 塣摦懴梕擻傪峫偊傞亃娙曋偵塣摦懴梕擻傪昡壙偡傞. 郷嶈怢柧1, 恄扟寬懢榊2, 徏塱撃旻2 (1儕僴價儕晹, 2堛椕塹惗妛晹): The Japanese Journal of Rehabilitation Medicine 2022/1; 59 (1): 4-11.
530015. [偦偺懠 (Research Letters)] Impact of Preoperative Muscle Strength on Walking Independence After Total Hip Arthroplasty. Nozaki K1, Nanri Y1, Yamamoto S2, Hamazaki N1, Noda T2, Yamashita M2, Shirota T1, Uchiyama K3, Fukushima K4, Kamiya K5, Takahira N5, Takaso M4: J Am Med Dir Assoc 2022/4; 23 (4): 695-7. doi: 10.1016/j.jamda.2021.11.006. Epub 2021 Dec 6. (栰嶈峃暯1, 撿棦桟懢1, 嶳杮彯暯2, 郷嶈怢柧1, 栰揷丂彔2, 嶳壓恀巌2, 戙揷晲戝1, 撪嶳彑暥3, 暉搰寬夘4, 恄扟寬懢榊5, 崅暯彯怢5, 崅憡徎巑4: 1儕僴價儕晹, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4惍奜, 5堛椕塹惗妛晹)
540055. [偦偺懠 (妛夛彺榐)] 擖堾壛椕傪梫偡傞戝寣娗幘姵姵幰偵偍偗傞媫惈婜帯椕幚巤慜屻偱偺暊晹崪奿嬝枾搙偺曄壔. 嶳壓恀巌1, 恄扟寬懢榊2, 杒懞丂棩3, 郷嶈怢柧4, 栰嶈峃暯4, 慜愳宐旤5, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠5, 媨抧丂娪3 (1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3怱憻寣娗奜, 4儕僴價儕晹, 5弞娐婍撪) 擔杮弞娐婍昦梊杊妛夛帍 2021/5; 56 (2): 176.
540056. [偦偺懠 (妛夛彺榐)] 嬞媫帠懺愰尵偑奜棃怱憻儕僴價儕僥乕僔儑儞嶲壛幰偺恎懱妶摦偵梌偊偨塭嬁乣扨巤愝慜岦偒娤嶡尋媶乣. 郷嶈怢柧1, 恄扟寬懢榊2, 栰嶈峃暯1, 巗愳婱暥1, 嶳壓恀巌3, 撪揷隳懢3, 栰揷丂彔3, 慜愳宐旤4, 垻屆弫嵠4 (1儕僴價儕晹, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢, 4弞娐婍撪): 擔杮弞娐婍昦梊杊妛夛帍 2021/5; 56 (2): 182.
[挊丂彂]
620184. [妛弍彂 (暘扴幏昅)]亂PT丒OT 價僕儏傾儖僥僉僗僩 ADL (戞2斉)亃夘彆曽朄偲楙廗巜摫 (擼懖拞愐悜亅懝彎埲奜偺幘姵)丂匑僷乕僉儞僜儞昦, p.178-84. 匒恄宱擄昦幘姵, p.191-200. 悈栰岞曘 (儕僴價儕晹), 曇: 幠丂婌悞, 壓揷怣柧, 梤搚幮, 搶嫗, 2021/10敪峴.
620185. [妛弍彂 (暘扴幏昅)]亂棟妛椕朄僈僀僪儔僀儞 戞2斉亃戞3復 恄宱擄昦丂僷乕僉儞僜儞昦, p.126-7. 悈栰岞曘 (儕僴價儕晹), 娔廋: 擔杮棟妛椕朄巑嫤夛, 曇: 擔杮棟妛椕朄妛夛楢崌 棟妛椕朄昗弨壔専摙埾堳夛僈僀僪儔僀儞晹夛, 堛妛彂堾, 搶嫗, 2021/10敪峴.
[妛夛丒尋媶夛摍]
713060. [妛夛 (崙嵺)] (堦斒島墘) Associations between kidney function and outcomes following cardiac rehabilitation in patients with heart failure (Nursing and Allied Proffesions Investigator Award Winner 庴徿墘戣). Hamazaki N1, Kamiya K2, Nozaki K1, Ichikawa T1, Matsuzawa R, Yamashita M3, Uchida S3, T Noda3, Maekawa E4, Meguro K4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: ESC Congress 2021 - The Digital Experience (2021/8/30), Web奐嵜. (郷嶈怢柧1, 恄扟寬懢榊2, 栰嶈峃暯1, 巗愳婱暥1, 嶳壓恀巌3, 撪揷隳懢3, 栰揷丂彔3, 慜愳宐旤4, 栚崟寬懢榊4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢, 4弞娐婍撪)
713061. [妛夛 (崙嵺)] (堦斒島墘) Validity and Utility of the Qustionnaire-based FRAIL scale in older patients with Heart Failure: Findings from the FRAGILE-HF. Nozaki K1, Kamiya K2, Hamazaki N1, Saito H, Saito K, Ogasahara Y, Maekawa E3, Konishi M, Kitai T, Iwata K, Jujo K, Kagiyama N, Matsue Y: ESC Congress 2021 - The Digital Experience (2021/8/30), Web奐嵜. (栰嶈峃暯1, 恄扟寬懢榊2, 郷嶈怢柧1, 慜愳宐旤3: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3弞娐婍撪)
713062. [妛夛 (崙嵺)] (堦斒島墘) Standing balance is superior to gait parameters for motor impairment risk assesment in preterm and very-low-birth-weight toddlers. Nomura Y1, Sato H, Kariya H1, Kamide K, Ooka M2, Kemmochi M2: 75th American Academy for Cerebral Palsy and Developmental Medicine (2021/10/6-7), Web奐嵜, Dev Med Child Neurol 2021/10; 63 (Suppl 3): 76-7. (栰懞桪巕1, 姟扟塸婭1, 戝壀杻棟2, 巛帩丂妛2: 1儕僴價儕晹, 2彫帣)
722328. [妛夛 (慡崙)] (僔儞億僕僂儉) 屇媧嬝僩儗乕僯儞僌偺僄價僨儞僗偲幚慔. 郷嶈怢柧 (儕僴價儕晹): 戞27夞擔杮怱憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2021/6/19), 愮梩 (僴僀僽儕僢僪奐嵜).
722329. [妛夛 (慡崙)] (僕儑僀儞僩僔儞億僕僂儉) 僐儘僫壭偱摼偨宱尡傪怱憻丒恡憻儕僴價儕僥乕僔儑儞偵妶偐偡. 郷嶈怢柧 (儕僴價儕晹): 戞27夞擔杮怱憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2021/6/19), 愮梩 (僴僀僽儕僢僪奐嵜).
722330. [妛夛 (慡崙)] (僕儑僀儞僩僔儞億僕僂儉) 廳暋忈奞偺儕僴價儕僥乕僔儑儞. 郷嶈怢柧 (儕僴價儕晹): 戞12夞擔杮恡憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2022/3/26), 壀嶳 (僴僀僽儕僢僪奐嵜).
723763. [妛夛 (慡崙)] (堦斒島墘) 嬞媫帠懺愰尵偑奜棃怱憻儕僴價儕僥乕僔儑儞嶲壛幰偺恎懱妶摦偵梌偊偨塭嬁乣扨巤愝慜岦偒娤嶡尋媶乣. 郷嶈怢柧1, 恄扟寬懢榊2, 栰嶈峃暯1, 巗愳婱暥1, 嶳壓恀巌3, 撪揷隳懢3, 栰揷丂彔3, 慜愳宐旤4, 垻屆弫嵠4, 徏塱撃旻2 (1儕僴價儕晹, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢, 4弞娐婍撪): 戞57夞擔杮弞娐婍昦梊杊妛夛妛弍廤夛 (2021/6/6), Web奐嵜.
723764. [妛夛 (慡崙)] (堦斒島墘) 恖岺屢娭愡慡抲姺弍偵偍偗傞弍慜塰梴忬懺偲弍屻14擔埲撪偺帺戭戅堾壜斲媦傃弍屻嵼堾擔悢偲偺娭楢. 撿棦桟懢1, 暉搰寬夘2, 撪嶳彑暥2,3, 崅暯彯怢4 (1儕僴價儕晹, 2惍奜, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞58夞擔杮儕僴價儕僥乕僔儑儞堛妛夛妛弍廤夛 (2021/6/10), 嫗搒 (僴僀僽儕僢僪奐嵜).
723765. [妛夛 (慡崙)] (堦斒島墘) IMPELLA 5.0憓擖姵幰偵懳偡傞儕僴價儕僥乕僔儑儞偲嬝椡丒妶摦搙偺夵慞亅徢椺曬崘亅. 栰嶈峃暯1, 郷嶈怢柧1, 抮揷桟婤2, 擇時垽幚1, 彫椦庡專1, 恄扟寬懢榊3, 慜愳宐旤4, 徏塱撃旻3, 搶瀶旤撧巕3, 垻屆弫嵠4 (1儕僴價儕晹, 2媬柦, 3堛椕塹惗妛晹, 4弞娐婍撪): 戞27夞擔杮怱憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2021/6/19-20), 愮梩 (僴僀僽儕僢僪奐嵜).
723766. [妛夛 (慡崙)] (堦斒島墘) 媫惈婡擻懖拞姵幰偺擖堾弶婜偵偍偗傞拲堄婡擻昡壙TMT-J Part A偲帺戭戅堾壜斲偲偺娭楢. 愮梩廃暯1, 嵅乆栘廏堦1, 揷岥惏婱1, 寉晹撝巕1, 暉揷椣栫2 (1儕僴價儕晹, 2堛椕塹惗妛晹): 戞55夞擔杮嶌嬈椕朄妛夛 (2021/9/10-11), Web奐嵜.
723767. [妛夛 (慡崙)] (堦斒島墘) 寬忢惉恖偵偍偗傞庤巜娭愡壜摦堟應掕偺専幰撪怣棅惈偍傛傃専幰娫怣棅惈偺専摙. 拞堜戶嵠1, 崅嫶崄戙巕2, 懞旜愮壺巕1, 揷岥惏婱1, 恄曐晲懃1 (1儕僴價儕晹, 2堛椕塹惗妛晹): 戞55夞擔杮嶌嬈椕朄妛夛 (2021/9/10-11), Web奐嵜.
723768. [妛夛 (慡崙)] (堦斒島墘) 媫惈婜偵偍偗傞擼峓嵡寣愷夞廂椕朄幰偺揤婥暿TMT-J partA偺悇堏. 揷岥惏婱1, 嵅乆栘廏堦1, 愮梩廃暯1, 拞墍揘帯1, 寉晹撝巕1 (1儕僴價儕晹): 戞55夞擔杮嶌嬈椕朄妛夛 (2021/9/10-11), Web奐嵜.
723769. [妛夛 (慡崙)] (堦斒島墘) 挻掅弌惗懱廳帣偺廋惓1嵨敿偍傛傃3嵨帪揰偱偺姶妎張棟擻椡偺摿挜. 徏堜垷嵐旤1,2, 崅嫶崄戙巕3, 抾撪姲恖2, 戝壀恀棟4, 拞惣廏旻4,5 (1戝妛堾堛椕宯尋媶壢, 2儕僴價儕晹, 3堛椕塹惗妛晹, 4彫帣, 5怴悽婭堛椕丒愭抂堛椕): 戞55夞擔杮嶌嬈椕朄妛夛 (2021/9/10-11), Web奐嵜.
723770. [妛夛 (慡崙)] (堦斒島墘) 嬀帇壓銯斅廋暅弍6儢寧偺姵幰棫媟宆Shoulder36偺嬝椡崁栚偵娭楢偡傞場巕偺専摙. 嵅乆栘廏堦1, 尒栚抭婭2, 抾撪姲恖1, 恄曐晲懃1, 柤憅捈廳, 拞榚廩復2, 揷郪丂椚2, 廆廳嬁巕3, 愇堜戝曘3, 崅憡徎巑2 (1儕僴價儕晹, 2惍奜, 3戝妛堾堛椕宯尋媶壢): 戞48夞擔杮尐娭愡妛夛妛弍廤夛丒戞18夞擔杮尐偺塣摦婡擻尋媶夛妛弍廤夛 (2021/10/29-30), 柤屆壆.
723771. [妛夛 (慡崙)] (堦斒島墘) 弍慜屻偺孅嬋/奜揮嬝椡斾 (FE斾) 偑椪彴強尒偵梌偊傞塭嬁. 抾撪姲恖1, 嵅乆栘廏堦1, 尒栚抭婭2, 恄曐晲懃1, 柤憅捈廳, 拞榚廩復2, 揷郪丂椚2, 廆廳嬁巕3, 愇堜戝曘3, 崅憡徎巑2 (1儕僴價儕晹, 2惍奜, 3戝妛堾堛椕宯尋媶壢): 戞48夞擔杮尐娭愡妛夛妛弍廤夛丒戞18夞擔杮尐偺塣摦婡擻尋媶夛妛弍廤夛 (2021/10/29-30), 柤屆壆.
723772. [妛夛 (慡崙)] (堦斒島墘) 挻掅弌惗懱廳帣偵偍偗傞敪払宱夁偺昡壙偲偟偰偺傾儖僶乕僞擕梒帣塣摦敪払専嵏朄偺桳梡惈. 栰懞桪巕1, 悈栰岞曘1, 姟扟塸婭1, 郷嶈怢柧1, 楅栘椙榓1, 拞墍揘帯1, 嫽捗棦曕1, 徏揷棟嵅巕1, 戝壀杻棟2, 巛帩丂妛2, 暉揷椣栫3 (1儕僴價儕晹, 2彫帣, 3堛椕塹惗妛晹): 戞8夞擔杮彫帣棟妛椕朄妛夛妛弍戝夛 (2021/11/27-28), Web奐嵜.
723773. [妛夛 (慡崙)] (堦斒島墘) 媫惈婜擼峓嵡姵幰偵偍偗傞壓巿Fugl Meyer assessment偼揮婣帪揰偺曕峴帺棫偺梊應偵桳梡偱偁傞. 拞墍揘帯1, 恄扟寬懢榊2, 姟扟塸婭1, 楅栘椙榓1, 悈栰岞曘1, 栰懞桪巕1, 嫽捗棦曕1, 徏揷棟嵅巕1, 愇扟悙婓1, 懪栴婱巕1, 愳抂椙帯1, 弔擔旤曐1, 暉揷椣栫2 (1儕僴價儕晹, 2堛椕塹惗妛晹): 戞19夞擔杮恄宱棟妛椕朄妛夛妛弍戝夛 in 偄傢偰 (2021/12/18-19), Web奐嵜.
732132. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 棟妛椕朄偺昗弨揑側忣曬廂廤: 帯椕曇乽奺庬僨僶僀僗乿. 郷嶈怢柧 (儕僴價儕晹): 戞2夞擔杮弞娐婍棟妛椕朄妛夛怱晄慡徢椺専摙僒僥儔僀僩僇儞僼傽儗儞僗 (2021/12/5), Web奐嵜.
732133. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 棟妛椕朄偺幚嵺: 棟妛椕朄偺昗弨壔偵岦偗偰乽壏搙斅側偳乿. 郷嶈怢柧 (儕僴價儕晹): 戞2夞擔杮弞娐婍棟妛椕朄妛夛怱晄慡徢椺専摙僒僥儔僀僩僇儞僼傽儗儞僗 (2021/12/5), Web奐嵜.
732134. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 棟妛椕朄偺幚嵺: 棟妛椕朄偺昗弨壔偵岦偗偰乽塣摦椕朄丒媫惈婜乿. 郷嶈怢柧 (儕僴價儕晹): 戞2夞擔杮弞娐婍棟妛椕朄妛夛怱晄慡徢椺専摙僒僥儔僀僩僇儞僼傽儗儞僗 (2021/12/5), Web奐嵜.
732135. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 暅怑偵惉岟偟偨挻崅楊媫惈怱晄慡偺堦椺. 栰嶈峃暯 (儕僴價儕晹): 戞1夞弞娐婍棟妛椕朄僩僺僢僋僗 徢椺専摙僒僥儔僀僩僇儞僼傽儗儞僗 (2021/12/15), Web奐嵜.
733273. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 暅怑婓朷偺恄宱銹夎庮姵幰偵懳偟ADOC傪梡偄偰弍屻憗婜偐傜OBP傪峴偭偨帠椺. 崟嶈丂嬻1, 嵅乆栘廏堦1, 揷岥惏婱1, 寉晹撝巕1, 恄曐晲懃1 (1儕僴價儕晹): 戞18夞恄撧愳導嶌嬈椕朄妛夛 (2021/12/4-5), Web奐嵜.
733274. [妛夛 (抧曽夛丒尋媶夛)] (僠儍儗儞僕敪昞) 媫惈婜偵偍偗傞揮堏惈擼庮釃姵幰偵懳偡傞戅堾巟墖傪幚慔偟偨1徢椺. 嶳壓榓壧巕1, 揷岥惏婱1, 嵅乆栘廏堦1, 崟嶈丂嬻1, 恄曐晲懃1 (1儕僴價儕晹): 戞18夞恄撧愳導嶌嬈椕朄妛夛 (2021/12/4-5), Web奐嵜.
733275. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 媫惈婜昦堾偵偰堄巚揱払憰抲傪摫擖偟壠懓偲偺僐儈儏僯働乕僔儑儞傪宲懕偱偒偨ALS徢椺. 暉揷丂朑1, 嵅乆栘廏堦1, 寉晹撝巕1, 崅嫶崄戙巕2, 恄曐晲懃1 (1儕僴價儕晹, 2堛椕塹惗妛晹): 戞18夞恄撧愳導嶌嬈椕朄妛夛 (2021/12/4-5), Web奐嵜.
733276. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 媫惈婜偵偍偗傞峈NMDA庴梕懱擼墛姵幰偵懳偟偰, MTDLP傪梡偄偰挷棟摦嶌傪妉摼偟偨堦徢椺. 彫尨桼婱1, 愮梩廃暯1, 嵅乆栘廏堦1, 抾撪姲恖1, 恄曐晲懃1 (1儕僴價儕晹): 戞18夞恄撧愳導嶌嬈椕朄妛夛 (2021/12/4-5), Web奐嵜.
733277. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 娭愡儕僂儅僠広懁曃埵偺恖岺巜娭愡抲姺弍屻椕朄偵巊梡偡傞怴偨側憰嬶偺帋傒亅擬壜慪惈僯僢僩慺嵽偲僱僆僾儗儞偱嶌惢偟偨僗僾儕儞僩亅. 嵅乆栘廏堦1, 彫徖尗帯2, 彆愳峗巑2, 戝抾桰嵠2, 抾撪姲恖1, 恄曐晲懃1, 尒栚抭婭2, 崅暯彯怢3 (1儕僴價儕晹, 2惍奜, 3堛椕塹惗妛晹): 戞22夞恄撧愳儕僂儅僠偺儕僴丒働傾尋媶夛 (2022/1/22), 墶昹 (僴僀僽儕僢僪奐嵜).
'20擭搙埲慜暘
[妛弍榑暥]
'20-110035. [尨挊] Prognostic value of cardio-hepatic-skeletal muscle syndrome in patients with heart failure. Noda T1, Kamiya K2, Hamazaki N3, Nozaki K3, Ichikawa T3, Nakamura T1, Yamashita M1, Uchida S1, Maekawa E4, Reed JL, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: Sci Rep 2021/2; 11 (1):3715. (栰揷丂彔1, 恄扟寬懢榊2, 郷嶈怢柧3, 栰嶈峃暯3, 巗愳婱暥3, 拞懞妜巎1, 嶳壓恀巌1, 撪揷隳懢1, 慜愳宐旤4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1戝妛堾堛椕尋媶壢, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4弞娐婍撪)
'20-110036. [尨挊] Post-intensive care syndrome as a predictor of mortality in patients with critical illness: A cohort study. Yanagi N, Kamiya K1, Hamazaki N2, Matsuzawa R, Nozaki K2, Ichikawa T2, Valley TS, Nakamura T3, Yamashita M3, Maekawa E4, Koike T5, Yamaoka-Tojo M1, Arai M6, Matsunaga A1, Ako J4: PLoS One 2021/3; 16 (3): e0244564. (恄扟寬懢榊1, 郷嶈怢柧2, 栰嶈峃暯2, 巗愳婱暥2, 拞懞妜巎3, 嶳壓恀巌3, 慜愳宐旤4, 彫抮朁岶5, 搶瀶旤撧巕1, 怴堜惓峃6, 徏塱撃旻1, 垻屆弫嵠4: 1堛椕塹惗妛晹, 2儕僴價儕晹, 3戝妛堾堛椕尋媶壢, 4弞娐婍撪, 5ME晹, 6怴悽婭堛椕丒墶抐揑堛椕)
塰梴晹
[妛弍榑暥]
110455. [尨挊] Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology. Kikuchi N1, Uojima H2, Hidaka H2, Iwasaki S2, Wada N2, Kubota K2, Nakazawa T2, Shibuya A3, Fujikawa T, Kako M, Sato T1, Koizumi W2: Hepatol Res 2021/9; 51 (9): 968-78. (媏抮撧曚巕1, 嫑搱惏婭2, 擔崅丂墰2, 娾嶈廏堦榊2, 榓揷彯媣2, 孍揷岾夘2, 拞郪婱廏2, 廰扟柧棽3, 嵅摗徠巕1, 彫愹榓嶰榊2 (1塰梴晹, 2徚壔婍撪, 3堛椕埨慡丒娗棟)
120045. [尨挊] 摐擜昦恡徢曐懚婜偺懡怑庬夘擖偼寣塼摟愅摫擖帪偺昦懺偍傛傃摫擖屻偺梊屻傪夵慞偡傞. 恖尒杻旤巕1, 嵅摗徠巕1, 戝娧宐巕2, 嶁杮攡巕2, 彑楥旤崄3, 嶰塝朏揟4, 庣壆払旤5 (1塰梴晹, 2娕岇晹, 3栻嵻晹, 4椪専晹, 5寬峃娗棟僙): 摐擜昦 2021/4; 64 (4): 263-8.
520016. [憤愢] 僠乕儉偱峔抸偟偨恡堏怉儗僔僺僄儞僩偺塰梴娗棟. 媑揷朁巕1, 愇堜戝曘2, 栰岥暥擳2, 堜懞梉昉3, 怷壀桪巕1, 垻晹揘栫4, 杒搰榓庽2, 抾撪峃梇4, 媑揷堦惉2,5 (1塰梴晹, 2斿擜婍, 3娕岇晹, 4恡憻撪, 5怴悽婭堛椕丒愭抂堛椕): 擔杮椪彴恡堏怉妛夛嶨帍 2021/7; 9 (1): 23亅9.
522596. [島嵗]亂摿廤: 抦偭偰偍偒偨偄! 堏怉堛椕偺幚嵺偲塰梴丒怘帠娗棟亃恡堏怉偺幚嵺偲塰梴丒怘帠娗棟. 媑揷朁巕 (塰梴晹): 椪彴塰梴 2021/7; 139 (1): 26-31.
522597. [島嵗]亂摿廤: CKD丒摟愅姵幰偺塰梴巜摫曽朄偲幚慔亃5 塰梴巜摫幚慔亅恡堏怉姵幰偺塰梴巜摫. 怷壀桪巕, 媑揷朁巕1 (1塰梴晹): 椪喱摟愅 2021/11; 37 (12): 77-82.
522598. [島嵗]亂摿廤: 擠怭摐擜昦丒摐擜昦崌暪擠怭偺儅僱僕儊儞僩丂寣摐僐儞僩 儘乕儖偲彆嶻働傾嵟怴僈僀僪亃07 擠怭拞乣嶻屻偺塰梴巜摫乣乽娗棟塰梴巑偲嫤椡乿偟彆嶻巘偵傕偱偒傞! 恖尒杻旤巕 (塰梴晹): 儁儕僱僀僞儖働傾 2021/11; 40 (11): 1100-6.
[挊丂彂]
620186. [妛弍彂 (暘扴幏昅)]亂恡憻昦椕梴巜摫巑偺偨傔偺CKD巜摫僈僀僪僽僢僋亃Chapter11 怘帠椕朄丂4 恡戙懼椕朄 (RRT) 暿偺怘帠娗棟 c恡堏怉, p.115-7. 媑揷朁巕 (塰梴晹), 娔廋: 擔杮恡憻昦嫤夛, 曇: 擔杮恡憻妛夛, 擔杮恡晄慡娕岇妛夛, 擔杮塰梴巑夛, 擔杮恡憻昦栻暔椕朄妛夛, 擔杮恡憻儕僴價儕僥乕僔儑儞妛夛, 搶嫗堛妛幮, 搶嫗, 2021/10敪峴.
620187. [妛弍彂 (暘扴幏昅)]亂擠晈偺摐戙幱堎忢 恌椕丒娗棟儅僯儏傾儖 戞3斉亃IV 嶻屻偺娗棟丂3. 嶻屻偺怘帠椕朄偲偦偺巟墖偼偳偆偟偨傜傛偄偱偡偐?, p.202-4. 恖尒杻旤巕 (塰梴晹). 曇: 擔杮摐擜昦丒擠怭妛夛, 儊僕僇儖價儏乕幮, 搶嫗, 2022/1敪峴.
[妛夛丒尋媶夛摍]
713063. [妛夛 (崙嵺)] (堦斒島墘) Multidisciplinary Predialyis Team Education for patients with Diabetic Nephropathy,Postponed Hemodialysis Induction, and Prolonged Survival After Hemodialysis Induction. Hitomi M1, Sato T1, Moriya T2: 戞81夞暷崙摐擜昦妛夛擭師妛弍廤夛 (ADA2021) (2021/6/25), Web奐嵜, HP偺揹巕攠懱偺傒 2021/6. (恖尒杻旤巕1, 嵅摗徠巕1, 庣壆払旤2: 1塰梴晹, 2寬峃娗棟僙)
722331. [妛夛 (慡崙)] (僔儞億僕僂儉) 恡晄慡姵幰偵懳偡傞宱挵塰梴嵻偺庬椶偲摿挜. 媑揷朁巕1, 惵嶳搶屲2, 抾撪峃梇2 (1塰梴晹, 2恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/4), 墶昹 (僴僀僽儕僢僪奐嵜), 戞66夞擔杮摟愅堛妛夛彺榐廤 (傾僾儕宖嵹偺傒) 2021/5. (HP偺揹巕攠懱偺傒)
722332. [妛夛 (慡崙)] (僔儞億僕僂儉) 摐戙幱堎忢傪桳偡傞擠晈偺懱廳娗棟偺尰忬偲壽戣丂塰梴巜摫偺娤揰偐傜. 恖尒杻旤巕 (塰梴晹): 戞37夞擔杮摐擜昦丒擠怭妛夛擭師妛弍廤夛 (2021/11/27), Web奐嵜, 戞37夞擔杮摐擜昦擠怭妛夛彺榐廤 2021/11; 21 (3): S-18.
723774. [妛夛 (慡崙)] (堦斒島墘) 摐擜昦恡徢曐懚婜偵懳偡傞懡怑庬夘擖偺岠壥傪媞娤揑偵専徹偡傞. 恖尒杻旤巕1, 嵅摗徠巕1, 庣壆払旤2 (1塰梴晹, 2寬峃娗棟僙): 戞64夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2021/5/20), Web奐嵜, 戞64夞擔杮摐擜昦擭師妛弍廤夛摐擜昦 2021; 64 (Suppl): 51.
723775. [妛夛 (慡崙)] (億僗僞乕) 旕寁夋寣塼摟愅摫擖姵幰偺ADL偵塰梴娗棟偼塭嬁偡傞. 媑揷朁巕1, 惵嶳搶屲2, 怷壀桪巕1, 摗堜錆幚1, 塱壀枹棃2, 崅嫶丂椛2, 撪摗惓媑2, 嵅栰丂棽2, 抾撪峃梇2 (1塰梴晹, 2恡憻撪): 戞66夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2021/6/5), 墶昹 (僴僀僽儕僢僪奐嵜), 戞66夞擔杮摟愅堛妛夛彺榐廤 (傾僾儕宖嵹偺傒) 2021/5. (HP偺揹巕攠懱偺傒)
732136. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) CKD姵幰偵偍偗傞嵞椕朄慖戰帪偺娗棟塰梴巑偺娭傢傝. 媑揷朁巕 (塰梴晹): 戞4夞恡晄慡僠乕儉堛椕嫤媍夛 (Kicos) 妛弍戝夛 (2021/8/22), Web奐嵜, 戞4夞恡晄慡僠乕儉堛椕嫤媍夛 (嶜巕側偟丆WEB宖嵹偺傒) 2021/8. (HP偺揹巕攠懱偺傒)
732137. [妛夛 (尋媶夛丒抧曽夛)] (僔儞億僕僂儉) 恡堏怉屻偺塰梴娗棟. 媑揷朁巕1, 怷壀桪巕1, 杒搰榓庽2, 愇堜戝曘2, 媑揷堦惉2,3 (1塰梴晹, 2斿擜婍, 3怴悽婭堛椕丒愭抂堛椕): 戞30夞擔杮恡晄慡奜壢尋媶夛妛弍廤夛 (2021/12/4), 壂撽 (僴僀僽儕僢僪奐嵜), 戞30夞擔杮恡晄慡奜壢尋媶夛彺榐廤 (嶜巕側偟, WEB宖嵹偺傒) 2021/11. (HP偺揹巕攠懱偺傒)
733278. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 廳徢姵幰偵偍偗傞僞儞僷僋幙搳梌検偲恎懱妶摦惈偺屻曽帇揑専摙. 怺戲嵅宐巕1,2, 曅壀桽堦3, 揷懞丂抭3, 媨嶈摴婸4, 揷懞抭巕5, 墦摗惉巕1, 嵅摗徠巕1, 榟郪彯岹2, 彫惣晀榊2 (1塰梴晹, 2搶嫗堛椕曐寬戝妛戝妛堾, 3媬柦, 4儕僴價儕晹, 5堛椕塹惗妛晹): 戞12夞擔杮椪彴塰梴戙幱妛夛庱搒寳巟晹夛妛弍廤夛 (2021/5/15), Web奐嵜, 戞12夞擔杮椪彴塰梴戙幱妛夛庱搒寳巟晹夛妛弍廤夛彺榐廤 2021/5; p.41.
733279. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 儈僩僐儞僪儕傾昦偵崌暪偟偨忋挵娫枌摦柆 (SMA) 徢岓孮傪娚夝偵摫偄偨塰梴椕朄偺堦椺. 媏抮撧曚巕1, 烴扟旤婱巕2, 怴尨惓戝2, 嵅摗徠巕1, 斾婇捈庽2 (1塰梴晹, 2忋晹徚壔娗奜): 戞12夞擔杮椪彴塰梴戙幱妛夛庱搒寳巟晹夛妛弍廤夛 (2021/5/15), Web奐嵜, 戞12夞擔杮椪彴塰梴戙幱妛夛庱搒寳巟晹夛妛弍廤夛彺榐廤 2021/5; p.55.
733280. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擔杮娞憻妛夛偺僒儖僐儁僯傾敾掕婎弨傪梡偄偨娞峝曄偺梊屻偺専摙偲僒儖僐儁僯傾懳嶔偵偍偗傞塰梴怘帠椕朄偺幚嵺. 媏抮撧曚巕1, 嫑搱惏婭2 (1塰梴晹, 2徚壔婍撪): 戞26夞娞幘姵偲塰梴尋媶夛 (2021/7/15), Web奐嵜.
733281. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摿掕廤拞帯椕幒偵偍偗傞憗婜塰梴夘擖娗棟壛嶼傊偺庢傝慻傒偲尰忬. 怺戲嵅宐巕1, 慜揷埢擳2, 嶰堜抭岲2, 撪摗垷庽2, 媑悾奊棟3, 郷揷柇巕2, 崟娾惌擵4, 嵅摗徠巕1 (1塰梴晹, 2娕岇晹, 3栻嵻晹, 4杻悓): 戞23夞恄撧愳NST僼僅乕儔儉 (2021/11/20), Web奐嵜, 戞23夞恄撧愳NST僼僅亅儔儉彺榐廤 (嶜巕側偟) 2021/11; p.8.
昦堾昦棟晹
[妛弍榑暥]
120046. [尨挊] 拝怓儂儖儅儕儞屌掕塼偍傛傃晻鉭梕婍偵傛傞堛椕帠屘杊巭偺採埬亅儂儖儅儕儞屌掕塼桼棃偺堛椕帠屘暘愅偐傜亅. 嶳壓榓栫1, 媣応丂庽1, 嶁岥丂擡1, 媑揷丂岟2, 懞塤朏庽3, 嶰巬丂怣3 (1昦棟晹, 2怴悽婭堛椕丒墶抐揑堛椕, 3昦棟妛): 堛妛専嵏 2021/7; 70 (3): 433-42.
120047. [尨挊] 悈梟惈僷儔僼傿儞傪梡偄偨僽儘僢僋僇僶乕偺桳梡惈偺専摙. 挿扟愳桽擇1, 嶳壓榓栫1, 媑揷丂岟2, 懞塤朏庽3, 嶰巬丂怣3 (1昦棟晹, 2怴悽婭堛椕丒墶抐揑堛椕, 3昦棟妛): 堛妛専嵏 2022/1; 71 (1): 10-9.
320030. [徢椺曬崘] 拞廲妘偵敪惗偟偨扙暘壔宆帀朾擏庮偺1椺. 拞愳恗旤1, 奰徖淎朚1, 嶳壓榓栫1, 嵅摗擵弐2, 堦屗 徆柧3, 媑揷丂岟4, 嶰巬丂怣3 (1昦棟晹, 2屇媧婍奜, 3昦棟妛, 4怴悽婭堛椕丒墶抐揑堛椕): 恄撧愳導椪彴嵶朎妛夛帍 2022/1; 26 (1): 14-29.
[妛夛丒尋媶夛摍]
723776. [妛夛 (慡崙)] (堦斒岥墘) 2020擭搙擔椪媄昦棟専嵏昗弨壔丒惛搙娗棟崌摨傾儞働乕僩挷嵏偺曬崘 (1). 椦丂桾巌1, 愇揷崕惉2, 楅栘弐婭3, 嶁崻弫堦4, 徏尨恀撧旤5, 搶丂丂妛6, 嶳壓榓栫7, 屆壆廃堦榊8 (1帬夑堛壢戝妛堛妛晹晬懏昦堾, 2峀搰戝妛堛妛晹晅懏昦堾, 3嶳宍戝妛堛妛晹晅懏昦堾, 4惷壀偙偳傕昦堾, 5搰崻導棫拞墰昦堾, 6崙棫昦堾婡峔敓娰昦堾, 7昦棟晹, 8拀攇戝妛晬懏昦堾): 戞70夞擔杮堛妛専嵏妛夛 (2021/5/15-6/14), Web奐嵜, 堛妛専嵏 2021/5; 70 (暿嶜): 223.
723777. [妛夛 (慡崙)] (億僗僞乕) 2020擭搙擔椪媄昦棟専嵏昗弨壔丒惛搙娗棟崌摨傾儞働乕僩挷嵏偺曬崘 (2). 椦丂桾巌1, 愇揷崕惉2, 楅栘弐婭3, 嶁崻弫堦4, 徏尨恀撧旤5, 搶丂丂妛6, 嶳壓榓栫7, 屆壆廃堦榊8 (1帬夑堛壢戝妛堛妛晹晬懏昦堾, 2峀搰戝妛堛妛晹晅懏昦堾, 3嶳宍戝妛堛妛晹晅懏昦堾, 4惷壀偙偳傕昦堾, 5搰崻導棫拞墰昦堾, 6崙棫昦堾婡峔敓娰昦堾, 7昦棟晹, 8拀攇戝妛晬懏昦堾): 戞70夞擔杮堛妛専嵏妛夛憤夛 (2021/5/15-6/14), Web奐嵜, 堛妛専嵏 2021/5; 70 (暿嶜): 224.
731083. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 堚揱巕専嵏偺婎慴 (慻怐専懱庢傝埖偄傪娷傔偨). 嶳壓榓栫 (昦棟晹): 椷榓3擭搙擣掕昦棟専嵏媄巘巜掕島廗夛 (2021/8/1-31), Web奐嵜, 巜掕島廗夛僥僉僗僩 2021/8; 椷榓3擭搙斉.
732138. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 擕娻昗杮嶌惢媄弍偺揰専 (擕娻丒堓娻HER2昦棟恌抐僈僀僪儔僀儞戞2斉偵妛傇). 嶳壓榓栫 (昦棟晹): 崄愳昦棟僙儈僫乕崄愳導椪彴嵶朎妛夛嫟嵜 (2021/10/23), Web奐嵜.
ME晹
[妛弍榑暥]
120048. [尨挊] ECMO巤峴帪偵偍偗傞恖岺攛偺僈僗岎姺擻晄懌偵懳偡傞恖岺攛暲楍愙懕偲捈楍愙懕偺斾妑専摙. 搶瀶孿堦1, 栘壓弔撧1, 晲揷復悢1, 戝搰峅擵1, 嬧愳旤嵐婭1, 拞懞嫳巕1, 摗堜惓幚1 (1ME晹): 懱奜弞娐媄弍 2022/3; 49 (1): 1-6.
320031. [徢椺曬崘] 僿僢僪儔僀僩偺僼傽僀僶乕働乕僽儖壏搙忋徃偺婋尟惈偵偮偄偰. 棫栰丂憦1, 搶瀶孿堦1, 摗堜惓幚1, 愳搰嵤壺1 (1ME晹): 擔杮庤弍堛妛夛夛帍 2021/10; 42 (3): 281-6.
320032. [徢椺曬崘] COVID-19梲惈媈偄姵幰偵懳偡傞怉崬傒宆曗彆恖岺怱憻憰拝弍偺宱尡. 戝搰峅擵1, 搶瀶孿堦1, 孠尨幯堖1, 揷拞桪旤1, 埳搶徦懢1, 媨抧丂娪2 (1ME晹, 2怱憻寣娗奜): 懱奜弞娐媄弍 2022/3; 49 (1): 11-5.
[挊丂彂]
620188. [妛弍彂 (暘扴幏昅)]亂僫乕僗偺偨傔偺ME婡婍儅僯儏傾儖 戞2斉亃II 昦堾撪偱巊梡偡傞ME婡婍丂姵幰儌僯僞儕儞僌偺偨傔偺婡婍丂5揹巕懱壏寁, p.37-40. 6 僷儖僗僆僉僔儊乕僞乕, p.41-6. 7 僇僂僲儊乕僞乕, p.47-51. 8 宱旂.僈僗儌僯僞, p.52-5. 搶瀶孿堦 (ME晹), 曇: 壛擺丂棽, 淎悾丂柅, 堛妛彂堾, 搶嫗, 2021/10敪峴.
620189. [妛弍彂 (暘扴幏昅)]亂僫乕僗偺偨傔偺ME婡婍儅僯儏傾儖 戞2斉亃II 昦堾撪偱巊梡偡傞ME婡婍丂弞娐傪彆偗傞婡婍丂18 曗彆弞娐梡億儞僾僇僥乕僥儖 (Impella), p.98-101. 屇媧傪彆偗傞婡婍丂23 壛壏壛幖婍偲僱僾儔僀僓, p.128-31. 24 巁慺棳検寁, p.132-6. 25 巁慺擹搙寁, p.137-9. 26 巁慺擹弅婍, p.140-3. 28 宱旲崅棳検巁慺椕朄 (僱乕僓儖僴僀僼儘乕僙儔僺乕), p.148-51. 29 崅婥埑巁慺帯椕憰抲, p.152-4. 栘壓弔撧 (ME晹), 曇: 壛擺丂棽, 淎悾丂柅, 堛妛彂堾, 搶嫗, 2021/10敪峴.
620190. [妛弍彂 (暘扴幏昅)]亂僫乕僗偺偨傔偺ME婡婍儅僯儏傾儖 戞2斉亃II 昦堾撪偱巊梡偡傞ME婡婍丂屇媧傪彆偗傞婡婍丂31 媧堷婍, p.160-3. 32 掅埑帩懕媧堷婍, p.164-67. 33 堛椕僈僗愝旛, p.168-70. 34 巁慺儃儞儀, p.171-4. 摗堜惓幚 (ME晹), 曇: 壛擺丂棽, 淎悾丂柅, 堛妛彂堾, 搶嫗, 2021/10敪峴.
620191. [妛弍彂 (暘扴幏昅)]亂僫乕僗偺偨傔偺ME婡婍儅僯儏傾儖 戞2斉亃II 昦堾撪偱巊梡偡傞ME婡婍丂庤弍偱巊傢傟傞婡婍丂41 挻壒攇庤弍憰抲, p.204-6. 42 儗乕僓乕庤弍憰抲, p.207-10. 43 杻悓婍, p.211-5. 棫栰丂憦 (ME晹), 曇: 壛擺丂棽, 淎悾丂柅, 堛妛彂堾, 搶嫗, 2021/10敪峴.
620192. [妛弍彂 (暘扴幏昅)]亂僫乕僗偺偨傔偺ME婡婍儅僯儏傾儖 戞2斉亃II 昦堾撪偱巊梡偡傞ME婡婍丂庤弍偱巊傢傟傞婡婍丂44 杻悓僈僗儌僯僞, p.216-7. 45 BIS儌僯僞, p.218-21. 46 寣塼壛幖婍, p.222-6. 47 挋寣幃帺屓寣夞廂憰抲, p.227-9. 48 壛幖丒椻媝僽儔儞働僢僩, 拞怱惷柆棷抲宆宱旂揑懱壏挷愡憰抲, p.230-7. 戝搰峅擵 (ME晹), 曇: 壛擺丂棽, 淎悾丂柅, 堛妛彂堾, 搶嫗, 2021/10敪峴.
620193. [妛弍彂 (暘扴幏昅)]亂僫乕僗偺偨傔偺ME婡婍儅僯儏傾儖 戞2斉亃II 昦堾撪偱巊梡偡傞ME婡婍丂嵼戭偱巊梡偡傞ME婡婍丂1 嵼戭堛椕偵偍偗傞ME婡婍偺巊梡, p.254-61. 2 嵼戭偱ME婡婍傪巊梡偡傞嵺偺慡斒揑側億僀儞僩, p.261. 晲揷復悢 (ME晹), 曇: 壛擺丂棽, 淎悾丂柅, 堛妛彂堾, 搶嫗, 2021/10敪峴.
621005. [妛弍彂 (曇廤)]亂椪彴岺妛媄弍償傿僕儏傾儖僔儕乕僘丂摦夋偲幨恀偱傑傞傢偐傝!丂恖岺屇媧亃搶瀶孿堦1, 摗堜惓幚1, 栘壓弔撧1, 晲揷復悢1, 棫栰丂憦1, 戝搰峅擵1, 懠 (1ME晹), 娔廋: 1ME晹, 曇: 搶瀶孿堦1, 尋儊僨傿僇儖廏弫幮, 搶嫗, 2021/9敪峴.
[妛夛丒尋媶夛摍]
722333. [妛夛 (慡崙)] (彽懸島墘) COVID-19梲惈媈偄姵幰偵懳偡傞懱奜弞娐偺宱尡. 戝搰峅擵1, 搶瀶孿堦1, 孠尨幯堖1, 揷拞桪旤1, 埳搶徦懢1, 媨抧丂娪2 (1ME晹, 2怱憻寣娗奜): 戞46夞擔杮懱奜弞娐媄弍堛妛夛戝夛 (2021/10/17), Web奐嵜, 懱奜弞娐媄弍 2021/9; 48 (3): 180.
722334. [妛夛 (慡崙)] (彽懸島墘) 堛椕婡婍拞墰娗棟偵偍偗傞姶愼奼戝婜偺懳墳. 搶瀶孿堦1, 摗堜惓幚1, 栘壓弔撧1, 棫栰丂憦1 (1ME晹): 戞96夞擔杮堛椕婡婍妛夛戝夛 (2021/12/13-2022/1/12), Web奐嵜, 堛椕婡婍妛 2021/4; 91 (2): 137-8.
722335. [妛夛 (慡崙)] (彽懸島墘) 僠乕儉堛椕傪怺壔偝偣傞嫵堢偺宱尡. 棫栰丂憦1, 搶瀶孿堦1, 摗堜惓幚1, 愳搰嵤壺1, 塿揷捈栱1, 揤栰捈婸1 (1ME晹): 戞43夞擔杮庤弍堛妛夛憤夛 (2022/1/28), Web奐嵜, 擔杮庤弍堛妛夛帍 2021/12; 42 (Suppl): 74.
723778. [妛夛 (慡崙)] (堦斒島墘) 傾儞僥僫働乕僽儖偵婲場偡傞僙儞僩儔儖儌僯僞傾儔乕儉偵懳偡傞専摙. 憗懍怲屷1, 搶瀶孿堦1, 摗堜惓幚1, 棫栰丂憦1, 塿揷捈栱1 (1ME晹): 戞31夞擔杮椪彴岺妛夛偍傛傃椷榓3擭搙岞塿幮抍朄恖擔杮椪彴岺妛媄巑夛憤夛 (2021/5/23), 孎杮, 擔杮椪彴岺妛媄巑夛夛帍 2021/4; 72: 242.
723779. [妛夛 (慡崙)] (堦斒島墘) 庤弍偵偍偗傞婡婍僩儔僽儖偺姵幰塭嬁偵娭偡傞専摙. 棫栰丂憦1, 搶瀶孿堦1, 摗堜惓幚1, 愳搰嵤壺1, 塿揷捈栱1, 揤栰捈婸1, 拞搰桰曘1 (1ME晹): 戞43夞擔杮庤弍堛妛夛憤夛 (2022/1/28), Web奐嵜, 擔杮庤弍堛妛夛帍 2021/12; 42 (Suppl): 106.
723780. [妛夛 (慡崙)] (堦斒島墘) VAVD巊梡帪偺僩儔僽儖偵懳偡傞媧堷傾僂僩儗僢僩晅偒億乕僞僽儖媧堷尮傪巊梡偟偨嬞媫懳墳偺幚尡揑専摙. 戝搰峅擵1, 搶瀶孿堦1, 孠尨幯堖1, 揷拞桪旤1, 埳搶徦懢1, 媨抧丂娪2 (1ME晹, 2怱憻寣娗奜): 戞46夞擔杮懱奜弞娐媄弍堛妛夛戝夛 (2021/10/16), Web奐嵜, 懱奜弞娐媄弍 2021/9; 48 (3): 227.
723781. [妛夛 (慡崙)] (堦斒島墘) COVID-19梲惈姵幰傗媈偄姵幰偵懳偟偰懱奜弞娐扴摉媄巑偼偳偆懳墳偟偨偐?亅堾撪姶愼傪杊巭偡傞偨傔偺摤偄亅堾撪姶愼傪杊巭偡傞偨傔偺摤偄亅COVID-19梲惈媈偄姵幰偵懳偡傞懱奜弞娐偺宱尡. 戝搰峅擵1, 搶瀶孿堦1, 孠尨幯堖1, 揷拞桪旤1, 埳搶徦懢1, 媨抧丂娪2 (1ME晹, 2怱憻寣娗奜): 戞46夞擔杮懱奜弞娐媄弍堛妛夛戝夛 (2021/10/16-17), 搶嫗 (僴僀僽儕僢僪奐嵜), 懱奜弞娐媄弍 2021/10; 48 (3): 180.
堛椕偺幙丒埨慡悇恑幒
姶愼娗棟幒
[妛弍榑暥]
120036. [尨挊] 杒棦戝妛昦堾偵偍偗傞僇儖僶儁僱儉懴惈挵撪嵶嬠栚嵶嬠偺専弌忬嫷偵偮偄偰偺扨巤愝屻曽帇揑尋媶. 擇杮桍怢1, 崅嶳梲巕2, 悾屗椙嫵1, 埨払丂忳3, 彫娧抭悽3, 嵅摗梙桽1, 曐嶁奊浠1, 媨嶈岻夘1, 嵅乆栘尠巕1, 崅栘桼旤巕1, 惎嶳棽峴4, 拞懞惓庽5, 椦丂揘斖6, 庪栰桳嶌6 (1姶愼娗棟幒, 2怴悽婭堛椕丒墶抐揑堛椕, 3椪専晹, 4銹尨昦丒姶愼撪, 5堛椕塹惗妛晹, 6椪専妛): 杒棦堛妛 2021/12; 51 (2): 83-94.
522599. [島嵗]亂Advanced & Focus摿廤: 怴宆僐儘僫僂僀儖僗傕尒摝偝側偄! 嶻壢仌NICU偺姶愼懳嶔 偁傞偁傞僠僃僢僋儕僗僩亃3. NICU偵偍偗傞姶愼懳嶔偺偁傞偁傞僠僃僢僋儕僗僩. 嶁栘惏悽1, 嵅乆栘尠巕2 (1崙嵺堛椕暉巸戝妛戝妛堾堛椕暉巸妛尋媶壢, 2姶愼娗棟幒): INFECTION CONTROL 2022/1; 31 (1): 77-81.
[妛夛丒尋媶夛摍]
722336. [妛夛 (慡崙)] (彽懸島墘摍) 埾堳夛婇夋乽(JHAIS埾堳夛) 偁偮傑傟丂僒乕儀僀儔儞僗偺怷乿. 怷寭孾懢1, 摗揷丂楏2, 嶁栘惏悽3, 嵅乆栘尠巕4, 愒栘恀帯5, 巐媨丂憦6, 孍揷巙曚7, 鉷抭崄巕8 (1嶳宍戝妛堛妛晹晅懏昦堾, 2崙嵺堛椕暉巸戝妛, 3崙嵺堛椕暉巸戝妛戝妛堾, 4姶愼娗棟幒, 5儅僣僟昦堾, 8枼柺巗棫昦堾, 7崙棫崙嵺堛椕尋媶僙儞僞乕, 9NTT搶擔杮娭搶昦堾): 戞36夞擔杮娐嫬姶愼妛夛憤夛丒妛弍廤夛 (2021/9/19), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723782. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞宱岥峈嬠栻偺巊梡検悇堏乣AMR懳嶔傾僋僔儑儞僾儔儞偺昡壙乣. 嵅摗圄桽1, 悾屗椙嫵1, 擇杮桍怢1, 惎嶳棽峴1,2, 崅嶳梲巕1,3, 岤揷岾堦榊4,5 (1姶愼娗棟幒, 2銹尨昦丒姶愼撪, 3怴悽婭堛椕丒墶抐揑堛椕, 4栻嵻晹, 5栻妛晹): 戞95夞擔杮姶愼徢妛夛妛弍島墘夛乛戞69夞擔杮壔妛椕朄妛夛憤夛崌摨妛夛 (2021/5/7-9), 墶昹 (僴僀僽儕僢僪奐嵜), 擔杮壔妛椕朄妛夛嶨帍 2021/4; 69 (Suppl): 297.
733282. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 杒棦戝妛昦堾偵偍偗傞宱岥峈嬠栻偺巊梡検悇堏偍傛傃揔惓壔偵岦偗偨夘擖岠壥偺専徹. 嵅摗圄桽1, 悾屗椙嫵1, 擇杮桍怢1, 惎嶳棽峴1,2, 崅嶳梲巕1,3, 岤揷岾堦榊4,5 (1姶愼娗棟幒, 2銹尨昦丒姶愼撪, 3怴悽婭堛椕丒墶抐揑堛椕, 4栻嵻晹, 5栻妛晹): 戞89夞恄撧愳導姶愼徢堛妛夛 (2022/1/22), Web奐嵜, 戞89夞恄撧愳導姶愼徢堛妛夛僾儘僌儔儉丒彺榐廤 2022/1; p.10.
恌椕忣曬娗棟幒
椪彴怱棟幒
[妛弍榑暥]
320033. [徢椺曬崘] 暋悢偺嫮敆揑側峴摦偵懳偡傞僔僃僀僺儞僌傪梡偄偨夘擖亅徢椺曬崘亅. 弿曽宑嶰榊1, 戧郪婤栴2, 撪揷杻堖2, 楅栘棿懢榊2, 嶳妏丂孿2, 戝愇丂抭2, 媨壀丂摍2 (1椪彴怱棟幒, 2惛恄): 惛恄壢帯椕妛 2021/8; 36 (8): 963-8.
僩乕僞儖僒億乕僩僙儞僞乕
堏怉堛椕巟墖幒
椪彴尋媶晹椪彴尋媶巟墖幒
[妛弍榑暥]
110456. [尨挊] Concentration-QTc analysis with two or more correlated baselines. Orihashi Y1, Kumagai Y2: J Pharmacokinet Pharmacodyn 2021/10; 48 (5): 615-22. (搉嫶丂桋1, 孎扟梇帯2: 1椪彴尋媶晹椪彴尋媶巟墖幒, 2椪彴尋媶丒僾儘僕僃僋僩)
僌儘乕僶儖椪彴尋媶巟墖僙儞僞乕